POINT_OF_CONTACT_ID|NCT_ID|NAME_OR_TITLE|ORGANIZATION|PHONE|EMAIL
34|NCT00048568|BMS Study Director|Bristol Myers-Squibb||clinical.trials@bms.com
35|NCT00048581|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
36|NCT00048724|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
37|NCT00048737|Issa Khouri, MD / Professor|UT MD Anderson Cancer Center||rvalverde@mdanderson.org
38|NCT00048893|Claude Sportes, M.D.|National Cancer Institute (NCI), National Institutes of Health (NIH)|301-435-5280|csportes@mail.nih.gov
39|NCT00048932|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
40|NCT00049036|Jeannette Lee|AIDS Malignancy Consortium|501-526-6712|jylee@uams.edu
41|NCT00049257|Dr. Fairooz Kabbinavar, Chief Medical Officer|Translational Oncology Research International|310 824 1934|FKabbina@mednet.ucla.edu
42|NCT00049517|Statistician|ECOG Statistical Office|617-632-3012|
43|NCT00049530|Study Statistician|ECOG Statistical Office|617-632-3012|
44|NCT00049842|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
45|NCT00050011|Study Director|Novartis Pharmaceuticals|862-778-8300|
46|NCT00050089|Dr. Sheldon Brown|VAMC Bronx|(718) 584-9000 ext 6666|sheldon.brown@va.gov
47|NCT00050167|Aman Buzdar, M.D./Professor|UT MD Anderson Cancer Center||agmadrig@mail.mdanderson.org
48|NCT00050778|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
49|NCT00050960|Eisai, Inc.|Eisai Call Center|888-422-4743|
50|NCT00050986|Mark Gilbert, MD|University of Texas, M. D. Anderson Cancer Center||CR_study_registration@mdanderson.org
51|NCT00051025|Eisai Inc|Eisai Call Center|888-422-4743|
52|NCT00051168|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
53|NCT00051558|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
54|NCT00051636|Study Director|Novartis|862-778-8300|
72|NCT00006184|Dr, Claude Sportes, M.D.|National Cancer Institute, National Institutes of Health|301-435-5280|csportes@mail.nih.gov
73|NCT00006237|SWOG Melanoma Statistician|SWOG statistical office|206-667-4408|
74|NCT00006305|Dr. Maria Brooks|University of Pittsburgh|4126241618|brooks@edc.pitt.edu
75|NCT00006392|Study Statistician|SWOG Statistical Center|2066674623|
76|NCT00006409|June Stevens|University of North Carolina - Chapel Hill|919-966-7218|june_stevens@unc.edu
77|NCT00006478|Bryan Ludwig, Regulatory Coordinator|University of Nebraska Medical Center Division of Oncology/Hematology|402-559-8071|bmludwig@unmc.edu
78|NCT00006721|Study Statistician|SWOG Statistical Center|206-667-4623|
79|NCT00006903|Melissa Leventhal|NRG Oncology, Statistics and Data Management Center, Buffalo Office|716-845-4030|mleventhal@gogstats.org
80|NCT00006916|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@acr.org
81|NCT00007644|Timothy Wilt, MD|Minneapolis VA Medical Center|612-467-2158|timothy.wilt@va.gov
82|NCT00008138|GYN Committee Statistician|SWOG Statistical Center|206-667-4623|
83|NCT00010257|Study Statistician|ECOG Statistical Office|617-632-3012|
84|NCT00010439|Deborah A Bowlby, M.D., Assistant Professor, Pediatric Endocrinology|Medical University of South Carolina|843-792-6807 ext NA|bowlbyd@musc.edu
85|NCT00010803|Steven T. DeKosky MD|University of Virginia|434-924-5118|SD3ZC@hscmail.mcc.virginia.edu
86|NCT00013611|Gary Collins, M.S.|University of Minnesota|612-626-9006|gary-c@ccbr.umn.edu
87|NCT00014560|Dr. Pamela Ely|Dartmouth Hitchcock|603-653-9071|
88|NCT00014911|Associate Director, Clinical Research Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
89|NCT00015457|Barbara I Karp, MD|National Institutes of Health|301-496-0150|karpb@ninds.nih.gov
90|NCT00015847|Dr. Brian Druker|OHSU Knight Cancer Institute|(503) 494 5596|drukerb@ohsu.edu
91|NCT00016354|Dr. Antonio Wolff|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|410-614-4192|awolff@jhmi.edu
92|NCT00017563|Tomasz Beer, M.D.|OHSU Knight Cancer Institute|503-494-1080|beert@ohsu.edu
93|NCT00019604|Caryn Steakley|National Cancer Institute, National Institutes of Health|301-435-3685|steaklec@mail.nih.gov
94|NCT00019747|Steven A. Rosenberg, M.D.|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
95|NCT00021229|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|Pediatric Brain Tumor Consortium|901-595-4986|james.boyett@stjude.org
96|NCT00021541|Brigitte Widemann, M.D.|National Institutes of Health, National Cancer Institute|301-496-7387|widemanb@mail.nih.gov
97|NCT00022490|Dr. Brian Druker|OHSU Knight Cancer Institute|(503) 494 5596|drukerb@ohsu.edu
98|NCT00022672|Medical Communications|Hoffman-LaRoche|800-821-8590|
99|NCT00023309|Marc G. Ghany, M.D|National Institute of Diabetes and Digestive and Kidney Diseases, NIH|3014961721|marcg@mail.nih.gov
100|NCT00023322|Theo Heller, M.D.|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|(301) 402-7147|Theoh@mail.nih.gov
101|NCT00023452|Dr Elsa Villarino|CDC|404-639-5340|mev1@cdc.gov
102|NCT00023673|Wendy Seiferheld|Radiation Therapy Oncology Group||wseiferheld@acr.org
103|NCT00023712|Melissa Leventhal|Gynecologic Oncology Group(GOG) Statistical and Data Center|716-845-4030|mleventhal@gogstats.org
104|NCT00023764|Dr. John Gerecitano|Memorial Sloan-Kettering Cancer Center|212-639-3748|gerecitj@mskcc.org
105|NCT00024102|Hyman Muss, MD|University of North Carolina||hyman.muss@gmail.com
106|NCT00025662|A. John Barrett|NHLBI|301-402-4170|barrettjj@mail.nih.gov
107|NCT00027378|Jack R. Cornelius, M.D., M.P.H.|University of Pittsburgh|412-246-5149|corneliusjr@upmc.edu
108|NCT00027560|Dr. Hugo Castro-Malaspina|Memorial Sloan-Kettering Cancer Center|212-639-8197|castro-h@mskcc.org
109|NCT00028002|Wendy Seiferheld|Radiation Therapy Oncology Group||wseiferheld@acr.org
110|NCT00028093|Combination of Pegylated Interferon and Ribavirin as Therapy for Patients With Chronic Hepatitis C W|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|3014961333|hoofnaglej@extra.niddk.nih.gov
111|NCT00028769|Study Statistician|SWOG Statistical Center|206-667-4623|
112|NCT00029107|Michael C Sneller, MD|NIAID/NIH|301-496-0491|msneller@niaid.nih.gov
113|NCT00029146|William J. Powers, MD|University of North Carolina at Chapel HIll||powersw@neurology.unc.edu
114|NCT00029172|Dr. Linda Williams|Roudebush VAMC Center of Excellence|317-988-3337|linda.williams6@va.gov
115|NCT00030901|Study Statistician|SWOG Statistical Center|206-667-4623|
116|NCT00030992|Tito Fojo, M.D.|National Cancer Institute, National Institutes of Health|301-496-2631|FojoT@mail.nih.gov
117|NCT00031447|Penelope M Jester|Collaborative Antiviral Study Group|205-934-2424|pjester@peds.uab.edu
1|NCT00040365|Kevin A. Camphausen|National Cancer Institute (NCI), National Institutes of Health (NIH)|301-496-5457|camphauk@mail.nih.gov
2|NCT00040664|GSK Response Center|GlaxoSmithKline|866-435-7343|
3|NCT00040937|Robert Z. Orlowski, MD,PhD|SWOG|(713) 792-2860|rorlowsk@mdanderson.org
4|NCT00041067|Study statistician|SWOG|206-667-4623|
5|NCT00041080|Melissa Leventhal|Gynecologic Oncology Group (GOG) Statistical and Data Center|716-845-4030|mleventhal@gogstats.org
6|NCT00041132|Study Statistician|SWOG Statistical Center|206-667-4623|
7|NCT00041392|Dr. Mark F. Newman|Duke University|919-681-6646|newma005@mc.duke.edu
8|NCT00041717|Andrew Blight, Ph.D. Chief Scientific Officer|Acorda Therapeutics, Inc.|914-347-4300 ext 5102|ablight@acorda.com
9|NCT00041756|Peter Thomas|Procter & Gamble|513.622.4838|thomas.pr@pg.com
10|NCT00041938|Dr. J.L.P. (Seamus) Thompson|Columbia University|212-342-1252|jlt12@columbia.edu
11|NCT00042432|Study Director|Amgen Inc.|866-572-6436|
12|NCT00042939|Study Statistician|ECOG Statistical Office|617-632-3012|
13|NCT00042991|Mehmet Kocak|Operations and Biostatistics Center for Pediatric Brain Tumor Consortium (PBTC)|9015952947|mehmet.kocak@stjude.org
14|NCT00043186|Study Director|Amgen Inc.|866-572-6436|
15|NCT00043979|Dr. Kristin Baird|National Cancer Institute, National Institutes of Health|301-451-0391|kbaird@mail.nih.gov
16|NCT00044005|Josephine Cucchiaro, PhD|Sunovion|201-592-2050|josepine.cucchiaro@sunovion.com
17|NCT00044044|Josephine Cucchiaro, Executive Director|Sunovion|201-592-2050|josephine.cucchiaro@sunovion.com
18|NCT00044213|Gervasio A. Lamas, M.D.|Mount Sinai Medical Center|305-674-2162|Gervasio.Lamas@msmc.com
19|NCT00044512|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
20|NCT00044655|Nancy H. Covell, Ph.D.|NYSPI|6469450227|covelln@nyspi.columbia.edu
21|NCT00045162|Lung Committee Statistician|SWOG Statistical Center|206-667-4623|
22|NCT00045487|Alain Mita, MD|University of Texas Health Science Center San Antonio|210-450-5094|goodwine@uthscsa.edu
23|NCT00045630|Study Statistician|SWOG Statistical Center|206-667-4623|
24|NCT00046228|Executive Director Clinical Research|Centocor Inc.|1-800-972-9063 ext 6171|EBarnath@ITS.JNJ.COM
25|NCT00046839|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@acr.org
26|NCT00046930|Study Statistician|ECOG Statistical Office|617-632-3012|
27|NCT00047008|Wendy Seiferheld|NRG Oncology||SeiferheldW@nrgoncology.org
28|NCT00047320|Results Reporting Coordinator|Children's Oncology Group|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org
29|NCT00047385|Christine D. Berg, M.D.|Early Detection Research Group, NCI, NIH|301-496-8544|bergc@mail.nih.gov
30|NCT00047463|Beth Malow/Principal Investigator|Vanderbilt University|615-322-0283|beth.malow@vanderbilt.edu
31|NCT00047879|Howard A. Fine, M.D.|National Cancer Institute, National Institutes of Health|301-402-6383|hfine@mail.nih.gov
32|NCT00048347|Peter Mannon, MD|NIAID|205-934-4726|pmannon@uab.edu
33|NCT00048542|Global Medical Services|Abbott|800-633-9110|
186|NCT00069160|Susan E. Bates, M.D.|National Cancer Institute, National Institutes of Health|301-402-1357|BatesS@mail.nih.gov
187|NCT00069264|Dr. Peter Tarassoff|Eisai Inc.|888-422--4743|
188|NCT00069277|Eisai Call Center|Eisai Inc|888-422-4743|
189|NCT00069784|Trial Transparency Team|sanofi||Contact_US@sanofi.com
190|NCT00069823|Ellen Brown|Johns Hopkins University|443-287-3170|ala-acrc@jhsph.edu
191|NCT00070018|Study Statistician|SWOG Statistical Center|206-667-4623|
192|NCT00070109|Results Reporting Coordinator|Children's Oncology Group|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org
193|NCT00070291|Study Statistician|ECOG Statistical Office|617-632-3012|
194|NCT00070499|SWOG Leukemia Statistician|SWOG Statistical Office|206-667-4408|
195|NCT00071006|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
196|NCT00071032|Jeffrey L Carson, MD|Rutgers Robert Wood Johnsom Medical School|732-235-7122|Jeffrey.Carson@rutgers.edu
197|NCT00071058|Antonio Fojo, M.D.|National Cancer Institute, National Institutes of Health|301-496-2631|FojoT@mail.nih.gov
198|NCT00071110|Benoit H. Mulsant, MD|University of Pittsburgh|(416) 535-8501 ext 3655|benoit_mulsant@camh.net
199|NCT00071396|Alessandra Ferrajoli, MD, BS / Assistant Professor|The University of Texas M. D. Anderson Cancer Center|713-745-4613|eharriso@mdanderson.org
200|NCT00071487|GSK Response Center|GlaxoSmithKline|866-435-7343|
201|NCT00071721|Paul Aisen|Alzheimer's Disease Cooperative Study|858-622-2028|paisen@ucsd.edu
202|NCT00071760|GSK Response Center|ViiV Healthcare|866-435-7343|
203|NCT00071799|CL Beach|Celgene Corporation||CLBeach@celgene.com
204|NCT00071812|GSK Response Center|GlaxoSmithKline|866-435-7343|
205|NCT00071890|Pr G. Chene|INSERM U897 Bordeaux FRANCE|557571392 ext +33|genevieve.chene@isped.u-bordeaux2.fr
206|NCT00071981|Study Statistician|Eastern Cooperative Oncology Group (ECOG) Statistical Office|617-632-3012|
207|NCT00072280|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
208|NCT00072449|Dr. Stuart A Grossman|Johns Hopkins University|410-955-3657|jfisher@jhmi.edu
209|NCT00072475|Pankaj Gupta, M.D.|University of Minnesota||gupta013@umn.edu
210|NCT00073008|GSK Response Center|GlaxoSmithKline|866-435-7343|
211|NCT00073021|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
212|NCT00073307|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
213|NCT00073333|Deborah C. Beidel, Ph.D.|University of Central Florida|407-823-3254|deborah.beidel@ucf.edu
214|NCT00073528|GSK Response Center|GlaxoSmithKline|866-435-7343|
215|NCT00073983|SARC Chief Operating Officer|SARC|734-930-7600|sarc@sarctrials.org
216|NCT00074165|Dr. Edward Neuwelt|OHSU Knight Cancer Institute|503-494-5626|neuwelte@ohsu.edu
217|NCT00074412|Statistical Research Associate|Statistical Center for HIV/AIDS Research and Prevention|2066677524|cherron@fhcrc.org
218|NCT00074815|Jeffrey Sapyta, PhD|Duke University School of Medicine|919-668-0069|jeffrey.sapyta@duke.edu
219|NCT00074958|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
220|NCT00074984|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
221|NCT00075088|Barbara J Drew, PhD|University of California, San Francisco|415-476-4302|barbara.drew@nursing.ucsf.edu
222|NCT00075218|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
223|NCT00075270|GSK Response Center|GlaxoSmithKline|866-435-7343|
224|NCT00075478|Dr. Brenda Sandmaier|Fred Hutchinson Cancer Research Center/|206-667-4961|bsandmai@fhcrc.org
225|NCT00075582|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
245|NCT00078312|Sponsor's Medical Director, Clinical Research|Cephalon|1-877-237-4879|
246|NCT00078325|Sponsor's Medical Director, Clinical Research|Cephalon|1-877-237-4879|
247|NCT00078377|Sponsor's Medical Director, Clinical Research|Cephalon, Inc.|1-877-237-4879|
248|NCT00078403|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School||sdac.ct.gov@sdac.harvard.edu
249|NCT00053417|Andrew Blight, PhD|Acorda Therapeutics|914-347-4300 ext 102|ablight@acorda.com
250|NCT00053482|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
251|NCT00053495|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
252|NCT00053703|Linmarie Sikich, MD|UNC Chapel Hill|919-972-9744|lsikich@med.unc.edu
253|NCT00054275|Paula Silverman, MD|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|216-844-3951|paula.silverman@uhhospitals.org
254|NCT00000371|Dr. Donald Goff|Freedom Clinic Trail, Massachusetts General Hospital|617-921-7899|goff@psych.mgh.harvard.edu
277|NCT00003869|Dr. Edith A. Perez|Mayo Clinic||perez.edith@mayo.edu
278|NCT00003896|Gynecologic Committee Statistician|SWOG Statistical Center|206-667-4623|
279|NCT00003907|Study Statistician|ECOG Statistical Office|617-632-3012|
280|NCT00003910|Study Statistician|ECOG Statistical Office|617-632-3012|
281|NCT00004143|Mitchell Horwitz, MD|Duke University Medical Center|919-668-1045|Mitchell.Horwitz@duke.edu
282|NCT00004228|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
283|NCT00004500|Dr. Robert Segal|Discovery Laboratories, Inc.|215-488-9300|rsegal@discoverylabs.com
284|NCT00004547|Marybeth S. Hughes, M.D.|National Cancer Institute, National Institutes of Health|301-594-9341|hughesm@mail.nih.gov
285|NCT00004562|Judith S. Hochman, M.D.|New York University School of Medicine|212-263-6927|judith.hochman@nyumc.org
286|NCT00004635|William  L. Dahut, M.D.|National Cancer Institute, National Institutes of Health|301-435-8183|dahutw@mail.nih.gov
287|NCT00004732|Thomas G. Brott, MD - Principal Investigator|Mayo Clinic|904-953-0556|Brott.thomas@mayo.edu
288|NCT00089895|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
289|NCT00089999|GSK Response Center|GlaxoSmithKline|866-435-7343|
290|NCT00090051|Medical Communications|Hoffmann-La Roche||global.clinical_trial_registry@roche.com
291|NCT00090103|GSK Response Center|GlaxoSmithKline|866-435-7343|
292|NCT00090142|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
293|NCT00090220|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
294|NCT00090233|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
295|NCT00090259|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
296|NCT00090285|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
297|NCT00090363|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
298|NCT00090402|Lynne Shinto, ND, MPH|Oregon Health & Science University|503-494-5035|shintol@ohsu.edu
299|NCT00090493|Frits van Rhee, MD, PhD|University of Arkansas for Medical Sciences - MIRT|(501) 686-8230|vanrheefrits@uams.edu
255|NCT00000479|Julie E. Buring|Brigham and Women's Hospital|617 732 4965|jburing@rics.bwh.harvard.edu
256|NCT00000575|Alice Sternberg|Johns Hopkins Bloomberg School of Public Health, Dept of Epidemiology|410-955-3752|asternbe@jhsph.edu
257|NCT00000620|Tim Craven / Senior Biostatistician|Wake Forest School of Medicine|336-716-6109|tcraven@wakehealth.edu
258|NCT00001151|Stephen J. Marx, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|NIH|3014965051|marxs@mail.nih.gov
259|NCT00001213|Rachel J. Bishop, MD, Principal Investigator, National Eye Institute|National Institutes of Health|301-402-3771|bishopra@nei.nih.gov
260|NCT00001566|Crystal Mackall, M.D.|National Cancer Institute (NCI), National Institutes of Health (NIH)|301-402-5940|mackallc@mail.nih.gov
261|NCT00001586|Wyndham H. Wilson, M.D.|National Cancer Institute, National Institutes of Health|301-435-2415|wilsonw@mail.nih.gov
262|NCT00001596|Dr. William A. Gahl|National Human Genome Research Institute|301-402-2739|gahlw@mail.nih.gov
263|NCT00001656|Judith L. Rapoport, M.D.|National Institute of Mental Health|301-496-6080|rapoporj@mail.nih.gov
264|NCT00001703|Samir N. Khleif, M.D.|National Cancer Institute, National Institutes of Health|301-496-0901|khleifs@mail.nih.gov
265|NCT00001723|Jack A. Yanovski, MD, PhD, Chief SGO, PDEGEN|National Institute of Child Health and Human Development, NIH|301-496-4686|yanovskj@mail.nih.gov
266|NCT00001832|Steven A. Rosenberg, M.D.|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
267|NCT00001941|Thomas Waldmann, M.D.|National Cancer Institute, National Institues of Health|301-496-6653|tawald@mail.nih.gov
268|NCT00001959|Jeffrey B Kopp, MD|NIDDK, NIH|3015943403|jbkopp@nih.gov
269|NCT00001984|Dr. Alan Kirk|NIDDK, NIH|NA|allank@intra.niddk.nih.gov
270|NCT00002540|Paul F. Pinsky, Ph.D.|Early Detection Research Group, NCI, NIH|301-496-8544|pinskyp@mail.nih.gov
271|NCT00002975|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
272|NCT00003138|Study Statistician|ECOG Statistical Office|617-632-3012|
273|NCT00003377|Melissa Leventhal|Gynecologic Oncology Group Statistical & Data Center|(716)845-5702|mleventhal@gogstats.org
274|NCT00003590|Study Statistician|SWOG Statistical Center|(206)667-4623|
275|NCT00003659|Dr. David Scheinberg|Memorial-Sloan Kettering Cancer Center|646-888-2190|scheinbd@mskcc.org
276|NCT00003782|Director, Division of Regulatory Affairs|NSABP Foundation, Inc.|412-330-4600|
163|NCT00065156|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
164|NCT00065429|CMO, ImmunoGen|ImmunoGen, Inc|781-895-0600|clinicaltrials@immunogen.com
165|NCT00065442|Kathleen Picha|Dendreon Corporation|206-274-6762|kpicha@dendreon.com
226|NCT00075881|Study Statistician|Eastern Cooperative Oncology Group (ECOG) Statistical Office|617-632-3012|
227|NCT00076011|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
228|NCT00076024|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
229|NCT00076102|Brigitte C. Widemann, M.D.|National Cancer Institute (NCI), National Institutes of Health (NIH)|301-496-7387|widemanb@mail.nih.gov
230|NCT00076219|Paul M. Palevsky MD|VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA|410-360-3932|paul.palevsky@va.gov
231|NCT00076245|Kelly J. Rohan, Ph.D.|Department of Psychology, University of Vermont|802-656-0798|kelly.rohan@uvm.edu
232|NCT00076336|Study Director|Novartis Pharmaceuticals|862-778-8300|
233|NCT00076570|Dr. Monique Cho|NIDDK, National Institutes of Health|3014355058|moniquec@intra.niddk.nih.gov
234|NCT00076687|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
235|NCT00076752|Dr. Steven Pavletic|National Cancer Institute, National Institutes of Health|301-402-4899|pavletis@mail.nih.gov
236|NCT00076804|Richard E. Chaisson|Johns Hopkins University Center for TB Research|4109551755|rchaiss@jhmi.edu
237|NCT00076999|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
238|NCT00077207|Results Reporting Coordinator|Children's Oncology Group|352-273-0567|Resultsreportingcoordinator@childrensoncologygroup.org
239|NCT00077376|Study Statistician|ECOG Statistical Office|617-632-3012|
240|NCT00077675|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|Theravance, Inc|650-808-6132|sbarriere@theravance.com
241|NCT00077857|Medical Communications|Hoffman-LaRoche|800-821-8590|
242|NCT00077922|Robert J. Kreitman, M.D.|National Cancer Institute, National Institutes of Health|301-496-6947|kreitmar@mail.nih.gov
243|NCT00077974|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
244|NCT00078286|Dr. Ranga Krishnan|Duke University|919-668-3647|krish001@mc.duke.edu
55|NCT00052962|Marybeth Hughes, M.D.|National Cancer Institute, National Institutes of Health|301-594-9341|hughesm@mail.nih.gov
56|NCT00053014|SWOG leukemia statistician|SWOG statistical office|206-667-4408|
57|NCT00053365|Melissa Leventhal|Gynecologic Oncology Group|716-845-4030|mleventhal@gogstats.org
58|NCT00004859|Study Statistician|Eastern Cooperative Oncology Group (ECOG) Statistical Office|617-632-3012|
59|NCT00004888|Study Statistician|Eastern Cooperative Oncology Group Statistical Office|617-632-3012|
60|NCT00004978|James Neaton, PhD|Division of Biostatistics, University of Minnesota|612-626-9040|jim@ccbr.umn.edu
61|NCT00004980|Ralph Hoffman|Yale University School of Medicine|203-688-9734|ralph.hoffman@yale.edu
62|NCT00005669|Jack A. Yanovski, MD, PhD, Chief, Unit on Growth and Obesity|National Institute of Child Health and Human Development, NIH|301-496-0858|yanovskj@mail.nih.gov
63|NCT00005906|Joel Moss|TMB/NHLBI|301-496-1597|mossj@nhlbi.nih.gov
64|NCT00005908|JoAnne Zujewski, M.D.|National Cancer Institute, National Institutes of Health|301-435-9207|zujewskij@mail.nih.gov
65|NCT00005947|Kathleen Picha|Dendreon Corporation|206-274-6762|kpicha@dendreon.com
66|NCT00006011|Jessalyn Reboy|NRG Oncology Statistic and Data Management Center, Buffalo Office|716-845-7738|ReboyJ@nrgoncology.org
67|NCT00006151|Peter Gariti|University of Pennsylvania||gar1iti@mail.med.upenn.edu
68|NCT00006156|Nelson, Lawrence Merle|National Institute of Child Health and Human Development|+1 301 402 6608|nelsonl@mail.nih.gov
69|NCT00006164|James E. Everhart, MD, MPH, Project Officer|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|301-594-8878|EverhartJ@extra.niddk.nih.gov
70|NCT00006170|Dr. Michele Levine|University of Pittsburgh|412-647-0703|levinem@upmc.edu
71|NCT00006178|Dr. Allan D. Kirk|National Institutes of Health|N/A|allank@intra.niddk.nih.gov
141|NCT00061945|Wendy Stock, M.D.|University of Chicago Medical Center||wstock@medicin.bsd.uchicago.edu
142|NCT00062010|Study Statistician|ECOG Statistical Office|617-632-3012|
143|NCT00062439|Lung Committee Statistician|SWOG Statistical Center|206-667-4623|
144|NCT00062647|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|Theravance, Inc|650-808-6132|sbarriere@theravance.com
145|NCT00062738|Matthew Menza, MD|UMDNJ - RWJMS|732-235-4440|menza@umdnj.edu
146|NCT00062751|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
147|NCT00062764|Jay H. Hoofnagle, MD|National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health|3014961333|hoofnaglej@extra.niddk.nih.gov
148|NCT00063232|Jay Hoofnagle, M.D.|National Institute of Diabetes and Digestive and Kidney Diseases|3014961333|hoofnaglej@extra.niddk.nih.gov
149|NCT00063258|Mellanie Price, B.S.|University of Texas M.D. Anderson Cancer Center|713-792-4392|mejprice@mdanderson.org
150|NCT00063362|Dr. Keming Gao|University Hospitals Case Medical Center|216-844-2865|keming.gao@UHhospitals.org
151|NCT00063570|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
152|NCT00063622|Arun J. Sanyal|Virginia Commonwealth University||asanyal@mcvh-vcu.edu
153|NCT00063635|Joel E. Lavine, MD, PhD|Columbia University Medical Center||jl3553@columbia.edu
154|NCT00063934|Francisco Esteva, MD, PHD / Professor|UTMDACC|713-792-2817|nsyates@mdanderson.org
155|NCT00063986|Study Statistician|ECOG Statistical Office|617-632-3012|
156|NCT00064025|Jessalyn Reboy|Gynecologic Oncology Group Statistical and Data Center|716-845-7738|reboyj@norgoncology.org
157|NCT00064038|Robert Z. Orlowski, MD, PhD|SWOG|(713) 792-2860|rorlowsk@mdanderson.org
158|NCT00064350|Study Statistician|Eastern Cooperative Oncology Group (ECOG) Statistical Office|617-632-3012|
159|NCT00064662|Anne M. Stoddard, ScD|New England Research Institutes|617-972-3331|astoddard@neriscience.com
160|NCT00064701|Vice President, Therapeutic Area Head, Transplantation|Astellas Pharma Global Development, Inc.||ClinicalTrials.Disclosure@us.astellas.com
161|NCT00064792|Dr. Forbes Porter, Clinical Director, NICHD|NICHD, NIH|301-435-4432|fdporter@mail.nih.gov
162|NCT00064844|Ned Cooney, PhD|Yale University School of Medicine|860-594-6339|ned.cooney@yale.edu
361|NCT00094172|Associate Director, Clinical Research Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
362|NCT00094328|Gerard Lynch|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
363|NCT00094458|Study Director|Centocor Ortho Biotech Services, L.L.C.|215 325-7405|
364|NCT00094575|Dr. Frank A. Lederle|VAMC Minneapolis, MN|612-725-2158|Frank.Lederle@va.gov
365|NCT00094653|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
366|NCT00094757|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
367|NCT00094770|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
368|NCT00094809|Study Director|Amgen Inc.|866-572-6436|
369|NCT00094835|Study Director|Amgen Inc.|866-572-6436|
370|NCT00094861|Hans Olivecrona, MD PhD|Biovitrum|+46 8 697 20 00|hans.olivecrona@sobi.com
371|NCT00094887|James Baldassare, MD|INO Therapeutics LLC|908-238-6603|james.baldassare@ikaria.com
372|NCT00094900|Raphaela Goldbach-Mansky, MD|National Inst of Arthritis and Musculoskeletal and Skin Diseases|13014356243|goldbacr@mail.nih.gov
373|NCT00095056|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
374|NCT00095121|John Flaherty, PharmD, Director, Clinical Research|Gilead Sciences|650-522-5592|John.Flaherty@gilead.com
375|NCT00095147|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
376|NCT00095199|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
377|NCT00095212|Steven Grinspoon, MD|Massachusetts General Hospital|617 724 9109|sgrinspoon@partners.org
378|NCT00095238|BMS Study Director|Britol-Myers Squibb||Clinical.Trials@bms.com
379|NCT00095498|Study Director|Amgen Inc.|866-572-6436|
380|NCT00095576|Vice President, Late Stage Development Group Leader|Merck, Sharp & Dohme||ClinicalTrialsDisclosure@merck.com
381|NCT00095875|Robert I Haddad, MD|Dana Farber Cancer Institute|617-632-3090|rihaddad@partners.org
382|NCT00095940|Assistant Director Operations and Biostatistics Center|Pediatric Brain Tumor Consortium|901-595-2617|dana.wallace@stjude.org
383|NCT00096018|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
384|NCT00096031|Study Statistician|SWOG Statistical Center|206-667-4623|
385|NCT00096122|Jorge Cortes, MD / Professor|UT MD Anderson Cancer Center|713-745-5783|eharrison@mdanderson.org
386|NCT00096174|Study Statistician|Eastern Cooperative Oncology Group (ECOG) Statistical Office|617-632-3012|
387|NCT00096200|Steven Waggoner, MD|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|216-844-5011|steven.waggoner@uhhospitals.org
388|NCT00096226|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@acr.org
389|NCT00096265|Wendy Seiferheld|Radiation Therapy Oncology Group||wseiferheld@acr.org
390|NCT00096278|Director, Division of Regulatory Affairs|NSABP Foundation, Inc.|412-330-4600|
391|NCT00096382|Steven A. Rosenberg, M.D.|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
392|NCT00096460|Steve Wease|The EMMES Corporation||swease@emmes.com
393|NCT00096681|Prof LG Bekker|Desmond Tutu HIV Centre|+2721 633 6599 ext 21|Linda-Gail.Bekker@hiv-research.org.za
394|NCT00096785|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
395|NCT00096954|Medical Communications|Hoffman-LaRoche|800-821-8590|
396|NCT00097253|Janice K. Kiecolt-Glaser, PhD|The Ohio State University, Department of Psychiatry|614-292-0033|Kiecolt-Glaser.1@osu.edu
397|NCT00097448|Dr. Steven Rauch|Massachusetts Eye and Ear Infirmary|617-573-1166|steven_rauch@meei.harvard.edu
398|NCT00097500|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
399|NCT00097591|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
400|NCT00097695|Alan Kimura, MD, PhD|Shire Human Genetic Therapies, Inc.|781-482-0738|akimura@shire.com
401|NCT00097721|Eisai Call Center|Eisai Inc|888-422-4743|
402|NCT00097773|Bonnie Ramsey, MD|Seattle Childrens Hospital|206-987-5725|bonnie.ramsey@seattlechildrens.org
403|NCT00097786|Study Director|Novartis Pharmaceuticals|862 778-8300|
404|NCT00097981|Medical Director|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|1 215 325-5329|
405|NCT00098059|Study Director|Novartis Pharmaceuticals|862-778-8300|
406|NCT00098254|Giuseppe Giaccone, M.D., PH.D.|National Cancer Institute|301-496-4916|giacconeg@mail.nih.gov
407|NCT00098293|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
408|NCT00098306|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
409|NCT00098345|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
410|NCT00098475|Study Statistician|ECOG Statistical Office|617-632-3012|
411|NCT00098670|Dr. Thomas Lin|The Ohio State University||thomas.lin@osumc.edu
412|NCT00098722|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
436|NCT00101452|Maurizio Fava|Massachusetts General Hospital|617-724-2513|mfava@partners.org
437|NCT00101582|Hans Olivecrona, MD PhD|Biovitrum|+46 8 697 20 00|hans.olivecrona@sobi.com
438|NCT00101647|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
439|NCT00078559|Arjang Djamali, MD, MS, FASN|University of Wisconsin - Department of Medicine, Madison, Wisconsin|608-262-7330|axd@medicine.wisc.edu
440|NCT00078715|Dr. Carlos A. Zarate, Jr.|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|301-451-0861|zaratec@mail.nih.gov
441|NCT00078728|Golda Ginsburg, PhD,Professor|The Johns Hopkins University School of Medicine|410-955-1544|gginnsbu@jhmi.edu
442|NCT00079040|Study Statistician|ECOG Statistical Office|617-632-3012|
443|NCT00079326|Craig Bunnell|Dana-Farber Cancer Institute|617-632-3800|cbunnell@partners.org
444|NCT00079339|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|Pediatric Brain Tumor Consortium|901-595-4986|james.boyett@stjude.org
445|NCT00079391|Minocher Battiwalla|NIH National Heart, Lung and Blood Institute|301-402-4170|battiwalla@nhlbi.nih.gov
446|NCT00079417|Results Reporting Coordinator|Children's Oncology Group|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org
447|NCT00079677|Sponsor's Medical Director, Clinical Research|Cephalon|1-877-237-4879|
448|NCT00079781|Dr. Martha Morrell, Chief Medical Officer|NeuroPace, Inc.|650-237-2776|mmorrell@neuropace.com
449|NCT00079937|Study Director|Novartis Pharmaceuticals|862-778-8300|
450|NCT00080119|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
451|NCT00080288|Sponsor's Medical Director, Clinical Research|Cephalon|1-877-237-4879|
452|NCT00080301|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
453|NCT00080470|Director of Clinical Operations|Boston Scientific|866-360-4747|Valerie.Lucero-Cimmarust@bsci.com
454|NCT00080483|Peter J. Snyder M.D.|University of Pennsylvania|215-898-0208|pjs@mail.med.upenn.edu
455|NCT00080535|Robert J. Kreitman, M.D.|National Cancer Institute, National Institutes of Health|301-496-6947|kreitmar@mail.nih.gov
456|NCT00080938|Study Statistician|Eastern Cooperative Oncology Group (ECOG) Statistical Office|617-632-3012|
457|NCT00081289|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@acr.org
458|NCT00081458|Head of Clinical Research|NPS Pharmaceuticals|908-450-5300|info@npsp.com
413|NCT00098748|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
414|NCT00098774|James Rubenstein, MD, PhD|University of California, San Francisco||jamesr@medicine.ucsf.edu
415|NCT00098787|Study Statistician|Eastern Cooperative Oncology Group (ECOG) Statistical Office|617-632-3012|
416|NCT00098813|Dr. David Pfister|Memorial Sloan-Kettering Cancer Center|646-888-4237|pfisterd@mskcc.org
166|NCT00065468|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
167|NCT00065507|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
168|NCT00065611|Jeffrey B Kopp, MD|NIDDK, NIH|3015943403|jbkopp@nih.gov
169|NCT00065806|Laura Schanberg, MD|Duke University Medical Center|919-684-6575|laura.schanberg@duke.edu
170|NCT00066066|Ricardo P Teles, DDS, DMSc|The Forsyth Institute|617 892-8556|rteles@forsyth.org
171|NCT00066170|Grace Wang, MD Director of Clinical Development & Medical Monitor|Jazz Pharmaceuticals, Inc|650-496-3777|
172|NCT00066469|Results Reporting Coordinator|Children's Oncology Group|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org
173|NCT00066573|Dr. Wendy Parulekar|NCIC Clinical Trials Group|1-613-533-6430|wparulekar@ctg.queensu.ca
174|NCT00066742|Lung Committee Statistician|SWOG Statistical Center|206-652-2267|
175|NCT00066963|Stuart Gansky|Professor, S/D- PREV/REST|415-502-8094|stuart.gansky@ucsf.edu
176|NCT00067236|Peter Thomas|Procter & Gamble|513.622.4838|thomas.pr@pg.com
177|NCT00067470|Medical Information Services|BioMarin Pharmaceutical Inc.|800-983-4587|medinfo@bmrn.com
178|NCT00067808|Hagop Kantarjian, MD / Professor|The University of Texas M. D. Anderson Cancer Center|713-792-7026|
179|NCT00068237|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@acr.org
180|NCT00068380|DCC Project Administrator|California Cancer Consortium|626-256-4673 ext 60094|CCCP@coh.org
181|NCT00068393|Study Statistician|ECOG Statistical Office|617-632-3012|
182|NCT00068419|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
183|NCT00068575|Peter Pisters, MD / Professor|UT MD Anderson Cancer Center||asanmigu@mdanderson.org
184|NCT00068822|David F. Kallmes, M.D.|Mayo Clinic|507-266-3350|kallmes.david@mayo.edu
185|NCT00069121|Medical Communications|Hoffman-LaRoche|800-821-8590|
118|NCT00031460|Penelope M. Jester|Collaborative Antiviral Study Group|(205) 934-2424|pjester@peds.uab.edu
119|NCT00031486|Penny Jester|University of Alabama at Birmingham|(877) 975-7280|pjester@peds.uab.edu
120|NCT00032487|Project Manager|Hines CSPCC|708-202-5785|tamara.paine@va.gov
121|NCT00032591|Bob Edson|Palo Alto CSPCC|(650) 493-5000 ext 22250|Bob.Edson@va.gov
122|NCT00032630|Frederick Grover, MD|VA Medical Center, Denver, Colorado|303-393-2863|Frederick.Grover@ucdenver.edu
123|NCT00033540|Study Statistician|Southwest Oncology Group (SWOG) Statistical Center|206-667-4623|
124|NCT00033657|Study Statistician|Eastern Cooperative Oncology Group (ECOG) Statistical Office|617-632-3012|
125|NCT00033917|Dr. Laura Ment|Yale University School of Medicine|203-785-5708|laura.ment@yale.edu
126|NCT00035555|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
127|NCT00035815|Eric J. Sorenson, MD|Mayo Clinic|507 538-1037|sorenson.eric@mayo.edu
128|NCT00035932|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
129|NCT00036270|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
130|NCT00036569|Kathy Warren, M.D.|National Cancer Institute|301-435-4683|warrenk@mail.nih.gov
131|NCT00037830|Dr. Jay Schneider|Thomas Jefferson University|215-503-0370|jay.schneider@jefferson.edu
132|NCT00038103|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
133|NCT00038467|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
134|NCT00038857|Dr. Richard E. Champlin|MDAnderson Cancer Center|713-792-8750|celsaenz@mdanderson.org
135|NCT00038948|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
136|NCT00039377|Meir Wetzler, M.D.|Roswell Park Cancer Institute||meir.wetzler@roswellpark.org
137|NCT00039741|ClinicalTrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
138|NCT00039871|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
139|NCT00061633|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|Theravance, Inc|650-808-6132|sbarriere@theravance.com
140|NCT00061893|Results Reporting Coordinator|Children's Oncology Group||resultsreportingcoordinator@childrensoncologygroup.org
345|NCT00059215|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
346|NCT00059475|Steven A. Rosenberg, M.D.|National Cancer Institute, National Institutes of Health|301-496-6375|nciirbadmin@mail.nih.gov
347|NCT00059839|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
348|NCT00060008|Dr. Michael Fisher|Children's Hospital of Philadelphia|215 590 2800|fisherm@email.chop.edu
349|NCT00060346|Study Statistician|ECOG Statistical Office|617-632-3012|
350|NCT00060528|James L. Gulley, M.D.|National Cancer Instititute (NCI), National Institutes of Health (NIH)|301-435-2956|gulleyj@mail.nih.gov
351|NCT00060840|James Baldassarre, MD|INO Therapeutics|908-238-6363|james.baldassarre@ikaria.com
352|NCT00060944|Senior Director|Janssen R&D US||ClinicalTrialDisclosure@its.jnj.com
353|NCT00061048|Thomas A. Waldmann, M.D.|National Cancer Institute, National Institutes of Health|301-496-6653|Thomas.Waldmann2@nih.gov
354|NCT00061373|Steven Warach, MD, PhD; Principal Investigator|NIH/NINDS and University of Texas Southwestern, Clinical Research Institute of Austin|512-324-8383|swarach@seton.org
355|NCT00093145|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
356|NCT00093379|Cathy Eng, MD/ Professor|The University of Texas (UT) MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
357|NCT00093496|Charles Erlichman, M.D.|Mayo Clinic Cancer Center||erlichman.charles@mayo.edu
358|NCT00094055|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
359|NCT00094094|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
360|NCT00094107|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
320|NCT00092495|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
321|NCT00054327|Kenneth Cooke MD|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|216-844-3345|kenneth.cooke@uhhospitals.org
322|NCT00054639|Anas Younes, MD / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
323|NCT00054665|Wyndham Wilson, M.D.|National Cancer Institute, National Institues of Health|301-435-2415|wilsonw@mail.nih.gov
324|NCT00054717|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
325|NCT00054847|Steven Goldman, MD|Southern Arizona VA Health Care System|(520) 792-1450 ext 4624|Steven.Goldman@va.gov
326|NCT00055237|Robert Yarchoan, M.D.|National Cancer Institute, National Institutes of Health|301-496-0328|Robert.Yarchoan@nih.gov
327|NCT00055471|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
328|NCT00055497|Global Medical Services|Abbott|800-633-9110|
329|NCT00056160|Robert Knight, M.D.|Celgene Corporation|908-673-9749|rknight@celgene.com
330|NCT00056316|Ann M. Steffen, PhD, Associate Professor|University of Missouri-St. Louis|314-516-5382|ann_steffen@umsl.edu
331|NCT00056407|GSK Response Center|GlaxoSmithKline|866-435-7343|
332|NCT00056472|Barnett S. Meyers, MD|Weill Cornell Medical College|914-997-5721|bmeyers@med.cornell.edu
333|NCT00056498|Robert W. Buchanan, MD|Maryland Psychiatric Research Center|410-402-7876|rwbuchanan@mprc.umaryland.edu
334|NCT00056550|Denise Tilton, RN, MHA, Director Clinical Development|GTC Biotherapeutics|508-370-5257|denise.tilton@gtc-bio.com
335|NCT00056563|Frances M. Weaver, Ph.D, Study Investigator|Center for Management of Complex Chronic Care|(708) 202-2414|Frances.Weaver@va.gov
336|NCT00056862|Jay H. Hoofnagle, M.D.|National Institute of Diabetes and Digestive and Kidney Diseases|3014961333|hoofnaglej@extra.niddk.nih.gov
337|NCT00057330|GSK Response Center|GlaxoSmithKline|866-435-7343|
338|NCT00057681|Barbara Geller, M.D.|Washington University in St. Louis|314-747-3657|gellerb@wustl.edu
339|NCT00057811|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
340|NCT00057837|Study Statistician|ECOG Statistical Office|617-632-3012|
341|NCT00057876|Study Statistician|Eastern Cooperative Oncology Group (ECOG) Statistical Office|617-632-3012|
342|NCT00057941|Study Statistician|Eastern Cooperative Oncology Group (ECOG) Statistical Office|617-632-3012|
343|NCT00057954|Study Statistician|ECOG Statistical Office|617-632-3012|
344|NCT00058019|Dr. Sonali M. Smith|University of Chicago Medical Center|773-834-2895|smsmith@medicine.bsd.uchicago.edu
482|NCT00084136|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
483|NCT00084266|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
484|NCT00084383|Dr. Daniel Laheru|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|410-955-8974|laherda@jhmi.edu
485|NCT00084409|Robert Keith, M.D.|University of Colorado Denver|303-399-8020 ext 3182|robert.keith@ucdenver.edu
486|NCT00084487|Afshin Dowlati MD|Case Comprehensive Cancer Center|216-844-1228|afshin.dowlati@uhhospitals.org
487|NCT00085098|Results Coordinator|Children's Oncology Group|(626) 447-0064|resultsreportingcoordinator@childrensoncologygroup.org
488|NCT00085202|Amar Gajjar, MD|St. Jude Children's Research Hospital|866-278-5833|info@stjude.org
489|NCT00085293|Steven I. Sherman, MD / Professor|University of Texas MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
490|NCT00085423|Dr. Marc Ernstoff|Dartmouth-Hitchcock|603 650 5534|marc.s.ernstoff@hitchcock.org
491|NCT00085436|Dr. Marc S. Ernstoff|Dartmouth-Hitchcock Medical Center|603-650-5534|marc.s.ernstoff@hitchcock.org
492|NCT00085631|Dr Mark Dewhirst|Duke University Medical Center|919 6683726|joan.cahill@dm.duke.edu
493|NCT00085644|Global Medical Services|Abbott|800-633-9110|
494|NCT00085709|SWOG Leukemia Statistician|SWOG Statistical Office|206-667-4408|
515|NCT00087555|Grace Wang, MD Director of Clinical Development & Medical Monitor|Jazz Pharmaceuticals, Inc.|650-496-3777|
516|NCT00087633|Medical Communications|Hoffmann-La Roche|800-821-8590|
517|NCT00087672|Jorge Cortes, M.D./ Professor|The University of Texas M. D. Anderson Cancer Center|713-794-5783|eharriso@mdanderson.org
518|NCT00087698|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
519|NCT00088153|Anne Klibanski|Massachusetts General Hospital|617-726-3870|aklibanski@partners.org
520|NCT00088166|Patrick O'Connor, MD, Managing Director Clinical Development|Celtic Pharma Development Services America Inc|212-616-4050|patrick.oconnor@dev.celticpharma.com
521|NCT00088218|Stefan Fader, M.D./Associate Professor|The University of Texas M. D. Anderson Cancer Center|713/745-4613|eharriso@mdanderson.org
522|NCT00088374|William M. Linehan, M.D.|National Cancer Institute, National Institutes of Health|301-496-6353|linehanm@mail.nih.gov
523|NCT00088465|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
524|NCT00088595|Study Director|Novartis Pharmaceuticals|862-778-8300|
525|NCT00088621|Josephine Cucchiaro, Executive Director|Sunovion|201-592-2050|josephine.cucchiaro@sunovion.com
526|NCT00088634|Josephine Cucchiaro, Executive Director|Sunovion|201-592-2050|josephine.cucchiaro@sunovion.com
527|NCT00088972|Study Statistician|SWOG|206-667-4623|
551|NCT00112905|Study Statistician|ECOG Statistical Office|617-632-3012|
552|NCT00112918|Medical Communications|Hoffman-LaRoche|800-821-8590|
553|NCT00113022|Dr. Carlos Zarate|Experimental Therapeutics and Pathophysiology Branch, NIMH|301-451-0861|zaratec@mail.nih.gov
554|NCT00113087|Lynn Sleeper|New England Research Institute|617-972-3235|lsleeper@neriscience.com
555|NCT00113217|Eric Jonasch, MD / Associate Professor|University of Texas (UT) MD Anderson Cancer Center|713-792-2830|CR_Study_Registration@mdanderson.org
556|NCT00113230|Christopher H. Crane, MD / Associate Professor|UT MD Anderson Cancer Center|713-792-2933|
557|NCT00113269|Senior Medical Director|Astellas Pharma Global Development||clinicaltrials@us.astellas.com
558|NCT00113295|Naomi M. Simon, M.D., M.Sc.|Massachusetts General Hospital|(617) 726-7913|nsimon@partners.org
559|NCT00113321|Hagop Kantarjian, M.D., Professor|The University of Texas M. D. Anderson Cancer Center|713/792-7026|eharriso@mdanderson.org
560|NCT00113334|Edward Kim, MD, BS / Assistant Professor|University of Texas (UT) MD Anderson Cancer Center|713-792-6363|CR_Study_Registration@mdanderson.org
561|NCT00113360|James Yao, M.D./Associate Professor|UT M. D. Anderson Cancer Center|713-792-2828|CR_Study_Registration@mdanderson.org
562|NCT00113386|Wendy Seiferheld|Radiation Therapy Oncology Group||wseiferheld@acr.org
563|NCT00113399|Wendy Seiferheld|Radiation Therapy Oncology Group||wseiferheld@acr.org
564|NCT00113490|M. Pamela Griffin, MD/ Clinical Development|MedImmune|301-398-0000|clinicaltrialenquiries@medimmune.com
565|NCT00113516|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
566|NCT00113529|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
567|NCT00113568|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
568|NCT00113607|Director Clinical Research Medical Leader|Janssen R&D US|908 704 5779|
569|NCT00113763|Study Director|Amgen Inc.|866-572-6436|
570|NCT00113841|Saroj Vadhan-Raj, MD/Professor|UT MD Anderson Cancer Center|713-792-9660|xzhou@mdanderson.org
571|NCT00113880|Chris Ambrose, MD, Sr Director, Medical Affairs|MedImmune, LLC|301-398-0000|ambrosec@medimmune.com
572|NCT00113919|Nathan Petty|University of Arkansas for Medical Sciences|501-837-3894|pettynathanm@uams.edu
573|NCT00114101|Philip McCarthy, MD|Roswell Park Cancer Institute||philip.mccarthy@roswellpark.org
574|NCT00114127|Dr. Naomi Simon|Massachusetts General Hospital|617-726-7913|nsimon@partners.org
575|NCT00114166|Jessalyn Reboy|NRG Oncology, Statistics and Data Management Center - Buffalo Office|716-845-7738|ReboyJ@nrgoncology.org
576|NCT00114634|Forbes D Porter|NICHD, NIH|301-435-4432|fdporter@mail.nih.gov
577|NCT00114972|Nic Van Dyck / Senior Program Manager|Boston Scientific|+ 31 43 356 8328|vandyckn@bsci.com
578|NCT00115063|Tiffany Prather, RN, CDE|PenningtonBRC|225-763-2979|tiffany.prather@pbrc.edu
579|NCT00115349|John Porter, MD, Principal Investigator|UCL Cancer Institute|+011 (44) 207 679 6224|j.porter@ucl.ac.uk
580|NCT00115739|Frances Worden, M.D.|University of Michigan Comprehensive Cancer Center|(734) 615-6633|fworden@umich.edu
581|NCT00115765|Study Director|Amgen Inc.|866-572-6436|
582|NCT00115804|Dr. Lesley Arnold|University of Cincinnati|513-475-8110|lesley.arnold@uc.edu
583|NCT00115869|Arthur V. Peterson, Jr. PhD|Fred Hutchinson Cancer Research Center|206-667-5131|avpeters@fhcrc.org
584|NCT00115934|Lynn Sleeper, ScD|New England Research Institutes|617-972-3235|lsleeper@neriscience.com
585|NCT00116168|Don Raible, MD|MedImmune|301-398-0000|raibleD@medimmune.com
586|NCT00116428|Melissa Schultz, Project Manager, Regulatory Affairs|Biosense Webster|800-729-9010 ext 8787|mschult1@its.jnj.com
587|NCT00116649|Sharon Levy, MD   VP Product Development|Graceway Pharmaceuticals LLC|267-948-0500|sharon.levy@gracewaypharma.com
588|NCT00116688|Study Director|Amgen Inc.|866-572-6436|
589|NCT00116753|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
590|NCT00116779|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
591|NCT00116805|Jane Anderson, Associate Director Clinical Research|Gilead Sciences|919-294-7160|Jane.anderson@gilead.com
592|NCT00116831|GSK Response Center|GlaxoSmithKline|866-435-7343|
593|NCT00116857|Robert M. Carney, Ph.D.|Washington University School of Medicine|314-286-1313|carneyr@bmc.wustl.edu
594|NCT00117286|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
595|NCT00117312|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
596|NCT00117338|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
495|NCT00085839|Medical Monitor|Astellas Pharma Global Development||clinicaltrials@us.astellas.com
496|NCT00085917|John Tierney|RCHSPB|301-451-5136|john.tierney@nih.gov
497|NCT00086047|Susmita Kashikar-Zuck, PhD|Cincinnati Children's Hospital Medical Center|513 636 6337|Susmita.Kashikar-Zuck@cchmc.org
498|NCT00086190|Irene H. Richard, MD|University of Rochester Medical Center|585-341-7500|irene_richard@urmc.rochester.edu
499|NCT00086281|Grace Wang, MD Director Clinical Development & Medical Monitor|Jazz Pharmaceuticals, Inc.|650-496-3777|
500|NCT00086307|Dr. Carlos A. Zarate|NIMH|301-451-0861|zaratec@mail.nih.gov
501|NCT00086346|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
502|NCT00086385|Sharon M. Hall, PhD|University of California, San Francisco|415-476-7574|sharon.hall@ucsf.edu
503|NCT00086411|Peter Gariti, Ph.D.|University of Pennsylvania|215-222-3200 ext 0|gar1iti@mail.med.upenn.edu
504|NCT00086502|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
505|NCT00086515|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
506|NCT00086580|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
507|NCT00086619|Robert Neer, MD|Massachusetts General Hospital|617-726-6723|rneer@partners.org
508|NCT00086684|SENIOR DIRECTOR CLINICAL LEADER|Janssen R&D US|1 609 730-4529|
509|NCT00086996|Study Statistician|SWOG Statistical Center|206-667-4623|
510|NCT00087139|Study Statistician|ECOG Statistical Office|617-632-3012|
511|NCT00087152|Lead Statistician - Breast Cancer Committee|SWOG|(206) 839-1761|williamb@crab.org
512|NCT00087438|Wendy Seiferheld|Radition Therapy Oncology Group (RTOG)||wseiferheld@gmail.com
513|NCT00087490|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
514|NCT00087516|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
417|NCT00098865|Mark W. Kieran, MD, PhD|DFCI|617-632-4907|mark_kieran@dfci.harvard.edu
418|NCT00099021|Frank G. Ondrey, M.D.|Masonic Cancer Center, University of Minnesota|612-625-3200|ondre002@umn.edu
419|NCT00099268|Study Director|Novartis Pharmaceuticals|862 778-8300|
420|NCT00099359|Margaret Camarca, Project Director|Westat|301-517-4128|margaretcamarca@westat.com
421|NCT00099437|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
422|NCT00099632|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.gov@sdac.harvard.edu
423|NCT00099983|John Krystal, MD|VA Connecticut HCS|203-937-4790|john.krystal@yale.edu
424|NCT00100048|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
425|NCT00100659|Kathleen B. Schwarz, M.D.|Johns Hopkins University School of Medicine|410-955-8769|kschwarz@jhmi.edu
426|NCT00100698|Janet Lo|Massachusetts General Hospital|617-724-9109|jlo@partners.org
427|NCT00100789|Study Statistician|SWOG Statistical Center|206-667-4623|
428|NCT00100932|Dr. Peter Tarassoff|Eisai|888-422-4743|
429|NCT00101101|Sophie Dessureault, M.D., Ph.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-1965|sophie.dessureault@moffitt.org
430|NCT00101166|Dr. Sophie Dessureault|H. Lee Moffitt Cancer Center and Research Institute|813-745-1965|sophie.dessureault@moffitt.org
431|NCT00101192|Melissa Leventhal|Gynecologic Oncology Group Statistical and Data Center|716-341-3408|mleventhal@gogstats.org
432|NCT00101283|Study Statistician|ECOG Statistical Office|617-632-3012|
433|NCT00101361|William A. Bauman, M.D.|James J. Peters VA Medical Center|718-584-9000|william.bauman@va.gov
434|NCT00101400|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
435|NCT00101413|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
300|NCT00090545|William Dahut, M.D.|National Cancer Institute, National Institues of Health|301-435-8183|dahutw@mail.nih.gov
301|NCT00090584|Anne Stoddard, ScD|New England Research Institutes|617-972-3331|astoddard@neriscience.com
302|NCT00090610|Angeles Alvarez Secord, Director of Gynecologic Oncology Clinical Trials|Duke University Medical Center|919-684-3765|secor002@mc.duke.edu
303|NCT00090753|Medical Communications|Hoffmann-La Roche|800-821-8590|
304|NCT00090779|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
305|NCT00090844|Pamela Munster, MD|Division of Hematology & Oncology, University of California, San Francisco|415-476-1000|Pmunster@medicine.ucsf.edu
306|NCT00090987|Jeannette Y. Lee, Director of Statistical Center|AMC|(501) 526-6712|jylee@uams.edu
307|NCT00091026|Hedy Kindler, MD|University of Chicago|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu
308|NCT00091273|Craig L. Slingluff, MD|University of Virginia|434-924-1730|cls8h@virginia.edu
309|NCT00091442|Director Medical Leader|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|908 218 7361 ext NA|
310|NCT00091507|Co-Principal Investigator|Tufts Medical Center|617-636-8788|jbeshansky@tuftsmedicalcenter.org
311|NCT00091572|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
312|NCT00091793|Study Director|Amgen Inc.|866-572-6436|
313|NCT00091819|Steven Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|Theravance, Inc.|650-808-6132|sbarriere@theravance.com
314|NCT00091832|Study Director|Amgen Inc.|866-572-6436|
315|NCT00092118|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
316|NCT00092131|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
317|NCT00092417|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
318|NCT00092443|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
319|NCT00092456|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
542|NCT00089843|Anne Klibanski, M.D.|Massachusetts General Hospital|617-726-3870|aklibanski@partners.org
543|NCT00092521|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
544|NCT00092534|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
545|NCT00092547|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
546|NCT00092677|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
547|NCT00093015|Study Director|Amgen Inc.|866-572-6436|
548|NCT00093041|VP Clinical Operations Eva Järlid Westerberg|Genmab A/S|+45 7020 2728|E.Westerberg@genmab.com
549|NCT00112489|Melissa Leventhal|NRG Oncology - Buffalo Office|716-341-3408|mleventhal@gogstats.org
550|NCT00112840|Jaime Merchan, M.D.|University of Miami – Sylvester Comprehensive Cancer Center||jmerchan2@med.miami.edu
459|NCT00081497|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
460|NCT00081653|Clinical Trials Study Director|Hoffmann-La Roche|+1 973 235 5000|
461|NCT00081731|Christopher Cooper, MD|University of Toledo|419-383-6297|christopher.cooper@utoledo.edu
462|NCT00081770|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
463|NCT00081861|Barbara Pro, MD / Associate Professor|U.T. M.D. Anderson Cancer Center||CR_Study_Registration@mdanderson.org
464|NCT00082017|Wyndham Wilson, M.D.|National Cancer Institute, National Institues of Health|301-435-2415|wilsonw@mail.nih.gov
465|NCT00082173|Dr. Richard Chaisson|Johns Hopkins University|410-955-1755|rchaiss@jhmi.edu
466|NCT00082329|Dr. Richard Childs|NHLBI NIH|301-594-8008|childsr@nhlbi.nih.gov
467|NCT00082342|Mark Hallett, MD, Chief|NINDS, NIH|301-496-9526|hallettm@ninds.nih.gov
468|NCT00082355|Dr Richard Chang|NIHCC|301-402-0256|rchang@cc.nih.gov
469|NCT00082381|Chief Medical Officer|Eli Lilly and Company||clinicaltrials@amylin.com
470|NCT00082407|Chief Medical Officer|Eli Lilly and Company||clinicaltrials@amylin.com
471|NCT00082433|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
472|NCT00082758|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
473|NCT00082888|Thomas E. Witzig, M.D.|Mayo Clinic|507-266-2040|witzig@mayo.edu
474|NCT00083122|Keith C. Bible, M.D, Ph.D.|Mayo Clinic Cancer Center||Bible.Keith@mayo.edu
475|NCT00083174|Dr. Paul Goss|Massachusetts General Hospital|617-724-3118|pgoss@partners.org
476|NCT00083616|Study Director|Amgen Inc.|866-572-6436|
477|NCT00083720|Chief Medical Officer|ImClone, LLC||ClinicalTrials@imclone.com
478|NCT00083759|Senior Director, Clinical Development|Elan Pharmaceuticals, Inc|1-650-877-0900|
479|NCT00083889|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
480|NCT00083915|Nathan M. Petty|University of Arkansas for Medical Sciences, Myeloma Institute|501-526-6990 ext 2461|pettynathanm@uams.edu
481|NCT00084084|Anna Wijatyk, MD, Medical Director|Shire Human Genetic Therapies|781-482-9622|awijatyk@shire.com
689|NCT00104728|Dr. Eric Haura|H. Lee Moffitt Cancer Center and Research Institute|813-745-6826|eric.haura@moffitt.org
690|NCT00104871|Steven Sherman, MD / Professor|The University of Texas (UT) MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
691|NCT00105027|Paul C. VanVeldhuisen, Ph.D.|The EMMES Corporation|301-251-1161|score@emmes.com
692|NCT00105079|Medical Communications|Hoffman-LaRoche|800-821-8590|
693|NCT00105157|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
694|NCT00105183|Regulatory Affairs|Fresenius Biotech|781 699 4618|anne.kuan@fresenius-biotech.com
695|NCT00105196|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
696|NCT00105235|Associate Director, Clinical Research Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
697|NCT00105443|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
698|NCT00105469|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
699|NCT00105482|Stephanie Samples O'Malley PhD, Director, Division of Substance Abuse Research|Yale School of Medicine, Department of Psychiatry|(203) 974-7590|stephanie.omalley@yale.edu
700|NCT00105534|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
701|NCT00105989|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
702|NCT00106002|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
703|NCT00106028|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
704|NCT00106106|Markus A. Heilig, M.D., Ph.D.|NIH/National Institute on Alcohol Abuse and Alcoholism|301-435-9386|mheilig@mail.nih.gov
705|NCT00106353|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
706|NCT00106392|Senior Medical Director, Medical Affairs|Astellas Pharma Global Development||clinicaltrials@us.astellas.com
707|NCT00106431|Elizabeth Faust, PhD, Vice President, Clinical Research Services|Celgene Corporation|617/583-1300|EFaust@Celgene.com
708|NCT00106535|Medical Communications|Hoffmann-La Roche|800-821-8590|
709|NCT00106626|Senior Vice President, Clinical and Quantitative Sciences|Merck & Co., Inc.|1-800-672-6372|
710|NCT00106639|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
711|NCT00106704|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
712|NCT00106964|James Korelitz|Westat|301-251-1500|jameskorelitz@westat.com
713|NCT00107042|James Korelitz|Westat|301-251-1500|jameskorelitz@westat.com
714|NCT00107120|Daniel Ventura, PhD|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|201-427-8252|daniel.ventura@frx.com
715|NCT00107276|Study statistician|SWOG|206-667-4623|
716|NCT00107315|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
717|NCT00107380|Study Statistician|SWOG Statistical Center|206-667-4623|
718|NCT00107575|Christopher Kahler|Brown University|(401) 863-6651|Christopher_Kahler@brown.edu
719|NCT00107614|Nathan M. Petty|University of Arkansas for Medical Sciences, Myeloma Institute|501-526-6990 ext 2461|pettynathanm@uams.edu
720|NCT00107783|William Gahl, MD/Clinical Director|NHGRI|301-402-2739|gahlw@mail.nih.gov
721|NCT00107952|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|Theravance Biopharma Antibiotics, Inc.|650-808-6132|sbarriere@theravance.com
722|NCT00107978|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|Theravance, Inc|650-808-6132|sbarriere@theravance.com
723|NCT00107991|Jennifer Goldfarb|UPenn|215-662-2540|jennifer.goldfarb@uphs.upenn.edu
724|NCT00108069|Teri Kreisl, M.D.|National Cancer Institute|301-402-3423|kreislt@mail.nih.gov
725|NCT00108082|GSK Response Center|GlaxoSmithKline|866-435-7343|
726|NCT00108160|Suzanne F. Bradley, M.D.|VA Ann Arbor Healthcare System|734-845-5820 ext 55826|sbradley@umich.edu
727|NCT00108342|Nina G. Schneider, Ph.D., Principle Investigator|Department of Veterans Affairs - VAGLA|310-268-3059|ngs@ucla.edu
728|NCT00108355|Guadalupe Garcia-Tsao|VA-CT Healthcare System|203-932-5711 ext 2210|guadalupe.garcia-tsao@yale.edu
729|NCT00108433|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
730|NCT00108524|William S Yancy, Jr. MD, MHSc|Durham VAMC|919-286-0411 ext 7770|william.yancy2@va.gov
731|NCT00108550|J. H. Atkinson MD|VA San Diego Healthcare System|858-642-3775|joseph.atkinson@va.gov
732|NCT00108732|Study Statistician|ECOG Statistical Office|617-632-3012|
733|NCT00108862|ClinicalTrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617)432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
734|NCT00108953|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
620|NCT00154102|Monika Foerster/Clinical Trial Leader|Merck Serono|+496151729517|monika.foerster@merck.de
621|NCT00154284|Study Director|Novartis Pharmaceuticals|862-778-8300|
622|NCT00154297|Study Director|Novartis Pharmaceuticals|862-778-8300|
623|NCT00154310|Study Director|Novartis Pharmaceuticals|862-778-8300|
624|NCT00154375|Study Director|Novartis Pharmaceuticals|862-778-8300|
625|NCT00154466|Dr. Bai-Chin Lee|National Taiwan University Hospital|0223123456 ext 63352|lebai@ntu.edu.tw
626|NCT00156013|Chadi Nabhan, MD|Oncology Specialists|847-268-8200|cnabhan@oncmed.net
627|NCT00156065|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
628|NCT00156533|Wilfred Pigeon|University of Rochester|585 275-3374|wilfred_pigeon@urmc.rochester.edu
629|NCT00156715|Christopher OKeefe, M.A|Dartmouth Medical School|603-271-5287|chris.okeefe@hitchcock.org
630|NCT00156910|Therapeutic Area Head|Allergan, Inc.|(714) 246-4500|clinicaltrials@allergan.com
631|NCT00156923|Bernard L. Silverman / VP, Clinical Development|Alkermes, Inc.|781-609-6000|bernard.silverman@alkermes.com
632|NCT00156936|Bernard L. Silverman / VP, Clinical Development|Alkermes, Inc.|781-609-6000|bernard.silverman@alkermes.com
633|NCT00117585|Dr. David Hickam|Portland VA Medical Center|(503) 721-7817|david.hickam@va.gov
634|NCT00117598|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
635|NCT00117637|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
636|NCT00117676|Jane Anderson, Associate Director Clinical Research|Gilead Sciences|919-294-7160|Jane.anderson@gilead.com
637|NCT00117793|Glenn K. Klute, PhD|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|206-277-6724|Glenn.Klute@va.gov
638|NCT00117845|Thomas Waldmann, M.D.|National Cancer Institute, National Institutes of Health|301-496-6656|tawald@mail.nih.gov
639|NCT00117949|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
640|NCT00117962|Dr. Ramaswamy Govindan|Washington Unveristy School of Medicine||rgovinda@dom.wustl.edu
641|NCT00117988|Dr. Anas Younes, MD / Professor|UT MD Anderson Cancer Center||etubbs@mdanderson.org
642|NCT00118053|Deborah Toppmeyer, MD|Cancer Institute of New Jersey|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
597|NCT00149825|Rachel Manber, PhD|Stanford University, School of Medicine|650-724-2377|Rmanber@stanford.edu
598|NCT00149890|Study Director|Novartis Pharmaceuticals|862-778-8300|
599|NCT00149994|Study Director|Novartis Pharmaceuticals|862-778-8300|
600|NCT00150176|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
601|NCT00150345|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
602|NCT00150592|Timothy Whitaker, MD|Shire Pharmaceuticals||twhitaker@shire.com
603|NCT00150618|Timothy Whitaker, MD|Shire Pharmaceuticals||twhitaker@shire.com
604|NCT00150969|Dr. Angela M Cheung|University Health Network|416-340-4841|jscher@uhnresearch.ca
605|NCT00151372|George S. Alexopoulos, M.D.|Weill Cornell Medical College|914-997-5767|gsalexop@med.cornell.edu
606|NCT00151411|Sandy Eyer|Penn State Hershey|717-531-1540|seyer@hmc.psu.edu
607|NCT00151476|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
608|NCT00151775|Howard Kessler, Senior Director Regulatory Operations|Daiichi Sankyo|732-590-5032|hmkessler@dsi.com
609|NCT00151814|Howard Kessler|Daiichi Sankyo|732-590-5032|hmkessler@dsi.com
610|NCT00151892|Timothy Whitaker, M.D.|Shire Pharmaceutical||twhitaker@shire.com
611|NCT00151996|Timothy Whitaker, MD|Shire Pharmaceutical||twhitaker@shire.com
612|NCT00152009|Timothy Whitaker, MD|Shire Pharmaceuticals||twhitaker@shire.com
613|NCT00152516|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
614|NCT00152763|Dr. Jane Irvine|University Health Network, Toronto General Hospital|(416) 736-5115 ext 22444|jirvine@yorku.ca
615|NCT00152971|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
616|NCT00153062|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
617|NCT00153101|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
618|NCT00153179|Mark A. Creager|Brigham and Women's Hospital|617-732-6320|mcreager@partners.org
619|NCT00153985|Catherine Wu, MD|Dana-Farber Cancer Institute|617-632-5943|cwu@partners.org
528|NCT00089076|Dr. Stephen Ansell|Mayo Clinic|507-284-0923|ansell.stephen@mayo.edu
529|NCT00089141|Paul J. Martin, M.D.|Fred Hutchinson Cancer Research Center (FHCRC)|206-667-4798|pmartin@fhcrc.org
530|NCT00089297|Study Statistician|ECOG Statistical Office|617-632-3012|
531|NCT00089479|Medical Communications|Hoffman-LaRoche|800-821-8590|
532|NCT00089505|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.gov@sdac.harvard.edu
533|NCT00089544|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@acr.org
534|NCT00089583|GSK Response Center|ViiV Healthcare|866-435-7343|
535|NCT00089609|William Dahut, M.D.|National Cancer Institute, National Institutes of Health|301-435-8183|dahutw@mail.nih.gov
536|NCT00089635|Study Director|Amgen Inc.|866-572-6436|
537|NCT00089648|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
538|NCT00089661|Study Director|Amgen Inc.|866-572-6436|
539|NCT00089674|Study Director|Amgen Inc.|866-572-6436|
540|NCT00089778|James Yang, M.D.|National Cancer Institute (NCI), National Institutes of Health (NIH)|301-496-1574|jamesyang@mail.nih.gov
541|NCT00089791|Study Director|Amgen Inc.|866-572-6436|
798|NCT00138125|Richard J. Pietras, M.D. Ph.D|University of California at Los Angeles|310 825 9769|rpietras@ucla.edu
799|NCT00138151|Lorna Rodriguez, MD, PhD|Rutgers Cancer Institute of New Jersey|732-235-8675|rodriglo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
800|NCT00138203|Dr. Anne Traynor|University of Wisconsin Carbone Cancer Center|(608) 262-8158|amt@medicine.wisc.edu
801|NCT00138424|Penelope Jester, BSN,MPH,CCRC|Collaborative Antiviral Study Group|(205) 877-975-7280|PJester@peds.uab.edu
802|NCT00138645|Corby K. Martin, Ph.D.; Assistant Professor|Pennington Biomedical Research Center|225-763-2585|martinck@pbrc.edu
758|NCT00110994|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
759|NCT00111007|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
760|NCT00111657|John S. Sundy, MD, PhD|Duke University Medical Center|919-684-2347|john.sundy@duke.edu
761|NCT00111761|Study Director|Amgen Inc.|866-572-6436|
762|NCT00111813|Vice President , Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
763|NCT00111917|Lisa Maier, MD|National Jewish Health|303-398-1983|maierl@njhealth.org
764|NCT00112047|Dara Wambach  MA, Associate Director, Regulatory Affairs|Gilead Sciences|650-522-5163|dara.wambach@gilead.com
765|NCT00112112|Raburn Mallory|MedImmune, LLC|301-398-0000|malloryr@medimmune.com
766|NCT00112294|BMS Study Director|Bristol-Myers Squibb||ClinicalTrials@bms.com
767|NCT00112359|Mark Bresnik, MD, Director, Clinical Research|Gilead Sciences, Inc.|(650) 522-5934|mark.bresnik@gilead.com
768|NCT00112385|A Pilot Study of Etanercept in Dermatomyositis|Brigham and Women's Hospital|617-732-8046|aamato@partners.org
769|NCT00112437|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
770|NCT00132769|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
771|NCT00132808|Study Director|Novartis Pharmaceuticals|862-778-8300|
772|NCT00132873|Mortimer Mamelak, MD|Jazz Pharmaceuticals, Inc.|650 496 3777|roman.skowronski@jazzpharma.com
773|NCT00133575|Lindsey R. Baden, M.D.|Brigham and Women’s Hospital|617-732-6801|LBaden@partners.org
774|NCT00133705|Dr. Kevin Fiscella|University of Rochester|585-271-1206 ext 205|kevin_fiscella@urmc.rochester.edu
775|NCT00133978|Dr. Daren Heyland|Clinical Evaluation Research Unit|613-549-6666 ext 4847|dkh2@queensu.ca
776|NCT00134043|Manisha Shah, MD|The Ohio State University Comprehensive Cancer Center|614-293-8629|manisha.shah@osumc.edu
777|NCT00134563|Trial Transparency Team|sanofi-aventis||Contact_US@sanofi-aventis.com
778|NCT00134719|GSK Response Center|GlaxoSmithKline|866-435-7343|
779|NCT00134784|Principal Investigator|Institute for Neurodegenerative Disorders|203 401 4300|kmarek@indd.org
780|NCT00134901|Dr Adam Bisaga|New York State Psychiatric Institute|(646) 774-6155|bisagaa@nyspi.columbia.edu
643|NCT00118131|Dr. Joseph Aisner|Cancer Institute of New Jersey|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
644|NCT00118144|DCC Project Administrator|California Cancer Consortium|626-256-4673 ext 60094|CCCP@coh.org
645|NCT00118248|Jeffrey F. Moley, M.D.|Washington University School of Medicine||moleyj@wustl.edu
646|NCT00118378|Dr. Judith Rabkin|New York State Psychiatric Institute|212.543.5762|jgr1@columbia.edu
647|NCT00118404|Dr. Robin B. Jarrett, Professor of Psychiatry|The University of Texas Southwestern Medical Center|214-648-5345|Robin.Jarrett@UTSouthwestern.edu
648|NCT00118417|Naomi M. Simon, MD|Massachusetts General Hospital|617-726-7913|nsimon@partners.org
649|NCT00118534|Dr. Miles McFall|VA Puget Sound (Seattle)|(206) 764-2177|Miles.McFall@va.gov
650|NCT00118742|Medical Communications|Hoffmann-La Roche|800-821-8590|
651|NCT00118755|Medical Communications|Hoffmann-La Roche|800-821-8590|
652|NCT00118898|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
673|NCT00103207|Study Statistician|ECOG Statistical Office|617-632-3012|
674|NCT00103259|ECOG Statistician|Eastern Cooperative Oncology Group (ECOG) Statistical Office|617-632-3012|
675|NCT00103610|Genzyme MedInfo|Genzyme Corporation||medinfo@genzyme.com
676|NCT00103662|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
677|NCT00103740|Study Director|Novartis Pharmaceuticals|862-778-8300|
678|NCT00103844|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
679|NCT00103857|Senior Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
680|NCT00104052|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
681|NCT00104104|Study Director|Novatis Pharmaceuticals|862-778-8300|
682|NCT00104234|Medical Information Services|BioMarin Pharmaceutical Inc.|8009834587|medinfo@bmrn.com
683|NCT00104247|Medical Information Services|BioMarin Pharmaceutical Inc.|1-800-983-4587|medinfo@bmrn.com
684|NCT00104299|Associate Director, Clinical Research Program|DAIT/NIAID|(301) 594-7669|DAITClinicalTrialsGov@niaid.nih.gov
685|NCT00104416|GSK Response Center|GlaxoSmithKline|866-435-7343|
686|NCT00104520|Mark Bresnik, MD, Director, Clinical Research|Gilead Sciences, Inc.|(650) 522-5934|mark.bresnik@gilead.com
687|NCT00104637|David J. Lederer, MD|Columbia University|212-305-7771|dl427@columbia.edu
688|NCT00104650|Study Director|Amgen Inc.|866-572-6436|
825|NCT00142818|Dr. Kyle Kampman|University of Pennsylvania|215-222-3200 ext 109|kampman@mail.med.upenn.edu
826|NCT00142909|Rajita Sinha, Ph.D|Yale University School of Medicine|203-737-5805|rajita.sinha@yale.edu
827|NCT00142935|Josiah D. Rich, MD, MPH|The Miriam Hospital/Brown University|401-793-4770|jrich@lifespan.org
828|NCT00143247|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
829|NCT00143312|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
830|NCT00143390|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
831|NCT00143403|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
832|NCT00143455|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
833|NCT00143598|Dr. Susan R Kahn|Centre for Clinical Epidemiology, Jewish General Hospital|514-340-8222 ext 7587|susan.kahn@mcgill.ca
834|NCT00143845|Dr. John Levine, M.D.|University of Michigan Comprehensive Cancer Center|734-936-8456|jelevine@umich.edu
835|NCT00144170|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
836|NCT00144300|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
837|NCT00144339|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
838|NCT00144781|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
839|NCT00144963|VP, Regulatory Affairs|Talon Therapeutics|650-228-5066|ttarlow@talontx.com
840|NCT00145041|Chief Medical Officer|Talon Therapeutics|650-588-6404|info@talontx.com
841|NCT00145119|Director CRDM|Medtronic Bakken Research Center|+31 43 3566 ext 566|
842|NCT00145249|Peter G. Pappas, MD|University of Alabama at Birmingham|205-934-9951|pappas@uab.edu
843|NCT00145327|Study Director|Novartis Pharmaceuticals|862-778-8300|
844|NCT00145418|Chadi Nabhan, MD|Oncology Specialists, S.C.|847-268-8200|cnabhan@oncmed.net
845|NCT00145496|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
846|NCT00145509|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
847|NCT00145574|Howard Kessler|Daiichi Sankyo|732-590-5032|hmkessler@dsi.com
848|NCT00145587|Kimberly Kasow, DO|St. Jude Children's Research Hospital|901-595-3300|kimberly_kasow@med.unc.edu
849|NCT00145600|Monika Metzger, MD|St. Jude Children's Research Hospital|1-866-278-5833|info@stjude.org
850|NCT00120250|Dr. Mark Pollack|Massachusetts General Hospital|312-942-5372|mark_pollack@rush.edu
851|NCT00120406|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|Cook|765-463-7537|ssnyder@medinst.com
852|NCT00120523|Clinical Research|MEDA Pharma GmbH & Co. KG|+49 6172 888 ext 01|clinical.research@medapharma.de
853|NCT00121134|Dr Harold J. Burstein|DFCI|617-632-3800|hal_burstein@dfci.harvard.edu
854|NCT00121186|Study Statistician|SWOG Statistical Center|206-667-4623|
855|NCT00121199|Study Statistician|SWOG Statistical Center|206-667-4623|
856|NCT00121472|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|Thoratec Corporation|(781) 852-8334|psood@thoratec.com
857|NCT00121485|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|Thoratec Corporation|781 852 8334|psood@thoratec.com
858|NCT00121641|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
859|NCT00121667|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
860|NCT00121810|Medical Communications|Hoffmann-La Roche|800-821-8590|
861|NCT00121836|Medical Communications|Hoffmann-LaRoche|800-821-8590|
862|NCT00122187|Linda Humphrey|VAHSRD|503-220-8262 ext 57176|linda.humphrey@va.gov
863|NCT00122369|Elvira V. Lang, MD|Beth Israel Deaconess Medical Center (at time of study); now Hypnalgesics, LLC|978 404 9724|elang@bidmc.harvard.edu
864|NCT00122382|Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
865|NCT00122447|Mary Rhee, M.D.|Emory University School of Medicine|404-778-1660|mrhee@emory.edu
866|NCT00122460|Inmaculada Ollero/Clinical Trial Manager|Merck Serono|+34935655433|iollero@merck.es
867|NCT00122681|GSK Response Center|GlaxoSmithKline|866-435-7343|
868|NCT00122954|Lynne Shinto, ND, MPH|Oregon Health & Science University|503-494-5035|shintol@ohsu.edu
653|NCT00118911|Susan Sprich, Ph.D.|Massachusetts General Hospital|617-726-5991|ssprich@partners.org
654|NCT00119015|Robert Naclerio|University of Chicago|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu
655|NCT00119158|Jonathan Spergel|The Children's Hospital of Philadelphia|215 590 1000|spergel@email.chop.edu
656|NCT00119262|Study Statistician|Eastern Cooperative Oncology Group (ECOG) Statistical Office|617-632-3012|
657|NCT00119678|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
658|NCT00120042|Dr Jan Dickinson|The University of Western Australia|61-8-93401330|Jan.Dickinson@uwa.edu.au
659|NCT00101660|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
660|NCT00101686|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
661|NCT00101816|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
662|NCT00101868|James F. Graumlich, MD, Professor of Medicine|University of Illinois|309-655-7734|jfg@uic.edu
663|NCT00101907|Study Director|Amgen Inc.|866-572-6436|
664|NCT00101933|Michele Herzog, Clinical Study Manager|Medtronic Neuromodulation|763-526-8092|medtronicneurotrials@medtronic.com
665|NCT00102063|Margaretta Nyilas|Otsuka Pharmaceutical Development & Commercialization, Inc.|609-452-5673|Margaretta.nyilas@otsuka-us.com
666|NCT00102440|Sr. VP, Clinical Science|Takeda Global Research & Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
667|NCT00102518|Margaretta Nyilas|Otsuka Pharmaceutical Development & Commercialization, Inc.|609-452-5673|Margaretta.nyilas@otsuka-us.com
668|NCT00102596|Mark Hallett, M.D.|NINDS/NIH|301-496-9526|hallettm@ninds.nih.gov
669|NCT00102687|CL Beach|Celgene Corporation||CLBeach@celgene.com
670|NCT00103012|Scott Penzak|National Institutes of Health, Clinical Center, Department of Pharmacy|301-496-2997|spenzak@cc.nih.gov
671|NCT00103142|Dr. Michael Morse|Duke University Medical Center|919-684-5705|michael.morse@dm.duke.edu
672|NCT00103194|"Study Statistician"|"ECOG Statistical Office"|617-632-3012|
735|NCT00109005|Steven A. Rosenberg, M.D.|National Cancer Institute, National Institutes of Health|301-435-7507|sbpso@mail.nih.gov
736|NCT00109031|Hans Olivecrona, MD PhD|Swedish Orphan Biovitrum|+46 8 697 20 00|hans.olivecrona@sobi.com
737|NCT00109343|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
738|NCT00109473|Lee A. Denson|Cincinnati Children's Hospital Medical Center|513-636-7575|lee.denson@cchmc.org
739|NCT00109577|Dr. Bonnie Kaplan|University of Calgary|403-955-7363|kaplan@ucalgary.ca
740|NCT00109590|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinialTrials.Gov@sdac.harvard.edu
741|NCT00109733|Sanja Dragnic/Medical Responsible|EMD Serono|+7816814017|sanja.dragnic@emdserono.com
742|NCT00109772|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
743|NCT00109837|SWOG Leukemia Statistician|SWOG Statistical Office|206-667-4408|
744|NCT00109850|Study Statistician|SWOG Statistical Center|206-667-4623|
745|NCT00109928|Study Statistician|SWOG Statistical Center|206-667-4623|
746|NCT00109967|Stephen M. Ansell, M.D., Ph.D.|Mayo Clinic||ansell.stephen@mayo.edu
747|NCT00110019|Study Statistician|ECOG Statistical Office|617-632-3012|
748|NCT00110084|Dr. Vivek Roy|Mayo Clinic|507-284-1159|roy.vivek@mayo.edu
749|NCT00110214|William Kevin Kelly, DO|Thomas Jefferson University||wm.kevin.kelly@jefferson.edu
750|NCT00110305|Director|Janssen-Virco BE|32 14 641418 ext NA|
751|NCT00110357|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
752|NCT00110396|Bettina Stubinski/Medical Responsible|Merck Serono SA|+41224143396|
753|NCT00110461|Andy Forbes|Otsuka Pharmaceutical Development & Commercialization, Inc.||andy.forbes@otsuka-us.com
754|NCT00110513|Denise Tilton, RN, MHA, Director Clinical Affairs|GTC Biotherapeutics|508-370-5257|denise.tilton@gtc-bio.com
755|NCT00110617|Study Director|Novartis Pharmaceuticals|862-778-8300|
756|NCT00110812|Deborah Wentworth|University of Minnesota|612-726-9005|wentw001@umn.edu
757|NCT00110890|Study Director|Amgen Inc.|866-572-6436|
781|NCT00135330|Chief Medical Officer|Eli Lilly and Company|1-800-LILLYRX|clinicaltrials@amylin.com
782|NCT00135356|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
783|NCT00135798|Gregory T. Everson, M.D., Director of Hepatology|University Colorado, Denver|720-848-2245|greg.everson@UCDenver.edu
784|NCT00136084|Jeffrey Rubnitz, M.D|St. Jude Children's Research Hospital|1-866-278-5833|info@stjude.org
785|NCT00136318|Professor Dr. Martin Schaefer|Kliniken Essen-Mitte, Department of Psychiatry|+49201-17430001|m.schaefer@kliniken-essen-mitte.de
786|NCT00136760|Jennifer Tidey, Ph.D.|Brown University|401-863-6418|Jennifer_Tidey@brown.edu
787|NCT00136916|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
788|NCT00136955|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
789|NCT00137046|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
790|NCT00137111|Ching-Hon Pui|St. Jude Children's Research Hospital|1-866-278-5833|info@stjude.org
791|NCT00137423|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
792|NCT00137436|Pfizer Clinical Trials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
793|NCT00137449|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
794|NCT00137631|Leo Wilton, PhD|Department of Human Development, State University of New York at Binghamton|607-777-9215|lwilton@binghamton.edu
795|NCT00137969|Medical Communications Specialist|Genentech, Inc.|800-821-8590|
796|NCT00138034|Professor Doctor F.W.A. Verheugt|Radboud University Medical Center Nijmegen|+31(0)24-3614533|f.verheugt@cardio.umcn.nl
797|NCT00138073|Jaime Chang|Massachusetts General Hospital|617-726-9069|jchang4@partners.org
973|NCT00175006|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
974|NCT00175019|Senior Vice President, Clinical Science|Takeda Global Research & Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
975|NCT00175877|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
976|NCT00176254|Dr. Emily Van Meter/Assistant Professor, Division of Cancer Biostatistics|University of Kentucky|859-323-3076|emily.vanmeter@uky.edu
977|NCT00176306|Aaron Cook|University of Kentucky|8593239258|amcook0@email.uky.edu
978|NCT00176436|M. Patricia Ball, R.N., C.,M.S.|Maryland Psychiatric Research Center|410-402-7663|pball@mprc.umaryland.edu
979|NCT00176462|Richard Drachtman, MD|Rutgers Cancer Institute of New Jersey|732-235-8675|drachtri@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu
980|NCT00176488|Deborah Toppmeyer, MD|Cancer Institute of New Jersey|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
981|NCT00176501|Dr. Roger Strair, MD, PhD|Rutgers Cancer Institute of New Jersey|732-235-8675|strairrk@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
939|NCT00130728|Medical Communications Specialist|Genentech, Inc.|800-821-8590|
940|NCT00130793|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
941|NCT00130832|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
942|NCT00130923|Dr. Mary Brunette|Psychopharmacology Research Group|603-271-5747|mary.f.brunette@hitchcock.org
943|NCT00131248|Kathleen A. Kennedy, MD, MPH|UT Houston Medical School|713 500-6708|kathleen.a.kennedy@uth.tmc.edu
944|NCT00131352|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
945|NCT00131378|Dr. Karen K. Miller|Massachusetts General Hospital|617-726-3870|kkmiller@partners.org
946|NCT00131456|Dr. Frances R. Levin|Columbia University|212-543-5896|frl2@columbia.edu
947|NCT00131508|Winfred Wang|St Jude Children's Research Hospital|1-866-278-5833|info@stjude.org
948|NCT00131573|Director of Clinical Operations|Boston Scientific|866-360-4747|valerie.lucero-cimmarusti@bsci.com
949|NCT00131664|Dr. Robert Josse|Dr. Anatoly Langer, Chair CHRC, Canadian Heart Research Centre|416-977-8010|langera@chrc.net
950|NCT00131677|Taraz Samandari|Centers for Disease Control and Prevention (CDC)|404-639-1676|tts0@cdc.gov
951|NCT00131885|Patricia Murphy, DrPH|University of Utah|801-793-5729|patricia.murphy@nurs.utah.edu
952|NCT00132028|Study Statistician|SWOG Statistical Center|206-667-4623|
953|NCT00132132|Dr. Shirley Gonzalez|SEMC|617-926-0114|shirley.gonzalez@steward.org
954|NCT00132314|Robert Rosenheck, MD|VA New England Mental Illness, Research, Education and Clinical Center|(203) 932-5711 ext 3723|Robert.Rosenheck@va.gov
955|NCT00132496|Yufang Lu, MD, PhD, Study Director|Eisai Medical Research Inc.|201-403-2500|
956|NCT00132678|Director of Clinical Research|Johnson & Johnson Pharmaceutical Research and Development|609 730-4576|
957|NCT00132691|John H. Kempen, MD, PhD, MUST Trial Vice-Chairman|Center for Presventive Ophthalmology and Biostatistics, Department of Ophthalmology, University of Pennsylvania|215-615-1500|john.kempen@uphs.upenn.edu
958|NCT00132730|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
959|NCT00172042|Study Director|Novartis Pharmaceuticals|862-778-8300|
960|NCT00172185|Vice President, Clinical Development|NPS Pharmaceuticals|908-450-5300|info@npsp.com
870|NCT00123123|Frank A. Scannapieco|University at Buffalo|716-829-3373|fas1@buffalo.edu
871|NCT00123630|Dr. John Fang|University of Utah|801-581-7802|john.fang@hsc.utah.edu
872|NCT00123643|Aaron S. Kelly, Ph.D.|University of Minnesota|612-626-3492|kelly105@umn.edu
873|NCT00123734|Dr Michael Gerometta|AGEN Biomedical Ltd|+61 408 885 416|mgerometta@agenix.com
874|NCT00124020|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|Theravance, Inc|650-808-6132|sbarriere@theravance.com
875|NCT00124072|CTSU Reception|CTSU, University of Oxford|01865 743743|secretary@ctsu.ox.ac.uk
876|NCT00124176|Joseph Zorc, MD|Children's Hospital of Philadelphia|215-590-1944|zorc@email.chop.edu
807|NCT00139737|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
808|NCT00139776|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
809|NCT00139997|Paul Desan, MD, PhD|Yale University|203 785 2618|paul.desan@yale.edu
810|NCT00140140|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
811|NCT00140556|David Brizel, MD|Duke University Medical Center, Dept Radiation Oncology|919 668-5637|david.brizel@duke.edu
812|NCT00140842|Madhu Misra, MD|Massachusetts General Hospital|617-724-5602|mmisra@partners.org
813|NCT00141037|Associate Director, Clinical Research Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
814|NCT00141102|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
815|NCT00141219|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
816|NCT00141271|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
817|NCT00141453|Howard Kessler|Daiichi Sankyo, Inc|732-590-5032|hmkessler@dsi.com
818|NCT00141726|Gregory Yanik, M.D.|University of Michgan Comprehensive Cancer Center|734-936-8785|gyanik@umich.edu
819|NCT00141739|Dr. John E. Levine|Blood and Marrow Transplant Program, University of Michigan|734-936-8456|jelevine@med.umich.edu
820|NCT00141765|Dr. John E. Levine, MD|University of Michigan Cancer Center|734-936-8456|jelevine@umich.edu
821|NCT00141778|Dr. Mias Pretorius|Vanderbilt University School of Medicine|16153430665|mias.pretorius@vanderbilt.edu
822|NCT00141817|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
823|NCT00142116|Steven P. Treon MD, PhD|Dana Farber Cancer Institute|617-632-2681|steven_treon@dfci.harvard.edu
824|NCT00142298|Study Director|Novartis Pharmaceuticals|862-778-8300|
1027|NCT00183963|Victoria Soto, Project Specialist, Clinical Investigations Support Office|USC Norris Comprehensive Cancer Center|323-226-6384|Victoria.Soto@med.usc.edu
877|NCT00124449|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
878|NCT00124579|Robert Z. Orlowski, MD, PhD|SWOG|(713) 792-2860|rorlowsk@mdanderson.org
879|NCT00124657|Alberto Broniscer, MD|St. Jude Children's Research Hospital|866-966-5934|info@stjude.org
880|NCT00124709|Study Director|Novartis Pharmaceuticals|862-778-8300|
881|NCT00124735|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
882|NCT00124748|Study Director|Novartis Pharmaceuticals|862-778-8300|
883|NCT00124943|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
884|NCT00124982|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
885|NCT00125034|Inmaculada Ollero/Clinical Trial Manager|Merck Serono|+34935655433|iollero@merck.es
886|NCT00125138|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com
887|NCT00125164|Medical Director, Pediatric Endocrinology|Ipsen|clinical.trials@ipsen.com|clinical.trials@ipsen.com
888|NCT00125190|Cathryn Clary, M.D.|Ipsen|+1 650-624-4919|cathryn.clary@ipsen.com
889|NCT00125268|Dr. Matthew A. Butters|Mayo Clinic|480-301-7745|butters.matthew@mayo.edu
890|NCT00125515|Dr Adam Bisaga|New York Psychiatric Institute|212-543-6542|bisagaa@nyspi.columbia.edu
891|NCT00125593|Professor Colin Baigent|Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford|+44 1865 743743|colin.baigent@ctsu.ox.ac.uk
892|NCT00125931|Beth Murphy, MD PhD|McLean Hospital|617-855-2297|BMurphy5@partners.org
803|NCT00138658|Dr. Patricia Stewart, Vice President Medical Affairs|OncoGenex Pharmaceuticals|425-686-1500|psstewartmd@oncogenex.com
804|NCT00138671|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
805|NCT00139477|Dr. Nelly Mauras, Chief, Division of Endocrinology|Nemours Children's Clinic|904-697-3674|nmauras@nemours.org
806|NCT00139659|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
869|NCT00122980|Russell E. Ware, MD, PhD, Director, Texas Children's Hematology Center|Baylor College of Medicine|(832) 824-1368|reware@bcm.edu
893|NCT00125957|Dr. Beth Murphy|McLean Hospital|617-855-2000 ext 2297|bmurphy5@partners.org
894|NCT00126191|Ann LaCasce, MD|DFCI|617-632-5959|ALACASCE@PARTNERS.ORG
895|NCT00126490|Mayer Fishman, M.D., Ph.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-8311|mayer.fishman@moffitt.org
896|NCT00126503|Jeffrey Sosman, MD|Vanderbilt-Ingram Cancer Center|615-936-3048|jeff.sosman@vanderbilt.edu
897|NCT00126568|Dr. Panayiotis Savvides|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|216-844-5946|Panayiotis.Savvides@uhhospitals.org
898|NCT00126581|Pasi Janne, MD, PhD|Dana-Farber Cancer Institute||pjanne@partners.org
899|NCT00126659|Eric Jonasch, MD / Associate Professor|UT MD Anderson Cancer Center||caperez@mdanderson.org
900|NCT00126776|Kathryn Rice MD|Minneapolis VAMC|612 725 2000 ext 4400|kathryn.rice@va.gov
901|NCT00127036|Jonathan Strosberg, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-2069|jonathan.strosberg@moffitt.org
902|NCT00127101|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|clinicaltrialsdisclosure@merck.com
903|NCT00127166|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp.|1-800-672-6372|
904|NCT00127192|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
905|NCT00127530|Andrew Blight, Chief Scientific Officer|Acorda Therapeutics, Inc.|914-347-4300 ext 102|ablight@acorda.com
906|NCT00127712|James E. Tisdale|Purdue University|317-613-2315 ext 306|jtisdale@iupui.edu
907|NCT00127790|Wilfred Pigeon, PhD|Universityy of Rochester|(585) 275-3374|wilfred_pigeon@urmc.rochester.edu
908|NCT00127803|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
909|NCT00127842|Study Director|Amgen Inc.|866-572-6436|
910|NCT00127855|GSK Response Center|GlaxoSmithKline|866-435-7343|
911|NCT00127933|Medical Communications|Hoffman-LaRoche|800-821-8590|
912|NCT00128180|Gregory Mertz, MD|UNewMexico|5059808601|gmertz@salud.unm.edu
913|NCT00128193|Patrick J. Brennan, Ph.D.|Colorado State University, Department of Microbiology, Immunology and Pathology|970-491-6700|patrick.brennan@colostate.edu
914|NCT00128206|Mary White|University of California, San Francisco|415-476-5213|mary.white@nursing.ucsf.edu
915|NCT00128219|Sharon Hillier, Ph.D.|University of Pittsburgh School of Medicine|412-641-6435|hillsl@mwri.magee.edu
916|NCT00128401|Cameron, Jennifer Ann|National Institute of Mental Health|+1 301 402 9356|cameronj@mail.nih.gov
917|NCT00128492|Mark Bresnik, Director of Clinical Research|Gilead Sciences, Inc.|650-522-5934|Mark.Bresnik@gilead.com
918|NCT00128661|GSK Response Center|GlaxoSmithKline|866-435-7343|
919|NCT00128713|Susan Assmann, PhD|New England Research Institutes|617-923-7747 ext 548|sassmann@neriscience.com
920|NCT00128830|Trial Physician|Tibotec Pharmaceuticals|+32-14-607-767|
921|NCT00128921|Nathan M. Petty|University of Arkansas for Medical Sciences, Myeloma Institute|501-526-6990 ext 2461|pettynathanm@uams.edu
922|NCT00129116|GSK Response Center|GlaxoSmithKline|866-435-7343|
923|NCT00129129|GSK Response Center|GlaxoSmithKline|866-435-7343|
924|NCT00129220|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
925|NCT00129246|Benjamin A. Toll, PhD|Associate Professor of Psychiatry and Program Director, Smoking Cessation Service at Smilow Cancer Hospital at Yale-New Haven|(203) 974 5767|benjamin.toll@yale.edu
926|NCT00129259|Associate Director, Clinical Research Operations Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
927|NCT00129311|Dr. Andrea Weinberger|Yale Unviersity|203-974-7598|andrea.weinberger@yale.edu
928|NCT00129402|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
929|NCT00129441|David A. Lewis, MD|University of Pittsburgh|(412) 246-6010|lewisda@upmc.edu
930|NCT00129467|Dr. Linda Ganzini|Portland Veterans Affairs Medical Center|(503) 220-8262 ext 56492|linda.ganzini@va.gov
931|NCT00129753|Anas Younes, MD / Professor|UT MD Anderson Cancer Center|713-792-2860|
932|NCT00129766|M. Pamela Griffin, Sr. Director, Clinical Development|MedImmune|301-398-0000|clinicaltrialenquiries@medimmune.com
933|NCT00129961|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
934|NCT00130039|Sun U. Kwon, MD, PhD, Prof|Asan Medical Center, University of Ulsan|82-2-3010-3960|sukwon@amc.seoul.kr
935|NCT00130247|John L. Johnson, M.D., Principal Investigator|Case Western Reserve University, Tuberculosis Research Unit|(216) 368-1949|jlj@case.edu
936|NCT00130286|Dr. Marshall J. Glesby|Weill Cornell Medical College|212-746-4177|mag2005@med.cornell.edu
937|NCT00130520|Setsuko K. Chambers, M.D.|Arizona Cancer Center, University of Arizona|520-626-0950|schambers@azcc.arizona.edu
938|NCT00130637|H. Nida Sen, MD, MHS|National Eye Institute, NIH|301-435-5139|senh@nei.nih.gov
961|NCT00174187|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
962|NCT00174252|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
963|NCT00174265|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
964|NCT00174291|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
965|NCT00174382|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
966|NCT00174447|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
967|NCT00174460|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
968|NCT00174785|International Clinical Development (ICD),  Clinical Study Director|sanofi-aventis||GV-Contact-us@sanofi-aventis.com
969|NCT00174915|Sr. VP, Clinical Science|Takeda Global Research & Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
970|NCT00174941|Sr VP, Clinical Science|Takeda Global Research & Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
971|NCT00174954|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
972|NCT00174967|Sr. VP, Clinical Science|Takeda Global Research & Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
1068|NCT00146328|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
1069|NCT00146757|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
1070|NCT00146770|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
1071|NCT00146848|Kira Stolen|Clinical Affairs|1 800 CARDIAC|cshd@bsci.com
1072|NCT00147199|Inhaled Treprostinil Program Head|United Therapeutics|919-485-8350|clinicalrecordsmanagement@unither.com
1073|NCT00147212|M. Dror Michaelson, MD PhD|MGH Cancer Center|6177261594|dmichaelson1@partners.org
1074|NCT00147225|Dr. Saroj Vadhan-Raj|University of Texas MD Anderson Cancer Center|713-792-7966|svadhanr@mdanderson.org
1075|NCT00147238|Haesun Choi, MD / Professor|UT MD Anderson Cancer Center|713-745-4693|
1076|NCT00147277|Laura Manotta|Medtronic Italia S.p.A.|003902241371|laura.manotta@medtronic.com
1077|NCT00147290|Elisabetta Santi|Medtronic|003906328141|elisabetta.santi@medtronic.com
1078|NCT00147316|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
1079|NCT00147446|David C. Mohr|Northwestern University|312-503-3128|m.lisetteluistro@northwestern.edu
1080|NCT00147498|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1081|NCT00147537|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1082|NCT00147745|John Raia, Senior Director, Professional Affairs|Daiichi Sankyo, Inc|(973) 944-2683|jraia@dsi.com
1083|NCT00147966|Arthur Kavanaugh|UCSD|858-657-7040|akavanaugh@ucsd.edu
1084|NCT00148109|Dr. Rashmi Chugh|University of Michigan Comprehensive Cancer Center|(734) 936-5710|rashmim@umich.edu
1085|NCT00148122|Dr. Francis Worden|University of Michigan Comprehensive Cancer Center|734-936-0453|fworden@umich.edu
1086|NCT00148668|Dr Eric Winer|Dana-Farber Cancer Institute|617-632-2335|eric_winer@dfci.harvard.edu
1087|NCT00148759|Ighovwerha Ofotokun, MD, MSc|Emory University|404-616-0659|iofotok@emory.edu
1088|NCT00148798|Merck KGaA Communication Center|Merck KGaA|+49-6151-72-5200|service@merckgroup.com
1089|NCT00148954|Greg Voss, Clinical Director|Boston Scientific|651-581-3068|gregory.voss@bsci.com
1090|NCT00149214|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1091|NCT00149227|Prof. Hiroaki Matsubara|Department of Cardiology, Kyoto Prefectural University of Medicine|+81-75-251-5511|matsubah@koto.kpu-m.ac.jp
1092|NCT00149630|Thomas R. Kosten, M.D.|Baylor College of Medicine|(713) 794-7032|kosten@bcm.edu
1093|NCT00149643|Jack R. Cornelius, M.D.|University of Pittsburgh|412-246-6906|corneliusjr@upmc.edu
1094|NCT00149747|Abby C. King|Stanford Prevention Research Center|6507252826|king@stanford.edu
1095|NCT00157014|Associate Director, Scientific Affairs|Astellas Pharma Canada, Inc||clinicaltrials@us.astellas.com
1096|NCT00157157|Brigitt Abbuehl, MD, Medical Director, Hematology/Hemophilia|Baxter Innovations GmbH||brigitt_abbuehl@baxter.com
1119|NCT00161382|Dr. Susan R. Tortolero|The University of Texas Health Science Center at Houston (UTHealth) School of Public Health|713-500-9634|Susan.Tortolero@uth.tmc.edu
1120|NCT00161473|Lucy Y. Wang, M.D.|VA Puget Sound Healthcare System|206-277-5089|wanglucy@u.washington.edu
1121|NCT00161616|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
1122|NCT00162032|Qi Zhu, MD|Lantheus Medical Imaging|978-671-8605|Qi.Zhu@lantheus.com
1123|NCT00162097|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
1124|NCT00162123|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
1125|NCT00162136|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
1126|NCT00162266|BMS Study Director|Bristol-Myers Squibb||clinical.trials@bms.com
1127|NCT00162942|Tao Wang|Otsuka America Pharmaceutical, Inc|240-683-3213|tao.wang@otsuka-us.com
1128|NCT00162981|Email contact via H. Lundbeck A/S|Lundbeck LLC||LundbeckClinicalTrials@lundbeck.com
1129|NCT00163020|Kimberly Maurel|Obstetrix Medical Group, Inc|714-593-9171|kimberly_maurel@pediatrix.com
1105|NCT00159783|Vice President, Late stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
1106|NCT00159822|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1107|NCT00159861|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1108|NCT00159874|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1109|NCT00159913|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1110|NCT00159965|W. Curt LaFrance, Jr., MD, MPH|Rhode Island Hospital|401-444-3534|William_LaFrance_Jr@Brown.edu
1111|NCT00160199|Sven Voet - Global Communication|Solvay Pharmaceuticals|+32(0)2 509 69 77|sven.voet@solvay.com
1112|NCT00160251|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
1113|NCT00160524|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
1114|NCT00160563|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
1115|NCT00160641|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
1116|NCT00160693|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
1117|NCT00160706|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
1118|NCT00161213|Dr. Susan Goodin (Deputy Director, Associate Director for Clinical Science)|UMDNJ|732-235-6783|goodin@umdnj.edu
982|NCT00176605|Dr. Mark Stein|Rutgers Cancer Institute of New Jersey|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
983|NCT00176631|Dr. Robert DiPaola, MD|Rutgers Cancer Institute of New Jersey|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
984|NCT00176644|Dr. Mark Stein|Cancer Institute of New Jersey|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
985|NCT00176826|Dr. Angela Smith|University of Minnesota|612-626-2778|smith719@umn.edu
986|NCT00176839|Margaret MacMillan, M.D.|University of Minnesota Masonic Cancer Center|612-626-2778|macmi002@umn.edu
987|NCT00176878|Paul Orchard, M.D.|Masonic Cancer Center, University of Minnesota|612-626-2313|orcha001@umn.edu
988|NCT00176904|Paul Orchard, M.D.|Masonic Cancer Center, University of Minnesota|612-626-2313|orcha001@umn.edu
989|NCT00176917|Paul J. Orchard, M.D.|Masonic Cancer Center, University of Minnesota|612-626-2313|orcha001@umn.edu
990|NCT00177294|Charles F. Reynolds III, MD|University of Pittsburgh|412-246-6414|reynoldscf@upmc.edu
991|NCT00177671|Charles F. Reynolds III, MD|University of Pittsburgh|412-246-6414|reynoldscf@upmc.edu
992|NCT00178191|Michael Flynn|University of Rochester|585-273-3232|Michaelk_flynn@urmc.rochester.edu
993|NCT00178256|Yuhchyau Chen MD, PhD|University of Rochester|585-275-5575|yuhchyau_chen@urmc.rochester.edu
994|NCT00178464|Dr. Norma B. Lerner|St. Christopher's Hospital for Children|215 427-5261|norma.lerner@drexelmed.edu
995|NCT00178477|Walter O'Dell, Ph.D.|University of Rochester Medical Center|585-275-9996|walter_odell@urmc.rochester.edu
996|NCT00178503|Deborah A. Pearson, Ph.D.|University of Texas Medical School at Houston|713-486-2588|Deborah.A.Pearson@uth.tmc.edu
997|NCT00178633|Heinrich Taegtmeyer, MD, DPhil,  Principal Investigator|University of Texas Medical School at Houston|713 500-6569|heinrich.taegtmeyer@uth.tmc.edu
998|NCT00178685|Dr. Geoffrey Williams|University of Rochester|585-530-2050|geoffrey_williams@urmc.rochester.edu
999|NCT00178711|Guy L Clifton|University of Texas Health Science Center|2024224824|guy@guyclifton.com
1000|NCT00178919|Italo Biaggioni|Vanderbilt University|615-343-6499|italo.biaggioni@vanderbilt.edu
1001|NCT00179309|Dr. James Gulley, M.D., Ph.D.|National Cancer Institute, National Institutes of Health|301-435-2956|gulleyj@mail.nih.gov
1002|NCT00179621|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
1003|NCT00179647|Robert D. Knight, M.D.|Celgene Corporation|908-673-9749|rknight@celgene.com
1004|NCT00179660|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
1005|NCT00179673|Senior Manager, Clinical Trials Disclosure|Celgene Corporation|888-260-1599|clinicaltrialdisclosure@celgene.com
1006|NCT00179959|Amy Paller, MD|Children's Memorial Hospital|312-695-6829|apaller@nmff.org
1007|NCT00180271|Lisa Melchior|Boston Scientific|800 227 3422|lisa.melchior@bsci.com
1008|NCT00180323|Dr. Jesper Hastrup Svendsen|Rigshospitalet, Copenhagen Unviversity Hospital, Denmark||jesper.hastrup.svendsen@rh.regionh.dk
1009|NCT00180479|Ellen Travis, Clinical Science|Abbott Vascular|408-845-1512|Ellen.Travis@av.abbott.com
1010|NCT00181610|Corrine Welt, MD|Massachusetts General Hospital|617-726-8437|cwelt@partners.org
1011|NCT00181623|Corrine Welt, MD|Massachusetts General Hospital|617-716-8437|cwelt@partners.org
1012|NCT00181714|Paul Hammerness, MD|Massachusetts General Hospital|617-503-1063|phammerness@partners.org
1013|NCT00181766|Joseph Biederman, MD|Massachusetts General Hospital|617-726-1743|jbiederman@partners.org
1014|NCT00181844|Janet Wozniak, MD|Massachusetts General Hospital|617-503-1038|jwozniak@partners.org
1015|NCT00181883|Janet Wozniak, MD|Massachusetts General Hospital|617-503-1038|jwozniak@partners.org
1016|NCT00182000|Sabine Wilhelm, PhD|Massachusetts General Hospital|6177246146|swilhelm@partners.org
1017|NCT00182078|Dr. Frederick J. Stoddard Jr., M.D.|Massachusetts General Hospital|6173714762|fstoddard@partners.org
1018|NCT00182091|Dr. Anne Klibanski|Massachusetts General Hospital|617-726-3870|
1019|NCT00182689|Study Statistician|SWOG Statistical Center|206-667-4623|
1020|NCT00183092|Michael Geschwind, MD, PhD|UCaliforniaSF|415-476-2901|mgeschwind@memory.ucsf.edu
1021|NCT00183196|Raymond F. Anton, MD|Medical University of South Carolina|843-792-1226|antonr@musc.edu
1022|NCT00183248|George W. Burke III, M.D.|University of Miami|(305) 355-5060|Gburke@med.miami.edu
1023|NCT00183339|Linmarie Sikich, MD|University of North Carolina|919 966 8653|Lsikich@med.unc.edu
1024|NCT00183430|Murray A. Raskind, MD|VA Puget Sound HCS|206-277-3797|Murray.Raskind@va.gov
1025|NCT00183456|Carl Latkin, PhD|Johns Hopkins Bloomberg School of Public Health||clatkin@jhsph.edu
1130|NCT00163215|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1131|NCT00163293|Respiratory Medical Advisor|Nycomed GmbH|0049-7531-840|clinicaltrials@nycomed.com
1132|NCT00165646|Nobuyuki Sugisaki,  Study Director|Eisai Co.,Ltd. Eisai Product Creation Systems|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp
1133|NCT00165672|Nobuyuki Sugisaki,  Study Director|Eisai Co.,Ltd. Eisai Product Creation Systems|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp
1134|NCT00165698|Takao Ishii, Asia regulatory affaires|Eisai Co., Ltd.|81-3-3817-3914|
1135|NCT00165776|Hiroki Shimizu, Study Director|Eisai Co., Ltd.|+81-3-3817-5245|
1136|NCT00165841|Yufang Lu, Study Director|Eisai Medical Research Inc.|201-403-2500|
1137|NCT00165958|Dr. Suephy Chen|Emory University|4047783084|schen2@emory.edu
1138|NCT00165984|Paul Kirshbom|Emory University|404-785-6330|pkirshb@emory.edu
1139|NCT00166036|Arshed A Quyyumi, MD|Emory University|404 712 2741|aquyyum@emory.edu
1140|NCT00166205|Sheryl Helsinger, Director|Worldwide Clinical Operations|513-337-3079|shelsing@its.jnj.com
1141|NCT00166296|Crisanto Diez-Quevedo|Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona|+34934978814|cdiezquevedo.germanstrias@gencat.cat
1097|NCT00157248|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
1098|NCT00157755|Clinical Program Manager|Medtronic Neuromodulation|763-526-8172|medtronicneurotrials@medtronic.com
1099|NCT00157820|Dr.A.Quesada|Hospital General Universitario de Valencia, Spain||aquesadad@secardiologia.es
1100|NCT00157950|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
1101|NCT00158197|Joy Chudzynski|Friends Research Institute|323-333-8122|joychud@ucla.edu
1102|NCT00158600|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
1103|NCT00158743|Suzanne Ward Pharm D|BTG International Inc|610-278-1660|suzanne.ward@btgplc.com
1104|NCT00159432|Victoria Soto, Project Specialist|USC Norris Comprehensive Cancer Center|323-226-6384|victoria.soto@med.usc.edu
1028|NCT00184028|Barbara Gitlitz, MD|USC/Norris Comrpehensive Cancer Center|323-865-3906|Gitlitz@usc.edu
1029|NCT00184054|Victoria Soto, Project Specialist, Clinical Investigations Support Office|USC Norris Comprehensive Cancer Center|323-226-6384|victoria.soto@med.usc.edu
1030|NCT00184548|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
1031|NCT00184600|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
1032|NCT00184717|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
1033|NCT00185211|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
1034|NCT00185380|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
1035|NCT00185458|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
1036|NCT00185588|George Albert Fisher, Associate Professor of Medicine, Stanford University|Stanford University|650-725-9057|georgeaf@stanford.edu
1037|NCT00185965|Ronald Levy, MD / Robert K and Helen K Summy Professor of Medicine|School of Medicine, Stanford University|650-725-6452|levy@stanford.edu
1038|NCT00186875|Deepa Bhojwani, MD|St. Jude Children's Research Hospital|901-595-5833|info@stjude.org
1039|NCT00186888|Ibrahim Qaddoumi MD|St. Jude Children's Research Hospital|1-866-278-5833|info@stjude.org
1040|NCT00186901|Sue Kaste, DO|St. Jude Children's Research Hospital|1-866-278-5833|info@stjude.org
1041|NCT00187096|Jeffrey Rubnitz, MD|St. Jude Children's Research Hospital|1-866-278-5833|info@stjude.org
1042|NCT00187135|Doralina Anghelescu, MD|St. Jude Children's Research Hospital|1-866-278-5833|info@stjude.org
1043|NCT00187226|Thomas E. Merchant, DO, PhD|St. Jude Children's Research Hospital|901-595-3604|thomas.merchant@stjude.org
1044|NCT00187486|Michael Prados, MD|University of California San Francisco|415 353 2076|PradosM@neurosurg.ucsf.edu
1045|NCT00187655|Richard Castro, MD|UCSF|4155144363|Rich.Castro@ucsf.edu
1046|NCT00187681|Kathy Giacomini, Ph.D|UCSF|4154761936|Kathy.Giacomini@ucsf.edu
1047|NCT00187720|Kathy Giacomini, Ph.D|UCSF|4154761936|Kathy.Giacomini@ucsf.edu
1048|NCT00187876|Peter Indelicato, MD|University of Florida|352-273-7017|wernegs@ortho.ufl.edu
1049|NCT00187889|Dr. Carl J. Pepine|University of Florida|352-273-9082|carl.pepine@medicine.ufl.edu
1050|NCT00189098|Prof. A. Schilder|Wilhelmina Children's Hospital, University Medical Center Utrecht|0031 302504580|A.Schilder@umcutrecht.nl
1051|NCT00189306|Medical Director|Graceway Pharmaceuticals|267-984-0400|jim.lee@gracewaypharma.com
1052|NCT00189423|Director of Clinical Trials|Advanced Circulatory Systems, Inc.|651-403-5600|csetum@advancedcirculatory.com
1053|NCT00189436|David Skoner, MD|Allegheny Singer Research Institute, WPAHS|412-359-4099|dskoner@wpahs.org
1054|NCT00189488|Hans Olivecrona, MD PhD|Biovitrum|+46 8 697 20 00|hans.olivecrona@sobi.com
1055|NCT00189540|Director of Clinical Operations|AnGes|240-780-9031|information@anges-mg.com
1056|NCT00190671|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1057|NCT00190684|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1058|NCT00190749|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1059|NCT00190775|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1060|NCT00190983|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1061|NCT00191100|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1062|NCT00191113|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1063|NCT00191139|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1064|NCT00191152|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1065|NCT00191165|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1066|NCT00145704|Timothy A. Damron|Upstate Orthopedics|315-464-8602|damront@upstate.edu
1067|NCT00145795|Dr. David Pitrak|The University of Chicago Department of Health Studies, Section of Infectious Diseases and Global Health|(773) 702-2710|dpitrak@medicine.bsd.uchicago.edu
1247|NCT00215553|Robert Segal, MD|Discovery Laboratories, Inc.|215-488-9300|rsegal@discoverylabs.com
1248|NCT00215657|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
1249|NCT00215683|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
1250|NCT00215787|Scott Phillips|Head and Neck Surgery Associates|317-926-1056|sphillips@hnsaonline.com
1251|NCT00215930|Gerald Bepler, M.D., via Moffitt Cancer Center|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|813-745-4398|beplerg@karmanos.org
1252|NCT00215943|Melissa Alsina, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-6886|melissa.alsina@moffitt.org
1253|NCT00216320|Director of Clinical Research|Innovative Neurotronics|512-721-1922|hrogers@ininc.us
1254|NCT00216476|EMEA Medical Affairs Director Psychiatry|Janssen Cilag European Medical Affairs|+34 91 7228043|
1255|NCT00216671|EMEA Medical Affairs Director Psychiatry|Janssen Cilag Spain|+34 91 7228043|
1256|NCT00217022|Dr. Darrell Pardi|Mayo Clinic, Rochester MN|507-538-1231|pardi.darrell@mayo.edu
1257|NCT00217399|Dr. Claudine Isaacs|Georgetown University|202-444-3677|isaacsc@georgetown.edu
1258|NCT00191191|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1259|NCT00191269|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1260|NCT00191282|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1261|NCT00191308|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1262|NCT00191334|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1263|NCT00191386|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1264|NCT00191451|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1265|NCT00191477|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1266|NCT00191646|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1267|NCT00191724|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1268|NCT00191789|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1269|NCT00191815|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1270|NCT00191854|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1271|NCT00191906|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1272|NCT00191945|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1273|NCT00191984|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1274|NCT00192023|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1275|NCT00192036|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1276|NCT00192075|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1277|NCT00192296|Joseph Parker, MD|MedImmune|301-398-0000|parkerj@medimmune.com
1278|NCT00193037|John D. Hainsworth, MD|Sarah Cannon Research Institute|615-329-7274|jhainsworth@tnonc.com
1279|NCT00193050|John D. Hainsworth, MD|Sarah Cannon Research Institute|877-691-7274|ASKSarah@scresearch.net
1280|NCT00193063|John D. Hainsworth, MD|Sarah Cannon Research Institute|877-691-7274|ASKSARAH@scresearch.net
1281|NCT00193128|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
1282|NCT00193180|John D. Hainsworth, MD|Sarah Cannon Research Institute|877-691-7274|ASKSARAH@scresearch.net
1283|NCT00193206|John D. Hainsworth, MD|Sarah Cannon Research Institute|877-691-7274|ASKSARAH@scresearch.net
1284|NCT00193219|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|ASKSARAH@scresearch.net
1285|NCT00193258|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
1286|NCT00193375|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|ASKSARAH@scresearch.net
1287|NCT00193414|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
1288|NCT00193427|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|ASKSARAH@scresearch.net
1289|NCT00193453|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|askSarah@scresearch.net
1290|NCT00193479|John D. Hainsworth, MD|Sarah Cannon Research Institute|615-329-7274|jhainsworth@tnonc.com
1291|NCT00193596|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
1292|NCT00193609|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
1293|NCT00194012|Robert Findling, MD, MBA, Director, Child and Adolescent Psychiatry|Johns Hopkins University School of Medicine|410-614-3225|rfindli1@jhmi.edu
1294|NCT00194025|Martha Sajatovic MD|Case Western Reserve University and Unversity Hospitals Case Medical Center|216-844-2808|martha.sajatovic@uhhospitals.org
1295|NCT00194077|Robert Findling, MD,MBA  Director, Child and Adolescent Psychiatry|Johns Hopkins University School of Medicine|410-614-3225|rfindli1@jhmi.edu
1296|NCT00194129|David Kemp, MD|UHCMC Mood Disorders Program|216-844-2865|David.Kemp@UHhospitals.org
1297|NCT00194532|Ann Stapleton, MD|University Of Washington|206-616-4121|stapl@uw.edu
1298|NCT00194610|Claire Yang, MD|University of Washington|206-744-6384|cyang@uw.edu
1299|NCT00194675|Alvin M. Matsumoto, MD|VA Puget Sound Health Care System|(206) 764-2760|alvin.matsumoto@med.va.gov
1300|NCT00194896|Jerry P. Palmer, MD|University of Washington|206-764-2495|jpp@u.washington.edu
1301|NCT00195260|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1302|NCT00195273|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
1303|NCT00195338|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1304|NCT00195351|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
1305|NCT00195403|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1306|NCT00195429|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
1210|NCT00206440|Mothaffar Rimawi|Baylor College of Medicine|713 798 1999|rimawi@bcm.tmc.edu
1307|NCT00195442|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1308|NCT00195494|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
1309|NCT00195507|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
1310|NCT00195650|Global Medical Services|Abbott|800-633-9110|
1311|NCT00195663|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
1312|NCT00195676|Global Medical Services|Abbott|800-633-9110|
1313|NCT00195702|Global Medical Services|Abbott|800-633-9110|
1314|NCT00195715|Global Medical Services|Abbott|1-800-633-9110|
1315|NCT00195819|Global Medical Services|Abbott|800-633-9110|
1316|NCT00196105|Scott Snyder|Cook|765-463-7537|ssnyder@medinst.com
1317|NCT00196196|Jandira Ramos, MPH|Codman & Shurtleff, Inc.|508-828-3127|jramos8@its.jnj.com
1318|NCT00196313|Duramed Research Protocol Chair|Duramed Research|215-293-7279|role_medical_affairs@tevapharm.com
1319|NCT00196326|Duramed Research Protocol Chair|Duramed Research|215-293-7279|medicalaffairs@barrlabs.com
1320|NCT00243347|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
1321|NCT00243386|Wing-Yen Wong, MD, Global Sr Medical Dir Hemophilia|Baxter Healthcare Corporation||wing_yen_wong@baxter.com
1322|NCT00243412|Medical Communications|Hoffman-LaRoche|800-821-8590|
1323|NCT00243503|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1324|NCT00243659|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
1325|NCT00243919|Pamela W. Duncan, PT, PhD, FAHA, FAPTA|Duke University|919-681-2060|pamela.duncan@duke.edu
1326|NCT00243932|Petra Kaufmann, MD, MSc|Columbia University|(212) 342-1252|pk88@columbia.edu
1327|NCT00244010|Kimberly Kasow, DO|St. Jude Children's Research Hospital|901-595-3300|kimberly_kasow@med.unc.edu
1026|NCT00183794|Agustin Garcia, MD|USC/Norris Cancer Comprehensive Cancer Center|323-865-3900|aagarcia@usc.edu
1164|NCT00170157|Eugene D. Kwon|Mayo Clinic||kwon.eugene@mayo.edu
1165|NCT00170846|Study director|Novartis Pharmaceuticals|862-778-8300|
1166|NCT00170950|Study Director|Novartis Pharmaceuticals|862 778-8300|
1167|NCT00171054|Study Director|Novartis Pharmaceuticals|862-778-8300|
1168|NCT00171210|Study Director|Novartis Pharmaceuticals|862-778-8300|
1169|NCT00171301|Study Director|Novartis Pharmaceuticals|862-778-8300|
1170|NCT00171314|Novartis Pharmaceuticals|Novartis Pharamaceuticals|862-778-8300|
1171|NCT00171340|Study Director|Novartis Pharmaceuticals|862- 778 8300|
1172|NCT00171704|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300|
1173|NCT00171834|Study Director|Novartis Pharmaceuticals|862-778-8300|
1174|NCT00171873|Carmen Schade-Brittinger|KKS Marburg|0049-6421-2866458|carmen.brittinger@kks.uni-marburg.de
1175|NCT00171925|Study Director|Novartis Pharmaceuticals|862-778-8300|
1176|NCT00200785|Larry D. Lawson|Silliker, Inc./Plant Bioactives Research Institute, Inc.|801-226-3041|larry.lawson@silliker.com
1177|NCT00200967|Vernon M. Chinchilli|Penn State College of Medicine|717-531-4262|vchinchi@psu.edu
1178|NCT00201006|Michael G. Perri, PhD|University of Florida|352 273-6214|mperri@ufl.edu
1179|NCT00201123|William Rom MD|NYU School of Medicine|212 263-6479|William.Rom@nyumc.org
1180|NCT00201201|Patricia J. Neafsey, PhD|University of Connecticut|860-486-0779|pjneafsey@actualmeds.com
1181|NCT00201643|Kimberly A. Maurel, MSN, CNS|Obstetrix Medical Group, Inc.|714-593-9171|kimberly_maurel@pediatrix.com
1182|NCT00201877|Kristie Blum, MD|The Ohio State University Comprehensive Cancer Center|614-293-4519|Kristie.Blum@osumc.edu
1183|NCT00202449|Murray Raskind, MD|VA PSHCS|206-764-2702|Murray.Raskind@va.gov
1184|NCT00202722|Tor Tveit|Sorlandet Hospital HF|+4738073608|tor.tveit@sshf.no
1185|NCT00202839|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
1186|NCT00203047|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
1187|NCT00203203|Emerson C. Perin, M.D., Ph.D.|Texas Heart Institute|832-355-9405|eperin@texasheart.org
1188|NCT00203216|Dr. William Young, Principal Investigator|Thomas Jefferson University/Jefferson Headache Center|215-955-2243|William.B.Young@Jefferson.Edu
1189|NCT00203229|M. Alan Stiles|Thomas Jefferson University|215-955-6215|Alan.Stiles@Jefferson.edu
1190|NCT00203242|Stephen D. Silberstein-Principal Investigator|Thomas Jefferson University/Jefferson Headache Center|215-955-9477|Stephen.Silberstein@jefferson.edu
1191|NCT00203268|Stephen D. Silberstein, MD|Thomas Jefferson University|215-955-2243|Stephen.Silberstein@Jefferson.edu
1192|NCT00203294|Kathleen Bradley|Thomas Jefferson University|215-955-2025|Kathleen.Bradley@Jefferson.edu
1193|NCT00203307|Stephen D. Silberstein, M.D.- Principal Investigator|Thomas Jefferson University/ Jefferson Headache Center|215-955-2243|stephen.silberstein@jefferson.edu
1194|NCT00203424|Dr. Fairooz F. Kabbinavar, Chief Medical Officer|Translational Oncology Research International|310-824-1934|FKabbina@mednet.ucla.edu
1195|NCT00203476|Raela Williford, PharmD|TuscaloosaREAC|(205) 554-2000 ext 2433|Raela.Williford@va.gov
1196|NCT00203892|Dr. Hedy Kindler|University of Chicago|773-702-0360|hkindler@medicine.bsd.uchicago.edu
1197|NCT00203931|Kristen Wroblewski|University of Chicago|773-702-7173|kwroblewski@health.bsd.uchicago.edu
1198|NCT00203996|David A. Ehrmann, MD|The University of Chicago|(773) 702-6138|dehrmann@medicine.bsd.uchicago.edu
1199|NCT00204373|Dr. C. Mel Wilcox|The University of Alabama at Birmingham|205-934-6060|melw@uab.edu
1200|NCT00205049|Research Program Manager - Kelly Richie|University of Wisconsin|608-262-5404|kr2@medicine.wisc.edu
1201|NCT00205504|Kai Cheang, Principal Investigator|Virginia Commonwealth University|804-828-9698|kicheang@vcu.edu
1202|NCT00205712|John Newcomer, MD|Washington University School of Medicine|314-362-3153|newcomerj@wustl.edu
1203|NCT00205777|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1204|NCT00205803|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1205|NCT00205855|Natalie Bloom Lyons|Boston Scientific Corporation|763-228-9040|lyonsn@bsci.com
1206|NCT00205881|Kenneth Ripley|Advanced Bionics, LLC|(661) 362-4572 ext N/A|Kenneth.Ripley@advancedbionics.com
1207|NCT00206076|David Reich, MD|Drexel University College of Medicine|215-762-7143|David.Reich@DrexelMed.edu
1208|NCT00206102|Gerard Lynch|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
1209|NCT00206427|Dr. Mothaffar Rimawi|Baylor Breast Cancer|713-798-1311|rimawi@bcm.tmc.edu
1234|NCT00212355|Department director of clinical development department 1|Nobelpharama|+81-3-5651-1177|murakami@nobelpharma.co.jp
1235|NCT00212758|Dr. Amira Al-Uzri|Oregon Health & Science University|503-494-7327|aluzria@ohsu.edu
1236|NCT00213135|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
1237|NCT00214201|Director of Clinical Trials|UW Madison|608-263-2565|
1238|NCT00214383|Alice Pulvermacher|University of Wisconsin - Madison|(608) 262-8448|alice.pulvermacher@chess.wisc.edu
1239|NCT00214461|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
1240|NCT00214487|Dr. Thomas Aller|Dr. Thomas Aller, Optometrist Inc.|650 871-1816|cptreyes@earthlink.net
1241|NCT00214526|Narinder S Shargill, PhD|Asthmatx, Inc.|408-419-0100|
1242|NCT00214539|Narinder S Shargill, PhD|Asthmatx, Inc.|408-419-0100|
1243|NCT00214786|Dr. Marlon Levy|Baylor University Medical Center|214-820-2050|Marlon.Levy@baylorhealth.edu
1244|NCT00215137|Wei Zhang MD|Duke University Medical Center Dept of Psychiatry|919 684 5645|wei.zhang@duke.edu
1245|NCT00215150|Wei Zhang, MD|Duke University Medical Center|(919) 684 5645|wei.zhang@duke.edu
1246|NCT00215540|Dr. Robert Segal|Discovery Laboratories, Inc.|215-488-9300|rsegal@discoverylabs.com
1158|NCT00168428|Therapeutic Area Head|Allergan, Inc.|(714) 246-4500|clinicaltrials@allergan.com
1159|NCT00168454|Therapeutic Area Head|Allergan, Inc.|(714)246-4500|clinicaltrials@allergan.com
1160|NCT00168805|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
1161|NCT00168818|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
1162|NCT00168831|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
1163|NCT00168844|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
1374|NCT00237666|Dr. Michael Liebowitz|The Medical Research Network, LLC|(212) 595-5012|MLiebowitz@MedicalResearchNetwork.com
1375|NCT00237718|T. Alp Ikizler, MD|Vanderbilt University||alp.ikizler@vanderbilt.edu
1376|NCT00237744|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|Malcom Randall VA Medical Center, Gainesville Florida|(352) 376-1611 ext 6603|jjd17@case.edu
1377|NCT00237770|Dr. Jill M. Wecht, principal Investigator|James J Peters VA Medical Center|718 584-9000 ext 3122|jm.wecht@va.gov
1378|NCT00238108|Dr. Frank Scheer|Brigham and Women's Hospital|617-732-7014|fscheer@rics.bwh.harvard.edu
1379|NCT00238121|Dr. Gini Fleming|University of Chicago Comprehensive Cancer Center|773-702-6712|gfleming@medicine.bsd.uchicago.edu
1380|NCT00238303|Evanthia Galanis, M.D.|Mayo Clinic|(507) 284-3902|galanis.evanthia@mayo.edu
1381|NCT00238355|Dr. Lynne Strasfeld|OHSU Knight Cancer Institute|503-494-1551|strasfel@ohsu.edu
1382|NCT00238615|Dr. Heather Wakelee|Stanford University|650-736-7221|hwakelee@stanford.edu
1383|NCT00239005|Study Director|Novartis Pharmaceuticals|862-778-8300|
1384|NCT00239226|Giorgio Corbucci - Sr Principal Scientist|Medtronic BRC  - Medtronic Italia SpA|+39 02 241371|giovanna.zucchi@medtronic.com
1385|NCT00239356|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
1386|NCT00239642|David Bregman, M.D., Ph.D.|Luitpold Pharmaceuticals, Inc.|601-650-4200|dbregman@lpicrd.com
1387|NCT00239681|Torbjorn Lundstrom|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
1388|NCT00239720|Marcus Clark, MD|University of Chicago|773-702-0202|mclark@medicine.bsd.uchicago.edu
1389|NCT00239837|Dr Leslie Leve|Oregon Social Learning Center|541-485-2711|lesliel@oslc.org
1390|NCT00239928|Pfizer Clinical Trails.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1391|NCT00240071|Carla I Falkson|University of Alabama at Birmingham|205-975-2691|cfalkson@uab.edu
1392|NCT00240162|Ravi Vij, M.D.|Washington University School of Medicine|314-454-8304|rvij@dom.wustl.edu
1393|NCT00240331|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
1394|NCT00240500|GSK Response Center|GlaxoSmithKline|866-435-7343|
1395|NCT00240526|GSK Response Center|GlaxoSmithKline|866-435-7343|
1396|NCT00240539|GSK Response Center|GlaxoSmithKline|866-435-7343|
1397|NCT00240994|Associate Director, Clinical Research Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
1398|NCT00241176|Barbara J Coffey, M.D, M.S.|NYU School of Medicine, NYU Child Study Center|(212)263-3926|barbara.coffey@mssm.edu
1399|NCT00241644|GSK Response Center|GlaxoSmithKline|866-435-7343|
1400|NCT00241839|Mark S. Segal, MD, PhD; Assistant Professor and Chief, Division of Nephrology|University of Florida|352-273-8821|Mark.Segal@medicine.ufl.edu
1401|NCT00242216|Dr. Roberto C. Arduino, Professor of Medicine|The University of Texas Health Science Center at Houston|713-500-6731|roberto.c.arduino@uth.tmc.edu
1402|NCT00242385|David Gelmont, MD, Global Medical Director, Head of Specialty Products TA, BioTherapeutics|Baxter Healthcare Corporation||david_gelmont@baxter.com
1403|NCT00242502|Ahmed Kaseb, MD/ Professor|University of Texas MD Anderson Cancer Center||MJLim@mdanderson.org
1404|NCT00242567|Study Director|Novartis Pharmaceuticals|862-778-8300|
1405|NCT00242580|Study Director|Novartis Pharmaceuticals|862 778-8300|
1406|NCT00242658|Chris Sciamanna, MD, MPH|Penn State Milton S. Hershey Medical Center|717-531-8161|cns10@psu.edu
1426|NCT00249873|International Clinical Development, Clinical Study Director|sanofi-aventis||GV-Contact-us@sanofi-aventis.com
1427|NCT00250432|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
1428|NCT00250458|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
1429|NCT00250588|Michael Seid|CCHMC|5138030083|michael.seid@cchmc.org
1430|NCT00250679|Respiratory Medical Director|Sepracor Inc.|1-866-503-6351|
1431|NCT00251004|Study Director|Novartis Pharmaceuticals|862-778-8300|
1432|NCT00251303|Dr. Susan E. Swedo|National Institute of Mental Health, Pediatrics and Developmental Neuroscience Branch|301-496-5323|swedos@mail.nih.gov
1433|NCT00251316|Dr. Monica Skarulis|NIDDK, NIH|301-496-6087|monicas@intra.niddk.nih.gov
1434|NCT00251589|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
1435|NCT00251641|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
1436|NCT00251693|Sr. VP Clinical Sciences|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
1437|NCT00251719|Sr. VP Clinical Sciences|Takeda Global Research & Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
1438|NCT00251745|Sr. VP Clinical Sciences|Takeda Global Research & Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
1439|NCT00251758|Sr. VP Clinical Sciences|Takeda Global Research & Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
1440|NCT00251862|Dr. Paul C. Schroy III|Boston Medical Center|617-638-8335|paul.schroy@bmc.org
1464|NCT00254982|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
1465|NCT00255008|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
1466|NCT00255034|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
1467|NCT00255047|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
1468|NCT00255151|Sr. VP Clinical Sciences|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
1469|NCT00255164|Sr. VP Clinical Sciences|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
1470|NCT00255177|Mary Giffear, Sr. Clinical Scientist|VGX Pharmaceuticals, LLC|267 440 4220|mgiffear@inovio.com
1471|NCT00255190|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
1472|NCT00255840|Dr Ian Sanne|CIPRA-SA|+27 11 276 8800|isanne@witshealth.co.za
1473|NCT00255970|Clinical Projects, Director|RTI Biologics|386-418-8888|rparkhurst@rtix.com
1474|NCT00256204|Dennis Ahern, MS, Director|Teva Branded Pharmaceutical Products R&D|215-293-6339|dennis.ahern@tevausa.com
1475|NCT00256243|Nicole Macaranas, Clinical Research Specialist|Chao Family Comprehensive Cancer Center|(714) 456-6550|nicole.macaranas@uci.edu
1476|NCT00256295|Nicole Macaranas|University of California, Irvine|714-456-6550|nicole.macaranas@uci.edu
1477|NCT00256698|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
1478|NCT00256724|Nathan Burkhart|Advanced Circulatory|651.403.5600|nburkhart@advancedcirculatory.com
1479|NCT00217425|Study Statistician|ECOG Statistical Office|617-632-3012|
1480|NCT00217438|Dr. William Bensinger|Fred Hutchinson Cancer Research Center|206-667-4933|wbensing@fhcrc.org
1481|NCT00217581|Philip A. Philip, M.D., Ph.D., F.R.C.P|Barbara Ann Karmanos Institute|(313) 576-8746|philipp@karmanos.org
1482|NCT00217620|Study Statistician|SWOG Statistical Center|206-667-4623|
1483|NCT00217724|Joseph Bublao|OHSU Knight Cancer Institute|503-494-1054|bubaloj@ohsu.edu
1484|NCT00217971|Frances R. Levin, M.D.|Columbia University|(212) 543-5896|frl2@columbia.edu
1485|NCT00218296|Dorothy Hatsukami, Ph.D.|University of Minnesota|612-626-2121|hatsu001@umn.edu
1486|NCT00218335|Carl Latkin, PhD|Johns Hopkins Bloomberg School of Public Health||clatkin@jhsph.edu
1441|NCT00251927|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
1442|NCT00251979|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
1443|NCT00252057|Brian Jack PI|Boston Medical Center|617-414-44675|brian.jack@bmc.org
1444|NCT00252187|Dr. Horng H. Chen|Mayo Clinic|507-778-2354|chen.horng@mayo.edu
1445|NCT00252499|Kristina Utzschneider, MD|VA Puget Sound Health Care System|206-277-3568|kristina.utzschneider@va.gov
1446|NCT00252512|Hildi Hagedorn|Minneapolis VA Health Care System|612-467-3875|hildi.hagedorn@va.gov
1447|NCT00252564|Allen L. Cohn|US Oncology|303- 388-4876|Allen.Cohn@USOncology.com
1448|NCT00252694|Niklas Berglind, GPS Atacand|AstraZeneca|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com
1449|NCT00252720|Niklas Berglind, GPS Atacand|AstraZeneca|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com
1450|NCT00252733|Niklas Berglind, GPS Atacand|AstraZeneca|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com
1451|NCT00252967|Samuel Dudley, MD, PhD|Brown University|4014443024|samuel_dudley@brown.edu
1452|NCT00253019|Carrie Cwiak, MD, MPH|Emory University|404-778-1696|ccwiak@emory.edu
1453|NCT00253448|Research Investigator|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|937-395-8646|douglas.einstein@khnetwork.org
1454|NCT00253513|Eneida Nemecek, MD|OHSU Knight Cancer Institute|(503) 494-0829|nemeceke@ohsu.edu
1455|NCT00253747|Dr. Theresa Winhusen|University of CIncinnati|513-487-7800|winhusen@carc.uc.edu
1456|NCT00253890|Dr. Michael D. Stein, MD|Butler Hospital|401-455-6646|mstein@butler.org
1457|NCT00253981|COL Richard Petri, Chief Integrative Pain Management|William Beaumont Army Medical Center|915-742-3245|richard.petri@amedd.army.mil
1458|NCT00254072|Ninh T. Nguyen, M.D.|UC Irvine Medical Center|714-456-8580|ninhn@uci.edu
1459|NCT00254293|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
1460|NCT00254462|Christopher J. Kratochvil, M.D.|University of Nebraska Medical Center|402-552-6005|ckratoch@unmc.ed
1461|NCT00254540|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1407|NCT00242710|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1408|NCT00243022|Dr. Glen Stevens|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center||steveng@ccf.org
1409|NCT00243191|SARC, Chief Operating Officer|SARC|734-930-7600|sarc@sarctrials.org
1410|NCT00243243|David G. Baer, PhD, Director Research|US Army Institute of Surgical Research|210-539-4327|david.g.baer@us.army.mil
1411|NCT00243269|Joseph Roscoe PhD|University of Rochester|585 275-9962|joseph_roscoe@urmc.rochester.edu
1412|NCT00247676|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1413|NCT00247962|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
1414|NCT00248547|Joseph Bubalo, PharmD|Oregon Health & Science University, Knight Cancer Institute|503-494-1054|bubaloj@ohsu.edu
1415|NCT00248560|Ammar Sukari, M.D.|Barbara Ann Karmanos Cancer Institute|313-576-8751|sukaria@karmanos.org
1416|NCT00248638|Thomas R. Ziegler M.D.|Emory University|4047277354|Tzieg01@emory.edu
1417|NCT00248651|Dr. Yuri A. Saito Loftus|Mayo Clinic|507-266-9094|saito.yuri@mayo.edu
1418|NCT00248781|Dr. David Sparrow|VA Boston Healthcare System|857-364-6407|david.sparrow@va.gov
1419|NCT00248807|Dr. Jill M. Wecht; Principal Investigator|James J Peters VAMC|718 584-9000 ext 3122|JM.Wecht@va.gov
1420|NCT00249002|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
1421|NCT00249249|Dr Neil Hounslow|Kowa Research Europe, Ltd.|+44 118 922 9004|nhounslow@kowa.co.uk
1422|NCT00249288|Michelle Hill|Schizophrenia Program, Massachusetts General Hospital|617-912-7846|michelehill1@gmail.com
1423|NCT00249613|Michael Prendergast|UCLA Integrated Substance Abuse Programs|310-267-5503|mlp@ucla.edu
1424|NCT00249795|International Clinical Development, Clinical Study Director|sanofi-aventis||GV-Contact-us@sanofi-aventis.com
1425|NCT00249821|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
1211|NCT00206726|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
1212|NCT00207090|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
1213|NCT00207142|Study Director|Bristol-Myers Squibb||clinical.trials@bms.com
1214|NCT00207714|Director Clinical Research|Centocor Research & Development, Inc.|1-800-457-6399|
1215|NCT00207727|Sr. Dir. Clinical Research|Centocor Research & Development, Inc.|1-800-457-6399|
1216|NCT00207740|Director Clinical Research|Centocor Research & Development, Inc.|1-800-457-6399|
1217|NCT00208091|Dr. Seth Pullman|Clinical Motor Physiology Laboratory|212-305-3808|sp31@columbia.edu
1218|NCT00208494|Jennifer Hoag, MS, Project Leader, Clinical Research|DePuy Orthopaedics, Inc.|574-372-7399|JHoag2@its.jnj.com
1219|NCT00208507|Dave Whalen|DePuy Orthopaedics, Inc|574-372-7028|DWhalen@its.jnj.com
1220|NCT00208767|Dr. Arshed Quyyumi|Emory University School of Medicine|404-727-3655|aquyyum@emory.edu
1221|NCT00208949|Dr. Sagar Lonial|Emory University|404-778-1900|SLONI01@emory.edu
1222|NCT00208975|Dr. Christopher Flowers|Emory University|404-778-3942|crflowe@emory.edu
1223|NCT00209027|Erica Duncan|Emory University|404-321-6111 ext 7532|erica.duncan@va.gov
1224|NCT00209092|Dr. Amelia Zelnak|Emory University|404-778-1900|amelia.zelnak@emory.edu
1225|NCT00209131|Dr. Kenneth Ogan|Emory University|404-778-4898|kogan@emory.edu
1226|NCT00209560|Eisai Medical Services|Eisai Inc|1-888-422-4743|
1227|NCT00210470|Zygmund Roth, Ph.D., V.P., Regulatory Affairs and QA|IRX Therapeutics, Inc.|631-465-2028|zroth@irxtherapeutics.com
1228|NCT00210626|Vice President Medical Affairs|Centocor Ortho Biotech Services, LLC (COBS)|215-325-4464|
1229|NCT00210639|Director, Clinical Research|Janssen R&D US|1 609 730-3158|
1230|NCT00211237|zhimin Liu|Medtronic Spine LLC|901-399-3123|zhimin.liu@medtronic.com
1231|NCT00211510|John Shin, PhD, MBA|Medtronic, Inc|818 576 4019|john.shin@medtronic.com
1232|NCT00211536|John Shin|Sr. Clinical Research Manager|818-576-4019|john.shin@medtronic.com
1233|NCT00211887|Dr. Fred D. Lublin|Icahn School of Medicine at Mount Sinai|212-241-6854|fred.lublin@mssm.edu
1142|NCT00166361|Dr. Lance A. Mynderse|Mayo Clinic|507-284-1250|mynderse.lance@mayo.edu
1143|NCT00166504|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
1144|NCT00166517|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
1145|NCT00167102|Dr. Maria Hordinsky|University of Minnesota|612-624-5721|hordi001@umn.edu
1146|NCT00167206|Margaret MacMillan, M.D.|Masonic Cancer Center, University of Minnesota|612-626-2778|macmi002@umn.edu
1147|NCT00167245|Dr. Kyle Kampman|University of Pennsylvania|2152223200 ext 109|kampman@mail.med.upenn.edu
1148|NCT00167544|Dr. Nehal Parikh|Nationwide Children's Hospital Clinical Research Institute|614-355-6657|nehal.parikh@nationwidechildrens.org
1149|NCT00167778|Glenn K. Klute, PhD|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|206-277-6724|Glenn.Klute@va.gov
1150|NCT00168038|Clinical Trial Disclosure Manager|CSL Behring||clinicaltrials@cslbehring.com
1151|NCT00168064|H. Jeffrey Wilkins, MD|Yaupon Therapeutics|4843247935 ext 935|hjwilkins@yaupontherapeutics.com
1152|NCT00168103|Clinical Program Director|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
1153|NCT00168298|Therapeutic Area Head|Allergan, Inc.|(714)246-4500|clinicaltrials@allergan.com
1154|NCT00168311|Professor Paul Fitzgerald|Monash Alfred Psychiatry Research Centre|+61 3 9076 6564|p.fitzgerald@alfred.org.au
1155|NCT00168324|Therapeutic Area Head|Allergan, Inc.|(714)246-4500|clinicaltrials@allergan.com
1156|NCT00168337|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
1157|NCT00168389|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
1521|NCT00226577|Gerold Bepler, M.D., Ph.D. via Moffitt Cancer Center|Karmanos Cancer Institute|813-745-4398|beplerg@karmanos.org
1522|NCT00226590|Gerald Bepler, M.D., Ph.D., c/o Moffitt Cancer Center|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|813-745-4398|beplerg@karmanos.org
1523|NCT00226655|Director Medical Sciences|Celtic Pharma Development Services America Inc|(212) 616 4016|henk-andre.kroon@dev.celticpharma.com
1524|NCT00226811|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1525|NCT00227266|Sandra Reyna, M.D.|University of Utah|801-581-3551|sreyna@genetics.utah.edu
1526|NCT00227305|Seroquel Medical Science Director, MD|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
1527|NCT00227370|Scott M. Palmer, MD, MHS|Duke Clinical Research Institute|919 684 0254|scott.palmer@duke.edu
1528|NCT00227591|Study Statistician|ECOG Statistical Office|617-632-3012|
1529|NCT00227903|Dr. Kimberly Yonkers|Yale University|1-203-764-6621|Kimberly.Yonkers@yale.edu
1530|NCT00228384|Chad  Badorek|W. L. Gore & Associates, Inc.|800/437-8181|cbadorek@wlgore.com
1531|NCT00228553|Sponsor's Medical Director, Clinical Research|Cephalon|1-877-237-4879|
1532|NCT00228566|Sponsor's Medical Director, Clinical Research|Cephalon, Inc.|1-877-237-4879|
1533|NCT00228943|Janet S. Carpenter|Indiana University|317-278-6093|carpentj@iupui.edu
1534|NCT00229203|Claudia Silvia Corrado M.D.|PharmaMar USA Inc|1 212 201 6770|cscorrado@pharmamar.com
1535|NCT00229619|Adrian Wiestner MD, NHLBI|NIH National Heart, Lung and Blood Institute|301-594-6855|wiestnera@nhlbi.nih.gov
1536|NCT00229658|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
1537|NCT00229723|Gerard Lynch|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
1538|NCT00229957|Dr. Julie Richardson|McMaster University|905-525-9140 ext 27811|jrichard@mcmaster.ca
1539|NCT00229970|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
1540|NCT00230009|Steven J. Ondersma, ,PI|Wayne State University|313-577-6680|s.ondersma@wayne.edu
1541|NCT00230022|Steven J. Ondersma|Wayne State University|313-577-6680|s.ondersma@wayne.edu
1542|NCT00230048|Steven J. Ondersma|Wayne State University|313-577-6680|s.ondersma@wayne.edu
1543|NCT00230178|International Clinical Development, Clinical Study Director|Sanofi-aventis||GV-Contact-us@sanofi-aventis.com
1544|NCT00230282|Steven E. Coutre, Associate Professor of Medicine|Stanford University|650-723-6661|coutre@stanford.edu
1545|NCT00230971|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
1546|NCT00231062|Laura England, Manager-Clinical Affairs|Acclarent|650-687-4466|lenglan1@its.jnj.com
1547|NCT00231114|Narinder S Shargill, PhD|Asthmatx, Inc.|408-419-0100|
1548|NCT00231153|Catherine Hardalo, MD Vice President Anti-Infectives, Clinical Development|Cadence Pharmaceuticals, Inc.|858-436-1439|chardalo@cadencepharm.com
1549|NCT00231179|Jerilynn Radcliffe, PhD|Children's Hospital of Philadelphia|215-590-7446|Radcliffe@email.chop.edu
1550|NCT00231283|Sidney Cohen, MD PhD, Vice President|Cordis|650 614-2726|scohen7@its.jnj.com
1551|NCT00231309|Kuang-Yueh Chiang, MD|Emory University|404-785-1441|kuang-yueh.chiang@choa.org
1552|NCT00231465|Alberto Chiappori, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-2158|alberto.chiappori@moffitt.org
1553|NCT00231478|Medical Communications|Hoffman-LaRoche|800-821-8590|
1554|NCT00231777|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
1579|NCT00235833|Medical Information Specialist|Abbott|800-633-9110|
1580|NCT00235872|Global Medical Services|Abbott|800-633-9110|
1581|NCT00235989|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
1582|NCT00236080|Sponsor's Medical Director, Clinical Research|Cephalon, Inc.|1-877-237-4879|
1583|NCT00236184|Yufang Lu, MD, PhD, Study Director|Eisai Medical Research Inc.|201-403-2500|
1584|NCT00236197|Yufang Lu, MD, PhD, Study Director|Eisai Medical Research Inc.|201-403-2500|
1585|NCT00236899|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1586|NCT00236938|Marc Tokars|Luitpold Pharmaceuticals, Inc.|610-650-4200|mtokars@lpicrd.com
1587|NCT00236951|Marc Tokars, Senior Director of Clinical Operations|Luitpold Pharmaceuticals|610-650-4200 ext 805|mtokars@lpicrd.com
1588|NCT00236977|Marc L. Tokars, Sr. Director of Clinical Operations|Luitpold Pharmaceuticals, Inc.|610-650-4200|mtokars@lpicrd.com
1589|NCT00237042|Dr. Judith Turner|University of Washington|206-543-3997|jturner@u.washington.edu
1590|NCT00267956|Senior Director Clinical Research|Centocor Research & Development, Inc|1-800-457-6399|
1591|NCT00267969|Dir. Clinical Research|Centocor Research & Development, Inc.|1-800-457-6399|
1592|NCT00268203|GSK Response Center|GlaxoSmithKline|866-435-7343|
1593|NCT00268346|David Adelstein MD|Cleveland Clinic Taussig Cancer Institute|216-444-9310|adelstd@ccf.org
1594|NCT00268463|Director, Division of Regulatory Affairs|NSABP Foundation, Inc.|412-330-4600|
1595|NCT00268762|Andrew D. Barreto, MD|University of Texas Health Science Center at Houston|713-500-7002|andrew.d.barreto@uth.tmc.edu
1596|NCT00268892|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
1597|NCT00268905|Prash Krishna, Study Director|Eisai|888-422-4743|
1598|NCT00268983|GSK Response Center|GlaxoSmithKline|866-435-7343|
1599|NCT00269152|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1600|NCT00269477|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
1601|NCT00269919|Medical CRA|Janssen Korea Ltd., Korea|+82-2-2094-4804|
1602|NCT00270205|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617)432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
1603|NCT00270231|Caryn Lerman, Ph.D.|University of Pennsylvania|215-746-7141|clerman@mail.med.upenn.edu
1604|NCT00270634|Robert Huizinga|Isotechnika Pharma Inc.|780 487 1600 ext 223|robert.huizinga@isotechnika.com
1605|NCT00270894|Vice President of Scientific Affairs|Accelerated Community Oncology Research Network, Inc.|901-435-5570|mwalker@acorncro.com
1606|NCT00271011|Dr. Mark Zalupski|University of Michigan Comprehensive Cancer Center|734-615-3969|zalupski@umich.edu
1607|NCT00271024|Dr. Andrea King|University of Chicago|7737026181|aking@bsdad.uchicago.edu
1608|NCT00271154|CRDM Core Clinical|Medtronic CRDM|800-328-2518|medtroniccrmtrials@medtronic.com
1609|NCT00271544|Hang Nguyen|Medtronic CRDM Clinical Research|800-328-2518 ext 62832|hang.t.nguyen@medtronic.com
1610|NCT00271570|Jane Burns, MD, Professor|University of California, San Diego|858-246-0155|jcburns@ucsd.edu
1611|NCT00271596|Leigh Beglinger, PhD|University of Iowa; Elks Rehab Hospital|319-353-4489|leigh-beglinger@elksrehab.org
1612|NCT00271609|Teri Kreisl, M.D.|National Cancer Institute, National Institutes of Health|301-402-3423|kreislt@mail.nih.gov
1613|NCT00271739|Walter Palmas, M.D.|Columbia University|212-305-3163|wp56@columbia.edu
1614|NCT00271817|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
1615|NCT00271856|Patricia Moran, PhD|UCSF Osher Center for Integrative Medicine|415.353.9745|moranp@ocim.ucsf.edu
1616|NCT00271947|Dr Richard Burt|Northwestern University|312-908-0059 ext N/A|rburt@northwestern.edu
1617|NCT00272038|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD, FACP (PI)|Oncology Specialists, S.C.|847-268-8200|shallmeyer@oncmed.net
1618|NCT00272311|Charles H. Hennekens, M.D.|Florida Atlantic University|n/a|chenneke@fau.edu
1619|NCT00272337|Charles H. Hennekens, M.D.|Florida Atlantic University|n/a|chenneke@fau.edu
1620|NCT00272779|BMS Study Director|Bristol-Myers Squibb||ClinicalTrials@bms.com
1621|NCT00272792|Medical Information Services|BioMarin Pharmaceutical Inc.|1-800-983-4587|medinfo@bmrn.com
1622|NCT00272961|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1623|NCT00272987|GSK Response Center|GlaxoSmithKline|866-435-7343|
1624|NCT00273052|GSK Response Center|GlaxoSmithKline|866-435-7343|
1462|NCT00254566|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1463|NCT00254592|Rita S. MEHTA, MD|University of California Irvine Medical Center|(714) 456-5153|rsmehta@uci.edu
1328|NCT00244101|Roger F. Soll, MD|Vermont Oxford Network|802 865 4814 ext 212|roger.soll@vtmednet.org
1329|NCT00244140|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
1330|NCT00244374|Dr. Paula J. Lum|University of California, San Francisco|415-476-4082 ext 411|plum@php.ucsf.edu
1331|NCT00244621|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
1332|NCT00244712|GSK Response Center|GlaxoSmithKline|866-435-7343|
1333|NCT00244764|GSK Response Center|GlaxoSmithKline|866-435-7343|
1334|NCT00244881|Dr Harold Burstein|Dana-Farber Cancer Institute|617-632-3800|hburstein@partners.org
1335|NCT00245050|Vivian von Gruenigen, MD|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|216-844-5011|vev1@case.edu
1336|NCT00245102|Dr. William Tap|Memorial Sloan-Kettering Cancer Center|646-888-4163|tapw@mskcc.org
1337|NCT00245128|Dr. Michael Mauro|OHSU Knight Cancer Institute|503-494-1080|maurom@ohsu.edu
1338|NCT00245466|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
1339|NCT00245557|Brent Forester MD|McLean Hospital|617-855-3622|bforester@mclean.harvard.edu
1340|NCT00245570|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
1341|NCT00245856|Suman Rathbun MD|University of Oklahoma Health Sciences Center|4052714742 ext 44773|suman-rathbun@ouhsc.edu
1342|NCT00245960|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
1343|NCT00246012|Senior Director|Centocor, Inc.|908-927-2116|
1344|NCT00246025|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
1345|NCT00246090|Eisai Inc.|Eisai Call Center|888-422-4743|
1346|NCT00246259|Director Medical Affairs - CNS|Janssen Inc., Toronto, ON, Canada|+1-416-382-5094|
1347|NCT00246324|Alireza Minagar, MD|LSU Health Sciences Center in Shreveport Department of Neurology|318-813-1481|aminag@lsuhsc.edu
1348|NCT00246337|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
1349|NCT00246519|Julie A. Johnson|University of Florida|352-273-6007|johnson@cop.ufl.edu
1350|NCT00246571|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1351|NCT00246805|Giorgio Corbucci - Sr Principal Scientist|Medtronic BRC - Medtronic Italia|+39 02 241371|giovanna.zucchi@medtronic.com
1352|NCT00247273|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
1353|NCT00247377|Ninh Nguyen|UCI|714-456-8598|ninhn@uci.edu
1354|NCT00247416|Suzane Arnold, MD|University of Kentucky Markey Cancer Center|859 323 8043|smarno0@uky.edu
1355|NCT00247611|Dr. Jeffrey Fisher, Principal Investigator|Center for Health, Intervention & Prevention|(860) 486-4940|jeffrey.fisher@uconn.edu
1356|NCT00196716|Genzyme MedInfo|Genzyme Corporation|800-745-4447|medinfo@genzyme.com
1357|NCT00196937|GSK Response Center|GlaxoSmithKline|866-435-7343|
1358|NCT00197015|GSK Response Center|GlaxoSmithKline|866-435-7343|
1359|NCT00197028|GSK Response Center|GlaxoSmithKline|866-435-7343|
1360|NCT00197106|GSK Response Center|GlaxoSmithKline|866-435-7343|
1361|NCT00197119|GSK Response Center|GlaxoSmithKline|866-435-7343|
1362|NCT00197184|GSK Response Center|GlaxoSmithKline|866-435-7343|
1363|NCT00197236|GSK Response Center|GlaxoSmithKline|866-435-7343|
1364|NCT00197392|J. Thomas Megerian, MD|Codman & Shurtleff, Inc|508.880.8274|jmegeri1@its.jnj.com
1365|NCT00198029|Dr. Lisa Mandl|Hospital for Special Surgery|212-774-2555|MandlL@hss.edu
1366|NCT00198822|Prof. Keith P West, Jr., Principal Investigator|Center for Human Nutrition, Department of International Health, Johns Hopkins Bloomberg School of Public Health|410-955-2061|kwest@jhsph.edu
1367|NCT00199381|Director of Clinical Trials|Kyowa Hakko Kirin Pharma, Inc.|609-919-1100|mcantillon@kyowa-kirin-pharma.com
1368|NCT00199914|Manee Rattanachaiyanont|Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand|+66-2419-4657|manee.rat@mahidol.ac.th
1369|NCT00200057|Chad Giese|Medtronic Neuromodulation|763-377-5955|chad.giese@medtronic.com
1370|NCT00200343|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
1371|NCT00200356|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
1372|NCT00237185|Study Director|Novartis|862-778-8300|
1373|NCT00237458|UCB (Study Director)|UCB Clinical Trial Call Center|+1 887 822 9493|
1510|NCT00224107|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|Watson Laboratories, Inc.|801-588-6641|gary.hoel@watson.com
1511|NCT00224120|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|Watson Laboratories, Inc.|801-588-6641|gary.hoel@watson.com
1512|NCT00224133|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|Watson Laboratories, Inc.|801-588-6641|gary.hoel@watson.com
1513|NCT00224289|Bruce Shields, MD|Principal Investigator|203-785-6288|bruce.shields@yale.edu
1514|NCT00224874|Nancy DiFronzo, Ph.D|National Heart, Lung, and Blood Institute|301-435-0065|difronzon@nhlbi.nig.gov
1515|NCT00225017|Robert Murphy|Northwestern University|312-503-9000|r-murphy@northwestern.edu
1516|NCT00225147|Medical Affairs Department|Pharming Technologies BV|+31715247400|medicalinfo@pharming.com
1517|NCT00225212|Neal Birkett, MS, RAC|Stanford University Medical Center|650-723-6456|nbirkett@stanford.edu
1518|NCT00225277|Sr. VP Clinical Sciences|Takeda Global Research and Development Center Inc.|800-778-2860|clinicaltrialregistry@tpna.com
1519|NCT00225732|Amy Rock, Ph.D.|Cumberland Pharmaceuticals Inc.|615-255-0068|arock@cumberlandpharma.com
1520|NCT00225784|J. Marc Pipas, MD|Dartmouth-Hitchcock|603-650-9474|J.Marc.Pipas@hitchcock.org
1642|NCT00275561|Jeffrey A. Alexander, MD, Assistant Professor of Medicine|Mayo Clinic|507-538-2403|alexander.jeffrey14@mayo.edu
1643|NCT00275821|Study Director|Novartis Pharmaceuticals|862-778-8300|
1644|NCT00275834|Kishore Gadde|Duke University Medical Center|919-668-0208|kishore.gadde@duke.edu
1645|NCT00276016|Vice President,  Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
1646|NCT00276094|Shionogi Clinical Trials Administrator|Shionogi Inc.|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
1647|NCT00276159|Sarah Cooley, MD|Masonic Cancer Center, University of Minnesota|612-625-8474|cool0023@umn.edu
1648|NCT00276406|Adil E. Bharucha, MD|Mayo Clinic|507-284-6439|bharucha.adil@mayo.edu
1555|NCT00231816|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
1556|NCT00232141|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1557|NCT00232180|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1558|NCT00232479|Judith Hurley|UMiami|305-243-6698|jhurley@miami.edu
1559|NCT00232544|Dr. David Sparrow|VA Boston Healthcare System|857-364-6407|david.sparrow@va.gov
1560|NCT00232557|Dr. David Sparrow|VA Boston Healthcare System|857-364-6407|david.sparrow@va.gov
1561|NCT00232596|GSK Response Center|GlaxoSmithKline|866-435-7343|
1562|NCT00232739|Sidney Cohen, MD PhD, Vice President|Cordis|650 614-2726|scohen7@its.jnj.com
1563|NCT00233064|Hasan S. Jafri, MD|MedImmune, LLC|301-398-0000|
1564|NCT00233402|Yngvil Kloster Thomas|Photocure|+1 2167732505|ykt@photocure.no
1565|NCT00233519|Richard T. Moxley, III MD|University of Rochester Medical Center|585-275-5006|RichardT_Moxley@urmc.rochester.edu
1566|NCT00233987|Lymphoma Committee Statistician|SWOG Statistical Center|206-667-4623|
1567|NCT00234039|Study Statistician|SWOG Statistical Center|206-667-4623|
1568|NCT00234065|Masahiko Abe, Director Cardiovascular Projects|Department of Clinical Research and Development, Otsuka Pharmaceutical Co., Ltd.|+81-6-6943-7722 ext 2545|abems@otsuka.jp
1569|NCT00234078|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
1570|NCT00234104|Director of Clinical Trials|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7314|
1571|NCT00234832|Global Medical Services|Abbott|800-633-9110|
1572|NCT00234884|Global Medical Services|Abbott|1-800-633-9110|
1573|NCT00235326|John Marshall|McMaster University|9055212100 ext 76782|marshllj@mcmaster.ca
1574|NCT00235391|Study Director|Novartis Pharmaceuticals|862-778-8300|
1575|NCT00235443|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
1576|NCT00235573|Gail Kauwell|University of Florida|352-392-1991 ext 227|gkauwell@ufl.edu
1577|NCT00235716|Peter Guarino, PhD, Director WH-CSPCC|Dept. of Veterans Affairs Cooperative Stduies Program|203-932-5711 ext 3780|peter.guarino@va.gov
1578|NCT00235755|GSK Response Center|GlaxoSmithKline|866-435-7343|
1487|NCT00218439|Dr. Michael Kotlyar|University of Minnesota College of Pharmacy|612-625-1160|kotly001@umn.edu
1488|NCT00218465|Sara Carlini|Center for Addiction Medicine|617-643-1990|scarlini@partners.org
1489|NCT00218543|Frances R Levin, MD|COLUMBIA UNIVERSITY|212-543-5896|FRL2@COLUMBIA.EDU
1490|NCT00218634|Steven Safren|Mass General Hospital|617 724 0817|ssafren@partners.org
1491|NCT00219141|Study Director|Novartis Pharmaceuticals|862 778-8300|
1492|NCT00219284|Study Director|Novartis Pharmaceuticals|862-778-8300|
1493|NCT00219349|Franklin Schneier MD|New York State Psychiatric Institute|2125435368|fschneier@nyspi.columbia.edu
1494|NCT00219544|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1495|NCT00219557|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1724|NCT00262730|Director of Adult Brain Tumor Consortium|Adult Brain Tumor Consortium Central Office- Johns Hopkins|410-955-3657|jfisher@jhmi.edu
1725|NCT00262743|Dr. Tait Shanafelt|Mayo Clinic||shanafelt.tait@mayo.edu
1726|NCT00262834|Vered Stearns|SKCCC|4432876489|vstearn1@jhmi.edu
1727|NCT00262847|Melissa Leventhal|Gynecologic Oncology Group (GOG) Statistical and Data Center|716-845-4030|mleventhal@gogstats.org
1728|NCT00262925|Study Statistician|ECOG Statistical Office|617-632-3012|
1729|NCT00262951|Edward Greeno, M.D.|University of Minnesota, Masonic Cancer Center|612-626-6418|green049@umn.edu
1730|NCT00262964|Elisa Fabbrini, MD|Washington University School of Medicine|314-362-8156|efabbrini@dom.wustl.edu
1731|NCT00263666|GSK Response Center|GlaxoSmithKline|866-435-7343|
1732|NCT00263757|Dr. Sean M. Caples|Mayo Clinic|507-293-1031|Caples.Sean@mayo.edu
1733|NCT00263887|Henry Li|Talecris Biotherapeutics|1-800-520-2807|henry.li@grifols.com
1734|NCT00264004|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
1735|NCT00264147|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
1736|NCT00264290|Peter W. Hunt, M.D.|University of California, San Francisco|415-476-4082 ext 345|phunt@php.ucsf.edu
1737|NCT00264303|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
1738|NCT00264381|Suman Rathbun MD,MS|University of Oklahoma Health Sciences Center|405271-4742 ext 44773|suman-rathbun@ouhsc.edu
1739|NCT00264498|Gerard Lynch|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
1740|NCT00264537|Director Clinical Research|Centocor Research & Development, Inc.|1-800-457-6399|
1741|NCT00264550|Director Clinical Research|Centocor Research & Development, Inc.|1-800-457-6399|
1742|NCT00264576|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
1743|NCT00264797|Dr. Paula Riggs; Dr. Theresa Winhusen|Univ of Colorado Denver; Univ of Cincinnati|303-724-2235; 513-487-7800|paula.riggs@ucdenver.edu; winhusen@carc.uc.edu
1744|NCT00264810|Dr. Martha Morrell, Chief Medical Officer|NeuroPace, Inc.|650-237-2776|mmorrell@neuropace.com
1745|NCT00264849|Study Director|Novartis Pharmaceuticals|862-778-8300|
1746|NCT00264875|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1747|NCT00265083|Director, Clinical Research|Centocor Research and Development, Inc.|1-800-457-6399|
1748|NCT00265096|Director, Clinical Research|Centocor Research and Development, Inc.|1-800-457-6399|
1749|NCT00265109|Katharine A. Phillips MD|Rhode Island Hospital Body Dysmorphic Disorder Program|401-444-1646|katharine_phillips@brown.edu
1750|NCT00265122|Sr. Dir. Clinical Research|Centocor Research & Development, Inc.|1-800-457-6399|
1751|NCT00265239|Dr. Kenichi Tsujita|Kumamoto University|+81-96-373-5175|tsujita@kumamoto-u.ac.jp
1752|NCT00265317|Pfizer Clinical Trials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com
1753|NCT00265330|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1754|NCT00265343|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
1755|NCT00265382|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1756|NCT00265395|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
1757|NCT00265473|Melena D. Bellin, MD|Schulze Diabetes Institute, University of Minnesota|612-625-4686|bell0130@umn.edu
1758|NCT00265616|Dr Andrea O. Rossetti|CHUV Lausanne|+41 21 314 1190|andrea.rosseti@chuv.ch
1759|NCT00265785|Study Statistician|SWOG Statistical Center|206-667-4623|
1760|NCT00265798|Dr. Hedy L. Kindler|University of Chicago|773-702-0360|hkindler@medicine.bsd.uchicago.edu
1761|NCT00265889|Brian Bowell, MD|Case Comprehensive Cancer Center|216-444-6922|bolwelb@ccf.org
1762|NCT00266032|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
1763|NCT00266227|Medical Communications Specialist|Genentech, Inc.|800-821-8590|
1764|NCT00266409|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
1765|NCT00266630|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1766|NCT00266799|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
1767|NCT00266812|Vice President of Late Stage Development|Merck, Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
1768|NCT00266864|William A. Bauman, M.D.|James J. Peters VA Medical Center|718-584-9000 ext 5428|william.bauman@va.gov
1769|NCT00267007|Vice President|Centocor Ortho Biotech Services, LLC (COBS)|215 325 4464|
1770|NCT00267046|Saroj Vadhan-Raj, MD/Professor|UT MD Anderson Cancer Center|713-792-7966|xzhou@mdanderson.org
1771|NCT00267059|Alessandra Ferrajoli, MD, BS / Associate Professor|The University of Texas M. D. Anderson Cancer Center|713-792-2063|eharriso@mdanderson.org
1772|NCT00267085|Jorge Cortes M.D./Professor|The University of Texas M. D. Anderson Cancer Center|713/794-5783|eharriso@mdanderson.org
1773|NCT00267098|BLOCK HF Clinical Trial Leader|Medtronic CRDM Clinical|763-526-2729|medtroniccrmtrials@medtronic.com
1774|NCT00267111|Dr. Vibhuti Shah|Mount Sinai Hospital|416-586-4816|vshah@mtsinai.on.ca
1775|NCT00267150|Study Director|Novartis Pharmaceuticals|862-778-8300|
1776|NCT00267189|Study Director|Novartis Pharmaceuticals|862-778-8300|
1777|NCT00267202|Clinical Director|Novartis Pharmaceuticals|862-778-1768|maria.figliomeni@novartis.com
1778|NCT00267293|Ian M Paul, MD, MSc|Penn State Children's Hospital|717-531-5656|ipaul@hmc.psu.edu
1779|NCT00267488|GSK Response Center|GlaxoSmithKline|866-435-7343|
1780|NCT00267631|Dr. Estevan Garcia, MD; Principal Investigator|Maimonides Medical Center|718-283-6352|EsGarcia@maimonidesmed.org
1781|NCT00267644|Dr. Eitan Dickman, MD; Principal Investigator|Maimonides Medical Center|718-283-6057|edickman@maimonidesmed.org
1782|NCT00267670|Mary E. Rinella, MD|Northwestern University|312-503-4592|m-rinella@northwestern.edu
1783|NCT00267748|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1496|NCT00220727|Henry Li|Grifols Therapeutics|1-800-520-2807|henry.li@grifols.com
1497|NCT00220779|Ralph Kantor, PhD|Talecris Biotherapeutics|1-800-520-2807|ralph.kantor@talecris.com
1498|NCT00223236|E. Sherwood Brown, M.D., Ph.D., Professor|The University of Texas Southwestern Medical Center|214-645-6950|sherwood.brown@utsouthwestern.edu
1499|NCT00223496|Dr. Vivek Singh|UTHSCSA|210-567-5479|vsingh@uthscsa.edu
1500|NCT00223704|Mias Pretorius, Associate Professor of Anesthesiology and Clinical Pharmacology|Vanderbilt University|615-8757402|mias.pretorius@vanderbilt.edu
1501|NCT00223795|Meika A. Fang, MD|VA Greater Los Angeles Healthcare System|310-268-4503|meika.fang@va.gov
1502|NCT00223808|Charles Burgar, MD|CTVHCS|254/743-0085|charles.burgar1@va.gov
1503|NCT00223821|Kathryn L. Burgio, PhD|Birmingham VA Medical Center|205-558-7064|kburgio@uabmc.edu
1504|NCT00223977|Gary Hoel, RPh, PhD|Watson Laboratories, Inc|801-588-6641|gary.hoel@watson.com
1505|NCT00224003|Gary Hoel, RPh, PhD|Watson Laboratories, Inc|801-588-6641|gary.hoel@watson.com
1506|NCT00224016|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|Watson Laboratories, Inc|801-588-6641|gary.hoel@watson.com
1507|NCT00224029|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|Watson Laboratories, Inc.|801-588-6641|gary.hoel@watson.com
1508|NCT00224042|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|Watson Laboratories, Inc.|801-588-6641|gary.hoel@watson.com
1509|NCT00224055|Naomi Dahl, PharmD Director, Clinical Affairs|Watson Pharmaceuticals, Inc||Naomi.dahl@watson.com
1719|NCT00262314|Fernando Dangond, M.D., Medical Responsible|EMD Serono, Inc.|+1 781 681 2348|
1720|NCT00262509|David A. Ross|Atlanta VA Rehabilitation R&D Center of Excellence|404-321-6111 ext 6817|ross0128@bellsouth.net
1721|NCT00262522|Global Medical Services|Abbott|800-633-9110|
1722|NCT00262600|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
1723|NCT00262639|Raymond F. Anton, M.D.|Medical University of South Carolina|843-792-1226|antonr@musc.edu
1625|NCT00273182|InSync Registry Clinical Trial Leader|Medtronic, Inc.||medtroniccrmtrials@medtronic.com
1649|NCT00276419|Dr. Robin L. Smith|Mayo Clinic|507-284-1210|smith.robin@mayo.edu
1650|NCT00276458|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
1651|NCT00276484|Senior Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
1652|NCT00276549|Dr. Robert Dreicer|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|216-445-4623|dreicer@ccf.org
1653|NCT00276614|Matthew Rettig, M.D.|David Geffen School of Medicine at UCLA|310-794-3565|mrettig@mednet.ucla.edu
1654|NCT00276861|Gilberto Lopes MD|Dept. of Oncology Johns Hopkins Singapore Intl Medical Center|656-880-2240|glopes@imc.jhmi.edu
1655|NCT00277212|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
1656|NCT00277355|Merit Cudkowicz, MD, MSc|Massachusetts General Hospital|617-726-1873|mcudkowicz@partners.org
1657|NCT00277394|Torsten Skov, Senior Medical Advisor|Leo Pharma|+45 72263990|tosdk@leo-pharma.com
1658|NCT00277446|Lewis J. Smith|Northwestern University|312-503-0501|ljsmith@northwestern.edu
1659|NCT00305942|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
1660|NCT00306163|Respiratory Medical Advisor|Nycomed GmbH|0049-7531-840|clinicaltrials@nycomed.com
1661|NCT00306189|Study Director|Amgen Inc.|866-572-6436|
1662|NCT00306202|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
1663|NCT00306384|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
1664|NCT00306488|Wai Wong, MD, PhD|National Eye Institute|301-496-7566|wongw@mail.nih.gov
1665|NCT00306527|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
1666|NCT00306592|Biogen Idec Study Medical Director|Biogen Idec||clinicaltrials@biogenidec.com
1667|NCT00306787|Study Director|Novartis Pharmaceuticals|862-778-8300|
1668|NCT00306891|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
1669|NCT00306917|Barry Sisson|DePuy Orthopaedics, Inc|574-372-7156|BSisson@its.jnj.com
1670|NCT00307047|Ellen Travis|Abbott Vascular|408-845-1512|ellen.travis@av.abbott.com
1671|NCT00307086|Mellisa Alsina, MD|H. Lee Moffitt Cancer Center|813-745-6886|Melissa.Alsina@moffitt.org
1626|NCT00273754|Samia Khalil, M.D./ Professor|University of Texas Medical School/ Houston|713-500-6242|Samia.N.Khalil@uth.tmc.edu
1627|NCT00273793|Dr. RJ Lamb|UTexas_SanAntonio|210-567-5480|lamb@uthscsa.edu
1628|NCT00273858|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1629|NCT00273910|Steven A. Rosenberg, M.D.|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
1630|NCT00274261|Jason Woo, MD, MPH|NICHD|301-496-1662|woojj@mail.nih.gov
1631|NCT00274287|Chadi Nabhan, MD|Oncology Specialists, S.C.|847-268-8200|cnabhan@oncmed.net
1632|NCT00274456|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
1633|NCT00274469|Gerard Lynch|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
1634|NCT00274716|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
1635|NCT00274768|Dr. Antonio Wolff|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|410-614-6192|awolff@jhmi.edu
1636|NCT00274846|Jeffrey Miller, M.D.|Masonic Cancer Center, University of Minnesota|612-625-7409|mille011@umn.edu
1637|NCT00274924|Study Statistician|ECOG Statistical Office|617-632-3012|
1638|NCT00275002|Dana Wallace|Pediatric Brain Tumor Consortium|901-595-2617|dana.wallace@stjude.org
1639|NCT00275262|Global Medical Services|Abbott|800-633-9110|
1640|NCT00275275|Kelly E. Lyons, PhD|University of Kansas Medical Center|913-588-7159|klyons@kumc.edu
1641|NCT00275340|Monica Parry, RN, PhD, CCN(C)|University of Toronto||parrym@kgh.kari.net
1682|NCT00258011|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
1683|NCT00258154|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
1684|NCT00258349|Study Statistician|Eastern Cooperative Oncology Group (ECOG) Statistical Office|617-632-3012|
1685|NCT00258362|Melissa Geller, M.D.|Masonic Cancer Center, University of Minnesota|612-626-3111|gelle005@umn.edu
1686|NCT00258440|Joseph Bubalo|Oregon Health and Science Univeristy|503-494-8007|bubaloj@ohsu.edu
1687|NCT00258674|Baylor Research Institute|Baylor Research Institute|214-820-9991|Elizabeth.Cothran@baylorhealth.edu
1688|NCT00258817|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
1689|NCT00258830|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
1690|NCT00258856|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
1691|NCT00258895|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
1692|NCT00258908|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
1693|NCT00259012|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
1694|NCT00259090|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
1695|NCT00259272|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1696|NCT00259285|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1697|NCT00259298|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1698|NCT00259610|Dr. Jeffrey R. Curtis,|University of Alabama at Birmingham|205-934-7733|jcurtis@uab.edu
1699|NCT00259649|Dawn marcus|University of Pittsburgh|412-953-4797|marcusd@upmc.edu
1700|NCT00259740|Study Director|Amgen Inc.|866-572-6436|
1701|NCT00259857|Deborah A Bowlby, MD, Asst.Professor, Pedeiatric Endocrinology|Medical University of South Carolina|843-792-6807 ext none|bowlbyd@musc.edu
1702|NCT00260065|Eisai Call Center|Eisai Inc.|888-422-4743|
1703|NCT00260195|Lisa Jaycox|RAND Corporation|703-344-8236 ext 5118|jaycox@rand.org
1704|NCT00260208|Study coordinator|Novartis Pharmaceuticals|862-778-8300|
1705|NCT00260429|Greg Kaufman, MD; Senior Director of Clinical Development|Auxilium Pharmaceuticals, Inc.|484 321 5900 ext 5920|gkaufman@auxilium.com
1706|NCT00260533|Murray B. Stein MD, MPH|University of California San Diego|858-534-6400|mstein@ucsd.edu
1707|NCT00260832|Peter Tarassoff, MD, PhD, Study Director|Eisai Inc.|201-949-4611|Peter_Tarasoff@eisai.com
1708|NCT00261443|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
1709|NCT00261495|EMEA Medical Affairs Director Analgesia|Janssen Pharmaceutica NV|+49 4107 312356|kpappert@its.jnj.com
1710|NCT00261846|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1711|NCT00261950|Study Director|Amgen Inc.|866-572-6436|
1712|NCT00262002|Posting Director|Novartis Vaccine and Diagnostics S.r.l||RegistryContactVaccineUS@novartis.com
1713|NCT00262041|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
1714|NCT00262067|Medical Communications|Genentech, Inc.|800 821-8590|
1715|NCT00262080|Pat T Horn|Dyax Corp.|617 250  5948|phorn@dyax.com
1716|NCT00262119|Senior Clinical Research Manager|Medtronic|0039-0632814225|andrea.grammatico@medtronic.com
1717|NCT00262223|Denise A. Hien, Ph.D.|The City College of New York|(212) 650-5666|dhien@ccny.cuny.edu
1718|NCT00262301|Medical Affairs Department|Pharming Technologies BV|+31715247400|medicalinfo@pharming.com
1858|NCT00295880|John E. Wagner, M.D.|Masonic Cancer Center, University of Minnesota Blood and Marrow Transplant Program|612-626-2961|wagne002@umn.edu
1859|NCT00296192|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
1860|NCT00296231|Tarah Colaizy|University of Iowa||tarah-colaizy@uiowa.edu
1861|NCT00296244|Carlo Gerardo B Ramirez, MD|Thomas Jefferson University|215-955-5909|carlo.ramirez@jefferson.edu
1862|NCT00296322|Dr. Yoon-Koo Kang|Asan Medical Center, University of Ulsan College of Medicine|+82-2-3010-3230|ykkang@amc.seoul.kr
1863|NCT00296335|Dr. Yoon-Koo Kang|Asan Medical Center|+82-2-3010-3210|ykkang@amc.seoul.kr
1864|NCT00296374|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
1865|NCT00296400|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
1866|NCT00296491|GSK Response center|GlaxoSmithKline|866-435-7343|
1867|NCT00296504|GSK Response Center|ViiV Healthcare|866-435-7343|
1868|NCT00296517|GSK Response Center|GlaxoSmithKline|866-435-7343|
1869|NCT00296647|Stevens Smith, PhD|UW-Center for Tobacco Research and Intervention|608-262-7563|sss@ctri.medicine.wisc.edu
1870|NCT00296816|Trial Trans[parency Team|Sanofi||Contact_us@sanofi.com
1871|NCT00297037|Dr. Christopher Hull|University of Utah|801-581-6465|christopher.hull@hsc.utah.edu
1872|NCT00297102|Respiratory Medical Advisor|Nycomed GmbH|0049-7531-840|clinicaltrials@nycomed.com
1873|NCT00297115|Respiratory Medical Advisor|Nycomed GmbH|0049-7531-840|clinicaltrials@nycomed.com
1874|NCT00297167|Robert Winkler, MD, VP, Clinical Development and Operations|Aptalis Pharma US, Inc.|1- 800- 472- 2634|
1875|NCT00297258|GSK Response Center|GlaxoSmithKline|866-435-7343|
1876|NCT00297492|Dr. John Hughes|University of Vermont|802-656-9610|John.Hughes@uvm.edu
1877|NCT00297596|John D. Hainsworth, MD|Sarah Cannon Research Institute|877-691-7274|ASKSarah@scresearch.net
1878|NCT00297648|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
1879|NCT00297778|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
1880|NCT00298090|Jane Youngers|UTHSCSA|210-567-2340|youngers@uthscsa.edu
1881|NCT00298233|Dr. Jeremy Farrar|Oxford University Clinical Research Unit|+84 839237954|info@oucru.org
1882|NCT00298272|Biogen Idec Study Medical Director|Biogen Idec|+1 617 679-2000|
1883|NCT00298363|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
1884|NCT00298558|Sharon L. Tennstedt, PhD|New England Research Institutes|617-972-3362|stennstedt@neriscience.com
1885|NCT00298766|Dr. Helgi van de Velde|Johnson & Johnson Pharmaceutical Research & Development||HVDVELDE@ITS.JNJ.COM
1886|NCT00299000|Medical Information Services|BioMarin Pharmaceutical Inc.|800-983-4587|medinfo@bmrn.com
1887|NCT00299104|Medical Communications|Genentech, Inc.|800-821-8590|
1888|NCT00299130|Medical Communications|Hoffman-LaRoche|800-821-8590|
1889|NCT00299416|James C. Grotta, MD|UT-Houston Health Science Center, Department of Neurology|713-500-7088|james.c.grotta@uth.tmc.edu
1890|NCT00299546|Associate Director Clinical Research|Centocor Research & Development, Inc.|1-800-457-6399|
1891|NCT00299689|Dr. Jason Chesney|James Graham Brown Cancer Center, University of Louisville|502/852-3679|jaches03@exchange.louisville.edu
1892|NCT00299702|Therapeutic Area Lead|Ortho-McNeil, Inc. N America Pharm CNS/IM|609-730-3693|
1893|NCT00299741|Dr. Dror Michaelson|Massachusetts General Hospital|617-726-1594|dmichaelson1@partners.org
1894|NCT00299975|Prof. Zhao-xiang Bian|Hong Kong Baptist University|(852) 3411 2905|bzxiang@hkbu.edu.hk
1895|NCT00300235|Karen Kesler, PhD|Rho Federal Systems Division|919-408-8000 ext 244|karen_kesler@rhoworld.com
1896|NCT00300274|Study Director|Novartis Pharmaceuticals|862-778-8300|
1897|NCT00307151|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
1898|NCT00307164|ClinicalTrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
1899|NCT00307333|Joseph R. Moorman, MD|University of Virginia|434-982-3367|rm3h@virginia.edu
1784|NCT00288639|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1785|NCT00288704|Doug Nadler, MS Statistics|Regeneron Pharmaceuticals|914 345 7905|clinicaltrials@regeneron.com
1786|NCT00288912|Dr. Kelli Allen|Durham VA HSR&D|919-286-0411 ext 7090|kelli.allen@va.gov
1787|NCT00289094|Tammy O'Dell, EMT, CCRA|DePuy Orthopaedics, Inc.|574-372-7104|TOdell2@its.jnj.com
1812|NCT00290251|Lynnette Nieman MD|NICHD, NIH|301-496-8935|NiemanL@nih.gov
1813|NCT00290290|Rabih Darouiche, M.D.|Baylor College of Medicine|713-794-8858|rabihd@bcm.edu
1814|NCT00290407|Roger H Herzig, MD|James Graham Brown Cancer Center|502/396-3119|rhherz01@louisville.edu
1815|NCT00290472|Dr. Sonali M. Smith|University of Chicago Comprehensive Cancer Center|7738342895|smsmith@medicine.bsd.uchicago.edu
1816|NCT00290537|Vali Papadimitrakopoulou, MD / Associate Professor|U.T. M.D. Anderson Cancer Center|713-792-6363|
1817|NCT00290615|Brant Hamel|Duke University Medical Center|919-68-1861|brant.hamel@duke.edu
1818|NCT00290693|Caio Max Rocha Lima MD|University of Miami Sylvester Comprehensive Cancer Center|305-243-7770|crocha@med.miami.edu
1819|NCT00290732|Dr. Vered Stearns|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|4432876489|vstearn1@jhmi.edu
1820|NCT00290771|Study Director|Novartis Pharmaceuticals|862 778-8300|
1821|NCT00290810|Tait Shanafelt, M.D.|Mayo Clinic||shanafelt.tait@mayo.edu
1822|NCT00290888|Dr. Peter MacDonald|Pan Am Clinic|204-925-7480|pmacdonald@panamclinic.com
1823|NCT00291135|Carol J. Fabian, M.D.|University of Kansas Medical Center Research Institute|913-588-7791|cfabian@kumc.edu
1824|NCT00291317|Frank Castello|Children's Specialized Hospital|732 258 7065|fcastello@childrens-specialized.org
1825|NCT00291330|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
1826|NCT00291551|Michael Kolber, General Manager, VP, Regulatory Affairs|Paracor Medical, Inc.|408-734-6000|info@paracor.com
1827|NCT00291577|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1828|NCT00291655|UCB Clinical trial call center|UCB Pharma|+1 877 822 9493|
1829|NCT00291694|Dr. Carol Fabian|University of Kansas Medical Center|913-588-3666|cfabian@kumc.edu
1830|NCT00291876|GSK Response Center|GlaxoSmithKline|866-435-7343|
1831|NCT00292162|Michael MacDonald|NHS|01412112000|michael.macdonald@nhs.net
1832|NCT00292188|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1833|NCT00292227|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
1834|NCT00292370|Mark Hamner, MD|Ralph H. Johnson VA Medical Center|843-789-7799|Mark.Hamner@va.gov
1788|NCT00289107|Tammy O'Dell, EMT, CCRA|DePuy Orthopaedics|574-372-7104|TOdell2@its.jnj.com
1789|NCT00289120|Kenneth Ogan|Emory University|404-778-4898|kogan@emory.edu
1790|NCT00289185|GSK Response Center|GlaxoSmithKline|866-435-7343|
1791|NCT00289211|Chief Scientific Officer|ViroPharma|610-458-7300|
1792|NCT00289276|CRDM Core Clinical|Medtronic CRDM Clinical Research|800-328-2518|medtroniccrmtrials@medtronic.com
1793|NCT00289289|Jen Lahr|Medtronic CRDM Clinical||jen.lahr@medtronic.com
1794|NCT00289341|Mayu Frank|Rockefeller University|212-327-7443|frankm@rockefeller.edu
1795|NCT00289458|Dr. Cathy M. Arnold|University of Saskatchewan|306 966 6588|cathy.arnold@usask.ca
1796|NCT00289471|John W. Williams|Durham VAMC|919-286-6963|jw.williams@duke.edu
1797|NCT00289536|Wing-Yen Wong, MD, Global Sr Medical Dir Hemophilia|Baxter Healthcare Corporation||wing_yen_wong@baxter.com
1798|NCT00289718|GSK Response Center|GlaxoSmithKline|866-435-7343|
1799|NCT00289744|GSK Response Center|GlaxoSmithKline|866-435-7343|
1800|NCT00289757|GSK Response Center|GlaxoSmithKline|866-435-7343|
1801|NCT00289770|GSK Response Center|GlaxoSmithKline|866-435-7343|
1802|NCT00289783|GSK Response Center|GlaxoSmithKline|866-435-7343|
1803|NCT00289848|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
1804|NCT00289874|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
1805|NCT00289887|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
1806|NCT00289913|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
1807|NCT00289978|Study Director|Novartis Pharmaceuticals|862 778-8300|
1808|NCT00289991|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1809|NCT00290186|Daniel J. Lacey, MD, PhD|Dayton Children's Hospital|937-641-3080|LaceyD@childrensdayton.org
1810|NCT00290199|Director Center for Women's Reproductive Health|UAB|205 934 1322|jbiggio@uab.edu
1811|NCT00290238|Clinical Research Manager|RS Medical|360-891-7299|
1672|NCT00256984|Susan Knippenberg, Clinical Scientist|Ethicon Endo-Surgery|513 337-3452|sknippen@its.jnj.com
1673|NCT00256997|Director Medical Affairs - CNS|Janssen Inc. Toronto, Ontario, Canada|+1-416-382-5094|
1674|NCT00257010|Vice President, Medical Affairs|Janssen-Ortho LLC||ClinicalTrialDisclosure@its.jnj.com
1675|NCT00257166|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1676|NCT00257192|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1677|NCT00257556|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
1678|NCT00257660|Senior Director, Medical Development, Neurology|Ipsen||clinical.trials@ipsen.com
1679|NCT00257686|Bill Arana|Kowa Research Institute|9194331600|barana@kowaus.com
1680|NCT00257920|Medical Information Specialist|Abbott|1-800-633-9110|
1681|NCT00257933|Joseph Zorc, MD|The Children's Hospital of Philadelphia|215-590-1944|zorc@email.chop.edu
1963|NCT00282828|Mark Pollack, M.D.|Rush University Medical Center|312-942-5372|mark_pollack@rush.edu
1964|NCT00282867|Karen C. Johnston, MD, MSc|University of Virginia|434 924-5323|kj4v@virginia.edu
1965|NCT00282919|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1966|NCT00282971|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1967|NCT00282984|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1968|NCT00283049|Medical Affairs study director|sanofi-aventis||publicregistryUSMA@sanofi-aventis.com
1969|NCT00283062|Trial Transparency Team|Sanofi||Contact-Us@sanofi.com
1970|NCT00283387|Dr. Dawn S. Milliner|Mayo Clinic|507-284-7431|milliner.dawn@mayo.edu
1971|NCT00283439|Study Director|Amgen Inc.|866-572-6436|
1972|NCT00283595|Anne Klibanski, MD|Massachusetts General Hospital|617-726-3870|aklibanski@partners.org
1973|NCT00283712|Associate Director, Clinical Research Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
1997|NCT00287079|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
1998|NCT00287222|Sandy Annis|University of Arkansas for Medical Sciences|5016868274|amannis@uams.edu
1999|NCT00287339|Dr Nicholas Shaheen|UNC_ChapelHill|919 9667047|nshaheen@med.unc.edu
2000|NCT00287716|Bill Bradford, MD, PhD|InterMune, Inc.|(415) 466-2200|bbradford@intermune.com
2001|NCT00287729|Bill Bradford, MD, PhD|InterMune, Inc.|(415) 466-2200|bbradford@intermune.com
2002|NCT00287872|Dr. Ivan Borrello|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|(410) 955-4967|iborrell@jhmi.edu
2003|NCT00288054|Lung Committee Statistician|SWOG Statistical Center|206-667-4623|
2004|NCT00288509|Senior Director, Medical Development, Neurology|Ipsen||clinical.trials@ipsen.com
2005|NCT00288587|Leighann Cesar, RN|Cleveland Clinic Foundation|216-445-6551|cesar1@ccf.org
2006|NCT00315705|Genzyme Medical Information|Genzyme Corporation|1-800-745-4447|
2007|NCT00315731|GSK Response Center|GlaxoSmithKline|866-435-7343|
2008|NCT00315939|Boris Kovatchev, PhD|University of Virginia|434-924-5592|bpk2u@virginia.edu
2009|NCT00316004|Susanne May, PhD|Clinical Trial Center, University of Washington, Seattle, WA|206-685-1302|sjmay@uw.edu
2010|NCT00316017|Susanne May, PhD|Clinical Trial Center, University of Washington, Seattle, WA|206-685-1302|sjmay@uw.edu
2011|NCT00316082|BMS Study Director|Bristol-Myers Squibb||clinical.trials@bms.com
2012|NCT00316121|Manny Lazaro, Director, Clinical Affairs|Advanced Technologies and Regenerative Medicine, LLC|508-828-2741|mlazaro@its.jnj.com
2013|NCT00316173|GSK Response Center|GlaxoSmithKline|866-435-7343|
2014|NCT00316186|GSK Response Center|GlaxoSmithKline|866-435-7343|
2015|NCT00316199|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2016|NCT00316225|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2017|NCT00316264|Pamela Griffin|MedImmune|301 398 0000|clinicaltrialenquiries@medimmune.com
2018|NCT00316277|Roger D. Weiss, M.D.|McLean Hospital/Harvard Medical School|617-855-2242|rweiss@mclean.harvard.edu
2019|NCT00316303|Stanley Rosenberg, Ph.D.|Dartmouth-Hitchcock|603-653-0740|Stanley.d.rosenberg@dartmouth.edu
2020|NCT00316693|GSK Response Center|GlaxoSmithKline|866-435-7343|
1974|NCT00283816|Kathleen M. Hoeger, MD, MPH|University of Rochester Medical Center|585-275-7891|Kathy_Hoeger@urmc.rochester.edu
1975|NCT00283842|U.S. Contact Center|Wyeth||clintrialresults@wyeth.com
1976|NCT00283868|Brett C. Meyer, MD|University of California, San Diego|619-543-7760|bcmeyer@ucsd.edu
1977|NCT00284050|Study Director|Novartis Pharmaceuticals|862 778-8300|
1978|NCT00284089|Study Director|Novartis Pharmaceuticals|862 778-8300|
1979|NCT00284141|Trial Transparency Team|Sanofi||Contact-Us@Sanofi.com
1907|NCT00308139|Vice President, Research and Development|Amylin Pharmaceuticals||clinicaltrials@amylin.com
1908|NCT00308230|Wendy Book|Emory University|404-778-5545|wbook@emory.edu
1909|NCT00308516|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
1910|NCT00308555|Dr. Donald I. Abrams|UCSF/San Francisco General Hospital|415-476-4082 ext 444|dabrams@hemeonc.ucsf.edu
1911|NCT00308581|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
1912|NCT00308620|David Boulware|University of Minnesota|6126269546|boulw001@umn.edu
1913|NCT00308711|Barbara L. Powers|Cytokine PharmaSciences, Inc.|610-687-1776 ext 214|bpowers@cytokinepharmasciences.com
1914|NCT00308997|Ralph Hoffman, MD|Yale University School of Medicine|203-688-9734|Ralph.Hoffman@yale.edu
1915|NCT00309387|Giovanni Maraini, MD|University of Parma|+39 0521 238527|maraini@unipr.it
1916|NCT00309465|Tamra Dukatz, CRNA, MSN|Beaumont Health System|248 992-4741 (pager)|tdukatz@beaumont.edu
1917|NCT00309608|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
1918|NCT00309738|Bill Arana|Kowa Research Institute|919 433 1600|barana@kowaus.com
1919|NCT00309751|Bill Arana|Kowa Research Institute Inc|919 433 1600|barana@kowaus.com
1920|NCT00277524|Melinda Hoey, Clinical Research Specialist|Medtronic Cardiac Rhythm Disease Management|763-526-2831|Melinda.hoey@medtronic.com
1921|NCT00278395|Dr. John Sarantopoulos|University of Texas Health Science Center at San Antonio|210-450-1000|sarantopoulo@uthscsa.edu
1922|NCT00278525|Dr. Richard Burt|Northwestern University|312-908-0059|rburt@northwestern.edu
1923|NCT00278655|Dr Richard Burt|Northwestern University|312-908-0059|rburt@northwestern.edu
1924|NCT00278863|Dr. Yoon-Koo Kang|Asan Medical Center|+82-2-3010-3210|ykkang@amc.seoul.kr
1925|NCT00278889|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
1926|NCT00278915|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
1927|NCT00278954|Margaret Stratford Bobbitt|Bio Products Laboratory|+44 20 8258 2288|Margaret.Stratford-Bobbitt@bpl.co.uk
1835|NCT00292461|Takao Ishii, Asia regulatory affaires|Eisai Co., Ltd.|81-3-3817-3914|
1836|NCT00292981|Clinical Program Director|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
1837|NCT00293020|Andrew Finn, Pharm.D.|BioDelivery Sciences International|919-582-9050|AFinn@bdsi.com
1838|NCT00293059|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
1839|NCT00293254|Executive Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
1840|NCT00293267|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
1841|NCT00293293|Patricia L. Judson, M.D.|Moffitt Cancer Center|813-745-1600|Patricia.Judson@moffitt.org
1842|NCT00293462|Marylin J. Dodd, RN, PhD, FAAN|University of California, San Francisco|415-476-2191|Marylin.dodd@nursing.ucsf.edu
1843|NCT00293709|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1844|NCT00293722|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1845|NCT00293813|Study Director|Amgen Inc.|866-572-6436|
1846|NCT00294047|GSK Response Center|GlaxoSmithKline|866-435-7343|
1847|NCT00294060|P3 Study Team|Medtronic CRDM|800-328-2518|medtroniccrmtrials@medtronic.com
1848|NCT00294515|Medical Communications|Hoffmann-La Roche|800-821-8590|
1849|NCT00294645|CRDM Clinical|Medtronic CRDM|800-328-2518|medtroniccrmtrials@medtronic.com
1850|NCT00294723|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
1851|NCT00294762|Medical Monitor|Astellas Pharma Global Development||clinicaltrials@us.astellas.com
1852|NCT00295009|Erin Prifogle|DePuy Synthes|508-977-6451|eprifog1@its.jnj.com
1853|NCT00295061|Henry Li|Grifols Therapeutics|1-800-520-2807|henry.li@grifols.com
1854|NCT00295490|Dr Sarah Brien|University of Southampton|07870642667|sbb@southampton.ac.uk
1855|NCT00295633|BMS Study Director|Bristol-Myers Squibb||Clinical.trials@bms.com
1856|NCT00295750|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
1857|NCT00295854|Richard E. Gammans PhD Chief Developing Officer|Medicinova Inc|848-373-1500|gammans@medicinova.com
2068|NCT00321672|Trudy Vanhove, VP Clinical Development|NeurogesX|650-393-7444|tvanhove@neurogesx.com
2069|NCT00321711|Study Director|Amgen Inc.|866-572-6436|
2070|NCT00321737|Sr. VP Clinical Sciences|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
2071|NCT00321763|GSK Response Center|GlaxoSmithKline|866-435-7343|
2072|NCT00321789|Corrine I. Voils|Veterans Affairs Medical Center|919-286-0411 ext 5196|corrine.voils@va.gov
2073|NCT00321828|Director, Division of Regulatory Affairs|NSABP Foundation, Inc.|412-330-4600|
2074|NCT00321854|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
2075|NCT00321906|Edward Garrity, MD|The University of Chicago|(773) 834-1119|egarrity@uchicago.edu
2076|NCT00321932|Linda Burns, M.D.|Masonic Cancer Center, University of Minnesota|612-624-8144|burns019@umn.edu
2077|NCT00321984|Sr. VP Clinical Sciences|Takeda Global Research & Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
2078|NCT00322101|Bart Lee Scott|Fred Hutchinson Cancer Research Center|206-667-1990|bscott@fhcrc.org
2079|NCT00322153|Stephen M Graham, PhD|Forest Research Institute|201-427-8156|Stephen.Graham@frx.com
2080|NCT00322231|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
2081|NCT00322335|GSK Response Center|GlaxoSmithKline|866-435-7343|
2082|NCT00322348|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
2083|NCT00322374|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
1980|NCT00284154|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
1981|NCT00284180|John D. Hainsworth, MD|Sarah Cannon Research Institute|877-691-7274|ASKSARAH@scresearch.net
1982|NCT00284518|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
1983|NCT00284557|Anne L. Dunlop, MD, MPH|Emory University|404-712-8520|amlang@emory.edu
1984|NCT00284856|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
1985|NCT00284934|Study Director|Novartis Pharmaceuticals|862-778-8300|
1986|NCT00285012|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1987|NCT00285207|Chief Medical Officer|TigrisPharmaceuticals||info@tigrispharma.com
1988|NCT00285584|Michael Marmor, Ph.D.|NYU School of Medicine|212-263-6667|michael.marmor@nyumc.org
1989|NCT00286325|Dr. Russell P Hall|Duke University Medical Center|919-684-3110|hall0009@mc.duke.edu
1990|NCT00286429|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
1991|NCT00286442|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
1992|NCT00286455|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
1993|NCT00286468|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
1994|NCT00286494|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
1995|NCT00286741|David Edelman|Durham VA Medical Center|919-286-6936|dedelman@duke.edu
1996|NCT00287053|Corby Martin, Ph.D.; Assistant Professor|Pennington Biomedical Reseach Center|225-763-2585|martinck@pbrc.edu
1905|NCT00308087|Genzyme MedInfo|Genzyme Corporation||medinfo@genzyme.com
1906|NCT00308113|Dr. Paula R. Clemens|University of Pittsburgh|412-648-9762|pclemens@pitt.edu
1900|NCT00307437|Senior Director, Compound Development Team Leader|Centocor Research & Development, Inc.|1 215 793-7612|
1901|NCT00307489|Stephen J. Rossi, PharmD|Gilead Sciences, Inc.|650-522-4212|stephen.rossi@gilead.com
1902|NCT00307684|European Medical Affairs Director Neurology|Janssen-Cilag G.m.b.H.|+49 2137 955258|bschaeu2@its.jnj.com
1903|NCT00307801|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
1904|NCT00307931|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
1928|NCT00278993|Eisai Inc.|Eisai Call Center|888-422-4743|
1929|NCT00279201|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
1930|NCT00279214|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
1931|NCT00279591|Dr. Michael Stroud|University of Arkansas for Medical Sciences|501-364-1861|StroudMichaelH@uams.edu
1932|NCT00279916|Dr. Laura Orvidas|Mayo Clinic|507-284-3410|orvidas.laura@mayo.edu
1933|NCT00279955|CRDM Core Clinical|Medtronic CRDM Clinical Research|800-328-2518|medtroniccrmtrials@medtronic.com
1934|NCT00280059|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1935|NCT00280293|Dr. E. Sherwood Brown|UT Southwestern Medical Center|214-645-6950|sherwood.brown@utsouthwestern.edu
1936|NCT00280384|Hiroki Shimizu, Study Director|Eisai Co., Ltd.|81-3-3817-5235|h3-shimizu@hhc.eisai.co.jp
1937|NCT00280566|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1938|NCT00280683|Dr. Nicholas Kenyon|UCaliforniaDavis|916-734-3564|njkenyon@ucdavis.edu
1939|NCT00280826|Robert Nussenblatt, MD, MPH|National Eye Institute|301-496-3123|drbob@intra.nei.nih.gov
1940|NCT00280904|J. Thomas Megerian|Codman & Shurtleff|1-508-828-8274|jmegeri1@its.jnj.com
1941|NCT00281099|MVP Clinical Trial Leader|Medtronic, Inc.||medtroniccrmtrials@medtronic.com
1942|NCT00281320|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
1943|NCT00281528|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
1944|NCT00281580|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
1945|NCT00281632|GSK Response Center|GlaxoSmithKline|866-435-7343|
1946|NCT00281658|GSK Response Center|GlaxoSmithKline|866-435-7343|
1947|NCT00281697|Medical Communications|Genentech, Inc.|800 821-8590|
1948|NCT00281827|Arkadiusz Dudek, M.D.|Masonic Cancer Center, University of Minnesota|612-624-0123|dudek002@umn.edu
1949|NCT00281879|Dr. Richard Maziarz|OHSU Knight Cancer Institute|503-494-1551|maziarzr@ohsu.edu
1950|NCT00281918|Medical Communications|Hoffmann-LaRoche|800-821-8590|
1951|NCT00281957|SWOG melanoma statistician|SWOG Statistical Office|206-667-4408|
1952|NCT00282048|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
1953|NCT00282113|Mark A. Underwood MD|University of California Davis|916-734-5061|mark.underwood@ucdmc.ucdavis.edu
1954|NCT00282243|Vice President, Therapeutic Area Head, Transplantation|Astellas Pharma Global Development, Inc.||ClinicalTrials.Disclosure@us.astellas.com
1955|NCT00282256|Vice President, Therapeutic Area Head, Transplantation|Astellas Pharma Global Development, Inc.||ClinicalTrials.Disclosure@us.astellas.com
1956|NCT00282282|Vincent T. Ho, MD Associate Professor of Medicine, Harvard Medical School|Dana-Farber Cancer Institute|(617) 632-5938|vincent_ho@dfci.harvard.edu
1957|NCT00282308|Medical Communications|Genentech, Inc.|800 821-8590|
1958|NCT00282334|Line Bille Madsen|Dept. of Medical Research, Holstebro Hospital|+45 99125421|linemads@rm.dk
1959|NCT00282347|Medical Communications|Genentech, Inc.|800-821-8590|
1960|NCT00282464|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
1961|NCT00282568|Vice President, Therapeutic Area Head, Transplantation|Astellas Pharma Global Development, Inc.||ClinicalTrials.Disclosure@us.astellas.com
1962|NCT00282815|Devin Brown, MD|University of Michigan|734-936-9075|devinb@umich.edu
2167|NCT00312338|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
2168|NCT00312377|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
2169|NCT00312494|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2170|NCT00312572|Clinical Leader|Purdue Pharma L.P.|800-733-1333|
2171|NCT00312728|Medical Communications|Hoffman-LaRoche|800-821-8590|
2172|NCT00312845|Yusri A. Elsayed, M.D., M.H.Sc., Ph.D.|Johnson & Johnson Pharmaceutical Research & Development||YElsaye1@ITS.JNJ.COM
2173|NCT00312858|Vice President,Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
2174|NCT00312923|Barbara Swanson|Rush University Medical Center|312-942-8977|barbara_a_swanson@rush.edu
2175|NCT00313014|Clinical Leader, Medical Director|Purdue Pharma L.P.|800-733-1333|
2176|NCT00313144|David Gelmont, MD Global Medical Director, Head of Specialty Products TA, BioTherapeutics|Baxter Healthcare Corporation||david_gelmont@baxter.com
2177|NCT00313170|Gerard Lynch|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
2178|NCT00313209|Respiratory Medical Advisor|Nycomed GmbH|0049-7531-840|clinicaltrials@nycomed.com
2179|NCT00313313|BMS Study Director|Bristol-Myers Squibb||clinical.trials@bms.com
2180|NCT00313443|Dr Carmelo Lafuente-Lafuente|Unité de Recherches Thérapeutiques. Service de Médecine Interne A. Hôpital Lariboisière. Paris, France|+33 1 49 95 63 37|c.lafuente@nodo3.net
2181|NCT00313703|Benjamin Friedman|Montefiore Medical Center|718-920-6626|befriedm@montefiore.org
2182|NCT00313716|Claudia Robertson, MD|Baylor College of Medicine|713-873-2792|claudiar@bcm.edu
2137|NCT00305253|Suellen Miller|University of California San Francisco (UCSF)|415 597 9394|smiller@globalhealth.ucsf.edu , suellenmiller@gmail.com
2138|NCT00305344|Dr Michael Haller|University of Florida|352.273.9264|hallemj@peds.ufl.edu
2139|NCT00305448|Gerard Lynch|Astrazeneca||AZTrial_Results_Posting@astrazeneca.com
2140|NCT00305565|Mark Bunker Sr. Director, Global Medical Affairs|Cyberonics Inc.|281-228-7223|Mark.Bunker@cyberonics.com
2141|NCT00305604|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
2142|NCT00305773|Steven Gore, MD|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins||gorest@jhmi.edu
2143|NCT00305864|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@acr.org
2144|NCT00305877|Study Statistician|ECOG Statistical Office|617-632-3012|
2145|NCT00309777|Neil Hounslow|Kowa Research Europe, Ltd.|01189229004|nhounslow@kowa.co.uk
2146|NCT00309907|Results Reporting Coordinator|Children's Oncology Group|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org
2147|NCT00309946|Dr. Hedy Kindler|The University of Chicago|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu
2148|NCT00310076|Greg Russell, MS|Comprehensive Cancer Center of Wake Forest University|336-716-5449|grussell@wakehealth.edu
2149|NCT00310362|Dr. Joan Griffin|MInneapolis VA Health Care System|507-538-1490|griffin.joan@mayo.edu
2150|NCT00310401|Lorraine B. Ware M.D.|Vanderbilt University|615 322 8614|lorraine.ware@vanderbilt.edu
2151|NCT00310427|Markus A. Heilig, M.D., Ph.D.|NIH/National Institute on Alcohol Abuse and Alcoholism|301-435-9386|mheilig@mail.nih.gov
2152|NCT00310466|Kim Simonsen, Senior Director|ALK-Abelló A/S|+4545747576|
2153|NCT00310791|Dr. Catherine Gordon|Children's Hospital Boston|401-444-4712|cgordon1@lifespan.org
2154|NCT00310804|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
2155|NCT00310856|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
2156|NCT00311155|Sr. Director, Regulatory Operations|Daiichi Sankyo Pharma Development|732-590-5032|hmkessler@dsi.com
2157|NCT00311181|Ashish Oza|St Jude Medical|818-493-3648|aoza@sjm.com
2158|NCT00311311|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2159|NCT00311363|XenoPort Call Center|XenoPort, Inc.|877-936-6778|
2021|NCT00316706|GSK Response Center|GlaxoSmithKline|866-435-7343|
2022|NCT00316719|GSK Response Center|GlaxoSmithKline|866-435-7343|
2023|NCT00316914|Dr. Axel Grothey|Mayo Clinic|507-184-2779|grothey.axel@mayo.edu
2024|NCT00317044|ClinicalTrialTransparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
2025|NCT00317239|Marc Tokars|Luitpold Pharmaceuticals, Inc.|610-650-4200|mtokars@lpicrd.com
2026|NCT00317642|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
2027|NCT00317720|Dr. Francisco Esteva|UT MD Anderson Cancer Center|713-563-0742|CR_Study_Registration@mdanderson.org
2028|NCT00317941|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
2029|NCT00318136|Medical Communications|Genentech, Inc.|800-821-8590|
2030|NCT00318292|Michaele Menghini|Mayo Clinic|480-301-6651|menghini.michaele@mayo.edu
2031|NCT00318370|Susan Weil, MD|Morphotek, Inc.|610-423-6182|sweil@morphotek.com
2032|NCT00318461|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
2033|NCT00318565|Christine Liu|Biosense Webster|9098398608 ext 8608|cliu10@its.jnj.com
2034|NCT00318591|Anna Karina Busch, Intl. Senior Scientific Manager|Coloplast|+45 49112350|dkakb@coloplast.com
2035|NCT00318656|GSK Response Center|GlaxoSmithKline|866-435-7343|
2036|NCT00318708|Vernon M. Chinchilli, PhD|Penn State Hershey College of Medicine|717-531-4262|vchinchi@psu.edu
2037|NCT00318812|Dr Deborah  Zimmerman, principal investigator|Ottawa Hospital  Research  Institute|613-738-8400 ext 82534|dzimmerman@toh.on.ca
2038|NCT00318929|Alan R. Towne, MD|Virginia Commonwealth University|804-282-9869|atowne@mcvh-vcu.edu
2039|NCT00319046|Cécile Luzy, MSc/Clinical Research Scientist|Actelion Pharmaceuticals Ltd|+ 41 61 565 6386|
2040|NCT00319111|Loïc Perchenet PhD/Clinical Trial Leader|Actelion Pharmaceuticals Ltd|+41 61 565 6457|
2041|NCT00319254|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2042|NCT00319436|Nancy Suchman, Ph.D., Associate Professor|Yale University School of Medicine, Department of Psychiatry and Yale Child Study Center|203-937-3486 ext 7430|nancy.suchman@yale.edu
2043|NCT00319449|Vice President, Late Stage Development Group leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
2044|NCT00319553|Medical Director|Sanofi Pasteur Inc.||RegistryContactUS@sanofipasteur.com
2045|NCT00319592|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
2046|NCT00319644|Julin Tang, MD|University of California, San Francisco|415-206-5274|tangj@anesthesia.ucsf.edu
2047|NCT00319696|Andjela Kusic-Pajic, MD/Clinical Project Team Leader|Actelion Pharmaceuticals Ltd|+41 61 565 64 17|
2048|NCT00319748|Melissa Geller, M.D.|Masonic Cancer Center, University of Minnesota|612-626-3111|gelle005@umn.edu
2049|NCT00320190|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2050|NCT00320216|Senior Director Clinical Research|Centocor Research & Development, Inc.|1-800-457-6399|
2051|NCT00320281|Dr. Gary Maerz|Craig Hospital|303-789-8220|adannels@craighospital.org
2052|NCT00320385|GSK Response Center|GlaxoSmithKline|866-435-7343|
2053|NCT00320411|GSK Response Center|GlaxoSmithKline|866-435-7343|
2054|NCT00320489|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2055|NCT00320515|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2056|NCT00320528|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2057|NCT00320541|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2058|NCT00320593|Raymond Kraker, MSPH|Jaeb Center for Health Research|813-875-8690|pedig@jaeb.org
2059|NCT00320606|Associate Director, Clinical Research Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov
2060|NCT00320710|Study Director|Novartis|862-778-8300|
2061|NCT00320788|Clinical Trials Administrator|Regeneron Pharmaceuticals, Inc.||clinicaltrials@regeneron.com
2084|NCT00322387|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
2085|NCT00322439|Study Director|Amgen Inc.|866-572-6436|
2086|NCT00322452|Gerard Lynch|AstraZeneca||AZTrial_results_posting@AstraZeneca.com
2087|NCT00322465|Jane R. Schwebke, MD|University of Alabama at Birmingham|(205) 975-5665|schwebke@uab.edu
2088|NCT00322491|Genzyme Medical Information|Genzyme Corporation||medinfo@genzyme.com
2089|NCT00322556|Clinical Trial Disclosure Manager|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
2090|NCT00322621|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
2091|NCT00322842|Genzyme Medical Information|Genzyme Corporation||medinfo@genzyme.com
2092|NCT00300430|Medical Information Specialist|Abbott|800-633-9110|
2093|NCT00300456|Medical Information Specialist|Abbott|800-633-9110|
2094|NCT00300469|Medical Information Specialist|Abbott|800-633-9110|
2095|NCT00300482|Medical Information Specialist|Abbott|800-633-9110|
2096|NCT00300677|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2097|NCT00300755|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
2098|NCT00300885|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
2099|NCT00301028|Merrill S. Kies, MD / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
2100|NCT00301080|Clinical Research Office|Northwestern University|312-695-1301|cancertrials@northwestern.edu
2101|NCT00301262|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2102|NCT00301366|Henry Li|Grifols Therapeutics|1-800-520-2807|henry.li@grifols.com
2103|NCT00301808|Shrish Gadgeel, M.D.|Barbara Ann Karmanos Cancer Institute|(313) 576-8753|gadgeels@karmanos.org
2104|NCT00301834|Dr. Morton Cowan|University of California San Francisco|4154762188|mcowan@peds.ucsf.edu
2105|NCT00301873|Mary Lou Affronti, RN, MSN, ANP, MHSc Senior Investigator|Duke Comprehensive Cancer Center|919-684-6239|mary.affronti@duke.edu
2106|NCT00302042|Dr. Ronald T. Ackermann|Northwestern University|3126036400|r.ackermann@northwestern.edu
2107|NCT00302068|Dr. James Blumenthal|DukeUMC|919-684-3969|blume003@mc.duke.edu
2108|NCT00302081|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
2109|NCT00302159|Kevin Camphausen, M.D.|National Cancer Institute, national Institutes of Health|301-496-5457|camphauk@mail.nih.gov
2110|NCT00302211|Desilu Villanueva MD, Associate Director, Medical Affairs|Actelion Pharmaceuticals US, Inc.|650-624-6900|desilu.villanueva@actelion.com
2111|NCT00302328|Ulrik Christensen|Glostrup Hospital|+4538634825|bisan@regionh.dk
2112|NCT00302458|Dr. Thomas Spencer|Massachusetts General Hospital|617-726-1731|spencer@helix.mgh.harvard.edu
2113|NCT00302848|Juergen Dinger, MD, PhD, Principal Investigator|Berlin Center for Epidemiology and Health Research, Germany|+49 30 94510145|dinger@zeg-berlin.de
2114|NCT00302952|Associate Director, Clinical Research Operations Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
2115|NCT00303069|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
2116|NCT00303186|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2117|NCT00303316|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
2118|NCT00303329|Study Director|Novartis Pharmaceuticals|862-778-8300|
2119|NCT00303446|Kenneth Fischbeck, M.D.|National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)|301-435-9318|kf@ninds.nih.gov
2120|NCT00303472|Study Director|Amgen Inc.|866-572-6436|
2121|NCT00303511|Dr. Wendy Book|Emory University|404-778-5545|wbook@emory.edu
2122|NCT00303602|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
2123|NCT00303823|H-H. Sherry Chow, Ph.D.|The University of Arizona|520-626-3358|schow@azcc.arizona.edu
2124|NCT00303862|Theodore Karrison, PhD|University of Chicago|773-702-9326|tkarrison@health.bsd.uchicago.edu
2125|NCT00303953|Lymphoma Committee Statistician|SWOG Statistical Center|206-667-4623|mleblanc@fhcrc.org
2126|NCT00303966|Dr. Wendy Stock|University of Chicago|773-834-8982|wstock@medicine.bsd.uchicago.edu
2127|NCT00303979|IMPROVE HF, Clinical Research Specialist|Medtronic Cardiac Rhythm Disease Management||medtronicCRMtrials@medtronic.com
2128|NCT00304031|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@acr.org
2129|NCT00304096|Kimberly Bullock, PhD and David Brenin, MD|University of Virginia|434-924-0180|kb9d@virginia.edu
2130|NCT00304187|Dr. Michael Devlin|New York State Psychiatric Institute|212-543-5748|mjd5@columbia.edu
2131|NCT00304265|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
2132|NCT00304746|Harrison G Pope Jr., M.D.|McLean Hospital|617-855-2911|hpope@mcLean.harvard.edu
2133|NCT00304915|Dr. Jeff Pyne|Central Arkansas Veterans Healthcare System|501-257-1083|jmpyne@uams.edu
2134|NCT00304954|Dr. Robert Nussenblatt, MD, MPH|NEI|301-496-3123|robert.nussenblatt@nih.gov
2135|NCT00305162|Meredith Todd|The Medicines Company|+19732906088|meredith.todd@themedco.com
2136|NCT00305227|Ann Stapleton, MD|University of Washington|206-616-4121|stapl@uw.edu
2160|NCT00311376|Therapeutic area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
2161|NCT00311402|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
2162|NCT00311584|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
2163|NCT00311766|Study Director, David R. Crockford|RegeneRx Biopharmaceuticals, Inc.|617-285-5588|dcrockford@regenerx.com
2164|NCT00312195|Clinical Leader, Executive Medical Director|Purdue Pharma L.P.|800-733-1333|
2165|NCT00312208|Medical Affairs study director|sanofi-aventis||publicregistryGMA@sanofi-aventis.com
2166|NCT00312221|Clinical Leader, Medical Director|Purdue Pharma L.P.|800-733-1333|
2240|NCT00332722|Dr. Laxmaiah Manchikanti, MD|Pain Management Center of Paducah|2705548373 ext 101|drlm@thepainmd.com
2241|NCT00332839|Study Director|Novartis Pharmaceuticals|+1 (862) 778-8300|
2242|NCT00333138|Study director|Novartis pharmaceuticals|862-778-8300|
2243|NCT00333359|XenoPort Call Center|XenoPort, Inc.|877-936-6778|
2244|NCT00333437|Jeffrey A. Golden, MD|University of California San Francisco|415-353-2935|Jeff.Golden@ucsf.edu
2245|NCT00333788|UCB Clinical Trial Call Center|UCB, Inc|+1 877 822 9493|
2246|NCT00333814|Therapeutic Area Head|Allergan, Inc|(714) 246-4500|clinicaltrials@allergan.com
2247|NCT00333840|Study Director|Novartis Pharmaceuticals|862-778-8300|
2248|NCT00333866|Pfizer ClinicalTrials.gov Call Center|Organization: Pfizer, Inc.|800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2249|NCT00333879|David Ross|Atlanta VA Rehab R&D Center|404-321-6111 ext 6817|rosss0128@bellsouth.net
2250|NCT00333983|Dr. Susan S. Conroy|VA Maryland Health Care System, Baltimore|(410) 605-7000 ext 3213|susan.conroy@va.gov
2251|NCT00334061|Siu Po Sit, PhD Study Coordinator|Penumbra Inc|510 748 3200 ext 221|siupo.sit@penumbrainc.com
2252|NCT00334074|Dr. Edward Agura|Baylor University Medical Center|214-818-8472|Sandyli@baylorhealth.edu
2276|NCT00336973|Medical Communications Specialist|Genentech, Inc.|800-821-8590|
2277|NCT00337077|Study Statistician|ECOG Statistical Office|617-632-3012|
2278|NCT00337103|Dr. Martin Olivo, M.D.|Eisai Inc.|888-422-4743|
2279|NCT00337129|Head and Neck Committtee Statistician|SWOG Statistical Center|(206)-667-4623|
2280|NCT00337168|SWOG Leukemia Statistician|SWOG Statistical Office|206-667-4623|
2281|NCT00337207|Clinical Research Office Administrator|Northwestern University|312-695-1301|cancertrials@northwestern.edu
2282|NCT00337272|Vice President of Scientific Affairs|Accelerated Community Oncology Research Network, Inc.||mwalker@acorncro.com
2283|NCT00337285|Timothy Whitaker|Shire Pharmaceutical Development, Inc.||twhitaker@shire.com
2284|NCT00337350|Dr. David Henderson|Massachusetts General Hospital Schizophrenia Research Program|(617) 912-7800|dchenderson@partners.org
2285|NCT00337428|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
2286|NCT00337467|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2287|NCT00337571|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2288|NCT00337610|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
2289|NCT00337662|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
2290|NCT00337675|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
2291|NCT00337727|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
2292|NCT00337779|Chen Duksin, MD|Teva Pharmaceutical Industries, Ltd.|972-9-863-4642|chen.duksin@teva.co.il
2293|NCT00337818|GSK Response Center|GlaxoSmithKline|866-435-7343|
2294|NCT00337935|Vice President, Medical Affairs|Centocor Ortho-Biotech LLC.|800.457.6399|
2295|NCT00338039|Christopher H. Crane, MD / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
2296|NCT00338104|Mark E. Molitch, M.D.|Northwestern University|312 503-4130|molitch@northwestern.edu
2297|NCT00338455|Sr. Director Clinical Leader|Scios R&D, Inc.|650 564-5084|
2298|NCT00338741|Liz Gedney/Clinical Trial Leader|EMD Serono|+781 681-2179|
2299|NCT00338884|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2300|NCT00338988|Melanie Thomas, MD/Assistant Professor|University Texas MD Anderson Cancer Center|713-794-4869|mjlim@mdanderson.org
2301|NCT00339040|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
2302|NCT00339144|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2345|NCT00325416|Daniel M. Sullivan, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-3878|dan.sullivan@moffitt.org
2346|NCT00325442|Kevin Laliberte, PharmD;  Senior Director, Product Development|United Therapeutics Corporation|919-425-8176|klaliberte@unither.com
2347|NCT00325468|Study Director|Amgen Inc.|866-572-6436|
2348|NCT00325780|Bill Arana|Kowa Research Institute|919 433 1600|barana@kowaus.com
2349|NCT00325819|Lisa Jackson, MD, MPH|Group Health Research Institute|206-442-5216|jackson.L@ghc.org
2350|NCT00325897|Dr. Richard Albert|Denver Health Medical Center|303-436-6900|ralbert@dhha.org
2351|NCT00326001|Dejan Danilovic|Biotronik GmbH&Co. KG, Berlin, Germany|+49 9131 8924 7832|dejan.danilovic@biotronik.com
2352|NCT00326118|GSK Response Center|GlaxoSmithKline|866-435-7343|
2353|NCT00326170|Guillermo Garcia-Manero, MD / Associate Professor|UT MD Anderson Cancer Center|713-792-7305|eharriso@mdanderson.org
2354|NCT00326183|Senior Vice President, Clinical and Quantitative Sciences|Merck & Co., Inc.|1-800-672-6372|
2355|NCT00326196|Masoor Kamalesh, MD|Roudebush VAMC|317-988-2401|masoor.kamalesh@va.gov
2356|NCT00326612|Maija Holsti, MD, MPH|DIvision of Pediatric Emergency Medicine|801-587-7450|maija.holsti@hsc.utah.edu
2357|NCT00326716|BMS Study Director|Bristol-Myers Squibb||clinical.trials@bms.com
2358|NCT00326781|Caryn Lerman, Ph.D.|University of Pennsylvania|215-746-7141|clerman@mail.med.upenn.edu
2359|NCT00326872|Dr. Dusica Babovic-Vuksanovic|Mayo Clinic||dbabovic@mayo.edu
2360|NCT00326885|Manager, Regulatory Affairs|Fresenius Biotech|781-699-4652|bao.le@fresenius-biotech.com
2361|NCT00326911|Chief Medical Officer|ImClone LLC||ClinicalTrials@ImClone.com
2362|NCT00326950|Eisai Inc.|Eisai Call Center|888-422-4743|
2363|NCT00327015|BMS Study Director|Bristol-Myers Squibb||clinical.trials@bms.com
2364|NCT00327171|Trial Transparency Team|Sanofi||Contact-Us@sanofi.com
2365|NCT00327340|Monica S. Krieger, PhD|OncoGenex Pharmaceuticals|425-686-1558|mkrieger@oncogenex.com
2366|NCT00327392|Eisai Medical Services|Eisai Inc|1-888-422-4743|
2367|NCT00327444|Trial Transparency Team|Sanofi||Contact-Us@sanofi.com
2321|NCT00323427|Mitchel Turbin, Ph.D.|Portland VA Medical Center|503-220-8262 ext 54525|bonnie.becker@va.gov
2322|NCT00323479|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
2323|NCT00323492|Camille Aubron-Olivier|Gilead Sciences|+33(0)1 42 737130|camille.aubron-olivier@gilead.com
2324|NCT00323557|Amar Safdar, MD/Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
2325|NCT00323609|John Tillman|Medtronic|408-548-6518|tillmj1@mspexcng.medtronic.com
2326|NCT00323622|GSK Response Center|GlaxoSmithKline|866-435-7343|
2327|NCT00323739|John D. Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
2328|NCT00323882|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2329|NCT00324038|Dr Paul Schofield, Medical Director|Napp Pharmaceutical Ltd|01223424444|info@contact-clinical-trials.com
2330|NCT00324116|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2331|NCT00324155|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2332|NCT00324168|Dr. Thomas Lietman|F.I. Proctor Foundation, University of Califonia, San Francisco|415-502-2662|tom.lietman@ucsf.edu
2333|NCT00324233|Kristine Gjødsbøl, PhD|Coloplast A/S|+4549113557|dkkg@coloplast.com
2334|NCT00324272|Mr. Henk Giele, Consultant Plastic & Reconstructive Surgeon|John Radcliffe Hospital|01865 231 056|henk.giele@orh.nhs.uk
2335|NCT00324350|Dr. Ann Schwartz|University of California, San Francisco|415-514-8000|aschwartz@psg.ucsf.edu
2336|NCT00324649|Pedro Ferrer|Gilead Sciences|+34 91 771 2478|pedro.ferrer@gilead.com
2337|NCT00324675|Dr. Frank Pistrosch|University Hospital "Carl Gustav Carus", Dresden|0049 351 4400580|frank.pistrosch@uniklinikum-dresden.de
2338|NCT00324896|Matthew Menza, MD|UMDNJ - RWJMS|732-235-4440|menza@umdnj.edu
2339|NCT00324961|GSK Response Center|GlaxoSmithKline|866-435-7343|
2340|NCT00325039|Heather Litman, PhD|New England Research Institutes, Inc.|617 972 3297|hlitman@neriscience.com
2341|NCT00325130|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
2342|NCT00325195|Medical Director|Savient Pharmaceuticals, Inc.|732-418-9300|
2343|NCT00325234|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2253|NCT00334204|Tibor Fulop, M.D./Associate Professor of Medicine|University of Mississippi|601 984-5670|tfulop@umc.edu
2254|NCT00334282|GSK Response Center|GlaxoSmithKline|866-435-7343|
2255|NCT00334295|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
2256|NCT00334542|Dr. Vered Stearns|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|4432876489|vstearn1@jhmi.edu
2257|NCT00334633|jane R Schwebke, MD|University of Alabama at Birmingham|205-975-5665|schwebke@uab.edu
2258|NCT00334802|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2259|NCT00334893|Dr. Martee L. Hensley|Memorial Sloan-Kettering Cancer Center|646-888-4222|hensleym@mskcc.org
2260|NCT00334958|Eisai Inc.|Eisai Call Center|888-422-4743|
2261|NCT00335283|Manager, Clinical Trials|Vanderbilt University Medical Center|615-322-4643|tina.higginbotham@vanderbilt.edu
2262|NCT00335322|Sean Emery|Kirby Institute|9385 0900|semery@kirby.unsw.edu.au
2263|NCT00335452|Trial Information Transparency Team|sanofi-aventis||GV-Contact-us@sanofi-aventis.com
2264|NCT00335478|Joseph Bubalo, PharmD, BCPS, BCOP|OHSU Knight Cancer Institute|503-494-1080|bubaloj@ohsu.edu
2265|NCT00335504|Dr. Paul Limburg|Mayo Clinic|507-266-9093|limburg.paul@mayo.edu
2266|NCT00335517|Glenn Rectine, MD|University of Rochester|585-275-8780|glenn_rectine@urmc.rochester.edu
2303|NCT00339183|Study Director|Amgen Inc.|866-572-6436|
2304|NCT00339833|Jonathan Krakoff, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|National Institutes of Health|6022005217|jkrakoff@mail.nih.gov
2305|NCT00340379|Frederick Cassidy|Duke University|919-575-7801|cassi002@mc.duke.edu
2306|NCT00340678|Renoprotection in Early Diabetic Nephropathy in Pima Indians|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|(602) 200-5205|rnelson@phx.niddk.nih.gov
2307|NCT00340834|Study Director|Novartis Pharmaceuticals|862-778-8300|
2308|NCT00342355|Michael A Polis, MD, MPH|National Institute of Allergy and Infectious Diseases, Dvision of Clinical Research|301-496-8027|mpolis@niaid.nih.gov
2309|NCT00342628|Feng-Ying (Kimi) Lin, MD, MPH|PDMI, NICHD, NIH|301-496-0295|link@mail.nih.gov
2310|NCT00343083|Ritesh Kataria|University of Marylnad Baltimore|410-328-8018|rkataria@umm.edu
2311|NCT00343252|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2312|NCT00343291|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2313|NCT00343512|Bapsi Chak, M.D.|Vanderbilt-Ingram Cancer Center|615-322-2555|
2314|NCT00323037|Sandy Stagge, RN, BSN|CTI Clinical Trial and Consulting Services|513-619-1837|sstagge@ctifacts.com
2315|NCT00323115|Dr. Camilo Fadul|Dartmouth-Hitchcock Medical Center|603-653-6312|camilo.e.fadul@hitchcock.org
2316|NCT00323258|Sara Calvert, PharmD|Duke University Medical Center|919-668-7540|sara.calvert@duke.edu
2317|NCT00323284|Jeff Wells, Sr. VP, Clinical, Regulatory, and Quality Affairs|Glaukos|949-367-9600 ext 227|jwells@glaukos.com
2318|NCT00323297|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2319|NCT00323310|Usha Halemane/Executive Director|Bracco Diagnostics Inc|609-514-2578|usha.halemane@diag.bracco.com
2320|NCT00323362|Dr. Joseph Aisner, MD|Rutgers Cancer Institute of New Jersey|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
2344|NCT00325403|Kevin Laliberte; Senior Director, Product Development|United Therapeutics Corporation|919-425-8176|klaliberte@unither.com
2062|NCT00320801|Clinical Leader, Executive Medical Director|Purdue Pharma L.P.|800-733-1333|
2063|NCT00321321|Dr. Kasper Aaboe|Gentofte Hospital, University of Copenhagen|+4539978474|Kasper@dadlnet.dk
2064|NCT00321373|GSK Response Center|GlaxoSmithKline|866-435-7343|
2065|NCT00321464|Study Director|Amgen Inc.|866-572-6436|
2066|NCT00321620|Study Director|Amgen Inc.|866-572-6436|
2067|NCT00321646|Mary-Ellen Taplin, MD|Dana-Farber Cancer Institute|617-582-8313|mary_taplin@dfci.harvard.edu
2206|NCT00362401|Dr. Thais A. Pedersen, primary investigator|Aarhus University Hospital, Skejby|+45 8949 5484|thais.a.pedersen@ki.au.dk
2207|NCT00362453|Chenchen Wang, MD, MSc, Associate Professor|Tufts Medical Center|617-636-3251|cwang2@tuftsmedicalcenter.org
2208|NCT00362466|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2209|NCT00362609|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
2210|NCT00362648|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
2211|NCT00363038|Murad Alam, MD|Northwestern University Department of Dermatology|312-695-6785|m-alam@northwestern.edu
2212|NCT00363051|Novartis Study Director|Novartis Pharmaceuticals|(862 778-8300|
2213|NCT00363077|GSK Response Center|GlaxoSmithKline|866-435-7343|
2214|NCT00363129|Lisa Kottschade, RN, MSN, CNP|Mayo Clinic|507-284-2511|kottschade.lisa@mayo.edu
2215|NCT00363142|GSK Response Center|GlaxoSmithKline|866-435-7343|
2216|NCT00363168|Neil M. Bressler|Johns Hopkins University|410-955-8342|nbressler@jhmi.edu
2217|NCT00363311|GSK Response Center|GlaxoSmithKline|866-435-7343|
2218|NCT00363415|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2219|NCT00363467|Jeffrey Lancet MD|H. Lee Moffitt Cancer Center|813-745-6841|Jeffrey.Lancet@moffitt.org
2220|NCT00363675|Mary Jo Baryza, Diredtor of Therapeutic Services|Shrines Hospitals for Children - Boston|617-371-4749|mbaryza@shrinenet.org
2221|NCT00363779|Kevin Conlon, M.D.|National Cancer Institute (NCI), National Institutes of Health (NIH)|301-496-7417|conlonkc@mail.nih.gov
2222|NCT00363805|Dr. Sherry Chow|University of Arizona|520-626-3358|schow@azcc.arizona.edu
2223|NCT00363896|Clinical Project Leader and Trial Manager|Almirall S.A.|+34 93 291 3200|
2224|NCT00364013|Study Director|Amgen Inc.|866-572-6436|
2225|NCT00364130|Mary Leonard, MD, MSCE|Children's Hospital of Philadelphia|215-590-0874|leonard@email.chop.edu
2226|NCT00364156|Dr. Caryn Lerman|University of Pennsylvania|215-746-7141|clerman@mail.med.upenn.edu
2227|NCT00364182|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2228|NCT00364286|Susan O'Brien, MD/ Professor|The University of Texas MD Anderson Cancer Center|713-792-7543|eharriso@mdanderson.org
2229|NCT00364351|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
2230|NCT00364377|Adrian Vella|Mayo Clinic|507-284-3754|vella.adrian@mayo.edu
2231|NCT00364533|Senior Director, Clinical Leader|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|609-730-6780|
2232|NCT00364611|Trial Transparency Team|Sanofi-aventis||Contact-us@sanofi.com
2233|NCT00364793|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2234|NCT00364845|Study Director|Amgen Inc.|866-572-6436|
2235|NCT00364858|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
2236|NCT00364923|Michael Saunders, M.D.|Allos Therapeutics, Inc|303-426-6262|msaunders@allos.com
2237|NCT00364949|Dr. Andrea Dunaif|Northwestern University|312-503-2902|a-dunaif@northwestern.edu
2238|NCT00365144|Andrew Ko, MD|UCaliforniaSF|415-353-9888|andrewko@medicine.ucsf.edu
2239|NCT00365261|Joel Dimsdale, M.D., Principal Investigator|University of California, San Diego|619 543-5592|jdimsdale@ucsd.edu
4292|NCT00447265|Associate Director for Clinical Research|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
4293|NCT00447278|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4294|NCT00447382|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
4295|NCT00447421|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4411|NCT00450294|Dr. Amit Chopra|Department of Anesthesia|204-880-5370|amitchopra1@live.com
4412|NCT00450333|Timothy Whitaker, MD|Shire Pharmaceuticals||twhitaker@shire.com
4413|NCT00450372|Lynn Feun MD|UM/Sylvester Comprehensive Cancer Center|305-243-4909|lfeun@med.miami.edu
4414|NCT00450424|Kristen Sorice|Fox Chase Cancer Center|215-214-1433|Kristen.Sorice@fccc.edu
4415|NCT00450437|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@Novartis.com
4416|NCT00450580|GSK Response Center|GlaxoSmithKline|866-435-7343|
4417|NCT00488592|Minoo Battiwalla, MD|Hematology Branch, NHLBI|301 827 0939|battiwam@nhlbi.nih.gov
4418|NCT00488631|Senior Director|Janssen Research & Development|215-793-7540|
4419|NCT00488644|Victor Levin, MD, BS / Professor|UT MD Anderson Cancer Center||kuhunter@mdanderson.org
4420|NCT00488683|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
4421|NCT00488774|Senior Director|Janssen Research & Development|215-793-7540|
4422|NCT00488826|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
4423|NCT00488865|James Bressler|Rex Medical|610-940-0665|ebressler@rexmedical.com
4424|NCT00489255|Medical Director, Neurology|Ipsen|clinical.trials@ipsen.com|clinical.trials@ipsen.com
4425|NCT00489268|David E. Fleischer, M.D.|Mayo Clinic, Arizona|(480) 301-4461|fleischer.david@mayo.edu
4426|NCT00489359|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4427|NCT00489424|Study Director|Novartis Pharmaceuticals|862-778-8300|
4858|NCT00496860|Hing C. Wong, Chief Clinical Officer|Altor Bioscience|9544438600|hingwong@altorbioscience.com
4859|NCT00496964|Dr. Sheryl Finucane|Virginia Commonwealth University|804-628-3639|sfinucan@vcu.edu
4860|NCT00497055|Phillip O. Coffin, Director of Substance Use Research|San Francisco Department of Public Health|415-437-6282|phillip.coffin@sfdph.org
4861|NCT00497146|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
4862|NCT00497198|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
4863|NCT00497770|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
4864|NCT00498186|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
4865|NCT00498355|Dr. Nisha Acharya|University of California San Francisco|415-476-8131|nisha.acharya@ucsf.edu
4866|NCT00498433|Study Director|Novartis Pharmaceuticals|862-778-8300|
4867|NCT00498550|Christopher OKeefe|Dartmouth Medical School|603-271-5287|chris.okeefe@hitchcock.org
4868|NCT00784459|Dr Jonathan Green|Washington University|314-747-3591|jgreen@wustl.edu
4869|NCT00784550|GSK Response Center|GlaxoSmithKline|866-435-7343|
4870|NCT00784654|Study Physician|Shire Development LLC|1 866-842-5335|
4871|NCT00784719|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4872|NCT00784784|Dr. Brenda Coleman|Mount Sinai Hospital|416-586-4800 ext 4161|bcoleman@mtsinai.on.ca
4873|NCT00784810|Director of Medical Affairs|Napp Pharmaceuticals Ltd|01223 424444|
4874|NCT00784836|Biogen Idec Medical Director|Biogen Idec Inc.||clinicaltrials@biogenidec.com
4875|NCT00784849|Dr. Eugene Woltering|LSU Dept of Surgery|504 464-8500|ewolte@lsuhsc.edu
4876|NCT00784875|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4877|NCT00785213|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
5452|NCT00759109|Senior Vice President,Global Clinical Development|Merck Sharp and Dohme Corp.||ClinicalTrialsDisclosure@merck.com
5453|NCT00759148|Alcon Clinical|Alcon Research, Ltd.|888.451.3937;817.568.6725|medinfo@alconlabs.com
5454|NCT00759174|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5455|NCT00759187|William DeVizio- DMD|Colgate Palmolive|732-878-7901|William_Devizio@colpal.com
5456|NCT00759356|Meena Venugopal, Director, Clinical R&D|Actavis Inc.|908-659-2885|MVenugopal@actavis.com
5457|NCT00759395|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
5458|NCT00759473|Dr. McRae-Clark|MUSC|843-792-5216|mcraeal@musc.edu
5459|NCT00759577|Dr. Victor Nitti|New York University|646 825 6300|Victor.Nitti@NYUMC.org
5460|NCT00759655|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5461|NCT00759668|Marcello Fornoni|Alcon Italia SpA|39.02.81.303.226|marcello.fornoni@alconlabs.com
5462|NCT00765765|Dr. Vassiliki Karantza|Cancer Institute of New Jersey|732-235-8675|karantva@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
5463|NCT00765817|Chief Medical Officer|Eli Lilly and Company||clinicaltrials@amylin.com
5464|NCT00765843|Ryan Crews|Rosalind Franklin University of Medicine and Science|847-578-8437|ryan.crews@rosalindfranklin.edu
5465|NCT00765882|Paul F.C. Eng, PhD. Director, Clinical Development|Forest Research Institute|201-427-8071|Paul.Eng@frx.com
5030|NCT00811928|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
5031|NCT00811941|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
5032|NCT00811954|ACTG Clinicaltrials.gov Coordinator|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|(301) 628-3313|ACTGCT.Gov@s-3.com
5033|NCT00812006|Senior Vice President,  Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
5034|NCT00812110|P. Cooper White, M.D.|Akron Children's Hospital|330-543-8530|CWhite@chmca.org
2481|NCT00361257|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
2482|NCT00361283|Reginald F. Frye, PhD, Associate Professor|University of Florida|3522735453|fryerf@ufl.edu
2506|NCT00365976|Jenny Bridgers, CRC|Duke University|919-684-0752|jenny.bridgers@duke.edu
2507|NCT00366028|Dr. Carol VanDeusen Lukas|Department of Veterans Affairs|857-364-5685|carol.vandeusenlukas@va.gov
2508|NCT00343889|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
2509|NCT00343915|GSK Response Center|GlaxoSmithKline|866-435-7343|
2510|NCT00344032|GSK Response Center|GlaxoSmithKline|866-435-7343|
2511|NCT00344175|Bill Arana|Kowa Research Institute|919 433-1600|barana@kowaus.com
2512|NCT00344305|Raburn Mallory MD/ Sr Dir Clinical Development|MedImmune, LLC|301-398-0000|clinicaltrialenquiries@medimmune.com
2513|NCT00344370|Bill Arana|Kowa Research Institute|919 433-1600|barana@kowaus.com
2514|NCT00344682|Dr. Kristina Deligiannidis|UMass Medical School|508-856-5928|kristina.deligiannidis@umassmemorial.org
2515|NCT00344773|Gerard Lynch|Astrazeneca||AZTrial_Results_Posting@astrazeneca.com
2516|NCT00344968|Kathleen Billman, Senior Director of Scientific Affairs|Alimera Sciences, Inc.|678-572-1302|kathleen.billman@alimerasciences.com
2517|NCT00345033|David C. Henderson|Massachusetts General Hospital|(617) 912-7800|dchenderson@partners.org
2518|NCT00345046|Louis B. Cantor|Indiana University|317-278-2651|lcantor@iupui.edu
2519|NCT00345176|Traci Clemons, PhD|The EMMES Corporation|301-251-1161 ext 212|tclemons@emmes.com
2520|NCT00345579|GSK Response Center|GlaxoSmithKline|866-435-7343|
2521|NCT00345592|Giovanni Luca Botto|S. Anna Hospital|0315851 ext +39|gluca.botto@gmail.com
2522|NCT00345631|Hans-Peter Stoll, M.D.|Cordis Corporation, a Johnson&Johnson company|908-541-4770|hpstoll@its.jnj.com
2523|NCT00345683|GSK Response Center|GlaxoSmithKline|866-435-7343|
4428|NCT00489489|Trial Transparency Team|sanofi-aventis||Contact_US@sanofi-aventis.com
4429|NCT00489541|Andrey Nersesov, Clinical Project Manager|Boston Scientific|508-683-4988|andrey.nersesov@bsci.com
4430|NCT00489554|GSK Response Center|GlaxoSmithKline|866-435-7343|
4431|NCT00489736|International Clinical Development, Clinical Study Director|sanofi-aventis||GV-Contact-us@sanofi-aventis.com
4432|NCT00489853|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
4433|NCT00489866|Christine E. Marx, MD|Durham VAMC|9192860411 ext 7426|marx0001@mc.duke.edu
4434|NCT00489970|GSK Response Center|GlaxoSmithKline|866-435-7343|
4548|NCT00492089|Monica Loghin, MD / Assistant Professor|The University of Texas MD Anderson Cancer Center|K Hunter, RN 713-745-5769|CR_Study_Registration@mdanderson.org
4549|NCT00492232|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
4550|NCT00492284|Medical Information Department|QLT Inc.|1-800-663-5486|medaff@qltinc.com
4551|NCT00492297|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
4552|NCT00492336|Dr. Robert Buchanan, M.D.|Maryland Psychiatric Research Center|410-402-7876|rwbuchanan@mprc.umaryland.edu
4553|NCT00492531|Mark Gladwin|Professor of Medicine: Chief, Pulmonary, Allergy and Critical Care Medicine: Director, Hemostasis and Vascular Biology Research Institute; University of Pittsburgh School of Medicine|412-692-2117|gladwinmt@upmc.edu
4554|NCT00792805|Study Director|Novartis Pharmaceuticals|862 778-8300|
4555|NCT00792935|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4556|NCT00793104|Robin Waite , Clinical Projects Director|RI Biologics|386-418-8888|rwaite@rtix.com
4557|NCT00834340|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4558|NCT00834366|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
4559|NCT00834405|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4878|NCT00785356|Jennifer Wike|Repros Therapeutics Inc.|2817193402|jwike@reprosrx.com
4879|NCT00785486|Medical Affairs Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
4880|NCT00785512|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|Forest Laboratories|1-201-427-8259|John.Whalen@frx.com
4881|NCT00785577|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4882|NCT00747812|Lyn Pimentel, Clinical Project Manager|Boston Scientific|(661) 949-4174|Lyn.Pimentel@bsci.com
4883|NCT00748085|Ann Murphy Legg, Director of Clinical Research|CSA Medical|781-538-4732|alegg@csamedical.com
4884|NCT00748098|XenoPort Call Center|XenoPort, Inc.|877-936-6778|
4885|NCT00748189|GSK Response Center|GlaxoSmithKline|866-435-7343|
4886|NCT00748241|Head of Clinical Research Area Dental|Astra Tech AB|+46317763000|
4887|NCT00748566|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4888|NCT00748579|Medical Director|Cytokinetics, Inc.|(650) 624-3011|
4889|NCT00748709|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
4890|NCT00748826|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
4891|NCT00748865|Alcon Clinical|Alcon Research Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
4892|NCT00748982|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
4893|NCT00749073|VP Clinical, Regulatory, Quality|Vertos Medical|9493490008 ext 216|cmyers@vertosmed.com
4894|NCT00749190|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
4895|NCT00749398|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
4896|NCT00749463|Joyce Hauze, Sr Specialist, Clinical Research Operations|J&J Consumer and Personal Products Worldwide|928-277-0715|jhauze@its.jnj.com
4897|NCT00749476|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
5035|NCT00812253|Kathleen Dungan|The Ohio State University|6146853333|kathleen.dungan@osumc.edu
5036|NCT00812331|Global Clinical DVLP Manager|Janssen Research & Development United States||ClinicalTrialDisclosure@its.jnj.com
5037|NCT00812461|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
5038|NCT00812487|Kathleen Dungan, MD, MPH|Ohio State University|614-685-3333|kathleen.dungan@osumc.edu
5039|NCT00812565|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|Octapharma USA|201-604-1155|michael.eppolito@octapharma.com
5040|NCT00812604|Dr. Ricky Wing Kit Wong, Associate professor in orthodontics|University of Hong Kong|852-2859 0554|fyoung@hkucc.hku.hk
5041|NCT00812812|GSK Response Center|GlaxoSmithKline|866-435-7343|
5042|NCT00812955|Gerard Lynch|AstraZeneca|+44 1509 645 895|aztrial_results_posting@astrazeneca.com
5043|NCT00812968|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
5044|NCT00813098|Clinical Project Manager|Lexicon Pharmaceuticals, Inc.|281-863-3000|
5045|NCT00813111|Executive Medical Director|Pacira Pharmaceuticals, Inc.|203-837-6500|ErolOnel@pacira.com
5046|NCT00813150|Therapeutic Areas Director|Jan-Cil Germany||ClinicalTrialDisclosure@its.jnj.com
5047|NCT00813319|Dr. Ralph DiClemente, Principal Investigator|Emory University Rollins School of Public Health|404-727-0237|rdiclem@emory.edu
5048|NCT00821821|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
5049|NCT00821873|Robin Waite, Director, Clinical Projects|RTI Biologics|386-418-8888 ext 4172|rwaite@rtix.com
5050|NCT00821951|Dr. Roy H Decker, MD PhD|Yale University|203 737-2758|roy.decker@yale.edu
5051|NCT00822172|William Hiatt, MD, President|CPC Clinical Research|3038609900|william.hiatt@cpcmed.org
5237|NCT00849862|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
5238|NCT00849901|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
5239|NCT00850070|Glen R. Elliott, Ph.D., M.D.|The Children's Health Council|650.688.3649|gelliott@chconline.org
2524|NCT00345839|Study Director|Amgen Inc.|866-572-6436|
2525|NCT00345878|GSK Response Center|GlaxoSmithKline|866-435-7343|
2526|NCT00346034|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2527|NCT00346151|Associate Director, Clinical Research Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
2528|NCT00346268|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2529|NCT00346333|Eliot L. Berson, M.D.|Harvard Medical School|617-573-3600|marilyn_sullivan@meei.harvard.edu
2483|NCT00361335|Senior Director Clinical Research|Centocor, Inc.|1-800-457-6399|
2484|NCT00361374|Dr David Mischoulon, Director of Research, Depression Clinical and Research Program|Massachusetts General Hospital|617-724-5198|dmischoulon@partners.org
2485|NCT00361439|Jayant Pinto, MD|University of Chicago|773-702-6727|jpinto@surgery.bsd.uchicago.edu
2486|NCT00361504|Senior Director, Clinical Leader|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|609-730-4537|
2487|NCT00361569|Duramed Research Protocol Chair|Duramed Research|215-293-7279|medicalaffairs@barrlabs.com
2488|NCT00361595|Chad Deal|Cleveland Clinic|216-444-6575|dealc@ccf.org
2489|NCT00361634|Study Director|Amgen Inc.|866-572-6436|
2490|NCT00362115|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
2491|NCT00365274|Michelle Fanale, MD / Associate Professor|The University of Texas (UT) MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
2492|NCT00365300|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
2493|NCT00365352|XenoPort Call Center|XenoPort, Inc.|877-936-6778|
2494|NCT00365365|Trial Transparency Team|Sanofi||Contact_Us@sanofi.com
2495|NCT00365378|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
2496|NCT00365391|Philip A. Philip, M.D., Ph.D., F.R.C.P.|Wayne State University||philipp@karmanos.org
4560|NCT00834418|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4561|NCT00834431|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4562|NCT00834444|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
4563|NCT00834483|Dr. Brett R. Levine|Rush University Medical Center|312-432-2466|brettlevine@gmail.com
4564|NCT00834522|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4565|NCT00834535|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4566|NCT00834561|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4567|NCT00834574|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4568|NCT00834587|Manger, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4569|NCT00834613|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4661|NCT00494494|Kennth L. Cohen, MD|University of North Carolina at Chapel Hill|919 843-0292|klc@med.unc.edu
4662|NCT00494507|Robert Griggs, MD|University of Rochester|585-275-3707|robert_griggs@urmc.rochester.edu
4663|NCT00834977|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4664|NCT00834990|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4665|NCT00835003|MD, PhD Julie Glavind|Aarhus University Hospital, Dep. Obstetrics and Gynecology, Aarhus, Denmark|+4578450000|julie.glavind@dadlnet.dk
4666|NCT00835042|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4667|NCT00835068|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4668|NCT00835081|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4669|NCT00835146|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4898|NCT00749580|Charurut Somboonwit, MD|USF Health|813 3078067|csomboon@health.usf.edu
4899|NCT00749684|Vice President, Late Stage Development Group Leader|Merck Sharp and Dohme Corp.|1-800-672-6372|clinicaltrialsdisclosure@merck.com
4900|NCT00749775|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4901|NCT00749931|Clinical Research Manager|Dune Medical Devices|+97246178000|shiri@dunemedical.com
4902|NCT00749944|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4903|NCT00749996|Irène Ayer, Clinical research specialist|Medtronic Spinal & Biologics|+41 21 803 84 27|irene.ayer@medtronic.com
4904|NCT00750139|Associate Medical Director- Dermatology|Merz Pharmaceuticals, LLC|800-334-0514|
4905|NCT00750152|Merz Pharmaceuticals, LLC|Merz Pharmaceuticals, LLC|800-334-0514|
4906|NCT00750191|Dr. Leonard Kapural|The Center for Clinical Research|1-336-765-6181|LKapural@ccrpain.com
4907|NCT00750282|Dr. Juergen Hirschfeld|Piramal Imaging|49 30 461 1246 15|juergen.hirschfeld@piramal.com
4908|NCT00750308|Dr. Nancy J. Brown|Vanderbilt University|615-343-8701|nancy.j.brown@vanderbilt.edu
4909|NCT00426660|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4910|NCT00426751|GSK Response Center|GlaxoSmithKline|866-435-7343|
4911|NCT00426764|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
4912|NCT00427011|Eisai Inc.|Eisai Call Center|888-422-4743|
4913|NCT00427037|Vin Tangpricha|Emory University School of Medicine|404-727-7254|vin.tangpricha@emory.edu
4914|NCT00427336|Paolo Anderlini, MD / Professor|UT MD Anderson Cancer Center||mvpacheco@mdanderson.org
4915|NCT00427557|Dr. Partow Kebriaei|MD Anderson Cancer Center|713-563-5174|celsaenz@mdanderson.org
4916|NCT00427635|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
4917|NCT00427765|Partow Kebriaei, MD/Associate Professor|UT MD Anderson Cancer Center||celsaenz@mdanderson.org
5240|NCT00850096|Chief Medical Officer|CPEX Pharmaceuticals, Inc.|603-658-6100 ext 503|
5241|NCT00850174|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
5242|NCT00852761|GSK Response Center|GlaxoSmithKline|866-435-7343|
5243|NCT00852917|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
5244|NCT00852969|Mark Sarnak, MD|Tufts Medical Center|617 636-1182|msarnak@tuftsmedicalcenter.org
5245|NCT00853099|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
5246|NCT00853151|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
5247|NCT00853333|Michael Froelich|University of Alabama at Birmigham|(205)975-0145|froelich@uab.edu
5248|NCT00853385|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5249|NCT00853567|Jennifer Wike|Repros Therapeutics Inc.|2817193402|jwike@reprosrx.com
5250|NCT00853593|4396 Clinical Research Specialist|Medtronic, Inc|800-328-2518 ext 62808|medtronicCRMtrials@medtronic.com
5251|NCT00853606|Wesley W Day PhD|Vivus, Inc|650-934-5200|
5252|NCT00853749|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5253|NCT00853827|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
5254|NCT00853840|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
5255|NCT00725751|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5256|NCT00725842|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme||ClinicalTrialsDisclosure@merck.com
5257|NCT00725920|Marcelo F Mello|Federal University of Sao Paulo|55 11 50822860|mf-mello@uol.com.br
5258|NCT00725985|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
5259|NCT00726063|Clinical Research Manager|Biomet 3i LLC|5617766722|cristina.matthews@biomet.com
2497|NCT00365417|Diana Gosik|NSABP Foundation, Inc.|412-330-4692|diana.gosik@nsabp.org
2498|NCT00365456|Clinical Trial Operations|Nycomed|+45 4677 1111|clinicaltrials@nycomed.com
2499|NCT00365508|Robert Schnoll|University of Pennsylvania|215-746-7143|schnoll@mail.med.upenn.edu
2500|NCT00365547|Arkadiusz Dudek, M.D.|Masonic Cancer Center, University of Minnesota|612-624-0123|dudek002@umn.edu
2501|NCT00365599|Susan Minton, D.O.|H. Lee Moffitt Cancer Center and Research Institute|813-745-3806|susan.minton@moffitt.org
2502|NCT00365716|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
2503|NCT00365846|Stuart Knechtle, MD|Emory University|404-727-8465|stuart.knechtle@emoryhealthcare.org
2504|NCT00365859|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2505|NCT00365872|Scott J. Antonia, M.D., Ph.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-3883|scott.antonia@moffitt.org
2368|NCT00327470|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2369|NCT00327717|Takao Ishii, Asia regulatory affairs|Eisai Co., Ltd.|81-3-3817-3914|
2370|NCT00328042|Dr. Erik Groessl|VA San Diego|858-552-8585|erik.groessl@va.gov
2371|NCT00328094|Dr. Balachundhar Subramaniam, MD MPH|Beth Israel Deaconess Medical Center, Boston, MA|6177542675|bsubrama@bidmc.harvard.edu
2372|NCT00328172|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
2373|NCT00328198|Genzyme Medical Information|Genzyme Corporation|1-800-745-4447|
2374|NCT00328263|Dr. Serge Carrière|Bio-K+ International Inc.|450-978-2465|scarriere@biokplus.com
2375|NCT00328510|Maria Werner-Wasik, MD|Thomas Jefferson University|215-955-7679|Maria.Werner-Wasik@jeffersonhospital.org
2376|NCT00328562|Maria Werner-Wasik, MD|Thomas Jefferson University|215-955-6702|Maria.Werner-Wasik@jeffersonhospital.org
2377|NCT00328614|Edouard Trabulsi, MD|Thomas Jefferson University|215-955-1000|Edouard.Trabulsi@jefferson.edu
4670|NCT00835159|ALEXANDER ZASLAVSKY|NYU Langone Medical Center|212-263-5569|michael.haile@nyumc.org
4671|NCT00835172|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4672|NCT00835198|Vice President Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
4673|NCT00706654|Global Medical Affairs|Otsuka Pharmaceutical Development and Commercialization|800 562-3974|
4674|NCT00706706|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4675|NCT00706719|Ronald Wiehle, PhD|Repros Therapeutics, Inc|281.719.3406|rwiehle@reprosrx.com
4676|NCT00706784|Alexandra B. Kimball, MD|MGH|617-726-5066|akimball@partners.org
4677|NCT00706797|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4678|NCT00706823|Carin A. Hagberg, MD|University of Texas Medical School at Houston|713-500-6222|carin.a.hagberg@uth.tmc.edu
4679|NCT00706849|Genzyme Medical Information|Genzyme Corporation|617-252-7832|
4680|NCT00706966|Mack Roach, MD|University of California San Francisco|415-353-9855|tdiep@radonc.ucsf.edu
4681|NCT00706979|Matthew J. Carpenter|Medical University of South Carolina`|843-792-3974|carpente@musc.edu
4682|NCT00706992|Dr. Steven Rosenberg|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
4296|NCT00447499|Bert Bakker, MD, PhD.|Ipsen|+1 650 238 1669|bert.bakker@ipsen.com
4297|NCT00447590|Laura Eaton, R.N., BSN, CCRN-R|Apollo Endosurgery|949-468-9301|laura.eaton@apolloendo.com
4298|NCT00447603|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4299|NCT00447902|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
4300|NCT00448175|Clinical Study Manager|Uroplasty, Inc|952-426-6153|megan.otoole@uroplasty.com
4301|NCT00448227|Study Director|Novartis Pharmaceuticals|862-778-8300|
4302|NCT00448344|Dr. Lori Bastian|VA Connecticut|860-667-6853|lori.bastian@va.gov
4918|NCT00427791|Dr. Partow Kebriaei, Associate Professor|UT MD Anderson Cancer Center|713-792-2648|ytdinh@mdanderson.org
4919|NCT00427804|Vin Tangpricha, M.D., Ph.D.|Emory University|404-727-7254|vin.tangpricha@emory.edu
4920|NCT00427895|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4921|NCT00427921|Medical Information Specialist|Abbott Laboratories|Phone: (800) 633-9110|
4922|NCT00427934|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4923|NCT00427960|Gerard Lynch|Astrazeneca||AZTrial_Results_Posting@astrazeneca.com
4924|NCT00428077|Michael Deininger, MD, PhD|University of Utah Huntsman Cancer Institute|801-585-3229|michael.deininger@hci.utah.edu
4925|NCT00428246|Rajiv Agarwal|Indiana University|317-988-2241|ragarwal@iupui.edu
4926|NCT00428389|Study Director|Novartis Pharmaceuticals|862-778-8300|
4927|NCT00428441|Dr. Walter Ageno|University of Insubria|+39 0332 278831|agewal@yahoo.com
4928|NCT00428584|Fernando Dangond, MD|EMD Serono, Inc.|781-681-2348|fernando.dangond@emdserono.com
4929|NCT00428597|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4930|NCT00428792|Study Director|Novartis Pharmaceuticals|862 778-8300|
4931|NCT00428844|Ed Campanaro, VP Clinical Operations|Cubist Pharmaceuticals, Inc.|781-860-8318|ed.campanaro@cubist.com
4932|NCT00428974|Pnina Fishman, PhD|Can-Fite BioPharma Ltd|011972 3 924 1114|pnina@canfite.co.il
4933|NCT00429026|Naoto Ueno, MD, PhD / Associate Professor|U.T. M.D. Anderson Cancer Center|713-792-8754|CR_Study_Registration@mdanderson.org
4934|NCT00429104|Naoto Ueno, MD.PhD./Professor|University of Texas MD Anderson Cancer Center|713-792-8754|CR_Study_Registration@mdanderson.org
4935|NCT00429143|Neal Flomenberg, MD|Thomas Jefferson University|215-955-4367|neal.flomenberg@jefferson.edu
4960|NCT00467389|Kenneth Grasing|Substance Abuse Research Laboratory, Kansas City VA Medical Center|(816) 922-2756|kenneth.grasing@va.gov
4961|NCT00467519|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
5466|NCT00765947|Study Director|Novartis Pharmaceuticals|862-778-8300|
5467|NCT00766051|Lynne La Corte, PhD, OTR/L, OTD|University of Utah at the time of the study|970 4330981|lflacorte@independence.net
5468|NCT00766090|GSK Response Center|GlaxoSmithKline|866-435-7343|
5469|NCT00766363|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|EnVivo Pharmaceuticals, Inc.|617-225-4264|mgawryl@envivopharma.com
5470|NCT00766376|Director of Regulatory Affairs|Palomar Medical Technologies, Inc.|781-993-2414|stimberlake@palomarmedical.com
5471|NCT00766415|Alison Holt|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
5472|NCT00766493|Bryan Randall|W. L. Gore & Associates|(800) 437-8181|BRandall@WLGore.com
5473|NCT00766506|Study Responsible Physician|Janssen-Cilag Ltd. 50-100 Holmers Farm Way, High Wycombe , BUCKS, UK, HP12 4EG|+44 (0) 1494 567 444|
5474|NCT00766532|Dr. Karen Hansen|University of Wisconsin|608-263-0517|keh@medicine.wisc.edu
5475|NCT00766649|Wai T. Wong|National Eye Institute|(301) 905-7301|wongw@nei.nih.gov
5476|NCT00766675|Medical Affairs Director|Janssen Pharmaceutics Taiwan|+886-2-23762155|
5477|NCT00766831|Clinical Research Associate|Medical Affairs|82-2-2094-4835|
5478|NCT00767000|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5479|NCT00767039|Alan Fujii MD (PI)|Boston Medical Center|617-4414-3735|Alan.Fujii@bmc.org
5480|NCT00767325|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
5481|NCT00767338|Gregory Christman, MD|University of Michigan|734-764-8142|growthh@umich.edu
5482|NCT00767364|Eric McGrath, MD|Wayne State University School of Medicine, Children's Hospital of Michigan|313-745-5863|emcgrath@med.wayne.edu
5483|NCT00767455|Jaime Dickerson, PhD|Smith & Nephew Biotherapeutics|817-302-3914|jaime.dickerson@smith-nephew.com
5484|NCT00767507|Meredith Todd - Sr. Director Program Management|The Medicines Company|+1.973.290.6088|meredith.todd@themedco.com
5485|NCT00767520|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2378|NCT00328627|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
2379|NCT00328770|Dr. Norman Kneteman|Liver Transplant Program, University of Alberta Hospitals|780-407-6168|norm.kneteman@albertahealthservices.ca
2380|NCT00328783|Rani Anne, MD|Thomas Jefferson University|215-955-6045|Rani.Anne@jeffersonhospital.org
2381|NCT00328861|Steven A. Rosenberg, M.D.|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
2382|NCT00328926|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
2383|NCT00329108|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2384|NCT00329160|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
2385|NCT00329238|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
2386|NCT00329407|Ofra sarid-Segal, MD|Boston University|617-414-1990|ofra.segal@bmc.org
2387|NCT00329420|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
2388|NCT00329433|Michael S. Avidan, MBBCh|Washington University School of Medicine|314-747-4155|avidanm@wustl.edu
2389|NCT00329524|John Dornhoffer, MD|UAMS Department of Otolaryngology|501-686-7000|dornhofferjohnl@uams.edu
2390|NCT00329550|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
2391|NCT00329602|GSK Response Center|GlaxoSmithKline|866-435-7343|
2392|NCT00329641|SWOG Melanoma Statistician|SWOG Statistical Office|206-667-4408|
2393|NCT00329732|Kathleen Bradley|Thomas Jefferson University|215-955-2025|Kathleen.Bradley@jefferson.edu
2394|NCT00329745|GSK Response Center|GlaxoSmithKline|866-435-7343|
2395|NCT00329771|Abraham A. Ashkenazi, M.D./Principal Investigator|Doylestown Hospital, Pennsylvania|215-625-2894|aashkenzai2001@yahoo.com
2396|NCT00329836|Abraham Ashkenazi, M.D./ Prinicpal Investigator|Doylestown Hospital|215-625-2894|aashkenazi@yahoo.com
2397|NCT00329849|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
4303|NCT00448435|GSK Response Center|GlaxoSmithKline|866-435-7343|
4304|NCT00448448|Dr. Lori A. Dolan|University of Iowa Dept of Orthopaedics and Rehabilitation|319-356-1075|lori-dolan@uiowa.edu
4305|NCT00448539|Eisai Inc.|Eisai Call Center|888-422-4743|
4306|NCT00486811|Claudia Leinweber|Grünenthal GmbH|+49 241 569 2509|claudia.leinweber@grunenthal.com
4307|NCT00486837|Henry Li|Grifols Therapeutics|1-800-520-2807|henry.li@grifols.com
4308|NCT00486863|Jennifer Friedman, M.D., Ph.D|Warren Alpert Medical School of Brown University, Lifespan Center for International Health Research|(401) 444-7449|jennifer_friedman@brown.edu
4309|NCT00486902|Dr. Robert J. McCarthy|Northwestern University Feinberg School of Medicine|312-926-9015|r-mccarthy@northwestern.edu
4310|NCT00486954|GSK Response Center|GlaxoSmithKline|866-435-7343|
4311|NCT00487084|Cynthia A. Wong,M.D.|Northwestern University|630-472-3555|c-wong2@northwestern.edu
4312|NCT00487162|J. Jeffrey Freda, MD, MBA|UMDNJ-NJMS|973 972-5007|jjfreda@umdnj.edu
4313|NCT00487188|Medical Communications|Hoffman-LaRoche|800-821-8590|
4314|NCT00487240|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4315|NCT00487279|Heidi Hinrichs/Sr. Director, Clinical Operations|St. Jude Medical CRMD|(818) 493-3297|hhinrichs@sjm.com
4316|NCT00487396|Director, Clinical Affairs|Given Imaging|+972-4-9097777|Hila.Debby@givenimaging.com
4317|NCT00487435|Senior Director, Clinical Leader|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|609-730-4537|
4318|NCT00487539|Senior Director|Janssen Research & Development|215-793-7540|
4435|NCT00490022|Dr. Stephanie Page, PhD, MD|University of Washington|206.616.0483|page@u.washington.edu
4436|NCT00490139|GSK Response Center|GlaxoSmithKline|866-435-7343|
4437|NCT00490256|Paul Kirshbom, MD|Emory University|404-785-6330|pkirshb@emory.edu
4438|NCT00490269|Dr. Lou Cantelina|Uniformed Services University for the Health Sciences|301-295-3240|louis.cantelina@usuhs.edu
4962|NCT00467558|Jon E. Grant, MD|University of Minnesota|612-273-9736|grant045@umn.edu
4963|NCT00467584|Dr. Dean M. Wingerchuk|Mayo Clinic|480-301-6328|wingerchuk.dean@mayo.edu
4964|NCT00467649|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4965|NCT00830219|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4966|NCT00699608|GSK Response Center|GlaxoSmithKline|866-435-7343|
4967|NCT00699699|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
4968|NCT00699751|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
4969|NCT00699842|Emmanuel Besa, MD|Thomas Jefferson University|215-955-8874|Emmanuel.Besa@jefferson.edu
4970|NCT00699972|Eisai Inc.|Eisai Call Center|888-422-4743|
4971|NCT00699998|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4972|NCT00700011|Dr. Seah Lim|Texas Oncology - Amarillo|806-358-8654|seah.lim@usoncology.com
4973|NCT00700063|Clinical Trial Disclosure Manager|Leo Pharma A/S|+45 4494 5888|ctr.disclosure@leo-pharma.com
4974|NCT00700115|Dr. Igho Ofotokun|Emory University School of Medicine|404-616-0659|iofotok@emory.edu
4975|NCT00700141|Medical Responsible|Nycomed Deutschland GmbH|+49 7531 3666 0|clinicaltrials@nycomed.com
4976|NCT00700180|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
4977|NCT00700271|Study Director|Novartis Pharmaceuticals|862-778-8300|
4978|NCT00700310|Eisai Inc.|Eisai Call Center|888-422-4743|
4979|NCT00700375|Prevention on Conrast-Induced Nephropathy With Bolus Injection of Sodium Bicarbonate|Osaka General Medical Center|81-6-6692-1201|u_hiromichi@yahoo.co.jp
4980|NCT00700427|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4981|NCT00700440|Dr. Lu Tai-xiang|Cancer Center, Sun Yat-sen University|86-20-87343372|lutx@mail.sysu.edu.cn
5083|NCT00702325|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
5084|NCT00702338|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5085|NCT00606944|Sung-Bum Kang|Seoul National University Bundang Hospital|+82-31-787-7093|kangsb@snubh.org
5086|NCT00607048|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5087|NCT00607087|Medical Affairs Study Director|sanofi-aventis||publicregistryGMA@sanofi-aventis.com
5088|NCT00607113|Dr. James Yao|UT MD Anderson Cancer Center|713-792-2828|mjlim@mdanderson.org
5089|NCT00607243|Myoung-don Oh, M.D.|Seoul National University Hospital|+82-2-2072-2945|mdohmd@snu.ac.kr
5090|NCT00607269|Jesse B. Fletcher, Ph.D., Statistician|Friends Research Institute, Inc.|323-463-1601|jfletcher@friendsresearch.org
5091|NCT00607321|K Bogdanovich|Medtronic Cardiovascular||rs.medtroniccardiovascularclinicaltrials@medtronic.com
5092|NCT00607373|Genzyme Medical Information|Genzyme Corporation|617-252-7832|
5093|NCT00607386|Arian Pano, MD, MPH|Shire HGT|781-482-0875|apano@shire.com
5094|NCT00607477|Michael Maitland, MD, PhD|University of Chicago|773-702-4400|mmaitlan@medicine.bsd.uchicago.edu
5095|NCT00607594|Dr. Heather-Jane Au|Cross Cancer Institute|780-432-8500|heathera@cancerboard.ab.ca
5096|NCT00607672|Dr. Mias Pretorius|Vanderbilt University School of Medicine|16153430665|mias.pretorius@vanderbilt.edu
5097|NCT00607789|Susan McElroy, MD|Lindner Center of HOPE|513-536-0718|susan.mcelroy@lindnercenter.org
5283|NCT00734656|Jonathan Covault|University of Connecticut Health Center|860-679-7560|jocovault@uchc.edu
5284|NCT00734929|Dr. Ashraf Habib|Duke University Medical Center|9196686265|habib001@mc.duke.edu
5285|NCT00734994|Zeljko Vujaskovic, MD, PhD|Duke University, Department of Radiation Oncology|919 668-5221|vujas001@mc.duke.edu
5286|NCT00735007|Elisabetta Verdun di Cantogno|Merck Serono International, S.A., an affiliate of Merck KGaA, Darmstadt, Germany|+41 22 414 4887|elisabetta.verdun@merckserono.net
2398|NCT00329901|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
2399|NCT00330161|Erin Sargent|University of Michigan Comprehensive Cancer Center|(734) 936-3348|esargent@umich.edu
2400|NCT00330421|Jeffrey A. Morgan, M.D.|Dana-Farber Cancer Institute|617-632-5204|jamorgan@partners.org
2401|NCT00330460|Study Director|Amgen Inc.|866-572-6436|
2402|NCT00330564|Quality Assurance Specialist|UT MD Anderson Cancer Center|713-563-1602|caperez@mdanderson.org
2403|NCT00330616|GSK Response Center|GlaxoSmithKline|866-435-7343|
2404|NCT00330668|Sr Vice President, Clinical Development and Medical Affairs|Ipsen, US|clinical.trials@ipsen.com|clinical.trials@ipsen.com
2405|NCT00330733|Peter Reaven|Phoenix VA Health Care System|602 277 5551 ext 5817|Peter.Reaven@va.gov
2406|NCT00330759|Study Director|Amgen Inc.|866-572-6436|
2407|NCT00330876|Bill Arana|Kowa Research Institute|919 433 1600|barana@kowaus.com
2408|NCT00330915|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2409|NCT00330928|Clinical Project Manager|InfraReDx, Inc|781-221-0053 ext 611|mhendricks@infraredx.com
2410|NCT00331006|Susan F. Assmann, PhD|New England Research Institutes, Inc.|617-972-3048|sassmann@neriscience.com
2411|NCT00331409|Christopher W. Ryan|Oregon Health and Science University|503-494-1951|ryanc@ohsu.edu
2412|NCT00331422|Melissa Geller, MD|Masonic Cancer Center, University of Minnesota|612-626-3111|gelle005@umn.edu
2554|NCT00349921|Regina Curry, RN, CCRC|Wake Forest University Health Sciences|(336) 716-4294|recurry@wfubmc.edu
2555|NCT00350142|Dr. Albert Koong|Stanford Cancer Center|650-498-7703|akoong@stanford.edu
2556|NCT00350207|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
2557|NCT00350220|Jill M. Cholette MD|University of Rochester Medical Center|585-275-0189|Jill_Cholette@urmc.rochester.edu
2558|NCT00350402|Dr. Dawn Bowers|University of Florida|(352) 392-3450|dawnbowers@phhp.ufl.edu
4439|NCT00490477|V. M. Ranieri, MD|University of Turin, Italy|00390116334001|marco.ranieri@unito.it
4440|NCT00490542|S. Nassir Ghaemi, MD, MPH|Tufts Medical Center|617-636-5735|nghaemi@tuftsmedicalcenter.org
4441|NCT00490555|Dr. Stephanie Page|University of Washington|2066160483|page@u.washington.edu
4442|NCT00490646|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4443|NCT00490698|Shi-Ming Tu, MD / Professor|The University of Texas (UT) MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
4444|NCT00490724|Manager|Clinical Science Initiative Dept. Janssen Pharmaceutical K.K./ Tokyo Japan|+81.3.4411.5653|
4445|NCT00790556|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
4446|NCT00790569|Dr. Michael Stein|Butler Hospital|401-455-6646|michael_stein@brown.ed
4447|NCT00790751|Wesley W Day PhD|Vivus, Inc|650-934-5200|
4448|NCT00790790|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4449|NCT00790803|Dr. Shree Kurup|Wake Forest Baptist Health Eye Center|336-716-4091|skurup@wakehealth.edu
4450|NCT00790855|Hagop M. Kantarjian, M.D.|The University of MD Anderson Cancer Center|713-792-7026|eharriso@mdanderson.org
4451|NCT00790907|GSK Response Center|GlaxoSmithKline|866-435-7343|
4452|NCT00791102|Robert Naclerio, MD|University of Chicago|773-702-0080|rnacleri@surgery.bsd.uchicago.edu
4453|NCT00791258|John Raia|Daiichi Sankyo, Inc|(973) 944-2683|jraia@dsi.com
4454|NCT00791323|Vice President Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
4455|NCT00791388|Peter Thomas|Procter & Gamble|513.622.4838|thomas.pr@pg.com
4456|NCT00791492|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4457|NCT00791518|GSK Response Center|GlaxoSmithKline|866-435-7343|
4570|NCT00834626|Dr. Neeraj Gupta|Kirloskar Hospital|+91-40-23296241|drugale@kirloskarhospital.com
4982|NCT00700635|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
4983|NCT00700752|Kurt Moody OD|Vistakon|904-443-3088|
5373|NCT00765336|Director of Clinical Trials|Medicis Global Services Corporation||ClinicalTrials@Medicis.com
5374|NCT00765362|Manager of Clinical Affairs|DJO Surgical|512-832-9500 ext 1323|jane.jacob@djosurgical.com
5375|NCT00765388|Seema Suchdev Wrisberg|Coloplast A/S|+4549113519|dkssw@coloplast.com
5376|NCT00765674|Study Director|Novartis Pharmaceuticals|862 778-8300|
5377|NCT00765726|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5378|NCT00735644|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
5379|NCT00735709|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
5380|NCT00735787|Global Medical Services|Abbott Laboratories|1-800-633-9110|
5381|NCT00735839|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5382|NCT00735904|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5383|NCT00735917|Wells A. Messersmith, M.D.|University of Colorado Cancer Center||wells.messersmith@ucdenver.edu
5384|NCT00735943|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5385|NCT00773955|Maria Q. Baggstrom, M.D.|Washington University||Mbaggstr@im.wustl.edu
5386|NCT00774046|Dr. Lucy A. Godley|University of Chicago|773-702-4140|lgodley@medicine.bsd.uchicago.edu
5387|NCT00774163|Dr. Richard Oberhelman|Tulane University School of Public Health and Tropical Medicine|504-988-2511|oberhel@tulane.edu
5388|NCT00774267|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5389|NCT00774748|Clinical Research Coordinator|UNC Chapel Hill School of Medicine Dept. Hematology|919-966-2359|catherine_soriano@med.unc.edu
5390|NCT00774787|Darrell Rigel|Rigel Dermatology|212-684-5964|dsrigel@prodigy.net
5486|NCT00767572|Dr. Doreen DeFaria Yeh|UCSF|617-643-7024|ddefariayeh@partners.org
5487|NCT00767676|Jaime Dickerson, PhD|Smith & Nephew Biotherapeutics|817-302-3914|jaime.dickerson@smith-nephew.com
5488|NCT00767806|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
5052|NCT00822185|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
5053|NCT00822237|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5054|NCT00822328|Dr.Yi-Hsien Lin|Cheng Hsin Rehabilitation Medical Center|+886-2-28264400 ext 5750|d49311001@ym.edu.tw
5055|NCT00822588|Head of Clinical Research Area Health Care|Astra Tech AB|+46317763000|
5056|NCT00822692|Gillian Schmitz, MD|Wilford Hall Medical Center|919-724-9185|gillianmd@gmail.com
5057|NCT00822757|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5058|NCT00822770|Marina Konopleva, MD, PhD / Associate Professor|The University of Texas (UT) MD Anderson Cancer Center|713-794-1628|mkonople@mdanderson.org
5059|NCT00823043|Arthur Shedden MD|Vistakon|904-443-1557|
5060|NCT00823069|Mary Sanstead|Medicis|480-291-5926|msanstead@medicis.com
5061|NCT00823095|Deborah Dodge|Loma Linda University Medical Center|(909) 558-4000 ext 48500|ddodge@llu.edu
5062|NCT00823199|Nigel Bark MD|Bronx Psychiatric Center|7188625429|Nigel.Bark@omh.ny.gov
5063|NCT00823212|Ruth Starzyk, PhD|Boston Scientific Corporation|508-683-6577|ruth.starzyk@bsci.com
5064|NCT00823264|Dr. Brent Morgan|Emory University|404-616-4403|bmorg02@emory.edu
5065|NCT00823303|Dr. Daniel W. Coyne|Washington University School of Medicine|3143627211|dcoyne@dom.wustl.edu
5066|NCT00688844|Rani H. Singh|Emory University|404-448-8519|rsingh@emory.edu
5067|NCT00688870|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5068|NCT00689052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
2559|NCT00350519|Vice President Medical Affairs COBS|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|215-325-4464|
2560|NCT00350532|Dr. James Eisenach|Wake Forest University School of Medicine|336-716-4498|jimeisenach@gmail.com
2561|NCT00350623|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
2562|NCT00350636|Gary Hoel, PhD, Executive Director|Watson Laboratories, Inc|801-808-8866|gary.hoel@watson.com
2563|NCT00350727|GSK Response Center|GlaxoSmithKline|866-435-7343|
2564|NCT00350779|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclsoure@merck.com
2565|NCT00350792|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2566|NCT00350844|Dr. Robert I. Liem|Ann and Robert H. Lurie Children's Hospital of Chicago|312-227-4842|Rliem@luriechildrens.org
2567|NCT00351000|Dr. David Henderson|Massachusetts General Hospital Schizophrenia Research Program|(617) 912-7800|dchenderson@partners.org
2568|NCT00351039|George Simon, M.D.|Fox Chase Cancer Center (formerly at H. Lee Moffitt Cancer Center & Research Institute)|215-728-2509|george.simon@fccc.edu
2569|NCT00351351|James Lingeman, MD|IU Health Methodist Hospital|317-962-0870|lrawlings@iuhealth.org
2570|NCT00351377|Study Director|Novartis Pharmaceuticals|862-778-8300|
2571|NCT00351533|Renee Stapleton, MD PhD|University of Vermont|802-656-7975|renee.stapleton@uvm.edu
2572|NCT00351741|Principal Investigator|USAISR|210-916-3054|kevin.chung@us.army.mil
2573|NCT00351936|Dr. David Henderson|Massachusetts General Hospital Schizophrenia Research Program|(617) 912-7800|dchenderson@partners.org
2574|NCT00352053|Dara Wambach, MA, Associate Director, Regulatory Affairs|Gilead Sciences|650 522 5163|Dara.Wambach@gilead.com
2575|NCT00352105|Dr. David Adelstein|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|216-444-9310|adelstd@ccf.org
2576|NCT00352118|Frank Ondrey, M.D.|Masonic Cancer Center, University of Minnesota|612-625-3200|ondre002@umn.edu
2577|NCT00352365|Study Statistician|SWOG|206-667-4623|
4571|NCT00834639|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4572|NCT00834717|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4573|NCT00834743|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4574|NCT00834756|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4575|NCT00834795|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4576|NCT00834808|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
4577|NCT00834873|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4578|NCT00834899|Kenneth I. Ataga, MD|University of North Carolina at Chapel Hill|919-966-0178|kataga@med.unc.edu
4579|NCT00834912|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
4580|NCT00834964|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4581|NCT00840086|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
4582|NCT00840099|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4583|NCT00840203|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4584|NCT00840216|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4585|NCT00840281|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4586|NCT00840294|Scott Eggener|University of Chicago|(773) 702-5195|seggener@surgery.bsd.uchicago.edu
4587|NCT00840411|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4588|NCT00840450|Franco Muggia, MD|NYU Cancer Institute|212-263-6485|franco.muggia@nyumc.org
4589|NCT00840476|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
5391|NCT00774800|Vice President, Endocrinology Clinical Development|Halozyme Therapeutics, Inc.|(858) 794-8889|
5392|NCT00774995|GSK Response Center|GlaxoSmithKline|866-435-7343|
5393|NCT00775021|Kurt Moody, Director Design R&D|Vistakon|904-443-3088|
5394|NCT00775203|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
5395|NCT00775229|Dr. Jon Grant|University of Chicago|773-834-1325|jongrant@uchicago.edu
4936|NCT00429169|Michael F. Grunebaum, MD|Columbia University/NYSPI|212-543-5842|mfg14@columbia.edu
4937|NCT00464672|Novartis Vaccines and Diagnostics|Novartis Vaccines and Diagnostics||RegContactVacUS.nvdit@Novartis.com
4938|NCT00464685|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
4939|NCT00464737|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
4940|NCT00464945|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
4941|NCT00465088|Global Medical Services|Abbott|800-633-9110|
4942|NCT00465361|Sarah S. Nyp|Children's Mercy Hospitals and Clinics|816-234-3000|ssnyp@cmh.edu
4943|NCT00465530|Dr. Julie Wei|University of Kansas Medical Center|(913) 588-6664|jwei@kumc.edu
4944|NCT00465647|Executive Medical Director|Purdue Pharma L.P.|800-733-1333|
4945|NCT00465738|Claus Goebel, MD|Merz Pharmaceuticals GmbH|+49-69-1503-6461|claus.goebel@merz.de
4946|NCT00465816|GSK Response Center|GlaxoSmithKline|866-435-7343|
4947|NCT00465894|Dr. Holly E. Richter|University of Alabama at Birmingham|205-934-1704|hrichter@uabmc.edu
4948|NCT00465972|Andrew Krystal, MD, MS, Professor of Psychiatry and Behavioral Sciences|Duke University School of Medicine|919-681-8742|andrew.krystal@duke.edu
4949|NCT00465985|Study Director|Novartis Pharmaceuticals|862-778-8300|
4950|NCT00466167|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
4951|NCT00466193|Clinical Leader|Purdue Pharma LP|800-733-1333|
5274|NCT00734214|Dr. Karen Choong|McMaster University|905-5212100 ext 75617|choongk@mcmaster.ca
5275|NCT00734409|DaiWai M Olson, PhD RN|Duke University Health System|(919) 668-3751|Olson006@mc.duke.edu
5276|NCT00734500|Michael Cohen-Wolkowiez|Duke University|9196688812|michael.cohenwolkowiez@duke.edu
5277|NCT00734539|Daniel K. Benjamin Jr|Duke Univiersity Medical Center|919-668-7081|danny.benjamin@dm.duke.edu
5278|NCT00734578|Timothy Whitaker, MD|Shire Pharmaceutical||twhitaker@shire.com
5279|NCT00734591|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5280|NCT00734604|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
5281|NCT00734617|Jed E. Rose, Ph.D.|Duke Center for Nicotine & Smoking Cessation Research|919 668-5093|rose0003@mc.duke.edu
5282|NCT00734630|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|Forest Laboratories, Inc.|2014278000 ext 2133|noah.rosenberg@frx.com
5489|NCT00776230|Katrin Dubischar-Kastner|Valneva Austria GmbH|+43120620 ext 0|info@valneva.com
5490|NCT00776295|Mohamed Kharfan Dabaja, MD|H. Lee Moffitt Cancer Center|961-1350000 ext 5350|MK143@aub.edu.lb
5491|NCT00776555|Gerald Tremblay, M.D.|Shire Pharmaceutical||gtremblay@shire.com
5492|NCT00776659|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5493|NCT00776789|Dr Anu Thukral|AIIMS|01126594605 ext -|dranuthukral@yahoo.com
5494|NCT00776919|GSK Response Center|GlaxoSmithKline|866-435-7343|
5495|NCT00776984|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5496|NCT00776997|Amy Derosier, VP of Clinical Affairs|Torax Medical|651-361-8900|aderosier@toraxmedical.com
5497|NCT00777023|Head of R&D|Depomed|650-462-5900 ext 108|msweeney@depomed.com
5498|NCT00777062|Dr. Kyle Kampman|University of Pennsylvania|215-222-3200 ext 109|kampman@mail.med.upenn.edu
5499|NCT00777153|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
2578|NCT00352417|Brian Cunningham, MD|Tallikut Pharmaceuticals, Inc.|312-505-0420|brian@baycitycapital.com
2579|NCT00352612|Aaron Chen|Johns Hopkins University|4109556143|achen33@jhmi.edu
2580|NCT00352664|Eduardo Bruera, MD / Professor|UT MD Anderson Cancer Center|713-792-6084|
2581|NCT00352781|Co-Investigator|Centre for Addiction and Mental Health|416-535-8501 ext 7422|laurie_zawertailo@camh.net
2582|NCT00352846|Fredrick Hagemeister, MD/Professor|The University of Texas (UT) MD Anderson Cancer Center||psanjorjo@mdanderson.org
2583|NCT00352885|Bobbi Woolwine|Emory University|404-712-9620|bwoolwi@emory.edu
2584|NCT00352911|Mary Giffear, Sr. Clinical Scientist|VGX Pharmaceuticals, LLC|267 440 4220|mgiffear@inovio.com
2585|NCT00353119|Annie Levesque|Innovaderm Research Inc|514-521-4285 ext 222|alevesque@innovaderm.ca
2586|NCT00353275|Dr. Lillian S. Kao|UT Health Science Center at Houston|713-566-5095|Lillian.S.Kao@uth.tmc.edu
2587|NCT00353301|Dr. Thomas Flaig|University of Colorado, Denver|(720) 848-0655|Thomas.Flaig@ucdenver.edu
2588|NCT00353366|GSK Response Center|GlaxoSmithKline|866-435-7343|
2589|NCT00353418|Medical Communications|Hoffmann-La Roche|800-821-8590|
2590|NCT00353431|Robert Thomann, MD|Intern Medicine Solothurn, Switzerland|+41326274501|endodiab.bss@bluewin.ch
2591|NCT00353704|Ulrich J Spreng|Baerum Hospital|004798499184|ulispreng@hotmail.com
2592|NCT00353795|David Bluemke|NIH|301 402 1854|bluemked@nih.gov
2593|NCT00353977|Minoo Battiwalla, MD|Hematology Branch, NHLBI|301 827 0939|battiwam@nhlbi.nih.gov
2594|NCT00354029|Ulrich J Spreng|Baerum Hospital|004798499184|ulispreng@hotmail.com
2595|NCT00354107|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
2596|NCT00354159|REDUCEhf Clinical Research Specialist|Medtronic CRDM|1-800-328-2518 ext 62736|medtronicCRMtrials@medtronic.com
2597|NCT00354172|Jeffrey Miller, M.D.|Masonic Cancer Center, University of Minnesota|612-625-7409|mille011@umn.edu
4590|NCT00840632|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4591|NCT00840658|Steffanie Strathdee, PhD|University of California, San Diego|(858) 822-1952|sstrathdee@ucsd.edu
4592|NCT00840840|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4683|NCT00707057|Stephen Turner, VP and Chief Technical Officer|SCOLR Pharma Inc|425-368-1050 ext 1001|sturner@scolr.com
4684|NCT00707161|Dennis Shrieve, MD|Huntsman Cancer Institute|801-581-8793|dennis.shrieve@hci.utah.edu
4685|NCT00707174|Glen Bowen, MD|University of Utah|801-581-0255|glen.bown@hci.utah.edu
4686|NCT00707239|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4687|NCT00707447|Norbert Hermanns|FIDAM|0049 7931 594 ext 553|hermanns@diabetes-zentrum.de
4688|NCT00707486|Staci McAdams|HemCon Medical Technologies|(503)245-0459 ext 103|staci@hemcon.com
4689|NCT00707655|Eva Järlid Westerberg, VP Clinical Operations|Genmab A/S|+45 7020 2728|E.Westerberg@genmab.com
4690|NCT00423267|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
4691|NCT00423293|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@acr.org
4692|NCT00423319|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4693|NCT00423332|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
4694|NCT00423436|Charles S Cleeland, PhD, Professor|UT MD Anderson Cancer Center||asaleeba@mdanderson.org
4695|NCT00423449|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4696|NCT00423488|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
4697|NCT00423579|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
4698|NCT00423592|Annemarie Vance|Gilead Sciences, Inc.|650-524-3829|Annemarie.Vance@gilead.com
4952|NCT00466206|Michael Harrison, MD|UCSF-Benioff Children's Hospital|415 476-2538|pedsurg@ucsfmedctr.org
4953|NCT00466310|Rima Kaddurah-Douk, Associate Professor|DUMC|919-684-2611|rima.kaddurah-daouk@duke.edu
4954|NCT00466505|Jordan Berlin, MD|Vanderbilt-Ingram Cancer center|615-343-4128|jordan.berlin@vanderbilt.edu
4955|NCT00466687|Jeffrey Sosman, M.D.|Vanderbilt-Ingram Cancer Center||jeff.sosman@vanderbilt.edu
4956|NCT00466817|David Kimberlin, MD|University of Alabama in Birmingham|205-934-2424|dkimberlin@peds.uab.edu
4957|NCT00466947|GSK Response Center|GlaxoSmithKline|866-435-7343|
4958|NCT00467259|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
4959|NCT00467363|Dr Enrique Schisterman|NICHD|(301) 435-6893|schistee@mail.nih.gov
5167|NCT00690495|Study manager|B.Braun Melsungen AG|+49 5661 71 ext 0|studies@bbraun.com
5168|NCT00690573|Global Medical Services|Abbott|800-633-9110|
5169|NCT00690612|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
5170|NCT00690794|Director of Alcon Clinical|Alcon Research, Ltd.|1-888-451-3937|medinfo@alconlabs.com
5171|NCT00690820|Sven Voet - Global Communication|Solvay Pharmaceuticals|+32(0)2 509 69 77|sven.voet@solvay.com
5172|NCT00690898|Medical Director, Endocrinology|Ipsen|clinical.trials@ipsen.com|clinical.trials@ipsen.com
5173|NCT00691028|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
5174|NCT00691054|Caio Max Rocha Lima MD|University of Miami Sylvester Comprehensive Cancer Center|305-243-7770|crocha@med.miami.edu
5175|NCT00691093|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
5176|NCT00691197|Therapeutic Area Head|Allergan, Inc.|(714)246-4500|clinicaltrials@allergan.com
5177|NCT00691327|Medical Monitor|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
5178|NCT00691483|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5287|NCT00735072|Peter W. Hunt, MD|UCaliforniaSF|(415) 476-4082 ext 345|phunt@php.ucsf.edu
5288|NCT00735306|Dr. Brian Czito|Duke University|919-668-7336|brian.czito@duke.edu
5289|NCT00735371|Timothy Whitaker, MD|Shire Pharmaceuticals||twhitaker@shire.com
5290|NCT00735436|Annick Desjardins, MD, FRCPC|Duke University Medical Center||annick.desjardins@dm.duke.edu
5291|NCT00735449|Vice President Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
5292|NCT00735462|Robert Babilon, Vice President, Product Development|Graceway Pharmaceuticals|267-948-0400 ext 20428|robert.babilon@gracewaypharma.com
5293|NCT00735475|Dr Russell Basser|CSL Limited|+61 3 9389 1569|russell.basser@csl.com.au
5294|NCT00735553|Jennifer Wike|Repros Therapeutics Inc.|2817193402|jwike@reprosrx.com
5295|NCT00735618|Ying Guo, MD, MS/Associate Professor|UT MD Anderson Cancer Center||jaallo@mdanderson.org
5296|NCT00656799|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
5297|NCT00656851|Kevin Yarasheski, PhD|Washington Univ Med Sch|3143628173|key@wustl.edu
5298|NCT00656916|Lara Bashoura, MD / Assistant Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
5299|NCT00656968|Dr. Ping-I Hsu|Kaohsiung Veterans General Hospital|886-7-3422121 ext 8233|pihsu@isca.vghks.gov.tw
5300|NCT00657020|Director of Medical Affairs, Clinical Trial Registry and Policy|GlaxoSmithKline|973-889-2361|kate.r.ernst@gsk.com
5301|NCT00657046|Chief Scientific Officer|Chelsea Therapeutics Inc.|704-973-4202|hewitt@chelsearx.com
5302|NCT00657150|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5303|NCT00657267|Patrick Y. Wen, MD|Dana-Farber Cancer Institute / Brigham & Women's Hospital|617-632-2166|pwen@partners.org
5304|NCT00657358|Dr. Michael Froelich|UAB|205-975-0145|froelich@uab.edu
5558|NCT00760578|Jerry Colca, PhD|Metabolic Solutions Development Company|269-343-6732|jcolca@msdrx.com
5559|NCT00760617|GSK Response Center|GlaxoSmithKline|866-435-7343|
2598|NCT00354484|Marc Tokars|Luitpold Pharmaceuticals, Inc.|610-650-4200|mtokars@lpicrd.com
2622|NCT00377403|Jane Garbut,MD|Washington University in St Louis|314-454-8613|jgarbutt@dom.wustl.edu
2623|NCT00377429|Anne Kuan|Fresenius Biotech|781 699 4618|anne.kuan@fresenius-biotech.com
2624|NCT00377455|Dr. Virginia Steen|Georgetown University|202-444-6200|steenv@georgetown.edu
2625|NCT00377520|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
2626|NCT00377572|Associate Director, Clinical Research Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
2627|NCT00377637|Medical Communications|Hoffman-LaRoche|800-821-8590|
2628|NCT00377676|Richard Scranton|VeroScience|401 816-0525|richard_scranton@veroscience.com
2629|NCT00377819|Study Director|Amgen Inc.|866-572-6436|
2630|NCT00377832|Daniel W. Skupski, MD|Weill Cornell Medical College|718-670-1495|dwskupsk@med.cornell.edu
2631|NCT00377858|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2632|NCT00377962|Study Director|Novartis Pharmaceuticals|862 778-8300|
2633|NCT00378014|Study Director|Novartis Pharmaceuticals|862-778-8300|
2634|NCT00378079|Dr. Timothy Kinlock|Friends Research Institute|(410) 837-3977 ext 224|tkinlock@friendsresearch.org
2635|NCT00378105|Dr. Richardson|Dana-Farber Cancer Institute|617-632-2104|Paul_Richardson@dfci.harvard.edu
2636|NCT00378209|Dr. Paul Richardson|Dana-Farber Cancer Institute|617-632-2104|Paul_Richardson@dfci.harvard.edu
2637|NCT00378378|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
2638|NCT00378508|Kevan Herold, MD|Yale University|203-785-6507|Kevan.Herold@yale.edu
2639|NCT00378560|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
2640|NCT00378573|Medical Affairs study director|sanofi-aventis||publicregistryUSMA@sanofi-aventis.com
4699|NCT00423605|Grace Wang, MD, Director Clinical Development & Medical Monitor|Jazz Pharmaceuticals, Inc.|650-496-3777|
4700|NCT00423657|Vice President, Clinical Sciences|Cerexa, Inc.|(510) 285-9200|clinicaltrials@cerexa.com
4701|NCT00423670|Vice President, Late Stage Development Group Leader|Merck, Sharp and Dohme||ClinicalTrialsDisclosure@merck.com
4702|NCT00423800|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
4703|NCT00423813|Grace Wang, MD, Medical Monitor & Director of Clinical Development|Jazz Pharmaceuticals, Inc.|650-496-3777|
4704|NCT00423878|Dr. Scott Stroup|Columbia University|212-543-5676|stroups@nyspi.columbia.edu
4705|NCT00423891|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4706|NCT00424008|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
4707|NCT00424021|Karen L Miller, PhD|Gilead Sciences, Inc.|650-524-3892|KarenL.Miller@gilead.com
4708|NCT00424177|GSK Response Center|GlaxoSmithKline|866-435-7343|
4709|NCT00424190|Vice President, Clinical Sciences|Cerexa|(510) 285-9200|clinicaltrials@cerexa.com
4710|NCT00424255|GSK Response Center|GlaxoSmithKline|866-435-7343|
4711|NCT00424268|Respiratory Medical Advisor|Nycomed GmbH|0049-7531-840|clinicaltrials@nycomed.com
4712|NCT00424294|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4713|NCT00424346|Study Director|Novartis Pharmaceuticals|862-778-8300|
4714|NCT00424372|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4715|NCT00424385|Sigrun Hallmeyer, MD  Director of Research; Chadi Nabhan, MD FACP (PI)|Oncology Specialists, SC|847-268-8200|shallmeyer@oncmed.net
4716|NCT00424398|Vice President, Clinical Research & Medical Affairs|ISTA Pharmaceuticals, Inc.|949-788-6000|tmcnamara@istavision.com
4717|NCT00460408|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5179|NCT00691652|Dr. Craig Okada|OHSU Knight Cancer Institute|503-494-1080|Okadac@ohsu.edu
5180|NCT00691665|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
5181|NCT00691704|Cristina Gasparetto, MD|Duke University Medical Center|919-668-1017|cristina.gasparetto@duke.edu
5182|NCT00691808|Joel P. Freiman, MD, MPH - Medical Director, Drug safety|Lexicon Pharmaceuticals, Inc.|281-863-3000|
5183|NCT00692003|Antonio Laurenza, MD, Executive Director|Eisai Inc|1 201 949-4157|antonio_laurenza@eisai.com
5184|NCT00692185|Evelyn Attia, MD|New York State Psychiatric Institute|212-543-5923|ea12@columbia.edu
5185|NCT00733512|Alcon Clinical|Alcon Research, Ltd|888.451.3937; 817.568.6725|medinfo@alconlabs.com
5186|NCT00608322|Stephen Trzeciak, MD, MPH|Cooper University Hospital|856-342-3342|trzeciak-stephen@cooperhealth.edu
5187|NCT00608491|Jenny Ibarra|Duke University|9192363291|jenny.ibarra@duke.edu
5188|NCT00608517|Brian Engelhardt, M.D.|Vanderbilt-Ingram Cancer Center|615-936-1803|
5189|NCT00608543|Dr.Prabha Sunderajan|UT Southwestern Medical Center|214-648-0156|prabha.sunderajan@utsouthwestern.edu
5396|NCT00775346|Manager, Clinical Affairs|Covidien|303 305 2591|Norma.Prince@Covidien.com
5397|NCT00775411|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
5398|NCT00775450|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
5399|NCT00775463|Oral Treprostinil Program Head|United Therapeutics Corporation|919-485-8350|klaliberte@unither.com
5400|NCT00775528|Sven Voet - Global Communication|Solvay Pharmaceuticals|+32 (0)2 509 69 77|sven.voet@solvay.com
5401|NCT00775606|Allan R. Tenorio|Rush University Medical Center|312-942-3665|allan_s_tenorio@rush.edu
5402|NCT00775671|Nancy J Brown|Vanderbilt University|615-343-8701|nancy.j.brown@vanderbilt.edu
5403|NCT00775944|Graeme Docherty|University of Nottingham|01158321380|graeme.docherty@nottingham.ac.uk
5404|NCT00775983|Abby Sokoloff|UCSF|4155140440|sokoloffa@obgyn.ucsf.edu
5069|NCT00689104|Director Medical Science|Astellas Pharma Europe B.V.||ClinicalTrials.Disclosure@us.astellas.com
5070|NCT00689117|GSK Response Center|GlaxoSmithKline|866-435-7343|
5071|NCT00689260|Sanja Dragnic, MD|EMD Serono, Inc.|781-681-2337|sanja.dragnic@emdserono.com
5072|NCT00689299|Mark Hites|Greer Laboratories, Inc. for Antigen Laboratories, Inc.|828-759-7548|mhites@greerlabs.com
5073|NCT00689338|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5074|NCT00689351|Pfizer Clinical Trials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com
5260|NCT00726180|Anne F. Schott, MD|Universtiy of Michigan|734-936-6000|aschott@umich.edu
5261|NCT00726232|Study Director|Incyte Corporation|1-855-463-3463|
5262|NCT00726375|Dr. Sung Choi|University of Michigan Comprehensive Cancer Center|734-615-5707|sungchoi@umich.edu
5263|NCT00726414|Medical Director|Mutual Phrmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
5264|NCT00726453|K. Bogdanovich|Medtronic Vascular||rs.medtroniccardiovascularclinicaltrials@medtronic.com
5265|NCT00726557|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
5266|NCT00726609|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
5267|NCT00726713|Page Young, Clinical Project Manager|Pamlab Inc.|985-867-5788|pyoung@pamlab.com
5268|NCT00726739|Arkadiusz Dudek, M.D.|Masonic Cancer Center, University of Minnesota|612-624-0123|dudek002@umn.edu
5269|NCT00733954|Ronald W. Gottschalk, MD / Medical Director|Galderma Laboratories, L.P.|817-961-5358|ron.gottschalk@galderma.com
5270|NCT00734071|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
5271|NCT00734097|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
5272|NCT00734149|Cristina Gasparetto, MD|Duke University Medical Center|919-668-1017|gaspa001@mc.duke.edu
5273|NCT00734162|Dara Wambach, Associate Director, Regulatory Affairs|Gilead Sciences, Inc.||Dara.Wambach@gilead.com
2641|NCT00378599|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
2642|NCT00379210|Amishi Jha|University of Pennsylvania|215-898-8011|apjha@psych.upenn.edu
2643|NCT00379236|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
2644|NCT00379288|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@spcorp.com
2668|NCT00381485|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@spcorp.com
2669|NCT00381550|Michael McDevitt, MD PhD|Sidney Kimmel Comprehensive Cancer Center|410-955-9175|mmcdev1@jhmi.edu
2670|NCT00381693|Dr. Ruben A. Mesa|Mayo Clinic|507-284-3533 ext 4-3533|mesa.ruben@mayo.edu
2671|NCT00381797|Shengjie Wu|St. Jude Children's Research Hospital|(901) 595-2859|shengjie.wu@stjude.org
2672|NCT00381810|Medical Communications Specialist|Genentech, Inc.|800-821-8590|
2673|NCT00381849|Beverly Tietje, Study Coordinator|Mayo Clinic|507-255-0401|tietje.beverly@mayo.edu
2674|NCT00381862|Joseph Bubalo, PharmD, BCPS, BCOP|OHSU Knight Cancer Institute|503-494-1080|bubaloj@ohsu.edu
2675|NCT00381888|Levi S. Downs, Jr., M.D.|Masonic Cancer Center, University of Minnesota|612-626-6628|downs008@umn.edu
2676|NCT00381940|Results Reporting Coordinator|Children's Oncology Group|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org
2677|NCT00382031|Eva Järlid Westerberg, VP Clinical Operations|Genmab A/S|+45 7020 2728|E.Westerberg@genmab.com
2678|NCT00382148|Medical Communications Specialist|Genentech, Inc.|800-821-8590|
2679|NCT00382174|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|RegeneRx Biopharmaceuticals, Inc.|301-280-1992 ext 108|nturjman@regenerx.com
2680|NCT00382291|Dr. Regina Bussing|University of Florida|(352) 273-7550|rbussing@ufl.edu
2681|NCT00382408|Duramed Research Protocol Chair|Duramed Research|215-293-7279|medicalaffairs@barrlabs.com
2682|NCT00382590|Guillermo Garcia-Manero, MD / Associate Professor|UT MD Anderson Cancer Center|713-745-3428|eharriso@mdanderson.org
4718|NCT00460421|Medical Program Director|Swedish Orphan Biovitrum|+46 8 697 20 00|clinical@sobi.com
4719|NCT00460525|Mahamadou A. Thera, MD, MPH|Department of Epidemiology of Parasitic Diseases, University of Bamako|223-222-8109|mthera@mrtcbko.org
4720|NCT00460551|Eva Järlid Westerberg PhD|Genmab A/S|+45 7020 2728|E.Westerberg@genmab.com
4721|NCT00460564|GSK Response Center|GlaxoSmithKline|866-435-7343|
4722|NCT00460577|Study Director|Novartis Pharmaceuticals|862-778-8300|
4723|NCT00460603|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4724|NCT00460655|GSK Response Center|GlaxoSmithKline|866-435-7343|
4725|NCT00460746|Vice President, Tibotec Therapeutics Clinical Affairs|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|877-732-2488|rfalcon@its.jnj.com
4726|NCT00460798|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4727|NCT00460811|Doug Levine, MD|Ironwood Pharmaceuticals|617.374.3906|dlevine@ironwoodpharma.com
4797|NCT00747747|Dr. Sandro Soriano/Director of Clinical Trials|Galsor s.r.l.|0039 0827 601723|sandro.soriano@galsor.it
4798|NCT00424476|GSK Response Center|GlaxoSmithKline|866-435-7343|
4799|NCT00424502|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
4800|NCT00424528|Respiratory Medical Affairs Director|Sepracor Inc|866-503-6351|
4801|NCT00424554|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
4802|NCT00424593|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4803|NCT00424619|Dr. Alexandra Papaioannou|McMaster University|905-521-2100 ext 77715|papaioannou@hhsc.ca
4804|NCT00424632|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4805|NCT00424645|Saroj Vadhan, MD|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
4806|NCT00424749|Dr. Fernando C. Fervenza|Mayo Clinic||fervenza.fernando@mayo.edu
5405|NCT00776009|Study Director|Novartis Pharmaceuticals|862 778-8300|
5406|NCT00513019|Jon E. Grant|University of Minnesota|612-273-9800|grant045@umn.edu
5407|NCT00513240|Dr. Dean B. Andropoulos|Baylor College of Medicine|832-826-5831|dra@bcm.edu
5408|NCT00513305|Sponsor's Medical Expert, Clinical Research|Cephalon, Inc.|1-800-896-5855|
5409|NCT00513344|Dr Maurice Beaumont, Principal Investigator|Clinical Development Unit / Metabolic Unit|+41217858054|maurice.beaumont@rdls.nestle.com
5410|NCT00513357|Dr. Egidio Del Fabbro|University of Texas MD Anderson Cancer Center|713-563-4157|ammarin@mdanderson.org
5411|NCT00513370|Medical Information Specialist|Abbott|1-800-633-9110|
5412|NCT00513409|GSK Response Center|GlaxoSmithKline|866-435-7343|
5413|NCT00513435|Matthew Fury, MD|Memorial Sloan-Kettering Cancer Center|646-888-4233|furym@mskcc.org
5414|NCT00513500|Kojo Yeboah-Antwi|Boston University|617-414-1275|kyantwi@bu.edu
5415|NCT00513526|Group Statistician|AMC|501-526-6712|jylee@uams.edu
5416|NCT00513604|Dr. Steven Rosenberg|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
5417|NCT00513617|Karen Kesler, PhD|Rho Federal Systems Division|919-408-8000 ext 244|karen_kesler@rhoworld.com
5418|NCT00513682|Robert Winkler, MD, VP, Clinical Development and Operations|Aptalis Pharma US, Inc.|1-800-472-2634|
5419|NCT00513708|Schieder, Jeffrey|SUNY Buffalo|716-645-2977|jss10@buffalo.edu
4984|NCT00700804|Janet Hunt, PhD|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Reserch Center|701-795-8353|janetrhunt@gmail.com
4985|NCT00700817|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
4986|NCT00700973|Christine Timko|VA Palo Alto Health Care System|650-617-2746|Christine.Timko@va.gov
4987|NCT00700999|Dr. K Luan Phan|Jesse Brown VA Medical Center|312-569-7161|Kinh.Phan@va.gov
4988|NCT00701038|Rami Khayat|The Ohio State Universtiy|614-247-7707|rami.khayat@osumc.edu
5500|NCT00777179|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
5501|NCT00777257|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
5502|NCT00777335|Dr. Richard Finn|University of California Los Angeles (UCLA) / Cancer International Research Group (CIRG) (Translational Research in Oncology TRIO) Inc.|+ 1 310 586 2091|RFinn@mednet.ucla.edu
5503|NCT00777556|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
5504|NCT00823472|Prof. dr. B.C.J.M. Fauser|UMC Utrecht|+31-88-7557524|b.c.fauser@umcutrecht.nl
5505|NCT00823615|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
5506|NCT00823719|GSK Response Center|GlaxoSmithKline|866-435-7343|
5507|NCT00823823|Dr. Donald Bae|Children's Hospital Boston|617-355-6808|donald.bae@childrens.harvard.edu
5508|NCT00823836|GSK Response Center|GlaxoSmithKline|866-435-7343|
5509|NCT00823901|Alexandra B. Kimball, MD|MGH CURTIS|617-726-5066|harvardskinstudies@partners.org
5510|NCT00823966|Pfizer ClinicalTraials.gov Call Center|Pfizer,  Inc.|1-800-718-1021|ClinicalTraials.govCallCenter@pfizer.com
5511|NCT00823979|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5075|NCT00701441|Rami Khayat|Ohio State University|614-247-7707|rami.khayat@osumc.edu
5076|NCT00701662|Clinical Trial Disclosure Manager|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
5077|NCT00701727|Michael H Davidson, MD FACC|Radiant Research|312-494-2220|michaeldavidson@radiantresearch.com
5078|NCT00701805|Global Medical Services|Abbott|800-633-9110|
5079|NCT00701935|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
5080|NCT00702143|Chief Medical Officer|Avid Radiopharmaceuticals|215-298-0700|clinicaloperations@avidrp.com
5081|NCT00702208|Heidi Jones|CUNY School of Public Health, Hunter College|212-396-7750|hjon@hunter.cuny.edu
5082|NCT00702299|Dr. Setsuko Chambers|University of Arizona|520/626.0950|schambers@azcc.arizona.edu
2683|NCT00382720|International Clinical Development Clinical Study Director|sanofi-aventis||contact-us@sanofi-aventis.com
2684|NCT00382733|Vice President of Scientific Affairs|Accelerated Community Oncology Research Network, Inc.||mwalker@acorncro.com
2685|NCT00382785|Paula Klemm, PhD, RN, OCN|University of Delaware|(302) 831-8501|klemmpa@udel.edu
2686|NCT00382863|Michael Kolber, General Manager, VP of Regulatory Affairs|Paracor Medical, Inc.|408-734-6000|info@paracor.com
2687|NCT00382928|Dr. A. Maziar Zafari|Atlanta Research and Education Foundation|404-321-6111 ext 4019|azafari@emory.edu
2688|NCT00382967|Igor Grachev, MD|GE Healthcare|1-609-514-6857|igor.grachev@ge.com
2689|NCT00382993|GSK Response Center|Glaxo Smith Kline|1-866-435-7343|
2690|NCT00383019|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2691|NCT00383071|John Beigel, M.D.|SAIC/National Institute of Allergy and Infectious Diseases|+1 301 451 9881|jbeigel@niaid.nih.gov
2692|NCT00383084|Kevin Fontaine, PhD|Johns Hopkins University|443-449-4314|kfontai1@jhmi.edu
2693|NCT00383110|Leonard Egede, MD, MS|Ralph H. Johnson VAMC|843-789-6670|leonard.egede@va.gov
2694|NCT00383123|GSK Response Center|GlaxoSmithKline|866-435-7343|
2695|NCT00383149|Name/Official Title: BMS Study Director|Organization: Bristol-Myers Squibb||Clinical.Trials@bms.com
2696|NCT00383162|GSK Response Center|GlaxoSmithKline|866-435-7343|
2697|NCT00383240|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
2698|NCT00383331|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
2699|NCT00383435|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
2700|NCT00383552|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
2701|NCT00383565|Dr. Luis E. Fayad / Associate Professor|MD Anderson Cancer Center|713-792-2860|jmdennison@mdanderson.org
2702|NCT00383721|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
4807|NCT00424762|Dr. Darren K. McGuire|University of Texas Southwestern Medical Center at Dallas|214 645 7520|darren.mcguire@utsouthwestern.edu
4808|NCT00424775|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
4809|NCT00425100|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4810|NCT00425113|Ray Chen|National Institute of Allergy and Infectious Diseases|301-443-5816|ray.chen@nih.gov
4811|NCT00425269|Victoria Telle Hjellset|University of Oslo|0047 22 85 06 12|t.v.t.hjellset@medisin.uio.no
4812|NCT00425308|Study Director|Novartis Pharmaceuticals|862-778-8300|
4813|NCT00425373|Study Director|Novartis Pharmaceuticals|862 778-8300|
4814|NCT00425386|Dr. Christopher Ryan|OHSU Knight Cancer Institute|5034946197|ryanc@ohsu.edu
4815|NCT00425438|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
4816|NCT00425503|Dr. Teresa Hayes - Associate Professor|Baylor College of Medicine|713-794-7368|thayes@bcm.edu
4817|NCT00425698|Prof. Dr. Danilo Fliser|Saarland University Medical Centre|(49) 6841 ext 1623526|indfli@uks.eu
4818|NCT00425750|Barbara Murphy, M.D.|Vanderbilt-Ingram Cancer Center|615-343-4677|
4819|NCT00425854|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
4728|NCT00460993|Dr. Patricia C. Griffiths|Atlanta VA Medical Center|404-321-6111 ext 7138|Patricia.Griffiths@va.gov
4729|NCT00461032|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
4730|NCT00461097|Associate Director, Clinical Research Operations Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov
4731|NCT00461123|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
4732|NCT00461292|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
4733|NCT00461305|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
4734|NCT00461331|Tina K. Thethi, MD, MPH|Tulane University Health Sciences Center|504-988-5044|tthethi@tulane.edu
4989|NCT00701090|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
4990|NCT00701129|Trial Transparency Team|Sanofi||Contact-us@sanofi.com
4991|NCT00701311|Kenneth M. Peters, MD|William Beaumont Hospital|248-551-0387|kmpeters@beaumont.edu
4992|NCT00701389|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4993|NCT00758069|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
4994|NCT00758160|Medical Affairs Director|Janssen Pharmaceutical, Taiwan|+886-2-23762155|
4995|NCT00758290|William DeVizio - DMD|Colgate Palmolive|732-878-7901|william_devizio@colpal.com
4996|NCT00758342|Alcon Clinical|Alcon Research, Ltd|888.451.3937; 817.568.6725|medinfo@alconlabs.com
4997|NCT00758394|William DeVizio - DMD|Colgate Palmolive|732-878-7901|william_devizio@colpal.com
4998|NCT00758420|David Wright MBBS|BTG International Inc.|610-943-3538|david.wright@btgplc.com
4999|NCT00758459|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
5000|NCT00758485|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
5001|NCT00758498|Medical Monitor|Cephalon, Inc.|1-800-896-5855|
5002|NCT00758550|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
5003|NCT00758563|William DeVizio - DMD|Colgate Palmolive|732-878-7901|William_DeVizio@colpal.com
5004|NCT00758576|Director of Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
5005|NCT00758589|Alison Holt|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
5006|NCT00802672|Jonathan Schwartz|Perrigo Company|718-960-0119|jonathan.schwartz@perrigo.com
5190|NCT00608569|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
5191|NCT00608777|Leon Kircik, M.D.|DermResearch, PLLC|502-5451-9000|wedoderm@yahoo.com
5560|NCT00760669|Clinical Research Associate|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|+82-2-2094-4879|
5561|NCT00760747|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
5562|NCT00805493|Kenneth Towbin, M.D., Chief Clinical Child and Adolescent Psychiatry|Emotion and Development Branch, NIMH-IRP|301-402-4403|Kenneth.Towbin@nih.gov
5563|NCT00805545|Patrick Duff, M.D.|University of Florida|352 273 7673|duffp@ufl.edu
5564|NCT00805675|Study Director|Novartis Pharmaceuticals|862-778-8300|
5565|NCT00805740|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5566|NCT00805766|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
5567|NCT00805792|James F. Meschia, MD|Mayo Clinic|904-953-2903|meschia.james@mayo.edu
5568|NCT00805870|Dr. Christopher C. Cheatham|Western Michigan University|269-387-2542|chris.cheatham@wmich.edu
5569|NCT00805935|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
5570|NCT00805961|John D. Hainsworth, MD.|Sarah Cannon Research Institute|877-691-7274|ASKSARAH@scresearch.net
5571|NCT00806026|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5572|NCT00768040|Study Director|Novartis Pharmaceuticals|862-778-8300|
5573|NCT00813904|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|ZymoGenetics, a Bristol-Myers Squibb company|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com
5574|NCT00813917|Jon O. Ebbert, MD|Mayo Clinic|507-266-1944|nicotineresearch@mayo.edu
5575|NCT00813982|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
5576|NCT00813995|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5577|NCT00814177|Sam Schulman, MD|McMaster University|1-905-5270271 ext 44479|schulms@mcmaster.ca
5578|NCT00814307|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2703|NCT00383786|Sanjay Mathew, MD/PI|Baylor College of Medicine|7137985439|sjmathew@bcm.edu
2704|NCT00384033|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2705|NCT00384059|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2706|NCT00384085|Trial Transparency Team|sanofi-aventis||Contact-US@sanofi-aventis.com
2707|NCT00384176|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
2708|NCT00384293|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
2709|NCT00384397|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
2710|NCT00384670|Sriluck Simasathien ; Infectious Disease Consultant|Department of Pediatrics, Pharamongkutklao Hospital|66-2-644-8971|
2711|NCT00384813|Marianne Celano, PhD, ABPP|Emory University School of Medicine|404-778-1536|mcelano@emory.edu
2712|NCT00384930|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
2645|NCT00379353|Dr. Eduardo Bruera, Professor|University of Texas M.D. Anderson Cancer Center|713-563-4157|ammarin@mdanderson.org
2646|NCT00379574|Dr. Cheolwon Suh|Asan Medical Center, Ulsan University College of Medicine|+82-2-3010-3209|csuh@amc.seoul.kr
2647|NCT00379587|Corey S. Cutler, MD, MPH|Dana-Farber Cancer Institute|617-632-5946|corey_cutler@dfci.harvard.edu
2648|NCT00379639|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
2649|NCT00379769|GSK Response Center|GlaxoSmithKline|866-435-7343|
2650|NCT00379795|Genentech|Genentech||ctg-post-d@gene.com
2651|NCT00379808|Dr Julie Johnson, PI|University of Florida|352-273-6007|johnson@cop.ufl.edu
2652|NCT00379821|Christopher Plowe, MD, MPH|Malaria Section, Center for Vaccine Development, University of Maryland School of Medicine|410-706-2491|cplowe@medicine.umaryland.edu
2653|NCT00379899|Study Director|Amgen Inc.|866-572-6436|
2654|NCT00380068|Martine Allard, PhD; Senior Clinical Research Scientist|Gilead Sciences Inc|650-524-3898|martine.allard@gilead.com
4735|NCT00461500|GSK Response Center|GlaxoSmithKline|866-435-7343|
4736|NCT00461630|Professor Jane Armitage|Clinical Trial Service Unit, University of Oxford|+44 (0)1865 743743|thrive@ctsu.ox.ac.uk
4737|NCT00461786|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
4738|NCT00461981|Christopher Ambrose, MD|MedImmune, LLC|301-398-0000|ambrosec@medimmune.com
4739|NCT00462020|Shawn D. St. Peter, MD|Children's Mercy Hospital|816-983-6479|sspeter@cmh.edu
4740|NCT00462072|Rick Barrett|University of Rochester|585-275-1647|rick_barrett@urmc.rochester.edu
4741|NCT00462228|Dr. S. Jon Rupright|Department of Physical Medicine and Rehabilitation, University of Missouri|573-882-3101|RuprightJ@health.missouri.edu
4742|NCT00462306|Dr. Robert J. McCarthy|Northwestern University Feinberg School of Medicine|312-926-9015|r-mccarthy@northwestern.edu
4743|NCT00462332|Alfonso Piciocchi|GIMEMA Foundation Data Center|+39 06 70390513|a.piciocchi@gimema.it
4744|NCT00494585|Srdan Verstovsek M.D./Associate Professor|The University of Texas M. D. Anderson Cancer Center|713-792-7305|eharriso@mdanderson.org
4745|NCT00494676|Alex Bowers|Schepens Eye Research Institute|617-912-2512|alex_bowers@meei.harvard.edu
4746|NCT00494780|GSK Response Center|GlaxoSmithKline|866-435-7343|
4747|NCT00494806|Robert L. Massey, PhD, RN|MD Anderson Cancer Center|713-792-3704|rlmassey@mdanderson.org
4748|NCT00494871|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
4749|NCT00494975|Ko Mei-Ju|Dermatology|886-223123456 ext 2141|kmjmay@gmail.com
4750|NCT00495079|Chief Medical Officer|Talon Therapeutics|650-588-6404|info@talontx.com
4751|NCT00495131|Chen-Hua Liu, MD|National Taiwan University Hospital|886223123456 ext 63572|jacque_liu@mail2000.com.tw
4752|NCT00495157|Vernon M. Chinchilli, PhD|Penn State Hershey College of Medicine|717-531-4262|vchinchi@psu.edu
4753|NCT00495222|Susan Knippenberg|Ethicon Endo-Surgery|513 337-3452|sknippen@its.jnj.com
4754|NCT00495391|Marc Ayers|Romark Laboratories, L.C.|813-282-8544|Marc.Ayers@romark.com
5192|NCT00608829|Tab Bonny|W.L. Gore and Associates|928 864 4275|tbonny@wlgore.com
5193|NCT00608868|Hui Jung Sin|Medical, Astrazeneca Korea||huijung.sin@astrazeneca.com
5194|NCT00608907|Helgi van de Velde, MD, PhD|Johnson & Johnson Pharmaceutical Research & Development||HVDVELDE@ITS.JNJ.COM
5195|NCT00608959|Catherine J Hardalo, MD Vice President, Anti-Infectives Clinical Development|Cadence Pharmaceuticals, Inc|858 4361439|chardalo@cadencepharm.com
5196|NCT00608985|Ouali Berkani/Clinical Trial Leader|Actelion Pharmaceuticals Ltd|+41 61 565 5342|
5197|NCT00609167|Dr. A. Keith Stewart|Mayo Clinic||stewart.keith@mayo.edu
5198|NCT00609362|Torben Harsløf, MD|University of Aarhus|+4589497681|torbhars@rm.dk
5199|NCT00609466|René Allard|Grunenthal|49 241 569 3223|Clinical-Trials@grunenthal.com
5200|NCT00609518|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
5201|NCT00609622|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5202|NCT00609674|GSK Response Center|GlaxoSmithKline|866-435-7343|
5203|NCT00609739|Margaret MacMillan, M.D.|Masonic Cancer Center, University of Minnesota|612-626-2778|macmi002@umn.edu
5204|NCT00655863|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
5205|NCT00655889|Dr. Joseph Fratantoni|Biologics Consulting Group|(301) 340-8432|jfratantoni@bcg-usa.com
5206|NCT00656136|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5207|NCT00656175|Dr. Jordan Lake|UCLA CARE Center|310-557-9679|jlake@mednet.ucla.edu
5208|NCT00656201|Elena Yanushpolsky, MD|Brigham and Women's Hospital|617-732-4648|lgreenberg@partners.org
5209|NCT00656370|Jonathan Leff, M.D., Chief Medical Officer|Halozyme Therapeutics Incorporated|858-704-8177|jleff@halozyme.com
5210|NCT00656448|Jorge Cortes M.D./Professor|The University of Texas M. D. Anderson Cancer Center|713/794-5783|eharriso@mdanderson.org
5211|NCT00656474|Dr. Reinhard Koenig, CEO|Glycotex|301-670-2825|Reinhard.Koenig@glycotexinc.com
2193|NCT00314574|Medical Communications|Hoffman-LaRoche|800-821-8590|
2194|NCT00314808|Deborah H. Allen, MSN, RN, CNS, FNP-BC, AOCNP|Duke University|(919) 681-4719|allen079@mc.duke.edu
2195|NCT00314951|Chief Scientific Officer|Optimer Pharmaceuticals, Inc.|1-855-343-4243|medinfo@optimerpharma.com
2196|NCT00315055|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
2197|NCT00315302|Raymond Kraker|Jaeb Center for Health Research|813-975-8690|pedig@jaeb.org
2198|NCT00315328|Raymond Kraker|Jaeb Center for Health Research|813-975-8690|pedig@jaeb.org
2199|NCT00315445|Medical Director|Purdue Pharma L.P.|800-733-1333|
2200|NCT00315458|Clinical Leader, Executive Medical Director|Purdue Pharma L.P.|800-733-1333|
2201|NCT00315614|Dr. Rodolfo Alejandro|University of Miami|3052435324|ralejand@med.miami.edu
2202|NCT00332709|Study Director|Novartis Pharmaceuticals|862-778-8300|
2203|NCT00362232|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
2204|NCT00362336|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
2205|NCT00362375|Dazon Dixon-Diallo, Executive Director|SisterLove, Inc.|404-505-7777|ddiallo@sisterlove.org
2413|NCT00331682|Dr. Eileen O'Reilly|Memorial Sloan-Kettering Cancer Center|646-888-4182|oreillye@mskcc.org
2414|NCT00331760|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@acr.org
2415|NCT00331799|Wei Zhang MD|Duke University Medical Center Dept of Psychiatry|919 684 5645|wei.zhang@duke.edu
2416|NCT00331864|Study Director|Novartis Pharmaceuticals|862-778-8300|
2417|NCT00332189|Medical Information Services|BioMarin Pharmaceutical, Inc.|1-800-983-4587|medinfo@bmrn.com
2418|NCT00332241|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@BMS.com
2419|NCT00332332|Study Director|Amgen Inc.|866-572-6436|
2420|NCT00332462|Study Director|Novartis Pharmaceuticals|862-778-8300|
2655|NCT00380081|Clinical Leader|Purdue Pharma LP|800-733-1333|
2656|NCT00380250|Taryn Joswick|Sucampo Pharmaceuticals, Inc.|301-961-3400|info@sucampo.com
2657|NCT00380367|Senior Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
2658|NCT00380588|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2659|NCT00380692|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2660|NCT00380718|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2661|NCT00380861|Tammy O'Dell|DePuy Orthopaedics|574-372-7104|TOdell2@its.jnj.com
2662|NCT00380874|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2663|NCT00380978|Dr. Robert J. McCarthy|Department of Anesthesiology; Northwestern University Feinberg School of Medicine|312-926-9015|r-mccarthy@northwestern.edu
2664|NCT00381043|Dr. J.C. Garbutt|University of North Carolina at Chapel Hill|919-966-4652|jc_garbutt@med.unc.edu
2665|NCT00381095|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2666|NCT00381303|Vice President, Tibotec Therapeutics Clinical Affairs|Tibotec Therapeutics Clinical Affairs (TTCA), Division of Centocor Ortho Biotech Services, LLC|877-732-2488|
2667|NCT00381381|Jihee Mun, Pharmacist, Medical team manager|Eisai Korea Inc.|+82-2-3451-5531|jihee_mun@eisaikorea.com
2599|NCT00354601|Doug Case Biostatistician|Wake Forest University Health Sciences|336-716-1048|dcase@wfubmc.edu
2600|NCT00354640|Dr. Vered Stearns|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|4432876489|vstearn1@jhmi.edu
2601|NCT00354744|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
2602|NCT00354770|Jon E. Grant|University of Chicago|773-834-1325|jongrant@uchicago.edu
2603|NCT00354887|Robert Wolff, MD / Professor|UT MD Anderson Cancer Center|713-792-2828|mjlim@mdanderson.org
2604|NCT00354913|Dr. Annick Desjardins|Duke University Medical Center|919-681-1691|annick.desjardins@dm.duke.edu
4755|NCT00495495|Domenick T. Zero, DDS MS Principal Investigator|Indiana University School of Dentistry|317-274-8822|dzero@iupui.edu
4756|NCT00495586|Carl Llor|CAMFIC|+34 3011777|carles.llor@urv.cat
4757|NCT00495612|Medical Communications|Genentech, Inc.|800 821-8590|
4758|NCT00495625|Jonathan Strosberg, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-7257|jonathan.strosberg@moffitt.org
4759|NCT00495677|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4760|NCT00495755|Corey S. Cutler, MD, MPH, FRCP(C)|Dana-Farber Cancer Institute|617-632-5946|cscutler@partners.org
4761|NCT00495794|Dr. Michele Heisler|VA Center for Clinical Management Research; University of Michigan|734-845-3504|mheisler@umich.edu
4762|NCT00496054|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
4763|NCT00496080|Piet Hinoul MD|Ethicon|908-218-2585|phinoul@its.jnj.com
4764|NCT00496197|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4765|NCT00496262|Program Director, Clinical R&D|CSL Behring|Use email contact.|clinicaltrials@cslbehring.com
4766|NCT00496340|Marcie Riches, MD|H. Lee Moffitt Cancer Center and Research Institute|813-745-6284|marcie.riches@moffitt.org
4767|NCT00496379|Dr. Nancy Lin|Dana-Farber Cancer Institute|617-632-2335|nlin@partners.org
4768|NCT00496470|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
4769|NCT00496626|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4770|NCT00496730|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
4771|NCT00707746|Genzyme Medical Information|Genzyme Corporation|617-252-7832|
4772|NCT00707915|Director of clinical trials|Minami-hanno Hospital|81.42.972.7111|haloperidol1mg@hotmail.com
4773|NCT00707954|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
4774|NCT00707980|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
5212|NCT00656669|Dr. Kathy Miller|IndianaU|317-944-0920|
5420|NCT00513799|Stephanie Fritz|Washington University|314-454-6050|fritz_s@kids.wustl.edu
5421|NCT00514020|Laura Goff, MD|Vanderbilt-Ingram Cancer Center|615-936-0059|laura.goff@vanderbilt.edu
5422|NCT00514137|Shaji Kumar, M.D.|Mayo Clinic Cancer Center||kumar.shaji@mayo.edu
5423|NCT00514592|Dr Elias Johansson|Umeå University|+46907850000|elias.johansson@neuro.umu.se
5424|NCT00514709|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
5425|NCT00514735|Linda Nelson, Director of Clinical Research|Medtronic|763-526-2891|linda.k.nelson@medtronic.com
5426|NCT00514813|Timothy Whitaker, MD|Shire Pharmaceutical||twhitaker@shire.com
5427|NCT00514852|Therapeutic Area Head|Allergan, Inc.|(714)246-4500|clinicaltrials@allergan.com
5428|NCT00514917|Trial Transparency Team|Sanofi||Contact-Us@sanofi.com
5429|NCT00514943|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5430|NCT00515034|Senior Director of Clinical Development|Johnson and Johnson Pharmaceutical Research and Development L.L.C.|510 248-2310|
5431|NCT00515073|Anuja Jhingran, MD / Professor, Radiation Oncology Department|University of Texas MD Anderson Cancer Center|713-563-6900|CR_Study_Registration@mdanderson.org
5432|NCT00515086|Study Director|Novartis Pharmaceuticals|862-778-8300|
5433|NCT00515099|Associate Director, Clinical Research Operations Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
5434|NCT00720629|Lia Perez, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-7202|lia.perez@moffitt.org
5435|NCT00720759|Stephen E. Nadeau|VAHSRD|352-374-6082|stephen.nadeau@va.gov
5436|NCT00720941|GSK Response Center|GlaxoSmithKline|866-435-7343|
5437|NCT00721123|Medical Communications|Hoffmann-La Roche|800 821-8590|
5438|NCT00721149|Diana Bordley, Director, Regulatory Affairs|Biosense Webster, Inc.|800-729-9010 ext 8604|dbordley@its.jnj.com
2421|NCT00332579|Jon E. Grant|University of Minnesota|612-273-9800|grant045@umn.edu
2422|NCT00332605|Jon E. Grant|University of Chicago|773-834-1325|jongrant@uchicago.edu
2423|NCT00332644|Piper, Megan E|University of Wisconsin|608-265-5472|mep@ctri.medicine.wisc.edu
2424|NCT00332696|Study Director|Novartis Pharmaceuticals|862-778-8300|
2425|NCT00356200|Alice B Gottlieb, MD, PhD|Tufts Medical Center|617 636 4802|agottlieb@tuftsmedicalcenter.org
2426|NCT00356304|Alejandro Interian, Principal Investigator|VA New Jersey Healthcare System|908-647-0180 ext 4617|alejandro.interian@va.gov
2427|NCT00356408|UCB (Study Director)|UCB Clinical Trial Call Center|+1 887 822 9493|
2428|NCT00356421|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2429|NCT00356525|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2430|NCT00356590|Study Director|Amgen Inc.|866-572-6436|
2431|NCT00356811|GSK Response Center|GlaxoSmithKline|866-435-7343|
2432|NCT00356863|Rachel S Dankner, MD, MPH|The Gertner Institute for Epidemiology and Health Service Research|972-3-5305390|RachelD@gertner.health.gov.il
2433|NCT00356889|William Schelman, M.D.|University of Wisconsin Cancer Center||wrs@medicine.wisc.edu
2434|NCT00356915|David Angulo, MD|Barrier Therapeutics (now part of Stiefel, a GSK company)|786-999-7038|david.a.angulo@stiefel.com
2435|NCT00357097|GSK Response Center|GlaxoSmithKline|866-435-7343|
2436|NCT00357110|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
2437|NCT00357162|Amanda Cashen, M.D.|Washington University||acashen@im.wustl.edu
2438|NCT00357500|Mark Kieran|Dana-Farber Cancer Institute|(617) 632-4907|mark_kieran@dfci.harvard.edu
2439|NCT00357552|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|6174322829|CBAR.ClincalTrials.Gov@sdac.harvard.edu
2440|NCT00357903|Study Director|Amgen Inc.|866-572-6436|
2605|NCT00354978|Scott Kopetz, MD Associate Professor|UT MD Anderson Cancer Center|713-792-2828|mjlim@mdanderson.org
2606|NCT00355082|GSK Response Center|GlaxoSmithKline|866-435-7343|
2607|NCT00355121|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
2608|NCT00355134|Study Director|Novartis Pharmaceuticals|862-778-8300|
2609|NCT00355368|Stephan Marsch|Medical Intensive care unit, University Hospital Basel|+ 41 61 265 2525|smarsch@uhbs.ch
2610|NCT00355394|Dr. Nicholas Abend|CHOP|215-590-1719|abend@email.chop.edu
2611|NCT00355472|Project Management Department, Development Division|Kyowa Hakko Kirin||clinical.info@kyowa-kirin.co.jp
2612|NCT00355615|Gerard Lynch|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
2613|NCT00355706|Laxmaiah Manchikanti, MD|Pain Management Center of Paducah|2705548373 ext 100|drm@asipp.org
2614|NCT00355784|Jeffrey F. Horowitz|University of Michigan, Ann Arbor, Michigan|734-647-1076|jeffhoro@umich.edu
2615|NCT00355797|CLEAR Study CSE|BIOTRONIK, Inc.|503-451-8051|
2616|NCT00355914|Laxmaiah Manchikanti, MD|Pain Management Center of Paducah, Paducah, KY|2705548373 ext 100|drlm@thepainmd.com
2617|NCT00356057|Katerina de Metz, Director Clinical Studies|BIOTRONIK, Inc.|5036752169|katerina.demetz@biotronik.com
2618|NCT00356122|Trial Transparency Team|Sanofi-Aventis||Contact-Us@sanofi.com
2619|NCT00356135|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2620|NCT00356148|Prof. Bahadir M Gulluoglu|Marmara University School of Medicine|902164256565 ext 4012|bmgulluoglu@marmara.edu.tr
2621|NCT00377364|E.Sherwood Brown, M.D., Ph.D.|UT Southwetern Medical Center at Dallas|214-645-6950|Sherwood.Brown@utsouthwestern.edu
2530|NCT00346398|Associate Director, Clinical Research Operations Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
2531|NCT00346476|Prof LG Bekker|Desmond Tutu HIV Centre|+27216506966|Linda-Gail.Bekker@hiv-research.org.za
2532|NCT00347009|GSK Response Center|GlaxoSmithKline|866-435-7343|
4775|NCT00707993|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
4776|NCT00708032|Kathy Osborn, OD|Johnson & Johnson Vision Care, Inc.|+1 904 443-1032|clinicalstudies@its.jnj.com
4777|NCT00708071|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery|Baxter Innovations, GmbH||edith_hantak@baxter.com
4778|NCT00708097|GSK Response Center|GlaxoSmithKline|866-435-7343|
4779|NCT00708110|GSK Response Center|ViiV Healthcare|866-435-7343|
4780|NCT00708123|GSK Response Center|GlaxoSmithKline|866-435-7343|
4781|NCT00708175|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
4782|NCT00708214|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
4783|NCT00708305|GSK Response Center|GlaxoSmithKline|866-435-7343|
4784|NCT00708422|Director of Medical Affairs|Alcon Research, Ltd.|1-800-862-5266|medinfo@alconlabs.com
4785|NCT00708435|Clinical Trial Disclosure Manager|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
4786|NCT00708461|Jennifer A. Linde, Ph.D.|University of Minnesota|612-624-0065|linde074@umn.edu
4787|NCT00708500|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
4788|NCT00708526|Dwayne Westenskow, PhD|University of Utah|801-581-2478|Dwayne.Westenskow@hsc.utah.edu
4789|NCT00708643|Kurt Moody, O.D. FAOO|Vistakon|904-443-3088|
4790|NCT00747227|Nicholas Taranatino, O.D., Head, Global Clinical Research & Devlopment|Abbott medical Optics, Inc.|866-427-8477 ext 8613|nicholas.tarantino@amo.abbott.com
4791|NCT00747344|Director, Clinical Research|Janssen Research & Development, LLC|215-793-7646|
4792|NCT00747474|Shu Chi Hsu|Taiwan Liposome Company, Ltd.|650-872-8816 ext 102|shuchi@tlcbio.com
4793|NCT00747552|Donald Null M.D.|University of Utah|801.588-3865|donald.null@imail.org
4794|NCT00747565|Nicholas Tarantino, O.D., Head, Global Clinical Research & Development|Abbott Medical Optics, Inc.|866-427-8477 ext 8613|nicholas.tarantino@amo.abbott.com
5439|NCT00721162|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
5440|NCT00721175|Assist. Prof. Apichat Sangchan|Khon Kaen University|66850004651|apichaz@yahoo.com
5441|NCT00721188|David Bregman, M.D., Ph.D.|Luitpold Pharmaceuticals, Inc.|610-650-4200|dbregman@lpicrd.com
5442|NCT00721227|Amy Mahanes, Senior Clinical Research Associate|Ethicon Endo Surgery, Inc.|513-337-8366|amahanes@its.jnj.com
5007|NCT00802685|Ilene R. S. Sosenko, M.D.|University of Miami|305-585-6408|isosenko@miami.edu
5008|NCT00802737|GSK Response Center|GlaxoSmithKline|866-435-7343|
5009|NCT00802867|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
5010|NCT00802997|Meghal Khakhar, Director of Regulatory and Scientific Affairs|Baylis Medical|9056024875|mkhakhar@baylismedical.com
5011|NCT00803010|Dr. Joseph Pidala|H. Lee Moffitt Cancer Center|813-745-4673 ext 2556|Joseph.Pidala@moffitt.org
5012|NCT00803023|Director of Clinical Development|Jazz Pharmaceuticals|650-496-3777|
5013|NCT00803101|Clinical Trial Disclosure Manager|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
5014|NCT00803114|Dr. Alison Macarthur|University of Toronto|416 586 4800 ext 6632|alison.macarthur@uhn.on.ca
5015|NCT00803179|Michael Stalvey, MD, Principal Investigator|UMass Medical School|508-856-4280|mstalvey@peds.uab.edu
5016|NCT00803270|Anne M. Stoddard|New England Resesarch Institutes|617-972-3331|astoddard@neriscience.com
5017|NCT00803283|Medical Advisor|Janssen Taiwan|886-2-23762158|
5018|NCT00803361|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
5019|NCT00803400|Dr. Marcelo Rudelir|Psychiatry Academic Unit at J.A.Fernandez Hospital, University of Buenos Aires Medicine School Department of Mental Health|54 11 48254740|mrudelir@hotmail.com
5020|NCT00803413|Mario Fereira Junior|Hospital das Clínicas - São Paulo University School of Medicine|55 11 3069-7691|mariofj@uol.com.br
5021|NCT00811564|Vice President Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
5022|NCT00811577|Denise Lamon|Capstone Therapeutics Corp.|602-286-5206|dlamon@capstonethx.com
2441|NCT00357955|Wen-Chih Wu, MD; Principal Investigator|Providence VA Medical Center|4012737100 ext 6237|wen-chih.wu@va.gov
2442|NCT00357968|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2443|NCT00358007|Pramila Rani Anne, MD|Thomas Jefferson University|215-955-6702|Pramila.Anne@jefferson.edu
2444|NCT00358150|Trial Transparency Team|Sanofi||Contact-us@sanofi.com
2445|NCT00358215|Study Director|Amgen Inc.|866-572-6436|
2446|NCT00358332|Christopher V. Plowe|University of Maryland School of Medicine|410-706-3082|cplowe@medicine.umaryland.edu
2447|NCT00358436|Clinical Project Leader and Trial Manager|Almirall SA|+34 93 291 3200|
2448|NCT00358462|Lisa E. Manhart, PhD - PI|University of Washington|206-744-3646|lmanhart@uw.edu
2449|NCT00358527|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
2450|NCT00358579|A/Prof Marcus Ong Eng Hock|Singapore General Hospital|+6563213590|marcus.ong.e.h@sgh.com.sg
2451|NCT00358644|Eisai Call Center|Eisai Inc.|888-422-4743|
2452|NCT00358670|Vice President of Late Stage Development|Merck Sharpe & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
2453|NCT00358826|Brian Cunningham, MD|Tallikut Pharmaceuticals, Inc.|312-505-0420|brian@baycitycapital.com
2454|NCT00358917|Medical Information Specialist|Abbott|800-633-9110|
2455|NCT00358956|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
2456|NCT00359021|SENIOR DIRECTOR R&D|Tibotec|1 609 730-7548|
2457|NCT00359138|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@spcorp.com
2458|NCT00359203|Silvia Giuli|Medtronic Italia SpA|003932814224|silvia.giuli@medtronic.com
2459|NCT00359216|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
2460|NCT00359281|Mark Sumeray, MD, Chief Medical Officer|Aegerion Pharmaceuticals|617-500-7867|msumeray@aegerion.com
2533|NCT00347022|Corinne DUBOURDIEU|GUERBET|+33.1.45.91.50.00|corinne.dubourdieu@guerbet-group.com
2534|NCT00347308|Anthony P. Sclafani, MD|The New York Eye & Ear Infirmary|212-979-4200|asclafani@nyee.edu
2535|NCT00347360|GSK Response Center|GlaxoSmithKline|866-435-7343|
2536|NCT00347919|GSK Response Center|GlaxoSmithKline|866-435-7343|
2537|NCT00347932|Timothy Comstock|Bausch & Lomb Incorporated|(585) 338-6631|timothy.comstock@bausch.com
2538|NCT00347958|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
2539|NCT00348283|Medical Information Specialist|Abbott|800-633-9110|
2540|NCT00348348|Timothy Comstock|Bausch & Lomb Incorporated|(585) 338-6631|timothy.comstock@bausch.com
2541|NCT00348374|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2542|NCT00348556|Dr. Horng Chen|Mayo Clinic|507-284-8846|chen.horng@mayo.edu
2543|NCT00348673|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2544|NCT00348686|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
2545|NCT00348881|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
2546|NCT00348933|Lynne M. Bird, MD|University of California and Rady Children's Hospital, San Diego|858-966-5840|Lbird@rchsd.org
2547|NCT00349336|Medical Communications|Hoffmann-La Roche|800-821-8590|
2548|NCT00349349|GSK Response Center|GlaxoSmithKline|866-435-7343|
2549|NCT00349388|Dr. Joel Rosh|Atlantic Health System|973-971-5676|joel.rosh@atlantichealth.org
2550|NCT00349466|Pnina Fishman, PhD|Can-Fite Biopharma|011972 3 924 1114|pnina@canfite.co.il
2551|NCT00349622|Merit Cudkowicz|MGH|617-724-1873|mcudkowicz@partners.org
2552|NCT00349752|Study Director|UCB Clinical Trial Call Center|+1 877 822 9493|
2553|NCT00349908|J. Thomas Megerian, MD|Codman & Shurtleff|508.828.8274|jmegerian1@its.jnj.com
4795|NCT00747617|R. Jeffrey Chang, M.D.|UCSD School of Medicine|858-534-8930|rjchang@ucsd.edu
4796|NCT00747643|Thomas H. Brandon, Ph.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-1750|thomas.brandon@moffitt.org
4820|NCT00425945|Dr. Randall Stafford|Stanford University School of Medicine|650-724-2400|rstafford@stanford.edu
4821|NCT00426153|Marie Hogan, MD, PhD, Assistant Prof of Medicine, College of Medicine|Mayo Clinic|507-266-9364|hogan.marie@mayo.edu
4822|NCT00426231|Dhananjay Vaidya|Johns Hopkins University|410-6142307|dvaidya1@jhmi.edu
4823|NCT00426270|Michael Eppolito|Octapharma USA|201 604-1155|michael.eppolito@octapharma.com
4824|NCT00426283|Marc E Rothenberg|Cincinnati Children's Hospital Medical Center|513-636-7177|rothenberg@cchmc.org
4825|NCT00426361|GSK Response Center|GlaxoSmithKline|866-435-7343|
4826|NCT00462423|Lynn E. Spitler, MD|Northern California Medical Center|415-435-9861|lynn@drspitler.com
4827|NCT00462449|Dr. Michael C. Munin|Department of Physical Medicine and Rehabilitation University of Pittsburgh|412-648-6848|muninm@upmc.edu
4828|NCT00462644|Amy N. Hildreth, MD|Wake Forest University, Department of Surgery||ahildret@gmail.com
4829|NCT00462670|Director of Clinical Trials|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7314|
4830|NCT00462709|Chief Scientific Officer|ViroPharma|610-458-7300|
4831|NCT00462748|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
4832|NCT00462826|Melissa Leventhal|Gynecologic Oncology Group Statistical and Data Center|716-845-4030|mleventhal@gogstats.org
4833|NCT00462839|Dr. Robert J. McCarthy|Northwestern University Feinberg School of Medicine|(312)926-9015|r-mccarthy@northwestern.edu
4834|NCT00462917|Robert C. Green, MD, MPH|Brigham and Women's Hospital and Harvard Medical School|617-264-5838|rcgreen@genetics.med.harvard.edu
4835|NCT00462943|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
4836|NCT00463047|Medical Monitor|Cephalon, Inc.|1-800-896-5855|
4837|NCT00463229|Maureen Markle-Reid|McMaster University|905-525-9140 ext 22306|mreid@mcmaster.ca
5023|NCT00811590|Dr. Randall Burt|Huntsman Cancer Institute|801-585-3281|randall.burt@hci.utah.edu
5024|NCT00811642|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
5025|NCT00811655|Denise Lally-Goss, NP|Duke University Medical Center|919-684-3862|denise.lallygoss@dm.duke.edu
5026|NCT00811720|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
5027|NCT00811733|GSK Response Center|GlaxoSmithKline|866-435-7343|
5028|NCT00811798|GSK Response Center|GlaxoSmithKline|866-435-7343|
5029|NCT00811850|Vice President, Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
5213|NCT00848107|Rex Mauthe, Assoc VP, Regulatory Affairs|United Therapeutics Corporation|(919) 485-8350|RMauthe@unither.com
5214|NCT00848172|Mark Hallett|NINDS|301-496-9526|hallettm@ninds.nih.gov
5215|NCT00848211|Gideon Goldstein, MD, PhD|Thymon LLC|(973) 467-9558|gidgold@gmail.com
5216|NCT00848354|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5217|NCT00848367|Dr. Giorgio Tasca|Ottawa Hospital Research Institute|1-613-737-8085|gtasca@toh.on.ca
5218|NCT00848484|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
5219|NCT00848536|Director Alcon Clinical|Alcon Research, Ltd.|888.451.3937 or 817.568.6725|
5220|NCT00848549|Eisai Inc.|Eisai Call Center|888-422-4743|
5221|NCT00848744|Jennifer Sorrell|Northwestern University|773-327-9642|jsorrell@childrensmemorial.org
5222|NCT00848783|Franco Muggia, MD|NYU Cancer Institute|212-263-6485|franco.muggia@nyumc.org
5223|NCT00848926|Chief Medical Officer|Seattle Genetics, Inc.|855-473-2436|medinfo@seagen.com
5224|NCT00848965|GSK Response Center|GlaxoSmithKline|866-435-7343|
5225|NCT00849017|GSK Response Center|GlaxoSmithKline|866-435-7343|
2461|NCT00359424|Joseph P. Broderick|University of Cincinnati Academic Health Center|513-558-5429|broderjp@ucmail.uc.edu
2462|NCT00359762|Chief Medical Officer|Eli Lilly and Company|1-877-285-4559|clinicaltrials@amylin.com
2463|NCT00359788|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
2464|NCT00359801|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2465|NCT00359944|Medical Director, CNS|Sunovion|1-866-503-6351|
2466|NCT00359983|GSK Response Center|GlaxoSmithKline|866-435-7343|
2467|NCT00360009|Michael Okun, M.D.|University of Florida Department of Neurology|352-273-5550|okun@neurology.ufl.edu
2468|NCT00360269|Aimee McRae-Clark, Pharm.D., BCPP|Medical University of South Carolina|843-792-5215|mcraeal@musc.edu
2469|NCT00360308|Eisai Inc.|Eisai Call Center|888-422-4743|
2470|NCT00360334|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2471|NCT00360360|John D. Hainsworth, MD|Sarah Cannon Research Institute|1-877-MY-1-SCRI|asksarah@scresearch.net
2472|NCT00360412|Eisai Inc.|Eisai Call Center|888-422-4743|
2473|NCT00360490|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
2474|NCT00360672|Gautam Borthakur, M.D./Associate Professor|UT MD Anderson Cancer Center|713-563-1586|eharriso@mdanderson.org
2475|NCT00360685|Janelle Perkins, PharmD|Moffitt Cancer Center|813-745-7226|Janelle.Perkins@moffit.org
2476|NCT00360698|Medical Affairs study director|sanofi-aventis||publicregistryGMA@sanofi-aventis.com
2477|NCT00360828|Edward Pan, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-3871|edward.pan@moffitt.org
2478|NCT00360971|Wendy Seiferheld|NRG Oncology||seiferheldw@nrgoncology.org
2479|NCT00361140|Dr. Teresa Field|Moffitt Cancer Center|(813) 745-7202|Teresa.Field@moffitt.org
2480|NCT00361218|John W. Denninger, MD, PhD|Massachusetts General Hospital|617-726-2985|jdenninger@partners.org
4272|NCT00839800|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
4273|NCT00839917|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4274|NCT00839930|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4275|NCT00840060|Monica Harn|Lamar University|409-880-8174|monica.harn@lamar.edu
4276|NCT00840073|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4277|NCT00446173|Marcos de Lima, MD/Associate Professor|UT MD Anderson Cancer Center|713-792-8750|
4278|NCT00446199|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
4279|NCT00446251|Dr. Connie L. Davis|University of Washington|206-598-6079|cdavis@u.washington.edu
4280|NCT00446264|Violeta Raverdy|University of Lille|00 33 3 20 62 34 30|vraverdi@univ-lille2.fr
4281|NCT00446459|Dr. Connie L. Davis|University of Washington|206-598-7162|cdavis@u.washington.edu
4282|NCT00446511|Study Director|Novartis Pharmaceuticals|862-778-8300|
4283|NCT00446563|Study Director|Novartis Pharmaceuticals|862-778-8300|
4284|NCT00446641|Professor Sun U. Kwon|Asan Medical Center, University of Ulsan College of Medicine|82-2-3010-3960|sukwon@amc.seoul.kr
4285|NCT00446654|Director of Clinical Trials|Progen Pharmacauticals Ltd|+61 7 32739133|
4286|NCT00446797|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4287|NCT00446849|Timothy Whitaker, M.D.|Shire Pharmaceutical||twhitaker@shire.com
4288|NCT00447005|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4289|NCT00447057|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4290|NCT00447122|Howard Safran, MD|BrUOG|4018633000|kayla_rosati@brown.edu
4291|NCT00447226|GSK Response Center|GlaxoSmithKline|866-435-7343|
4838|NCT00463385|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
4839|NCT00463437|GSK Response Center|GlaxoSmithKline|866-435-7343|
4840|NCT00463567|Study Director|Novartis Pharmaceuticals|862-778-8300|
4841|NCT00463580|Andrew H. Miller|Emory University|404-727-8260|amill02@emory.edu
4842|NCT00463606|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
4843|NCT00463788|Merck KGaA Communication Center|Merck KGaA|+49-6151-72-5200|service@merckgroup.com
4844|NCT00463801|Study Director|Novartis Pharmaceuticals|862-778-8300|
4845|NCT00463840|Theresa Ryan, MD|New York University Cancer Institute|212-731-5430|theresa.ryan@nyumc.org
4846|NCT00463866|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
4847|NCT00464087|Ron Waksman, MD|Medstar Health Research Institute|202-877-2812|ron.waksman@medstar.net
4848|NCT00464204|Professor Dr. Martin Westphal|Fresenius Kabi Aktiengesellschaft|+49 6172 686 ext 7280|martin.westphal@fresenius-kabi.com
4849|NCT00464308|Executive Director, Medical & Scientific Affairs|Janssen-Cilag Pty Ltd|+61 2 9815 3219|mhandel@its.jnj.com
4850|NCT00464334|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4851|NCT00464438|Therapeutic Area Head|Allergan, Inc.|(714) 246-4500|clinicaltrials@allergan.com
4852|NCT00464542|Thomas Cherpes|University of Pittsburgh|412 692 5930|cherpestl@upmc.edu
4853|NCT00464646|Diana Gosik|NSABP Foundation, Inc.|412-339-5333|diana.gosik@nsabp.org
4854|NCT00496769|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4855|NCT00496782|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4856|NCT00496808|David Welch, Manager, Clinical Protocol Administration|UT MD Anderson Cancer Center||dwelch@mdanderson.org
4857|NCT00496834|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
5226|NCT00849056|GSK Response Center|GlaxoSmithKline|866-435-7343|
5227|NCT00849121|Dr. Douglas McNeel|University of Wisconsin Carbone Cancer Center|608-265-8131|dm3@medicine.wisc.edu
5228|NCT00849212|Eisai Inc.|Eisai Call Center|888-422-4743|
5229|NCT00849290|Kathleen Picha|Dendreon Corporation|206-274-6762|kpicha@dendreon.com
5230|NCT00849381|GSK Response Center|GlaxoSmithKline|866-435-7343|
5231|NCT00849472|GSK Response Center|GlaxoSmithKline|866-435-7343|
5232|NCT00849485|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-3848-5525|clinicaltrialqueries@tevausa.com
5233|NCT00849680|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||clinicaltrialsdisclosure@merck.com
5234|NCT00849693|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
5235|NCT00849797|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
5236|NCT00849810|Professor of Medicine|University of Mississippi Medical Center|601-984-5600|DMinor@umc.edu
5443|NCT00721253|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
5444|NCT00758602|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
5445|NCT00758680|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5446|NCT00758745|Director of Clinical Research|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
5447|NCT00758758|Laura Herdrich, Sr. CRA|Zimmer, Inc|952-830-6224|laura.herdrich@zimmer.com
5448|NCT00758771|John V. Fahy, MD, MSc|UCSF|4154769940|john.fahy@ucsf.edu
5449|NCT00758836|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5450|NCT00759031|William DeVizio - DMD|Colgate Palmolive|732-878-7901|william_devizio@colpal.com
5451|NCT00759096|Benny Li, PhD|Alcon Research, Ltd.|+86 21 6375 8762|Benny.Li@Alconlabs.com
4232|NCT00706355|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4233|NCT00706433|Anna Houlihan|Dusa Pharmaceuticals, Inc.||houlihana@dusapharma.com
4234|NCT00706550|Dr. Maria C. Rodriguez-Barradas|Michael E. DeBakey Veterans Affairs Medical Center|713-794-7384|Maria.Rodriguez-Barradas2@va.gov
4235|NCT00706563|GSK Response Center|GlaxoSmithKline|866-435-7343|
4236|NCT00706589|Medical Director|Kiho Moon|+82-2-3287-9009|khmoon@otsuka.co.kr
4237|NCT00744237|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|Forest Laboratories, Inc|2014278000 ext 2133|noah.rosenberg@frx.com
4238|NCT00744497|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4239|NCT00744523|Steve Camp, Vice President Clinical and Regulatory Affairs|Invatec, Inc.|(610) 625-1402|steve.camp@invatec.com
4240|NCT00744627|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
4241|NCT00744653|MD Louise Wichmann Matthiessen|Copenhagen University Hospital Herlev|+ 45 38 68 98 58|louise.wichmann.matthiessen@gmail.com
4242|NCT00744692|Dr. Suhag Parikh|Duke University Medical Center|919-668-1100|suhag.parikh@dm.duke.edu
4243|NCT00744757|Medical Director|Medical Affairs, Janssen Taiwan|+886-2-23761255|
4244|NCT00744848|Executive Medical Director|Pacira Pharmaceuticals, Inc.|203-837-6500|ErolOnel@pacira.com
4245|NCT00744874|Linda Nelson, RN, BSN, MBA- AF Solutions Clinical Operations Director|Medtronic AF Solutions|(763)526-2891|linda.k.nelson@medtronic.com
4246|NCT00744939|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
4247|NCT00744978|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4248|NCT00745030|Angelica Marconi|Northwestern University|312-503-1999|a-marconi@northwestern.edu
4365|NCT00797862|Study Director|Novartis Pharmaceuticals|862- 778- 8300|
4366|NCT00798018|Han Huang|Department of Anesthesiology, West China Second Hospital|80-028-8550-3753|huanghan1981@hotmail.com
4367|NCT00798096|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3269|NCT00793611|Yuko Komesu MD|University of New Mexico Health Sciences Center and CTSC|505-925-4395|ykomesu@salud.unm.edu
3270|NCT00793624|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
3271|NCT00793650|Dr. Sagar Lonial|Emory University|404-727-5572|sloni01@emory.edu
3272|NCT00793819|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|Watson Pharmaceuticals|801-588-6641|gary.hoel@watson.com
3273|NCT00793910|Matthew Kuhnle, DO|Carl R. Darnall Army Medical Center|216-965-3518|matthew.kuhnle@us.army.mil
3274|NCT00794118|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3275|NCT00794144|Alcon Clinical|Alcon Research Ltd|888.451.3937; 817.568.6725|medinfo@alconlabs.com
3276|NCT00794157|Study Director|Novartis Pharmaceuticals|862 778-8300|
3277|NCT00794170|Karen Glanz|University of Pennsylvania|215-898-0613|kglanz@upenn.edu
3278|NCT00794365|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3279|NCT00794469|Gal Dubnov-Raz|Hadassah Medical Organization|+972+54-4570250|gal-d@bezeqint.net
3280|NCT00794547|Dr. Nithya Ramnath|University of Michigan Comprehensive Cancer Center|734-647-1417|nithyar@umich.edu
3281|NCT00794560|Dr. Seraina Mengiardi|Pharmaceutical Care Research Group, University of Basle, Switzerland|061 267 15 29 ext 0041|seraina.mengiardi@unibas.ch
3282|NCT00794664|Genzyme Medical Information|Genzyme Corporation|617-252-7832|
3283|NCT00794677|Ronald M Krauss|Children's Hospital Oakland Research Institute|510.450.7912|rkrauss@chori.org
3284|NCT00794924|Hilla Zaharoni|Kaplan-Harzfeld Geriatric Medical Center|97288595350|hilla_z@clalit.org.il
3285|NCT00794963|Peter Manu, MD|North Shore Long Island Jewish Health System, Zucker Hillside Hospita, Glen Oaks, NY|718 470-8290 pmanu@nshs.edu|
3286|NCT00795002|Judith Karp, MD|The Sidney Kimmel Comprehensive Cancer Center|410-502-7726|jkarp2@jhmi.edu
3287|NCT00795132|Dr. Michael Pulsipher|University of Utah|801-588-2680|michael.pulsipher@hsc.utah.edu
3605|NCT00711022|Senior Manager Global Clinical Research|DENTSPLY Implants|+46313763500|clinicalresearchmolndal@dentsply.com
3606|NCT00711113|Manager Global Clinical Operations|DENTSPLY Implants|+46313763500|
3607|NCT00711191|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3976|NCT00441974|GSK Response Center|GlaxoSmithKline|866-435-7343|
3977|NCT00478231|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3978|NCT00478244|John E. Wagner, M.D.|Masonic Cancer Center, University of Minnesota|612-626-2961|wagne002@umn.edu
3979|NCT00478556|Lisa Nelson|UAB Hospital Radiology|205-934-4015|lnelson@uabmc.edu
3980|NCT00478569|Medical Director|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
3981|NCT00478608|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
3982|NCT00478647|Tiffany Crump|Shire HGT|484-595-8850|tcrump@shire.com
3983|NCT00478673|Jim Taufen, Regulatory Affairs Manager|Boston Scientific Corporation|763-255-0683|taufenj@bsci.com
3984|NCT00478777|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
3985|NCT00478881|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
3986|NCT00479037|Clinical Trial Operations|Nycomed|+45 4677 1111|clinicaltrials@nycomed.com
3987|NCT00479154|Fatta Nahab|NINDS/NIH|301-496-9526|nahabf@ninds.nih.gov
3988|NCT00479232|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
3989|NCT00479258|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3990|NCT00479336|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
3991|NCT00479388|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
3992|NCT00479401|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5130|NCT00813488|Sponsor's Medical Expert, Clinical Research|Cephalon, Inc.|1-800-896-5855|
5131|NCT00813592|Randy Jensen, MD, PhD|Huntsman Cancer institute|801-585-0255|randy.jensen@hci.utah.edu
5132|NCT00813709|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
5133|NCT00813761|Kristy Canavan, OD|Vistakon|1-904-443-1474|kcanava2@its.jnj.com
5134|NCT00813800|Mark Frye, MD|Mayo Clinic|507-255-9391|mfrye@mayo.edu
5135|NCT00850395|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5136|NCT00850421|Park Nicollet Institute|Park Nicollet Institute|952-993-3123|
5137|NCT00850499|Andrew Cakana, MD, FRC Path|Johnson & Johnson Pharmaceutical Research & Development||[ACAKANA@ITS.JNJ.COM
5138|NCT00850564|Steven Grinspoon, MD|Massachusetts General Hospital|617-724-9109|sgrinspoon@partners.org
5139|NCT00850603|Medical Director|Sanofi Pasteur Inc||RegistryContactUs@sanofipasteur.com
5140|NCT00850720|Kiran Hebbar, MBBS|Children's Healthcare of Atlanta|404-785-1600|kiran.hebbar@choa.org
5141|NCT00850759|David Schwebel|UAB|205-934-8745|schwebel@uab.edu
5142|NCT00850889|Steven P. James, MD, VP, Global Medical Affairs|Allergan, Inc.|714-246-4500|james_steven@allergan.com
5143|NCT00850993|Dan Isaacman|InfaCare Pharmaceutical|(267) 515-5852|disaacman@infacare.com
5328|NCT00719186|Heping Zhang|Yale University|203-785-5185|rmn-dcc@panlists.yale.edu
5329|NCT00719264|Study Director|Novartis Pharmaceuticals|862-778-8300|
5330|NCT00719329|Dr. Luke Mullany|Johns Hopkins Bloomberg School of Public Health|410-502-2626|lmullany@jhsph.edu
5331|NCT00719355|Eileen G. Collins PhD, RN|University of Illinois at Chicago|312-413-5621|ecollins@uic.edu
5332|NCT00719472|Medical Communications|Genentech, Inc.|800-821-8590|
5333|NCT00719563|Debra L. Barton, RN, PhD, AOCN, FAAN|University of Michigan School of Nursing|734-763-3868|debbartn@umich.edu
4368|NCT00798135|Kathy Miller, MD|IndianaU||kathmill@iupui.edu
4369|NCT00798161|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
4370|NCT00798317|Aniz Girach|ThromboGenics|+32 16751310|aniz.girach@thrombogenics.com
4371|NCT00798369|Study Director|Novartis Pharmaceuticals|862-778-8300|
4372|NCT00798434|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4373|NCT00798486|Clinical Research Scientist|Bayer Healthcare, Diabetes Care|914-333-6245|jeannellen.fullam.b@bayer.com
4374|NCT00836407|Dr. Dung Le|The Sidney Kimmel Comprehensive Cancer Center at Johns||dle@jhmi.edu
4375|NCT00836472|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4376|NCT00836498|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
4377|NCT00836641|Prof Markus Rose|Goethe University Childrens Hospital|0049-696301 ext 5754|Markus.Rose@kgu.de
4378|NCT00836693|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4379|NCT00836706|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4380|NCT00836719|Jesus Lovera MD|LSU Health Sciences Center-New Orleans|5045686700|jlover@lsuhsc.edu
4381|NCT00836745|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4382|NCT00836875|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4383|NCT00836901|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4384|NCT00836953|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
4385|NCT00837031|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
4386|NCT00837161|Sarah Baxter|Philips Healthcare|425-487-7665|sarah.baxter@philips.com
4387|NCT00837200|Joseph J Drabick, MD|Milton S Hershey Medical Center|717-531-5911|jdrabick@hmc.psu.edu
3288|NCT00795145|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3289|NCT00429182|Naoto Ueno, MD / Professor|University of Texas MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
3290|NCT00429403|Naoto Ueno, MD / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
3291|NCT00429416|John Wagner, MD|Thomas Jefferson University|215-955-8874|John.Wagner@jefferson.edu
3292|NCT00429494|Dr. Naoto T. Ueno, MD, PhD / Professor|The University of Texas (UT) MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
3293|NCT00429572|Naoto Ueno, MD, PhD/Professor|UT MD Anderson Cancer Center|713-792-8754|CR_Study_Registration@mdanderson.org
3294|NCT00429702|SunCoast CCOP Research Base Lead Biostatistician|SunCoast CCOP Research Base|18009091242|ccop@epi.usf.edu
3295|NCT00429793|Melissa Leventhal|Gynecologic Oncology Group Statistical and Data Center|716-845-4030|mleventhal@gogstats.org
3296|NCT00429923|Jeremy Brace|Sirion Therapeutics, Inc.|813-496-7325 ext 343|jbrace@siriontherapeutics.com
3297|NCT00429949|Ravi Vij, M.D.|Washington University School of Medicine|314-454-8304|rvij@dom.wustl.edu
3298|NCT00430027|Dr. Tracey Schefter|University of Colorado, Denver|720-848-0100|Tracey.Schefter@ucdenver.edu
3299|NCT00430092|Jeremy Brace|Sirion Therapeutics, Inc.|813-496-7325 ext 343|jbrace@siriontherapeutics.com
3300|NCT00430248|Sr. VP, Clinical Sciences|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
3301|NCT00430300|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3302|NCT00430508|James McCarthy / Director Regulatory Operations|Daiichi Sankyo|732-590-3430|jmccarthy@dsus.com
3303|NCT00430625|Tiffany Crump|Shire Human Genetic Therapies (Shire HGT)|484-595-8850|tcrump@shire.com
3304|NCT00430638|John J. Raia, R.Ph., Pharm.D.|Daiichi Sankyo|1-877-437-7763|druginfo@dsus.com
3305|NCT00430677|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
3306|NCT00430716|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3993|NCT00479466|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
3994|NCT00479713|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
3995|NCT00479765|Claire Daugherty|BTG International Inc|610-278-1660|claire.daugherty@btgplc.com
3996|NCT00479856|GSK Response Center|GlaxoSmithKline|866-435-7343|
3997|NCT00480324|GSK Response Center|GlaxoSmithKline|866-435-7343|
3998|NCT00480493|Susan Sullivan-Bolyai|University of Massachusetts, Worcester|508-856-4185|susan.sullivan-bolyai@umassmed.edu
3562|NCT00474760|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3563|NCT00832455|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
3564|NCT00832520|Nicole Stephens, PhD, CCRP, CRA|UNM Cancer Center|505-925-0350|nstepehens@salud.unm.edu
3565|NCT00702364|Cynthia Harrison-Felix, PhD|Craig Hospital|303-789-8565|charrison-felix@craighospital.org
3566|NCT00702377|Alcon Clinical|Alcon Research Ltd|888.451.3937; 817.568.6725|medinfo@alconlabs.com
3567|NCT00702468|Richard Potts Clinical Operations Director|GW Pharma Ltd|+44 1353 616600|rp@gwpharm.com
3568|NCT00702507|GSK Response Center|GlaxoSmithKline|866-435-7343|
3569|NCT00702520|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
3570|NCT00702650|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
3571|NCT00702689|Edward Cowen, M.D.|National Cancer Institute, National Institutes of Health|301-496-4299|cowene@mail.nih.gov
3572|NCT00702702|Jennifer L. Wike|Repros Therapeutics Inc.|281-719-3402|jwike@reprosrx.com
3573|NCT00702715|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
3574|NCT00702754|Sharon Reinhard, M.S, Associate Director, Clinical Development|Solstice Neurosciences, Inc|267-620-8083|Sharon.Reinhard@solsticeneuro.com
5334|NCT00719615|Whitney S Goldner, MD|University of Nebraska Medical Center|402-559-6205|wgoldner@unmc.edu
5335|NCT00719680|Clinical Trial Disclosure Manager|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
5336|NCT00719706|Dr. Brian Brennan|McLean Hospital|617-855-2911|bbrennan@partners.org
5337|NCT00719732|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
5338|NCT00719810|Eugene Sun, M.D.|Melinta Therapeutics|203.624.5606|esun@melinta.com
5339|NCT00719862|William Wheeler, PhD|Meda Pharmaceuticals|732-564-2351|WWheeler@medapharma.us
5340|NCT00719901|A. Keith Stewart|Mayo Clinic|480-301-4411|stewart.keith@mayo.edu
5341|NCT00719914|C. Michael Gibson, MS, MD|Brigham and Women's Hospital|617-632-7753|mgibson@perfuse.org
5342|NCT00719953|Professor N. Vaisman|Sourazky Tel-Aviv Medical Center|972-3-6974807|vaisman@tasmc.health.gov.il
5343|NCT00720057|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
5344|NCT00720083|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@acr.com
5345|NCT00720096|Robert Wenham, M.D., via Moffitt Cancer Center|H. Lee Moffitt Cancer Center and Research Institute|813-745-4933|robert.wenham@moffitt.org
5346|NCT00720122|Madhusmita Misra, M.D., Associate Professor in Pediatrics, Assistant Pediatrician|Massachusetts General Hospital|617-724-5602|mmisra@partners.org
5347|NCT00720278|William Wheeler, PhD|Meda Pharmaceuticals|732-564-2393|WWheeler@medapharma.us
5348|NCT00720369|Cara McCabe, BA|McLean Hospital|617-855-2410|cfmccabe@partners.org
5349|NCT00720382|William Wheeler, PhD|Meda Pharmaceuticals|732-564-2393|WWheeler@medapharma.us
5350|NCT00720434|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5581|NCT00814580|Senior Director of Clinical Development, Pain|Ortho-McNeil Janssen Scientific Affair, LLC|(908)927-5469|GVorsang@its.jnj.com
5582|NCT00814658|Medical Group Manager|Jan-Cil Brazil|55 11 3030-2770|
5583|NCT00814697|Dr. Gayatri Devi|The NY Memory and Healthy Aging Services|212-517-6881|gd@nymemory.org
4503|NCT00450749|Powel H Brown, MD, PhD/Professor of Medicine and Cancer Prevention|University of Texas MD Anderson Phase I/II Prevention Consortium||CR_Study_Registration@mdanderson.org
4504|NCT00450866|David Peereboom, MD|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|216-445-6068|peerebd@ccf.org
4505|NCT00454805|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
4506|NCT00454818|Jeffrey J. Rudy, Vice President|Celladon Corporation|1 858-366-4288|jrudy@celladon.net
4507|NCT00454857|Study Director|Amgen Inc.|866-572-6436|
4508|NCT00455013|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4509|NCT00455195|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
4510|NCT00455429|William Barchuk, M.D.|Janssen Research and Development, 3210 Merryfield Row San Diego, CA 92121|858-784-3111|
4511|NCT00455455|Dr Craig A Woods|CCLR|519 888 4567 ext 36547|cawoods@uwaterloo.ca
4512|NCT00455520|Senior Director, Clinical Leader|Johnson & Johnson Pharmaceutical Research & Development|609-730-4537|
4513|NCT00455533|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4514|NCT00455702|Donald C Goff|Massachusetts General Hopsital|617-912-7899|goff@psych.mgh.harvard.edu
4515|NCT00455858|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
4516|NCT00456261|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
4517|NCT00456495|Clinic Coordinator|The New York Eye Cancer Center|212-832-8170|kchin@eyecancer.com
4518|NCT00456508|William E. Pullman|Dyax Corp.|617-250-2500|bpullman@dyax.com
4519|NCT00456547|Dr. Robert J McCarthy, Pharm D|Northwestern University Feinberg School of Medicine|312-926-9015|r-mccarthy@northwestern.edu
4520|NCT00456599|Mark Zalupski, MD|University of Michigan|734-615-3969|zalupski@med.umich.edu
4521|NCT00456625|GSK Response Center|GlaxoSmithKline|866-435-7343|
4522|NCT00456755|Zhao Yu|Department of Otorhinolaryngology, Head & Neck Surgery, West China Hospital, Sichuan University, China||yutzhao@gmail.com
3307|NCT00430781|GSK Response Center|GlaxoSmithKline|866-435-7343|
3308|NCT00430937|Study Director|Novartis Pharmaceuticals|862-778-8300|
3309|NCT00430950|James McCarthy Director Regulatory Operations|Daiichi Sankyo|732-590-3430|jmccarthy@dsus.com
3310|NCT00431041|Astellas Medical Monitor|Astellas Pharma Global Development||ClinicalTrials@us.astellas.com
3311|NCT00451048|Dr. Karen Yee|Princess Margaret Hospital|416-946-4495|karen.yee2@uhn.on.ca
3312|NCT00451191|Kathryn Hirst, PhD, Research Professor, PI of coordinating center|George Washington University Biostatistics Center|301-881-9260 ext 8025|khirst@bsc.gwu.edu
3313|NCT00451451|Biogen Idec Study Medical Director|Biogen Idec||clinicaltrials@biogenidec.com
3314|NCT00451698|Dr. Steven Zangwill|Medical College of Wisconsin|414-266-2380|szangwill@chw.org
3315|NCT00451958|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
3316|NCT00467740|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
3317|NCT00467753|Sherie Novotny, MD|UMDNJ|(732) @35-4119|novotnsl@rutgers.edu
3318|NCT00467831|Dr. Thomas Markello|NHGRI/NIH|301-451-1305|markellot@mail.nih.gov
3319|NCT00467844|Senior Director, Clinical Operations|GTx Inc.|901-523-9700|mdesordi@gtxinc.com
3320|NCT00467857|Dr. Shu-Ping Yang|Kimberly-Clark Health Care|770-587-7267|Shu-Ping.Yang@kcc.com
3321|NCT00467896|Wade Benton, Pharm D / Director, Medical Affairs Veletri and Ventavis|Actelion Pharmaceuticals, US, Inc.|(650) 624-6900|wade.benton@actelion.com
3322|NCT00468104|George Thommi|Midwest Pulmonary and critical care|402 206 7372|tommi4@cox.et
3323|NCT00468208|Carol A Langford, MD MHS|Vasculitis Clinical Research Consortium|216-445-6056|langfoc@ccf.org
3324|NCT00468286|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
3325|NCT00468299|Dr. Sarah Betstadt|University of Rochester|585-276-5368|sarah_betstadt@urmc.rochester.edu
3326|NCT00468312|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
3575|NCT00702780|Young Min Choe|Seoul National University Hospital|82-2-2072-1730|howlow44@daum.net
3576|NCT00702923|Douglas McNeel, M.D., Ph.D.|University of Wisconsin Carbone Cancer Center|(608) 263-4198|dm3@medicine.wisc.edu
3577|NCT00703053|Robert Belshe, MD|Saint Louis University|314-977-9030|belsherb@slu.edu
3578|NCT00703092|Dr. John Nestler|Virginia Commonwealth University|804-828-3389|jnestler@mcvh-vcu.edu
3579|NCT00703118|Medical Leader|Tibotec|1 609 730-3174|
3580|NCT00703261|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
3581|NCT00703326|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
3582|NCT00703339|Rosa Negro-Vilar|Lung Rx|240-821-1881|rnegrovilar@lungrx.com
3583|NCT00703391|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3584|NCT00703534|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3792|NCT00743249|Theresa A. Landry, Ph.D.|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
3793|NCT00743262|Prof. Dr. F.J.M. Hilgers|Netherlands Cancer Institute|+31-20-5252550|f.hilgers@nki.nl
3794|NCT00743275|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
3795|NCT00743288|Director, Clinical Operations|Oncotherapeutics|323-623-1200|lthulin@oncotherapeutics.com
3796|NCT00743431|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
3797|NCT00743444|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
3798|NCT00743509|Scott Schuetze|University of Michigan|734-647-8925|scotschu@umich.edu
3799|NCT00743574|Dr. Lubna Pal|Yale University|203-737-5619|lubna.pal@yale.edu
3800|NCT00743652|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3801|NCT00743717|Dr. Perry Secor|Los Alamitos Orthopaedic Group|805-384-2748|vsarin@kinamed.com
5584|NCT00814710|GSK Response Center|GlaxoSmithKline|866-435-7343|
5585|NCT00814801|Director|Janssen Pharm KK Japan|81-3-4411-5717|
5586|NCT00814892|Dr. Manish Kohli|Mayo Clinic|507-284-2511|kohli.manish@mayo.edu
5587|NCT00814970|Beaux S. Alexander - Clinical Research Director, Peripheral Clinical|Medtronic Endovascular Therapies|(707) 591-7291|beaux.s.alexander@medtronic.com
5588|NCT00814983|Mitchell Horwitz, MD|Duke University Medical Center|919-668-1045|Mitchell.Horwitz@duke.edu
5589|NCT00815087|Dr.Wang TG|Wang tyng|+886-2-23123456 ext 67587|patty.jt@gmail.com
5590|NCT00815308|Jinming Yu|Shandong Cancer Hospital and Institute|86-531-87984729|jn7984729@public.jn.sd.cn
5591|NCT00815347|MArk Metersky, MD|University of Connecticut Health Center|860-679-3582|metersky@nso.uchc.edu
5592|NCT00815490|Dr David MacLeod|Duke University Medical Center|919-812-3201|david.macleod@duke.edu
5593|NCT00815659|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
5594|NCT00815685|Nagi Kumar, Ph.D., via Moffitt Cancer Center|H. Lee Moffitt Cancer Center and Research Institute|813-745-6885|nagi.kumar@moffitt.org
5595|NCT00815776|Lawrence G. Clayton, M.A., Study Director|Ascentia Health, Inc.|(815) 484-9258|LGClayton@aol.com
5596|NCT00815919|John Koreth, MBBS, DPhil|Dana-Farber Cancer Institute|617-632-2949|John_Koreth@dfci.harvard.edu
5597|NCT00816023|Alistair Wheeler, MD, MFPM, Senior Director Clinical Research|Cubist Pharmaceuticals, Inc.|781-860-8660|awheeler@cubist.com
5598|NCT00816036|David Katz, MD, MSc|Department of Veterans Affairs|319-338-0581 ext 7598|david-katz@uiowa.edu
5599|NCT00824291|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5600|NCT00824369|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5601|NCT00824382|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5602|NCT00824421|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4523|NCT00456807|GSK Response Center|GlaxoSmithKline|866-435-7343|
4524|NCT00456846|Anne McClain|Celgene Corporation|888-260-1599|clinicaltrialdisclosure@celgene.com
4525|NCT00457002|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4638|NCT00492726|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
4639|NCT00492752|Therapeutic Area Head|BAYER|<not disclosed>|clinical-trials-contact@bayerhealthcare.com
4640|NCT00492856|SWOG Leukemia Committee Statistician|SWOG Statistical Center|206-667-4408|
4641|NCT00492973|Cale Jacobs, PhD|Lexington Clinic|859-258-8238|cjaco@lexclin.com
4642|NCT00493012|Dr. Armin Zittermann|Heart and Diabetes Center North Rhine-Westfalia|+49 5731 97 ext 1912|azittermann@hdz-nrw.de
4643|NCT00493038|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
4644|NCT00493181|Jorge Cortes M.D./Professor|The University of Texas M. D. Anderson Cancer Center|713/794-5783|eharriso@mdanderson.org
4645|NCT00493220|George Harb, MD, MPH|Baxter Healthcare Corporation||george_harb@baxter.com
4646|NCT00493246|Mike Royal, MD, JD, MBA. Vice President Clinical Development- Analgesics|Cadence Pharmaceuticals|858 436 1400|mroyal@cadencepharm.com
4647|NCT00493285|Elissa Malkin, DO, MPH|MedImmune, LLC|301-398-0000|malkine@medimmune.com
4648|NCT00493311|Mike Royal, MD JD MBA, Clinical Development Analgesics|Cadence Pharmaceuticals|858-436-1400|mroyal@cadencepharm.com
4649|NCT00493454|Felipe Samaniego, MD / Associate Professor|The University of Texas (UT) MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
4650|NCT00493636|Study Chair|ACORN Research, LLC|901-435-5570|lschwartzberg@acornresearch.net
4651|NCT00493779|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4652|NCT00493805|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
4653|NCT00493974|Prescott Woodruff|University of CA|415-514-2061|prescott.woodruff@ucsf.edu
4654|NCT00494013|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
3327|NCT00468481|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
3328|NCT00468559|Gerard Lynch|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
3329|NCT00468650|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3330|NCT00468676|Dr Wayne Katon, Professor and Vice Chair|Dept Psychiatry, University of Washington Medical School|206-543-7177|wkaton@uw.edu
3331|NCT00468728|Chief Scientific Officer|Optimer Pharmaceuticals, Inc.|1-855-343-4243|medinfo@optimerpharma.com
3332|NCT00468819|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
3333|NCT00468845|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3334|NCT00469079|Dorothy Hatsukami, Ph.D.|University of Minnesota|612-626-2121|hatsu001@umn.edu
3335|NCT00469092|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
3336|NCT00469209|Muzaffar H. Qazilbash, MD|University of Texas M.D. Anderson Cancer Center|713-745-3458|CR_Study_Registration@mdanderson.org
3337|NCT00469274|Dr. Thomas R. Talbot|Vanderbilt University Medical Center|615-322-2789|tom.talbot@vanderbilt.edu
3338|NCT00469456|Stephen Graham, PhD|Forest Research Institute, a subsidiary of Forest Laboratories Inc.|201-427-8156|stephen.graham@frx.com
3339|NCT00469508|Steven Shoptaw PhD|UCLA Center for Behavioral and Addiction Medicine|310 794 0619 ext 225|sshoptaw@mednet.ucla.edu
3340|NCT00469859|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
3341|NCT00469898|Leora Horn, M.D.|Vanderbilt-Ingram Cancer Center|615-322-4967|leora.horn@vanderbilt.edu
3342|NCT00470054|Antonius Miller|Wake Forest University||aamiller@wfubmc.edu
3343|NCT00785629|Geoffrey A. Block, MD|Denver Nephrologists, P.C.|303-364-4775|gablock@denverneph.net
3344|NCT00785772|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3345|NCT00785980|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
3802|NCT00744042|Alexion Pharma International Sàrl|Alexion Pharma International Sàrl||ClinicalTrials@alxn.com
3803|NCT00787527|Yasuhiro Oki, MD/ Associate Professor|University of Texas MD Anderson Cancer Center|713-792-2860|yoki@mdanderson.org
3804|NCT00787566|Vanaja V. Ragavan, M.D.|Aviana Consulting, LLC|610-795-7403|vvragavan@comcast.net
3805|NCT00787605|Study Director|Novartis Pharmaceuticals|862-778-8300|
3806|NCT00787618|Jennifer Wike|Repros Therapeutics Inc.|2817193402|jwike@reprosrx.com
3807|NCT00787761|Asad Bashey, MD, PhD, Principal Investigator|Blood and Marrow Transplant Group of Georgia|404-255-1930|abashey@bmtga.com
3808|NCT00787800|Paul A. Friedman, MD, Professor of Medicine|Mayo Clinic|507-284-7661|friedman.paul@mayo.edu
3809|NCT00787852|Howard Safran, MD|BrUOG|4018633000|kayla_rosati@brown.edu
3810|NCT00787891|PORTFOLIO/CDT LEADER|Janssen R&D US|1 609 730-2548|
3811|NCT00787917|Study Director|Novartis Pharmaceuticals|862 778-8300|
3812|NCT00837330|Dr. Dennis M Marcus Principal Investigator|Southeast Retina Center, P.C.|706-650-0061|dmarcus@southeastretina.com
3813|NCT00837447|Young-Hoo Kim, MD|Ewha Womans University School of Medicine|822-26505900|younghookim@ewha.ac.kr
3814|NCT00837512|Dr. Eric Felner|Emory University School of Medicine|404-727-7651|efelner@emory.edu
3999|NCT00480532|Bliss Kaneshiro|University of Hawaii (UH)|808-203-6500|bkaneshiro@ucera.org
4000|NCT00480636|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4001|NCT00480987|Gautam Borthakur, MBBS / Assistant Professor|The University of Texas M. D. Anderson Cancer Center|713-792-7305|eharriso@mdanderson.org
4002|NCT00481065|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
4003|NCT00481195|Medical Monitor|Cephalon, Inc.|1-800-896-5855|
4004|NCT00832585|Dr. Michael D. Tharp|Rush University Medical Center - Department of Dermatology|312-563-4001|derm@rush.edu
4005|NCT00832624|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
5603|NCT00824434|Ruth Starzyk, PhD|Boston Scientific|508-683-6577|ruth.starzyk@bsci.com
5144|NCT00851084|Trial Transparency Team|Sanofi||Contact-Us@sanofi.com
5145|NCT00851318|Medical Director, Global Medical Sciences|Astellas Pharma Inc.||ClinicalTrials.Disclosure@astellas.com
5146|NCT00851409|Medical Affairs Department|Pharming Technologies BV|+31715247400|medicalinfo@pharming.com
5147|NCT00851552|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
5148|NCT00851591|Thomas Hale, PhD.|Texas Tech University Health Sciences Center|806-354-5528|thomas.hale@ttuhsc.edu
5149|NCT00851630|Dr. Nathan Thielman|Duke University Medical Center|919-6687174|n.thielman@duke.edu
5150|NCT00851643|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
5151|NCT00851721|Wing-Yen Wong, MD, Global Sr Medical Dir Hemophilia|Baxter Healthcare Corporation||wing_yen_wong@baxter.com
5152|NCT00851786|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
5153|NCT00851903|Trial Transparency Team|sanofi-aventis||Contact-US@sanofi.com
5154|NCT00852137|Dr. Torsten Skov|LEO Pharma|+4520736294|torsten.skov@leo-pharma.com
5155|NCT00852397|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5156|NCT00852540|GSK Response Center|GlaxoSmithKline|866-435-7343|
5157|NCT00852631|Gerard Lynch|AstraZeneca||clinicaltrialtransparency@astrazeneca.com
5158|NCT00689481|GSK Response Center|GlaxoSmithKline|866-435-7343|
5159|NCT00689793|Dr Bernard Favrat MD|Departement of ambulatory care and community medicine, University of Lausanne, Switzerland|+41795566183314|Bernard.favrat@chuv.ch
5160|NCT00689819|Phillip Levy, MD|Wayne State University|3139938558|plevy@med.wayne.edu
5161|NCT00689871|Medical Monitor|Allergan Medical|(805) 961-5000|devicetrials@allergan.com
5162|NCT00689884|John M. Hill, MD - Principal Investigator|Dartmouth-Hitchcock Medical Center|603-650-4628|john.m.hill@hitchcock.org
4655|NCT00494026|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4656|NCT00494091|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4657|NCT00494143|Dr. Joseph Czerniecki|VA Puget Sound Health Care System|206 277 5188|joseph.czerniecki@va.gov
4658|NCT00494221|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
4659|NCT00494299|Therapeutic Area Head|Bayer HealthCare AG||clinical-trials-contact@bayerhealthcare.com
4660|NCT00494481|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
4249|NCT00800540|Director, Global Medical Affairs|Alcon Research, Ltd.|1-888-451-3937|
4250|NCT00800683|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
4251|NCT00800735|Medical Communications|Hoffmann-La Roche|800 821-8590|
4252|NCT00800865|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
4253|NCT00800982|Dr Ethan Levin|University of California San Francisco|4154764019|levine@derm.ucsf.edu
4254|NCT00801099|Franziska Saxer, MD|Swiss Tropical Institute||franziskabrenneke@yahoo.com
4255|NCT00801229|Joseph Biderman, MD|Massachusetts General  Hospital|617-726-1746|
4256|NCT00801242|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
4257|NCT00801684|Bernard L. Silverman, MD|Alkermes, Inc.|781-609-6000|bernard.silverman@alkermes.com
4258|NCT00801801|Dr. Francisco Robert|UAB|205-934-5077 ext N/A|pacorobertuab@cs.com
4259|NCT00801892|E. Chasens, PhD|University of Pittsburgh|412-624-9380|chasense@pitt.edu
4260|NCT00801983|Dr. Nancy Baker|University of Pittsburgh|412 383-6607|nab36@pitt.edu
4261|NCT00802100|Scott Stroup|Columbia University|(212) 543-5676|stroups@nyspi.columbia.edu
4262|NCT00802178|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
3346|NCT00786188|Sailaja Bhaskar, Executive Director, Clinical Research|Noven Therapeutics, LLC|(212) 287-0798|sbhaskar@noven.com
3347|NCT00786422|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
3348|NCT00786565|Jon Hayashida|Bausch & Lomb|(585) 338-6370|jon.hayashida@bausch.com
3349|NCT00786643|Vice President of Scientific Affairs|Accelerated Community Oncology Research Network, Inc.|901-435-5570|mwalker@acorncro.com
3350|NCT00786682|Dr. Mark Stein|Cancer Institute of New Jersey|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
3351|NCT00786799|Robert L. Hendren, D.O.|University of California, San Francisco|415-476-7198|robert.hendren@ucsf.edu
3352|NCT00786838|Senior Medical Director|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|1 908 704-5779|
3353|NCT00786864|Gina L Fanucchi|University of the Witwatersrand|+27 11 616 4400|gfanucs@mweb.co.za
3354|NCT00787020|DaiWai M Olson|Duke University Medical Center|9196683751|Olson006@mc.duke.edu
3355|NCT00787124|Brian Smith|Duke University Medical Center|9196688951|brian.smith@duke.edu
3356|NCT00787137|John Powell|PanGenetics UK Limited|+441763257869|info@pangenetics.com
3357|NCT00787150|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3358|NCT00787189|Elvira Walls, Clinical Consultant|Regulatory Insight, Inc.|615-712-9743|elvira@reginsight.com
3359|NCT00787202|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3360|NCT00787241|Dr. Robert J. McCarthy|Northwestern University Feinberg School of Medicine|312-926-9015|r-mccarthy@northwestern.edu
3361|NCT00787254|Sr. VP Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
3362|NCT00787319|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3363|NCT00787332|Director of Clinical Trials|Canyon Pharmaceuticals|888-434-7003|info@canyonpharma.com
3364|NCT00830232|Dr. Carlos H Timaran|Dallas VA Medical Center|2148570336|carlos.timaran@va.gov
4006|NCT00832650|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4007|NCT00833027|Vice President of Late Stage Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
4008|NCT00833053|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Company||clinicaltrialsdisclosure@merck.com
4009|NCT00833092|Forrest H Nielsen, PhD|USDA Grand Forks Human Nutrition ResearchCenter|701-790-8455|forrest.nielsen@ars.usda.gov
4010|NCT00833248|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
4011|NCT00833417|Medical Communications|Genentech, Inc.|800-821-8590|
4012|NCT00833443|Keith Heinzerling MD|UCLA|323-461-3106|kheinzerling@mednet.ucla.edu
4013|NCT00833469|Dr. Marlene Freeman, MD|Massachusetts General Hospital|617-643-6403|mfreeman@partners.org
4014|NCT00833482|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4015|NCT00833521|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4016|NCT00833547|Dr. Dara Manoach|Massachusetts General Hospital|617-726-6148|dara@nmr.mgh.harvard.edu
4017|NCT00833560|Therapeutic Areas Director|Jan-Cil Germany|+49 2137 955-492|
4018|NCT00833586|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4019|NCT00833638|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4020|NCT00833664|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4021|NCT00833690|Michael A. Schwarzschild, MD, PhD|The Parkinson Study Group|617-724-9611|mschwarzschild@partners.org
3608|NCT00711347|Erin Rogut|Alcon Research, Ltd.|813-426-4036|Erin.Rogut@alconlabs.com
3609|NCT00711425|Manager Global Clinical Operations|DENTSPLY Implants|+46313763500|
3610|NCT00711490|Catherine Meyerle, MD|National Eye Institute|301-435-7821|meyelec@nei.nih.gov
3611|NCT00711516|Sponsor's Medical Expert, Clinical Research|Cephalon, Inc.|1-800-896-5855|
5163|NCT00690339|Medical Monitor|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
5164|NCT00690430|Study Director|Novartis Pharmaceuticals|862-778-8300|
5165|NCT00690443|Chief Medical Officer|Aegerion Pharmaceuticals|617-500-7867|
5166|NCT00690482|Alison Holt|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
5351|NCT00726752|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5352|NCT00726830|Michael J. Fisch, MD, MPH, FACP|University of Texas MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
5353|NCT00726895|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
5354|NCT00726986|Afshin Dowlati MD|Case Comprehensive Cancer Center|216-844-1228|afshin.dowlati@uhhospitals.org
5355|NCT00726999|Lynn Rusy, MD|Medical College of Wisconsin|414-266-2555|lrusy@chw.org
5356|NCT00727025|Dr. Carolyn Kerrigan|Dartmouth-Hitchcock|603 650-5148|carolyn.l.kerrigan@hitchcock.org
5357|NCT00727064|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
5358|NCT00727090|Andrew M Naidech|Northwestern University|312-503-3592|a-naidech@northwestern.edu
5359|NCT00727259|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5360|NCT00727272|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
5361|NCT00727298|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@Merck.com
5362|NCT00727311|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclsoure@merck.com
5363|NCT00727402|Loretta Szczotka-Flynn OD, PhD|Case Western Reserve University Dept Ophthalmology & Visual Sciences|216-844-3609|loretta.szczotka@uhhospitals.org
5364|NCT00727506|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5365|NCT00727558|Kurt Moody OD, FAAO/ Director|Vistakon|904-443-3088|kmoody1@its.jnj.com
5366|NCT00727571|Study Director|Amgen Inc.|866-572-6436|
4263|NCT00802360|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
4264|NCT00802503|Dr CP Heidegger|Geneva University Hospitals, Division of Intensive Care,Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14/Switzerland|+41223827440|claudia-paula.heidegger@hcuge.ch
4265|NCT00802633|Sam Chang|Vanderbilt University|615-322-2101|sam.chang@Vanderbilt.Edu
4266|NCT00839072|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
4267|NCT00839241|Head of Clinical Research Area Health Care|Astra Tech AB|+46317761000|
4268|NCT00839319|Mara Roth, MD|University of Washington|206-221-0519|mylang@u.washington.edu
4269|NCT00839423|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
4270|NCT00839527|GSK Response Center|GlaxoSmithKline|866-435-7343|
4271|NCT00839540|Dr. Gary E.Stein, Pharm.D.|Michigan State University|517-353-5126|steing@msu.edu
4388|NCT00837213|GSK Response Center|GlaxoSmithKline|866-435-7343|
4389|NCT00837252|Catherine M. Meyerle, MD|National Eye Institute|301-435-7821|meyerlec@nei.nih.gov
4390|NCT00448630|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4391|NCT00448682|Bach Ardalan MD|University of Miami Sylvester Comprehensive Cancer Center|305-243-6608|bardalan@med.miami.edu
4392|NCT00448708|Dr. Trudy Estridge|Angiotech Pharmaceuticals|604-221-7676|testridge@angio.com
4393|NCT00448760|Bach Ardalan MD, Professor|UM/Sylvester Comprehensive Cancer Center|305-243-4909|bardalan@med.miami.edu
4394|NCT00449033|Therapeutic Area Head|Bayer HealthCare AG||clinical-trials-contact@bayerhealthcare.com
4395|NCT00449046|GSK Response Center|GlaxoSmithKline|866-435-7343|
4396|NCT00449072|Trial Transparency Team|sanofi-aventis||Contact-Us@sanofi.com
4397|NCT00449150|Daniel Croteau, Medical Manager|AEterna Zentaris|418-652-7669 ext 272|DCroteau@aezsinc.com
4398|NCT00449163|Bach Ardalan MD|UM/Sylvester Comprehensive Cancer Center|305-243-4909|bardalan@med.miami.edu
3365|NCT00830258|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3366|NCT00830310|Christopher Bialko|University Hospitals Case Medical Center|216-286-4362|Christopher.Bialko@UHhospitals.org
3367|NCT00830336|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3368|NCT00830362|Dr. Michael Saladin|Medical University of South Carolina|843-792-5306|saladinm@musc.edu
3369|NCT00830375|Jon E. Grant|University of Minnesota|612-273-9800|grant045@umn.edu
3370|NCT00795210|Steven Grinspoon, MD|Massachusetts General Hospital|617-724-9109|sgrinspoon@partners.org
3371|NCT00795509|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3372|NCT00795600|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
3373|NCT00795639|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3374|NCT00795704|Daniel Riche|University of Mississippi Medical Center|601-984-2640|driche@umc.edu
3375|NCT00795886|Michael Pulsipher, MD|Primary Children's Medical Center|801-662-4732|Michael.Pulsipher@hsc.utah.edu
3376|NCT00795951|SE Jacob, MD and L Eichenfield, MD|Rady Children’s Hospital, San Diego, CA|858-576-1700 ext 4825|leichenfield@rchsd.org
3377|NCT00835211|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3378|NCT00835224|Dr. Jill M. Wecht|James J Peters VAMC|718 584-9000 ext 3122|jm.wecht@va.gov
3379|NCT00835237|GSK Response Center|GlaxoSmithKline|866-435-7343|
3380|NCT00835263|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3381|NCT00835276|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
3382|NCT00835341|Department of Etiology|Peking University School of Oncology|+8610-88196752|dengdajun@bjmu.edu.cn
3383|NCT00835354|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3646|NCT00435539|Aniz Girach, MD|ThromboGenics|+32 16751310|aniz.girach@thrombogenics.com
3647|NCT00435591|Senior Medial Director, Medical Affairs|Astellas Pharma Global Development||clinicaltrials@us.astellas.com
3648|NCT00474786|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3649|NCT00474812|Charles Nock MD|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|216-844-3862|charles.nock@uhhospitals.org
3650|NCT00474903|Paul J. Limburg, M.D., M.P.H.|Mayo Clinic Rochester||limburg.paul@mayo.edu
3651|NCT00474968|Richard Domanik, Ph.D.|CytoCore, Inc.|312-222-9550|rdomanik@cytocoreinc.com
3652|NCT00475033|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3653|NCT00475085|Dr. Charles Heckler|University of Rochester|585 273-1141|checkler@urmc.rochester.edu
3654|NCT00475150|Mark B. Juckett, MD|University of Wisconsin Comprehensive Cancer Center||mbj@medicine.wisc.edu
3838|NCT00712166|Mark Bresnik, MD, Director, Clinical Research|Gilead Sciences, Inc.|(650) 522-5934|mark.bresnik@gilead.com
3839|NCT00438672|Dr. David Ring|Massachusetts General Hospital|617-724-3953|dring@partners.org
3840|NCT00438750|David Ring, MD, PhD|Orthopaedic Hand and Upper Extremity Service, Massachusetts General Hospital|617-724-3953|dring@partners.org
3841|NCT00438815|Chief Scientific Officer|ViroPharma|610-458-7300|
3842|NCT00438854|Philip C. Amrein, M.D.|Massachusetts General Hospital|617-726-8748|pamrein@partners.org
3843|NCT00438880|Thomas E. Witzig, M.D.|Mayo Clinic Cancer Center||witzig.thomas@mayo.edu
3844|NCT00438932|Tamara Isakova, MD, MMSc|University of Miami Miller School of Medicine|305-243-4374|tisakova@med.miami.edu
3845|NCT00438971|Dr. Mark Pollack|Rush University|312-942-5372|mark_pollack@rush.edu
3846|NCT00439140|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
3847|NCT00439179|Howard Safran, MD|BrUOG|4018633000|Hsafran@lifespan.org
3848|NCT00439218|René Gonin, PhD (Math. Stats.)|Westat|301-251-1500|renegonin@westat.com
5367|NCT00727597|Dr. Princy Kumar|Georegtown University|2024440086|kumarp@georgetown.edu
5368|NCT00727636|Dr. Athos Bousvaros|Children's Hospital Boston|617-355-2962|athos.bousvaros@childrens.harvard.edu
5369|NCT00727844|Dr. Clifton Barry|Tuberculosis Research Section, LCID, NIAID, NIH|301-451-9554|cbarry@niaid.nih.gov
5370|NCT00727857|Sr. VP Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
5371|NCT00765206|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
5372|NCT00765232|Mitchell R. Humphreys MD|Mayo Clinic|480-301-8000|humphreys.mitchell@mayo.edu
5535|NCT00561457|Director of Clinical Affairs|Bard Peripheral Vascular|480-303-2644|John.Reviere@crbard.com
5536|NCT00561470|International Clinical Development Study Director|sanofi-aventis||contact-us@sanofi.com
5537|NCT00561574|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5538|NCT00561600|Dave Whalen Clinical Portfolio Leader|DePuy Orthopaedics|574-372-7028|dwhalen@its.jnj.com
5539|NCT00561730|Medical Responsible|Nycomed Deutschland GmbH|+49 7531 3666 0|clinicaltrials@nycomed.com
5540|NCT00561795|GSK Response Center|GlaxoSmithKline|866-435-7343|
5541|NCT00561821|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5542|NCT00561912|Ana M. Aparicio, MD / Assistant Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
5543|NCT00561925|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5544|NCT00759681|David Cull, MD|Greenville Memorial Hospital|864-455-9825|
5545|NCT00759759|Meena Venugopal, Director, Clinical R&D|Actavis Inc.|908-659-2885|MVenugopal@actavis.com
5546|NCT00759811|Daniel Medeiros Moreira, MD. MSc.|Instituto de Cardiologia do Rio Grande do Sul|55 (51) 3219-2802|danielmedeirosmoreira@gmail.com
5547|NCT00759863|Bruno Kajiyama|Photozig, Inc.|650-694-7496 ext 3|lifezig@photozig.com
4399|NCT00449176|Senior Director, Clinical Leader|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|609-730-4537|
4400|NCT00449540|Cynthia Merrell|Neuralieve|408-245-6400|cmerrell@neuralieve.com
4401|NCT00449644|Medical Leader|Janssen Infectious Diseases – Diagnostics BVBA|1 609 730-7768|
4402|NCT00449696|Clinical Development Dept.|Seikagaku Corporation|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp
4403|NCT00449748|Srdan Verstovsek M.D./Associate Professor|The University of Texas M. D. Anderson Cancer Cent|713-792-7305|eharriso@mdanderson.org
4404|NCT00449787|Benjamin Friedman|Montefiore Medical Center|718-920-6626|bwfriedmanmd@gmail.com
4405|NCT00449930|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp.|1-800-672-6372|
4406|NCT00449956|Senior Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
4407|NCT00450073|Vin Tangpricha|Emory University|4047277254|vin.tangpricha@emory.edu
4408|NCT00450112|Clinical Development Dept.|Seikagaku Corporation|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp
4409|NCT00450216|Amy Grahn, MS  Senior Vice President, Clinical Development and Operations|Horizon Pharma, Inc.|224-383-3012|agrahn@horizonpharma.com
4410|NCT00450242|Denniz Zolnoun, MD, MPH|University of North Carolina, Dept. of Obstetrics and Gynecology|919-966-7764|denniz_zolnoun@med.unc.edu
4526|NCT00457015|Patrick T Horn|Dyax Corp.|617 250 5948|phorn@dyax.com
4527|NCT00457249|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
4528|NCT00490815|Kathleen Billman, Senior Director of Scientific Affairs|Alimera Sciences, Inc|678-527-1302|kathleen.billman@alimerasciences.com
4529|NCT00490841|Ellen Travis|Abbott Vascular|408-845-1512|Ellen.Travis@av.abbott.com
4530|NCT00490919|Clinical Leader, Medical Director|Purdue Pharma L.P.|800-733-1333|
4531|NCT00490945|Marlene Dressman, Ph.D.|Vanda Pharmaceuticals Inc.|202-734-3462|marelene.dressman@vandapharma.com
4532|NCT00490971|Clinical Leader|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|609-730-2436|
3384|NCT00835367|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3385|NCT00835380|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
3386|NCT00835406|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3387|NCT00835484|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3388|NCT00835497|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3389|NCT00835510|Medical Director|Taro Pharmaceuticals|(914) 345-9001 ext 6427|medical.affairs@taro.com
3390|NCT00835536|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3391|NCT00835549|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3392|NCT00835575|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3393|NCT00835588|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3394|NCT00835614|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3395|NCT00835640|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com
3396|NCT00835666|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3397|NCT00452114|Stephen Krinzman, Principal Investigator|University of Massachusetts Medical School|508-856-1975|stephen.krinzman@umassmed.edu
3398|NCT00452348|GSK Response Center|GlaxoSmithKline|866-435-7343|
3399|NCT00452361|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
3400|NCT00452374|William Wierda, M.D./Associate Professor|The University of Texas M. D. Anderson Cancer Center|713-745-0428|eharriso@mdanderson.org
3401|NCT00452387|Vice President of Scientific Affairs|Accelerated Community Oncology Research Network, Inc.||mwalker@acorncro.com
3402|NCT00452400|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
3815|NCT00837577|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
3816|NCT00837616|Dr. Nelly Mauras|Nemours Children's Clinic|(904) 697-3674|nmauras@nemours.org
3817|NCT00837759|Dr. Rana Malek|NIDDK, National Institutes of Health|3015945288|malekr@mail.nih.gov
3818|NCT00837824|Genzyme MedInfo|Genzyme Corporation|800-745-4447|medinfo@genzyme.com
3819|NCT00837876|Jordan Berlin, MD|Vanderbilt-Ingram Cancer Center|615-343-4128|jordan.berlin@vanderbilt.edu
3820|NCT00837967|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3821|NCT00838097|Study Director|Amgen Inc.|866-572-6436|
3822|NCT00838110|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3823|NCT00838136|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3824|NCT00838162|VP Head of Discovery & Early Development|Jan-Cil UK|44 1494 553458|ksimmen1@its.jnj.com
3825|NCT00838201|Study Director|Amgen Inc.|866-572-6436|
3826|NCT00838279|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3827|NCT00838630|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3828|NCT00838682|Hiun-Suk Chae|The Catholic University of Korea, Uijeongbu St. Mary's Hospital|82-31-820-3019|chs@catholic.ac.kr
3829|NCT00838903|GSK Response Center|GlaxoSmithKline|866-435-7343|
3830|NCT00838916|GSK Response Center|GlaxoSmithKline|866-435-7343|
3831|NCT00838929|Wenyin Shi, MD, PhD|Thomas Jefferson University|215-955-4111|Wenyin.Shi.@jefferson.edu
3832|NCT00711594|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
3833|NCT00711646|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd.|0044 1223 266800|rp@gwpharm.com
3834|NCT00711867|Terrence L Trentman MD|Mayo Clinic|480-301-8000|trentman.terrence@mayo.edu
5548|NCT00759902|Meena Venugopal, Director, Clinical R&D|Actavis Inc.|908-659-2885|MVenugopal@actavis.com
5549|NCT00759915|Meena Venugopal, Director, Clinical R&D|Actavis Inc.|908-659-2885|MVenugopal@actavis.com
5550|NCT00759941|Head, Global Medical Affairs|Alcon Research, Ltd.|800-862-5266|medinfo@alconlabs.com
5551|NCT00759954|Meena Venugopal, Director, Clinical R&D|Actavis Inc.|908-659-2885|MVenugopal@actavis.com
5552|NCT00760084|Yufang Lu, MD, PhD|Eisai Inc.|888-422-4743|
5553|NCT00760214|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
5554|NCT00760266|Study Director|Novartis Pharmaceuticals|862-778-8300|
5555|NCT00760474|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
5556|NCT00760487|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
5557|NCT00760526|Katrina Ruedy|Jaeb Center for Health Research|813-975-8690|direcnet@jaeb.org
4180|NCT00445224|Dr. Tim L. Uhl Principal Investigator|University of Kentucky|859-323-1100 ext 80858|tluhl2@uky.edu
4181|NCT00445302|Genzyme Medical Information|Genzyme Corporation|1-800-745-4447|
4182|NCT00445315|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4183|NCT00445328|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4184|NCT00445341|Kieron Dunleavy, M.D.|National Cancer Institute, National Institutes of Health|301-435-1007|DunleavK@mail.nih.gov
4185|NCT00445432|Global Medical Services|Abbott|800-633-9110|
4186|NCT00445549|Elise C. Kohn, M.D.|National Cancer Institute, National Institutes of Health|301-496-4916|kohne@mail.nih.gov
4187|NCT00445679|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
4188|NCT00445705|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
4189|NCT00445770|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4533|NCT00491075|Quality Assurance Specialist|U.T. MD Anderson Cancer Center|713-792-2830|guclinicaltrials@mdanderson.org
4534|NCT00491179|Chen-Hua Liu|National Taiwan University Hospital|886223123456 ext 63572|jacque_liu@mail2000.com.tw
4535|NCT00491244|Dr. Chen-Hua Liu|National Taiwan University Hospital|+886-2-23123456 ext 63572|jacque_liu@mail2000.com.tw
4536|NCT00491374|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
4537|NCT00491387|Myron Gerson MD|University of Cincinnati|5135583974|myron.gerson@uc.edu
4538|NCT00491400|Joseph A. Vita, MD|Boston University|617-638-8700|jvita@bu.edu
4539|NCT00491504|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
4540|NCT00491530|Medical Information Specialist|Abbott|800-633-9110|
4541|NCT00491608|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|ZymoGenetics, a Bristol-Myers Squibb company|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com
4542|NCT00491738|Medical Communications Specialist|Genentech, Inc.|800-821-8590|
4543|NCT00491764|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4544|NCT00491829|Scientific Program Director|Sprout Pharmaceuticals|9198820850|clinicaltrials@sproutpharma.com
4545|NCT00491894|Shionogi Clinical Trials Administrator|Shionogi USA|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
4546|NCT00492024|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
4547|NCT00492063|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
2828|NCT00375752|Study Director|Novartis Pharmaceuticals|862-778-8300|
2829|NCT00375934|Steve Boesing|Xanodyne Pharmaceuticals, Inc.|1-877-926-6396|clinical-trials@xanodyne.com
2830|NCT00375999|Dr. Jae Yong Cho|Gangnam Severance Hospital, Yonsei University College of Medicine|82-2-2019-4363|chojy@yuhs.ac
2831|NCT00376168|Einat Almon|Protalix Ltd.|972-4-9889488 ext 137|einata@protalix.com
3403|NCT00452426|James Martin, PhD|Ethicon Endo-Surgery|513 337-7000|
3404|NCT00452452|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
3405|NCT00452530|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
3406|NCT00452543|Dr. Janet Witte|Massachusetts General Hospital|617-726-5104|jwitte@partners.org
3407|NCT00452673|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
3408|NCT00452699|GSK Response Center|GlaxoSmithKline|866-435-7343|
3409|NCT00452790|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3410|NCT00452868|Dr. Janet Tooze|Wake Forest Baptist Health|336-716-0286|jtooze@wakehealth.edu
3411|NCT00453063|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
3412|NCT00453193|Farhad Ravandi-Kashani MD/Associate Professor|The University of Texas M D Anderson Cancer Center|713-745-0394|eharriso@mdanderson.org
3413|NCT00453206|David Hurd, MD|Wake Forest University Health Sciences|336-716-2843|dhurd@wakehealth.edu
3414|NCT00453336|Francisco Civantos MD|University of Miami Sylvester Comprehensive Cancer Center|305-243-5276|fcivanto@med.miami.edu
3415|NCT00453349|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
3416|NCT00453362|Medical Communications|Hoffman-LaRoche|800-821-8590|
3417|NCT00453973|Vice President, Clinical Development|Affymax|650-812-8700|info@affymax.com
3418|NCT00453986|GSK Response Center|GlaxoSmithKline|866-435-7343|
3419|NCT00454051|Study Director|Novartis Pharmaceuticals|862-778-8300|
3420|NCT00454116|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3421|NCT00454181|Martin J. Cummins|Amarillo Biosciences, Inc.|806-376-1741 ext 14|mcummins@amarbio.com
3422|NCT00454207|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3612|NCT00711529|Shannon MacLaughlan, MD|Stanford Hospital|650-724-0456|smaclaug@stanford.edu
3613|NCT00711555|Sandra Cuellar|University of Illinois|312-996-6985|scuell1@uic.edu
3614|NCT00750360|GSK Response Center|GlaxoSmithKline|866-435-7343|
3615|NCT00750373|Dr. Duk-Hyun Kang|Asan Medical Center|82-2-3010-3149|dhkang@amc.seoul.kr
3616|NCT00750815|Melissa Alsina, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-6886|melissa.alsina@moffitt.org
3617|NCT00750880|Medical Communications|Hoffmann- LaRoche|800-821-8590|genentech@druginfo.com
3618|NCT00750893|GSK Response Center|GlaxoSmithKline|866-435-7343|
3619|NCT00433771|Jeremy Bolt|Boston Scientific Corporation|508-683-4006|boltj@bsci.com
3620|NCT00433836|Study Director|Novartis Pharmaceuticals|862-778-8300|
3621|NCT00434057|Joanna Adrian / Director, Clinical Operations and Medical Affairs|Electro-Optical Sciences, Inc.|(914)591-3783 ext 732|adrian@eosciences.com
3622|NCT00434109|Jonathan Strosberg, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-7257|jonathan.strosberg@moffitt.org
3623|NCT00434122|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
3624|NCT00434148|Study Director|Novartis Pharmaceuticals|862-778-8300|
3625|NCT00434213|Timothy Whitaker, M.D.|Shire Pharmaceutical Development Inc.||twhitaker@shire.com
3626|NCT00434226|Medical Communications Specialist|Genentech, Inc.|800-821-8590|
3627|NCT00434252|Medical Communications|Genentech, Inc.|800-821-8590|
3628|NCT00434278|Medical Communications|Genentech, Inc.|800-821-8590|
3629|NCT00434304|GSK Response Center|GlaxoSmithKline|866-435-7343|
3630|NCT00434330|Vice President, Clinical Development|Affymax|650-812-8700|info@affymax.com
3631|NCT00434356|Medical Communications Specialist|Genentech, Inc.|800-821-8590|
4190|NCT00445939|Global Medical Services|Abbott|800-633-9110|
4191|NCT00446030|Trial Transparency Team|sanofi-aventis||Contact-us@sanofi-aventis.com
4192|NCT00446134|Senior Director Clinical Development|Valeant Pharmaceuticals International, Inc.|908-927-1782|ralph.doyle@valeant.com
4193|NCT00446147|Dr. Yoon-Koo Kang|Asan Medical Center|+82-2-3010-3210|ykkang@amc.seoul.kr
4194|NCT00484159|Steven P. Cohen|Johns Hopkins|410-955-1822|scohen40@jhmi.edu
4195|NCT00484185|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4196|NCT00484289|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4197|NCT00484315|Andrey Nersesov, Clinical Project Manager|Boston Scientific|508-683-4988|andrey.nersesov@bsci.com
4198|NCT00484419|John Raia, Director, Professional Affairs|Daiichi Sankyo Inc.|973-630-2683|jraia@dsus.com
4199|NCT00484679|Maria Hordinsky, MD|University of Minnesota|612-624-5721|hordi001@umn.edu
4200|NCT00484939|Medical Communications|Hoffmann-La Roche|800 821-8590|
4201|NCT00485069|GSK Response Center|GlaxoSmithKline|866-435-7343|
4202|NCT00485173|Clinical Department|Medtronic Spinal|1800-876-3133 ext 6068|msbkclinicalresearch@medtronic.com
4319|NCT00487552|Scott Snyder, Ph.D., Manager, Biostatistics and Data Management, Senior Statistician|MED Institute, Inc.|765-463-7537|ssnyder@medinst.com
4320|NCT00487565|Tammy O'Dell|DePuy Orthopaedics, Inc.|574-372-7104|TOdell2@its.jnj.com
4321|NCT00487578|M.E. Beach|Clinvest|(417) 841-3618|mbeach@clinvest.com
4322|NCT00487669|James Rigas, MD|Dartmouth-Hitchcock Medical Center|603-650-6344|james.r.rigas@hitchcock.org
4323|NCT00487695|Dr. Marcia Canto.|Johns Hopkins University School of Medicine Division of Gastroenterology and Hepatology|410-614-5388|mcanto@jhmi.edu
4324|NCT00487721|Dr. Thomas Flaig|University of Colorado, Denver|(720) 848 0655|Thomas.Flaig@ucdenver.edu
4325|NCT00487825|Study Director|Novartis Pharmaceuticals|862-778-8300|
2832|NCT00376259|Study Director|Novartis Pharmaceuticals|862-778-8300|
2833|NCT00376506|Christy L. Ludlow, PhD|James Madison University|540-568-3876|ludlowcx@jmu.edu
2834|NCT00376532|David J. Whellan MD|Thomas Jefferson University|215 955 2636|david.whellan@jefferson.edu
2835|NCT00376688|Dr. Gini F. Fleming|The University of Chicago Comprehensive Cancer Center|773-702-6712|gfleming@medicine.bsd.uchicago.edu
2836|NCT00376805|Sarah Cooley, MD|Masonic Cancer Center, University of Minnesota|612-625-8474|cool0023@umn.edu
2837|NCT00376935|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.gov@sdac.harvard.edu
2838|NCT00376948|Almhanna  Khaldoun, M.D.|Barbara Ann Karmanos Cancer Institute|313-576-8746|almhanna@karmanos.org
2839|NCT00376961|Lymphoma Committee Statistician|SWOG Statistical Center|206-667-4623|
2840|NCT00377260|Efficacy of Antimicrobials in Young children with Acute Otitis Media|Children's Hospital of Pittsburgh of UPMC|412-692-5249|Hoberman@chp.edu
2841|NCT00377299|Dr. E. Sherwood Brown, M.D., Ph.D.|UT Southwestern Medical Center at Dallas|214-645-6950|sherwood.brown@utsouthwestern.edu
2842|NCT00392379|Jon O. Ebbert, MD|Mayo Clinic|507-266-1944|nicotineresearch@mayo.edu
2843|NCT00392392|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|ASKSARAH@scresearch.net
2844|NCT00392444|Dr. Scott Laurie|The Ottawa Hospital Cancer Centre|613-737-7700 ext 70175|slaurie@toh.on.ca
2845|NCT00392496|Dr. Rena Buckstein|Sunnybrook Health Sciences Centre|416-480-5847|rena.buckstein@sunnybrook.ca
2846|NCT00392678|Allison B. Goldfine, MD co-investigator|Joslin Diabetes Center|617-309-2643|allison.goldfine@joslin.harvard.edu
2847|NCT00392704|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
2848|NCT00392769|Judith Wolff, MD / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
2849|NCT00392782|Daniel Weisdorf, M.D.|Masonic Cancer Center, University of Minnesota|612-624-0123|weisd001@umn.edu
2968|NCT00410163|GSK Response Center|GlaxoSmithKline|866-435-7343|
3423|NCT00454246|Medical Communications|Hoffman-LaRoche|800-821-8590|
3424|NCT00454532|Mary Tagliaferri, MD|Bionovo|5106012000|clinicaltrials@bionovo.com
3425|NCT00470067|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
3426|NCT00470158|Stephanie Chang|AHRQ|301 427-1490|stephanie.chang@ahrq.hhs.gov
3427|NCT00470184|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
3428|NCT00470275|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
3429|NCT00470392|Kevin D. Cooper MD|Louis Stokes VA Medical Center and University Hospitals Case Medical Center|216 844 3111|kevin.cooper@uhhospitals.org
3430|NCT00470600|Amy Rock, Ph.D.|Cumberland Pharmaceuticals|615-255-0068|arock@cumberlandpharma.com
3431|NCT00470626|Scott Snyder|Cook|765-463-7537|ssnyder@medinst.com
3432|NCT00470834|GSK Response Center|GlaxoSmithKline|866-435-7343|
3433|NCT00470847|Nancy Lin, MD|Dana-Farber Cancer Institute|617-632-2335|nlin@partners.org
3434|NCT00471068|Alcon Clinical|Alcon Labs|888.451.3937; 817.568.6725|medinfo@alconlabs.com
3435|NCT00471107|Eric Wassermann|NIH/NINDS|301-496-0151|wassermanne@ninds.nih.gov
3436|NCT00471146|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3437|NCT00471276|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3438|NCT00471315|Peter Cotton, MD|Medical University of South Carolina|(843) 792-6999|CottonP@MUSC.edu
3439|NCT00471328|Study Director|Novartis Pharmaceuticals|862-778-8300|
3440|NCT00471354|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
3441|NCT00471380|Alcon Clinical|Alcon Research, LTD|888.451.3937; 817.568.6725|medinfo@alconlabs.com
3442|NCT00471497|Study Director|Novartis Pharmaceuticals|862-778-8300|
3849|NCT00439231|Georg Aue|NHLBI/NIH|301.451.7141|AueG@nhlbi.nih.gov
3850|NCT00439244|Study Director|Novartis Pharmaceuticals|862-778-8300|
3851|NCT00439270|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
3852|NCT00439309|Jen Doyle|Covidien|781.839.1770|Jennifer.doyle@covidien.com
3853|NCT00439335|Shital Patel, MD|Baylor College of Medicine|713-798-3793|shitalp@bcm.tmc.edu
3854|NCT00439517|Merck KGaA Communication Center|Merck KGaA|+49-6151-75-5200|service@merckgroup.com
3855|NCT00439569|René Gonin, PhD (Math. Stats.)|Westat|301-251-1500|renegonin@westat.com
3856|NCT00439608|Howard Safran, MD|BrUOG|401-863-3000|Hsafran@lifespan.org
3857|NCT00439647|Novartis Study Director|Novartis Pharmaceuticals|862-778-8300|
3858|NCT00439725|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
3859|NCT00439738|Study Director|Novartis Pharmaceuticals|1-862-778-8300|
3860|NCT00439777|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
3861|NCT00439946|Remodulin Program Leader|United Therapeutics|(919) 485-8350|ClinicalRecordsManagement@unither.com
4045|NCT00796653|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
4046|NCT00796666|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4047|NCT00796705|Associate Director, Clinical Research Operations Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
4048|NCT00796744|Dr. Shelagh Verco|US Biotest|805-595-1300|shelagh.verco@usbiotest.com
4049|NCT00796822|Dr. Samir K. Gupta|Indiana University School of Medicine|317-274-7926|sgupta1@iu.edu
4050|NCT00796926|Dr Louis Tong|Singapore National Eye Center|65 62277255|Louis.tong.h.t@snec.com.sg
4051|NCT00796991|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4326|NCT00487942|Medical Monitor|Cephalon, Inc.|1-800-896-5855|
4327|NCT00487981|Lyn M. Pimentel, M.B.A.|Boston Scientific|(661) 949-4174|Lyn.Pimentel@bsci.com
4328|NCT00488059|Medical Communications|Hoffmann-La Roche|800-821-8590|
4329|NCT00488319|Director Clinical Research|Johnson & Johnson Research & Development, LLC|1-609-730-6771|
4330|NCT00488345|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4331|NCT00488475|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4332|NCT00488488|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4333|NCT00488514|GSK Response Center|GlaxoSmithKline|866-435-7343|
4334|NCT00745095|Dr. Mark A. Korsten, Chief of Gastroenterology|JJPVAMC National Center of Excellence for the Medical Consequeunces of Spinal Cord Injury|718-584-9000 ext 6753|mark.korsten@va.gov
4335|NCT00745251|Wesley W. Day, PhD|Vivus, Inc|650-934-5200|day@vivus.com
4336|NCT00745290|Executive Medical Director|Pacira Pharmaceuticals Inc.|203-837-6500|ErolOnel@pacira.com
4337|NCT00745368|Robert DiCenzo|University of Rochester|518 694 7228|rob.dicenzo@acphs.edu
4338|NCT00745823|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1- 800-672-6372|ClinicalTrialsDisclosure@merck.com
4339|NCT00745875|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
4340|NCT00745901|Chief Scientific Officer|North America Pharmaceutical (Ortho-McNeil Janssen Scientific Affairs, LLC)|1-888-526-5060 ext 2915|
4341|NCT00745940|Dr. Michel Bédard|Lakehead University|807-343-8630|mbedard@lakeheadu.ca
4458|NCT00791557|Dr. Amanda Suggs, MD|University Hospitals of Cleveland|216-844-7546|Amanda.suggs@uhhospitals.org
4459|NCT00791661|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4460|NCT00791765|Study Director|Amgen Inc.|866-572-6436|
4461|NCT00791778|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
2969|NCT00410202|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2970|NCT00410384|GSK Response Center|GlaxoSmithKline|866-435-7343|
2971|NCT00410410|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2972|NCT00410488|Saroj Vadhan-Raj, MD / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
2973|NCT00410514|Associate Medical Director, Medical Sciences|Astellas Pharma Global Development, Inc. (APGD)||ClinicalTrials.Disclosure@us.astellas.com
2974|NCT00410761|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
2975|NCT00410826|Renato G. Martins, MD, MPH|University of Washington|2062882048|rgmart@uw.edu
2976|NCT00387010|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
2977|NCT00387023|Bita Esmaeli, MD / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
2978|NCT00387036|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|clinicaltrialsdisclosure@merck.com
2979|NCT00387088|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
2980|NCT00387153|Richard Wenstrup, MD, VP Chief Medical Officer|Myriad Therapeutics, Inc.|801-584-3009|rwenstru@myriad.com
2981|NCT00387335|Ezra Cohen|University of Chicago|773-702-4137|ecohen@medicine.bsd.uchicago.edu
2982|NCT00387348|William F Pirl, MD|Massachusetts General Hospital|617-724-9151|wpirl@partners.org
2983|NCT00387426|Srdan Verstovsek, MD / Associate Professor|UT MD Anderson Cancer Center||eharriso@mdanderson.org
2984|NCT00387621|Dr Horng Chen|Mayo Clinic|507-284-4343|chen.horng@mayo.edu
2985|NCT00387647|Jeffrey Lancet, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-6841|jeffrey.lancet@moffitt.org
2986|NCT00387751|Dr. John Sarantopoulos|University of Texas Health Science Center at San Antonio|210-450-1000|sarantopoulo@uthscsa.edu
2987|NCT00387764|GSK Response Center|GlaxoSmithKline|866-435-7343|
3443|NCT00471536|Ulka Vaishampayan, M.D.|Karmanos Cancer Institute at Wayne State University||vaishamu@karmanos.org
3444|NCT00471705|Iván Darío Vélez Bernal|Universidad de Antioquia - Colombia|574 + 219 6501 - 02|idvelez@pecet-colombia.org
3445|NCT00471718|Jeff Sosman, MD|Vanderbilt-Ingram Cancer Center|615-936-3048|jeff.sosman@vanderbilt.edu
3446|NCT00471822|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3447|NCT00472030|Janet Fairley, M.D.|University of Iowa|319-384-8560|janet-fairley@uiowa.edu
3448|NCT00472056|Chitra M. Hosing, MD / Associate Professor|UT MD Anderson Cancer Center||mvpacheco@mdanderson.org
3449|NCT00472082|Kenneth A. Newell, MD, PhD|Emory University|404-727-2489|kanewel@emory.edu
3450|NCT00472199|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
3451|NCT00472290|Study Director|Amgen Inc.|866-572-6436|
3452|NCT00472303|Director of Clinical Trials|Grünenthal GmbH|+49 241 569 3223|Clinical-Trials@grunenthal.com
3453|NCT00830388|Wendy Cantrell|University of Alabama at Birmingham|205-502-9960|wcantrell@uabmc.edu
3454|NCT00830765|Dr John Morrison|UMississippi|601-984-5300|jmorrison@umc.edu
3455|NCT00830791|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|(800) 672-6372|ClinicalTrialsDisclosure@merck.com
3456|NCT00830804|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
3457|NCT00830947|Zaffer Syed, Director of Clinical & Regulatory Affairs|OrthoAccel Technologies, Inc.|(832) 803-0339|zsyed@orthoaccel.com
3458|NCT00830960|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
3459|NCT00831129|Dr. George Bakris|University of Chicago|773-702-7936|bbrisky@medicine.bsd.uchicago.edu
3460|NCT00831233|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
3461|NCT00831311|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
3462|NCT00831389|Harry Clark|Medtronic Diabetes|818-576-5653|bud.clark@medtronic.com
3835|NCT00711880|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd|0044 1223 266800|rp@gwpharm.com
3836|NCT00711997|Monique Ben-Am, M.Sc.|BioCancell Ltd.|+972-2-5486533|monique.ben-am@biocancell.com
3837|NCT00712010|Dr Maurice Beaumont|Clinical Development Unit / Metabolic Unit|+41217858054|maurice.beaumont@rdls.nestle.com
4022|NCT00833703|Trial Transparency Team|sanofi-aventis||Contact_US@sanofi-aventis.com
4023|NCT00833794|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
4024|NCT00833833|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
4025|NCT00833859|Gregory Springett, M.D., Ph.D., via Moffitt Cancer Center|H. Lee Moffitt Cancer Center and Research Institute|813-745-6898|gregory.springett@moffitt.org
4026|NCT00833911|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
4027|NCT00833937|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4028|NCT00834041|Study Director|Novartis Pharmaceuticals|862 778-8300|
4029|NCT00834067|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4030|NCT00834080|Bernard L. Silverman, MD|Alkermes, Inc.|781-609-6000|Bernard.Silverman@alkermes.com
4031|NCT00753506|Dr. Faith Dickerson|Sheppard Pratt|410-938-4359|fdickerson@sheppardpratt.org
4032|NCT00753519|David H. Benninger, MD|Department of Neurology, Centre Hospitalier Universitaire Vaudois||David.Benninger@chuv.ch
4033|NCT00753545|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
4034|NCT00753623|Dr. Jianren Mao|MGH Center for Translational Pain Research|617-724-6102|mghpainresearch@partners.org
4035|NCT00796003|Director|Janssen Pharm KK Japan|+81-3-4411-5801|
4036|NCT00796120|Medical Specialist, Clinical Oncology|PharmaMar SA Av de los Reyes 1, Poligono Industrial La Mina 28770 Colmenar Viejo, Madrid, Spain|+34 91 646-6087|
4037|NCT00796224|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4038|NCT00796315|Guhan Balan|Procter & Gamble|513.622.2657|balan.g@pg.com
4462|NCT00791817|Peter Thomas|Procter & Gamble|513.622.4838|thomas.pr@pg.com
4463|NCT00791908|Murad Alam, MD|Northwestern University|312-695-6785|m-alam@northwestern.edu
4464|NCT00791921|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|Professor, Department of Allergy and Rheumatology, Division of Internal Medicine, Graduate School of Medicine, University of Tokyo|+81 3 5800 8825|yamamoto-tky@umin.ac.jp
4465|NCT00791934|Clinical Director|Acclarent, Inc.|650-687-5888|lenglan1@its.jnj.com
4466|NCT00791973|Dr. Robert Naclerio|University of Chicago|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu
4467|NCT00791999|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|Medical Advisor of the Clinical Trial|+81 3 5800 8825|yamamoto-tky@umin.ac.jp
4468|NCT00792103|Mark Pierce, MD PhD|NuPathe Inc.|484-567-0130|mpierce@nupathe.com
4469|NCT00792116|Craig Johnston|Baylor|713-798-2068|caj@bcm.edu
4470|NCT00792610|Jan, Chyi-Feng|National Taiwan University Hospital|886-2-23562147|jcf036@ntu.edu.tw
4471|NCT00792636|GSK Response Center|GlaxoSmithKline|866-435-7343|
4472|NCT00792688|Dr. Reinhard Koenig, CEO|Glycotex, Inc.|301-670-2825|Reinhard.Koenig@glycotexinc.com
4473|NCT00715078|Lynn Ngo|Dendreon|206-274-6763|lngo@dendreon.com
4474|NCT00753636|Dr. Tanya Simuni, MD|Northwestern University|312-503-2970|tsimuni@nmff.org
4475|NCT00753675|Ian Thomas|AstraZeneca|+44 1625 515571|ClinicalTrialTransparency.@astrazeneca.com
4476|NCT00753688|GSK Response Center|GlaxoSmithKline|866-435-7343|
4477|NCT00753714|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
4478|NCT00753766|Paul R. Conlin, M.D.|VA Boston Healthcare System|8572035111|paul.conlin@va.gov
4479|NCT00753896|Chief Medical Officer|Eli Lilly and Company|1-877-285-4559|clinicaltrials@amylin.com
4480|NCT00753922|Michael L. Schwiers|Ethicon Endo-Surgery|513-337-1172|mschwier@its.jnj.com
4593|NCT00840866|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
2988|NCT00387790|Results Reporting Coordinator|Children's Oncology Group|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org
2989|NCT00387829|Director of Medical Affairs|Intergra LifeSciences|609-275-0500|clinicalaffairs-neuro@integralife.com
2990|NCT00387881|GSK Response Center|GlaxoSmithKline|866-435-7343|
3106|NCT00417170|Study Director|Novartis Pharmaceuticals|862-778-8300|
3107|NCT00417274|Michael Kurman, MD|Clevland BioLabs|716-849-6810|mkurman@cbiolabs.com
3108|NCT00417417|Richard O. Cannon III, MD|NHLBI/NIH|301-496-9895|cannonr@nih.gov
3109|NCT00417482|Davangere P. Devanand, MD|New York State Psychiatric Institute|212-543-5612|dpd3@columbia.edu
3110|NCT00417885|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3111|NCT00417963|Director of Clinical Affairs|C.R. Bard Inc.|480-303-2644 ext 2644|john.reviere@crbard.com
3112|NCT00417989|Scott Lee, M.D.|Medtronic|8185764204|scott.w.lee@medtronic.com
3113|NCT00418015|Dr. Robert J. McCarthy|Northwestern University Feinberg School of Medicine|3129269015|r-mccarthy@northwestern.edu
3114|NCT00418093|Neil Horowitz, MD|Dana-Farber Cancer Institute|617-732-8843|nhorowitz@partners.org
3115|NCT00418184|Yael Richter Ph.D|Enzymotec Ltd|+972 74 7177 177 ext 144|Yaelr@enzymotec.com
3116|NCT00418522|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3117|NCT00418574|Clinical Research Director|Menarini Ricerche SpA||abagovomab@menarini-ricerche.it
3118|NCT00418665|Study Director|Amgen Inc.|866-572-6436|
3119|NCT00418691|Dr. Jeffrey Wefel, Assistant Professor|UT MD Anderson Cancer Center|713-563-0514|CR_Study_Registration@mdanderson.org
3120|NCT00418717|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
3121|NCT00418834|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
3122|NCT00418886|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3463|NCT00831415|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3464|NCT00831428|Dr Karine Clearie|University of Dundee|01382 496440|k.clearie@dundee.ac.uk
3465|NCT00831493|Sunil Krishnan, MD / Associate Professor|UT MD Anderson Cancer Center||mclemons@mdanderson.org
3466|NCT00831675|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
3467|NCT00831701|Räto T. Strebel|Department of Urology, University Hospital Zürich, Switzerland|0041-44-2551111|raeto.strebel@ksgr.ch
3468|NCT00831753|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
3469|NCT00831987|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
3470|NCT00832000|Richard J. Barohn, MD|University of Kansas Medical Center|913-588-6095|rbarohn@kumc.edu
3471|NCT00832078|Scientific Manager|Coloplast|+4549113557|dkkg@coloplast.com
3472|NCT00832091|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|RegeneRx Biopharmaceuticals, Inc.|301-208-9191 ext 108|nturjman@regenerx.com
3473|NCT00832117|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
3474|NCT00832130|Christy Stevens, OD|TearScience, Inc. (formerly Kolis Scientific)|919-459-4815|cstevens@tearscience.com
3475|NCT00832260|Dr. José Olagüe|Hospital Universitari i politecnic La Fe|+34 961 24 40 00|jolague@terra.com
3476|NCT00832299|Peter Kozuch, MD|Beth Israel Medical Center||pkozuch@chpnet.org
3477|NCT00832377|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
3478|NCT00832390|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
3479|NCT00832416|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
3480|NCT00835679|Emily Chan, MD|Vanderbilt-Ingram Cancer Center|615-343-4677|emily.chan@vanderbilt.edu
3481|NCT00835692|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3482|NCT00835705|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4039|NCT00796328|Dr. Ron George|IWK Health Centre|470-6627|rbgeorge@dal.ca
4040|NCT00796367|Wesley W Day, PhD|Vivus, Inc|650.934.5200|day@vivus.com
4041|NCT00796510|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4042|NCT00796523|Jonna M. McRury, M.D.|University of Toledo|419-389-1118|jmcrury@aol.com
4043|NCT00796549|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
4044|NCT00796614|Director Clinical Trial Disclosure|Astellas Pharma Global Development||clinicaltrials_info@jp.astellas.com
3632|NCT00434434|Medical Communications|Genentech, Inc.|800-821-8590|
3633|NCT00434590|Study Director|Novartis Pharmaceuticals|862-778-8300|
3634|NCT00434642|Medical Communications|Hoffman-LaRoche|800-821-8590|
3635|NCT00434759|Prof. Martin Bohus|Central Institute of Mental Health, Mannheim, Germany|+49 621 1703 4002|martin.bohus@zi-mannheim.de
3636|NCT00434876|Subhajit Chakravorty|Philadelphia VAMC|215-823-5800 ext 3405|Subhajit.Chakravorty@va.gov
3637|NCT00434954|Chief Medical Officer|Eli Lilly and Company||clinicaltrials@amylin.com
3638|NCT00434967|Gerard Lynch|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
3639|NCT00434993|David Schoenfeld, ARDSNet CCC PI|Acute Respiratory Distress Syndrome (ARDS) Network|617-726-6111|dschoenfeld@partners.org
3640|NCT00435019|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
3641|NCT00435045|GSK Response Center|GlaxoSmithKline|866-435-7343|
3642|NCT00435162|Study Director|Novartis Pharmaceuticals|862-778-8300|
3643|NCT00435370|Dr. Thomas R. Kosten|Baylor College of Medicine|(713) 794-7032|kosten@bcm.edu
3644|NCT00435409|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3645|NCT00435487|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4594|NCT00840879|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4595|NCT00841204|H-H. Sherry Chow, Ph.D.|The University of Arizona|520-626-3358|schow@azcc.arizona.edu
4596|NCT00841321|Dennis Bourdette, MD|Portland VA Medical Center Multiple Sclerosis Center of Excellence|503-220-8262 ext 54594|dennis.bourdette@va.gov
4597|NCT00841542|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4598|NCT00841659|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4599|NCT00841672|Study Director|Novartis Pharmaceuticals|862-778-8300|
4600|NCT00841698|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4601|NCT00841763|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
4602|NCT00841776|GSK Response Center|GlaxoSmithKline|866-435-7343|
4603|NCT00841815|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4604|NCT00842023|Dr. Sheryl L. Chow|Western University of Health Sciences|9094695379|schow@westernu.edu
4605|NCT00715117|Jill P Smith, MD Professor Emeritus of medicine|Pennsylvania State University|717-531-3694|jsmith2@psu.edu
4606|NCT00715208|Carol Ann Satler, MD, PhD|Millennium Pharmaceuticals|617- 551-3729|carol.satler@mpi.com
4607|NCT00715390|Ronald Litman, DO|The Children's Hospital of Philadelphia|215-590-5091|litmanr@email.chop.edu
4608|NCT00457301|Maria Jose Santana|Lung transplant program, University of Alberta Hospital|780-441-1661|msantana@ualberta.ca
4609|NCT00457392|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4610|NCT00457418|Senior Vice President,Global CLinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
4611|NCT00457691|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4612|NCT00457743|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3123|NCT00418938|Study Director|Amgen Inc.|866-572-6436|
3124|NCT00418951|Jorge Cortes, MD / Professor|The University of Texas MD Anderson Cancer Center|713-745-5783|eharrison@mdanderson.org
3125|NCT00418964|Pauline Lui|The Chinese University of Hong Kong|852 2632 3072|pauline@ort.cuhk.edu.hk
3126|NCT00418977|Katharine Loeb, PhD|Icahn School of Medicine at Mount Sinai|212-659-8724|katharine.loeb@mssm.edu
3127|NCT00419094|Study Director|UCB, Inc.|+1 877 822 9493|
3128|NCT00419120|Sunita Sheth, MD - Chief Medical Officer|Tengion, Inc.|267-960-4805|sunita.sheth@tengion.com
3246|NCT00406354|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
3247|NCT00406367|Angelika Hanschmann|Merz Pharmaceuticals GmbH|++49-69-1503 ext 538|angelika.hanschmann@merz.de
3248|NCT00406640|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
3249|NCT00406653|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
3250|NCT00406692|Clifford Knapp, PhD|Boston University|617-414-1990|cknapp@bu.edu
3251|NCT00406783|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
3252|NCT00406848|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
3253|NCT00407030|Angelika Hanschmann|Merz Pharmaceuticals GmbH|++49-69-1503 ext 538|angelika.hanschmann@merz.de
3254|NCT00407355|Peter Campocahiro|Wilmer Eye Institute|: 410-955-5106|pcampo@jhmi.edu
3255|NCT00407511|Pfizer Clinical Trials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3256|NCT00407537|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3257|NCT00407550|Julian R. Molina, M.D., Ph.D.|Mayo Clinic|507-284-8318|molina.julian@mayo.edu
3258|NCT00410891|Professor|Stanford|6504984791|cta@stanford.edu
3259|NCT00410904|Shirish M. Gadgeel, M.D.|Barbara Ann Karmanos Cancer Institute|313-576-8753|gadgeels@karmanos.org
3483|NCT00835731|Principal Investigator|Planned Parenthood League of Massachusetts|6176161600|
3484|NCT00835796|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3485|NCT00835861|M. Ashley Hickman Zink|Maternal-Fetal Medicine and Obstetrics at UT Southwestern|469-303-3591|m.ashley.hickman@gmail.com
3486|NCT00835926|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
3487|NCT00835978|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3488|NCT00835991|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3489|NCT00836004|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3490|NCT00836017|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
3491|NCT00836056|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3492|NCT00836095|Sonia Vaida MD, Professor of Anesthesiology|Penn State Milton S. Hershey Medical Center|7175318433|svaida@hmc.psu.edu
3493|NCT00836342|Kristen Corey|Clinical Unit for Research Trials in Skin, Massachusetts General Hospital|617-726-1302|kcorey1@partners.org
3494|NCT00708682|Pfizer Clinical Trials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com
3495|NCT00708877|Dr. Jason Schwarz|University of Utah|8015852708|jason.schwartz@hsc.utah.edu
3496|NCT00708942|Bjørn Klem, Project Director|Photocure|+47 22 06 22 10|bk@photocure.no
3497|NCT00709059|Vice President,Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
3498|NCT00709098|Laila Rouault, MD/International Clinical Leader|Actelion Pharmaceuticals Ltd|+ 41 61 565 8128|
3499|NCT00709111|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
3500|NCT00709228|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
3501|NCT00709319|Adam R. Glassman, Director DRCR.net Coordinating Center|Jaeb Center for Health Research|813-975-8690|drcrstat3@jaeb.org
2267|NCT00335777|Stephen D. Silberstein, MD|Jefferson Headache Center|215-955-2243|stephen.silberstein@jefferson.edu
2268|NCT00335959|Study Statistician|SWOG Statistical Center|206-667-4623|
2269|NCT00336284|Justin Michalski, M.S. / Clinical Studies Engineer|Biotronik, Inc.|503-675-2155|justin.michalski@biotronik.com
2270|NCT00336323|Name/Official Title: Adam Glassman, M.S., Director|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|(813) 975-8690|drcrnet@jaeb.org
2271|NCT00336479|Jeff Chodakewitz, M.D.|Vertex Pharmaceuticals Incorporated|617-341-6777|Jeff_Chodakewitz@vrtx.com
2272|NCT00336492|Senior Director, Clinical Research|Johnson & Johnson Pharmaceutical Research and Development|610-240-8092|
2273|NCT00336505|David Eiznhamer, PhD, Executive Vice President, Clinical Development|Advanced Life Sciences|630-739-6744|deiznhamer@advancedlifesciences.com
2274|NCT00336544|David Eiznhamer, PhD, Executive Vice President, Clinical Development|Advanced Life Sciences|630-739-6744|deiznhamer@advancedlifesciences.com
2275|NCT00336583|Cheolwon Suh|Asan Medical Center|82 2 3010 3209|csuh@amc.seoul.kr
2183|NCT00313781|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2184|NCT00313820|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2185|NCT00313846|Clinical Leader, Medical Director|Purdue Pharma L.P.|800-733-1333|
2186|NCT00313911|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
2187|NCT00314106|Steven A. Rosenberg, M.D.|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
2188|NCT00314132|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
2189|NCT00314145|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
2190|NCT00314249|Robert Palmer, MD|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|1-201-427-8218|robert.palmer@frx.com
2191|NCT00314340|Barth Wilsey MD|UC Davis Medical Center|916-843-7165|blwilsey@ucdavis.edu
2192|NCT00314353|Diana Gosik|NSABP Foundation, Inc.|412-330-4692|diana.gosik@nsabp.org
4613|NCT00457795|Vice President, Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
4614|NCT00457821|Medical Monitor|Vertex|617-444-6777|medicalinfo@vrtx.com
4203|NCT00485303|Senior Director, Clinical Research|Janssen Research & Development, 10990 Wilshire Blvd, Suite 1200, Los Angeles, California 90024|(310) 943-8040 ext 2917|
4204|NCT00485433|Executive Medical Director|Pacira Pharmaceuticals, Inc.|203-837-6500|ErolOnel@pacira.com
4205|NCT00485472|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
4206|NCT00485485|Anne Tsao, M.D. / Associate Professor|UT MD Anderson Cancer Center|713-792-6363|mejprice@mdanderson.org
4207|NCT00485693|Executive Medical Director|Pacira Pharmaceuticals, Inc.|203-837-6500|ErolOnel@pacira.com
4208|NCT00485732|GSK Response Center|GlaxoSmithKline|866-435-7343|
4209|NCT00485758|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
4210|NCT00485836|Medical Communications|Genentech, Inc.|800-821-8590|
4211|NCT00485953|Dr. Susan Greenspan|University of Pittsburgh|412-692-2476|greenspn@pitt.edu
4212|NCT00486018|Medical Communications|Genentech, Inc.|800-821-8590|
4213|NCT00486226|Arnaud Nicolas|Codman&Shurtleff|+33  0 155 004 543|anicolas@its.jnj.com
4214|NCT00486252|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4215|NCT00486265|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
4216|NCT00486291|Wesley W. Day, PhD|Vivus, Inc|650-934-5200|day@vivus.com
4217|NCT00486330|R. Douglas Bruce|Yale University AIDS Program|2037374040|robert.bruce@yale.edu
4218|NCT00486434|Bente Juel Riis, Medical Director|Nordic Bioscience A/S|+4522901317|bjr@nordicbioscience.com
4219|NCT00486525|Janice Kiecolt-Glaser, Principal Investigator|Ohio State University Comprehensive Cancer Center|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu
4220|NCT00486720|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
3260|NCT00411151|M. Kabisch|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|++49 (0)6131-179922|kabisch@izks-mainz.de
3261|NCT00411216|Susan J Herdman, PT, PhD|Emory|4047120612|sherdma@emory.edu
3262|NCT00793169|Murad Alam, MD|Northwestern University|312-695-6785|m-alam@northwestern.edu
3263|NCT00793325|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3264|NCT00793403|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3265|NCT00793455|Kenzie A. Cameron, PhD, MPH|Northwestern University|312-503-3910|k-cameron@northwestern.edu
3266|NCT00793520|Allan Spera|Forest Research Institute|201-427-8399|allan.spera@frx.com
3267|NCT00793546|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3268|NCT00793585|Xueqing Yu ,  M.D. & Ph.D.|1st Affiliated Hospital, Sun Yat-Sen University|8620-87766335|yuxq@mail.sysu.edu.cn
2850|NCT00392808|Javier Diez-Domingo|Centro Superior de Investigacion en Salud Publica|+34961925937|diez_jav@gva.es
2851|NCT00392821|John D Hainsworth, MD|Sarah Cannon Research Institute|877-691-7274|ASKSARAH@scresearch.net
2852|NCT00392834|Jeannette Lee, Ph.D.|University of Arkansas for Medical  Sciences|501-526-6712|jylee@uams.edu
2853|NCT00392860|Michael L Boninger|Human Engineering Research Laboratories|412-822-3700|boninger@upmc.edu
2854|NCT00392925|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2855|NCT00393029|Steven Rosenberg, M.D., Ph.D.|National Cancer Institute (NCI), National Institutes of Health (NIH)|301-496-4164|Steven.Rosenberg@nih.gov
2856|NCT00393068|Johanna C. Bendell, MD|Sarah Cannon Research Institute|615-329-7274|jbendell@tnonc.com
2857|NCT00393094|Howard A. Fine, M.D.|National Cancer Institute, National Institutes of Health|301-402-6383|hfine@mail.nih.gov
2858|NCT00393367|Cynthia J. Mollen|The Children's Hospital of Philadelphia|215-590-4410|mollenc@email.chop.edu
2859|NCT00393380|Adam Mendizabal, Statistician|The EMMES Corporation|301-251-1161 ext 221|amendizabal@emmes.com
3502|NCT00709618|GSK Response Center|GlaxoSmithKline|866-435-7343|
3503|NCT00709761|GSK Response Center|GlaxoSmithKline|866-435-7343|
3504|NCT00709826|Tracy Parrott|Tragara Pharmaceuticals|760-208-6919|tparrott@tragarapharma.com
3505|NCT00709852|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
3506|NCT00709878|Mario Lacouture, MD|Northwestern University|212-610-0079|LacoutuM@mskcc.org
3507|NCT00454584|Senior Director, Compound Development Team Leader|Centocor Research & Development, Inc.|1 215-793-7612|
3508|NCT00454649|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3509|NCT00454779|Study Director|Amgen Inc.|866-572-6436|
3510|NCT00431067|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
3511|NCT00431132|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
3512|NCT00431184|Beth Murphy MD|McLean Hospital|617-855-2297|BMurphy5@partners.org
3513|NCT00431444|Study Director|Novartis Pharmaceuticals|862-778-8300|
3514|NCT00431496|Study Director|Amgen Inc.|866-572-6436|
3515|NCT00431834|Kristin Lawman|Medtronic, Inc.|763-514-9809|kristin.j.lawman@medtronic.com
3516|NCT00431951|Annie Frimm, Vice President, Regulatory Affairs|SIGA Technologies, Inc.|951-303-8797|afrimm@siga.com
3517|NCT00432159|Lynn Wilson|Depuy Synthes|508-880-8109|lwilso45@its.jnj.com
3518|NCT00432237|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialDisclosure@spcorp.com
3519|NCT00432276|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
3520|NCT00432341|Vice President Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
3521|NCT00432458|Dr. Thomas Witzig|Mayo Clinic||witzig@mayo.edu
5579|NCT00814463|Denise Lally-Goss, NP|Duke University Medical Center|919-684-3862|denise.lallygoss@dm.duke.edu
5580|NCT00814489|GSK Response Center|GlaxoSmithKline|866-435-7343|
5098|NCT00607880|Albert G. Hakaim, M.D.|Mayo Clinic||Hakaim.Albert@mayo.edu
5099|NCT00607919|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
5100|NCT00608023|Jean-Claude Mamputu, PhD, Senior Medical Advisor|Theratechnologies|514-336-7800|jmamputu@theratech.com
5101|NCT00608140|Kathy Moore|Duke University|919-668-8065|kathy.moore@duke.edu
5102|NCT00608205|Dr. David Adelstein|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|216-444-9310|adelstd@ccf.org
5103|NCT00803517|Jiwon Lim|Samsung Medical Center|82-10-9933-5596|samnyasa@naver.com
5104|NCT00803595|Howard Kessler|Daiichi Sankyo Pharma Development|732-590-5032|hmkessler@dsi.com
5105|NCT00803634|Jason Campagna|The Medicines Company|973-290-6199|jason.campagna@themedco.com
5106|NCT00803686|Nicholas LaBella, Jr. Vice-President Global RA/QA|Tarsa Therapeutics, Inc|267-273-7944|nlabella@tarsatherapeutics.com
5107|NCT00803712|Study Director|Amgen Inc.|866-572-6436|
5108|NCT00803738|Jonathan Schwartz|Perrigo Pharmaceuticals|718-960-0119|jonathan.schwartz@perrigo.com
5109|NCT00803777|Carmine Greene, Clinical Research Scientist|Bayer Healthcare, Diabetes Care|574-257-3040|carmine.greene.b@bayer.com
5110|NCT00803790|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
5111|NCT00803959|Heather Litman, PhD|New England Research Institutes|617 972 3297|hlitman@neriscience.com
5112|NCT00804193|Jonathan Schwartz|Perrigo|718-960-0119|jonathan.schwartz@perrigo.com
5113|NCT00804596|Clinical Research Scientist|Bayer Healthcare, Diabetes Care|574-257-3040|carmine.greene.b@bayer.com
5114|NCT00804648|Arthur Shedden MD|Vistakon|904-443-1557|
5115|NCT00804687|Senior Medical Director|Janssen Research and Development|858-784-3111|
4221|NCT00486759|Medical Communications|Hoffmann-La Roche|800 821-8590|
4222|NCT00705666|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
4223|NCT00705718|Karla Betz, Principal Clinical Research Specialist|Medtronic|763-526-2737|karla.h.betz@medtronic.com
4224|NCT00705783|Global Medical Affairs|Otsuka Pharmaceutical Development and Commercialization|800 562-3974|
4225|NCT00705874|Director of Clinical Trials|Progen Pharmaceuticals Pty Ltd|+61 7 32739133|darrynb@progen-pharma.com
4342|NCT00746096|Department director of clinical development department 1|Nobelpharma|+81-3-5651-1177|murakami@nobelpharma.co.jp
4343|NCT00746187|Senior Manager Global Clinical Research|DENTSPLY Implants|+46313763500|clinicalresearchmolndal@dentsply.com
4344|NCT00746330|Study Director|Novartis Pharmaceuticals|862-778-8300|
4345|NCT00746356|Ashish Oza, Clinical Studies Director|St. Jude Medical|818 362 6822 ext 3648|aoza@sjm.com
4346|NCT00746421|Jeffrey Rakofsky, MD|Emory University|404-712-5083|jrakofs@emory.edu
4347|NCT00746512|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
4348|NCT00746694|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@spcorp.com
4349|NCT00746733|Gerald Tremblay, M.D.|Shire Pharmaceuticals||gtremblay@shire.com
4350|NCT00746785|Kent Hutchison, Ph.D.|The Mind Reseach Network|505-272-5028|khutchison@mrn.org
4351|NCT00746798|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
4352|NCT00746863|Gena Dunivan, MD|UNC Hospitals|919-966-4717|gdunivan@med.unc.edu
4353|NCT00746889|Jeannie Chao|UCSD|858-657-7040|j5chao@ucsd.edu
4354|NCT00746941|Biogen Idec Study Medical Director|Biogen Idec||clinicaltrials@biogenidec.com
4355|NCT00747149|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
4356|NCT00747214|Margaret Lee, PhD|Zalicus|617-301-7142|mlee@zalicus.com
2860|NCT00393458|Study Director|Novartis Pharmaceuticals|862 778-8300|
2861|NCT00393484|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2862|NCT00393510|Prof. Leung Ping Chung|Institute of Chinese Medicine, Chinese University of Hong Kong|(852)2252 8863|pingcleung@cuhk.edu.hk
2863|NCT00393523|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
2864|NCT00393705|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2865|NCT00393718|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
2866|NCT00393848|Arny Ferrando|UAMS|501-526-5711|aferrando@uams.edu
2867|NCT00393939|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2868|NCT00394082|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
2869|NCT00394095|Melissa DelBello, MD|University of Cincinnati|513-558-4489|melissa.delbello@uc.edu
2870|NCT00394212|Dawn Heimer, Clinical Research|Davol Inc., Subsidiary of C.R. Bard|401-825-8681|Dawn.Heimer@crbard.com
2871|NCT00394251|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
2872|NCT00394277|Medical Communications|Hoffmann-La Roche|800-821-8590|
2991|NCT00387894|Michael Prados, MD|University of California San Francisco|415-353-7500|PradosM@neurosurg.ucsf.edu
2992|NCT00388505|Study Director|Novartis Pharmaceuticals|862-778-8300|
2993|NCT00388583|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
2994|NCT00388726|Dr. Peter Tarassoff|Eisai|888-422-4743|
2995|NCT00388804|Andrew Lee, MD / Professor|UT MD Anderson Cancer||lhamblin@mdanderson.org
2996|NCT00388947|Dr Samuel Zylstra|Whitinsville Medical Center|508-243-6260|samuelzylstra@milreg.org
2997|NCT00388973|Medical Science Director, Seroquel|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
3522|NCT00432562|Chief Executive Officer|Adventrx Pharmaceuticals|858-768-6325|culley@adventrx.com
3523|NCT00432666|Angelika Hanschmann|Merz Pharmaceuticals GmbH|++49-69-1503 ext 538|angelika.hanschmann@merz.de
3524|NCT00432744|Dr. Peter W Stacpoole|University of Florida|352-273-9023|pws@ufl.edu
3525|NCT00432809|Dr. Philip Schauer|Cleveland Clinic|216-444-4794|schauep@ccf.org
3526|NCT00432835|Thomas L. Abell, MD, Professor of Medicine|University of Mississippi Medical Center|6019844540|tabell@umc.edu
3527|NCT00433017|Study Director|Novartis Pharmaceuticals|862 778-8300|
3528|NCT00433160|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
3529|NCT00433199|Global Medical Services|Abbott|800-633-91110|
3530|NCT00433290|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
3531|NCT00433329|Rajiv Patni/Medical Officer|Actelion Pharmaceuticals, US, Inc.|(650) 624-6900|
3532|NCT00433381|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@acr.org
3533|NCT00433446|Study Statistician|SWOG Statistical Center|206-667-4623|
3534|NCT00433654|EnRhythm MRI Clinical Research Specialist|Medtronic, Inc|800-328-2518 ext 62813|medtronicCRMtrials@medtronic.com
3535|NCT00433745|Minoo Battiwalla, MD|Hematology Branch, NHLBI|301 827 0939|battiwam@nhlbi.nih.gov
3536|NCT00472576|Dr. Carlos Zarate|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|301-451-0861|zaratec@mail.nih.gov
3537|NCT00472797|Fernando Dangond, MD|EMD Serono, INc.|781 681 2348|fernando.dangond@emdserono.com
3538|NCT00472849|William G. Wierda, MD, PhD, BS / Associate Professor|The University of Texas MD Anderson Cancer Center|713-745-0428|eharriso@mdanderson.org
3539|NCT00473330|Medical Communications|Genentech, Inc.|800 821-8590|genentech@druginfo.com
3540|NCT00473382|Medical Communications|Genentech, Inc.|800 821-8590|genentech@druginfo.com
3541|NCT00473434|Regional Medical Affairs Therapeutic Lead Immunol|Jan-Cil Australia|61 2 88753219|
5116|NCT00804843|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5117|NCT00804986|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
5118|NCT00805025|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
5119|NCT00805038|Ash Sehgal|Case Western Reserve University|216-778-7728|axs81@cwru.edu
5120|NCT00805142|Senior Director, Clinical Leader|Janssen R&D, 1125 Trenton-Harbourton Road, Titusville, PA 18902, USA|609-730-6777|
5305|NCT00657371|Robert S. Bresalier, MD / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
5306|NCT00657553|Nathan M. Petty|University of Arkansas for Medical Sciences, Myeloma Institute|501-569-6990 ext 2461|pettynathanm@uams.edu
5307|NCT00657657|GSK Response Center|GlaxoSmithKline|866-435-7343|
5308|NCT00658138|Professor Giovanni Dondi dall'Orologio|University of Bologna, Italy|+39 051-2088132|gdondi@alma.unibo.it
5309|NCT00658320|Study Director|Novartis Pharmaceuticals|862-778-8300|
5310|NCT00658333|Study Director|Novartis Pharmaceuticals|862-778-8300|
5311|NCT00658411|Philippe Armand, MD, PhD|Dana-Farber Cancer Institute|617-632-2305|parmand@partners.org
5312|NCT00658541|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
5313|NCT00658567|Roger Mills, MD|ACADIA Pharmaceuticals Inc.|858-202-7563|rmills@acadia-pharm.com
5314|NCT00658606|Director, Scientific Affairs|Astellas Pharma Canada, Inc.||ClinicalTrials@us.astellas.com
5315|NCT00658619|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
5316|NCT00658684|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5317|NCT00658723|Jonathan Batiller, Director Clinical Development|ETHICON, Inc.|908-218-2819|JBatill2@its.jnj.com
5318|NCT00658788|Elizabeth M Nieman|Galderma Laboratories, L.P.|817-961-5000|elizabeth.nieman@galderma.com
5319|NCT00658814|Study Statistician|SWOG|206-667-4623|
4357|NCT00790192|Josephine Cucchiaro, PhD, Executive Director|Sunovion|201-592-2050|josephine.cucchiaro@sunovion.com
4358|NCT00790270|Adam Singer|Stony Brook U|631 444 7856|adam.singer@stonybrook.edu
4359|NCT00790296|Andrew Winokur MD PhD|University of Connecticut Health Center|860-679-6775|awinokur@uchc.edu
4360|NCT00790400|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300|
4361|NCT00790452|Victor A Levin, MD, BS / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
4362|NCT00797667|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4363|NCT00797797|Robert Palmer, MD|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|1-201-427-8218|robert.palmer@frx.com
4364|NCT00797823|W Kenneth Ward MD|Legacy Health System|503-413-5171|wardk@ohsu.edu
4481|NCT00753948|Joshua Hobson|James J. Peters VAMC|(718) 584-9000 ext 3129|joshua.hobson@va.gov
4482|NCT00754013|Eisai Medical Services|Eisai inc.|1-888-422-4743|
4483|NCT00754065|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
4484|NCT00754130|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4485|NCT00754156|Phillip Chang, M.D. PI or Anna Rockich, Pharm.D. GSRP Director|University of Kentucky Medical Center|859-323-6346 ext 247|arockich@uky.edu
4486|NCT00754234|Brenda Ling|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|701-795-8300|brenda.ling@ars.usda.gov
4487|NCT00754338|Craig A Woods, Research Manager|Centre for Contact Lens Research|1 519 888 4567 ext 36547|cawoods@sciborg.uwaterloo.ca
4488|NCT00754390|Brenda Ling|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|701-795-8300|brenda.ling@ars.usda.gov
4489|NCT00754442|Elizabeth A Streeten, MD|University of Maryland School of Medicine|410-328-6219|estreete@medicine.umaryland.edu
4490|NCT00754546|Donald A. Mahler, M.D.|Dartmouth-Hitchcock Medical Center|603 650-5533|Donald.a.mahler@hitchcock.org
4491|NCT00754559|Medical Communications|Hoffmann- LaRoche|800-821-8590|genentech@druginfo.com
2998|NCT00389064|Gerard Lynch|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
2999|NCT00389207|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
3000|NCT00389324|Benjamin King, PhD|Grifols Therapeutics, Inc.|800-520-2807|ben.king@grifols.com
3001|NCT00389441|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3002|NCT00389467|Chelsea S. Kidwell, MD|Georgetown University|202-687-7302|ck256@georgetown.edu
3003|NCT00389493|Dr. Helen Blair Simpson|New York State Psychiatric Institute|646-774-7000|kimeldo@nyspi.columbia.edu
3004|NCT00389519|Professional Information Services|King Pharmaceuticals, Inc.|1-800-776-3637|
3005|NCT00389532|Medical Director|Sanofi pasteur Inc||RegistryContactUS@sanofipasteur.com
3006|NCT00389597|Noah Bartsch, VP, Clinical,Regulatory,Quality|LDR Spine|512-344-3319|noah.bartsch@ldrspine.com
3007|NCT00389818|Ronald Mitsuyasu, MD|AMC|310-557-1803|rmitsuya@mednet.ucla.edu
3008|NCT00389831|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
3009|NCT00389857|Medical Director|Sanofi Pasteur Inc||RegistryContactUs@sanofipasteur.com
3010|NCT00390182|Nancy Kennedy|University of Maryland Baltimore|410-328-2513|nkennedy@umm.edu
3011|NCT00390468|Quality Assurance Specialist|UT MD Anderson Cancer Center|713-792-2830|caperez@mdanderson.org
3012|NCT00390546|Dr. Shubhayan Sanatani|University of British Columbia|604-875-2345 ext 7955|ssanatani@cw.bc.ca
3013|NCT00390559|Thomas Eissenberg|Virginia Commonwealth University|804.827.4617|teissenb@vcu.edu
3129|NCT00419159|Study Director|Novartis Pharmaceuticals|862-778-8300|
3130|NCT00419341|Clinical Trial Disclosure Manager|CSL Behring|Use email contact.|clinicaltrials@cslbehring.com
3131|NCT00419393|UCB (Study Director)|UCB Clinical Trial Call Center|+1 887 822 9493|
3132|NCT00419445|Carl Grove|CoMentis (formerly Athenagen)|650-869-7600|cgrove@comentis.com
3542|NCT00473512|Senior Director, Clinical Research|Janssen R & D|(310) 943-8040 ext 2917|
3543|NCT00473590|Medical Communications|Hoffman-LaRoche|800-821-8590|
3544|NCT00473642|Scott Westhouse, DO|Retina Specialists of Michigan|616-954-2020|s.westhouse@gmail.com
3545|NCT00473655|Gerard Lynch|AstraZeneca|09645895 ext 44 15|aztrial_results_posting@astrazeneca.com
3546|NCT00473746|Sr. Director, Clinical Research|Janssen R&D US|(310)914-2917|
3547|NCT00473824|Shailesh Chavan, MD|Biotest Pharmaceuticals|561-989-5748|schavan@biotestpharma.com
3548|NCT00473876|Professor Chim C Lang|University of Dundee|0044(0)1382 496375|c.c.lang@dundee.ac.uk
3549|NCT00473889|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
3550|NCT00474045|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
3551|NCT00474058|UCB Clinical Trial Call Center|UCB|+1877 822 9493|
3552|NCT00474123|Comparison of Antiplatelet and Anti-inflammatory Effects of High Dose Statin Monotherapy Versus Mode|Heart Institute (InCor) Hospital of the Faculty of Medicine, University of São Paulo (HCFMUSP)|55-11-30695058|eduardopesaro@hotmail.com
3553|NCT00474175|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3554|NCT00474188|Robert Kinght, M.D.|Celgene Corporation|908-673-9749|rknight@celgene.com
3555|NCT00474201|Scott Penzak|National Institutes of Health|301-496-2997|sp286u@nih.gov
3556|NCT00474240|Chief Medical Officer|Aegerion Pharmaceuticals|617-500-7867|
3557|NCT00474383|Senior Director|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024.|310-943-8040 ext 2917|
3558|NCT00474487|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@Novartis.com
3559|NCT00474526|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
3560|NCT00474539|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
3561|NCT00474708|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
5320|NCT00658996|Gerard Cairns, PhD, MCOptom|Bausch & Lomb Incorporated|(585) 338-5170|gerard.cairns@bausch.com
5321|NCT00659061|Professor Zulfiqar Ahmed Bhutta|Aga Khan University|4930051 ext 4782|zulfiqar.bhutta@aku.edu
5322|NCT00512876|Principal Investigator|U.S. Army Warfighter Refractive Surgery Research Center|571-231-1600|rose.sia@us.army.mil
5323|NCT00850200|Bradford Hoppe, MD, MPH|University of Florida Proton Therapy Institute|904-588-1800|bhoppe@floridaproton.org
5324|NCT00850343|Medical Director, Global Medical Sciences|Astellas Pharma Inc.||ClinicalTrials.Disclosure@astellas.com
5325|NCT00718887|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
5326|NCT00719043|GSK Response Center|GlaxoSmithKline|866-435-7343|
5327|NCT00719160|Karl L. Insogna, M.D.|Yale University|203-737-2871|Karl.insogna@yale.edu
5512|NCT00824005|Lemuel Moye, MD, PhD|UT-Houston School of Public Health|713-500-9518|Lemmoye@msn.com
5513|NCT00824044|Dr. Amy Farabaugh|Massachusetts General Hospital|617-726-1629|afarabaugh@partners.org
5514|NCT00824070|Tuyen Ong, MD|Bausch & Lomb Inc|(973) 360-6389|tuyen.ong@bausch.com
5515|NCT00824161|Scott Kopetz, MD|The University of Texas M.D. Anderson Cancer Center|713-792-2828|
5516|NCT00515112|Dr. Walter Stadler|The University of Chicago|773-702-4400|wstadler@medicine.bsd.uchicago.edu
5517|NCT00515177|Cynthia Gross PhD|University of Minnesota|612-624-8676|gross002@umn.edu
5518|NCT00515203|Study Director|Amgen Inc.|866-572-6436|
5519|NCT00515437|Sharon Reinhard, MS, Director Clinical Development|Solstice Neurosciences, Inc|267-620-8083|sharon.reinhard@solsticeneuro.com
5520|NCT00515463|Study Director|Amgen Inc.|866-572-6436|
5521|NCT00515502|GSK Response Center|GlaxoSmithKline|866-435-7343|
5522|NCT00515541|Dr. Don A. Gabriel|Invitrox, Inc|(919) 485-4600|dgabriel@invitrox.com
5523|NCT00515619|UCB (Study Director)|UCB Clinical Trial Call Center|+1 887 822 9493|
4492|NCT00754650|Medical Communications|Hoffmann-La Roche|800 821-8590|
4493|NCT00754793|Dr. Greg E. Davis, MD MPH|University of Washington|206-543-5230|gedavis@uw.edu
4494|NCT00754832|Dr. Michelle Cameron|Oregon Health & Science University|503-418-1971|cameromi@ohsu.edu
4495|NCT00754923|Miguel Villalona|OSU|614-366-5068|miguel.villalona@osumc.edu
4496|NCT00755079|Joshua Hobson, MS|VAHSRD|(718) 584-9000 ext 3129|joshua.hobson@va.gov
4497|NCT00755105|Janet Hunt, PhD|USDA Grand Forks Human Nutrition Research Center|701-795-8353|janetrhunt@gmail.com
4498|NCT00755131|Prof. Carlo Vigorito, Director Cardiac Rehabilitation Unit, Federico II University|University of Naples Federico II|+39081746 ext 2639|vigorito@unina.it
4499|NCT00755222|Gregory J. Kaufman, MD, Sr. Director Clinical Development|Auxilium Pharmaceuticals, Inc.|484-321-5920|gkaufman@auxilium.com
4500|NCT00450619|Dr. James Gulley, M.D.|National Cancer Institute, National Institutes of Health|301-435-2956|gulleyj@mail.nih.gov
4501|NCT00450658|Amy Grahn, MS  Senior Vice President, Clinical Development and Operations|Horizon Pharma, Inc.|224-383-3012|agrahn@horizonpharma.com
4502|NCT00450723|Eli Avisar MD|UM/Sylvester Comprehensive Cancer Center|305-243-4902|eavisar@med.miami.edu
4615|NCT00458211|Nigel Bark MD|Bronx Psychiatric Center|718 862 5429|Nigel.Bark@omh.ny.gov
4616|NCT00458302|EMEA Medical Affairs Director Virology|Jan-Cilag Germany|+49 7624 907580|
4617|NCT00458406|Paul R. Gallagher, MA|CTRC, Children's Hospital of Philadelphia|215-590-2739|gallagherp@email.chop.edu
4618|NCT00459043|Robert Haddad|DFCI|6176326725|robert_haddad@dfci.harvard.edu
4619|NCT00459056|Aaron S. Kelly, Ph.D.|University of Minnesota|612-626-3492|kelly105@umn.edu
4620|NCT00459121|Shirish Gadgeel, M.D.|Barbara Ann Karmanos Cancer Institute|313-576-8753|gadgeels@karmanos.org
4621|NCT00459186|Dr. Mary-Ellen Taplin|Dana-Farber Cancer Institute|617-632-3237|Mary_Taplin@dfci.harvard.edu
4622|NCT00459290|Jessalyn Reboy|Gynecologic Oncology Group Statistical and Data Center|716-845-7738|ReboyJ@nrgoncology.org
4623|NCT00459303|Fung-Rong Hu|National Taiwan University Hospital|+886223123456 ext 2131|fungronghu@ntuh.gov.tw
3133|NCT00419744|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3134|NCT00419757|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3135|NCT00419770|Brad Spellberg|Los Angeles Biomedical Research Institute|310-781-3680|bspellberg@labiomed.org
3136|NCT00419926|Study Director|Novartis Pharmaceuticals|862-778-8300|
3137|NCT00419952|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3138|NCT00420017|James E Tisdale PharmD|Purdue University|317-613-2315 ext 306|hwroblew@iupui.edu
3139|NCT00420095|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
3140|NCT00420199|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
3141|NCT00420212|Biogen Idec Study Medical Director|Biogen Idec||clinicaltrials@biogenidec.com
3142|NCT00420238|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
3143|NCT00420290|Adriana Hung, MD|Vanderbilt University||adriana.hung@vanderbilt.edu
3144|NCT00420303|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
3145|NCT00420342|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
3146|NCT00420407|Stephen Cohn, M.D.|University of Texas Health Science Center at San Antonio|210-567-5724|mccarthyj@uthscsa.edu
3147|NCT00420420|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
3148|NCT00420511|Dr. Ravi Retnakaran|Leadership Sinai Centre for Diabetes, Mount Sinai Hospital|416-586-4800 ext 3941|rretnakaran@mtsinai.on.ca
3149|NCT00420628|Timothy Comstock OD|Bausch & Lomb|(585) 338-6631|tcomstock@bausch.com
3150|NCT00420745|GSK Response Center|GlaxoSmithKline|866-435-7343|
3151|NCT00396812|Associate Director, Clinical Research Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
3152|NCT00396877|Trial Transparency Team|sanofi-aventis||Contact-US@sanofi-aventis.com
3585|NCT00703677|René Gonin, PhD (Math. Stats.)|Westat|301-251-1500|renegonin@westat.com
3586|NCT00703781|Tim McNamara, PharmD|ISTA Pharmaceuticals, Inc.|949-788-6000|tmcnamara@istavision.com
3587|NCT00703846|GSK Response Center|GlaxoSmithKline|866-435-7343|
3588|NCT00703911|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
3589|NCT00703937|Marc Tokars|Luitpold Pharmaceuticals, Inc.|610-650-4200|mtokars@lpicrd.com
3590|NCT00703963|Dr. Hartzell V. Schaff|Mayo Clinic|507-255-7068|schaff@mayo.edu
3591|NCT00709956|Laila Rouault, M.D.|Actelion|+ 41 61 565 8128|laila.rouault@actelion.com
3592|NCT00710021|Associate Director, Clinical Research Operations Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
3593|NCT00710203|Daniel Eisen, M.D.|UC Davis, Department of Dermatology|916-734-6479|dbeisen@ucdavis.edu
3594|NCT00710424|Mr Richard Potts, Clinical Operations Director|GW Pharm Ltd|0044 1223 266800|rp@gwpharm.com
3595|NCT00710554|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd.|0044 1223 266800|rp@gwpharm.com
3596|NCT00710749|Head of Clinical Research Area Health Care|Astra Tech AB|+46317763000|
3597|NCT00710866|Danuta M Skowronski, MD|British Columbia Centre for Disease Control|604-660-6067|danuta.skowronski@bccdc.ca
3598|NCT00710879|Joseph Barr, OD, MS|Bausch & Lomb Incorporated|(585) 338-6439|joseph.t.barr@bausch.com
3599|NCT00710905|Director of Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
3600|NCT00710931|Director of Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
3601|NCT00710944|Senior Manager Global Clinical Research|DENTSPLY Implants|+46313763500|clinicalresearchmolndal@dentsply.com
3602|NCT00710970|Seth P. Lerner, M.D., F. A. C. S.|Baylor College of Medicine|713-798-6841|slerner@bcm.edu
3603|NCT00710996|Rick Potvin|Alcon Research, Ltd.|817-551-4815|Rick.Potvin@alconlabs.com
3604|NCT00711009|Global Medical Services|Abbott|800-633-9110|
5524|NCT00560612|Christine Marx, MD|Durham VA Medical Center|919 286-0411 ext 7426|marx0001@mc.duke.edu
5525|NCT00560703|Michael Graeber|Organization: Galderma R&D, Inc|609-409-7701|clinicaltrials@galderma.com
5526|NCT00560833|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5527|NCT00560885|Jim Lucky|AtriCure, Inc.|1-513-755-4101|jlucky@atricure.com
5528|NCT00560937|Christine E. Marx, MD, MA|Durham Veterans Affairs Medical Center|919 286-0411 ext 7426|marx0001@mc.duke.edu
5529|NCT00560950|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
5530|NCT00561002|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
5531|NCT00561015|Clinical Leader|Janssen Research & Development, LLC|609-730-3174|
5532|NCT00561353|Global Clinical Development Manager|Jan-Cil France||ClinicalTrialDisclosure@its.jnj.com
5533|NCT00561392|Study Director|Novartis Pharmaceuticals|862 778-8300|
5534|NCT00561431|Ashita Tolwani, M.D.|University of Alabama at Birmingham|2059752021|atolwani@uab.edu
5121|NCT00805285|Raymond Cross, MD, MS|University of Maryland, Baltimore|410-706-3387|rcross@medicine.umaryland.edu
5122|NCT00805389|GSK Response Center|GlaxoSmithKline|866-435-7343|
5123|NCT00805467|Dave Goldstraw|AstraZeneca Pharmaceuticals|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
5124|NCT00847626|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
5125|NCT00847665|Dr. Francisco Manzano|University Hospital Virgen de las Nieves|34958020125|fmanzano@mailpersonal.com
5126|NCT00847808|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
5127|NCT00847886|Joel P. Freiman, MD, MPH - Medical Director, Drug Safety|Lexicon Pharmaceuticals, Inc.|281-863-3000|
5128|NCT00848016|Michael E. Menefee, M.D.|Mayo Clinic Cancer Center||menefee.michael@mayo.edu
5129|NCT00848081|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4624|NCT00459316|Clinicaltrals.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
4625|NCT00459342|Faye Johnson, MD / Associate Professor|The University of Texas (UT) MD Anderson Cancer Center|713-792-7734|CR_Study_Registration@mdanderson.org
4626|NCT00459368|L. Keoki Williams, MD, MPH|Henry Ford Health System|313-874-5454|
4627|NCT00459537|Study Director|Novartis Pharmaceuticals|862 778-8300|
4628|NCT00459667|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
4629|NCT00459706|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4630|NCT00459732|Ellen Fung, PhD RD CCD|Children's Hospital & Research Center, Oakland|510-428-3885 ext 4939|efung@mail.cho.org
4631|NCT00459810|Study Coordinator|Oregon Health & Science University Knight Cancer Institute|(503) 494-2897|eilersk@ohsu.edu
4632|NCT00459862|Julian Molina, M.D, Ph.D.|Mayo Clinic||Molina.julian@mayo.edu
4633|NCT00459979|Dr. Brian Rini|CCCC|216-444-9567|rinib2@ccf.org
4634|NCT00460265|Study Director|Amgen Inc.|866-572-6436|
4635|NCT00492544|GSK Response Center|GlaxoSmithKline|866-435-7343|
4636|NCT00492557|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4637|NCT00492583|Daniel J Merenstein, MD|Georgetown University|202-687-2745|djm23@georgetown.edu
4226|NCT00705939|Vice President Product Development|Protalix Ltd.|+(972) 4-9889488 ext 137|einata@protalix.com
4227|NCT00706004|Catherine O'Brien|University of Arkansas for Medical Sciences|501-364-1828|obriencatherinee@uams.edu
4228|NCT00706095|Eisai Inc.|Eisai Call Center|888-422-4743|
4229|NCT00706134|Study Director|Novartis Pharmaceuticals|862-778-8300|
4230|NCT00706329|Dr. Neil Feins|Children's Hospital Boston and South Shore Hospital|6173556915|
4231|NCT00706342|Bernadette Weidman|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
2728|NCT00385944|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2729|NCT00385996|Nasser Altorki, MD|Weill Cornell Medical College|212-746-5156|nkaltork@med.cornell.edu
2730|NCT00386009|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2731|NCT00366106|Vice President of Scientific Affairs|Accelerated Community Oncology Research Network, Inc.|901-435-5570|mwalker@acorncro.com
2732|NCT00366249|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
2733|NCT00366275|Luca Arcaini MD|Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia|+390382501308|luca.arcaini@unipv.it
2734|NCT00366301|Aruna Pradhan|Brigham and Women's Hospital|617-732-8777|apradhan@partners.org
2735|NCT00366340|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2873|NCT00394329|Vernon M. Chinchilli, PhD|Penn State College of Medicine|717-531-4262|vchinchi@psu.edu
2874|NCT00394355|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@spcorp.com
2875|NCT00394472|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
2876|NCT00394524|Guillermo Umpierrez, MD|Emory University|404-778-1665|geumpie@emory.edu
2877|NCT00394589|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
2878|NCT00394654|Don Raible, MD|MedImmune|301-398-0000|raibleD@medimmune.com
2879|NCT00394706|Siobhan Brown, PhD-Biostatistician|University of Washington|206-685-1302|spes@uw.edu
2880|NCT00394771|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
2881|NCT00394836|GSK Response Center|GlaxoSmithKline|866-435-7343|
2882|NCT00394888|Dr. Beth Drolet|Medical College of Wisconsin|414-266-1569|bdrolet@mcw.edu
2883|NCT00394901|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2884|NCT00394914|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
3092|NCT00415506|Dr. Eric B. Suhler|Oregon Health & Science University|503-494-5023|suhlere@ohsu.edu
3093|NCT00415532|Study Director|Amgen Inc.|866-572-6436|
3094|NCT00415597|Vice President, Clinical Development|King Pharmaceuticals Research and Development, Inc.|919-653-7001|
3095|NCT00415623|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3096|NCT00415857|Jorge Cortes M.D./Professor|The University of Texas M. D. Anderson Cancer Center|713/792-7305|eharrison@mdanderson.org
3097|NCT00415870|Project Coordinator|UCSD|858-534-9329|ldillon@ucsd.edu
3098|NCT00415909|Jorge Cortes, MD / Professor, Leukemia|University of Texas MD Anderson Cancer Center|713-794-5783|CR_Study_Registration@mdanderson.org
3099|NCT00416195|Eisai Inc.|Eisai Call Center|888-422-4743|
3100|NCT00416494|Brant Hamel|Duke University Medical Center|919-68-1861|brant.hamel@duke.edu
3101|NCT00416598|William Blum, M.D.|The Ohio State University||William.Blum@osumc.edu
3102|NCT00416793|Gauri Varadhachary, MD Associate Professor|UT MD Adnderson Cancer Center|713-792-2828|mjlim@mdanderson.org
3103|NCT00416884|Center for Hematologic Malignancies|Center for Hematologic Malignancies|503-494-1551|
3104|NCT00417027|Robert J. McCarthy, PharmD|Northwestern University Feinberg School of Medicine|312-926-9015|r-mccarthy@northwestern.edu
3105|NCT00417079|International Clinical Development Study Director|sanofi-aventis||GV-Contact-us@sanofi-aventis.com
3223|NCT00404079|Project Manager: Philip Wilkens|Oslo University Hospital Ullevaal|004723016140|philip.wilkens@medisin.uio.no
3224|NCT00404092|Oliver A. Cornely|University of Cologne|+49 221 478 6494|Oliver.Cornely@zks-koeln.de
3225|NCT00404352|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
3226|NCT00404495|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3227|NCT00404547|Respiratory Medical Advisor|Nycomed GmbH|0049-7531-840|clinicaltrials@nycomed.com
3228|NCT00404651|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
7660|NCT00536471|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
7661|NCT00536484|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
7662|NCT00536510|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
7663|NCT00536575|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
7664|NCT00536731|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7665|NCT00536744|Dr. Daniel Jorgensen, MD|SANUWAVE, Inc.|678-578-0116|daniel.jorgensen@sanuwave.com
7666|NCT00536809|GSK Response Center|GlaxoSmithKline|866-435-7343|
7667|NCT00582660|Martin J. Heslin M.D.|University of Alabama at Birmingham|205-975-0450|marty.heslin@ccc.uab.edu
7668|NCT00582738|Novartis|Pharmaceuticals|41613241111|
7669|NCT00582790|Study coordinator|University of Wisconsin Carbone Cancer Center|(608) 263-7107|uwcccgu@medicine.wisc.edu
7670|NCT00582894|George Selby, MD|University of Oklahoma Health Sciences Center|405/271-4022|george-selby@ouhsc.edu
7671|NCT00582907|Philip Hashkes, MD, MSc|Shaare Zedek Medical Center/Cleveland Clinic|972-2-6555307|hashkesp@szmc.org.il
7672|NCT00582972|Dr. Karen Hansen|University of Wisconsin|608-263-3457|keh@medicine.wisc.edu
7673|NCT00583219|Dr. Steven P. Petrou|Mayo Clinic|904-953-7330|petrou.steven@mayo.edu
7674|NCT00583557|GSK Response Center|GlaxoSmithKline|866-435-7343|
7675|NCT00583596|Jeffrey Mifek|St. Jude Medical Formally AGA Medical Corporation|6517565586|jmifek@sjm.com
7676|NCT00583622|Yago Nieto, MD, PhD / Professor|The University of Texas MD Anderson Cancer||celsaenz@mdanderson.org
7677|NCT00583661|Robert Kroslowitz, CEO|Berlin Heart Inc.|1-281-863-9700|kroslowitz@berlinheart.com
7678|NCT00583700|Geraldine Jacobson, MD, MBA, MPH, FACR|West Virginia University|(304) 293-7227|GMJACOBSON@hsc.wvu.edu
7679|NCT00583713|Russell Pelham, PhD|Braintree Laboratories, Inc.|781-843-2202|rpelham@braintreelabs.com
3692|NCT00741988|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
3693|NCT00742053|Christopher DiMatteo/Clinical Scineces Manager|C.R. Bard|801-522-5487|chris.dimatteo@crbard.com
3694|NCT00742079|Jennifer Gottlieb, PhD|Massachusetts General Hospital|617-912-7800|jgottlieb2@partners.org
3695|NCT00742183|Viktoria Ahlenius Körner|Mölnlycke Health Care|+46-31-722 32 46|viktoria.ahleniuskorner@molnlycke.com
3696|NCT00742209|XenoPort Call Center|XenoPort, Inc.|877-936-6778|
3697|NCT00742235|Principal Investigator|Massachusetts General Hospital|617-726-3934|ibhan@partners.org
3698|NCT00742274|Jennifer Gorman|W.L. Gore and Associates|928-864-3381|jgorman@wlgore.com
3885|NCT00477607|Dawn Konrad-Martin|VA RR&D National Center for Rehbilitative Auditory Research|503-220-8262 ext 52962|dawn.martin@va.gov
3886|NCT00477633|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
3887|NCT00477672|Roger Mills, MD|ACADIA Pharmaceuticals Inc.|858-202-7563|rmills@acadia-pharm.com
3888|NCT00477685|S.P.S Grewal, MD|Grewal Eye Institute|+91-172-5056969|drgrewal@gmail.com
3889|NCT00477750|Dr. Vivek Roy|Mayo Clinic||roy.vivek@mayo.edu
3890|NCT00478023|Claudia Leinweber|Grunenthal GmbH|49 241 569 2509|claudia.leinweber@grunenthal.com
3891|NCT00478140|Dr. Ahmed Kaseb / Associate Professor|The University of Texas (UT) MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
3892|NCT00478192|Senior Medical Director, Medical Affairs|Astellas Pharma Global Development||clinicaltrials@us.astellas.com
3893|NCT00478205|Eisai Inc.|Eisai Call Center|888-422-4743|
3894|NCT00478218|Dr. Shaji Kumar|Mayo Clinic||kumar.shaji@mayo.edu
3895|NCT00787930|John Beyer, MD|Duke University Medical Center|919-668-0209|john.beyer@dm.duke.edu
3896|NCT00787943|Amy Paller, MD|Northwestern University|773-327-9642|apaller@northwestern.edu
3897|NCT00788073|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|Seaside Therapeutics|617-374-9009 ext 1015|pwang@seasidetherapeutics.com
2885|NCT00395018|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2886|NCT00395057|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
2887|NCT00395083|Dr. Sarah Leatherman|VA Boston Healthcare System - MAVERIC|857-364-4220|sarah.leatherman@va.gov
2888|NCT00395135|Associate Director, Clinical Operations|Arena Pharmaceuticals, Inc.|858-453-7200 ext 1602|sstubbe@arenapharm.com
2889|NCT00395161|Jeri Burr, MS, RN-BC, CCRC|University of Utah|801-587-7753|jeri.burr@hsc.utah.edu
2890|NCT00395226|Brian Johnson|Essentia Institute of Rural Health|218-786-8856|bjohnson3@eirh.org
2891|NCT00395291|W. Kline Bolton, MD|University of Virginia|434-924-9692|wkb5s@Virginia.edu
2892|NCT00395304|Vernon M. Chinchilli|Penn State Hershey College of Medicine|717-531-4262|vchinchi@psu.edu
2893|NCT00395343|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
2894|NCT00395447|Crystal Miller, Clinical Studies Engineer|BIOTRONIK, Inc|503-387-2579|crystal.miller@biotronik.com
2895|NCT00395460|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
3014|NCT00390689|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
3015|NCT00390780|Dr Pierre Attali|Bioalliance Pharma|+33 (0)1 45 58 76 00|pierre.attali@bioalliancepharma.com
3016|NCT00390806|GSK Response Center|GlaxoSmithKline|866-435-7343|
3017|NCT00390858|Study Director|Novartis Pharmaceuticals|862-778-8300|
3018|NCT00390884|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
3019|NCT00391027|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3020|NCT00391053|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
3021|NCT00391079|Richard Potts Clinical Operations Director|GW Pharmaceuticals|+44 1223 266800|rp@gwpharm.com
3022|NCT00391222|EMEA Medical Affairs Director|Janssen Cilag Spain|+34 91 7228043|
3229|NCT00404820|Study Director|Novartis Pharmaceuticals|862 778-8300|
3230|NCT00404924|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3231|NCT00405067|Chief Medical Officer|Aegerion Pharmaceuticals|617-500-7867|
3232|NCT00405275|James R. O'Dell, MD|VA Nebraska-Western Iowa Health Care System|402-559-7288|jrodell@unmc.edu
3233|NCT00405288|Dr. Gideon Koren|The Hospital for Sick Children||gkoren@sickkids.ca
3234|NCT00405548|Dr. Horng H. Chen|Mayo Clinic|507-538-2354|chen.horng@mayo.edu
3235|NCT00405639|Dr. Horng H. Chen|Mayo Clinic|507-538-2354|chen.horng@mayo.edu
3236|NCT00405652|Study Director|Novartis Pharmaceuticals|862-778-8300|
3237|NCT00405756|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
3238|NCT00405821|Steven Reynolds|NIAID|256-772-220-087|sjreynolds@niaid.nih.gov
3239|NCT00405912|Dr. Amit Sood|Mayo Clinic|507-266-1944|nicotineresearch@mayo.edu
3240|NCT00405938|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
3241|NCT00405964|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@spcorp.com
3242|NCT00406107|John A. Wells, III, M.D.|Palmetto Retina Center|803-931-0077|jackwells@palmettoretina.com
3243|NCT00406133|Roy W. Beck, M.D., Ph.D., Director|Jaeb Center for Health Research|813-975-8690|rbeck@jaeb.org
3244|NCT00406276|Dr.Suresh Ramalingam, MD|Emory University|404-778-5378|ssramal@emory.edu
3245|NCT00406315|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2805|NCT00372775|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2806|NCT00373113|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2807|NCT00373256|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7680|NCT00583908|Kurt Moody, OD FAAO|Vistakon|904-443-3088|kmoody1@its.jnj.com
7681|NCT00542971|Farhad Ravandi-Kashani, M.D./Associate Professor|The University of MD Anderson Cancer Center|713-745-0394|fravandi@mdanderson.org
7682|NCT00542997|Program Director, Clinical R&D|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
7683|NCT00543101|Clavin Cohen MD|Community Research Initiative of New England (CRINE)|617 502 1700|ccohen@crine.org
7684|NCT00543296|Glenn J. Jaffe, MD|Duke University Medical Center|919-684-4458|jaffe001@mc.duke.edu
7685|NCT00543725|Medical Leader|Tibotec|1 609 730 7561|kboven@its.jnj.com
7686|NCT00543764|Bernard Lee|BIDMC|617-632-7835|blee3@bidmc.harvard.edu
7687|NCT00543803|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7688|NCT00543855|Masaki Nakagawa, Study Director|Eisai Co., Ltd.|+81-3-3817-5245|
7689|NCT00544167|John Hainsworth, MD|Sarah Cannon Research Institute|877-691-7274|ASKSARAH@scresearch.net
7690|NCT00544440|Senior Director|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024|310-943-8040 ext 2917|
7691|NCT00544544|Brian P. Brennan, M.D.|McLean Hospital|617-855-2911|bbrennan@partners.org
7692|NCT00544648|Vicki Keedy, MD|Vanderbilt-Ingram Cancer Center|615-936-3524|vicki.keedy@vanderbilt.edu
7693|NCT00544674|Director of Clinical Development|Proacta, Inc.|858-642-0386|clinicalops@proacta.com
7694|NCT00544713|Therapeutic Area Head|Allergan, Inc.|(714)246-4500|clinicaltrials@allergan.com
7695|NCT00544778|Paul Frankel, Ph. D.|City of Hope National Medical Center|(626)359-8111 ext 65265|pfrankel@coh.org
7696|NCT00544817|John D. Hainsworth, MD|Sarah Cannon Research Institute|877-691-7274|ASKSARAH@scresearch.net
7697|NCT00544869|Director of Clinical Trials|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7314|
7698|NCT00544882|Director of Clinical Research|Teva Branded Pharmaceutical Products R&D|610-786-7047|clinicaltrialsdisclosure@tevapharm.com
7699|NCT00545025|GSK Response Center|GlaxoSmithKline|866-435-7343|
3898|NCT00788372|Director, Clinical Research|Janssen Research & Development, L.L.C. USA|1 609 730-3387|
3899|NCT00788593|Robert Winkler, MD, VP, Clinical Development and Operations|Aptalis Pharma US, Inc.|1-800-472-2634|
3900|NCT00788710|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
3901|NCT00789035|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
3902|NCT00789074|Professor Peter Hajek|Queen Mary University of London|+44 207 882 8231|p.hajek@qmul.ac.uk
3903|NCT00789191|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
3904|NCT00789256|Marc Gautier, MD - Principal Investigator|Dartmouth-Hitchcock Medical Center|603-650-5529|marc.gautier@hitchcock.org
3905|NCT00789321|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|clinicaltrialsdisclosure@merck.com
3906|NCT00789373|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4090|NCT00481988|Peter Bulow MD, Assistant Professor of Clinical Psychiatry|Division of Experimental Therapeutics, NY State Psychiatric Organization|(212) 543 5664|pb2182@columbia.edu
4091|NCT00482014|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
4092|NCT00482170|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4093|NCT00482274|Study Coordinator|Oregon Health & Science University Knight Cancer Institute|503 494-2897|eilersk@ohsu.edu
4094|NCT00482547|Vanessa Dell Clinical Research Scientist|C. R. Bard|908-277-8094|vanessa.dell@crbard.com
4095|NCT00482612|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
4096|NCT00482625|Dr. Steven Lipkin|Weill Cornell College of Medicine|212-774-7160|stl2012@med.cornell.edu
4097|NCT00482703|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4098|NCT00482729|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
4099|NCT00482911|Steven A. Rosenberg, M.D.|National Cancer Institute, National Institutes of Health|301-435-7507|sbpso@mail.nih.gov
3023|NCT00391274|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
3024|NCT00391391|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
3025|NCT00391443|Isabelle Leconte,PhD -Data Science Group Leader, Director|Actelion Pharmaceuticals Ltd|+41 61 565 64 18|isabelle.leconte@actelion.com
3026|NCT00391625|Eric Crombez, M.D., Senior Medical Director|Shire Human Genetics Therapy (Shire HGT)|1-617-349-0200|ecrombez@shire.com
3027|NCT00391768|Penelope Jester|Collaborative Antiviral Study Group|877-975-7280|PJester@peds.uab.edu
3028|NCT00391807|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
3029|NCT00391846|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3030|NCT00391872|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3031|NCT00391898|Study Director|Novartis Pharmaceuticals|862 778-8300|
3032|NCT00391976|Study Director|Novartis Pharmaceuticals|862 778-8300|
3033|NCT00392171|Head, Clinical Trial Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
3034|NCT00392197|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
3035|NCT00392223|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3036|NCT00392236|Delbert Robinson, M.D.|Feinstein Institute for Medical Research|718 470-8195|drobinso@nshs.edu
3153|NCT00396981|S. Claiboren Johnston, MD, PhD|University of California, UCSF Medical Center|415-502-7487|Clay.Johnston@ucsfmedctr.org
3154|NCT00397033|Vice President, Medical Affairs, CNS|Ortho McNeil Janssen Scientific Affairs, LLC|609-730-2136|
3155|NCT00397189|VP clinical and regulatory affairs|Neurim Pharmaceuticals|+972-3-6499340|Talin@neurim.com
3156|NCT00397215|GSK Response Center|GlaxoSmithKline|866-435-7343|
3157|NCT00397254|M.E. Beach|Clinvest|417-841-3618|mbeach@clinvest.com
3158|NCT00397514|Dr. Shubhayan Sanatani|University of British Columbia|6048752345 ext 7955|ssanatani@cw.bc.ca
2808|NCT00373334|Clinical Operations Manager|Braintree Laboratories, Inc.|781-843-2202|jmcgowan@braintreelabs.com
2809|NCT00373360|Rex Mauthe; Senior Director, Regulatory Affairs|United Therapeutics Corporation|919-485-8350|rmauthe@unither.com
2810|NCT00373425|Senior Medical Director, Medical Oncology|Astellas Pharma Global Development, Inc.||clinicaltrial.disclosure@us.astellas.com
2811|NCT00373490|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
2812|NCT00373529|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
2813|NCT00373685|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2814|NCT00373958|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2815|NCT00374088|Ranjit Aiyagari, MD|University of Michigan - Pediatric Cardiology|734-647-8761|ranjita@umich.edu
2816|NCT00374140|Ahmad Tarhini, MD, PhD|University of Pittsburgh|(412) 648-6578|tarhiniaa@upmc.edu
2817|NCT00374322|GSK Response Center|GlaxoSmithKline|866-435-7343|
2818|NCT00374335|Dr. Kimberly Horii|Children's Mercy Hospitals and Clinics|816-234-3924|kahorii@cmh.edu
2819|NCT00374543|Naomi M. Simon, M.D., M.Sc.|Massachusetts General Hospital|(617) 726-7913|nsimon@partners.org
2820|NCT00374803|Rita Alloway, PharmD|University of Cincinnati|5135581568|rita.alloway@uc.edu
2821|NCT00374842|GSK Response Center|GlaxoSmithKline|866-435-7343|
2822|NCT00374868|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2823|NCT00374907|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2824|NCT00375219|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
2825|NCT00375427|Study Director|Novartis Pharmaceuticals|862-778-8300|
2826|NCT00375492|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2827|NCT00375713|UCB Clinical Trial Call Center|UCB Pharma|+ 1 877 822 9493|
7700|NCT00545064|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
7701|NCT00545103|Study Physician|Shire Development LLC|+1 866 842 5335|
7702|NCT00545155|Manish N. Shah|University of Rochester|585-463-2920|manish.shah@rochester.edu
7703|NCT00545168|Director, Quality and Regulatory|ParaPRO LLC|317-810-6205|kerrym@parapro.com
7704|NCT00545181|David Haas, MD MS|Indiana University School of Medicine|3176307837|dahaas@iupui.edu
7705|NCT00545233|Medical Communications|Hoffman-LaRoche|800-821-8590|
7706|NCT00545272|Study Director|Novartis Pharmaceuticals|862-778-8300|
7707|NCT00545298|Frank J. McCaney, CEO Sponsor|Nitric BioTherapeutics Inc|215-788-6200|fmccaney@nbtherapeutics.com
7708|NCT00591253|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
7709|NCT00648895|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|Forest Laboratories|1-201-427-8259|John.Whalen@frx.com
7710|NCT00648908|Andrew Blight, PhD Chief Scientific Officer|Acorda Therapeutics, Inc.|914-347-4300 ext 4102|ablight@acorda.com
7711|NCT00649220|Manager Public Disclosure|Merz Pharmaceuticals GmbH|+49 69 1503 865|matthias.zerm@merz.de
7712|NCT00649389|Howard Kessler|Daiichi Sankyo|732-590-5032|hmkessler@dsi.com
7713|NCT00649428|Kevin Hennegan|CBR International Corp.|720-746-1190|khennegan@cbrintl.com
7714|NCT00649792|Andrew Blight, PhD Chief Scientific Officer|Acorda Therapeutics, Inc.|914-347-4300 ext 4102|ablight@acorda.com
7715|NCT00649961|Dr Nazakat Merchant|Imperial College London|00447825881907|nazakat.merchant@kcl.ac.uk
7716|NCT00650078|Senior Vice President, Clinical Development & Operations|Horizon Pharma|224-383-3012|agrahn@horizonpharma.com
7717|NCT00650104|GSK Response Center|GlaxoSmithKline|866-435-7343|
7718|NCT00650260|Enrico Camporesi MD|University of South Florida Dept of Surgery/Anesthesiology|813-844-7170|ecampore@health.usf.edu
7719|NCT00650585|Heddy Clark|PIRE|919-265-2643|hclark@pire.org
4100|NCT00483002|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4101|NCT00483041|Joseph Parker, MD|MedImmune|301-398-0000|parkerj@medimmune.com
4102|NCT00483184|Hasan Zeytin MD., Ph.D.|Nobel Ilac San ve Tic. A.S.|+90 216 6336012 ext 6012|hasan.zeytin@nobel.com.tr
4103|NCT00483262|Irene Ghobrial, MD|Dana-Farber Cancer Institute|617-632-4198|irene_ghobrial@dfci.harvard.edu
4104|NCT00483379|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
4105|NCT00483496|Clinical project manager|Orfagen|0033534506462|caroline.miklaszewski@orfagen.com
4106|NCT00483548|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4107|NCT00483574|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
4108|NCT00483652|Andrew Blight, Chief Scientific Officer|Acorda Therapeutics, Inc.|(914) 347-4300 ext 102|ablight@acorda.com
4109|NCT00483704|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4110|NCT00483756|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4111|NCT00834132|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
3699|NCT00742313|Terry Ainsworth, Director, Clinical Research Operations, Education & Training|Duke University Medical Center|919-681-7084|terry.ainsworth@duke.edu
3700|NCT00742326|Colleen Hadigan MD MPH|NIAID|301-594-5754|hadiganc@niaid.nih.gov
3701|NCT00742391|Dr. Torsten Skov|LEO Pharma|+4520736294|torsten.skov@leo-pharma.com
3702|NCT00750919|Senior Vice President,  Global Clinical Development|Merck Sharp & Dohme|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
3703|NCT00751036|Study  Director|Novartis Pharmaceuticals|862-778-8300|
3704|NCT00751114|Trial Transparency Team|sanofi-aventis||Contact-US@sanofi.com
3705|NCT00751140|Philippe E. Spiess, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-8343|philippe.spies@moffitt.org
3159|NCT00397540|Won Kim|Seoul National University Hospital Boramae Medical Center|82 2 870 2233|wonshiri@yahoo.com
3160|NCT00397631|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
3161|NCT00397839|Medical Communications|Hoffmann-La Roche|800-821-8590|
3162|NCT00397878|Cathy Eng, MD / Professor|University of Texas MD Anderson Cancer Center|713-792-7734|CR_Study_Registration@mdanderson.org
3163|NCT00397891|Pfizer ClinicalTrials.gov Call Center|Wyeth|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3164|NCT00398047|Ralph D'Agostino Jr., Ph.D.|Wake Forest University Health Sciences|113-716-3483|rdagosti@wfubmc.edu
3165|NCT00398086|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
3166|NCT00398112|Tait Shanafelt|Mayo Clinic||shanafelt.tait@mayo.edu
3167|NCT00398320|Pamela L. Kunz|Stanford University School of Medicine|650-725-8738|pkunz@stanford.edu
3168|NCT00398411|Prof. Dr. Oliver A. Cornely|University of Cologne|+49 221 478 88794|oliver.cornely@zks-koeln.de
3169|NCT00398918|Ofra Sarid-Segal, MD|Boston University|617-414-1990|ofra.segal@bmc.org
3170|NCT00398983|Farhad Ravandi-Kashani, MD / Associate Professor|The University of Texas MD Anderson Cancer Center|713-745-0394|eharrison@mdanderson.org
3171|NCT00399035|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
3172|NCT00399308|Mollie Carter, MD, Medical Director|Shire Regenerative Medicine|(858) 754-5678|mcarter@shire.com
3173|NCT00399360|Dr. Steven Grinspoon, Principal Investigator|Massachusetts General Hospital|617-726-3890|sgrinspoon@partners.org
3174|NCT00399516|Brad Hershey, MS|Boston Scientific|(661) 949-4828|Brad.Hershey@bsci.com
3175|NCT00399542|Raymond Panas, PhD|Sucampo Pharmaceuticals, Inc.|301-961-3400|info@sucampo.com
2736|NCT00366444|Steve Boesing|Xanodyne Pharmaceuticals, Inc.|1-877-926-6396|clinical-trials@xanodyne.com
2737|NCT00366548|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
7152|NCT00541671|Deb Marco|Christiana Care Health System|302-733-4130|DMarco@christianacare.org
7153|NCT00541775|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
7154|NCT00541970|GSK Response Center|GlaxoSmithKline|866-435-7343|
7155|NCT00542178|Dr. Walter Ambrosius, PhD|Wake Forest University School of Medicine|336-716-6281|wambrosi@wakehealth.edu
7156|NCT00588380|Adrian Vella|Mayo Clinic|507-284-3754|vella.adrian@mayo.edu
7157|NCT00588471|Dr. Amir Lerman|Mayo Clinic|507-255-7760|lerman.amir@mayo.edu
7158|NCT00588692|Dr. Barry  A. Borlaug|Mayo Clinic|507-284-4442|borlaug.barry@mayo.edu
7159|NCT00588822|Dr. Benn E. Smith|Mayo Clinic|480-301-6711|bsmith@mayo.edu
7160|NCT00588848|Dr. Dennis Auckley|MetroHealth Medical Center|216-778-7212|dauckley@metrohealth.org
7161|NCT00550550|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
7162|NCT00550589|Jeannette Lee|Statistical Center of AIDS Malignancy  Consortium|(501) 526-6712|jylee@uams.edu
7163|NCT00550654|Deborah Citrin, M.D.|National Cancer Institute, National Institutes of Health|301-496-5457|citrind@mail.nih.gov
7164|NCT00550732|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
7165|NCT00550745|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
7166|NCT00550771|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
7167|NCT00550862|Dr. David Shapiro|Intercept Pharmaceuticals|858-652-6800|dshapiro@interceptpharma.com
7168|NCT00596427|Carine Beysen, PhD|Kinemed, Inc|5106556525 ext 123|cbeysen@kinemed.com
7169|NCT00596466|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7170|NCT00596635|Manisha Juthani-Mehta, MD|Yale University School of Medicine|(203)785-4140|manisha.juthanimehta@yale.edu
7171|NCT00596687|Guillermo Umpierrez|Emory Univ SOM|4047781665|geumpie@emory.edu
7720|NCT00650806|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|Janssen Research & Development, LLC|1 800 526 7736|
7721|NCT00650858|Daniel F. Hanley, MD|Johns Hopkins University|410-614-6996|dhanley@jhmi.edu
7722|NCT00651118|David Ginsberg,..|Meda Pharmaceutical|732 564 2364|david.ginsberg@meda.us
7723|NCT00651157|Evanthia Galanis, M.D.|Mayo Clinic Cancer Center||galanis.evanthia@mayo.edu
7724|NCT00651183|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7725|NCT00651313|George W. Creasy, MD  Vice President, Clinical Research|Columbia Laboratories, Inc.|973-486-8797|gcreasy@columbialabs.com
7726|NCT00651482|Associate Professor of Medicine (Oncology)|Stanford University Medical Center|650-725-2078|sandysri@stanford.edu
7727|NCT00651755|Saroj Vadhan-Raj, MD / Professor|University of Texas MD Anderson Cancer Center||xzhou@mdanderson.org
7728|NCT00651820|Herbert B. Slade, M.D., FAAAI|Healthpoint, Ltd.|817-900-4000|bert.slade@healthpoint.com
7729|NCT00652327|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
7730|NCT00652340|Tracy Parrott|Tragara Pharmaceuticals|858-350-6919|tparrott@tragarapharma.com
7731|NCT00652626|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
7732|NCT00652899|Melissa Geller, M.D.|University of Minnesota, Dept. Ob/Gyn|612-626-3111|gelle005@umn.edu
7733|NCT00652938|GSK Response Center|GlaxoSmithKline|866-435-7343|
7734|NCT00653133|Alan Dine Director of Clinical Research|I-Flow Corporation|513-253-8033|alan.dine@kcc.com
7735|NCT00653159|Dr. Sydeaka Watson, PhD|The University of Chicago Department of Health Studies, Biostatistics Laboratory|773-834-2378|swatson@health.bsd.uchicago.edu
7736|NCT00574275|International Clinical Development Study Director|Sanofi||Contact-Us@sanofi.com
7737|NCT00574340|Dr. Stephen N. Davis|University of Maryland, Baltimore|410-328-2488|sdavis@medicine.umaryland.edu
7738|NCT00574405|Kathryn Thrailkill, MD|Arkansas Children's Hospital Research Institute|501-364-1430|thrailkillkathrynm@uams.edu
3706|NCT00751179|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
3707|NCT00751400|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
3708|NCT00751530|Project Manager|Community Research Initiative|617 502 1700|pmacht@crine.org
3709|NCT00751621|Clinical Trial Disclosure Manager|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
3710|NCT00751634|Dr. Andrew Naidech|Northwestern University|312-503-3335|a-naidech@northwestern.edu
3711|NCT00751777|Head Clinical Development|Valneva Austria GmbH|0043120620 ext 0|info@valneva.com
3712|NCT00751790|Eija Lundström|Debiopharm S.A.|+41 21 3210111|elundstrom@debiopharm.com
3713|NCT00751881|Trial Transparency Team|Sanofi||Contact_US@sanofi.com
3714|NCT00751972|Director Clinical Project Management|HeartWare Inc|508 739-0867|sbell@heartwareinc.com
3715|NCT00751998|Joyce Peetermans, PhD, Director Endoscopy Clinical|Boston Scientific Corporation|508-683-4211|peetermj@bsci.com
3716|NCT00752128|Marianne Wanten|Medtronic Bakken Research Center B.V.|+3143356 ext 6815|marianne.wanten@medtronic.com
3717|NCT00752609|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
3718|NCT00752622|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
3719|NCT00752726|GSK Response Center|GlaxoSmithKline|866-435-7343|
3720|NCT00752791|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
3721|NCT00752973|Director, Clinical Research|Taro Pharmaceuticals U.S.A., Inc.|914 345 9001|natalie.yantovskiy@taro.com
3907|NCT00789438|Christoph Ilies M.D.|Institut für Anästhesiologie und Operative Intensivmedizin, Universitätsklinukum Schleswig-Holstein, Campus Kiel|+49-431-597 ext 2991|christoph.ilies@anaesthesie.uni-kiel.de
3908|NCT00789477|Clinical Trial Management|Regeneron|9148475385|clinicaltrials@regeneron.com
3909|NCT00789529|Dr. George Zikos|Manhattan Vision Associates / Institute for Vision Research|2126884277|gzikos@mvaivr.com
2738|NCT00366626|Dr. Raymond F. Anton,  Distinguished University Professor|Medical University of South Carolina|843-792-1226|antonr@musc.edu
2739|NCT00366678|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
2740|NCT00366899|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
2741|NCT00367055|GSK Response Center|GlaxoSmithKline|866-435-7343|
2742|NCT00367133|Adam R. Glassman, Director DRCR.net Coordinating Center|Jaeb Center for Health Research|813-975-8690|drcrnet@jaeb.org
2743|NCT00367237|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
2744|NCT00367341|Helen Mayberg, MD|Emory University School of Medicine|404-727-6740|hmayber@emory.edu
2745|NCT00367380|Sócrates Herrera MD, principal investigator|Malaria Vaccine and Drug Development|(572) 5216232 - 5574929|sherrera@inmuno.org
2746|NCT00367432|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
2747|NCT00367484|Bettina Stubinski/Senior Medical Director|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|+49 6151 72 5200|service@merckgroup.com
2748|NCT00367679|GSK Response Center|GlaxoSmithKline|866-435-7343|
2749|NCT00367835|Timothy Whitaker, MD|Shire Pharmaceuticals||twhitaker@shire.com
2750|NCT00367991|Stuart Katz, MD|New York University School of Medicine|212-263-3946|stuart.katz@nyumc.org
2751|NCT00368069|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
2752|NCT00368108|Eisai Inc.|Eisai Call Center|888-422-4743|
2753|NCT00368277|Study Director|Novaris Phamaceuticals|862-778-8300|
2754|NCT00368290|Dr. Kyle Kampman|University of Pennsylvania|215-222-3200 ext 109|kampman@mail.med.upenn.edu
2755|NCT00368316|Dr. Rachel Schneerson, Co-Director|PDMI, NICHD, NIH|301-469-0850|schneerr@mail.nih.gov
2756|NCT00368537|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
2757|NCT00368550|Henry R. Kranzler, M.D.|University of Pennsylvania|215-222-3200 ext 137|kranzler_h@mail.trc.upenn.edu
7172|NCT00596752|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
7173|NCT00596817|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com
7174|NCT00596830|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7289|NCT00506597|Robert J. Wells, MD / Professor|The University of Texas (UT) MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
7290|NCT00506662|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
7291|NCT00506675|Raymond Kraker, MSPH|Jaeb Center for Health Research|813-975-8690|pedig@jaeb.org
7292|NCT00506714|Meika A. Fang, MD|Arthritis Foundation|310-478-3711 ext 84503|meika.fang@va.gov
7293|NCT00506831|Lorinda Chung|Stanford University|650-493-5000 ext 62042|shauwei@stanford.edu
7294|NCT00506857|Richard E. Champlin/Professor|UT MD Anderson Cancer Center||ytdinh@mdanderson.org
7295|NCT00506883|Medical Director|AR Scientific, Inc.|215-697-1743|clinicaltrials@urlmutual.com
7296|NCT00506922|Marcos de Lima, MD / Professor|UT MD Anderson Cancer Center|713-745-3219|bmcmullin@mdanderson.org
7297|NCT00506948|Amin Alousi, MD / Professor|University of Texas (UT) MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
7298|NCT00574080|Nathan M. Petty|University of Arkansas for Medical Sciences, Myeloma Institute|501-526-6990 ext 2461|PettyNathanM@uams.edu
7299|NCT00574145|Nancy Wells, DNSc., R.N|Vanderbilt-Ingram Cancer Center|615-322-6184|nancy.wells@vanderbilt.edu
7300|NCT00574249|Medical Information Specialist|Abbott|1-800-633-9110|
7301|NCT00617279|Chad Badorek, Clinical Study Manager|W. L. Gore & Associates, Inc.|928.864.3486|cbadorek@wlgore.com
7302|NCT00617305|Ellen Shen, PhD, Senior Manager, Regulatory Affairs|Gilead Sciences|+1 (650) 522-5278|Ellen.Shen@gilead.com
7303|NCT00617396|Dr. Douglas Drossman|UNC Chapel Hill|919-966-0141|douglas_drossman@med.unc.edu
7304|NCT00617461|XenoPort Call Center|XenoPort, Inc.|877-936-6778|
7305|NCT00617591|Rachid Baz, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-8212|rachid.baz@moffitt.org
7841|NCT00646399|Irwin Scher, MD|Biosynexus|301-330-5800|irwinscher@biosynexus.com
7842|NCT00646581|Matthew Goodnow|UMass Medical School|508-856-2494|matthew.goodnow@umassmed.edu
7843|NCT00504660|Charles A. Conrad, MD / Professor|UT MD Anderson Cancer Center|713-745-1896|skang@mdanderson.org
7844|NCT00504725|Andrew Shaw MD|Duke University Medical Center|9192866938|andrew.shaw@duke.edu
7845|NCT00504777|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
7846|NCT00504985|Xin Shelley Wang, MD, MPH / Associate Professor|UT MD Anderson Cancer Center|713-745-3504|
7847|NCT00576732|Clinical Leader|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|609 730 2317|
7848|NCT00576758|Medical Communications|Hoffman-LaRoche|800-821-8590|
7849|NCT00576823|Trial Transparency Team|sanofi-aventis||Contact-Us@sanofi-aventis.com
7850|NCT00576901|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
7851|NCT00576927|Dr. Patricia Griffiths|Emory University Division of General Medicine and Geriatrics|404-321-6111 ext 7138|pcgriff@emory.edu
7852|NCT00577096|Elizabeth Ann Coleman|University of Arkansas for Medical Sciences|501-661-7902|colemanelizabetha@uams.edu
7853|NCT00577122|Kathy Miller, MD|IndianaU||kathmill@iupui.edu
7854|NCT00577135|Jeff Sharp|Duke University|919.668.7086|jeff.sharp@dm.duke.edu
7855|NCT00577356|Jacqueline Vuky, MD|Virginia Mason Medical Center|(206) 223-6193 ext 32246|Jacqueline.Vuky@vmmc.org
7856|NCT00619489|Medical Director|Millennium Pharmaceuticals Inc|800-778-2860|clinicaltrialregistry@tpna.com
7857|NCT00619502|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
7858|NCT00619619|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7859|NCT00619762|Director of Clinical Operations|LifeCell|908.809.7856|djacobs@lifecell.com
7860|NCT00619801|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
3910|NCT00789555|Terri Pasquine, Sr. Clinical Lead|Alcon Research|817-551-4760|terri.pasquine@alconlabs.com
3911|NCT00789672|Raymond Kraker, MSPH|Jaeb Center for Health Research|813-875-8690|pedig@jaeb.org
3912|NCT00789698|Medical Director, CNS|Sunovion Pharmaceuticals|1-866-503-6351|
3913|NCT00789724|Antonio Abbate, MD, PhD|VCU Pauley Heart Center|8048280513|aabbate@mcvh-vcu.edu
3914|NCT00789737|Director Metabolic Clinical Development|Daiichi Sankyo Pharma Development|732-590-5000|
3915|NCT00789815|Ting-Yu Lin|Chung Gung Memorial Hospital|886 3 3281200 ext 5108|yuebaoyuebao@yahoo.com.tw
3916|NCT00789828|Study Director|Novartis Pharmaceuticals|862-778-8300|
3917|NCT00789854|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3918|NCT00789880|Associate Director, Clinical Research Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
3919|NCT00790023|Respiratory Medical Director|Sunovion|1-866-503-6351|
3920|NCT00790062|Alan T. N. Tita, MD|University of Alabama at Birmingham|(205) 934-9616|atit@uab.edu
3921|NCT00832572|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
3922|NCT00755235|Gregory Simon, Principal Investigator|Group Health Research Institute|206-287-2979|simon.g@ghc.org
3923|NCT00755274|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
3924|NCT00755417|Head of Research & Development|Depomed|650-462-5900 ext 108|msweeney@depomed.com
3925|NCT00755755|Dr Elke Bestel|PregLem S.A.|+41 22 884 03 40|medical@preglem.com
3926|NCT00755807|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
3927|NCT00755846|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
3928|NCT00755911|Darnell Kaigler|University of Michigan|734-998-1468|dkaigler@umich.edu
3929|NCT00755937|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
2758|NCT00368641|Bruce Culleton, MD|Baxter Healthcare|800-422-9837|onebaxter@baxter.com
2896|NCT00395486|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
2897|NCT00395512|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
2898|NCT00395629|Study Director|Novartis Pharmaceuticals|862-778-8300|
2899|NCT00395642|Katerina de Metz (Director, Clinical Studies)|BIOTRONIK, Inc.|800-547-0394|katerina.demetz@biotronik.com
2900|NCT00395694|GSK Response Center|GlaxoSmithKline|866-435-7343|
2901|NCT00395733|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
2902|NCT00395746|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
2903|NCT00395850|Dr. Alison Oliveto|University of Arkansas for Medical Sciences|501-526-8441|olivetoalison@uams.edu
2904|NCT00395863|Gianpaolo Pirovano|Executive Director, Head Corporate Medical Development|609-514-2226|gianpaolo.pirovano@diag.bracco.com
2905|NCT00395876|Medical Communications|Genentech, Inc.|800-821-8590|
2906|NCT00395967|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
2907|NCT00395993|Marc Tokars|Luitpold Pharmaceuticals, Inc.|610-650-4200|mtokars@lpicrd.com
2908|NCT00396006|David Gelmont, MD Global Medical Director, Head of Specialty Products TA, BioTherapeutics|Baxter Healthcare Corporation||david_gelmont@baxter.com
2909|NCT00396032|Medical Communications|Genentech, Inc.|800-821-8590|
2910|NCT00396084|John L. Johnson, M.D.|Case Western Reserve University, Tuberculosis Research Unit|(216) 368-1949|jlj@case.edu
2911|NCT00396097|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2912|NCT00396136|Clinical Studies|Biotronik, Inc.|503-451-8050|katerina.demetz@biotronik.com
2913|NCT00396201|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
2914|NCT00396253|Medical Communications|Genentech, Inc.|800-821-8590|
7306|NCT00617669|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7307|NCT00617708|Study Statistician|SWOG|206-667-4623|
7308|NCT00617773|Dr. Oren Smaletz, M.D., Medical Director|Recepta Biopharma|55 11 3709-2140|oren.smaletz@receptabiopharma.com.br
7309|NCT00617851|Posting Director|Novartis Vaccines and Diagnostics||RegContactVacUS.nvdit@Novartis.com
7310|NCT00617903|Therapeutic Area Head|Bayer HealthCare Pharmaceuticals, Inc. (formerly Intendis GmbH)||clinical-trials-contact@bayerhealthcare.com
7311|NCT00618072|Harriette R. Mogul MD MPH|New York Medical College|914-594-2278|Harriette_Mogul@NYMC.edu
7426|NCT00668746|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|OraPharma|215-420-4064|bpatel@orapharma.com
7427|NCT00668863|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7428|NCT00669019|Dr. Thomas F. Gajewski|University of Chicago|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu
7429|NCT00669071|Ronald W. Gottschalk, MD / Medical Director|Galderma Laboratories, L.P.|817-961-5358|ron.gottschalk@galderma.com
7430|NCT00669110|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7431|NCT00669214|Medical Communications|Genentech, Inc.|800-821-8590|
7432|NCT00669240|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7433|NCT00669279|Dr. Benjamin J Epstein|University of Florida|3523590945|epstein@cop.ufl.edu
7434|NCT00669318|Timothy G. Call MD|Mayo Clinic Cancer Center||call.timothy@mayo.edu
7435|NCT00676403|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
7436|NCT00676455|Christopher Wald, MD|Lahey Clinic|781-744-8710|Christopher.Wald@lahey.org
7437|NCT00676494|Kevin Peters/Director of Clinical Affairs|Pathway Medical Technologies, Inc.|425-636-4053|petersk@pathwaymedical.com
7438|NCT00676520|Ellen Travis|Abbott Vascular|408-845-3000|Ellen.Travis@av.abbott.com
7439|NCT00676650|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7739|NCT00574548|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7740|NCT00574704|Head of Clinical Develpment|Cytos Biotechnology AG|+41 44 733 4 ext 7 47|info@cytos.com
7741|NCT00574795|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
7742|NCT00574873|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7743|NCT00575016|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
7744|NCT00575029|Dr. Donald Bodenner|University of Arkansas|501-526-5710|bodennerdonald@uams.edu
7745|NCT00575042|Dr. Cynthia Levy|University of Miami|305-243-2330|clevy@med.miami.edu
7746|NCT00575094|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
7747|NCT00575146|Dr. Johannes Rieger|Dr. Senckenberg Institute of Neurooncology|+49 69 6301 ext 87711|johannes.rieger@med.uni-frankfurt.de
7748|NCT00575367|Karen Kuhn/ Director|Inspire Pharmaceuticals, Inc.|919 941-9777|kkuhn@inspirepharm.com
7749|NCT00575380|Mike Schiewe|Inspire|919-941-9777|mschiewe@inspirepharm.com
7750|NCT00575510|Dr. Carmen Radecki Breitkopf|Mayo Clinic|507-266-0969|radeckibreitkopf.carmen@mayo.edu
7751|NCT00575588|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7752|NCT00575666|Xiaoduo Fan, MD, MPH, MS|UMass Medical School|508-856-3881|Xiaoduo.Fan@umassmed.edu
7753|NCT00575887|Ufuk Abacioglu|Marmara University|902123853100|ufuk@abacioglu.com
7754|NCT00576147|Claudia Robertson|Baylor College of Medicine|(713) 798-8932|claudiar@bcm.edu
7755|NCT00576199|Medical Communications|Hoffmann-La Roche|800 821-8590|
7756|NCT00576251|Alcon Clinical|Alcon Research, Ltd|888.451.3937; 817.568.6725|medinfo@alconlabs.com
7757|NCT00576316|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7758|NCT00576381|Dr Athena Zuppa|The Children's Hospital of Philadelphia|267-426-5753|zuppa@email.chop.edu
4134|NCT00705536|Vice President, Endocrinology Clinical Development|Halozyme Therapeutics, Inc.|(858) 794-8889|
4135|NCT00705575|Study Director|Novartis Pharmaceuticals|862 778-8300|
4136|NCT00705614|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4137|NCT00705653|Michael Fitzgerald|Progen Industries|919-803-9988|michaelf@progen-pharma.com
4138|NCT00712244|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
4139|NCT00712335|Dr. Chang-Keun Kim|Inje University|82-2-950-8832|kimck@paik.ac.kr
4140|NCT00712348|VP Medical Affairs|Protalix Ltd.|+972-4-9028100|raul@protalix.com
4141|NCT00712530|Dr. Denes Banhegyi|Szent Laszlo Hospital, Budapest, Hungary|+3614558152|immunol@mail.datanet.hu
4142|NCT00712543|Bryan Voss, Ph.D.|Cumberland Pharmaceuticals Inc.|615-255-0068|bvoss@cumberlandpharma.com
4143|NCT00712725|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4144|NCT00712920|William Wheeler, PhD|Meda Pharmaceuticals|732-564-2393|WWheeler@medapharma.us
4145|NCT00712959|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
4146|NCT00712985|Allan Lipton, MD|Milton S. Hershey Medical Center|717-531-5960|alipton@hmc.psu.edu
4147|NCT00713206|Clinical Research Manager|Biomet 3i LLC|5617766722|cristina.matthews@biomet.com
4148|NCT00713258|Clinical Trial Operations|Nycomed|+45 4677 1111|clinicaltrials@nycomed.com
4149|NCT00713310|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
4150|NCT00713323|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd.|0044 1223 266800|rp@gwpharm.com
4151|NCT00713349|Jaime Dickerson, PhD|Smith & Nephew Biotherapeutics|817-302-3914|jaime.dickerson@smith-nephew.com
4152|NCT00713479|Dr Edythe London|University of California, Los Angeles|(310) 825-0606|elondon@mednet.ucla.edu
4153|NCT00713544|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
2915|NCT00396266|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
2916|NCT00396279|Study Director|Amgen Inc.|866-572-6436|
2917|NCT00396292|Marc Tokars|Luitpold Pharmaceuticals, Inc.|610-650-4200|mtokars@lpicrd.com
2918|NCT00396318|Medical Communications|Genentech, Inc.|800-821-8590|
2919|NCT00396331|Medical Monitor|Genzyme||medinfo@genzyme.com
3037|NCT00392288|Respiratory Medical Advisor|Nycomed GmbH|0049-7531-840|clinicaltrials@nycomed.com
3038|NCT00411411|Dr. Kasper Aaboe|Gentofte University Hospital|+4522170200|kasper@dadlnet.dk
3039|NCT00411554|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
3040|NCT00411749|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
3041|NCT00412061|Study Director|Novartis Pharmaceuticals|862-778-8300|
3042|NCT00412113|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3043|NCT00412243|Stefan Fader, M.D./Associate Professor|The University of Texas M. D. Anderson Cancer Center|713/745-4613|eharriso@mdanderson.org
3044|NCT00412373|Vice President, Medical Affairs, CNS|Ortho McNeil Janssen Scientific Affairs, LLC|609-730-2136|jhulihan@its.jnj.com
3045|NCT00412425|Agop Bedikian, MD Professor|UT MD Anderson Cancer Center||asreckew@mdanderson.org
3046|NCT00412451|Aniz Girach, MD|ThromboGenics NV|+32 16751310|aniz.girach@thrombogenics.com
3047|NCT00412464|Guy Young|Children's Hospital Los Angeles|323-361-5507|gyoung@chla.usc.edu
3048|NCT00412529|Study Director|Novartis Pharmaceuticals|862-778-8300|
3049|NCT00412542|Vinay Puduvalli, MD / Associate Professor|UT MD Anderson Cancer Center|713-745-5769|kuhunter@mdanderson.org
3050|NCT00412737|Medical Communications Specialist|Hoffmann-La Roche|800-821-8590|
3051|NCT00412750|Study Director|Novartis Pharmaceuticals|862-778-8300|
7440|NCT00676676|Dr. Karen K. Miller|Massachusetts General Hospita|617-726-3870|kkmiller@partners.org
7441|NCT00676780|Dr. Jerry W. McLarty, Ph.D.|LSUShreveport|(318)813-1446|jmclar@lsuhsc.edu
7442|NCT00676793|Dr. Jerry w. McLarty, Ph.D.|LSU Health, Shreveport|(318)813-1446|jmclar@lsuhsc.edu
7443|NCT00683020|Dean Schillinger, MD/Study Principal Investigator|University of California, San Francisco|415-206-8940|dschillinger@medsfgh.ucsf.edu
7444|NCT00683046|Dr. Andrew Artz|University of Chicago Medicine|773-834-8980|aartz@medicine.bsd.uchicago.edu
7445|NCT00683085|Hitomi Nagayama, M.D., Ph.D. / Project Lecturer|Research Hospital, The Institute of Medical Science, The University of Tokyo|+81-3-3443-8111|zephyrus@ims.u-tokyo.ac.jp
7446|NCT00683163|Dr. Dennis Black|UNIVERSITY OF CALIFORNIA, SAN FRANCISCO|415-514-8159|dblack@psg.ucsf.edu
7447|NCT00683293|Dimtri SARLOS|Kantonsspital Aarau|00418384141|la.kots@ksa.ch
7539|NCT00526123|Dr. Klemens B. Meyer|Tufts Medical Center|617-636-9421|kmeyer@tuftsmedicalcenter.org
7540|NCT00526162|CRDM Core Clinical Organization|Medtronic CRDM|800-328-2518|jamie.l.reynolds@medtronic.com
7541|NCT00526188|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
7542|NCT00526227|CRDM Core Clinical Organization|Medtronic CRDM|800-328-2518|jamie.l.reynolds@medtronic.com
7543|NCT00683930|Medical Communications|Hoffmann-La Roche|800-821-8590|
7544|NCT00684021|Lemuel Moye, MD, PhD|UT-Houston School of Public Health|713-500-9518|Lemmoye@msn.com
7545|NCT00684060|Lemuel Moye, MD, PhD|UT-Houston School of Public Health|713-500-9518|Lemmoye@msn.com
7546|NCT00684073|Head, Clinical Trials Registry and Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
7547|NCT00684138|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
7548|NCT00684177|GSK Response Center|GlaxoSmithKline|866-435-7343|
7549|NCT00534313|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
7550|NCT00534352|Vice President, Tibotec Therapeutics Clinical Affairs|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|877-732-2488|
7779|NCT00585221|Director of Clinical Trials|Huntsman Cancer Institute|801-213-4241|candace.larson@hci.utah.edu
7780|NCT00585286|Christopher Zachary, FRCP, MBBS/Prinicipal Investigator|University of California, Irvine|(949) 824-7103|czachary@uci.edu
7781|NCT00585351|Enrique Leira, MD, MS|University of Iowa|319-356-8755|enrique-leira@uiowa.edu
7782|NCT00585494|Ann Marie Sheehy, M.D., M.S.|University of Wisconsin Madison|608-335-6734|asr@medicine.wisc.edu
7783|NCT00585533|Wallace Akerley, MD|Huntsman Cancer Institute/University of Utah|801-585-5986|wallace.akerley@hci.utah.edu
7784|NCT00585650|Steven Feldman, MD, PhD|Wake Forest Baptist Health, Department of Dermatology|336-716-3775|sfeldman@wakehealth.edu
7785|NCT00585689|Dr. David Smith, M.D.|University of Michigan Comprehensive Cancer Center|734-936-6884|dcsmith@umich.edu
7786|NCT00627523|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7787|NCT00627679|VP, Scientific Affairs|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|(650) 386-3100|dkellerman@mappharma.com
7788|NCT00627861|Warren Bobb, N.P.|The Rogosin Institute|212-746-9114|wab9006@nyp.org
7789|NCT00627926|Jeff Chodakewitz, M.D.|Vertex Pharmaceuticals Incorporated|617-341-6777|Jeff_Chodakewitz@vrtx.com
7790|NCT00628108|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
7791|NCT00628134|Tim Corcoran, Ph.D.|University of Pittsburgh|412-624-8918|corcorante@upmc.edu
7792|NCT00591266|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
7793|NCT00591578|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
7794|NCT00591591|Antonios Michalos|ISS, Inc., Champaign Illinois|217-359-8681|antonios.michalos@iss.com
7795|NCT00591721|Marcia Finlayson, PhD|University of Illinois at  Chicago|312-996-4603|marciaf@uic.edu
7796|NCT00591734|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
7797|NCT00591760|Prof. Antonio Cittadini|Federico II University|0039(0)817464375|antonio.cittadini@unina.it
4154|NCT00713596|Dr. Oren Friedman|Mayo Clinic|507-538-1392|
4155|NCT00713648|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
4156|NCT00713661|Clinical Trial Operations|Nycomed|+45 4677 1111|clinicaltrials@nycomed.com
3722|NCT00753012|Dr. Paul Hammerness|Massachusetts General Hospital|(503)617-1040|phammerness@partners.org
3723|NCT00753142|Guillermo Umpierrez|Emory University|404-778-1665|geumpie@emory.edu
3724|NCT00753272|GSK Response Center|GlaxoSmithKline|866-435-7343|
3725|NCT00753298|Head of Therapeutic Area Health Care|Astra Tech AB|+46317763000|
3726|NCT00753337|Beaux Alexander-Director of Clinical Affairs|Medtronic EndoVascular Therapies|707 591 7291|beaux.s.alexander@medtronic.com
3727|NCT00753415|Senior Vice President, Global Clinical Development|Merck Sharpe & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
3728|NCT00753454|UCB (Study Director)|UCB Clinical Trial Call Center|1-887-822-9493|
3729|NCT00435825|Medical Communications|Hoffman-LaRoche|800-821-8590|
3730|NCT00436007|GSK Response Center|GlaxoSmithKline|866-435-7343|
3731|NCT00436046|Robert Couch, MD|Baylor College of Medicine|713-798-4474|rcouch@bcm.tmc.edu
3732|NCT00436345|GSK Response Center|GlaxoSmithKline|866-435-7343|
3733|NCT00436553|Study Director|Novartis Pharmaceuticals|862 778-8300|
3734|NCT00436566|Dr. Edith A. Perez|Mayo Clinic|507-266-0800|perez.edith@mayo.edu
3735|NCT00436605|Harriet Kluger|Yale University School of Medicine|203-737-2572|Harriet.Kluger@yale.edu
3736|NCT00436618|Thomas E. Witzig M.D.|Mayo Clinic|(507) 284-0527|witzig.thomas@mayo.edu
3737|NCT00436644|Dr. Paul Haluska|Mayo Clinic|507-266-2123|haluska.paul@mayo.edu
3738|NCT00436826|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
3052|NCT00412867|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
3053|NCT00412932|John Raia|Daiichi Sankyo|973-630-2683|jraia@dsus.com
3054|NCT00412958|Aniz Girach|ThromboGenics|+32 16751310|aniz.girach@thrombogenics.com
3055|NCT00412971|Gregers G. Hermann|Fredriksberg hospital|(+45) 38163536|gregershermann@hotmail.com
3056|NCT00412984|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
3057|NCT00413010|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3058|NCT00413036|Associate Director, Clinical Trial Disclosure|Celgene|1-888-260-1599|clinicaltrialdisclosure@celgene.com
3059|NCT00413049|Study Director|Novartis Pharmaceuticals|862 778-8300|
3176|NCT00399568|Mike Royal, MD, JD, MBA.Vice President Clinical Development-Analgesics|Cadence Pharmaceuticals|858 436 1400|mroyal@cadencepharm.com
3177|NCT00399893|Michael Freemark, MD|Duke University Medical Center|919-684-5091|andrea.haqq@albertahealthservices.ca
3178|NCT00400153|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257 Option 4|clintriage.rdg@boehringer-ingelheim.com
3179|NCT00400179|Fabio Benedetti, MD, Chief Medical Officer|Taiho Pharma USA, Inc.|609-750-5300|benedetti@taihopui.com
3180|NCT00400205|Nabil Saba, MD|Emory University Winship Cancer Institute|1-888-946-7447|nfsaba@emory.edu
3181|NCT00400400|Study Director|Novartis Pharmaceuticals|862-778-8300|
3182|NCT00400569|Alberto Chiappori, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-2158|alberto.chiappori@moffitt.org
3183|NCT00400634|Raymond T. Bartus, Executive Vice President and Cheif Scientific Officer|Ceregene, Inc.|858-458-8823|rtbartus@ceregene.com
3184|NCT00400764|Medical Communications|Hoffman-LaRoche|800-821-8590|
3185|NCT00400803|Arkadiusz Dudek, M.D.|Masonic Cancer Center, University of Minnesota|612-624-0123|dudek002@umn.edu
3186|NCT00400881|Juan Figueroa-Casas|Texas Tech University|915 5456626 ext 235|juan.figueroa@ttuhsc.edu
3187|NCT00401102|Dr. Colleen Jacobsonn|Iona College|646-207-3563|cjacobson@iona.edu
7551|NCT00534417|Vice President of Scientific Affairs|Accelerated Community Oncology Research Network, Inc.|901-435-5570|mwalker@acorncro.com
7552|NCT00534599|Gerard Lynch|AstraZeneca||AZtrial_results_posting@astrazeneca.com
7553|NCT00534794|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp||clinicaltrialsdisclosure@merck.com
7554|NCT00534833|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
7555|NCT00534937|Dr. Satish Muluk|Allegheny General Hospital|(412) 359-3714|muluk@usa.net
7556|NCT00534976|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
7557|NCT00535132|Vice President, Medical Affairs, CNS|Ortho McNeil Janssen Scientific Affairs, LLC|609-730-2136|
7558|NCT00535145|Vice President, Medical Affairs, CNS|Ortho-McNeil Janssen Scientific Affairs, LLC|609-730-2136|
7559|NCT00535288|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7560|NCT00535301|John N. Nguyen, MD|SCPMG|562-657-2642|john.n.nguyen@kp.org
7561|NCT00535392|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
7175|NCT00596947|Jennifer Trofe-Clark, Clinical Transplant Research Pharmacist|Hospital of the University of Pennsylvania|215-614-4274|jennifer.trofe-clark@uphs.upenn.edu
7176|NCT00597012|Jeffrey N. Katz, MD, MSc|The Brigham and Women's Hospital|617-732-5338|jnkatz@partners.org
7177|NCT00597038|Adil Daud, Director, Melanoma Clinical Research|UCSF Helen Diller Family Comprehensive Cancer Center|415-353-7392|adaud@medicine.ucsf.edu
7178|NCT00597116|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7179|NCT00597207|Sr. Director of Clinical Research|ZOLL Medical Corporation|978-421-9655|uherken@zoll.com
7180|NCT00597376|Raj C. Shah, MD|Rush University Medical Center|312-563-2902|Raj_C_Shah@rush.edu
7181|NCT00597402|Annick Desjardins, MD, FRCPC|Duke University Medical Center|9196846173|annick.desjardins@duke.edu
7182|NCT00597493|David Reardon, MD|Duke University Health System|617-632-2166|David_Reardon@DFCI.harvard.edu
8249|NCT00546637|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
8250|NCT00546728|Aaron S. Kelly, Ph.D.|University of Minnesota|612-626-3492|kelly105@umn.edu
8251|NCT00546754|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
8252|NCT00546819|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
8253|NCT00546871|Richard Schiff, MD, PhD, Medical Director, Specialty Products TA, BioTherapeutics|Baxter Healthcare Corporation||richard_schiff@baxter.com
8254|NCT00546910|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8255|NCT00547157|Study Director|Amgen Inc.|866-572-6436|
8256|NCT00547365|Alan Solomon, MD|University of Tennessee Graduate School of Medicine|865-305-9167|asolomon@utmck.edu
8257|NCT00521456|Therapeutic Area Head|Allergan, Inc.|(714)246-4500|clinicaltrials@allergan.com
8258|NCT00521599|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
8259|NCT00521924|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
8260|NCT00521976|Dennis W.T. Nilsen MD PhD FESC FAHA|Stavanger University Hospital|+4705151 ext 9455|nide@sus.no
8261|NCT00521989|Margaret Lee, PhD|Zalicus|617-301-7142|mlee@zalicus.com
8262|NCT00522171|Sheryl Helsinger|Ethicon Endo-Surgery|513-337-3079|SHelsing@its.jnj.com
8263|NCT00522275|UCB (Study Director)|UCB Clinical Trial Call Center|+1 887 822 9493|
8264|NCT00522379|UCB (Study Director)|UCB Clinical Trial Call Center|+1 887 822 9493|
8265|NCT00522418|Senior Director, Global Medical Affairs|Cyberonics, Inc|281-228-7223|Mark.Bunker@cyberonics.com
8266|NCT00522431|Fiona Miller|Strakan Pharmaceuticals Ltd.|01896 66868|fiona.miller@prostrakan.com
8267|NCT00522457|Manager of Regulatory Affairs|Fresenius Biotech North America|781-699-4652|bao.le@fresenius-biotech.com
8268|NCT00522626|Dr. Lauren Jansson|Johns Hopkins University School of Medicine|410-550-5438|ljansson@jhmi.edu
3739|NCT00436852|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
3740|NCT00436904|Dr. Clive Zent|Mayo Clinic|507-284-5362|zent.clive@mayo.edu
3741|NCT00436917|Stephanie L. Hines, M.D.|Mayo Clinic Jacksonville|507-266-0800|hines.stephanie@mayo.edu
3742|NCT00436956|William L. Dahut, M.D.|National Cancer Institute|301-435-8183|dahutw@mail.nih.gov
3743|NCT00436969|Aileen Michael|DePuy Mitek|508.828.3337|amichae2@its.jnj.com
3744|NCT00437073|GSK Response Center|GlaxoSmithKline|866-435-7343|
3745|NCT00437125|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
3930|NCT00756002|Sr VP, Clinical Science|Takeda Global Research & Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
3931|NCT00798577|Alcon Clinical|Alcon Labs|1.888.451.3937; 817.568.6725|medinfo@alconlabs.com
3932|NCT00798707|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3933|NCT00798759|Director of Alcon Clinical|Alcon Research, Ltd.|1-888-451-3937|medinfo@alconlabs.com
3934|NCT00798889|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3935|NCT00798967|Head, Clinical Development|NPS Pharmaceuticals|908-450-5300|
3936|NCT00799227|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
3937|NCT00799292|Charles Ascher-Walsh MD, MPH|Mt Sinai School of Medicine, Department of Obstetrics and Gynecology|212-241-2827|charles.ascher-walsh@mssm.edu
3938|NCT00799409|VP Medical Affairs, CNS|Ortho-McNeil Janssen Scientific Affairs, LLC|609-730-2136|
3939|NCT00799422|Head, Alcon Clinical|Alcon Research, Ltd.|1-888-451-3937|medinfo@alconlabs.com
3940|NCT00799474|Dr. Noel Brewer, PhD|The University of North Carolina at Chapel Hill, Gillings School of Global Public Health|919-966-3282|ntb1@unc.edu
3941|NCT00799487|VP Medical Affairs, CNS|Ortho-McNeil Janssen Scientific Affairs, LLC|609-730-2136|
3942|NCT00799578|Dr. Joel Lavine|Columbia University|212 304 5533|jl3553@columbia.edu
3188|NCT00401193|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
3189|NCT00401245|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3190|NCT00401258|Brian Brennan, M.D.|McLean Hospital|617-855-2911|bbrennan@partners.org
3191|NCT00401401|Eva Järlid Westerberg, VP Clinical Operations|Genmab A/S|+45 7020 2728|E.Westerberg@genmab.com
3192|NCT00401414|Mark A. Creager|Brigham and Women's Hospital|617-732-5267|mcreager@partners.org
3193|NCT00401531|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
3194|NCT00401544|Study Director|Amgen Inc.|866-572-6436|
3195|NCT00401622|Mike Grady|LifeScan Scotland|(44) 01463 721889|mgrady@its.jnj.com
3196|NCT00401726|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
3197|NCT00401752|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3198|NCT00401830|Study Director|UCB Clinical Trial Call Center|+1 877 822 9493|
2759|NCT00368745|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2760|NCT00368849|Leigh J. Beglinger, Ph.D.|The University of Iowa|319-335-8765|leigh-beglinger@uiowa.edu
2761|NCT00368927|James R. Jett, M.D.|National Jewish Health|303-270-2601|JettJ@NJHealth.org
2762|NCT00368966|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
2763|NCT00368979|GSK Response center|GlaxoSmithKline|866-435-7343|
2764|NCT00369122|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@acr.org
2765|NCT00369161|Study Director|Novartis Pharmaceuticals|862-778-8300|
2766|NCT00369226|John Koreth, MBBS, D.Phil|Dana-Farber Cancer Institute|(617) 632-2949|jkoreth@partners.org
2767|NCT00369265|Robert T. Sataloff, M.D., D.M.A., FACS|Philadelphia ENT Associates|215-545-3322|rtsataloff@phillyent.com
2768|NCT00369278|Study Director|Novartis Pharmaceuticals|862-778-8300|
7183|NCT00597506|Herbert Hurwitz, MD|Duke University Medical Center|919-668-1861|herbert.hurwitz@duke.edu
7184|NCT00597584|Vice President, Clinical Development|Affymax|650-812-8700|info@affymax.com
7185|NCT00597701|Charles E Gessert, MD, MPH|Essentia Health|218-786-8176|cgessert@eirh.org
7186|NCT00597714|David Rizzieri, MD|Duke University Medical Center|919-668-1040|david.rizzieri@duke.edu
7187|NCT00597753|Vice President, Clinical Development|Affymax|650-812-8700|info@affymax.com
7188|NCT00571649|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
7189|NCT00571662|Bryan Ludwig, Regulatory Coordinator|University of Nebraska Medical Center Division of Oncology/Hematology|402-559-8071|bmludwig@unmc.edu
7190|NCT00571961|R. Douglas Bruce, MD, MA, MSc|Yale University AIDS Program|(203) 737-6133|robert.bruce@yale.edu
7191|NCT00571974|Gal Shafirstein, D.Sc.|Roswell Park Cancer Institute|716-845-4025|Gal.Shafirstein@RoswellPark.org
7192|NCT00572260|Yong Choi, Clinical Research Coordinator|Duke University Health System|919-684-7584|yong.choi@duke.edu
7193|NCT00572533|Adam E Gaweda|University of Louisville|502-852-0766|adam.gaweda@louisville.edu
7194|NCT00572832|Richard Zimmerman|University of Pittsburgh|412-383-2354|zimmer@pitt.edu
7195|NCT00572910|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7196|NCT00573066|Athena Zuppa|Children's Hospital of Philadelphia|267-426-7359|zuppa@email.chop.edu
7312|NCT00618332|Dr. Robert Naclerio|University of Chicago|773-702-0080|rnacleri@surgery.bsd.uchicago.edu
7313|NCT00618410|Dr. Robert M. Naclerio, MD|The University of Chicago|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu
7314|NCT00618436|Dr. Lori Shutter|University of Pittsburgh|1-412-647-8410|shutterla@upmc.edu
7315|NCT00618449|Julius Schachter, PhD / Emeritus Professor of Laboratory Medicine|University of California, San Francisco|+1 (415) 824-5115|Julius.Schachter@ucsf.edu
7316|NCT00618748|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
7759|NCT00576420|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery|BAXTER INNOVATIONS GmbH||edith_hantak@baxter.com
7760|NCT00576472|Heather Conklin PhD|St. Jude Children's Research Hospital|1-866-278-5833|info@stjude.org
7761|NCT00576524|Marsha Wallace|Children's Hospital of Philadelphia|(215) 590-0119|wallacem@email.chop.edu
7762|NCT00576576|Dr. Habib Samady|Emory|4047781237|hsamady@emory.edu
7763|NCT00576693|Marc I. Chimowitz, MBChB|Medical University of South Carolina|843-792-3020|mchimow@musc.edu
7764|NCT00583947|Respiratory Medical Director|Sepracor Inc|866-503-6351|
7765|NCT00584220|Kurt Moody, OD, FAAO|Vistakon|904-443-3088|kmoody1@its.jnj.com
7766|NCT00584415|Sunny Po, MD., Study Principal Investigator|University of Oklahoma Health Sciences Center|405-271-9696|sunny-po@ouhsc.edu
7767|NCT00584480|Robert L. Hendren, D.O.|UCSF|415-476-7198|Robert.Hendren@ucsf.edu
7768|NCT00584701|Robert Hendren, DO|UCSF|415-476-7198|robert.hendren@ucsf.edu
7769|NCT00584727|Kurt Moody, OD, FAAO|Vistakon|904-443-3088|
7770|NCT00584831|Kurt Moody, OD, FAAO|Vistakon|904-443-3088|kmoody1@its.jnj.com
7771|NCT00584857|J. Michael Straughn, MD|UAB|205-934-4986|Michael.straughn@ccc.uab.edu
7772|NCT00584909|J. MIchael Straughn, MD|UAB|205-934-4986|Michael.Straughn@ccc.uab.edu
7773|NCT00584935|Wendy Cantrell, CRNP|UAB Department of Dermatology|205-502-9960|wcantrell@uabmc.edu
7774|NCT00584987|Dr. Robert M. Naclerio, MD|The University of Chicago|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu
7775|NCT00585039|Dr Blake Bulloch|Phoenix Children's Hospital|602-546-1950|bbulloch@phoenixchildrens.com
7776|NCT00585104|Andrew D. Michaels, MD|University of Utah Health Sciences Center|(801) 585-5971|Andrew.Michaels@hsc.utah.edu
7777|NCT00585169|Marc N. Potenza, M.D., Ph.D.|Yale Unviersity|203-737-3553|marc.potenza@yale.edu
7778|NCT00585182|Dr Robert Pendleton|University of Utah|801 581 7818|robert.pendleton@hsc.utah.edu
3943|NCT00799591|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3944|NCT00799604|Jason Campagna. MD, PhD|The Medicines Company|973-290-6199|jason.campagna@themedco.com
3945|NCT00799643|Allison B.Goldfine|Joslin Diabetes Center|617-309-2400|allison.goldfine@joslin.harvard.edu
3946|NCT00799708|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
3947|NCT00799773|Susan F. Assmann, PhD|New England Research Institutes, Inc.|617-923-7747 ext 548|sassmann@neriscience.com
3948|NCT00799825|GSK Response Center|GlaxoSmithKline|866-435-7343|
3949|NCT00440297|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
3950|NCT00440401|Medical Responsible|Medical Scientific Strategy|+45 4677 1111|clinicaltrials@nycomed.com
3951|NCT00440466|Peter Bowers|J&J PRD|908-927-2116|
3952|NCT00440505|Pamela Flood, MD|Columbia University|212-305-2008|pdf3@columbia.edu
4112|NCT00834171|Vice President Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
4113|NCT00834197|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4114|NCT00834210|Vice President, Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
4115|NCT00834249|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4116|NCT00834275|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
4117|NCT00834288|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
4118|NCT00704769|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
4119|NCT00704808|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
4120|NCT00704847|Bente Juel Riis, Medical Director|Nordic Bioscience A/S|+45 22901317|bjr@nordicbioscience.com
4121|NCT00704938|Steven A. Rosenberg, M.D.|National Cancer Institute, National Institues of Health|301-496-4164|sar@mail.nih.gov
2769|NCT00369343|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
2770|NCT00369382|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2771|NCT00369486|Adam R. Glassman, M.S., Director|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|(813) 975-8690|drcrnet@jaeb.org
2772|NCT00369512|Eben Rosenthal, MD Department of Surgery Department|University of Alabama at Birmingham|(205) 934-9714|erosenthal@uabmc.edu
2773|NCT00369564|Scott Bradfield, MD|Nemours Children's Clinic|904-697-3793|sbradfie@nemours.org
2774|NCT00369655|Dr. Timothy Hobday|Mayo Clinic|507-284-1159|hobday.timothy@mayo.edu
2775|NCT00369668|James Cauraugh, Ph.D., PI|University of Florida, Motor Behavior Laboratory|352-294-1623|jcaura@hhp.ufl.edu
2776|NCT00369746|Patrick J. McGrath, M.D.|New York State Psychiatric Institute|646-774-8076|mcgrath@nyspi.columbia.edu
2777|NCT00369824|GSK Response Center|GlaxoSmithKline|866-435-7343|
2778|NCT00369928|Peter Thomas|Procter & Gamble|513.622.4838|thomas.pr@pg.com
2779|NCT00369941|Executive Vice President, Late-Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
2780|NCT00370032|GSK Response center|GlaxoSmithKline|866-435-7343|
2781|NCT00370071|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
2920|NCT00396383|Genzyme Medical Information|Genzyme Corporation|800-745-4447|
2921|NCT00396409|Study Director|Novartis Pharmaceuticals|862-778-8300|
2922|NCT00396565|Director of Clinical R&D Dept. 3|Janssen Pharmaceutical K.K.|81-3-4411-5652 ext 10118|
2923|NCT00396591|Trial Transparency Team|sanofi-aventis||Contact-Us@sanofi.com
2924|NCT00396630|GSK Response Center|GlaxoSmithKline|866-435-7343|
2925|NCT00396656|Study Director|Novartis Pharmaceuticals|862 778-8300|
2926|NCT00386100|GSK Response Center|GlaxoSmithKline|866-435-7343|
7317|NCT00618774|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7318|NCT00618787|Tonya Eggleston, RN, MPH, Study Director|Tyco Healthcare Group|(508) 261-8420|Tonya.Eggleston@Covidien.com
7319|NCT00618813|Results Reporting Coordinator|Children's Oncology Group|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org
7320|NCT00618839|Mary Lokuta|Stratatech Corporation|608-441-8358|mlokuta@stratatechcorp.com
7321|NCT00618956|Robert Palmer, MD|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|201-427-8218|robert.palmer@frx.com
7322|NCT00618982|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
7323|NCT00618995|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7324|NCT00619073|Alan D. Michelson, M.D.|Children's Hospital Boston|617-919-2116|alan.michelson@childrens.harvard.edu
7325|NCT00624780|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7326|NCT00624832|Study Director|Novartis Pharmaceuticals|862-778-8300|
7327|NCT00625183|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
7328|NCT00625365|Dana Washburn, M.D.|Lantheus Medical Imaging|978-671-8686|dana.washburn@lantheus.com
7329|NCT00625391|Dr. Chwan-Li Shen|Texas Tech University Health Sciences Center|(806) 743-2815|Leslie.Shen@ttuhsc.edu
7330|NCT00625404|Jennifer Deese, Principal Investigator|FHI 360|919-544-7040 ext 11292|jdeese@fhi360.org
7331|NCT00625586|Sr. Director of Clinical Operations|MacroGenics, Inc.|650 624 2676|baughmanj@macrogenics.com
7332|NCT00625729|Veronika Bachanova, M.D.|Masonic Cancer Center, University of Minnesota|612-625-5469|bach0173@umn.edu
7333|NCT00625872|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7448|NCT00683332|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7449|NCT00683384|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7798|NCT00591773|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
7799|NCT00591864|Amy Lynn Conners MD|Mayo Clinic|(507) 284-2511|MBI@mayo.edu
7800|NCT00592085|David Wetter, PHD, MS, BA /Professor|UT MD Anderson Cancer Center|713-745-2682|
7801|NCT00592176|Dr. Tyler Hall, M.D.|University of Alabama at Birmingham|205-325-8310|tandrewhall@yahoo.com
7802|NCT00592319|Dr. Zhi Wang|Trustee of Boston Univ. Medical Campus|617-414-1590|zwang@bu.edu
7803|NCT00592358|Janet Wozniak, MD|Massachusetts General Hospital|(617)503-1038|jwozniak@partners.org
7804|NCT00592475|Senior Medical Director, Medical Affairs|Astellas Pharma Global Development||clinicaltrials@us.astellas.com
7805|NCT00592488|Todd Rice, MD|Vanderbilt University|615 322-3412|todd.rice@vanderbilt.edu
7806|NCT00592683|Janet Wozniak, MD|Massachusetts General Hospital|617-503-1038|jwozniak@partners.org
7807|NCT00592761|Gary McCullough|UAMS Medical Center|501-852-7886|mcculloughgaryh@uams.edu
7808|NCT00592774|Eisai Inc.|Eisai Call Center|888-422-4743|
7809|NCT00592839|Duramed Research Protocol Chair|Duramed Research|215-293-7279|medicalaffairs@barrlabs.com
7810|NCT00592852|Gagan Joshi, MD|Massachusetts General Hospital|617-503-1084|joshi.gagan@mgh.harvard.edu
7811|NCT00592904|Eisai Inc.|Eisai Call Center|888-422-4743|
7812|NCT00592943|Thomas J. Spencer, MD|Massachusetts General Hospital; Harvard Medical School|(617) 726-1731|tspencer@partners.org
7813|NCT00593112|Paul Hammerness, M.D.|Massachusetts General Hospital|617-503-1040|phammerness@partners.org
7814|NCT00593333|Taylor Vlack, Research Nurse Coordinator|Department of Surgery/Division of Orthopaedics|205-996-6781|tmwebb@uabmc.edu
7838|NCT00645827|G. Randy Smith Jr.|Emory University|404.686.6730|grsmith@emory.edu
7839|NCT00645853|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7840|NCT00646048|Colleen Holthe, Clinical Project Manager|Boston Scientific|651-581-4632|Colleen.Holthe@bsci.com
4122|NCT00704964|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
4123|NCT00705003|Maurizio Fava, MD|Massachusetts General Hospital|617-724-2513|mfava@partners.org
4124|NCT00705016|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
4125|NCT00705081|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
4126|NCT00705107|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
4127|NCT00705159|Tuyen Ong, MD, MRCOphth|Bausch & Lomb Incorporated|(973) 360-6389|tuyen.ong@bausch.com
4128|NCT00705224|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
4129|NCT00705263|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
4130|NCT00705289|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
4131|NCT00705341|Anne Capser|Johns Hopkins University|410-955-8183|ashankli@jhsph.edu
4132|NCT00705367|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4133|NCT00705432|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
3746|NCT00437203|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3747|NCT00437281|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3748|NCT00437398|Dr. Yogish Kudva|Mayo Clinic|507-284-3964|kudva.yogish@mayo.edu
3749|NCT00437489|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3750|NCT00437645|Study Director|Novartis Pharmaceuticals|862 778-8300|
3751|NCT00437983|Prof. A. Korczyn|Sourazky Tel-Aviv Medical Center|972-3-6974229|amosk@tasmc.health.gov.il
3752|NCT00438204|Antionette J. Wozniak, M.D., F.A.C.P.|Barbara Ann Karmanos Cancer Institute|(313)576-8752|wozniakt@karmanos.org
2927|NCT00386152|Nephrology Therapeutic Area, Medical Lead|Centocor Ortho Biotech Services, LLC|215-325-4176|
2928|NCT00386243|Matthew J. Bair, MD MS|Center on Implementing Evidence Based Practice|317-988-2058|mbair@iupui.edu
2929|NCT00386256|Nancy Harada, PhD|VA Greater Los Angeles Healthcare System|310-268-3632|Nancy.Harada@va.gov
2930|NCT00386308|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
2931|NCT00386334|Lunesta Medical Director|Sepracor Inc.|1-866-503-6351|
2932|NCT00386360|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
2933|NCT00386425|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2934|NCT00386477|David M. Haas, MD, MS|Indiana University School of Medicine|317-630-7837|dahaas@iupui.edu
2935|NCT00386607|Study Director|Novartis Pharmaceuticals|862-778-8300|
2936|NCT00386776|Dr. Warner V. slack|Beth Israel Deaconess Medical Center|617 278 8155|wslack@bidmc.harvard.edu
2937|NCT00386880|Abraham A. Ashkenazi, MD-Principal Investigator|Doylestown Hospital|215-625-2894|aashkenazi2001@yahoo.com
2938|NCT00407563|Vice President of Scientific Affairs|Accelerated Community Oncology Research Network, Inc.|901-435-5570|mwalker@acorncro.com
2939|NCT00407745|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
2940|NCT00407797|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2941|NCT00407966|Judith Karp, MD|SKCCC|410-502-7726|jkarp2@jhmi.edu
2942|NCT00408070|Paige Dunion|UCHC|860-679-6571|pdunion@uchc.edu
2943|NCT00408200|Anthony Killian|University of Pennsylvania|215-615-5299|tony.killian@uphs.upenn.edu
3060|NCT00413062|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
3061|NCT00413153|Steven K. Grinspoon, MD|Massachusetts General Hospital|617-724-9109|sgrinspoon@partners.org
3062|NCT00413231|PJ Belmont, Clinical Research Specialist|Medtronic Vascular, Inc.|707-525-0111|PJ.Belmont@Medtronic.com
7450|NCT00683410|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7451|NCT00683449|Kazuko Matsuda, MD PhD MPH, Vice President, Clinical Development|MediciNova, Inc.|858-373-1500 ext 132|matsuda@medicinova.com
7452|NCT00683475|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
7453|NCT00683592|Director of Medical Affairs|PGxHealth, LLC|203-786-3400|
7454|NCT00683618|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7455|NCT00683657|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
7456|NCT00683696|Kelly Mohr|Biotronik, Inc.|800-547-0394|kelly.mohr@biotronik.com
7457|NCT00683774|Dr. John Nestler|Virginia Commonwealth University|804-828-3389|jnestler@mcvh-vcu.edu
7458|NCT00683800|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7459|NCT00683826|Henry N. Ginsberg MD, Gissette Reyes Soffer MD|Columbia University Medical Center|2123059298|gr2104@columbia.edu
7460|NCT00683904|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
7461|NCT00683917|Jennifer Wike|Repros Therapeutics Inc.|2817193402|jwike@reprosrx.com
7462|NCT00635232|Director of Project Management|Ligand Pharmaceuticals|858-550-7892|hzientek@ligand.com
7463|NCT00635349|Clinical Research Director|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|82-2-2094-4518|
7464|NCT00635362|Amy Whitaker, MD|University of Chicago|773-834-4129|awhitaker@babies.bsd.uchicago.edu
7465|NCT00635427|MedInfo|Shire|+1-866-888-0660|US_ShireHGT_Medicalinformation@shire.com
7466|NCT00635479|Brett Crist, MD|University of Missouri, Department of Orthopaedics|573-882-6562|cristb@health.missouri.edu
7467|NCT00635492|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
7468|NCT00635570|Melissa Gilliam|Department of Obstetrics and Gynecology, The University of Chicago|773-834-0840|mgilliam@babies.bsd.uchicago.edu
7469|NCT00635609|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
8269|NCT00522795|Kayla Rosati|BrUOG|401-863-3000|Kayla_Rosati@brown.edu
8270|NCT00522873|Therapeutic Area Head|Bayer HealthCare AG||clinical-trials-contact@bayerhealthcare.com
8271|NCT00522925|Ram Kapil, PhD/ Sr. Director, Clinical Pharmacology|Ligand Pharmaceuticals, Inc.|858-550-7603|rkapil@ligand.com
7815|NCT00593372|Gary McCullough|UAMS Medical Center|501-852-7886|garyhmccullough@uams.edu
7816|NCT00593450|Dr. Maureen Maguire|CATT research group|215-615-1501|maguirem@mail.med.upenn.edu
7817|NCT00593606|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
7818|NCT00593645|Ravi Vij, M.D.|Washington University School of Medicine|314-454-8304|rvij@dom.wustl.edu
7819|NCT00643604|Remodulin Program Leader|United Therapeutics Corporation|919-485-8350|clinicalrecordsmanagement@unither.com
7820|NCT00643682|Brian Jacobson, MD, Principal Investigator|Boston Medical Center|6176386563|brian.jacobson@bmc.org
7821|NCT00643760|XenoPort Call Center|XenoPort, Inc.|877-936-6778|
7822|NCT00643916|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
7823|NCT00644280|Shan C. Lin, MD|University of California San Francisco|415-353-2608|lins@vision.ucsf.edu
7824|NCT00644332|Emmanuelle Bellemin, Senior Manager, Regulatory Affairs|Gilead Sciences||emmanuelle.bellemin@gilead.com
7825|NCT00644592|Reginald F. Frye, PhD, Associate Professor|University of Florida|3522735453|fryerf@ufl.edu
7826|NCT00644657|Eliot Schechter, MD|University of Oklahoma Health Sciences Center|405-456-5378|eliot-schechter@ouhsc.edu
7827|NCT00644787|Director, Clinical Research|Janssen Research & Development, L.L.C. USA|1 609 730-3387|
7828|NCT00644917|Jaime E Dickerson, Jr, PhD|Smith & Nephew Biotherapeutics|817-302-3914|jaime.dickerson@smith-nephew.com
7829|NCT00644969|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7830|NCT00644995|Jennifer McClure, PhD|Group Health Cooperative|206-287-2737|mcclure.j@ghc.org
7831|NCT00645099|EMEA Therapeutic Area Leader CNS|Janssen-Cilag Germany|+492137955153|
3753|NCT00438360|Study Director|Novartis Pharmaceuticals|862-778-8300|
3754|NCT00438399|Farzaneh SIDOU Clinical Project Manager|Galderma|00 33 4 93 95 70 70 ext 70 51|farzaneh.sidou@galderma.com
3755|NCT00438451|C. Ruckes|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|+49 (0) 6131 17 ext 9919|ruckes@izks-mainz.de
3756|NCT00438490|Corrine Welt, MD|Massachusetts General Hospital|617-726-8437|cwelt@partners.org
3757|NCT00476827|Kimberly Blackwell, MD|Duke University|919-668-1748|kimberly.blackwell@duke.edu
3758|NCT00476957|Dr. Frank van Leeuwen, Director Clinical Research Coronary and Renal Denervation|Medtronic Bakken Research Center|+31 43 3566622|frank.van.leeuwen@medtronic.com
3759|NCT00477152|George Harb, MD, MPH|Baxter Halthcare Corporation||george_harb@baxter.com
3760|NCT00477204|David Maahs, MD, PhD|University of Colorado Denver|303-724-2323|david.maahs@ucdenver.edu
3761|NCT00477230|Burke T. Barrett, Study Director|CardioFocus, Inc.|508 658-7200|bbarrett@cardiofocus.com
3762|NCT00477295|Eisai Inc.|Eisai Call Center|888-422-4743|
3763|NCT00498628|Dr. Raye Litten|NIAAA|301-443-0636|
3764|NCT00498706|Dr. David C. Mohr|Northwestern University|312-503-1403|d-mohr@northwestern.edu
3765|NCT00498797|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3766|NCT00498940|Santos Cabreriza/ Associate Scientist|Columbia University Medical Center|212-305-9515|sc45@cumc.columbia.edu
3767|NCT00499031|Melissa Leventhal|NRG Oncology Statisics and Data Management Center, Buffalo Office|716-845-4030|mleventhal@gmail.com
3768|NCT00499109|Charles C. Williams, M.D., Study Chair|H. Lee Moffitt Cancer Center and Research Institute|813-745-7282|charles.williams@moffitt.org
3953|NCT00440518|Study Director|UCB Clinical Trial Call Center|+1 877 822 9493|
3954|NCT00440531|Senior Vice President, Clinical and Quantitative Sciences|Merck & Co., Inc.|1-800-672-6372|
3955|NCT00440557|Sr Director of Clinical Research|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|908-927-2116 ext NA|
3956|NCT00440700|Dr. Linda Chlan|University of Minnesota|612-624-6658|chlan001@umn.edu
3063|NCT00413283|Study Director|Amgen Inc.|866-572-6436|
3064|NCT00413335|Dr. Sonia Caprio, Principal Investigator|Yale University School of Medicine|203-785-5692|Sonia.Caprio@yale.edu
3065|NCT00413374|Research Coordinator|Brigham and Women's Hospital|617-732-6984|arao2@partners.org
3066|NCT00413400|Steven K. Grinspoon|Massachusetts General Hospital|617-724-9109|sgrinspoon@partners.org
3067|NCT00413413|Study Director|Novartis Pharmaceuticals|862 778-8300|
3068|NCT00413582|Shawn D. St. Peter, MD|Children's Mercy Hospital|816-983-6479|sspeter@cmh.edu
3069|NCT00413634|Timothy Whitaker, M.D.|Shire||twhitaker@shire.com
3070|NCT00413660|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3071|NCT00413920|Study Director|Novartis Pharmaceuticals|862-778-8300|
3072|NCT00413959|Sigrun Hallmeyer, MD Director of Research|Oncology Specialists SC|847-268-8200|shallmeyer@oncmed.net
3073|NCT00413972|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
3074|NCT00414011|Principal Investigator|U.S. Army Warfighter Refractive Surgery Research Center|571-231-1600|rose.sia@us.army.mil
3075|NCT00414050|Senior Vice President, Clinical and Quantitative Sciences|Merck & Co., Inc.|1 800 672 6372|
3076|NCT00414167|Dr. Marney A. White|Yale University School of Medicine|203-785-4349|marney.white@yale.edu
3077|NCT00414206|Carl Grove|CoMentis, Inc.|650-869-7600|cgrove@comentis.com
3078|NCT00414388|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD (PI)|Oncology Specialists, S.C.|847-268-8200|shallmeyer@oncmed.net
3079|NCT00414466|Robert Spencer, Clinical Research Manager|Medtronic Neuromodulation|(763) 514-0253|robert.j.spencer@medtronic.com
3080|NCT00414518|Michelle A. Barron|University of Colorado Denver|303-724-4939|michelle.barron@ucdenver.edu
3081|NCT00414544|Dr. David B. Masters|Cosmeta, A Gel-Del Technolgies Company|651 209-0707|dmasters@gel-del.com
3082|NCT00414609|Study Director|Novartis Pharmaceuticals|862-778-8300|
7470|NCT00635648|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7562|NCT00535405|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7563|NCT00535496|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
7564|NCT00535587|Kim Dupree Jones|Oregon Health & Science University|503 494 3837|joneskim@ohsu.edu
7565|NCT00535730|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7566|NCT00535769|Dr. Alexa B. Kimball|MGH Curtis|617-726-5066|harvardskinstudies@partners.org
7567|NCT00535782|Medical Communications|Hoffman-LaRoche|800-821-8590|
7568|NCT00535821|H. Bryant Nguyen|Loma Linda University|909-558-4000 ext 44023|hbnguyen@llu.edu
7569|NCT00535847|Jeff Chodakewitz, M.D.|Vertex Pharmaceuticals Incorporated|617-341-6777|Jeff_Chodakewitz@vrtx.com
7570|NCT00685165|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
7571|NCT00685334|Evelyn Attia, MD|New York State Psychiatric Institute|212-253-5923|ea12@columbia.edu
7572|NCT00685373|Study Director|Novartis Pharmaceuticals|862-778-8300|
7573|NCT00685685|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
7574|NCT00685763|Charles Nichols, M.D.|University of Florida Proton Therapy Institute|904-588-1800|rnichols@floridaproton.org
7575|NCT00685802|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
7576|NCT00685880|Dr. Jeffrey S. Brault|Mayo Clinic|507-284-1643|brault.jeffrey@mayo.edu
7577|NCT00685945|Dr. Mias Pretorius|Vanderbilt University|615-343-0665|mias.pretorius@vanderbilt.edu
7578|NCT00686036|Gerard Lynch|AstraZeneca|+44 1509 645895|ClinicalTrialTransparency@astrazeneca.com
7579|NCT00686075|Filip Dubovsky, Vice President, Clinical Development|MedImmune, LLC.|301-398-0000|dubovskyf@medimmune.com
3658|NCT00475332|Bridget Fitzgerald, Clinical trials coordinator|University of Florida|(352) 265-0680 ext 87829|fitzgb@shands.ufl.edu
3659|NCT00475501|Stephen Borst, Ph.D|Geriatric Research Education and Clinical Center|352-374-6114 ext 5033|stephen.borst@va.gov
3660|NCT00475657|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
3661|NCT00475670|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
3662|NCT00475709|Kelly Erickson|St Jude Medical|16517566580|kaerickson@sjm.com
3663|NCT00475735|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
3664|NCT00475852|Vice President, Franchise Development|Johnson & Johnson Pharmaceutical Research & Development, LLC|610-651-6628 ext NA|
3665|NCT00475865|Trial Transparency Team|sanofi-aventis||Contact_US@sanofi.com
3666|NCT00475878|Dr. Michael Stein|Butler Hospital|401-455-6646|michael_stein@brown.edu
3667|NCT00475904|Chief Medical Officer|EpiCept Corporation|914-606-3500|sallard@epicept.com
3668|NCT00476008|Peter Holland, MD|Charles E. Schmidt College of Medicine, Florida Atlantic University|561-297-0164|holland@fau.edu
3669|NCT00476151|Chief Medical Officer|EpiCept Corporation|914-606-3500|deverton@epicept.com
3670|NCT00476229|Chitra M. Hosing, MD/Associate Professor|UT MD Anderson Cancer Center||gmccormi@mdanderson.org
3671|NCT00476242|Adam Bisaga|NYS Psychiatric Institute|646-774-6155|amb107@columbia.edu
3672|NCT00476593|Dr Alexandra Wexler|Department of Ophthalmology, St. Olavs Hospital, Trondheim Norway|99716763 ext 0074|a.wexler@online.no
3673|NCT00476645|Associate Professor of Medicine (Oncology)|Stanford University Medical Center|650-725-2078|sandysri@stanford.edu
3674|NCT00476788|Elaine Moreland MD|Greenville Hospital System|8644545661|emoreland@ghs.org
3675|NCT00704028|Marc Tokars|Luitpold Pharmaceuticals, Inc.|610-650-4200|mtokars@lpicrd.com
3676|NCT00704132|Vice President, Laste Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
3862|NCT00440011|Vice President Medical Affairs|Allergan, Inc.|(714)246-4500|clinicaltrials@allergan.com
3957|NCT00440830|Pamela Flood, MD|Columbia University|212-305-2008|pdf3@columbia.edu
3958|NCT00440947|GSK Response Center|ViiV Healthcare|866-435-7343|
3959|NCT00441012|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
3960|NCT00441064|Study Director|Novartis Pharmaceuticals|862-778-8300|
3961|NCT00441103|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
3962|NCT00441116|GSK Response Center|GSK|866-435-7343|
3963|NCT00441168|EMEA Medical Affairs Director Oncology|Jan-Cilag Germany|+49 2137 955-492|rangermu@its.jnj.com
3964|NCT00441259|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
3965|NCT00441272|Colleen Hadigan, MD, MPH|National Institute of Allergy and Infectious Diseases|301-594-5754|hadiganc@niaid.nih.gov
3966|NCT00441285|Hector H. Garcia, MD, PhD|Universidad Peruana Cayetano Heredia|+511 3287360|hgarcia@jhsph.edu
3967|NCT00441441|GSK Response Center|GlaxoSmithKline|866-435-7343|
3968|NCT00441480|Prof. Dror Harats|The Institute for Lipid and Atherosclerosis Research and Internal Medicine C, Sheba Medical Center, Tel Hashomer|972-3-5302940|dror@vbl.co.il
3969|NCT00441545|Timothy Whitaker, MD|Shire||twhitaker@shire.com
3970|NCT00441558|Krista Barbour, Ph.D.|Sprout Pharmaceuticals|9198820850|kbarbour@sproutpharma.com
3971|NCT00441584|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
3972|NCT00441701|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
3973|NCT00441727|Gerard Lynch|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
3974|NCT00441766|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
3975|NCT00441792|Erik Kulstad, MD, MS|Advocate Christ Medical Center|7086843889|kulstad@uic.edu
4157|NCT00713700|Jeff Mifek|St. Jude Medical|651-756-5586|jmifek@sjm.com
3199|NCT00401973|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
3200|NCT00402051|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
3201|NCT00402103|Study Director|Novartis Pharmaceuticals|862-778-8300|
3202|NCT00402194|Dr. Kieren Mather|Indiana University|317-278-7826|kmather@iu.edu
3203|NCT00402233|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
3204|NCT00402246|CONNECT Clinical Trial Specialist|Medtronic, Inc||medtronicCRMtrials@medtronic.com
3205|NCT00402285|Peter Carroll, MD|University of California, San Francisco|415-353-7098|pcarroll@urology.ucsf.edu
3206|NCT00402324|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
3207|NCT00402337|Doug Levine, MD|Ironwood Pharmaceuticals|617.374.3906|dlevine@ironwoodpharma.com
3208|NCT00402363|GSK Response Center|GlaxoSmithKline|866-435-7343|
3209|NCT00402597|VP FRANCHISE MED LDR|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|1 908 927 7767|
3210|NCT00402649|Ina Stephens, MD|University of Maryland Center for Vaccine Development|410-706-1123|istephen@medicine.umaryland.edu
3211|NCT00402688|Therapeutic Area Lead, Anti-Infective Franchise|Ortho-McNeil Janssen Scientific Affairs, LLC|908-927-5220|
3212|NCT00402727|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
3213|NCT00402740|Ellen Travis, MS, NFP|Abbott Vascular|408 845-1512|Ellen.Travis@av.abbott.com
3214|NCT00402883|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
3215|NCT00402987|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3216|NCT00403234|Clinical Leader, Director of Clinical Research|Purdue Pharma L.P.|800-733-1333|
3217|NCT00403403|Medical Communications|Genentech, Inc.|800-821-8590|
3218|NCT00403481|John J. Raia, R.Ph, Pharm. D.|Daiichi Sankyo|1-877-437-7763|druginfo@dsus.com
7580|NCT00686127|Dr. Christine Miaskowski, PI|University of California, San Francisco|415-476-9407|chris.miaskowski@nursing.ucsf.edu
7581|NCT00686205|Peggy Moreno|Abbott Diagnostics Division|847-937-2044|Peggy.Moreno@abbott.com
7582|NCT00686231|Andrew Boyle|UCSF|415-514-0827|aboyle@medicine.ucsf.edu
7583|NCT00686257|Nicholas Hill MD|Tufts Medical Center|617-636-4288|nhill@tuftsmedicalcenter.org
7584|NCT00686335|Senior Vice President, Clinical Development & Operations|Horizon Pharma|224-383-3012|agrahn@horizonpharma.com
7585|NCT00686517|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
7586|NCT00686543|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
7587|NCT00686595|Vice President of Late Stage Development|Merck Sharpe & Dohme Corp||ClinicalTrialsDisclosure@merck.com
7588|NCT00542269|Study Director|Novartis Pharmaceuticals|862 778-8300|
7589|NCT00542308|Eva Järlid Westerberg, VP Clinical Operations|Genmab A/S|+45 7020 2728|E.Westerberg@genmab.com
7590|NCT00542321|Sandra K. Hanneman, PhD, RN, FAAN|University of Texas Health Science Center at Houston|713-500-2030|Sandra.K.Hanneman@uth.tmc.edu
7591|NCT00542425|Program Director|Radius Health, Inc.|(617) 551-4700|info@radiuspharm.com
7592|NCT00542620|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
7593|NCT00542789|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7594|NCT00542815|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
7595|NCT00542828|Genzyme MedInfo|Genzyme Corporation|800-745-4447|medinfo@genzyme.com
7596|NCT00542880|Gerard Lynch|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
7597|NCT00507130|Don Raible, MD|MedImmune|301-398-0000|raibleD@medimmune.com
7598|NCT00507416|Medical Director|Millennium Pharmaceuticals Inc|1-800-778-2860|clinicaltrialregistry@tpna.com
7599|NCT00507429|Peter Langecker, MD, PhD|OXiGENE, Inc.|650 635 7008|plangecker@oxigene.com
3863|NCT00440050|Joseph Quinn, MD|Oregon Health and Sciences University/Portland VA Medical Center, Portland, Oregon.|503-494-6976|quinnj@ohsu.edu
3864|NCT00440193|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
3865|NCT00440232|Stephen D. Silberstein, M.D.|Jefferson Headache Center/Thomas Jefferson University|215-955-2243|stephen.silberstein@jefferson.edu
3866|NCT00440271|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
3867|NCT00500266|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3868|NCT00500292|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
3869|NCT00500318|Cynthia F. Caracta, MD FCCP|Forest Research Institute|201-427-8000|cynthia.caracta@frx.com
3870|NCT00500357|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3871|NCT00500370|Chief Medical Officer|Eli Lilly and Company|1-800-LILLYRX|clinicaltrials@amylin.com
3872|NCT00500539|Study Director|Novartis Pharmaceuticals|862-778-8300|
3873|NCT00500578|Roy F Chemaly, MD/MPH, MBA /Associate Professor|UT MD Anderson Cancer Center|713-745-1116|rfchemaly@mdanderson.org
3874|NCT00500656|Alan Kimura, MD, PhD|Shire Human Genetic Therapies, Inc.|781-482-0738|akimura@shire.com
3875|NCT00500760|Study Director|Amgen Inc.|866-572-6436|
3876|NCT00501007|Marc L. Steinberg, Ph.D.|Rutgers, The State University of New Jersey|732-235-4341|marc.steinberg@rutgers.edu
3877|NCT00501228|Martin Korbling, MD / Professor|U.T. M.D. Anderson Cancer Center|713-745-3219|
3878|NCT00501293|Timothy Whitaker, MD|Shire Pharmaceutical||twhitaker@shire.com
3879|NCT00501345|Jean-Bernard Durand, MD / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
3880|NCT00501592|Cathi Sciacca, Sr. Director, Clinical Operations|Intercept Pharmaceuticals, Inc.|858-652-6800|csciacca@interceptpharma.com
3881|NCT00477334|Study Director|Novartis Pharmaceuticals|862-778-8300|
3882|NCT00477386|Daniela Matai, MD|IndianaU|317-944-0920|dmatai@iupui.edu
4158|NCT00713817|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd|0044 1223 266800|rp@gwpharm.com
4159|NCT00714233|Kathleen M Hoeger MD MPH|University of Rochester|5852757891|Kathy_hoeger@urmc.rochester.edu
4160|NCT00714285|GSK Response Center|GlaxoSmithKline|866-435-7343|
4161|NCT00714389|Gunhilde Buchsbaum, MD|University of Rochester|585-273-3232|gunhilde_buchsbaum@urmc.rochester.edu
4162|NCT00714493|Sr. Director, Clinical Research - Medical Affairs|Centocor Ortho Biotech, Inc.|215-325-6811|Ddeckto2@its.jnj.com
4163|NCT00714688|EMEA Medical Affairs Director|Janssen-Cilag Germany|+49 2137 955258|
4164|NCT00714714|David Lineberry, Associate Director Clinical Operations|Valeant Pharmaceuticals International, Inc|949-973-1153|David.Linberry@valeant.com
4165|NCT00714870|Dr. Shirley Gonzalez|St. Elizabeth's Medical Center|617-926-0114|shirleyg2008@gmail.com
4166|NCT00443755|K. Sreekumaran Nair, MD, Ph.D.|Mayo Clinic|507-255-3605|nair@mayo.edu
4167|NCT00443781|Zhimin Liu|Medtronic Spine LLC|901-399-3123|zhimin.liu@medtronic.com
4168|NCT00443820|Study Director|Novartis Pharmaceuticals|862-778-8300|
4169|NCT00443898|Study Director|Novartis Pharmaceuticals|862-778-8300|
4170|NCT00444067|Jen Doyle|Confluent Surgical Inc., dba Covidien|781.839.1770|Jennifer.doyle@covidien.com
4171|NCT00444106|Study Director|Novartis Pharmaceuticals|862-778-8300|
4172|NCT00444275|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
4173|NCT00444457|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4174|NCT00444535|GSK Response Center|GlaxoSmithKline|866-435-7343|
4175|NCT00444600|Adam R. Glassman, Director DRCR.net Coordinating Center|Jaeb Center for Health Research|813-975-8690|drcrnet@jaeb.org
4176|NCT00444912|Medical Information|Genzyme||medinfo@genzyme.com
4177|NCT00444925|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
3219|NCT00403585|GSK Response Center|GlaxoSmithKline|866-435-7343|
3220|NCT00403754|Study Director|Novartis Pharmaceuticals|862 778-8300|
3221|NCT00403767|Head of Development, CV & UROL|Johnson & Johnson Pharmaceutical Research & Development L.L.C.|1 908-927-7767|
3222|NCT00403845|Study Director|Novartis Pharmaceuticals|862 778-8300|
2782|NCT00370292|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2783|NCT00370331|GSK Response Center|GlaxoSmithKline|866-435-7343|
2784|NCT00370552|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2785|NCT00370838|Dr. Harvey Singer|Johns Hopkins University|410-955-7212|hsinger@jhmi.edu
2786|NCT00371137|Grace Wang, MD, Medical Monitor & Director of Clinical Development|Jazz Pharmaceuticals, Inc.|650-496-3777|
2787|NCT00371150|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2788|NCT00371176|Dr. Brett Litz|Boston VA Healthcare System|857 364 4131|brett.litz@va.gov
2789|NCT00371254|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2790|NCT00371345|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2791|NCT00371397|Janice Kiecolt-Glaser, PhD|Ohio State University Institute for Behavioral Medicine Research|614-292-0033|Kiecolt-Glaser.1@osu.edu
2792|NCT00371566|GSK Response Center|GlaxoSmithKline|866-435-7343|
2793|NCT00371761|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@spcorp.com
2794|NCT00371787|Dr. Craig Woods|Centre for Contact Lens Research|1-519-888-4567 ext 36547|cawoods@uwaterloo.ca
2795|NCT00371826|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
2796|NCT00372060|Senior Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
2797|NCT00372385|Jeff Chodakewitz, M.D.|Vertex Pharmaceuticals Incorporated|617-341-6777|Jeff_Chodakewitz@vrtx.com
7600|NCT00507442|Dixie-Lee Esseltine, MD|Millennium Pharmaceuticals, Inc|(617) 679-7000|
7601|NCT00550953|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7602|NCT00551031|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
7603|NCT00551135|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7604|NCT00551161|Marc L. Gordon,MD|North Shore-LIJ Health System|516-562-3492|MLGordon@nshs.edu
7605|NCT00551174|Medical Communications|Hoffmann-La Roche|800-821-8590|
7606|NCT00551642|James Baldassarre, MD|INO Therapeutics LLC|908-238-6363|james.baldassarre@ikaria.com
7607|NCT00551707|Margaret Lee, PhD|Zalicus|617-301-7142|mlee@zalicus.com
7608|NCT00551746|Benjamin D Horne, PhD, MPH|Intermountain Healthcare|801-507-4708|Benjamin.Horne@imail.org
7609|NCT00551759|Study Statistician|ECOG Statistical Office|617-632-3012|
7610|NCT00552032|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
7611|NCT00552058|Study Director|UCB|+1 877 822 9493|
7612|NCT00552110|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@spcorp.com
7613|NCT00552175|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
7614|NCT00552188|Brian Cunningham, MD|Tallikut Pharmaceuticals, Inc.|312-505-0420|brian@baycitycapital.com
7615|NCT00552240|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7616|NCT00552279|GSK Response Center|GlaxoSmithKline|866-435-7343|
7617|NCT00552305|UCB (Study Director)|UCB Clinical Trial Call Center|+1 887 822 9493|
7618|NCT00552396|Dr Renaud Buffet Senior Director, Clinical Development and Translational Research|Innate Pharma|+33430303032|renaud.buffet@innate-pharma.fr
7619|NCT00552409|Dr. Ian de Boer|University of Washington|206-616-5403|deboer@u.washington.edu
3883|NCT00477464|GSK Response Center|GlaxoSmithKline|866-435-7343|
3884|NCT00477594|Genzyme Medical Information|Genzyme Corporation|617-252-7832|
4068|NCT00442702|Medical Communications|Hoffman-LaRoche|800-821-8590|
4069|NCT00442897|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
4070|NCT00442936|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4071|NCT00442962|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
4072|NCT00443040|Dr. Allen Mangel, Chief Medical Officer|Tioga Pharmaceuticals|919-485-5668|mangel@tiogapharma.com
4073|NCT00443053|GSK Response Center|GlaxoSmithKline|866-435-7343|
4074|NCT00443209|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4075|NCT00443352|William B Young, MD|Thomas Jefferson University|215-955-2243|william.b.young@jefferson.edu
4076|NCT00443430|Carol Wallace, MD  Principal Investigator|University of Washington and Seattle Children's Hospital|206-987-2057|cwallace@u.washington.edu
4077|NCT00443456|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4078|NCT00443534|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4079|NCT00443560|Dr. Robert J. McCarthy, PharmD|Northwestern University Feinberg School of Medicine|312-926-9015|r-mccarthy@northwestern.edu
4080|NCT00443599|Dr. Michael Agus|Boston Children's Hospital|617-355-5849|michael.agus@childrens.harvard.edu
4081|NCT00443651|Medical Communications|Genentech, Inc.|800-821-8590|
4082|NCT00443703|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
4083|NCT00443729|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4084|NCT00481247|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
4178|NCT00444951|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
4179|NCT00445003|Adam R. Glassman, Director DRCR.net Coordinating Center|Jaeb Center for Health Research|813-975-8690|aglassman@jaeb.org
3769|NCT00499122|Alberto Montero MD|UM/Sylvester Comprehensive Cancer Center|305-243-3771|amontero2@med.miami.edu
3770|NCT00499252|Melissa Leventhal|Gynecologic Oncology Group Statistical and Data Center|716-845-4030|mleventhal@gogstats.org
3771|NCT00499343|Chitra M. Hosing, MD / Associate Professor|U.T. M.D. Anderson Cancer Center|713-792-8750|
3772|NCT00499369|Study Statistician|SWOG|206-667-4623|
3773|NCT00499408|K.C. Balaji, MD|Comprehensive Cancer Center of Wake Forest University|336-716-5690|kbalaji@wakehealth.edu
3774|NCT00499447|Dr. James Urbanic|Comprehensive Cancer Center of Wake Forest University|336-713-3600|jurbanic@wakehealth.edu
3775|NCT00499603|Dr. Ana Gonzalez-Angulo|The University of Texas MD Anderson Cancer Center|713-792-8370|CR_Study_Registration@mdanderson.org
3776|NCT00499681|Ingrid Mayer, MD, Principal Investigator|Vanderbilt-Ingram Cancer Center|615-936-2033|ingrid.mayer@vanderbilt.edu
3777|NCT00499694|Ulka Vaishampayan, M.D.|Barbara Ann Karmanos Cancer Institute|(313) 576-8718|vaishamu@karmanos.org
3778|NCT00499863|Timothy Whitaker, MD|Shire||twhitaker@shire.com
3779|NCT00499889|Richard E. Champlin, MD/Professor|UT MD Anderson Cancer Center|713-792-8848|pmcadams@mdanderson.org
3780|NCT00500071|Timothy Whitaker, MD|Shire Pharmaceutical Development Inc||twhitaker@shire.com
3781|NCT00500110|Quality Assurance Specialist|MD Anderson Cancer Center|713-563-1602|caperez@mdanderson.org
3782|NCT00500149|Timothy Whitaker, MD|Shire||twhitaker@shire.com
3783|NCT00500240|Khanh D Vu, MD/ Associated Professor|UT MD Anderson Cancer Center|713-745-4516|eharriso@mdanderson.org
3784|NCT00742508|GSK Response Center|GlaxoSmithKline|866-435-7343|
3785|NCT00742625|Eyal Attar, MD|Massachusetts General Hospital Cancer Center|617-724-1124|eattar@partners.org
3786|NCT00742781|Dr. Margherita Cantorna|Pennsylvania State University|814-863-2819|mxc69@psu.edu
2798|NCT00372411|Peter Guarino, MPH, PhD, Director, WH-CSPCC|Dept. of Veterans Affairs, Cooperative Studies Program, West Haven, CT|203-932-5711 ext 3780|peter.guarino@va.gov
2799|NCT00372424|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2800|NCT00372489|VP, Clinical Development|Affymax|650-812-8700|info@affymax.com
2801|NCT00372528|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2802|NCT00372567|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2803|NCT00372619|Results Reporting Coordinator|Children's Oncology Group|352-273-0567|ResultsReportingCoordinator@childrensoncologygroup.org
2804|NCT00372697|Study Director|Novartis Pharmaceuticals|862 778-8300|
2944|NCT00408317|Robert Winkler, MD, VP, Clinical Development and Operations|Aptalis Pharma US, Inc.|1-800-472-2634|
2945|NCT00408421|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
2946|NCT00408629|Global Medical Services|Abbott|800-633-9110|
2947|NCT00408694|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@acr.org
2948|NCT00408876|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
2949|NCT00408928|John Wagner, MD|Thomas Jefferson University|215-955-8874|John.Wagner@jefferson.edu
2950|NCT00408993|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
2951|NCT00409006|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2952|NCT00409175|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
2953|NCT00409240|Wen-Chih Wu, MD|Providence VAMC|401-273-7100 ext 6237|wen-chih.wu@va.gov
2954|NCT00409292|Brian Wolpin, MD|Dana-Farber Cancer Institute|617-632-3000|brian_wolpin@dfci.harvard.edu
2955|NCT00409331|Mark Chambers, DMD / Associate Professor|UT MD Anderson Cancer Center|713-745-2672|
2956|NCT00409344|Ulrich Schmidt, MD PhD|Massachusetts General Hospital|617-724-6490|uschmidt@partners.org
7620|NCT00552513|TIMACS Project Office|Population Health Research Institute|19055244322|timacs@phri.ca
7621|NCT00552578|R Blondell|SUNY Buffalo|716-898-4971|blondell@buffalo.edu
7622|NCT00552669|Alfredo Rodriguez, MD, PHD|Centro de Estudios en Cardiologia Intervencionista|541149648721|rodrigueza@sanatorio-otamendi.com.ar
7623|NCT00552695|Adam Singer|Stony Brook U|631-444-7857|adam.singer@stonybrook.edu
7624|NCT00552760|Edward R. Norris, MD|Lehigh Valley Hospital|(610) 402-5766|Edward.Norris@lvh.com
7625|NCT00526331|Gabriel Mena, MD / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
7626|NCT00526474|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7627|NCT00526669|GSK Response Center|GlaxoSmithKline|866-435-7343|
7628|NCT00526994|Joanne Klevens|CDC|770-488-1386|dzk8@cdc.gov
7629|NCT00527072|Sr. Director, Clinical Research - Medical Affairs|Janssen Biotech, Inc.|215-325-5711|
7630|NCT00527098|Kenneth Proctor, PhD|University of Miami|305-243-4694|kproctor@med.miami.edu
7631|NCT00527124|Elisabeth I. Heath|Barbara Ann Karmanos Cancer Institute|313-576-8715|heathe@karmanos.org
7632|NCT00527319|Dr. Richard Guarino|Oxford Pharmaceutical Resources, Inc.|973-256-0600|Guarino@oxfordpharm.com
7633|NCT00527332|Dr Preben Kjolhede|Deptartment of Obstetrics and Gynecology, University Hospital, Linköping, Sweden|+46101030000 ext 3187|Preben.Kjolhede@lio.se
7634|NCT00527397|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
7635|NCT00527423|Clinical Trials Administrator|Regeneron Pharmaceuticals||clinicaltrials@regeneron.com
7636|NCT00527475|David Callanan, MD|Texas Retina Associates|817-261-9625|dcallanan@texasretina.com
7637|NCT00527488|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
7638|NCT00527514|John Raia|Daiichi Sankyo|(973) 630-2683|jraia@dsus.com
7639|NCT00527592|Director of Medical Affairs|Alcon Research, Ltd.|1-800-862-5266|medinfo@alconlabs.com
4085|NCT00481351|Otavio Celeste Mangili, MD|Universidade de São Paulo|+554499928818|otaviomangili@yahoo.com.br
4086|NCT00481507|Daniel Merenstein, MD|GEORGETOWN UNIVERSITY|202-687-2745|djm23@georgetown.edu
4087|NCT00481676|Study Director|Novartis Pharmaceuticals|862 778-8300|
4088|NCT00481767|GSK Response Center|GlaxoSmithKline|866-435-7343|
4089|NCT00481871|Michael Saunders, MD|Allos Therapeutics, Inc.|303-426-6262|msaunders@allos.com
3677|NCT00704171|Jennifer L. Doyle, Global Director of Clinical Affairs|Covidien|781-839-1770|jennifer.doyle@covidien.com
3678|NCT00704340|Jen Doyle|Covidien|781.839.1770|Jennifer.doyle@covidien.com
3679|NCT00704353|Marc Tokars|Luitpold Pharmaceuticals, Inc.|610-650-4200|mtokars@lpicrd.com
3680|NCT00704418|Tim McNamara, Vice President, Clinical Research & Medical Affairs|ISTA Pharmaceuticals, Inc.|949-788-6000|tmcnamara@istavision.com
3681|NCT00704522|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
3682|NCT00704535|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
3683|NCT00704717|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
3684|NCT00704730|Yifah Yaron, MD  Senior Director, Clinical Research, Clinical Development|Exelixis, Inc|650-837-7678|yyaron@exelixis.com
3685|NCT00741286|Sang Won Han|Department of Neurology, Sanggye Paik Hospital, Inje University College of Medicine|82-2-950-8864|swhan@paik.ac.kr
3686|NCT00741338|Trial Transparency Team|Sanofi||Contact-us@sanofi.com
3687|NCT00741390|Kenneth Kassler-Taub, VP Medical Affairs|Becton Dickinson|201-847-7009|kenneth_kassler_taub@bd.com
3688|NCT00741468|Jennifer Wike|Repros Therapeutics Inc.|281-719-3402|jwike@reprosrx.com
3689|NCT00741611|Anne Marie Harcarik|CR Bard|908-277-8051|annemarie.harcarik@crbard.com
3690|NCT00741819|Inhaled Treprostinil Program Head|United Therpaeutics Corporation|919-485-8350|clinicalrecordsmanagment@unither.com
3691|NCT00741936|Prof. Zhao-xiang Bian|Hong Kong Baptist University|(852) 3411 2905|bzxiang@hkbu.edu.hk
3787|NCT00742872|Dr. Ala Sharara|American University of Beirut Medical Center|+961-3-350000|as08@aub.edu.lb
3788|NCT00742885|GSK Response Center|GlaxoSmithKline|866-435-7343|
3789|NCT00742924|Results Reporting Coordinator|Children's Oncology Group|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org
3790|NCT00743093|Jody Green, PhD|Denver Heatlh Rocky Mountain Poison and Drug Center|303-389-1246|jody.green@rmpdc.org
3791|NCT00743197|Dr. Martha Gulati, Principal Investigator|Northwestern University|312-695-4965|mgulati@nmh.org
2713|NCT00384956|Ravi Vij, M.D.|Washington University School of Medicine|314-454-8304|rvij@dom.wustl.edu
2714|NCT00385138|Meredith Todd|The Medicines Company|973.290.6088|meredith.todd@themedco.com
2715|NCT00385203|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
2716|NCT00385216|Pamela Flood, MD|Columbia University|212-305-2008|pdf3@columbia.edu
2717|NCT00385268|Dr. Helen Pettinati|University of Pennsylvania|215-222-3200 ext 139|helenp@mail.med.upenn.edu
2718|NCT00385515|Eward G. Fey, PhD|Mucosal Therapeutics, LLC|857-228-1100|
2719|NCT00385541|Pamela  Flood MD|Columbia University|201-768-8262|pdf3@columbia.edu
2720|NCT00385580|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2721|NCT00385593|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
2722|NCT00385671|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
2723|NCT00385723|Dr. Janice K. Kiecolt-Glaser|Institute for Behavioral Medicine Research, Ohio State University College of Medicine, OH, USA|+1 614 293 3499|Janice.Kiecolt-Glaser@osumc.edu
2724|NCT00385736|Global Medical Services|Abbott|800-633-9110|
2725|NCT00385827|Director|Janssen Research & Development||ClinicalTrialDisclosure@its.jnj.com
2726|NCT00385840|GSK Response Center|GlaxoSmithKline|866-435-7343|
2727|NCT00385918|Peter H. Gorman, MD Chief Division of Rehabilitation Medicine|University of Maryland Rehabiitation and Orthopaedic Institute|410-448-6261|pgorman@umm.edu
2957|NCT00409578|Study Director|Novartis Pharmaceuticals|862 778-8300|
2958|NCT00409617|Global Medical Services|Abbott|800-633-9110|
2959|NCT00409682|Global Medical Services|Abbott|800-633-9110|
2960|NCT00409708|Study Director|Novartis Pharmaceuticals|862 778-8300|
2961|NCT00409773|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
2962|NCT00409786|Kathleen McTigue|University of Pittsburgh|412-692-2940|mctiguekm@upmc.edu
2963|NCT00409838|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2964|NCT00410046|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
2965|NCT00410072|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
2966|NCT00410124|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300|
2967|NCT00410150|Dr. Derek Wheeler|Cincinnati Children's Hospital Medical Center|513-636-4239|derek.wheeler@cchmc.org
3083|NCT00414635|Calvin Cohen, MD|Community Research Initiative of New England (CRINE)|617 502 1700|ccohen@crine.org
3084|NCT00414661|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
3085|NCT00414700|Nel Van Lommel, MSc, Manager Clinical Operations Europe, TiGenix n.v.|TiGenix n.v.|+3216396060|nel.vanlommel@tigenix.com
3086|NCT00414726|Aneesh B. Singhal, MD|Massachusetts General Hospital|617 726 8459|asinghal@partners.org
3087|NCT00414908|Sven Voet - Global Communication|Abbott Products|+41 61 487 08 56|sven.voet@abbott.com
3088|NCT00414973|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
3089|NCT00415168|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
3090|NCT00415194|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
3091|NCT00415493|Principal Investigator|ASTHMA Inc.|(510) 620-5714|dennis.shusterman@cdph.ca.gov
7640|NCT00527605|GSK Response Center|GlaxoSmithKline|866-435-7343|
7641|NCT00527618|Tara Perti, MD|University of Washington, Virology Research Clinic|(206) 520-4340|tarap@u.washington.edu
7642|NCT00527722|Sanjay Gupta, MD|UT MD Anderson Cancer Center|713-563-7341|srao@mdanderson.org
7643|NCT00527735|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
7644|NCT00527787|Senior Vice President, Clinical Research|POZEN Inc|919-913-1030|eorlemans@pozen.com
7645|NCT00527826|GSK Response Center|GlaxoSmithKline|866-435-7343|
7646|NCT00527878|Alexandra Freeman MD, Staff Clinician, Lead Associate Investigator for Protocol|NIAID, NIH|301-594-9045|freemaal@mail.nih.gov
7647|NCT00527904|Senior Vice President, Clinical Research|POZEN|919-913-1030|eorlemans@pozen.com
7648|NCT00527943|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7649|NCT00527982|Waun K. Hong, MD/Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
7650|NCT00528021|Thomas Logan Ph.D.|BTG International|610-943-3518|thomas.logan@btgplc.com
7651|NCT00528112|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
7652|NCT00528372|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
7653|NCT00535873|Alessandra Ferrajoli, MD/Associate Professor|The University of Texas M D Anderson Cancer Center|713-792-2063|eharriso@mdanderson.org
7654|NCT00535938|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
7655|NCT00536107|Sharon Chang|AstraZeneca||aztrial_results_posting@astrazeneca.com
7656|NCT00536120|Biogen Idec Medical Director|Biogen Idec Inc.||clinicaltrials@biogenidec.com
7657|NCT00536172|William Burke MD|University of Nebraska|4025526005|wjburke@Unmc.edu
7658|NCT00536263|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
7659|NCT00536380|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
8455|NCT00603915|Dr. Lillian Siu|Univerisity Health Network|416-946-2911|lillian.siu@uhn.on.ca
7975|NCT00686725|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
7976|NCT00686777|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
7977|NCT00686790|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
7978|NCT00686803|Robert Jordan, Executive Director of Clinical Operations|Palatin Technologies, Inc.|609.495.2200|rjordan@palatin.com
7979|NCT00686842|Susan Krown, MD, Protocol Chair|AMC|301-251-1161|amcpm@emmes.com
7980|NCT00686855|Nathaniel S. Treister, DMD, DMSc|Dana-Farber Cancer Institute|617-632-2806|ntreister@partners.org
7981|NCT00686881|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
7982|NCT00630916|Director of Clinical and Medical Affairs|Sorin Group USA|512-435-3602|barbara.mathews@sorin.com
7983|NCT00630955|Dr. Suchitra Krishnan-Sarin, Associate Professor of Psychiatry|Yale University|203-974-7595|suchitra.krishnan-sarin@yale.edu
7984|NCT00677014|Greg Voss, Clinical Director|Boston Scientific|651-581-3068|gregory.voss@bsci.com
7985|NCT00677235|John Van Vleet|Bard Peripheral Vascular|1-800-321-4254|John.VanVleet@CRBard.com
7986|NCT00677352|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7987|NCT00677365|Jeff Loutit, MD; Chief Medical Officer|Rempex Pharmaceuticals Inc.|858.875.6665|jloutit@rempexpharma.com
7988|NCT00677534|Dr. Jason Stubbs|University of Kansas Medical Center|913-588-3867|jstubbs@kumc.edu
7989|NCT00677690|Ercole Zanotti|Fondazione Salvatore Maugeri, IRCCS, Pavia, Italy|39 385 247 ext 324|ercole.zanotti@fsm.it
7990|NCT00677807|Study Director|Novartis Pharmaceuticals|862-778-8300|
7991|NCT00677820|Raburn Mallory, MD/ Sr Dir Clinical Development|MedImmune LLC, an affiliate of AstraZeneca|301-398-0000|malloryr@medimmune.com
7992|NCT00677833|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7104|NCT00532935|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
7220|NCT00581581|Ronnie Guillet, MD, PhD|University of Rochester|585-275-6209|ronnie_guille@urmc.rochester.edu
7221|NCT00581776|Brad S Kahl|University of Wisconsin- Madison|608-263-1836|bsk@medicine.wisc.edu
7222|NCT00581828|Dr Karen Hansen|University of Wisconsin|608-263-3457|keh@medicine.wisc.edu
7223|NCT00581854|Brad S Kahl, MD|University of Wisconsin|608-263-1836|bsk@medicine.wisc.edu
7224|NCT00581945|Novartis Pharmaceuticals|Study Director|862-778-8300|
7225|NCT00581971|Dr. Sharon Spencer Professor of Radiation Oncology|UAB Hospital|205-934-2762|sspencer@uabmc.edu
7226|NCT00582036|George Selby, MD|University of Oklahoma Health Sciences Center|405-271-4022|george-selby@ouhsc.edu
7227|NCT00582309|Gary Iwamoto|UNM|505-272-4751|giwamoto@salud.unm.edu
7228|NCT00582361|Research Nurse Coordinator|UAB|205-996-6781|Talyor.vlack@ortho.uab.edu
7229|NCT00582426|Study Director|Novartis|1-800-778-8300|
7230|NCT00582491|Peter Morgan, MD, PhD|Yale University School of Medicine|203-974-7515|Peter.Morgan@yale.edu
7231|NCT00582517|Taylor Vlack, RN|University of Alabama at Birmingham|205-996-6781|tmwebb@uabmc.edu
7232|NCT00582556|Dr. Douglas McNeel|University of Wisconsin Carbone Cancer Center|608-263-4198|dm3@medicine.wisc.edu
7233|NCT00624052|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7234|NCT00624065|GSK Response Center|GlaxoSmithKline|866-435-7343|
7235|NCT00624195|Dr. Ron Ellis|UCSD|619-543-5079|roellis@ucsd.edu
7236|NCT00624221|Marianne O. Price, PhD|Cornea Research Foundation of America|317-814-2990|mprice@cornea.org
7237|NCT00624286|Study Director|Novartis Pharmaceuticals|862 778-8300|
7238|NCT00624377|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6139|NCT00818961|Scott R. Solomon, MD|Blood and Marrow Transplant Group of Georgia|404-255-1930|ssolomon@bmtga.com
6140|NCT00819013|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
6141|NCT00826267|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6142|NCT00826280|Senior Medical Director|Astellas Pharma Global Development||clinicaltrials@us.astellas.com
6143|NCT00826540|Dr. Axel Grothey, M.D.|Mayo Clinic|(507) 284-4430|grothey.axel@mayo.edu
6144|NCT00826618|Thomas A. Albini, MD|University of Miami|3054825006|talbini@med.miami.edu
5742|NCT00566254|Eisai Inc.|Eisai Call Center|888-422-4743|
5743|NCT00566462|Eisai Inc.|Eisai Call Center|888-422-4743|
5744|NCT00566501|Andrew Satlin, Senior Vice President, Neuroscience Product Creation Unit|Eisai, Inc.|201-949-4597|Andrew_Satlin@eisai.com
5745|NCT00566579|Bandit Chumworathayi|Department of OBGYN, Faculty of Medicine, Khon Kaen University, 40002, THAILAND|66818733327|bunchu@kku.ac.th
5746|NCT00566631|EMEA Therapeutic Area Leader CNS|Janssen-Cilag Germany|+492137955153|
5747|NCT00566722|Global Medical Services|Abbott|800-633-9110|
5748|NCT00566735|Dr. John Matthews|Massachusetts General Hospital|617-724-0847|jmatthews@partners.org
5749|NCT00566930|Martin Descarreaux|UQTR|819 376-5011 ext 3077|martin.descarreaux@uqtr.ca
5750|NCT00566943|Lesa Hobright-Turner, Director Clinical Affairs|Synovis Surgical Innovations|651-796-7506|lesa.hobrightturner@synovissurgical.com
5751|NCT00566982|Shionogi Clinical Trials Administrator|Shionogi Inc.|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
5752|NCT00567008|Jennifer Plebani|UPenn|2152223200 ext 152|jplebani@mail.med.upenn.edu
5753|NCT00567112|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5754|NCT00567164|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
5755|NCT00567190|Medical Communications|Genentech, Inc.|800 821-8590|
8070|NCT00687297|Study Statistician|PrECOG|617-632-3633|jmanola@jimmy.harvard.edu
8071|NCT00687323|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8072|NCT00687362|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
8073|NCT00687401|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@spcorp.com
8074|NCT00687440|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
8075|NCT00687453|Stanley H. Hsia, MD|Charles R. Drew University of Medicine and Science|323-357-3633|stanleyhsia@cdrewu.edu
8076|NCT00687531|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
8077|NCT00687544|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
8078|NCT00687609|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8079|NCT00687674|Dr. Shaji Kumar|Mayo Clinic||kumar.shaji@mayo.edu
8080|NCT00687804|Study Director|Novartis Pharmaceuticals|862 778-8300|
8081|NCT00687908|Clinical Project Manager|Galderma|+33 492 95 29 21|jean-charles.dhuin@galderma.com
8082|NCT00687973|Study Director|Novartis Pharmaceuticals|862 778-8300|
8083|NCT00688064|Jean-Charles Dhuin, Clinical Project Manager|Galderma|+33 4 92 95 29 21|jean-charles.dhuin@galderma.com
8084|NCT00688519|GSK Response Center|GlaxoSmithKline|866-435-7343|
8085|NCT00688545|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8086|NCT00688688|Medical Director, Global Medical Sciences|Astellas Pharma Global Development, Inc.||ClinicalTrials.Disclosure@us.astellas.com
8087|NCT00688740|International Clinical Development Study Director|sanofi-aventis||Contact-us@sanofi-aventis.com
8295|NCT00577655|Teva Study Physician|Teval Global Respiratory Research LLC|215-293-6482|
8296|NCT00577720|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
7993|NCT00677898|Julie Kreyenbuhl, Pharm.D., Ph.D.|VA VISN 5 Mental Illness Research, Education and Clinical Center|410-637-1864|Julie.Kreyenbuhl@va.gov
7994|NCT00677924|Eva Järlid Westerberg, VP Clinical Operations|Genmab A/S|+45 7020 2728|E.Westerberg@genmab.com
7995|NCT00678015|Dr. Terence Friedlander|University of California, San Francisco|415-353-7171|terence.friedlander@ucsf.edu
7996|NCT00678210|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8180|NCT00528840|Greg Kaufman, MD|Auxilium Pharmaceuticals, Inc.|(484)-321-5920 ext 5920|gkaufman@auxilium.com
8181|NCT00528879|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
8182|NCT00528931|Greg Kaufman, MD|Auxilium Pharmaceuticals, Inc.|484-321-5920 ext 5920|gkaufman@auxilium.com
8183|NCT00528957|Dara Wambach, MA, Associate Director, Regulatory Affairs|Gilead Sciences|650 522 5163|Dara.Wambach@gilead.com
8184|NCT00529035|John Koreth, MBBS, D.Phil|Dana-Farber Cancer Institute|(617) 632-2949|jkoreth@partners.org
8185|NCT00529087|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
8186|NCT00529100|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8187|NCT00529126|Executive Medical Director|Pacira Pharmaceuticals, Inc.|203-837-6500|ErolOnel@pacira.com
8188|NCT00529152|Dian Shaw, Manager Clinical Research|ApoPharma|416-401-7283|dshaw@apotex.com
8189|NCT00529191|Steve Willi, MD|CHOPhiladelphia|267-426-7037|willi@chop.email.edu
8190|NCT00529217|Dr. Antonio Mantovani|Columbia University Department of Psychiatry, City University of New York|212-650-5417|AMantovani@med.cuny.edu
8191|NCT00529243|William Towner, MD|Kaiser Permanente|323-783-7855|William.J.Towner@KP.org
8192|NCT00529282|Clincal Team Lead|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|908 927-3785|
8193|NCT00529308|Dr. Angeli Landeros-Weisenberger|Yale University||angeli.landeros-weisenberger@yale.edu
8194|NCT00529451|Study Director|Novartis Pharmaceuticals|862-778-8300|
8195|NCT00529464|Helen E. Rhodes, MD / Assistant Professor|UT MD Anderson Cancer Center|713-792-2933|CR_Study_Registration@mdanderson.org
7239|NCT00624416|Leanne Redman|Pennington Biomedical Research Center|225-763-0947|Leanne.Redman@pbrc.edu
7240|NCT00624442|Medical Director|Cytokinetics, Inc.|(650) 624-3011|
7241|NCT00624559|Dr. William Farquhar|University of Delaware|302-831-6178|wbf@udel.edu
7242|NCT00624585|Alan F. List, Executive  Vice President & President, Moffitt Medical Group|H. Lee Moffitt Cancer Center and Research Institute|813-745-6086|alan.list@moffitt.org
7357|NCT00633464|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
7358|NCT00633477|Takeda Study Registration Call Center|Takeda|800-778-2860|medicalinformation@tpna.com
7359|NCT00633750|Carlos Arteaga, M.D.|Vanderbilt-Ingram Cancer Center|(615) 936-1919|
7360|NCT00633867|W Brampton|NHS Grampian||william.brampton@nhs.net
7361|NCT00633880|Chief Scientific Officer|Chelsea Therapeutics Inc.|704-973-4202|hewitt@chelsearx.com
7362|NCT00633893|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
7363|NCT00633919|Santiago Martín - Trial Manager|ALK-Abelló S.A.|+34 913276127|santiago.martin@alk-abello.com
7364|NCT00633932|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7365|NCT00633984|Dr. Stefan G. Hofmann|Boston University|617 353 9233|shofmann@bu.edu
7366|NCT00634088|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
7367|NCT00634114|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7368|NCT00634322|VP Clinical Development, BTG International|BTG International (Protherics)|610-943-3632|janet.rush@btgplc.com
7369|NCT00634504|SVP, Clinical Development|BTG International Inc.|610-278-1660|angela.ogden@btgplc.com
7370|NCT00634543|Clinical Research Director|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|82-2-2094-4518|
7371|NCT00634582|Gary Schwartz, PhD|Comprehensive Cancer Center of Wake Forest Univeresity|336-716-7446|gschwart@wakehealth.edu
7372|NCT00634621|Emilio Moreno Carretero, M.D.|GE Healthcare|011-34-9166-30970|Emilio.Morenocarretero@ge.com
5756|NCT00567242|Bruce Crosson, PhD / Professor|University of Florida|352-273-6617|nossorc1@phhp.ufl.edu
5757|NCT00567320|Mehmet Sofuoglu, M.D., Ph.D.|Yale University|203-937-4809|mehmet.sofuoglu@yale.edu
5758|NCT00612690|Marc S. Atkins, Ph.D.|University of Illinois at Chicago|312-413-1048|atkins@uic.edu
5759|NCT00612807|Jill Compton, Ph.D.|Duke University Medical Center|919-416-2089|compton@duke.edu
5760|NCT00613015|Dr. McRae-Clark|MUSC|843-792-5216|mcraeal@musc.edu
5761|NCT00613028|David A. Reardon, MD|Preston Robert Tisch Brain Tumor Center at Duke|919-668-1409|reard003@mc.duke.edu
5762|NCT00613080|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@acr.com
5763|NCT00613106|Amy Grahn, MS  Senior Vice President, Clinical Development and Operations|Horizon Pharma, Inc.|224-383-3012|agrahn@horizonpharma.com
5764|NCT00613301|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5877|NCT00856778|Clinical Trial Manager|Coloplast Corp|612-302-4990|usdibe@coloplast.com
5878|NCT00721279|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5879|NCT00721500|Kurt Moody OD FAOO / Director|Vistakon|904-443-3088|
5880|NCT00721578|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5881|NCT00721968|Jeff Wells. Sr VP, Clinical, Regulatory, and Quality Affairs|Glaukos|949-367-9600 ext 227|jwells@glaukos.com
5882|NCT00722072|Dr. Stephen Chui|OHSU Knight Cancer Institute|503-494-8534|chuis@ohsu.edu
5883|NCT00722124|Amit Sood, MD|Mayo Clinic|507-266-1944|nicotineresearch@mayo.edu
5884|NCT00722371|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5885|NCT00722553|Medical Monitor|Allos Therapeutics, Inc.|303-426-6262|gweems@allos.com
5886|NCT00722566|Helgi Van de Velde, M.D., Ph.D.|Johnson & Johnson Pharmaceutical Research & Development||HVDVELDE@ITS.JNJ.COM
5887|NCT00722761|Alexa B. Kimball|MGH Curtis|617-726-5066|harvardskinstudies@partners.org
8297|NCT00577772|Dr. John K. DiBaise|Mayo Clinic|480-301-6990|dibaise.john@mayo.edu
8298|NCT00577824|Chief Medical Officer|Eli Lilly and Company||clinicaltrials@amylin.com
8299|NCT00577863|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8300|NCT00577889|Robert McWilliams, M.D.|Mayo Clinic Cancer Center||McWilliams.robert@mayo.edu
8301|NCT00578071|Dr Brian Czito|Duke University Medical Center Radiation Oncology|668-7336|brian.czito@duke.edu
8302|NCT00578136|Harshad Gurnaney, MBBS, MPH|The Children's Hospital of Philadelphia|267-426-5850|gurnaney@email.chop.edu
8303|NCT00578175|GSK Response Center|GlaxoSmithKline|866-435-7343|
8304|NCT00578214|Dr. Clark C. Otley|Mayo Clinic|507-284-3579|otley.clark@mayo.edu
8305|NCT00578227|GSK Response Center|GlaxoSmithKline|866-435-7343|
8306|NCT00578279|Julia K. LeBlanc, MD|Indiana University Medical Center|(317) 948-8125|juleblan@iupui.edu
8307|NCT00578318|Alfiee M. Breland-Noblem Ph.D., MHSc|Georgetown University Medical Center|2026872392|ab2892@georgetown.edu
8308|NCT00578331|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
8309|NCT00578383|Dr. Rinah Yamamoto|McLean Hospital|617-855-2861|yamamoto@mclean.harvard.edu
8310|NCT00578448|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
8311|NCT00578461|Robert Krance, MD|Baylor College of Medicine|832-824-4661|rakrance@txch.org
8312|NCT00578539|Robert Krance, MD|Baylor College of Medicine|832-824-4661|rakrance@txch.org
8313|NCT00586469|GSK Response Center|GlaxoSmithKline|866-435-7343|
8314|NCT00586495|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
8315|NCT00586521|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
8316|NCT00586573|Craig Surman, MD|Massachusetts General Hospital|617-503-1424|csurman@partners.org
8317|NCT00586612|GSK Response Center|GlaxoSmithKline|866-435-7343|
8196|NCT00529516|GSK Response Center|GlaxoSmithKline|866-435-7343|
8197|NCT00529529|Study Director|Novartis Pharmaceuticals|862 778-8300|
8198|NCT00529542|Richard S. Legro|Milton S. Hershey Medical Center|717-531-8478|rsl1@psu.edu
8199|NCT00529555|Marie Wilson, Clinical Program Manager|Sunstar Americas, Inc|773-481-3327|marie.wilson@us.sunstar.com
8200|NCT00529568|GSK Response Center|GlaxoSmithKline|866-435-7343|
8201|NCT00537940|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8202|NCT00537979|Global Medical Services|Abbott|800-633-9110|
8387|NCT00570141|Herbert B. Slade, M.D., FAAAI|Healthpoint, Ltd.|917-900-4000|bert.slade@healthpoint.com
8388|NCT00570310|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8389|NCT00570349|Brahm Goldstein|INO Therapeutics|908-238-6495|brahm.goldstein@ikaria.com
8390|NCT00570362|Jung-Il Moon|St.Mary's Hospital, College of Medicine, The Catholic University of Korea|82-2-3779-2114 ext 1243|jimoon@catholic.ac.kr
8391|NCT00570492|GSK Response Center|GlaxoSmithKline|866-435-7343|
8392|NCT00570505|Laura Eaton|Apollo Endosurgery|949-468-9301|laura.eaton@apolloendo.com
8393|NCT00615069|Tab Bonny|W.L. Gore and Associates|928 864 4275|tbonny@wlgore.com
8394|NCT00615108|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8395|NCT00578552|Amit Sood|Mayo Clinic|507-266-1944|nicotineresearch@mayo.edu
8396|NCT00578565|Eric. L. Matteson, M.D.|Mayo Clinic|507-284-8450|
8397|NCT00578617|Kristi Monahan|Mayo Clinic|507-255-6676|CABANA@mayo.edu
8398|NCT00578734|Dr. Neal J. Thomas|Penn State Children's Hospital|717-531-5337|nthomas@hmc.psu.edu
8399|NCT00578786|Hunter Gillies, MD, DSEM|Gilead Sciences, Inc.|650-522-1214|hunter.gillies@gilead.com
7373|NCT00634647|Dr. William Dahut|National Cancer Institute, National Institutes of Health|301-435-8183|dahutw@mail.nih.gov
7374|NCT00634842|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
7375|NCT00634894|Judith Wolf, MD/Associate Professor|UT MD Anderson Cancer Center|713-792-7310|
7376|NCT00634920|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
7377|NCT00634933|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7378|NCT00635024|Dr. Shaji Kumar|Mayo Clinic||kumar.shaji@mayo.edu
7379|NCT00635154|Dr. John Lust|Mayo Clinic||lust.john@mayo.edu
7493|NCT00598559|Mike Royal. MD, JD, MBA. Vice President Clinical Development- Analgesics|Cadence Pharmaceuticals, Inc|858 436 1400|mroyal@cadencepharm.com
7494|NCT00598650|Masaki Nakagawa|Eisai Co., Ltd.|+81-3-3817-5245 ext 5245|
7495|NCT00598702|Mike Royal MD, JD, MBA.Vice President Clinical Development- Analgesics.|Cadence Pharmaceuticals, Inc.|858 436 1400|mroyal@cadencepharm.com
7496|NCT00598819|Dr. Jeffrey C. Milliken|University of California, Irvine Medical Center|714-456-3634|jcmillik@uci.edu
7497|NCT00598832|Michael Graeber MD/ Head of Global Clinical Project Management|Galderma|609-860-8201|michael.graeber@galderma.com
7498|NCT00598871|NabilaTurjman, PhD, Executive Director, Regulatory Affairs & Drug Safety|RegeneRx Biopharmaceuticals, Inc.|301-208-9191 ext 108|nturjman@regenerx.com
7499|NCT00599014|Dr. Javed Butler|Emory University|404-778-5136|jbutle4@emory.edu
7500|NCT00599027|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7501|NCT00599053|Dr. David Randolph|University of Alabama at Birmingham|205-934-4680|drandolph@peds.uab.edu
7502|NCT00599131|Dr. Francis Worden|University of Michigan Comprehensive Cancer Center|734-936-0453|fworden@umich.edu
7503|NCT00642603|Medical Communications|Genentech, Inc.|800-821-8590|
7504|NCT00642642|Dr/ Joseph Fratantoni|Biologics Consulting Group|(301) 340-8432|jfratantoni@bcg-usa.com
5888|NCT00722800|Alexandra B. Kimball, MD|MGH|617-726-5066|harvardskinstudies@partners.org
5889|NCT00723008|LTC. Elizabeth Mann-Salinas, PhD, RN,CCRN,CCNS|U.S. Army Institute of Surgical Research|210-916-3527|Elizabeth.Mann@us.army.mil
5890|NCT00723021|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5891|NCT00723073|David Kubiak, Principle Investigator|Brigham and Women's Hospital|617-525-8417|dwkubiak@partners.org
5892|NCT00723125|William Sikov, MD|BrUOG|4018633000|kayla_rosati@brown.edu
5893|NCT00723190|Shionogi Clinical Trials Administrator|Shionogi USA|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
5894|NCT00723203|Paul Frankel, Ph.D.|City of Hope National Medical Center|(626)359-8111 ext 65265|pfrankel@coh.org
5895|NCT00723450|GSK Response Center|GlaxoSmithKline|866-435-7343|
5896|NCT00723489|Associate Director, Clinical Research Operations Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
5897|NCT00723528|Senior Director, Clinical Development|Janssen Research & Development, LLC|793-7633 ext 215|
5898|NCT00723554|Wade Benton, PharmD/ Director, Medical Affairs Veletri and Ventavis|Actelion Pharmaceuticals, US, Inc.|(650) 624-6900|wade.benton@actelion.com
6011|NCT00768599|Candis Edwards|AmDerma Pharmaceuticals|631-974-7949|cedwards@amderma.com
6012|NCT00768755|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6013|NCT00768898|Alison Ramsey, O.D., Manager|Alcon Research, Ltd.|817-551-6986|Alison.ramsey@alconlabs.com
6014|NCT00768989|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
6015|NCT00769119|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
6016|NCT00769132|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6017|NCT00769314|Dr Pierre ATTALI|BioAlliance Pharma|+33145587600|pierre.attali@bioalliancepharma.com
6018|NCT00769561|Dr. Meike Shedden Mora|Department of Clinical Psychology and Psychotherapy, Philipps University of Marburg, Germany|+49-6421-282 ext 3657|m.shedden@staff.uni-marburg.de
8318|NCT00586625|Vice President, Clinical Research & Medical Affairs|ISTA Pharmaceuticals, Inc.|949-788-6000|tmcnamara@istavision.com
7884|NCT00629239|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7885|NCT00629499|Director, Breast Cancer Research|Sarah Cannon Research Institute|615-329-7274|asksarah@scresearch.net
7886|NCT00629525|Dr. Daniel George|Duke University|919-668-4615|daniel.george@duke.edu
7887|NCT00629707|Dr. Nicole Glaser|University of California, Davis|916-734-7098|nsglaser@ucdavis.edu
7888|NCT00629772|Annie Levesque|Innovaderm Research|514 521 4285 ext 222|alevesque@innovaderm.ca
7889|NCT00629850|Chris Russian, Associate Professor|Texas State Respiratory Care Department|512-245-3794|cr23@txstate.edu
7890|NCT00630058|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
7891|NCT00630292|William Irvin, Jr. MD / Co-Principal Investigator|University of North Carolina|919-966-6735|william_irvin@med.unc.edu
7892|NCT00630331|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
7893|NCT00630344|Mary-Ellen Taplin, MD|Dana-Farber Cancer Institute|617-582-8313|mary_taplin@dfci.harvard.edu
7894|NCT00630396|David Hess, MD|Georgia Health Sciences University|706-721-1691|dhess@georgiahealth.edu
7895|NCT00630487|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
7896|NCT00630539|Shionogi Clinical Trials Administrator|Shionogi Inc.|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
7897|NCT00630734|Christina Aquilante, Pharm.D.|University of Colorado Denver|303-724-6126|christina.aquilante@ucdenver.edu
7898|NCT00630747|Dr. Arian Pano, Medical Director|Shire Human Genetic Therapies|781-482-0875|apano@shire.com
7899|NCT00630786|Study Director|Amgen Inc.|866-572-6436|
7900|NCT00630864|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7901|NCT00630877|Medical Information Specialist|Abbott|800-633-9110|
8400|NCT00578812|Mandy Wright, Sr. Clinical Affairs Associate|NuVasive, Inc|858-349-6581|mwright@nuvasive.com
8401|NCT00578864|Peter Zage, MD|BAYLOR|832-824-4615|pezage@txch.org
8402|NCT00578903|Kathryn Leung|Baylor College of Medicine|832-824-4269|kleung@bcm.edu
8403|NCT00578929|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
8404|NCT00578942|David Rizzieri, MD|Duke University Medical Center|919-668-1040|david.rizzieri@duke.edu
8405|NCT00578968|Bruce D. Johnson, PhD|Mayo Clinic|507-284-4441|johnson.bruce@mayo.edu
8406|NCT00579059|Megan Lawson, Clinical Research Specialist|Biomet, LLC|1-800-348-9500 ext 1183|megan.lawson@biomet.com
8407|NCT00579098|Paul A. Friedman, MD|Mayo Clinic|507-255-2398|friedman.paul@mayo.edu
8408|NCT00579111|Rammurti Kamble, MD|Baylor|713-394-6252|rtkamble@tmhs.org
8409|NCT00621764|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
7997|NCT00678249|John Reviere, Director, Clinical Affairs|Bard Peripheral Vascular, Inc.|480-303-2644|john.reviere@crbard.com
7998|NCT00678288|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
7999|NCT00678392|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8000|NCT00678418|Bernard L. Silverman, MD|Alkermes, Inc.|1-781-609-6000|bernard.silverman@alkermes.com
8001|NCT00678470|John Koo MD|University of California at San Francisco|4154764701|john.koo@ucsfmedctr.org
8002|NCT00678535|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merck.de
8003|NCT00678587|GSK Response Center|GlaxoSmithKline|866-435-7343|
8004|NCT00678639|Chadwick Miller, MD|Wake Forest University Baptist Medical Center|336-716-1740|cmiller@wfubmc.edu
8005|NCT00678795|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd.|0044 1223 266800|rp@gwpharm.com
8006|NCT00678834|Dr. Chandan K. Sen, PhD. Professor and Associate Dean|The Ohio State University Wexner Medical Center|614-247-7658|chandan.sen@osumc.edu
7505|NCT00642694|Dr.Prabha Sunderajan- Assistant Professor|UT Southwestern Medical Center|214-645-6964|psunderajan@utsouthwestern.edu
7506|NCT00642707|Clinical Project Manager|Progenics Pharmaceuticals, Inc.|914-784-1868|trawls@progenics.com
7507|NCT00642746|Charles Lopez, MD|OHSU Knight Cancer Institute|503-494-8534|lopezc@ohsu.edu
7508|NCT00642772|Dr. Kelli Allen|Center for Health Services Research in Primary Care, Durham VA Medical Center|919-286-0411 ext 7090|kelli.allen@va.gov
7509|NCT00642811|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7510|NCT00643006|Dr. K Mannerkorpi|Gothenburg University|046-31-24220|kaisa.mannerkorpi@rheuma.gu.se
7511|NCT00643097|Dr. John H. Sampson|Duke University Medical Center|919-684-9041|john.sampson@duke.edu
7512|NCT00643201|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
7513|NCT00643448|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7514|NCT00643578|Dr. Leslie Hendeles|University of Florida Asthma Research Lab|352-273-6027|hendeles@cop.ufl.edu
7105|NCT00533273|Greg Kaufman, MD|Auxilium Pharmaceuticals, Inc.|484-321-5920 ext 5920|gkaufman@auxilium.com
7106|NCT00533351|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
7107|NCT00533507|GSK Response Center|GlaxoSmithKline|866-435-7343|
7108|NCT00533702|Chief Medical Officer|Eli Lilly and company|800-545-5979|
7109|NCT00533897|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
7110|NCT00534092|Zhimin Liu|Medtronic Spine LLC|901-399-3123|zhimin.liu@medtronic.com
7111|NCT00534105|Glenn Markenson MD|Baystate Medical Center|413-794-8073|glenn.markenson@bhs.org
7112|NCT00534209|Luis Raez MD|UM/Sylvester Comprehensive Cancer Center|305-243-4909|lraez@med.miami.edu
7113|NCT00534248|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
7114|NCT00579137|Robert Krance, MD|Baylor|832-824-4661|rkrance@bcm.edu
6019|NCT00769652|Dr. Elizabeth Poplin, MD (sub-investigator)|Rutgers Cancer Institute of New Jersey|732-235-8675|poplinea@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
6020|NCT00770029|Dr. Matthias Zerm|Merz Pharmaceuticals GmbH|0049-69-1503 ext 865|matthias.zerm@merz.de
6021|NCT00770146|Genzyme Medical Information|Genzyme Corporation|617-252-7832|
6022|NCT00770211|Dr. Matthias Zerm|Merz Pharmaceuticals GmbH|0049-69-1503 ext 865|matthias.zerm@merz.de
6023|NCT00770289|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6024|NCT00770315|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6025|NCT00770341|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@Merck.com
6026|NCT00770367|Dana King MD|Medical University of South Carolina|843-792-8112|kingde@musc.edu
6027|NCT00770432|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6028|NCT00770510|Atsushi Kamijo, Study Director|Eisai Co., Ltd.|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp
6029|NCT00770588|Gerard Lynch|AstraZeneca|52564555 ext 86 21|aztrial_results_posting@astrazeneca.com
6030|NCT00770653|Medical Director|Takeda Pharma GmbH, Aachen (Germany)|+49 800 8253325|clinicaltrialregistry@tpna.com
6031|NCT00770692|Atsushi Kamijo, Study Director|Eisai Co., Ltd.|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp
6032|NCT00770861|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|Forest Laboratories|1-201-427-8259|John.Whalen@frx.com
6145|NCT00826943|Douglas Tzanetos|Vanderbilt University|615-942-7971|dtzanetos@hotmail.com
6146|NCT00827073|Joseph Selem, MD|Robert Cizik Eye Clinic|713-559-5263|laurabaker@cizikeye.org
6147|NCT00827099|Scott R. Solomon, MD|Blood and Marrow Transplant Group of Georgia|404-255-1930|ssolomon@bmtga.com
6148|NCT00827112|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6149|NCT00827242|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
7902|NCT00593736|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
7903|NCT00593814|Tab Bonny|W.L. Gore and Associates|928 864 4275|tbonny@wlgore.com
7904|NCT00593827|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
7905|NCT00593866|Dr. Mark Zalupski|University of Michigan Comprehensive Cancer Center|734-615-3969|zalupski@umich.edu
7906|NCT00593918|Theresa Guilbert, MD|University of Wisconsin-Madison|608-263-9608|tguilbert@wisc.edu
8088|NCT00528411|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
8089|NCT00528424|Greg Kaufman, MD|Auxilium Pharmaceuticals, Inc.|484-321-5920 ext 5920|gkaufman@auxilium.com
8090|NCT00528528|Clinical Leader|Janssen Research & Development, LLC Titusville, NJ|609-730-3174|
8091|NCT00679263|Kazuko Matsuda, MD, Vice President Clinical Development|Medicinova Inc|858-373-1500 ext 132|matsuda@medicinova.com
8092|NCT00679302|Dr. Myto Duong, Pediatric Emergency Medicine Director|Southern Illinois University, School of Medicine|217-545-7409|myto_duong@yahoo.com
8093|NCT00679341|Medical Communications|Genentech, Inc.|800 821-8590|
8094|NCT00679354|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
8095|NCT00679380|Michael Huang, M.D., Senior Medical Director|Santarus, Inc.|858-314-5700|contact@santarus.com
8096|NCT00679432|Michael Huang, MD, Senior Medical Director, Clinical Research|Santarus, Inc.|8583145700|mhuang@santarus.com
8097|NCT00679627|Director, Clinical Research|Johnson & Johnson Pharmaceutical Research & Development|1 609-730-7674|
8098|NCT00679783|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
8099|NCT00679913|Sun-Whe Kim, M.D., Ph.D., FACS|Seoul National University Hospital|82-2-2072-2310|sunkim@plaza.snu.ac.kr
8100|NCT00536913|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
8101|NCT00536978|Issa F. Khouri, MD / Professor|UT MD Anderson Cancer Center||pmcadams@mdanderson.org
8007|NCT00679081|Director of Clinical Operations|Organogenesis Inc.|781-575-0775|clinicaltrials@organo.com
8008|NCT00679211|Medical Communications|Genentech, Inc.|800-821-8590|
8009|NCT00637273|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
8010|NCT00637299|Ercole Zanotti|Fondazione Salvatore Maugeri|39 385 247 ext 324|ercole.zanotti@fsm.it
8011|NCT00637312|Ruba Sarris|Orthofix|214-937-2256|rubasarris@orthofix.com
8012|NCT00637377|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
8013|NCT00637923|Marc Ayers|Romark Laboratories, L.C.|813-282-8544|Marc.Ayers@romark.com
8014|NCT00638014|Elliott Bennett-Guerrero|Duke University|9196819660|benne011@mc.duke.edu
8015|NCT00638157|Ed Campanaro / Vice President, Clinical Operations|Cubist Pharmaceuticals|781-860-8318|ed.campanaro@cubist.com
8016|NCT00638183|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8017|NCT00638365|Nestor A. Molfino, MD., MSc|KaloBios Pharmaceuticals, Inc.|650-243-3103|nmolfino@kalobios.com
8018|NCT00638378|Study Director|Incyte Corporation|1-855-463-3463|
8019|NCT00638651|Dr. Keyvan Nouri|University of Miami|305-243-3380|knouri@med.miami.edu
8203|NCT00538213|GSK Response Center|GlaxoSmithKline|866-435-7343|
8204|NCT00538291|Paul Frankel, Ph.D.|City of Hope National Medical Center|(626)359-8111 ext 65265|pfrankel@coh.org
8205|NCT00538304|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
8206|NCT00538473|GSK Response Center|GlaxoSmithKline|866-435-7343|
8207|NCT00538512|Arnold S. Monto, MD|University of Michigan School of Public Health|734-764-5453|asmonto@umich.edu
8208|NCT00538590|Thomas Dietlein, Ph. D., MD|Hospital of Universität Köln|+49 221 4785862 ext 4300|thomas.dietlein@uk-koeln.de
8209|NCT00538616|Dr. Carmelo Graffagnino|Duke University|919/681-3751|Carmelo.Graffagnino@duke.edu
7115|NCT00579254|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
7116|NCT00579345|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
7117|NCT00579501|Medical Specialist, Clinical Oncology|PharmaMar SA, Av de los Reyes 1 Mine Industrial Estate, 28770 Colmenar Viejo, Madrid, Spain|+34 91 646-6087|
7118|NCT00579670|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7119|NCT00579813|Robert E. McGehee Jr., Ph.D.|University of Arkansas for Medical Sciences|501-603-1998|rem@uams.edu
7120|NCT00579982|GSK Response Center|GlaxoSmithKline|866-435-7343|
7121|NCT00580034|David Rizzieri, MD|Duke University Medical Center|919-668-1040|david.rizzieri@duke.edu
7122|NCT00580138|Gary McCullough|University of Arkansas for Medical Sciences Medical Center|501-852-7886|mcculloughgaryh@uams.edu
7123|NCT00580606|Associate Director, Clinical Research Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov
7124|NCT00580671|Alan J. Budney, PhD|Geisel School of Medicine at Dartmouth|855-290-2822|alan.j.budney@dartmouth.edu
7125|NCT00580723|Brian Swasdibutra, Clinical Research Coordinator|University of California, Irvine|9498247103|bswasdib@uci.edu
7126|NCT00580801|Clinical Leader|Janssen Research & Development, LLC, Titusville, NJ|609-730-3174|
7127|NCT00580840|UCB (Study Director)|UCB Clinical Trial Call Center|+1 887 822 9493|
7243|NCT00588861|Nick Higdon, Clinical Research Specialist|Biomet Manufacturing|1-800-348-9500 ext 3047|nicholas.higdon@biomet.com
7244|NCT00588965|Dr. Elizabeth Kaufman|MetroHealth Medical Center|216-778-2349 ext none|ekaufman@metrohealth.org
7245|NCT00589108|Dr. Robert T. Trousdale|Mayo Clinic|507-284-3663|trousdale.robert@mayo.edu
7246|NCT00589277|Benjamin Toll, Ph.D. Associate Professor of Psychiatry|Yale University School of Medicine|(203) 974 5767|benjamin.toll@yale.edu
7247|NCT00589290|Arun Rajan, M.D.|National Institutes of Health (NIH), National Cancer Institute (NCI)|301-594-5322|rajana@mail.nih.gov
7248|NCT00589303|Dr. Win K. Shen|Mayo Clinic|480-342-0348|wshen@mayo.edu
6150|NCT00827255|Vice President, Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
6151|NCT00827502|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
6152|NCT00827541|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6153|NCT00827567|Allan Lipton, MD|Penn State|717-531-5960|alipton@psu.edu
6154|NCT00827632|Carolyn Westhoff|Columbia University|212-305-4805|clw3@columbia.edu
6155|NCT00827918|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6156|NCT00827931|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6157|NCT00827983|Clinical trial manager|IBSA Institut biochimique|+41583601000|barbara.cometti@ibsa.ch
6158|NCT00828061|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
6159|NCT00828113|Douglas E. Jorenby, Ph.D.|University of Wisconsin School of Medicine and Public Health|6082627527|dej@ctri.medicine.wisc.edu
6160|NCT00828191|IBSA U.S. Agent|IBSA Institut Biochimique SA|805 376 00 78|cejtwsxx@verizon.net
6161|NCT00828204|Biogen Idec Medical Director|Biogen Idec Inc.||clinicaltrials@biogenidec.com
6162|NCT00828295|Salvatore Chessari|Helsinn Healthcare SA|+41 91 985 21 21|salvatore.chessari@helsinn.com
6163|NCT00828308|Anthony Mega, MD|BrUOG|4018633000|kayla_rosati@brown.edu
6164|NCT00828321|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
6165|NCT00828412|Joanne Fraser|Promius Pharma|908 429-4504|joannefraser@promiuspharma.com
6166|NCT00828464|GSK Response Center|GlaxoSmithKline|866-435-7343|
6167|NCT00696384|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
6168|NCT00696423|GSK Response Center|GlaxoSmithKline|866-435-7343|
6169|NCT00610701|Brett D. Crist, MD|University of Missouri|5738826562|cristb@health.missouri.edu
8102|NCT00537030|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
8103|NCT00537082|Study Director|Novartis Pharmaceuticals|862-778-8300|
8104|NCT00537095|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
8105|NCT00537199|Mark Chambers, MS, DMD / Professor|UT MD Anderson Cancer Center|713-792-6510|
8106|NCT00537238|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8107|NCT00537277|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
8108|NCT00537303|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
8109|NCT00537316|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
8110|NCT00537329|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
8319|NCT00586664|Vice President, Clinical Research & Medical Affairs|ISTA Pharmaceuticals, Inc.|949-788-6000|tmcnamara@istavision.com
8320|NCT00586690|David Rizzieri, MD|Duke University Medical Center|919-668-1040|david.rizzieri@duke.edu
8321|NCT00586703|David Rizzieri, MD|Duke University Medical Center|919-668-1040|david.rizzieri@duke.edu
8322|NCT00586729|Karen Richey, RN|Maricopa Integrated Health System|602-344-5125|karen.richey@mihs.org
8323|NCT00586820|Dr. Amir Lerman|Mayo Clinic|507-255-6670|lerman.amir@mayo.edu
8324|NCT00587041|Use of Symbiotics to Reduce Urinary Oxalate Excretion|Mayo Clinic|507-266-7960|lieske.john@mayo.edu
8325|NCT00587132|Dr. Naoki Takahashi|Mayo Clinic|507-284-7249|takahashi.naoki@mayo.edu
8326|NCT00587158|Hatem Amer, MD, FASN; Assistant Professor of Medicine; Division of Nephrology and Hypertension|Mayo Clinic|507-256-1963|amer.hatem@mayo.edu
8327|NCT00587171|Raymond Kraker, M.S.P.H.|Jaeb Center for Health Research|813-975-8690|pedig@jaeb.org
8328|NCT00587223|Director of Clinical Operations|Organogenesis Inc.||kgiovino@organo.com
8329|NCT00587431|Dr. Dana Rathkopf|Memorial Sloan-Kettering Cancer Center|646-422-4379|rathkopd@mskcc.org
8210|NCT00538629|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
8211|NCT00538642|Dr. Alexander Miller|University of Texas Health Science Center at San Antonio|210-567-5508|millera@uthscsa.edu
8212|NCT00538785|Pamela Griffin, Senior Director, Clinical Development|MedImmune, LLC|301 398 0000|griffinp@medimmune.com
8213|NCT00538850|Larry Dillaha, M.D., Chief Medical Officer|Insys Therapeutics, Inc.|602 910-2617|ldillaha@insysrx.com
8214|NCT00538863|Larry Dillaha, M.D., Chief Medical Officer|Insys Therapeutics, Inc.|602-910-2617|ldillaha@insysrx.com
8215|NCT00538902|Global Medical Services|Abbott|800-633-9110|
8216|NCT00538915|Richard L. Wasserman, M.D., Ph.D.|DallasAllergyImmunology|(972) 566-7788|drrichwasserman@gmail.com
8217|NCT00539006|GSK Response Center|GlaxoSmithKline|866-435-7343|
8218|NCT00539032|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
8219|NCT00585715|Kristen M. Kelly, M.D.|University of California, Irvine|949-824-7103|kmkelly@uci.edu
8220|NCT00585910|Kerry Brodziak|Massachusetts General Hospital|617-503-1043|kbrodziak@partners.org
8221|NCT00585923|Jacquelyn Hughes|Biomet|973-299-9300 ext 3075|jacquelyn.hughes@biomet.com
8222|NCT00585975|Tim McNamara, PharmD|ISTA Pharmaceuticals, Inc.|949-788-6000|tmcnamara@istavision.com
8223|NCT00586105|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
8224|NCT00586157|Timothy Wilens, MD|Massachusetts General Hospital|617-726-1731|twilens@partners.org
8225|NCT00586196|Edward R Marcantonio|BIDMC|617-754-1405|emarcant@bidmc.harvard.edu
8456|NCT00603993|Global Medical Services|Abbott|1-800-633-9110|
8457|NCT00604019|Gourang Patel, PharmD|RUSH University Medical Center|312-942-4258|gourang_p_patel@rush.edu
8458|NCT00604045|Dr. Nader Amir|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|6192293740|namir@mail.sdsu.edu
8459|NCT00604162|Hila Debby|Given Imaging|+972 4 9097774|Hila.Debby@givenimaging.com
7249|NCT00589563|Dr. Ryotaro Nakamura|City of Hope Medical Center|626-256-4673 ext 65285|rnakamura@coh.org
7250|NCT00589628|Dr. C. Egla Rabinovich|Duke Health Systems|919-668-0238|egla.rabinovich@duke.edu
7251|NCT00589667|David Pfister, MD|Memorial Sloan-Kettering Cancer Center|646-888-4232|pfisterd@mskcc.org
7252|NCT00589693|Sr Director Clinical Development|Janssen R&D US|1 510 248-2310|
7253|NCT00589849|Dr. Aryan Mooss|Creighton University|402-280-4566|aryanmooss@creighton.edu
7254|NCT00589888|Guillermo Umpierrez, MD|Emory Univ SOM|4047781665|geumpie@emory.edu
7255|NCT00589914|Clinical Leader Psychiatry|Johnson & Johnson Pharmaceutical Research & Development LLC|1 609 730-2324|
7256|NCT00589979|Endo Clinical Trials Response Center|Endo Pharmaceuticals Inc.|1-800-462-3636|clinicaltrials@endo.com
7257|NCT00590005|Dr. Anne Fitzpatrick, Director, Emory Asthma Clinical Research Program|Emory University Department of Pediatrics|404-727-9112|anne.fitzpatrick@emory.edu
7258|NCT00590044|Guillermo Umpierrez|Emory University SOM|4047781663|geumpie@emory.edu
7259|NCT00590161|Claudia O. Zein, MD, MSc|Cleveland Clinic Lerner College of Medicine of Case Western Reserve University|216-444-0421|zeinc@ccf.org
7260|NCT00590226|Guillermo Umpierrez, MD|EUSOM|4047781665|geumpie@emory.edu
7261|NCT00590317|Dr. Daniel Wu|Emory University|(404) 251-8875|dtwu@emory.edu
7262|NCT00590369|Nancy M. Albert PhD, RN|Cleveland Clinic|216-444-7028|albertn@ccf.org
7263|NCT00590460|Malcolm Brenner, MD|BAYLOR|832-824-4663|mbrenner@bcm.edu
7264|NCT00590538|Ronald Rubenstein, MD, PhD|The Children's Hospital of Philadelphia|1-215-590-1281|rubensteinr@email.chop.edu
7265|NCT00590577|Compound Development Team Leader, Paliperidone|Johnson & Johnson Pharmaceutical Research & Development|609-730-4530|
7380|NCT00635219|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
7381|NCT00601354|Dr. Debra L Safer|Stanford University|650-723-7928|dlsafer@stanford.edu
7382|NCT00601367|Krista Barbour, Ph.D.|Sprout Pharmaceuticals|9198820850|kbarbour@sproutpharma.com
6249|NCT00846391|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6250|NCT00846495|Rebecca Browning|Clinvest|417-841-3664|rbrowning@clinvest.com
6251|NCT00696436|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
6252|NCT00696696|Deirdre Cohen, MD|NYU Cancer Institute|212-731-5656|deirdre.cohen@nyumc.org
6253|NCT00696761|Kanghyon Song, Myung-Soo Choo, Kyu-Sung Lee, Ji-Yeon Han, Young-Suk Lee,|the Department of Urology, Asan Medical Center, University of Ulsan College|82-2-3010-3735|mschoo@amc.seoul.kr
6254|NCT00696774|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6255|NCT00696787|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
6256|NCT00696800|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6257|NCT00697073|Dr Thomas Meier|Santhera|+41 61 906 8964|thomas.meier@santhera.com
6258|NCT00697112|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6259|NCT00697190|John Buch OD|Vistakon|904-443-1707|
6260|NCT00697255|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6261|NCT00697515|Timothy Whitaker, MD|Shire Pharmaceuticals||twhitaker@shire.com
6262|NCT00697541|Michael Graeber, MD|Galderma|609-860-8201|michael.graeber@galderma.com
6263|NCT00697593|Merck KGaA Communication Center|Merck Serono S.A., a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
6264|NCT00697619|Dr. Li Zhang|Sun Yat-sen University Cancer Centre|86-20-87343458(O)|zhangli6@mail.sysu.edu.cn
6265|NCT00697697|VP, Scientific Affairs|MAP Pharmaceuticals, Inc. a wholly owned subsidiary of Allergan|650-386-3100|dkellerman@mappharma.com
6266|NCT00697801|VP, Scientific Affairs|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|650-386-3100|dkellerman@mappharma.com
6267|NCT00697827|Ann Marie Simon|Synthes|610-719-5418|simon.annmarie@synthes.com
8330|NCT00587483|Dr. William Mauermann|Mayo Clinic|507-255-4240|mauermann.william@mayo.edu
8331|NCT00587587|Director of Clinical Operations|Organogenesis Inc.|781-575-0775|clinical@organo.com
8332|NCT00587639|Dr. Christopher Wall|Mayo Clinic|5072843352|wall.chris@mayo.edu
8333|NCT00587678|Dr Christopher Kramer|University of Virginia|434-243-0736|
8334|NCT00587769|Jon O. Ebbert|Mayo Clinic|507-284-2511|ebbert.jon@mayo.edu
8335|NCT00587834|Director of Clinical Operations|Organogenesis Inc.|781-575-0775|clinical@organo.com
8336|NCT00587860|Yuri A. Saito Loftus, M.D., M.P.H.|Mayo Clinic|507-284-5010|saito.yuri@mayo.edu
8337|NCT00588146|Karen L. Swanson, D.O.|Mayo Clinic|507-255-3214|swanson.karen@mayo.edu
8338|NCT00588159|Dr. Michelle A. O. Kinney|Mayo Clinic|507-266-9877|kinney.michelle@mayo.edu
8339|NCT00588354|Dr. Marc A. Huntoon|Mayo Clinic|(507) 284-2511|huntoon.marc@mayo.edu
8340|NCT00630994|Dr. Ruben A. Mesa|Mayo Clinic|507-284-2511|mesa.ruben@mayo.edu
8341|NCT00547521|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
7907|NCT00593957|Dr Sakkubai Naidu Professor of Neurology and Pediatrics|Kennedy Krieger Institute|443-923-2778|naidu@kennedykrieger.org
7908|NCT00594035|Jennifer Doyle, MS, CCRA-  Global Director, Clinical Affairs- Biosurgery|Covidien|781-839-1770|jennifer.doyle@covidien.com
7909|NCT00635830|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7910|NCT00635882|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
7911|NCT00636077|Richard A Ward, Ph.D.|Kidney Disease Program, University of Louisville|502-852-5757|richard.ward@louisville.edu
7912|NCT00636155|Mark Lanasa, MD, PhD|Duke University Medical Center|919-286-6897|mark.lanasa@duke.edu
7913|NCT00636168|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
7914|NCT00636194|Robert Steffen OD|Bausch & Lomb|(585) 338-6399|robert.steffen@bausch.com
8460|NCT00604175|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
8461|NCT00604188|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
8462|NCT00604214|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8463|NCT00604279|Local Trial Manager|Xian-Janssen Pharmaceutical Ltd|86-10-5821 8213|
8464|NCT00604461|Tawee Tanvetyanon, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-3050|tawee.tanvetyanon@moffitt.org
8465|NCT00604500|Vice President, Late Stage Development Group Leader|Merck Sharp and Dohme Corp.|1-800-672-6372|clinicaltrialsresultsdisclosure@merck.com
8466|NCT00604552|Angela Parsons|Medtronic Vascular|707-591-2293|angela.r.parsons@medtronic.com
8467|NCT00604669|Guillermo Umpierrez|Emory University|404-778-1665|geumpie@emory.edu
8468|NCT00604695|C. Michael Gibson, MS, MD|Brigham & Women's Hospital|617-632-7753|mgibson@perfuse.org
8469|NCT00604708|Senior Manager Clinical Research|Intercell AG|+43 1 206 20 ext 1175|kdubischar-kastner@intercell.com
8470|NCT00604721|Bert. H. O'Neil, Associate Professor, Clinical Research|UNC Lineberger Comprehensive Cancer Center|919-966-4431|bert_oneil@med.unc.edu
8471|NCT00604812|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8472|NCT00604851|W Gerald Teague|University of Virginia|434-243-0613|wgt2p@hscmail.mcc.virginia.edu
8473|NCT00604968|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8474|NCT00605033|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
8475|NCT00605072|Dr. Ihab Hajjar|University of Southern California|323-226-6720|ihajjar@usc.edu
8476|NCT00653263|Michael J Mancino|UArkansas|501-526-8442|mjmancino@uams.edu
8477|NCT00653328|Marta Crispens, M.D.|Vanderbilt-Ingram Cancer Center|800-811-8480|marta.crispens@vanderbilt.edu
8020|NCT00638690|Senior Director, Clinical Research|Johnson & Johnson Pharmaceutical Research & Development|310-914-2915 ext NA|
7383|NCT00601419|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7384|NCT00601458|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
7385|NCT00601523|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7386|NCT00601731|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
7387|NCT00601796|Alberto Chiappori, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-2158|alberto.chiappori@moffitt.org
7388|NCT00601835|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
7389|NCT00601952|Dr. Nader Amir|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|6192293740|namir@mail.sdsu.edu
7390|NCT00602290|Dr. Helen Lavretsky|University of California, Los Angeles|310-794-4619|hlavretsky@mednet.ucla.edu
7391|NCT00602446|Linda J. Burns, MD|Masonic Cancer Center, University of Minnesota|612-624-8144|burns019@umn.edu
7392|NCT00602472|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7393|NCT00602771|Judith Karp, MD|SKCCC|410-502-7726|jkarp2@jhmi.edu
7394|NCT00602836|Dr. Tait Shanafelt|Mayo Clinic||shanafelt.tait@mayo.edu
7395|NCT00602927|Dr. Caryn Lerman|University of Pennsylvania|215-746-7141|clerman@mail.med.upenn.edu
7396|NCT00603187|Dr. John K. Amory|University of Washington|206.616.1727|jamory@u.washington.edu
7397|NCT00603239|Chief Medical Officer|Eli Lilly and Company||clinicaltrials@amylin.com
7398|NCT00603278|GSK Response Center|GlaxoSmithKline|866-435-7343|
7399|NCT00603291|Associate Director, Clinical Operations|Arena Pharmaceuticals, Inc.|858-453-7200 ext 1602|sstubbe@arenapharm.com
7400|NCT00603304|Dr. Alan Cantor|University of Alabama at Birmingham|(205) 934-6887|acantor@uab.edu
7401|NCT00646646|Dr. Michael Froelich|University of Alabama at Birmingham|205-934-4711|froelich@uab.edu
6190|NCT00612677|Alberto Chiappori, M.D., via Moffitt Cancer Center|H. Lee Moffitt Cancer Center and Research Institute|813-745-3050|alberto.chiappori@moffitt.org
6191|NCT00659165|Mark Burge|Univ NM|505-272-4658|mburge@salud.unm.edu
6192|NCT00659295|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
6193|NCT00659334|Dr. Edward Neuwelt|OHSU Knight Cancer Institute|503-494-5626|neuwelte@ohsu.edu
6194|NCT00659438|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6195|NCT00659490|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6196|NCT00808899|Wayne L. Furman|St. Jude Children's Research Hospital|1-866-278-5833|info@stjude.org
6197|NCT00809094|Dr. Carol Conrad|Stanford University|650-723-8325|cconrad@stanford.edu
6198|NCT00809146|Robert Silbergleit MD, Principal Investigator|University of Michigan|734-232-2142|robie@umich.edu
6199|NCT00809185|Anjali Advani|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|216-445-9354|advania@ccf.org
6200|NCT00809328|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6201|NCT00809445|Dr. Lisa Metsch|Columbia University, Mailman School of Public Health|212-305-3577|lm2892@columbia.edu
6202|NCT00809471|Wesley W Day PhD|Vivus, Inc|650-934-5200|
6203|NCT00809523|Paul Desan, MD, PhD|Yale University|203 785 2618|paul.desan@yale.edu
6204|NCT00809757|Respiratory Medical Director|Sunovion|1-866-503-6351|
6205|NCT00809809|David Riley, MD|Integrative Medicine Institute|505 690-0688|dsriley@integrativemed.org
6206|NCT00809848|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
6207|NCT00809926|Study Director|Novartis Pharmaceuticals|862-778-8300|
6208|NCT00809965|Development Head Cardiovascular/Urology|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|1 215 628-5257|
6209|NCT00810043|John Tillman|Medtronic|408-548-6518|tillmj1@mspexcng.medtronic.com
7915|NCT00636207|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7916|NCT00636220|Javan Esfandiari|Chembio Diagnostic Systems, Inc.|(631) 924-1135 ext 112|jesfandiari@chembio.com
7917|NCT00636363|Robert Steffen|Bausch & Lomb|(585) 338-6399|robert.steffen@bausch.com
7918|NCT00636389|Jeff Shideman, Ph.D.|Gambro Renal Products|952-835-4018|Jeff.Shideman@us.gambro.com
7919|NCT00636610|Medical Communications|Genentech, Inc.|800-821-8590|
7920|NCT00636636|Head of R&D|Depomed|650-462-5900 ext 108|msweeney@depomed.com
7921|NCT00636649|Kishore Gadde|Duke University Medical Center|919-668-0208|kishore.gadde@duke.edu
7922|NCT00636792|Carol Satler|Millennium Pharmaceutical Inc|(617) 551-3729|
7923|NCT00636805|Mary Lou Affronti|Duke University Medical Center|919-6846239|mary.affronti@dm.duke.edu
7924|NCT00636818|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
7925|NCT00636961|Study Director|Novartis Pharmaceuticals|862-778-8300|
7926|NCT00637000|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|Reckitt Benckiser Pharmaceuticals, Inc.|804-379-1090 ext 7089|ed.johnson@reckittbenckiser.com
7927|NCT00637195|GSK Response Center|GlaxoSmithKline|866-435-7343|
7928|NCT00637247|Robert Dorr|AmpliMed Corporation|520-626-7892|bdorr@azcc.arizona.edu
7929|NCT00552786|Dr. Yue-Liang Guo|National Taiwan University|+886-2-33228216|leonguo@ntu.edu.tw
8111|NCT00537381|Senior Director|Janssen Research & Development, L.L.C.|908-927-2116|
8112|NCT00537394|ACTG Clinicaltrials.gov Coordinator|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|(301)628-3313|ACTGCT.Gov@s-3.com
8113|NCT00537485|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6131-7366|
8114|NCT00537511|Associate Director, Clinical Trial Disclosure|Celgene|1-888-260-1599|clinicaltrialdisclosure@celgene.com
8115|NCT00537680|Dr Thomas Meier|Santhera Pharmaceuticals|+41619068964|thomas.meier@santhera.com
8021|NCT00638820|Paul Orchard, M.D.|Masonic Cancer Center, University of Minnesota|612-626-2313|orcha001@umn.edu
8022|NCT00638846|Kurt Moody OD|Vistakon|904-443-3088|
8023|NCT00638924|Juliana Gomes Zabatiero|Unicamp||juzabatiero@yahoo.com.br
8024|NCT00638963|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
8025|NCT00679939|GSK Response Center|GlaxoSmithKline|866-435-7343|
8026|NCT00679952|Clinical instructor|Seoul National University College of Medicine|82-2-2072-2817|meejookang@gmail.com
8027|NCT00680017|Gerard Lynch|AstraZeneca|+44 1509 645 895|aztrial_results_posting@astrazeneca.com
8028|NCT00680043|Vice President, Clinical Development|Affymax|650-812-8700|info@affymax.com
8029|NCT00680056|Danilo Berton|UNIFESP|55-11-55718384|dcberton@gmail.com
8030|NCT00680121|Ann Manzardo, PhD|University of Kansas Medical Center|(913) 588-6473|amanzardo@kumc.edu
8031|NCT00680186|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8032|NCT00680316|Medical Communications|Genentech, Inc.|800-821-8590|
8033|NCT00680459|Dr. Christine McKiernan|Baystate Medical Center|413-794-5370|Christine.McKiernan@bhs.org
8034|NCT00680524|Bradford Felker, MD|VA Puget Sound Health Care System|(206)277-1191|Bradford.Felker@VA.GOV
8035|NCT00680628|Jeffrey Kline|Indiana University School of Medicine|3172873004|jefkline@iupui.edu
8036|NCT00680706|Howard Smithline|Baystate Medical Center|413-794-3433|howard.smithline@baystatehealth.org
8037|NCT00653224|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
8038|NCT00507455|Senior Medical Director, Medical Affairs|Astellas Pharma Global Development, Inc.||clinicaltrials@us.astellas.com
8039|NCT00507507|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
8040|NCT00507546|Dr. Jamie Zeitzer|VAPAHCS|6504935000 ext 62410|jzeitzer@stanford.edu
7402|NCT00646763|Edmund Waller, MD, PhD|Emory University Winship Cancer Institute|1-888-946-7447|ewaller@emory.edu
7515|NCT00669396|David Turok, MD|University of Utah|801-581-7647|david.turok@hsc.utah.edu
7516|NCT00669461|Muhannad Heif, MD|University of Arkansas for Medical Sciences|5016500215|mmheif@gmail.com
7517|NCT00669539|Raymond Kraker, MSPH|Jaeb Center for Health Research|813-875-8690|pedig@jaeb.org
7518|NCT00669552|Jose' Dizon, MD|Columbia University|212-305-8559|jmd11@columbia.edu
7519|NCT00669578|Ayalew Tefferi, M.D.|Mayo Clinic||tefferi.ayalew@mayo.edu
7520|NCT00669617|Study Director|Novartis Pharmaceuticals|862-778-8300|
7521|NCT00669682|Jose' Dizon, MD|Columbia University|212-305-8559|jmd11@columbia.edu
7522|NCT00669864|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
7523|NCT00669903|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7524|NCT00669955|Monique Giguere, PhD, Programs Director,|Axcan Pharma Inc.|1-800-565-3255 ext 2078|
7525|NCT00670228|Trial Transparency Team|sanofi-aventis||GV-contact-us@sanofi-aventis.com
7526|NCT00670241|Anders Rhod Larsen, Scientific Advisor|LEO Pharma|+4572262990|anders.larsen@leo-pharma.com
7527|NCT00670306|Daniel Croteau, Medical Manager|AEterna Zentaris|418-652-7669 ext 272|DCroteau@aezsinc.com
7528|NCT00670449|Study Director|Novartis Pharmaceuticals|862 778-8300|
7529|NCT00670540|Jean-Luc Bosson|University Hospital Grenoble|33 4 76 76 50 40|jean-luc.bosson@imag.fr
7530|NCT00670709|Jennifer Villalobos|UCLA|310-825-3351|info@brain.ucla.edu
7531|NCT00670800|Yolanda Smith|University of Michigan|(734) 936-7401|ysmith@umich.edu
7532|NCT00670930|Study Director|Novartis Pharmaceuticals|862-778-8300|
7533|NCT00670982|Harold J. Burstein, MD|Dana-Farber Cancer Institute|617-632-2335|hal_burstein@dfci.harvard.edu
7534|NCT00671060|Hillary Bracken|Gynuity Health Projects|2124481230|hbracken@gynuity.org
6170|NCT00610714|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6171|NCT00610740|Levi Downs, Jr., M.D.|Masonic Cancer Center, University of Minnesota|612-626-6628|downs008@umn.edu
6172|NCT00611026|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6173|NCT00611130|M Douglas Winship|Catalyst Pharmaceutical Partners, Inc.|305-529-2522 ext 12|dwinship@catalystpharma.com
6174|NCT00611247|Bruno C Medeiros, MD|Stanford University Medical Center|650-498-6000|bruno.medeiros@stanford.edu
6175|NCT00611325|Dr. Katherine B. Peters|Duke University Medical Center|(919) 684-6173|katherine.peters@duke.edu
6176|NCT00611403|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
6177|NCT00611442|Dr. Joel Stengel|Carl R Darnall Army Medical Center|2545531804|joel.stengel@us.army.mil
6178|NCT00611455|GSK Response Center|GlaxoSmithKline|866-435-7343|
6179|NCT00611468|Vice President of Scientific Affairs|Accelerated Community Oncology Research Network, Inc.||mwalker@acorncro.com
6180|NCT00611559|GSK Response Center|GlaxoSmithKline|866-435-7343|
6181|NCT00611715|Ingrid Mayer, MD|Vanderbilt-Ingram Cancer Center|615-936-2033|ingrid.mayer@vanderbilt.edu
6182|NCT00611806|Joshua L. Roffman, MD|Massachusetts General Hospital|617-724-1920|jroffman@partners.org
6183|NCT00612105|Associate Director Clinical Operations|Valeant Pharmaceuticals International, Inc.|919-294-3080|david.lineberry@valeant.com
6184|NCT00612222|Steven A. Rosenberg, M.D.|National Cancer Institute (NCI), National Institutes of Health (NIH)|301-496-4164|sar@mail.nih.gov
6185|NCT00612339|Katherine Peters, MD, PhD|Duke University Medical Center|9196846173|katherine.peters@duke.edu
6186|NCT00612430|David Reardon, MD|Duke University Medical Center|919-668-2329|David_Reardon@DFCI.harvard.edu
6187|NCT00612508|Oregon Health & Science University|Women's Health Research Unit|503-494-3666|whru@ohsu.edu
6188|NCT00612534|Pamela Palmer, MD PhD|AcelRx|650-216-3500|ppalmer@acelrx.com
6189|NCT00612573|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
8116|NCT00537745|Patricia Hokanson|PIRE|505-765-2325|info@bhrcs.org
8117|NCT00537771|James J. Armbrust|AstraZeneca|+44 1625 518062|ClinicalTrialTransparency@astrazeneca.com
8118|NCT00680745|Eva Johnsson|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
8119|NCT00680771|Wilfred Pigeon|University of rochester|(585) 275-3374|Wilfred_pigeon@urmc.rochester.edu
8120|NCT00680836|Ashok Tuteja, M.D.|George E. Wahlen V.A. Medical Center, Salt Lake City, UT|801-582-1565 ext 4019|ashok.tuteja@va.gov
8121|NCT00680901|GSK Response Center|GlaxoSmithKline|866-435-7343|
8122|NCT00680914|GSK Response Center|GlaxoSmithKline|866-435-7343|
8123|NCT00680953|H. Takami|Daiichi Sankyo Co., Ltd.|+81 3 5740 3445|takami.hideo.hs@daiichisankyo.co.jp
8124|NCT00681109|Dr. Reza Dana|Massachusetts Eye and Ear Infirmary|(617) 573-4331|Reza_Dana@meei.harvard.edu
8125|NCT00681187|Medical Director, Endocrinology|Ipsen|clinical.trials@ipsen.com|clinical.trials@ipsen.com
8126|NCT00681265|David M. Kleinman|Eyeon Therapeutics, Inc.|n/a|dave@eyeontherapeutics.com
8127|NCT00681538|Richard Potts, Clinical Operations Director|GW Pharma Ltd|+44 1353 616600|rp@gwpham.com
8128|NCT00681564|Jorge Hernán Ramírez and Adolfo Contreras (adolfo@yahoo.com).|Universidad del Valle|5723753778|jorge.h.ramirez00@gmail.com
8129|NCT00681629|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
8130|NCT00681668|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
8131|NCT00681811|Norman Barton|Shire Human Genetic Therapies, Inc.|781-482-9297|nbarton@shire.com
8132|NCT00681824|Guenter Zuelow, Associate Medical Director|Baxter Healthcare Corporation||guenter_zuelow@baxter.com
8133|NCT00681863|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8342|NCT00547534|Dr. Jonathan Friedberg|University of Rochester Medical Center|585-275-4911|Jonathan_Friedberg@urmc.rochester.edu
8343|NCT00547638|John Lombard, Clinical Research Manager|Ethicon, Inc.|908 218 2877|jlombar8@its.jnj.com
8041|NCT00507689|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
8042|NCT00507767|Dr. Vassiliki Papadimitrakopoulou, Professor|MD Anderson Cancer Center|713-792-6363|vpapadim@mdanderson.org
8226|NCT00586261|Dr. Patricia Best|Mayo Clinic|507-284-4441|best.patricia@mayo.edu
8227|NCT00586326|Nancy Chenette, Director, Clinical Affairs|Hologic, Inc.|508-263-8770|nancy.chenette@hologic.com
8228|NCT00586339|GSK Response Center|GlaxoSmithKline|866-435-7343|
8229|NCT00545662|Dr. William Friedewald|Columbia University|212-305-3017|wtf1@columbia.edu
8230|NCT00545740|Study Physician|Shire Development LLC|+1 866 842 5335|
8231|NCT00545753|Director of Quality and Regulatory|ParaPRO LLC|317-810-6205|kerrym@parapro.com
8232|NCT00545766|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
8233|NCT00545792|Akila N. Viswanathan, MD, MPH|Dana-Farber Cancer Institute|617-732-6331|aviswanathan@lroc.harvard.edu
8234|NCT00545844|Senior Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
8235|NCT00545948|Neal Ready, PhD, MD|Duke University Medical Center|919-681-6932|neal.ready@duke.edu
8236|NCT00545974|Dr. Adam L. Boxer|UCSF Memory and Aging Center|4154760668|aboxer@memory.ucsf.edu
8237|NCT00546000|Angela C. Kaplan|Fougera Pharmaceuticals Inc.|631-659-2256|angela.kaplan@sandoz.com
8238|NCT00546052|Senior Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
8239|NCT00546078|GSK Response Center|GlaxoSmithKline|866-435-7343|
8240|NCT00546104|Kimberly Blackwell, MD|Duke University Health System|919-668-1478|kimberly.blackwell@duke.edu
8241|NCT00546117|Judith Lieu, MD|Washington University|314-454-6162|lieuj@wustl.edu
8242|NCT00546156|Dr Ian Krop|Dana-Farber Cancer Institute|617-632-2335|ian.krop@dfci.harvard.edu
8243|NCT00546260|Kevin Romanko, Senior Director Clinical Operations|Portola Pharmaceuticals Inc.|650-246-7305|kromanko@portola.com
7535|NCT00525876|Issa F. Khouri, MD/ Professor|UT MD Anderson Cancer Center||celsaenz@mdanderson.org
7536|NCT00525902|Eric B. Suhler|Oregon Health & Science University|503-494-5023|suhlere@ohsu.edu
7537|NCT00526058|Kevin Minnich, Manager Clinical  Affairs/Safety Officer|B. Braun Medical Inc.|610-596-2358|kevin.minnich@bbraun.com
7538|NCT00526097|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7128|NCT00581061|Doug Skarecky|University of California, Irvine|714-456-6744|dwskarec@uci.edu
7129|NCT00581100|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
7130|NCT00581113|Martha D. Wellons|Virginia Commonwealth University|804-628-1939|mwellons@vcu.edu
7131|NCT00581308|Joth Jacobson|W. L. Gore & Associates|(800) 437-8181|jjacobso@wlgore.com
7132|NCT00539942|Warner K. Huh, MD|University of Alabama at Birmingham|205-996-4662|warner.huh@ccc.uab.edu
7133|NCT00539994|GSK Response Center|GlaxoSmithKline|866-435-7343|
7134|NCT00540124|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
7135|NCT00540228|GSK Response Center|GlaxoSmithKline|866-435-7343|
7136|NCT00540293|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
7137|NCT00540423|GSK Response Center|GlaxoSmithKline|866-435-7343|
7138|NCT00540436|GSK Response Center|GlaxoSmithKline|866-435-7343|
7139|NCT00540449|Medical Leader|Tibotec|1 609 730 7561|kboven@its.jnj.com
7140|NCT00540514|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
7141|NCT00540579|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|asksarah@scresearch.net
7142|NCT00540592|GSK Response Center|GlaxoSmithKline|866-435-7343|
7143|NCT00541099|Shirish Gadgeel, M.D.|Barbara Ann Karmanos Cancer Institute|(313) 576-8753|gadgeels@karmanos.org
6268|NCT00698009|Dr. Laurence Cooper, Professor|UT MD Anderson Cancer Center||rnjackso@mdanderson.org
6269|NCT00698022|Robert Roe, MD|Corcept_Therapeutics|650-688-8812|rroe@corcept.com
6270|NCT00698035|Michelle Melisko, MD|University of California, San Francisco|415-353-7070|mmelisko@medicine.ucsf.edu
6271|NCT00698139|Dr. Paolo C. Colombo|Columbia University|212-305-2638|pcc2001@columbia.edu
6272|NCT00698204|Dr. Rajesh V. Lalla|University of Connecticut Health Center|860-679-8007|lalla@uchc.edu
6273|NCT00698451|Senior Director|Janssen Services, LLC|1 215 325-5329|tmcgowan@its.jnj.com
6274|NCT00698516|GSK Response Center|GlaxoSmithKline|866-435-7343|
6275|NCT00698646|Study Director|Novartis Pharmaceuticals|862-778-8300|
6276|NCT00698685|Andrew M. Yeager, MD|University of Arizona, Arizona Cancer Center|520-626-0662|ayeager@azcc.arizona.edu
6277|NCT00698841|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
6278|NCT00698932|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6279|NCT00518336|GSK Response Center|GlaxoSmithKline|866-435-7343|
6280|NCT00518531|Study Director|Amgen Inc.|866-572-6436|
6281|NCT00518622|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
6282|NCT00518687|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6283|NCT00518713|Email contact via H. Lundbeck A/S|Lundbeck LLC||LundbeckClinicalTrials@lundbeck.com
6284|NCT00518882|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
6285|NCT00518986|Medical monitor|Cephalon, Inc.|1-800-896-5855|
6286|NCT00519077|Ezra Cohen, MD|The University of Chicago|(773) 702-4137|ecohen@medicine.bsd.uchicago.edu
6287|NCT00519090|Study Director|Novartis Pharmaceuticals|862-778-8300|
8344|NCT00547703|Fernando Castro|Cleveland Clinic Florida|954-659-5646|castrof@ccf.org
8345|NCT00594100|Andrew Garcia|W. L. Gore & Associates|(800) 437-8181|AGarcia@WLGore.com
8346|NCT00594165|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
8347|NCT00594178|Thomas S. Kiser|Dept of PM&R; University of Arkansas for Medical Sciences|501-221-1311|kiserthomass@uams.edu
8348|NCT00594204|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
8349|NCT00594230|John Hainsworth, MD|Sarah Cannon Research Institute|1-877-691-7274|ASKSARAH@scresearch.net
8350|NCT00594308|Robert Nelson, MD|Indiana University School of Medicine|317-278-6871|ronelson@iupui.edu
8351|NCT00594386|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
8352|NCT00594425|David Pariser MD|Virginia Clinical Research, Inc|757-625-0151|dpariser@pariserderm.com
8353|NCT00594464|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
8354|NCT00594516|Mila Etropolski, MD  Clinical Leader|Johnson & Johnson Pharmaceutical Research & Development|609-730-4537|metropol@its.jnj.com
8355|NCT00594568|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8356|NCT00594659|Alan J. Budney, PhD Principal Investigator|Geisel School of Medicine at Dartmouth College|855-290-2822|Alan.J.Budney@dartmouth.edu
8357|NCT00594685|Susan Assmann|New England Research Institutes|617-923-7747 ext 548|sassmann@neriscience.com
8358|NCT00594854|Senior Vice President, Clinical Research|Pozen Inc.|919-913-1030|eorlemans@pozen.com
8359|NCT00594906|Dr. J. Edward Puzas|University of Rochester|(585) 275-3664|edward_puzas@urmc.rochester.edu
8360|NCT00594945|Executive Director, Clinical Development|Jazz Pharmaceuticals, Inc.|650 496 3777|
8361|NCT00594958|Senior Manager Clinical Research|Intercell AG|+43 1 206 20 ext 0|kdubischar-kastner@intercell.com
8362|NCT00595075|Daniel Cohen|Sentara Neurology Specialists|757-388-6323|dacohen@sentara.com
8363|NCT00595088|Dr. Sarel Halachmi|Bnai Zion Medical Center|+97248359542|sarel.halachmi@b-zion.org.il
8244|NCT00546273|Cristina Vilaplana, MD|UTE. Fund. Inst. Germans Trias i Pujol|+34 93 497 86 81|cvilaplana@gmail.com
8245|NCT00546351|UCB (Study Director)|UCB Clinical Trial Call Center|1-887-822-9493|
8246|NCT00546364|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
8247|NCT00546429|Sam Himden|DePuy Orthopaedics, Inc.|574-372-7231|SHimden@its.jnj.com
8248|NCT00546572|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8410|NCT00621842|Christopher Bialko|Case Western Reserve University|216-286-4362|Christopher.Bialko@UHhospitals.org
8411|NCT00621855|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8412|NCT00621933|Vice President, Medical Affairs|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
8413|NCT00621946|E. Sherwood Brown, MD, PhD|The University of Texas Southwestern Medical Center|214-645-6950|Sherwood.Brown@UTSouthwestern.edu
8414|NCT00621959|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
8415|NCT00621985|Joseph Majzoub|Children's Hospital Boston|617-355-7476|joseph.majzoub@childrens.harvard.edu
8416|NCT00622167|Iris McNulty, RN|Massachusetts General Hospital|617 726 2612|imcnulty@partners.org
8417|NCT00622284|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8418|NCT00622388|GSK Response Center|GlaxoSmithKline|866-435-7343|
8419|NCT00622427|Rachel Fargason|University of Alabama at Birmingham|205-934-5151|mfargason@uab.edu
8420|NCT00622440|Naomi Jay, PhD|UCSF|415-353-7443|Naomi.Jay@ucsf.edu
8421|NCT00622518|James A. Taylor, MD|University of Washington|206-616-1206|uncjat@u.washington.edu
8422|NCT00622635|Study Director|Novartis Pharmaceuticals|862 778-8300|
8423|NCT00622713|Study Director|Novartis Pharmaceuticals|862-778-8300|
8424|NCT01293825|Martha Sajatovic, Professor of Psychiatry|University Hospitals of Cleveland|(216) 844-2808|martha.sajatovic@uhhospitals.org
7144|NCT00541190|Tim Corcoran|University of Pittsburgh|412-624-8918|corcorante@upmc.edu
7145|NCT00541229|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
7146|NCT00541242|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
7147|NCT00541307|Chad Badorek|W. L. Gore & Associates, Inc.|928/437-8181|cbadorek@wlgore.com
7148|NCT00541346|Thomas M. Lock, M.D.|University of Oklahoma Health Sciences Center|405-271-5700 ext 45167|Thomas-Lock@ouhsc.edu
7149|NCT00541450|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||clinicaltrialsdisclosure@spcorp.com
7150|NCT00541593|Dr. John R. Romanelli|Baystate Medical Center|(413) 794-3175|john.romanelli@bhs.org
7151|NCT00541658|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
7266|NCT00590590|Jim Joffrion, Sr. Director, Clinical Affairs|KV Pharmaceutical|314-645-6600|jjoffrion@kvph.com
7267|NCT00590720|Joseph Parker, MD|MedImmune|301-398-0000|parkerj@medimmune.com
7268|NCT00590759|Robert Makowsky|W. L. Gore and Associates, Inc.|6232345784|rmakowsk@wlgore.com
7269|NCT00590863|Madhukar H. Trivedi, M.D.|Univeristy of Texas Southwestern Medical Center, Dallas|214-648-0188|Madhukar.Trivedi@UTSouthwestern.edu
7270|NCT00505284|Eisai Inc.|Eisai Call Center|888-422-4743|
7271|NCT00505414|Claudia Leinweber|Grünenthal GmbH|+49 (0)241 569 2509|claudia.leinweber@grunenthal.com
7272|NCT00505518|Albert Yeung|Massachusetts General Hospital|617-724-5138|ayeung@partners.org
7273|NCT00505622|Eisai Inc.|Eisai Call Center|888-422-4743|
7274|NCT00505635|Nicholas E. Papadopoulos, MD / Professor|UT MD Anderson Cancer Center|713-792-2921|CR_Study_Registration@mdanderson.org
7275|NCT00505661|John Kavanagh, MD / Professor|UT MD Anderson Cancer Center|713-792-2933|
7276|NCT00505687|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
7277|NCT00505752|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
6210|NCT00810069|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6211|NCT00810082|Dr. Jon D. Lurie, MD, MS|Dartmouth College|603-653-3575|Jonathan D. Lurie <Jonathan.D.Lurie@hitchcock.org>
6212|NCT00810095|Dr. Thomas J. McCarthy|MindFrame, Inc .|949-204-0806|tmccarthy@mindframeinc.com
6213|NCT00810108|Dr. Brookie M. Best, Associate Professor|University of California San Diego|858-822-5550|brookie@ucsd.edu
6214|NCT00810199|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
6215|NCT00810303|Danilo Wegner|Department of Clinical Pharmacology|+4903834865640|dwegner@uni-greifswald.de
6216|NCT00810511|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
6217|NCT00810576|Barbara Pro, MD|UT MD Anderson Cancer Center|713-792-2933|
6218|NCT00810602|Dr. Sung Choi|University of Michigan Comprehensive Cancer Center|734-764-8630|sungchoi@med.umich.edu
6219|NCT00810641|Treatment of apogeotropic HC BPPV|KONOS|82 10 5538 6565|ohsun@jbnu.ac.kr
6220|NCT00810693|Therapeutic Area Head|Bayer||clinical-trials-contact@bayerhealthcare.com
6221|NCT00811018|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6222|NCT00811057|Dr. Rick Martin|University of Mississippi Medical Center|601-815-7035|rmartin@umc.edu
6223|NCT00811070|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6224|NCT00819039|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@Merck.com
6225|NCT00819052|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6226|NCT00819091|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6227|NCT00819156|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
6228|NCT00819182|Janet S Carpenter, PhD, RN, FAAN|Indiana University|317-278-6093|carpentj@iupui.edu
8364|NCT00595153|John V. Fahy, MD, MSc|University of California, San Francisco|4154769940|john.fahy@ucsf.edu
7930|NCT00552812|Dr. Richard E. Ringel|Johns Hopkins School of Medicine|410-614-6745|rringel@jhmi.edu
7931|NCT00553267|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7932|NCT00553280|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7933|NCT00553319|Frances R. Levin, M.D.|Columbia University|646-774-6137|frl2@columbia.edu
7934|NCT00553358|GSK Response Center|GlaxoSmithKline|866-435-7343|
7935|NCT00553436|Amy Mahanes, Clinical Research Associate II|Ethicon Endo-Surgery, Inc|513-337-8366|amahanes@its.jnj.com
7936|NCT00553475|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
7937|NCT00553501|Barbara Grant, MD|University of Vermont, Vermont Cancer Center||barbara.grant@vtmednet.org
7938|NCT00553514|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
7939|NCT00553605|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7940|NCT00553631|Tiffany Crump, Medical Communications Manager|Shire HGT|484-595-8850|tcrump@shire.com
7941|NCT00599196|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
7942|NCT00599326|Amit Pandya, M.D.|UT Southwestern Medical Center at Dallas|214-645-8300|amit.pandya@utsouthwestern.edu
7943|NCT00599521|Michael Graeber MD/ Head of Global Clinical Project Management|Galderma|609-860-8201|michael.graeber@galderma.com
7944|NCT00599755|Vice President, Late Stage Development Group Leader|Merck Sharp and Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7945|NCT00599924|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
7946|NCT00600015|John D. Hainsworth, MD|Sarah Cannon Research Institute|877-691-7274|ASKSARAH@scresearch.net
7947|NCT00600067|Wesley W. Day, PhD|Vivus, Inc|650-934-5200|day@vivus.com
8425|NCT01293968|Dr.Katayun Borhanmojabi|Qazvin University of Medical Sciences|09127841440|ka.mojabi@yahoo.com
8426|NCT01294371|Global Medical Services|Abbvie (prior sponsor, Abbott)|800-633-9110|
8427|NCT01294384|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
8428|NCT01294423|Eva Johnsson|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
8429|NCT01294436|Eva Johnsson|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
8430|NCT01294462|Judith Hsia|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
8431|NCT01294514|Ulf Borg, Director of Clinical Affairs|Covidien|303 305 2400|ulf.borg@covidien.com
8432|NCT01294553|GSK Response Center|GlaxoSmithKline|866-435-7343|
7059|NCT00549055|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7060|NCT00549198|GSK Response Center|GlaxoSmithKline|866-435-7343|
7061|NCT00549302|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
7062|NCT00549328|GSK Response Center|GlaxoSmithKline|866-435-7343|
7063|NCT00549549|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7064|NCT00549601|Study Director|Novartis Pharmaceuticals|862-778-8300|
7065|NCT00549640|Dr. Richard D. Hurt|Mayo Clinic|507-266-1944|nicotineresearch@mayo.edu
7066|NCT00549718|Josephine Cucchiaro|Sunovion Pharmaceuticals Inc.|201-592-2050|josephine.cucchiaro@sunovion.com
7067|NCT00549757|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
7068|NCT00549783|Vice President, Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
7069|NCT00549900|GSK Response Center|GlaxoSmithKline|866-435-7343|
7070|NCT00549939|Trial Transparency Team|sanofi-aventis||Contact-US@sanofi-aventis.com
7071|NCT00550173|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
7278|NCT00505778|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
7279|NCT00505921|Issa F. Khouri, MD / Associate Professor|UT MD Anderson Cancer Center|713-792-8848|pmcadams@mdanderson.org
7280|NCT00505934|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
7281|NCT00506025|Deborah A. Wing, MD|University of California Irvine Medical Center|714-456-5967|dwing@uci.edu
7282|NCT00506064|Una Srejic, MD / Professor|UT MD Anderson Cancer Center|713-792-6914|CR_Study_Registration@mdanderson.org
7283|NCT00506077|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
7284|NCT00506389|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7285|NCT00506415|Study Director|Novartis|862 778 8300|
7286|NCT00506441|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
7287|NCT00506454|Vice President|Sepsicure L.L.C.|212-606-4352|bianuale@metromediacompany.com
7288|NCT00506493|Kristin Lawman|Medtronic, Inc.|763-514-9809|kristin.j.lawman@medtronic.com
7403|NCT00646776|BMS Study Director|Bristol-Myers Squibb||ClinicalTrials@bms.com
7404|NCT00646958|Eugene Sun, M.D.|Melinta Therapeutics|203.624.5606|esun@melinta.com
7405|NCT00647270|Global Medical Services|Abbott|800-633-9110|
7406|NCT00647400|Global Medical Services|Abbott|800-633-9110|
7407|NCT00647556|Ronald W. Gottschalk, MD / Medical Director|Galderma Laboratories, L.P.|817-961-5358|ron.gottschalk@galderma.com
7408|NCT00619099|Erhan Berrack, M.D.|Eisai Inc.|888-422-4743|
7409|NCT00619112|Nicholas Butowski|UCSF|4153532966|Butowski@neurosurg.ucsf.edu
7410|NCT00619151|Barbara Mathews Director Clinical and Medical Affairs|Sorin Group USA, Inc.|512-435-3602|Barbara.mathews@sorin.com
7411|NCT00619177|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6229|NCT00819234|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
6230|NCT00819247|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
6231|NCT00819260|Carolyn L. Kerrigan MD|Dartmouth-Hitchcock|603-650-5148|carolyn.kerrigan@hitchcock.org
6232|NCT00819286|Brian Hatcher|Biomet Microfixation|904-741-4400|brian.hatcher@biomet.com
6233|NCT00819390|ACTG Clinicaltrials.gov Coordinator|ACTG Network Coordinating Center, Social and Scientific Systems|(301) 628-3313|ACTGCT.Gov@s-3.com
6234|NCT00819585|Study Director|Novartis Pharmaceuticals|862-778-8300|
6235|NCT00819637|Richard M Nowak MD|Henry Ford Health System, Detroit, Michigan|313 881 0023|rnowak1@hfhs.staff
6236|NCT00845481|Torsten Skov, Senior Medical Advisor|LEO Pharma|+45 20 73 62 94|torsten.skov@leo-pharma.com
6237|NCT00845663|UCB Clinical Trial Call Center|UCB Pharma|+1 877 822 9493|
6238|NCT00845676|Brad Hare, MD|San Francisco General Hospital/UCSF|415-476-4082 ext 556|chare@php.ucsf.edu
6239|NCT00845702|Pierre Desche, MD, Head of Clinical and Regulatory Affairs|Guerbet|+33 1 45 91 50 00|pierre.desche@guerbet-group.com
6240|NCT00845728|Study  Director|Novartis Pharmaceuticals|862-778-8300|
6241|NCT00845845|Scott Cotler, M.D. Professor of Medicine|The University of Illinois Chicago|708-216-3789|scotler@lumc.edu
6242|NCT00845858|Marilyn R. Carlson|Evoke Pharma|858-345-1494|mcarlson@evokepharma.com
6243|NCT00845897|Mary Hastings PT, DPT, ATC|Washington University School of Medicine|314 286 1433|hastingsmk@wustl.edu
6244|NCT00845975|Louis A Looper, MA, CCC-A|McDonald hearing Aid Centers|916-218-4100|llooper@hearingmed.com
6245|NCT00846027|Medical Communications|Hoffmann-La Roche|800 821-8590|
6246|NCT00846066|Nasreen Talib MD, MPH.|Childrens Mercy Hospital|816-234-3242|ntalib@cmh.edu
6247|NCT00846287|Dr. Mitchell Albert|UMass Medical School|(807) 684-7270|albertmi@tbh.net
6248|NCT00846365|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
7948|NCT00600080|Kurt Moody, OD|Johnson & Johnson Vision Care|+1 904 443-3088|kmoody1@its.jnj.com
7949|NCT00600171|GSK Response Center|GlaxoSmithKline|866-435-7343|
7950|NCT00600704|Dr Athina Kleitsaki|Larissa University Hospital Dept. of Anesthesiology|00306948481865|theoath1@gmail.com
7951|NCT00600756|Gerard Lynch|AstraZeneca||clinicaltrialtransparency@astrazeneca.com
7952|NCT00600821|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8134|NCT00681889|Dr. Reza Dana|Massachusetts Eye and Ear Infirmary|617-573-3313|Cornea_Research@meei.harvard.edu
8135|NCT00682461|GSK Response Center|GlaxoSmithKline|866-435-7343|
8136|NCT00682565|Medical Director|Cytokinetics, Inc.|650-624-3053|
8137|NCT00682643|GSK Response Center|GlaxoSmithKline|866-435-7343|
8138|NCT00682734|Benjamin Friedman|Montefiore Medical Center|718 920 6626|befriedm@montefiore.org
8139|NCT00682786|Benjamin R. Tan, M.D.|Washington University School of Medicine|314-362-3560|btan@dom.wustl.edu
8140|NCT00682851|Lorna Rabe|Magee-Womens Research Institute|412-641-6042|lrabe@mwri.magee.edu
8141|NCT00682890|Dr. John Nestler|Virginia Commonwealth University|804-828-3389|jnestler@mcvh-vcu.edu
8142|NCT00545402|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
8143|NCT00545506|Helmut Hager|Dep. Anesthesia And Intensive Care|+43 1 40400 4102|helmut.hager@meduniwien.ac.at
8144|NCT00545584|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8145|NCT00545623|Bei-Hung Chang|Boston University|508-856-8959|bhchang@bu.edu
8146|NCT00664560|Sr VP Clinical Research|POZEN Inc|919-913-1030|eorlemans@pozen.com
8147|NCT00664742|Study Director|Novartis Pharmaceuticals|862-778-8300|
8148|NCT00665002|Jeffrey E. Lancet, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-6841|jeffrey.lancet@moffitt.org
7072|NCT00550277|John D. Hainsworth, MD|Sarah Cannon Research Institute|615-329-7274|jhainsworth@tnonc.com
7073|NCT00550407|GSK Response Center|GlaxoSmithKline|866-435-7343|
7074|NCT00550446|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7075|NCT00550459|Frank Czerwiec, MD, PhD; Sr. Director, Global Clinical Development|Otsuka Pharmaceutical Development & Commercialization, Inc.|(240) 683-3523|frank.czerwiec@otsuka.com
7076|NCT00524264|Therapeutic Area Head|Allergan, Inc.|(714)246-4500|clinicaltrials@allergan.com
7077|NCT00524303|GSK Response Center|GlaxoSmithKline|866-435-7343|
7078|NCT00524316|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
7079|NCT00524368|Medical Leader|Tibotec Pharmaceuticals, Ireland|+32 015 461 497|
7080|NCT00524420|David H. Avery, MD, Professor|University of Washington|206-744-4527|averydh@u.washington.edu
7081|NCT00524459|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
7197|NCT00573131|Senior Manager Biostatistics|BTG International|801-556-8882|claire.daugherty@btgplc.com
7198|NCT00573144|Dr. Horng H. Chen|Mayo Clinic|507-284-1644|chen.horng@mayo.edu
7199|NCT00573170|GSK Response Center|GlaxoSmithKline|866-435-7343|
7200|NCT00573183|Dr. Dennis Donovan|Univerity of Washington Alcohol & Drug Abuse Institute|206-543-0937|ddonovan@u.washington.edu
7201|NCT00573248|Jean Gehricke, Ph.D.|University of California, Irvine|949-824-1834|jgehrick@uci.edu
7202|NCT00573261|Dr. Wei Jiang|Duke University Medical Center|919-668-0762|weijiang@duke.edu
7203|NCT00573287|Alan I. Green, M.D.|Geisel School of Medicine at Dartmouth|6036507549|alan.i.green@dartmouth.edu
7204|NCT00573313|Dr. Charles H. Halsted|University of California Davis|530-752-4054|chhalsted@ucdavis.edu
7205|NCT00573391|Nathan M. Petty|University of Arkansas for Medical Sciences, Myeloma Institute|501-526-6990 ext 2461|pettynathanm@uams.edu
7206|NCT00573430|Gerard Lynch|AstraZeneca|+44 7780 956181 ext 5895|aztrial_results_posting@astrazeneca.com
7412|NCT00619190|Linmarie Sikich, MD|UNC Chapel Hill|919-972-7499|lsikich@med.unc.edu
7413|NCT00619229|UCB Clinical Trial Call Center|UCB|+ 1 877 822 9493 (UCB)|
7414|NCT00619242|Ezra Cohen, MD|The University of Chicago|773/702-4137|ecohen@medicine.bsd.uchicago.edu
7415|NCT00619307|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|+49-6151-72-5200|service@merckgroup.com
7416|NCT00619359|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
7417|NCT00619385|Jennifer Wike|Repros Therapeutics|2817193402|jwike@reprosrx.com
7418|NCT00619476|XenoPort Call Center|XenoPort, Inc.|877-936-6778|
7419|NCT00668265|Igor Galynker, MD|Beth Israel Medical Center|212 420 4535|igalynke@chpnet.org
7420|NCT00668317|Clinical trials Manager|Hull and East Yorkshire Hospitals Trust|01482 624067|c.e.wright@hull.ac.uk
7421|NCT00668382|Dr. Sheila Noone|UMass Medical Scool|508 856 5015|Sheil.Noone@umasmed.edu
7422|NCT00668395|Zeruesenay Desta, PhD|Indiana University School of Medicine|317-274-2823|zdesta@iu.edu
7423|NCT00668525|Carl Gommoll, MS|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|201-427-8000|carl.gommoll@frx.com
7424|NCT00668564|Paul Orchard, M.D.|Masonic Cancer Center, University of Minnesota|612-626-2313|orcha001@umn.edu
7425|NCT00668733|Sharon F. Levy, MD / Sr. VP, Clinical Product Development|Graceway Pharmaceuticals|267-948-0400|sharon.levy@gracewaypharma.com
5719|NCT00693498|Jill M. Cholette MD, Principle Investigator|University of Rochester|585-275-8138|Jill_Cholette@urmc.rochester.edu
5720|NCT00693706|GSK Response Center|GlaxoSmithKline|866-435-7343|
5721|NCT00693719|Dr. Robert Livingston|University of Arizona Cancer Center|520/626-4175|rlivingston@azcc.arizona.edu
5722|NCT00693784|Jeff F. Doerzbacher|Spinal Restoration, Inc.|512 225-0405|jeffdoerzbacher@spinalrestoration.com
5723|NCT00694070|Clinical Research Scientist|Bayer Healthcare, Diabetes Care|574-257-3063|
5724|NCT00694161|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
4052|NCT00797212|Carmine Greene, Clinical Research Scientist|Bayer Healthcare, Diabetes Care|574-257-3040|carmine.greene.b@bayer.com
4053|NCT00797277|Dr. Tzung-Jeng Hwang|National Taiwan University Hospital|+886-2-23123456 ext 66792|tjhwang@ntu.edu.tw
4054|NCT00797316|Study Director|Novartis Pharmaceuticals|862-778-8300|
4055|NCT00797459|Ron Staugaard|Medicis|480-291-5652|rstaugaard@medicis.com
4056|NCT00797511|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
4057|NCT00797563|Carmine Greene, Clinical Research Scientist|Bayer Healthcare, Diabetes Care|574-257-3040|carmine.greene.b@bayer.com
4058|NCT00442013|Janet Holbrook|Johns Hopkins University|443-287-3170|ala-acrc@jhsph.edu
4059|NCT00442117|Senior Vice President, Global Clinical Development|Merck Sharp and Dohme Corp.||ClinicalTrialsDisclcosure@merck.com
4060|NCT00442169|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
4061|NCT00442338|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
4062|NCT00442351|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
4063|NCT00442364|David DI Wright MB BS|BTG International Inc|610-278-1660|david.wright@btgplc.com
4064|NCT00442468|GSK Response Center|GlaxoSmithKline|866-435-7343|
4065|NCT00442546|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
4066|NCT00442559|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
4067|NCT00442689|Dr. Laura Torchen|Northwestern University|312-227-6492|ltorchen@luriechildrens.org
3655|NCT00475176|Jay H. Hoofnagle, M.D.|National Institute of Diabetes and Digestive and Kidney Diseases, National In|301-496-1333|hoofnaglej@mail.nih.gov
3656|NCT00475306|Dr. BW Friedman|Montefiore Medical Center|718-920-6626|befriedm@montefiore.org
3657|NCT00475319|Eiji Murakami|Dermatologicals & Ophthalmologicals, Otsuka Pharmaceutical Co., Ltd.|+81-6-6231-6067|
8149|NCT00665353|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
8150|NCT00665366|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
8151|NCT00665431|Sr VP Clinical Research|Pozen|919 913 1030|eorlemans@pozen.com
8152|NCT00665470|Dr. Steven Rosenberg|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
8153|NCT00665704|Sonia A. Duffy, Ph.D., R.N., FAAN|VA Center for Clinical Management Research Health Services Research & Development, VA Ann Arbor Healthcare System, Ann Arbor, MI.|734.395.0613|Sonia.Duffy@va.gov
8154|NCT00665847|Senior Director|Tibotec Pharmaceuticals, Ireland|32 14 641 265|gdsmedt1@its.jnj.com
8155|NCT00519623|Pei-Ling Roerig, Sr. Manager Clinical Research, Altea Therapeutics|Altea Therapeutics|404-835-6415|proerig@alteatherapeutics.com
8156|NCT00519636|GSK Response Center|GlaxoSmithKline|866-435-7343|
8365|NCT00595270|Senior Manager Clinical Research|Intercell AG|+43 1 206 20 ext 0|kdubischar.kastner@intercell.com
8366|NCT00595309|Senior Manager Clinical Research|Intercell AG|+43 1 206 20 ext 1175|kdubischar-kastner@intercell.com
8367|NCT00595335|Dr. Rebecca S. Bahn|Mayo Clinic|507-284-2462|bahn.rebecca@mayo.edu
8368|NCT00595361|Elliot Israel, MD|Brigham and Women's Hopsital|617-732-8110|eisrael@partners.org
8369|NCT00568451|Svetomir N. Markovic M.D., Ph.D.|Mayo Clinic Cancer Center|507-284-2511 ext 4-2511|markovic.svetomir@mayo.edu
8370|NCT00568685|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
8371|NCT00568776|Executive Vice President of Global Development and Chief Medical Officer|Elan Pharmaceuticals, Inc.|650 877 0900|
8372|NCT00568958|Dr. Stephanie S. O'Malley|Yale University School of Medicine|203-974-7590|stephanie.omalley@yale.edu
8373|NCT00569010|Jean-Pierre Issa, M.D./Professor|The University of MD Anderson Cancer Center|713-745-2260|eharriso@mdanderson.org
8374|NCT00569166|Dr. Amit Sood|Mayo Clinic|507-538-7623 ext 8-7623|sood.amit@mayo.edu
8375|NCT00569192|VP, Scientific Affairs|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|650-386-3100|dkellerman@mappharma.com
7207|NCT00573443|Joao Siffert, MD, SVP R&D|Avanir Pharmaceuticals|949-268-1174|jsiffert@avanir.com
7208|NCT00573469|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
7209|NCT00573508|Astellas Medical Monitor|Astellas Pharma Global Development||clinicaltrials@us.astellas.com
7210|NCT00573534|Stephen J. Donovan MD|Columbia University|212 543 5768|sd45@columbia.edu
7211|NCT00573755|Dr. Vivek Roy|Mayo Clinic|507-284-1159|roy.vivek@mayo.edu
7212|NCT00573768|Sandy Hamelsky|Novartis Consumer Health|+19735037258|sandy.hamelsky@novartis.com
7213|NCT00573859|Jean Gehricke, Ph.D.|University of California, Irvine|949-824-1834|jgehrick@uci.edu
7214|NCT00573937|Eric E Prommer MD|Mayo Clinic|480-301-8000|prommer.eric@mayo.edu
7215|NCT00581347|Peter Szilagyi|University of Rochester Medical Center|585-275-5798|peter_szilagyi@urmc.rochester.edu
7216|NCT00581386|Dr. Carin A. Hagberg|UTHSC- Houston Medical School|713.500.6222|maddukuri.vineela@uth.tmc.edu
7217|NCT00581399|Dr. Jeffrey C. Milliken|University of California, Irvine Medical Center|714-456-3634|jcmillik@uci.edu
7218|NCT00581529|Dr. Lori Pierce, M.D.|University of Michigan Comprehensive Cancer Center|734-764-9922|ljpierce@umich.edu
7219|NCT00581555|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7334|NCT00626028|James Baldassarre, MD|Ikaria|908-238-6363|james.baldassarre@ikaria.com
7335|NCT00626093|Ashish Oza|St. Jude Medical|818-493-3648|aoza@sjm.com
7336|NCT00626327|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
7337|NCT00626392|Medical Information Specialist|Abbott|800-633-9110|
7338|NCT00626431|Global Medical Services|Abbott|800-633-9110|
7339|NCT00626548|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7340|NCT00626561|Michael M. Frumovitz, MD / Professor, Gynecologic Oncology|University of Texas MD Anderson Cancer Center|713-792-9599|CR_Study_Registration@mdanderson.org
5725|NCT00694304|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
5726|NCT00694369|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
5727|NCT00694551|Mayer Fishman, M.D., Ph.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-4398|mayer.fishman@moffitt.org
5728|NCT00694564|Dr. Jeannie Huang|UC San Diego|858-576-1700 ext 7322|jshuang@ucsd.edu
5729|NCT00694603|Dr. Lecia Sequist|Massachusetts General Hospital|617-724-4000|lvsequist@partners.org
5730|NCT00695019|Martin J. Cummins, Director of Clinical & Regulatory Affairs|Amarillo Biosciences, Inc.|806-376-1741 ext 14|mcummins@amarbio.com
5731|NCT00695097|Flavio Vincenti|University of California, San Francisco|415-353-1322|flavio.vincenti@ucsfmedctr.org
5732|NCT00695136|Susan E. Swedo, MD|Pediatrics & Developmental Neuroscience Branch, NIMH|301-496-5323|swedos@mail.nih.gov
5733|NCT00695188|Eva-Luise Hobl|Department of Clinical Pharmacology, Medical University of Vienna|+43 1 40400 2981|eva-luise.hobl@meduniwien.ac.at
5734|NCT00695292|Dr. David Spigel|Sarah Cannon Research Institute|615-329-7274|askSARAH@scresearch.net
5735|NCT00695396|Senior Director, Head of Hematology and Nephrology|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||pbowers@its.jnj.com
5736|NCT00695435|Alcon Clinical|Alcon Research, LTD|888.451.3937; 817.568.6725|medinfo@alconlabs.com
5737|NCT00565461|Head Clinical Development|Valneva Austria GmbH|0043120620 ext 0|info@valneva.com
5738|NCT00565604|Daniel Pepper, MD|Lake Washington Vascular Surgery|(425) 453-1772|
5739|NCT00565721|Paul Gordon, PhD|GE Healthcare|011-47-2318-5822|paul.gordon@ge.com
5740|NCT00565747|Chief Scientific Officer|Origio A/S|+45 46790200|sbendz@origio.com
5741|NCT00566020|GSK Response Center|GlaxoSmithKline|866-435-7343|
5855|NCT00562627|Ulrich Johannes Spreng|Baerum Hospital|004798499184|ulispreng@hotmail.com
5856|NCT00563368|Wesley W. Day PhD|Vivus, Inc.|650-934-5200|day@vivus.com
5857|NCT00563381|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7832|NCT00645164|Herbert B. Slade MD, FAAAAI|DFB Pharmaceuticals|817.302.3919|bert.slade@dfbpharmaceuticals.com
7833|NCT00645333|Anne F. Schott, MD|University of Michigan|1-800-865-1125|canceranswerline@umich.edu
7834|NCT00645411|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
7835|NCT00645671|Dr. Tuyen Ong|Bausch & Lomb|(973) 360-6389|Tuyen.Ong@bausch.com
7836|NCT00645762|Entellus Medical|Entellus Medical|763-463-1599|
7837|NCT00645788|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
8043|NCT00508001|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
8044|NCT00508027|Dr. Carolyn Hoppe, Principal Investigator|Children's Hospital & Research Center Oakland|(510)428-3193|choppe@mail.cho.org
8045|NCT00508118|Andrew Shaw MD|Duke University Medical Center|919 286 6938|andrew.shaw@duke.edu
8046|NCT00508157|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
8047|NCT00508274|GSK Response Center|GlaxoSmithKline|866-435-7343|
8048|NCT00508313|Zhongxing Liao, MD/Associate Professor|UT MD Anderson Cancer Center|713-563-2300|
8049|NCT00508391|Clay Cohorn|BIOTRONIK, Inc.|503-387-2614|clay.cohorn@biotronik.com
8050|NCT00508469|Severine Durier, PharmD|Alcon France|+33 1 47 10 48 43|
8051|NCT00508482|Dr. Zhishun Liu|Guang'anmen Hospital Affiliated to China Academy of Chinese Medical Sciences|0086-010-88001124|liuzhishun@aliyun.com
8052|NCT00508521|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|Malcom Randall VA Medical Center, Gainesville Florida|(352) 376-1611 ext 6603|janis.daly@neurology.ufl.edu
8053|NCT00508651|Judith Falloon, MD|MedImmune, LLC|301 398 0000|falloonj@medimmune.com
8054|NCT00508742|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8055|NCT00508755|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|Malcom Randall VA Medical Center, Gainesville Florida|(352) 376-1611 ext 5223|janis.daly@neurology.ufl.edu
8056|NCT00508820|Study Director|Amgen Inc.|866-572-6436|
8376|NCT00569231|Mayumi Nakagawa, MD, PhD|University of Arkansas for Medical Sciences|(501) 686-8635|mnakagawa@uams.edu
8377|NCT00569270|Arthur F Gelb MD Principal Investigator|Arthur F Gelb MD|562-633-2204|afgelb@msn.com
8378|NCT00569374|Dr. Alison Oliveto|University of Arkansas for Medical Sciences Center for Addiction Research|501-526-8441|olivetoalison@uams.edu
8379|NCT00569582|Medical Director|Corcept Therapeutics|650-327-3270|info@corcept.com
8380|NCT00569660|Srdan Verstovsek M.D./Associate Professor|The University of Texas M. D. Anderson Cancer Center|713-792-7305|eharriso@mdanderson.org
8381|NCT00569673|Jessalyn Reboy|NRG Oncology, Statistics and Data Management Center, Buffalo Office|716-845-7738|ReboyJ@nrgoncology.org
8382|NCT00569777|Brian Pall OD MS FAAO|Vistakon|904-443-1290|
8383|NCT00569855|Research Program Manager, Cardiovascular Surgery, Dept. of Pediatrics|University of Arkansas, Arkansas Children's Hospital, Dept. of Pediatrics|501-364-1100 ext 5859|althagekarena@uams.edu
8384|NCT00569868|Nathan M. Petty|University of Arkansas for Medical Sciences, Myeloma Institute|5015266990 ext 2461|pettynathanm@uams.edu
8385|NCT00569946|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8386|NCT00570037|Emmanuel Walter MD, Principal Investigator|Duke University Medical Center|919-620-5374|walte002@mc.duke.edu
7953|NCT00600938|Study Director|Novartis Pharnaceuticals|862-778-8300|trialandresults.registries@novartis.com
7954|NCT00601107|Trial Transparency Team|Sanofi||Contact-us@sanofi.com
7955|NCT00601250|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7956|NCT00620711|William F Walsh|Vanderbilt university|615-322-0545|bill.walsh@vanderbilt.edu
7957|NCT00620750|Marc Gourevitch, MD, MPH|New York University School of Medicine|212-263-8553|marc.gourevitch@nyumc.org
7958|NCT00620763|Brenda Ling|United States Department of Agriculture Grand Forks Human Nutrition Research Center|701-795-8300|brenda.ling@ars.usda.gov
7959|NCT00620815|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
7960|NCT00620828|Michael Bolognesi, MD|Duke UMC|919-668-4732 ext 2|bolog002@mc.duke.edu
7341|NCT00626574|Enrico M Camporesi MD|University of South Florida|813-844-7170|ecampore@health.usf.edu
7342|NCT00626639|Hans Olivecrona, MD PhD|Biovitrum|+46 8 697 20 00|hans.olivecrona@sobi.com
7343|NCT00626743|Jae Gook Shin, MD,PhD|INJE University Pusan Paik Hospital|+82-51-890-8954|phshinjg@paik.ac.kr
7344|NCT00626808|Chris Ambrose|MedImmune, LLC|301-398-0000|ambrosec@medimmune.com
7345|NCT00626821|Helle Aaes Senior Scientific Manager|Coloplast|+45 49112949|dkheaa@coloplast.com
7346|NCT00627016|Sr. VP Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
7347|NCT00627042|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
7348|NCT00627406|Dr. Peter Humaidan|Fertility Clinic Regional Hospital Skive|+45 78 44 57 60|peter.humaidan@viborg.rm.dk
7349|NCT00627445|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
7350|NCT00627497|Zhimin Liu|Medtrionic spinal and biologics|901-3993123|zhimin.liu@medtronic.com
7351|NCT00676338|Chief Medical Officer|Eli Lilly and Company|1-877-285-4559|clinicaltrials@amylin.com
7352|NCT00676364|Jenny Boucher|Lehigh Valley Health Network|610-402-8844|jenny.boucher@LVH.com
7353|NCT00591019|Dr John Dornhoffer|University of Arkansas for Medical Sciences (UAMS)|501 686-5140|dornhofferjohnl@uams.edu
7354|NCT00591214|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
7355|NCT00591227|David Baldwin MD|Rush University Medical Center|312-942-6163|david_baldwin@rush.edu
7356|NCT00633399|George I Papakostas, M.D. - Scientific Director|Massachusetts General Hospital CNTI|6177266697|gpapakostas@partners.org
7471|NCT00635661|Dr. Irene Ward|New York University,. Rusk Institute|212-263-6073|Irene.ward@nyumc.org
7472|NCT00635817|Global Medical  Services|Abbott|800-633-9110|
7473|NCT00684203|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7474|NCT00684242|Sriram Yennurajalingam, MD / Assistant Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
5858|NCT00563576|Carolyn Westhoff|Columiba University|212-305-4805|clw3@columbia.edu
5859|NCT00563706|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5860|NCT00609765|Jonathan Strosberg, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-2069|jonathan.strosberg@moffitt.org
5861|NCT00609869|Javier Pinilla-Ibarz|H. Lee Moffitt Cancer Center and Research Institute|813-745-1387|javier.pinilla@moffitt.org
5862|NCT00609973|Hans Herfarth|University of North Carolina|9199666806|hherf@med.unc.edu
5863|NCT00609986|Dr. Kathie Hermayer|Medical University of South Carolina|843-792-2529|hermayer@musc.edu
5864|NCT00610155|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5865|NCT00610207|Jason Hodde, Clinical Affairs Manager|Cook Biotech, Incorporated|765-497-3355|jhodde@CookBiotech.com
5866|NCT00610311|Steven A. Rosenberg, M.D.|National Cancer Institute, National Institues of Health|301-496-4164|sar@mail.nih.gov
5867|NCT00610441|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5868|NCT00610532|Dr. Jim McAuley|The Ohio State University|614-292-9713|mcauley.5@osu.edu
5869|NCT00610649|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5870|NCT00610675|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5871|NCT00610688|Dr. Adekunle Dawodu|Cincinnati Children's Hospital Medical Center|513-636-1966|Adekunle.Dawodu@cchmc.org
5872|NCT00856349|Daniel Lexcen, Clinical Research Specialist|Medtronic Cardiac Rhythm Disease Management|763-526-9702|daniel.lexcen@medtronic.com
5873|NCT00856414|Vice President, Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
5874|NCT00856544|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5875|NCT00856583|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com
5876|NCT00856635|Scott Kolodny, M.D.|Teva Pharmaceuticals, Medical Affairs|440-327-1811|scott.kolodny@tevapharm.com
8057|NCT00508872|Eddie Abdalla, MD/Assistant Professor|UT MD Anderson Cancer Center|713-792-6940|
8058|NCT00508924|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
8059|NCT00509028|Gerard Lynch|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
8060|NCT00509041|Arkadiusz Dudek, MD, PhD|University of Minnesota Masonic Cancer Center||dudek002@umn.edu
8061|NCT00509067|Dr. Stephen I. Deutsch|Department of Psychiatry Georgetown University Medical School|757.446.5888|DeutscSI@EVMS.EDU
8062|NCT00509106|Vice President, Clinical Sciences|Cerexa, Inc.|(510) 285-9200|clinicaltrials@cerexa.com
8063|NCT00509223|Jonathan Shaw, MD, FRACP, FRCP|Baker IDI Heart and Diabetes Institute|+61 (0) 3 8532 1821|jonathan.shaw@bakeridi.edu.au
8064|NCT00686894|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
8272|NCT00522951|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
8273|NCT00523237|Philip Grant, MD|Stanford University|650-723-2804|pmgrant@stanford.edu
8274|NCT00523367|Juan Munoz, MD|University of Florida|904-633-0089|juan.munoz@jax.ufl.edu
8275|NCT00567476|Study Director|Novartis Pharmaceuticals|862 778-8300|
8276|NCT00567593|James D. Lewis, MD, MSCE|University of Pennsylvania|215-573-5137|lewisjd@mail.med.upenn.edu
8277|NCT00567892|Dr. Jay F. Piccirillo|Washington University|314.362.8641|piccirilloj@ent.wustl.edu
8278|NCT00567996|Study Director|Novartis Pharmaceuticals|862-778-8300|
8279|NCT00568022|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
8280|NCT00568061|James Baldassarre, MD|INO Therapeutics LLC|908-238-6603|james.baldassarre@ikaria.com
8281|NCT00568087|Gihyun Yoon, MD|Minneapolis VA Health Care System|612-467-3996|Gihyun.Yoon@va.gov
8282|NCT00568178|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@Merck.com
8283|NCT00568386|Alcon Clinical|Alcon Research|888.451.3937; 817.568.6725|medinfo@alconlabs.com
7961|NCT00620854|Thomas Wicks, Ph.D., Vice-President Global RA/QA|Tarsa Therapeutics, Inc.|267 273 7946|twicks@tarsatherapeutics.com
7962|NCT00621023|Dr. Carlos de Castro|Duke University Medical Center|919-684-8964|decas003@mc.duke.edu
7963|NCT00621140|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7964|NCT00621153|Gerard Lynch|AstraZeneca|+44 1509 64589 ext 4589|aztrial_results_posting@astrazeneca.com
7965|NCT00621192|David Siegel, MD|Eunice Kennedy Shriver National Institute of Child Health and Human Development|301-595-8670|siegelda@mail.nih.gov
7966|NCT00621296|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
7967|NCT00621348|Rakesh Lodha|AIIMS|91 11 26593621|rakesh_lodha@hotmail.com
7968|NCT00621504|Vice President, Clinical Sciences|Cerexa, Inc|(510) 285-9200|clinicaltrials@cerexa.com
7969|NCT00621517|Max Bayard MD|East Tennessee State University|802-524-8805|mmbayard3@gmail.com
7970|NCT00621543|Sarah Betstadt, MD, MPH|University of Rochester|585-276-5368|sarah_betstadt@urmc.rochester.edu
7971|NCT00621582|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7972|NCT00686647|Gary Gershony, MD/ Chief Medical Officer|AngioScore|510-933-7900|gary@angioscore.com
7973|NCT00686686|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
7974|NCT00686712|Stanley H. Hsia, MD|Charles R. Drew University of Medicine and Science|323-357-3633|stanleyhsia@cdrewu.edu
8157|NCT00519649|GSK Response Center|GlaxoSmithKline|866-435-7343|
8158|NCT00519779|Dr. Janice Kiecolt-Glaser|The Ohio State University|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu
8159|NCT00519818|Richard JM Ross|Diurnal Ltd|0044 114 2712386|r.j.ross@sheffield.ac.uk
8160|NCT00520234|Luis Ostrosky-Zeichner, MD|Mycoses Study Group|(713) 500-6733|Luis.Ostrosky-Zeichner@uth.tmc.edu
8161|NCT00520351|Craig A Woods, Research Manager|Centre for Contact Lens Research|519-888-4567 ext 36547|cawoods@sciborg.uwaterloo.ca
7475|NCT00684255|Dr. Mitchell S. Cairo|New York Medical College|914-594-3650|mitchell_cairo@nymc.edu
7476|NCT00684307|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7477|NCT00684320|Dr. Nader Amir|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|(619) 229-3740|namir@mail.sdsu.edu
7478|NCT00684424|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
7479|NCT00684515|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7480|NCT00684541|Professor Nader Amir|SDSU|6192293744|namir@mail.sdsu.edu
7481|NCT00684567|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7482|NCT00684645|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7483|NCT00684671|GSK Response Center|GlaxoSmithKline|866-435-7343|
7484|NCT00684723|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
7485|NCT00684762|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
7486|NCT00684814|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
7487|NCT00684996|Study Statistician|SWOG Statistical Center|206-667-4623|
7488|NCT00685139|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
7489|NCT00598078|Grace Wang, MD Director Clinical Development and Medical Monitor|Jazz Pharmaceuticals|650-496-3777|
7490|NCT00598273|Vice President, Clinical Development|Affymax|650-812-8700|info@affymax.com
7491|NCT00598442|Vice President, Clinical Development|Affymax|650-812-8700|info@affymax.com
7492|NCT00598507|Ronald DeConti, M.D., Principal Investigator|H. Lee Moffitt Cancer Center and Research Institute|813-745-8466|ronald.deconti@moffitt.org
7082|NCT00524511|Dawn Tasillo, MD|UMass Memorial Medical Center|5083346255|tasillod@ummhc.org
7083|NCT00524576|GSK Response Center|GlaxoSmithKline|866-435-7343|
5989|NCT00723801|Mark Creager|Brigham and Women's Hospital|617-732-5267|mcreager@partners.org
5990|NCT00723827|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
5991|NCT00723840|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
5992|NCT00723892|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800--672-6372|ClinicalTrialsDisclosure@merck.com
5993|NCT00760838|dr. Brusselle Guy|Ghent University Hospital|003293322604|guy.brusselle@uzgent.be
5994|NCT00761007|Angela Capriati MD PhD, Clinical Research Director|Menarini Group- Clinical Research|+39 055 5680 ext 9933|acapriati@menarini-ricerche.it
5995|NCT00761150|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
5996|NCT00761189|Senior Clinical Research Associate|Clinical Research Team, Medical Affairs Korea|82-2094-4804|
5997|NCT00761202|Vice President Medical Affairs - Europe|Allergan, Inc.|(714)246-4500|clinicaltrials@allergan.com
5998|NCT00761215|Philippe Prokocimer, MD|Cubist Pharmaceuticals, Inc.|858-452-0370 ext 241|philippe.prokocimer@cubist.com
5999|NCT00761280|Medical Officer|Isarna Therapeutics GmbH, formerly Antisense Pharma GmbH|+49-89-890831 ext 0|info@isarna-therapeutics.com
6000|NCT00761306|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
6001|NCT00761319|Director of Alcon Clinical|Alcon Research, Ltd.|1-888-451-3937|medinfo@alconlabs.com
6002|NCT00761462|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
6003|NCT00761514|Medical Information Specialist|Abbott|1-800-633-9110|
6004|NCT00761527|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6005|NCT00761579|Senior Clinical Research Associate|Clinical Research Team, Medical Affairs Korea|82-2094-4804|
6006|NCT00761592|Vice President Medical Affairs|Allergan, Inc.|(714)246-4500|clinicaltrials@allergan.com
6007|NCT00768300|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
8284|NCT00568399|James Delmez, MD|Washington University School of Medicine|314 362 7207|jdelmez@dom.wustl.edu
8285|NCT00529659|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@Merck.com
8286|NCT00529763|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
8287|NCT00529789|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8288|NCT00530023|Harold Torunsky|Director, Program Management, Clinical Research|8185765445|harold.torunsky@medtronic.com
8289|NCT00530088|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
8290|NCT00577395|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
8291|NCT00577460|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8292|NCT00577473|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
8293|NCT00577512|Nathan M. Petty|University of Arkansas for Medical Sciences, Myeloma Institute|501-526-6990 ext 2461|pettynathanm@uams.edu
8294|NCT00577629|Anne Beaven, MD|Duke University Medical Center|919-684-8964|anne.beaven@duke.edu
7861|NCT00619918|Susan Wu|Children's Hospital Los Angeles|323-361-6177|suwu@chla.usc.edu
7862|NCT00619957|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
7863|NCT00620022|Study Director|Novartis Pharmaceuticals|862 778-8300|
7864|NCT00620035|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
7865|NCT00620074|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
7866|NCT00620126|PI|University of Maryland. Baltimore|410-706-3387|rcross@medicine.umaryland.edu
7867|NCT00620282|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
7868|NCT00620373|Dr. Deborah J. Rhodes|Mayo Clinic|507-538-1703|rhodes.deborah@mayo.edu
7869|NCT00620425|Edward Smith III, PhD, VP Regulatory Affairs & Product Quality/Safety|Zogenix, Inc|510 550 8325|esmith@zogenix.com
8162|NCT00520468|Gautam Borthakur, MBBS / Assistant Professor|The University of Texas M. D. Anderson Cancer Center|713-792-7305|eharriso@mdanderson.org
8163|NCT00520494|Clinical Trial Disclosure Manager|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
8164|NCT00520546|Major Medical Corps Dr. Markus Hartenbach|German Federal Armed Forces Hospital, Ulm|0049 731 1710 1851|markushartenbach@bundeswehr.org
8165|NCT00520572|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
8166|NCT00520676|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8167|NCT00520741|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
8168|NCT00520936|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8169|NCT00521053|Eric Wachter, Chief Technology Officer|Provectus Biopharmaceuticals, Inc.|1-865-769-4011 ext 23|wachter@pvct.com
8170|NCT00521144|Dr. Lee Krug|Memorial Sloan-Kettering Cancer Center|646 888 4201|krugl@mskcc.org
8171|NCT00521352|Dr. Antonio Mantovani|Columbia University Department of Psychiatry, City University of New York|212-650-5417|AMantovani@med.cuny.edu
8172|NCT00521365|Gerard Lynch|AstraZeneca|09645895 ext 4415|ClinicalTrialTransparency@astrazeneca.com
8173|NCT00528541|Vice President Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
8174|NCT00528567|Medical Communications|Hoffman-LaRoche|800-821-8590|
8175|NCT00528606|Greg Kaufman, MD|Auxilium Pharmaceuticals, Inc.|484-321-5920 ext 5920|gkaufman@auxilium.com
8176|NCT00528645|Julian R. Molina, M.D., Ph.D.|Mayo Clinic|507-284-8318|molina.julian@mayo.edu
8177|NCT00528775|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
8178|NCT00528788|Jula Inrig, MD|Duke University Medical Center|919-660-6882|Jula.Inrig@duke.edu
8179|NCT00528801|Elliott Vichinsky, MD|Children's Hospital of Oakland and Research Institute|510-428-3651|evichinsky@mail.cho.org
8433|NCT01294592|GSK Response Center|GlaxoSmithKline|866-435-7343|
8434|NCT01294696|Vice President, Late Stage Group Development Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
7084|NCT00524589|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
7085|NCT00524745|Kathleen Neuzil, Principal Investigator|PATH|206-285-3500 ext 4864|kneuzil@path.org
7086|NCT00524771|Dr. Juergen Dinger|Center for Epidemiology and Health Research, Germany|0049 (0)30 945 101 20|dinger@zeg-berlin.de
7087|NCT00524940|Medical Director|Sanofi Pasteur Inc||RegistryContactUs@sanofipasteur.com
7088|NCT00525148|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7089|NCT00525174|Raymond Kraker, MSPH|Jaeb Center for Health Research|813-875-8690|pedig@jaeb.org
7090|NCT00525265|Director of Clinical Trials|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7314|
7091|NCT00525421|Nita Chainani-Wu|University of California San Francisco|415-476-2045|nita.wu@ucsf.edu
7092|NCT00525499|Charles CY Shih, PhD|AndroScience Corp|(858) 638-7230|cyshih@androscience.com
7093|NCT00525512|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7094|NCT00525603|William G. Wierda, MD/Associate Professor|The University of MD Anderson Cancer Center|713-745-0428|eharriso@mdanderson.org
7095|NCT00525798|Dr. Bente Juul Riis|Nordic Bioscience|+45 22901317|bjr@nordicbioscience.com
7096|NCT00525824|Gerard Lynch|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
7097|NCT00525837|Noah S. Philip MD|Butler Hospital|401-455-6258|noah_philip@brown.edu
7098|NCT00570713|Susan Weil, MD|Morphotek, Inc.|610-423-6182|sweil@morphotek.com
7099|NCT00570739|John Raia, Senior Director Professional Affairs|Daiichi Sankyo, Inc.|(973) 944-2683|jraia@dsi.com
7100|NCT00570765|Cathi Sciacca, Sr. Director, Clinical Operations|Intercept Pharmaceuticals, Inc.|858-652-6803|csciacca@interceptpharma.com
7101|NCT00570778|Study Director|Novartis Pharmaceuticals|862-778-8300|
7102|NCT00570908|Dr. Mothaffar Rimawi|Baylor Coolege of Medicine|7137981811|rimawi@bcm.edu
7103|NCT00571428|Brovana Medical Director|Sunovion|1-866-503-6351|
6008|NCT00768430|Dr. Sanjay Mathew|Baylor College of Medicine|7137911414 ext 5439|sjmathew@bcm.edu
6009|NCT00768521|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
6010|NCT00768560|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
6123|NCT00818116|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6124|NCT00818168|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6125|NCT00818207|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6126|NCT00818246|Dr Daniel Barolet|RoseLab Skin Optics Laboratory|(514) 343-4444|daniel.barolet@mcgill.ca
6127|NCT00818272|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6128|NCT00818324|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
6129|NCT00818337|Kathleen Packard, PharmD|Creighton University|402-280-2668|kpackard@creighton.edu
6130|NCT00818389|Elizabeth Simpson|Massachusetts General Hospital|617-726-3430|esimpson1@partners.org
6131|NCT00818454|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6132|NCT00818519|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
6133|NCT00818623|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
6134|NCT00818649|Erica Warlick, M.D.|Masonic Cancer Center, University of Minnesota|612-625-5467|ewarlick@umn.edu
6135|NCT00818753|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6136|NCT00818779|Gary Meyerrose|Texas Tech University Health Sciences Center School of Medicine|806-743-3150|gary.meyerrose@ttuhsc.edu
6137|NCT00818805|Alcon Clinical|Alcon Labs|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6138|NCT00818883|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
7870|NCT00620464|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
7871|NCT00620542|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7872|NCT00620555|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7873|NCT00620659|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
7874|NCT00620698|Seward Rutkove|Beth Israel Deaconess Medical Center|617-667-8130|srutkove@bidmc.harvard.edu
7875|NCT00628212|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
7876|NCT00628355|Omero Benedicto Poli Neto|Ribeirao Preto Medical School - University of Sao Paulo|551636023183|polineto@fmrp.usp.br
7877|NCT00628407|Vinay Nadkarni, MD|Children's Hospital of Philadelphia|215-590-7430|nadkarni@email.chop.edu
7878|NCT00628446|Dr. Jesse Lieberman|Carolinas Healthcare System|704-355-0649|Jesse.Lieberman@Carolinashealthcare.org
7879|NCT00628628|Saroj Vadhan-Raj, MD / Professor|The University of Texas (UT) MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
7880|NCT00628758|Gerard Lynch|AstraZeneca|+44 1509 645895|aztrial_results_posting@astrazeneca.com
7881|NCT00628862|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
7882|NCT00628901|Ana Becker / Sr. Clinical Program Manager|Boston Scientific|651-581-4605|Ana.Becker@bsci.com
7883|NCT00628927|Dr. Theresa Winhusen|University of Cincinnati|513-487-7800|winhusen@carc.uc.edu
8065|NCT00686998|Gerard Lynch|Astrazeneca||aztrial_results_posting@astrazeneca.com
8066|NCT00687076|Gerd Brunner, PhD|Baylor College of Medicine|713-790-5800|gbrunner@bcm.edu
8067|NCT00687167|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
8068|NCT00687193|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8069|NCT00687219|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
8435|NCT01294709|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8436|NCT01294748|Dennis Donohoe, MD, Chief Medical Advisor|Micell Technologies|919-313-2102|ddonohoeconsult@gmail.com
8437|NCT01294787|Study Director|Novartis Pharmaceuticals|41 61 324 1111|
8438|NCT01294917|Clinical Scientist|Centre for Contact Lens Research|519-888-4567 ext 36590|marc.schulze@uwaterloo.ca
8439|NCT01295281|Dikran Shamoun|Wellspect HealthCare|+46313764275|dikran.shamoun@wellspect.com
8440|NCT01295879|David E. Leaf, M.D., Renal Fellow|Brigham and Women's Hospital|617-732-5951|DELEAF@partners.org
8441|NCT01295905|Director of Alcon Clinical, Atlanta|Alcon Research|1-800-241-7629|
8442|NCT01296412|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8443|NCT01379768|Director of Alcon Clinical, Atlanta|Alcon Research|1-800-241-7629|
8444|NCT01379937|GSK Response Center|GlaxoSmithKline|866-435-7343|
8445|NCT01380093|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8446|NCT01380327|Associate Director, Clinical Research Operations Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
8447|NCT01380366|Dr. Jonathan Fryer, MD|Northwestern University|312-695-2125|jfryer@nmh.org
8448|NCT01380639|Dr. Klaus Kenn|Schön Klinik Berchtesgadener Land|+49 8652 931541|kkenn@schoen-kliniken.de
8449|NCT01380782|Patrick Y. Wen, MD|Dana-Farber Cancer Institute|6176322166|pwen@partners.org
8450|NCT01381120|Dr. Joseph Zadra|Barrie Urology Associates||joezadra@rogers.com
8451|NCT01381406|GSK Response Center|GlaxoSmithKline|866-435-7343|
8452|NCT00603837|Doug Dannaway, MD|University of Oklahoma Health Sciences Center|405-271-5215 ext 42048|douglas-dannaway@ouhsc.edu
8453|NCT00603889|Dr. David Diemert, Director of Clinical Trials|Albert B. Sabin Vaccine Institute|202-842-5025|david.diemert@sabin.org
8454|NCT00603902|Associate Director, Clinical Operations|Arena Pharmaceuticals, Inc.|858-453-7200 ext 1602|sstubbe@arenapharm.com
6931|NCT00674154|Lars Rolighed|Aarhus University Hospital|004520677876|larsrolighed@gmail.com
6932|NCT00674206|Dr. Amelia Zelnak|Emory University|404-778-1900|amelia.zelnak@emoryhealthcare.org
6933|NCT00674323|Study Director|Novartis Pharmaceuticals|862-778-8300|
6934|NCT00674362|UCB (Study Director)|UCB Clinical Trial Call Center|+1 887 822 9493|
6935|NCT00674609|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd.|0044 1223 266800|rp@gwpharm.com
6936|NCT00674739|Robert Babilon, Vice President, Product Development|Graceway Pharmaceuticals|267-948-0400 ext 20428|robert.babilon@gracewaypharma.com
6937|NCT00502216|Benjamin Toll, Ph.D.|Yale University School of Medicine|203-974-5767|benjamin.toll@yale.edu
6938|NCT00502242|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6939|NCT00502320|Edward R. Norris, MD|Lehigh Valley Hospital|610-402-5766|Edward.Norris@lvh.com
6940|NCT00502593|GSK Response Center|GlaxoSmithKline|866-435-7343|
6941|NCT00502775|GSK Response Center|GlaxoSmithKline|1-866-435-7343|
6942|NCT00502801|Vice President, Data Generation|Janssen Scientific Affairs, LLC|908 927-2943|
6943|NCT00502840|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
6534|NCT00725452|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6535|NCT00725491|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6536|NCT00725530|Director of Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6537|NCT00725543|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6538|NCT00725608|Global Medical Director|RB Pharmaceuticals|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com
6539|NCT00725621|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6540|NCT00762515|William Devizio|Colgate Palmolive Co.|732-878-7901|William_Devizio@colpal.com
6838|NCT00641667|Director, Clinical Research|Janssen Research & Development, L.L.C. USA|1 609 730-3387|
6839|NCT00641706|Evanthia Galanis, M.D.|Mayo Clinic|(507) 284-3902|Galanis.evanthia@mayo.edu
6840|NCT00641719|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6841|NCT00641745|Josephine Cucchiaro, PhD; Executive Director|Sunovion|201-592-2050|josephine.cucchiaro@sunovion.com
6842|NCT00642174|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6843|NCT00642278|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|Janssen Research & Development, LLC|1-800-526-7736|
6844|NCT00642356|Study Director|Novartis Pharmaceuticals|862 778-8300|
6845|NCT00642369|Zhang Bin|Guang Dong Provinical Mental Health Institute|86-20-81888553|zhang73bin@hotmail.com
6846|NCT00642460|Medical Communications|Hoffman-LaRoche|800-821-8590|
6847|NCT00501631|Bernard L. Silverman, MD|Alkermes, Inc.|1-781-609-6000|bernard.silverman@alkermes.com
6848|NCT00501644|Michael E. Garcia, RN, BSN|UT MD Anderson Cancer Center||mgarcia@mdanderson.org
6849|NCT00501852|Study Director|Novartis Pharmaceuticals|862-778-8300|
6850|NCT00501891|Annick Desjardins, MD|The Preston Robert Tisch Brain Tumor Center at Duke|919-684-6173|annick.desjardins@duke.edu
6851|NCT00501943|Dr Emmanuelle Waubant, MD|UCSF|415- 514 2468|Emmanuelle.Waubant@ucsf.edu
6852|NCT00501969|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
7036|NCT00539110|Michele Gottschlich PhD|Shriners Hospitals for Children|513-872-6298|mgottschlich@shrinenet.org
7037|NCT00539188|Christopher Pittenger, MD Ph.D|Yale University School of Medicine|203-974-7675|christopher.pittenger@yale.edu
7038|NCT00539240|Christopher Wendel, MS|Southern Arizona VA Health Care System|520 792 1450 ext 1824|christopher.wendel@va.gov
7039|NCT00539305|Monique Cherrier PhD.|University of Washington|206-277-3594|cherrier@u.washington.edu
7040|NCT00539513|Christopher Pittenger, MD Ph.D|Yale University School of Medicine|203-974-7675|christopher.pittenger@yale.edu
6084|NCT00614939|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6085|NCT00615017|Justin Lindemann|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
6086|NCT00615030|Study Director|Novartis Pharmaceuticals|862-778-8300|
6087|NCT00761605|Senior Clinical Research Associate|Clinical Research Team, Medical Affairs Korea|82-2-2094-4804|
6088|NCT00761631|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6089|NCT00761735|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6090|NCT00761748|Director of Medical Outcome|Coloplast A/S||dkbir@coloplast.com
6091|NCT00761930|William Devizio|Colgate Palmolive Co.|732-878-7901|William_Devizio@colpal.com
6092|NCT00761956|Kacy Arnold, Associate Director, Clinical Affairs|Zimmer, Inc|574-371-8336|kacy.arnold@zimmer.com
6093|NCT00762021|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6094|NCT00762034|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6095|NCT00762086|Shmulik Adler|A. Stein Regulatory Affairs Consulting|972-9-767-0002|shmulik@asteinrac.com
6096|NCT00762164|Dr. Lawrence Baruch|Bronx VA Medical Center|718-584-9000 ext 6776|lawrence.baruch@va.gov
6097|NCT00762177|William De Vizio|Colgate Palmolive Co.|732-878-7901|William_Devizio@colpal.com
6098|NCT00762216|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6099|NCT00762229|Dr. Lawrence Baruch|Bronx VA Medical Center|718-584-9000 ext 6776|lawrence.baruch@va.gov
5673|NCT00808015|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5674|NCT00808067|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5675|NCT00808132|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5676|NCT00808236|Becky Inderbitzen, Vice President of Clincial Affairs|BeneChill, Inc.|858-695-8118|binderbitzen@benechill.com
6385|NCT00740220|Arjun Chatterjee, MD, MS, FCCP|Wake Forest University|336.716.4649|achatter@wfubmc.edu
6386|NCT00740480|Gabriele Niederauer, PhD|ENTrigue Surgical, Inc.|210-298-6398 ext 6336|gabi.niederauer@entriguesurgical.com
6387|NCT00420784|Jeff Chodakewitz, M.D.|Vertex Pharmaceuticals Incorporated|617-341-6777|Jeff_Chodakewitz@vrtx.com
6388|NCT00420849|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
6389|NCT00420927|Global Medical Services|Abbott|1-800-633-9110|
6390|NCT00420992|Vice President, Clinical Development|King Pharmaceuticals Research and Development, Inc.|919-653-7001|
6391|NCT00421343|Sarah Berry|Hebrew SeiorLife|617-971-5355|sarahberry@hrca.harvard.edu
6392|NCT00421408|Dr. Karl Insogna|Yale University|203-737-2871|Karl.insogna@yale.edu
6393|NCT00421603|Daniel Brooks|NYSPI|212-740-3205|brooksd@nyspi.columbia.edu
6394|NCT00421733|Global Medical Services|Abbott|800-633-9110|
6395|NCT00421928|Senior Director, Clinical Leader|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|609-730-4537|
6396|NCT00421993|Michael Graeber, MD|Galderma|609-860-8201|michael.graeber@galderma.com
6397|NCT00422032|Hagop Kantarjian, MD / Professor|The University of Texas M. D. Anderson Cancer Center|713-792-7026|eharriso@mdanderson.org
6398|NCT00422058|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
6399|NCT00422097|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
6400|NCT00422162|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6401|NCT00422201|Head of Clinical Research|HRA Pharma|0033140331130|s.durand@hra-pharma.com
6402|NCT00422227|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
6403|NCT00422292|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
6404|NCT00422448|Prof. Dr. Iris Zalaudek|Medical University of Graz - Austria|+436763328269|iris.zalaudek@gmail.com
6541|NCT00762528|William DeVizio, DMD|Colgate Palmolive Company|732-878-7901|william_Devizio@colpal.com
6542|NCT00762606|Director of Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6543|NCT00762619|William De Vizio|Colgate Palmolive Co.|732-878-7901|William_Devizio@colpal.com
6544|NCT00762645|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6545|NCT00762723|Laura Herdrich|Zimmer|952-830-6224|laura.herdrich@zimmer.com
6546|NCT00762762|William DeVizio, DMD|Colgate Palmolive Co.|732-878-7901|william_devizio@colpal.com
6547|NCT00762853|William Devizio|Colgate Palmolive Co.|732-878-7901|William_Devizio@colpal.com
6548|NCT00762996|Kurt Moody, OD, FAAO|Vistakon|904-443-3088|
6549|NCT00763048|William Devizio|Colgate Palmolive Co.|732-878-7901|William_Devizio@colpal.com
6550|NCT00763061|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6551|NCT00733421|Jan Jakobsson PI, MD, PhD, Professor|Foot & Ankle Surgical Centre|46702500960|jan.jakobsson@ki.se
6552|NCT00733499|Kimberly Dwyer, PhD, CCRA|DePuy Ortho Joint US||kdwyer2@its.jnj.com
6553|NCT00771472|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6554|NCT00771537|Gregory D Zimet|Indiana University|317-274-8812|gzimet@iupui.edu
6555|NCT00771602|Stefan Faderl, MD / Professor|UT MD Anderson Cancer Center|713-745-4613|
6556|NCT00771615|GSK Response Center|GlaxoSmithKline|866-435-7343|
6739|NCT00640042|Professional Information Services|King Pharmaceuticals, Inc.|1-800-776-3637|
6740|NCT00640315|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
6741|NCT00640328|GSK Response Center|GlaxoSmithKline|866-435-7343|
6742|NCT00640341|Gerard Cairns|Bausch & Lomb Incorporated|(585) 338-5170|gerard.cairns@bausch.com
7041|NCT00539526|Vice President, Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
7042|NCT00539539|Susanne May, Ph.D.|Resusciatation Outcomes Consortium, University of Washington|206-685-1302|sjmay@uw.edu
7043|NCT00539591|Fariba Navid, MD|St. Jude Children's Research Hospital|901-595-2573|info@stjude.org
7044|NCT00539617|W. Michael Korn, MD|UCSF|415-502-2844|michael.korn@ucsf.edu
7045|NCT00539695|Dr. Kathryn Leung|Texas Children's Hospital|832-824-4219|kleung@bcm.edu
7046|NCT00539734|Patama Bhurayanontachai|Prince of Songkla University|66-74-451380|tpatama@hotmail.com
7047|NCT00539864|Lisa M. Dunkle, M.D., Chief Medical Officer|Protein Sciences Corporation|203-599-6064 ext 153|ldunkle@proteinsciences.com
7048|NCT00547911|Dr. David Goldstein|National Institutes of Health|301-496-1115|goldsteind@ninds.nih.gov
7049|NCT00548132|Bernard C. Camins, MD|Washington University School of Medicine|3144548351|bcamins@dom.wustl.edu
7050|NCT00548145|Hiroaki Kazui,Ph.D.|Osaka University Hospital|81-6-6879-3051|kazui@psy.med.osaka-u.ac.jp
7051|NCT00548184|Dr. Mothaffar Rimawi|Baylor College of Medicine|713-798-1311|rimawi@bcm.edu
7052|NCT00548249|Richard C. Yocum, MD|Rockwell Medical|858-229-8585|ryocum@rockwellmed.com
7053|NCT00548262|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7054|NCT00548327|Jose A. Apud MD, PhD|Clinical Brain Disoders Branch-National Institute of Mental Health (NIMH)-National Institute of Health (NIH)|301 5946561|apudj@mail.nih.gov
7055|NCT00548418|David G. Mutch, M.D.|Washington University School of Medicine|314-362-2181|mutchd@wudosis.wustl.edu
7056|NCT00548431|Thomas Frandsen|Rigshospitalet, Juliane Marie Centret|+45 35458364|thomas.leth.frandsen@rh.regionh.dk
7057|NCT00548548|Medical Communications|Hoffman-LaRoche|800-821-8590|
7058|NCT00548808|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6648|NCT00764790|GSK Response Center|GlaxoSmithKline|866-435-7343|
6649|NCT00764868|Timothy Whitaker, MD|Shire Pharmaceutical||twhitaker@shire.com
5677|NCT00808249|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
5678|NCT00808340|Tom Karkkainen, OD|Vistakon|904-443-3402|
5679|NCT00853957|Study Director|Novartis Pharmaceuticals|862-778-8300|
5680|NCT00853970|Tim McNamara, Vice President, Clinical Research & Medical Affairs|ISTA Pharmaceuticals, Inc.|949-788-6000|tmcnamara@istavision.com
5681|NCT00816101|Scott Sheftel, MD|Sheftel Associates Dermatology, LLC|520-293-5757 ext 7106|ssheftel@sheftelderm.com
5682|NCT00816166|Jonathan Megerian, MD PhD|Codman Neuro|508-880-8274|jmegeri1@its.jnj.com
5683|NCT00816556|Maire Brid MacBride MB BCh|Mayo Clinic|507-538-2271|MacBride.Maire@mayo.edu
5684|NCT00816595|Tait Shanafelt, M.D.|Mayo Clinic||shanafelt.tait@mayo.edu
5685|NCT00816829|Sven Voet, Global Communication|Solvay Pharmaceuticals|+32 (0) 2 509 69 77|sven.voet@solvay.com
5686|NCT00816907|Dr. Scott Stroup|Columbia University|212-543-5676|stroups@nyspi.columbia.edu
5687|NCT00817219|Malin Järnkrants|LEO Pharma A/S|+45 7226 2990|malin.jaernkrants@leo-pharma.com
5688|NCT00817531|Dr. Mothaffar Rimawi|Baylor College of Medicine|713-798-1311|rimawi@bcm.edu
5689|NCT00817596|Clinical Trials Manager|Medasys, Inc.|973-426-9229|jarrambide@medasyspumps.com
5690|NCT00856791|Francois E. Wilhelm, MD, PhD|Onconova Therapeutics, Inc.|609 281-7086|fwilhelm@onconova.us
5691|NCT00856843|John McGowan|Braintree Laboratories, Inc.|781-843-2202|jmcgowan@braintreelabs.com
5692|NCT00856908|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
5693|NCT00856934|Dr. Wassim Raffoul|CHUV - CPR|+41 21 314 25 05|Wassim.Raffoul@chuv.ch
5694|NCT00856973|CNS Medical Director|Sunovion|866-503-6357|
5695|NCT00856986|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
5833|NCT00736502|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6405|NCT00422513|Medical Communications|Hoffman-LaRoche|800-821-8590|
6406|NCT00422656|Irene M. Ghobrial, MD|Dana-Farber Cancer Institute|617-632-4198|irene_ghobrial@dfci.harvard.edu
6407|NCT00422669|Optimize RV Trial Leader|Medtronic, Inc.|1-800-328-2518|medtroniccrmtrials@medtronic.com
6408|NCT00422734|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
6409|NCT00422903|GSK Response Center|GlaxoSmithKline|866-435-7343|
6410|NCT00422942|Medical Communications Organization|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
6411|NCT00423046|GSK Response Center|GlaxoSmithKline|866-435-7343|
6412|NCT00423085|Study Director|Novartis Pharmaceuticals|862-778-8300|
6413|NCT00423098|Study Director|Novartis Pharmaceuticals|862-778-8300|
6414|NCT00423150|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6415|NCT00423176|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
6416|NCT00844519|Dr. Priscilla Hsue|University of California San Francisco|415-206-8257|phsue@medsfgh.ucsf.edu
6417|NCT00844532|Ellen Travis|Abbott Vascular|408-845-3000|Ellen.Travis@av.abbott.com
6418|NCT00844649|Anne McClain|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
6419|NCT00844714|Priscilla Hsue, MD|University of California, San Francisco|415-206-8257|phsue@medsfgh.ucsf.edu
6420|NCT00844805|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6421|NCT00844857|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6422|NCT00845065|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6423|NCT00845195|Alcon Clinical|Alcon Research Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6424|NCT00845429|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
6743|NCT00640393|Annie Levesque|Innovaderm Research Inc|514-521-4285 ext 222|alevesque@innovaderm.ca
6744|NCT00640510|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6745|NCT00615199|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6746|NCT00615290|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6747|NCT00615433|Josephine Cucchiaro, Executive Director|Sunovion Pharmacetuicals Inc.|201-592-2050|josephine.cucchiaro@sunovion.com
6748|NCT00615459|Study Director|Novartis Pharmaceuticals|862-778-8300|
6749|NCT00615550|George W Creasy MD|Columbia Laboratories|973-486-8797|Gcreasy@columbialabs.com
6750|NCT00615719|John D. Grizzard|VCU|804-828-8569|jdgrizzard@vcu.edu
6751|NCT00615914|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6752|NCT00615927|Annick Desjardins, MD, FRCPC|Duke University Medical Center|919-668-|annick.desjardins@dm.duke.edu
6753|NCT00615992|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6754|NCT00616018|Jody Green|Denver Health|303-389-1246|jody.green@rmpdc.org
6755|NCT00616109|Gregory Kalemkerian, M.D.|University of Michigan|(734) 936-4991|kalemker@umich.edu
6756|NCT00616122|Hope S. Rugo|UCSF Helen Diller Family Comprehensive Cancer Center|415-353-7618|hrugo@medicine.ucsf.edu
6757|NCT00616200|Stephan R. Weinland, Ph.D.|UNC Center for Functional GI & Motility Disorders|9198437828|stephan_weinland@med.unc.edu
6758|NCT00616239|Amit Pandya, M.D.|UT Southwestern Medical Center at Dallas|214-645-8300|amit.pandya@utsouthwestern.edu
6759|NCT00616343|Dr. David Swope|Loma Linda University|909-558-4908|Thamilton@llu.edu
6760|NCT00616421|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@Novartis.com
6761|NCT00616434|Biogen Idec Study Medical Director|Biogen Idec||clinicaltrials@biogenidec.com
6944|NCT00502905|Gabriela Rondon, MD / Assistant Professor|UT MD Anderson Cancer Center|713 745-2294|celsaenz@mdanderson.org
6650|NCT00764881|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
6651|NCT00764946|Vice President, Late Stage Development Group Leader|Merck Sharpe & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6652|NCT00765037|Jane M. Jacob - Manager of Clinical Affairs|DJO Surgical|512-834-6323|jane.jacob@djosurgical.com
6653|NCT00765063|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6654|NCT00765076|GSK Response Center|GlaxoSmithKline|866-435-7343|
6655|NCT00765102|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
6656|NCT00765128|Mitchell R. Humphreys MD|Mayo Clinic|480-301-8000|humphreys.mitchell@mayo.edu
6657|NCT00765193|Iris Zalaudek, MD|Department of Dermatology, Medical University of Graz-Austria|+436763328269|iris.zalaudek@medunigraz.at
6658|NCT00811395|Trial Transparency Team|sanofi-aventis||Contact_US@sanofi-aventis.com
6659|NCT00811434|Girish Subbarao|Riley Hospital|317-944-3774|gsrao@iupui.edu
6660|NCT00811473|Gerard Lynch|AstraZeneca||aztrail_results_posting@astrazeneca.com
6661|NCT00772889|GSK Response Center|GlaxoSmithKline|866-435-7343|
6662|NCT00772915|Dr. Shaji Kumar|Mayo Clinic||kumar.shaji@mayo.edu
6663|NCT00772928|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
6664|NCT00772941|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6665|NCT00772954|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
6666|NCT00772967|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6667|NCT00773097|Robert E. Schoen ME|University Pittsburgh|412-648-9115|rschoen@pitt.edu
6668|NCT00773136|Dr. Sara Wester|University of Miami|305-326-6132|swester2@med.miami.edu
6669|NCT00773253|Graham A. Glass, MD|University of California San Francisco|415-353-2311|Graham.Glass@ucsf.edu
5834|NCT00736580|Michael Stitely, MD|West Virginia University|304-293-1566|mstitely@hsc.wvu.edu
5835|NCT00736840|Clinical Trial Manager|Exalenz Bioscience|972-8-9737500 ext 513|avrahamh@exalenz.com
5836|NCT00736853|Medical Director|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K.|+81-3-4411-5509|
5837|NCT00736879|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
5838|NCT00736944|Dr. Douglas R. Adkins|Washington University School of Medicine|314-362-5654|dadkins@dom.wustl.edu
5839|NCT00736957|Medical Director|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K. 5-2, Nishi-kanda 3-chome, Cyiyoda-ku, Tokyo 101-0065 JAPAN|+81-3-4411-5509|
5840|NCT00737048|Medical Director|JANSSEN PHARMACEUTICAL. K.K. , Neuroscience Department, Clinical Science Division|+81-3-4411-5509|
5841|NCT00737061|Edward Evantash, MD, Medical Director, Vice President Medical Affairs|Hologic, Inc.|508-263-8475|edward.evantash@hologic.com
5842|NCT00737100|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5843|NCT00737178|Anne Davis, MD|Columbia University|2123054951|ard4@columbia.edu
5844|NCT00737204|Judith G. Rabkin, Ph.D., M.P.H.|New York State Psychiatric Institute|(646) 774-8075|jgr1@columbia.edu
5845|NCT00561951|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
5846|NCT00561977|Barbara Olendzki, RD MPH LDN|UMass Medical School|508-856-5195|barbara.olendzki@umassmed.edu
5847|NCT00562094|Medical Responsible|Nycomed Deutschland GmbH|+49 7531 3666 0|clinicaltrials@nycomed.com
5848|NCT00562120|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5849|NCT00562159|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
5850|NCT00562302|Thomas Doyle|Angiotech|352.338.0440|tdoyle@angio.com
5851|NCT00562328|Dr. Clive Zent|Mayo Clinic||zent.clive@mayo.edu
5852|NCT00562354|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6425|NCT00723931|Senior Vice President, Global Clinical Development|Merck Sharp and Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6426|NCT00723944|Clinical Research Manager|Biomet 3i LLC|5617766722|cristina.matthews@biomet.com
6427|NCT00723957|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
6428|NCT00724009|Wendy Stock, MD|The University of Chicago|773-834-8982|wstock@medicine.bsd.uchicago.edu
6429|NCT00724061|Dr. Timothy Kuzel|Northwestern University|312-695-6180|cancertrials@northwestern.edu
6430|NCT00724126|David Sorscher|Salix|919-862-1827|david.sorscher@salix.com
6431|NCT00724243|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6432|NCT00724308|Dr. Scott Sherman|VA NY Harbor Healthcare System|212-686-7500 ext 7386|scott.sherman@va.gov
6433|NCT00724373|Vice President,Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6434|NCT00724451|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6435|NCT00724464|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@Merck.com
6436|NCT00724477|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6437|NCT00724568|Dr. Moshe Talpaz|University of Michigan Comprehensive Cancer Center|734-764-8195|mtalpaz@umich.edu
6438|NCT00724698|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
6439|NCT00724711|Dara Wambach, MA, Associate Director, Regulatory Affairs|Gilead Sciences|650 522 5163|Dara.Wambach@gilead.com
6440|NCT00724815|Mark Pierce, MD, PhD|NuPathe Inc.|484-567-0130|mpierce@nupathe.com
6441|NCT00724854|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6442|NCT00724893|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6466|NCT00733226|Cem Hasan RAZİ|Kecioren Education and Training Hospital|090 312 3659000 ext 1139|cemrazi2@gmail.com
6945|NCT00502944|Rochelle P. Walensky, MD, MPH|Massachusetts General Hospital|(617) 724-8445|rwalensky@partners.org
6946|NCT00503009|GSK Response Center|GlaxoSmithKline|866-435-7343|
6947|NCT00503113|Medical Communications|Hoffman-LaRoche|800-821-8590|
6948|NCT00503308|Deborah Cohan, MD|UCSF, San Francisco General Hospital|415 206 3658|cohand@obgyn.ucsf.edu
6949|NCT00503399|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6950|NCT00503698|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
6951|NCT00503750|Dr. Ruth O'Regan|Emory University|404-778-8808|roregan@emory.edu
6952|NCT00503776|Barbara Murphy, MD|Vanderbilt-Ingram Cancer Center|615-343-9444|barbara.murphy@vanderbilt.edu
6953|NCT00503841|Dr. Elaina Gartner|Barbara Ann Karmanos Cancer Institute|313-576-8724|gartnere@karmanos.org
6954|NCT00503906|Stefan Gluck MD|UM/Sylvester Comprehensive Cancer CEnter|305-243-4909|sgluck@med.miami.edu
6955|NCT00503919|Andrea Milbourne, MD, MS, BA/Assoc. Professor|UT MD Anderson Cancer Center|713-745-6986|
6956|NCT00503997|Jill Gilbert, M.D.|Vanderbilt-Ingram Cancer Center|615-343-4677|jill.gilbert@vanderbilt.edu
6957|NCT00504075|Tim Aldwinckle, MD|Bio Products Laboratory Limited|+44 2089572565|Tim.Aldwinckle@bpl.co.uk
6958|NCT00504153|Dr. Hedy Kindler|The University of Chicago|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu
6959|NCT00504166|Dr. Thomas M. Link|University of California San Francisco|415-353-2450|Thomas.Link@ucsf.edu
6960|NCT00504231|Ru-Chien Chi B.S., M.D., M.S.|University of Washington|206 768-5217|rchi@u.washington.edu
6961|NCT00504257|Robert Wenham, Principal Investigator|H. Lee Moffitt Cancer Center and Research Institute|813-745-8478|robert.wenham@moffitt.org
6962|NCT00504426|IMAOKA, Kyoji, Operatin Officer, Gemeral Manager|Headwuarters of New Product Evaluation and Development, Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
6963|NCT00504504|Anas Younes, MD / Professor|University of Texas (UT) MD Anderson Cancer||CR_Study_Registration@mdanderson.org
6964|NCT00504595|Study Director|Novartis Pharmaceuticals|862-778-8300|
6670|NCT00773383|Medical Communications|Hoffman-LaRoche|800-821-8590|
5604|NCT00824460|Medical Information|Vifor Pharma|41 58 851 8222|medinfo@viforpharma.com
5605|NCT00824473|William Wheeler, PhD|Meda Pharmaceuticals|732-564-2393|WWheeler@medapharma.us
5606|NCT00824512|Medical Director, Primary Care|Ipsen|clinical.trials@ipsen.com|clinical.trials@ipsen.com
5607|NCT00824538|Hope S Rugo|University of California San Francisco|415-353-7618|hrugo@medicine.ucsf.edu
5608|NCT00824564|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5609|NCT00824616|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5610|NCT00824655|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5611|NCT00824720|Brian Schwam MD/Director Clinical Affairs & Ocular Sciences|Vistakon|904-443-1482|
5612|NCT00824746|Young-Chul Kim, MD, PhD|Chonnam National University Hwasun Hospital|82-61-379-7614|kyc0923@jnu.ac.kr
5613|NCT00824772|Kye-Min Kim, Associate Professor, Dept of Anesthesiology & Pain Medicine|Inje University|82-2-950-1168|kyemin@paik.ac.kr
5614|NCT00824850|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5615|NCT00825162|Dr Russell Basser|CSL Limited|61 3 93891569|russell.basser@csl.com.au
5616|NCT00825175|Julia Looper|University of Michigan|253 534 8499|jlooper@umich.edu
5617|NCT00825227|Vice President, Clinical Research|Cephalon, Inc.|1-800-896-5855|
5618|NCT00825305|Posting Director|Novartis Vaccines and Diagnostics||RegContactVacUS.nvdit@Novartis.com
5619|NCT00825318|James Jones, MD|St. Luke's-Roosevelt Hospital Center|2125233530|JaJones@chpnet.org
5620|NCT00825344|Dr. Steven P. Cohen|Johns Hopkins|410-955-1818|scohen40@jhmi.edu
5621|NCT00825565|Benjamin Bohaty, MD|Ann and Robert H. Lurie Children's Hospital of Chicago|312-227-6486|benjamin.bohaty@northwestern.edu
5622|NCT00692211|Richard Hoffman, MD|New Mexico VA Health Care System|505-265-1711 ext 5318|richard.hoffman2@va.gov
5853|NCT00562484|Dr Russell Basser|CSL Limited|61393891569|russell.basser@csl.com.au
5854|NCT00562588|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5967|NCT00516893|Biogen Idec  Medical Director|Biogen Idec Inc.||clinicaltrials@biogenidec.com
5968|NCT00516906|J M Heilman|3M|651-733-9897|jmheilman@mmm.com
5969|NCT00516919|Dr. Carlos Grilo|Yale University School of Medicine|203-785-2792|carlos.grilo@yale.edu
5970|NCT00517192|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5971|NCT00517361|Dr. Rita Nanda|The University of Chicago|773-834-2756|rnanda@medicine.bsd.uchicago.edu
5972|NCT00517595|Vice President of Scientific Affairs|Accelerated Community Oncology Research Network, Inc.|901-435-5570|mwalker@acorncro.com
5973|NCT00517634|GSK Response Center|GlaxoSmithKline|866-435-7343|
5974|NCT00517699|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
5975|NCT00517933|Kevin J Anstrom, PhD|Duke Clinical Research Institute|919-668-8902|kevin.anstrom@duke.edu
5976|NCT00518089|Therapeutic Area Head|Allergan, Inc.|(714) 246-4500|clinicaltrials@allergan.com
5977|NCT00518115|GSK Response Center|GlaxoSmithKline|866-435-7343|
5978|NCT00518180|Posting Director|Novartis Vaccine and Diagnostics||RegistryContactVaccinesUS@Novartis.com
5979|NCT00518284|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
5980|NCT00518323|Compound Development Team Leader (CDTL)|Johnson & Johnson Pharmaceutical Research & Development|609-730-4530|
5981|NCT00723580|Bill J. Duke, Ph.D.|Child Psychopharmacology Institute|701-241-9281 ext 2|bduke@ChildPsychopharmacologyInstitute.org
5982|NCT00723606|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5983|NCT00723632|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6467|NCT00733278|Dr. Anita Nelson|LA BioMed||anitanelsonwhc@earthlink.net
6468|NCT00733291|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6469|NCT00733330|Kimberly Dwyer|DePuy International||kdwyer2@its.jnj.com
6470|NCT00733369|Kimberly Dwyer, PhD, CCRA|DePuy Ortho Joint US||kdwyer2@its.jnj.com
6471|NCT00740584|Clinical Development Manger|Starpharma Pty Ltd|+61 3 9532 2700|clare.price@starpharma.com
6472|NCT00740597|Paul Frankel, Ph.D.|City of Hope National Medical Center|(626)359-8111 ext 65265|pfrankel@coh.org
6473|NCT00740714|M. Flint Beal, MD|Weill Medical College of Cornell University|212-746-6575|fbeal@med.cornell.edu
6474|NCT00740727|Stephen H. Thomas MD MPH|Massachusetts General Hospital|6177267622|stephen-thomas@ouhsc.edu
6475|NCT00740779|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|Watson Pharmaceuticals|801-588-6641|gary.hoel@watson.com
6476|NCT00740792|David Ginsberg,D.O.|Meda Pharmaceuticals|7325642364|david.ginsberg@meda.us
6477|NCT00740831|Dr Elke Bestel|PregLem SA|+41 22 884 03 40|medical@preglem.com
6478|NCT00740857|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
6479|NCT00741013|Delphine L. Chen|Washington University School of Medicine|314-362-7029|chend@mir.wustl.edu
6480|NCT00741026|Vance L. Albaugh, Principle Investigator|American Medical Association|(800) 243-1455|vance.l.albaugh@vanderbilt.edu
6481|NCT00741091|Todd Kornmann, Specialist, Prin Reg Affairs|Boston Scientific Corporation|763-494-1348|Todd.Kornmann@bsci.com
6482|NCT00741104|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
6483|NCT00741273|Jennifer Wike|Repros Therapeutics|2817193402|jwike@reprosrx.com
6484|NCT00780741|Ray Kraker, Director of PEDIG Coordinating Center|Jaeb Center for Health Research|813-975-8690|rkraker@jaeb.org
6485|NCT00780910|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
6486|NCT00781274|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
6965|NCT00667342|Fariba Navid, MD|St. Jude Children's Research Hospital|866-278-5833|info@stjude.org
6966|NCT00667355|Global Medical Services|Abbott|1-800-633-9110|
6557|NCT00771667|Director, Clinical Research|Janssen Research and Development, US|610-651-6554|
6558|NCT00771758|Senior Director of Clinical Development, Pain|Ortho-McNeil Janssen Scientific Affair, LLC.|(908)927-5465|
6559|NCT00771810|Leanne Drummond|US Biotest, Inc.|805-595-1300|leanne.drummond@usbiotest.com
6560|NCT00771849|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
6561|NCT00771914|Robert Block, MD, MPH, FACP|University of Rochester Division of Epidemiology, Department of Community and Preventive Medicine|585-275-3356|robert_block@urmc.rochester.edu
6562|NCT00771927|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
6563|NCT00771953|Michelle Medeiros|University of Maryland Baltimore Greenebaum Cancer Center|410-328-1160|mmedeiros@umm.edu
6564|NCT00772005|Vice President, Clinical Research, CNS/Pain|Cephalon, Inc.|1-800-896-5855|
6565|NCT00772031|Anne S Lindblad, PhD|The EMMES Corporation|301 251 1161 ext 105|alindblad@emmes.com
6566|NCT00772070|Medical Director|Sanofi Pasteur Inc||RegistryContactUs@sanofipasteur.com
6567|NCT00772109|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
6568|NCT00772304|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6569|NCT00772369|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
6570|NCT00772382|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
6571|NCT00772538|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6572|NCT00772577|Study Director|Novartis Pharmaceuticals|862-778-8300|
6573|NCT00772590|Sean Emery|Kirby Institute, University of New South Wales|+612 938509900|semery@kirby.unsw.edu.au
6574|NCT00772603|Stefan Schwabe, M.D., Ph.D., Chief Medical Officer|Supernus Pharmaceuticals, Inc|301-838-2500 ext 2527|sschwabe@supernus.com
5623|NCT00692237|Dr Andrea Isidori|Sapienza University of Rome|+39 0649970540|andrea.isidori@uniroma1.it
5624|NCT00692341|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|Pfizer, Inc.|ClinicalTrials.gov_Inquiries@pfizer.com
5625|NCT00692406|Dr. F. Joseph McClernon|DukeUMC|919-668-3987|mccle011@mc.duke.edu
5626|NCT00659529|Jennifer L. Taylor-Cousar, MD|National Jewish Health|(303) 270-2764|Taylor-CousarJ@NJHealth.org
5765|NCT00854087|Dr. Tarek Hassanein|SCTI Research Foundation|6195220330|thassanein@livercenters.com
5766|NCT00854113|Yuan-Di Halvorsen|Theracos|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu
5767|NCT00854308|Medical Communications|Hoffman-LaRoche|800-821-8590|
5768|NCT00854360|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
5769|NCT00854373|Mitchell P. Rosen, MD|University of California, San Francisco|415-353-7475|rosenm@obgyn.ucsf.edu
5770|NCT00854607|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5771|NCT00854724|David M. Penetar|BPRL, McLean Hospital|617-855-2913|dpenetar@mclean.harvard.edu
5772|NCT00854906|Richard Harper|University of Arkansas for Medical Sciences|501 526-6000 ext 2616|harperricharda@uams.edu
5773|NCT00855062|Sachiko Miyahara|Harvard School of Public Health|617-432-2837|miyahara@sdac.harvard.edu
5774|NCT00855166|Eva Johnsson|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
5775|NCT00855218|Therapeutic Area Head|BAYER||clinical-trial-contact@bayerhealthcare.com
5776|NCT00855309|LeAnne Kenndy, PharmD|Comprehensive Cancer Center of Wake Forest University|336-713-3416|lakenned@wakehealth.edu
5777|NCT00855465|Therapeutic Area Head|Bayer||clinical-trials-contact@bayerhealthcare.com
5778|NCT00855582|Chief Medical Office|Eli Lilly and Company|800-545-5979|
5779|NCT00855595|Therapeutic Area Head|Intendis GmbH||clinical-trials-contact@bayerhealthcare.com
5780|NCT00855738|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10166|NCT01292486|Jerome R Bill, M.D.|Terumo BCT|303-231-4729|jerry.bill@terumobct.com
10167|NCT01292538|Elvira Walls|Regulatory Insight, Inc.|615-712-9743|elvira@reginsight.com
10168|NCT01292642|Kevin P Hill, MD, MHS|McLean Hospital|617-855-4501|khill@mclean.harvard.edu
10169|NCT01292837|UCB Clinical Trial Call Center|UCB|++1 877 822 9493|
10170|NCT01293006|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10171|NCT01293240|Peter Bergenske|Alcon Research|1-800-241-7629|
10172|NCT00946920|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
10173|NCT00946985|Clinical Project Scientist|Ortho-McNeil Janssen Scientific Affairs, LLC|609-730-3229|
10174|NCT00947115|GSK Response Center|GlaxoSmithKline|866-435-7343|
10175|NCT00947219|David Michaels|Lexington International, LLC|561-417-0200|dm@hairmax.com
10176|NCT00947271|Dr. Michael Carey|The Miriam Hospital|401-793-8218|michael_carey@brown.edu
10177|NCT00947284|Jon Levine MD, PhD|UCaliforniaSF|415-476-5108|jon.levine@ucsf.edu
10178|NCT00947297|Tristen Moors - Associate Director, Clinical Operations|Hyperion Therapeutics|650-745-7840|tristen.moors@hyperiontx.com
10179|NCT00947310|Dr. Arthur J. Moss|University of Rochester, Heart Research Follow-up Program|585-275-5391|arthur.moss@heart.rochester.edu
10180|NCT00947505|David Michaels|Lexington International, LLC|561-417-0200|dm@hairmax.com
10181|NCT00947518|Mari Jeeva Sankar|Department of Pediatrics, All India Institute of  Medical Sciences, New Delhi|+91-11-26594372|jeevasankar@gmail.com
10182|NCT00947531|Dr. Philipp Novak|Ebewe Neuro Pharma|+43 7665 8123 ext 733|philipp.novak@ebewe-neuro.com
10295|NCT01004263|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10296|NCT01004354|Benjamin U  Nwosu, MD|University of Massachusetts Medical School|5083347872|benjamin.nwosu@umassmemorial.org
10297|NCT01004432|Study Director|Janssen Scientific Affairs, LLC|215-325-4209|rdehorat@its.jnj.com
6487|NCT00781365|Dr. Karen Margolis, MD MPH|HealthPartners Institute for Education and Research|952-967-7301|karen.l.margolis@healthpartners.com
6488|NCT00781456|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
6853|NCT00501995|Gwen Leatherman,R.N.,M.S.|Johns Hopkins University|410-550-8582|gleathe@jhmi.edu
6854|NCT00502203|Lois M. Ramondetta, MD / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
6855|NCT00617097|Dr. Catherine Cansino|University of California, Davis|9167346930|Catherine.Cansino@ucdmc.ucdavis.edu
6856|NCT00617123|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6857|NCT00617175|Laura Manotta|MEDTRONIC Clinical Research Institute|+39022413.1|laura.manotta@medtronic.com
6858|NCT00617188|Peter Argenta, M.D.|Masonic Cancer Center, University of Minnesota|612-626-6037|argenta@umn.edu
6859|NCT00617201|Dr. Sharon Walsh|University of Kentucky|859-257-2684|sharon.walsh@uky.edu
6860|NCT00617240|Linmarie Sikich, MD|The University of North Carolina at Chapel Hill|(919) 972-7500|lsikich@med.unc.edu
6861|NCT00666211|Nancy Wells, Director of Nursing Research Patient Care Svcs|Vanderbilt-Ingram Cancer Center|615-322-6184|nancy.wells@vanderbilt.edu
6862|NCT00666224|Yossi Gilgun, PhD, Global Clinical Leader|Teva Pharmaceutical Industries, Ltd.|972-9-863-1491|yossi.gilgun@teva.co.il
6863|NCT00666263|David Gelmont, MD, Head Clinical Research, Biotherapeutics|Baxter Healthcare Corporation||david_gelmont@baxter.com
6864|NCT00666276|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6865|NCT00666328|Jason Campagna. MD, PhD|The Medicines Company|973-290-6199|jason.campagna@themedco.com
6866|NCT00666406|Brigitt Abbühl, MD, Medical Director, Hematology/Hemophilia|Baxter||brigitt_abbuehl@baxter.com
6867|NCT00666458|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6868|NCT00666536|Study Director|Novartis Pharmaceuticals|862-778-8300|
6869|NCT00666588|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
6575|NCT00772629|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
6576|NCT00772668|Denise Pereira MD|UM/Sylvester Comprehensive Cancer|305-243-9127|dpereira2@med.miami.edu
6577|NCT00772707|Jami Kern, Ph.D.|Alcon Global Medical Affairs|1-888-451-3937|
6578|NCT00772772|Dr. Mansih Ponda|The Rockefeller University|212-327-7631|mponda@rockefeller.edu
6579|NCT00782418|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6762|NCT00616603|Patricia Moore, CCRP|Loma Linda University Department of Anesthesiology|909-558-8493|pamoore@llu.edu
6763|NCT00616629|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6764|NCT00616642|Anthony Heaney, M.D. Ph.D|University of California Los Angeles|310 267 4980|aheaney@mednet.ucla.edu
6765|NCT00616759|Ronald L. Warnell, M.D.|Loma Linda University|909-558-9551|rwarnell@llu.edu
6766|NCT00616772|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
6767|NCT00616902|Global Medical Services|Abbott|800-633-9110|
6768|NCT00616928|GSK Response Center|GlaxoSmithKline|866-435-7343|
6769|NCT00616967|Dr. Vered Stearns|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|443-287-6489|vstearn1@jhmi.edu
6770|NCT00617058|Linmarie Sikich, M.D.|The University of North Carolina at Chapel Hill|(919) 972-7499|lsikich@med.unc.edu
6771|NCT00617084|Miraida Weldam|Medtronic Bakken Research Center B.V.|+ 31 43 356 ext 6652|miraida.weldam@medtronic.com
6772|NCT00622726|Helen Mintz-Hittner, M.D.|University of Texas Health Science Center-Houston|713-559-5277|Helen.A.Mintz-Hittner@uth.tmc.edu
6773|NCT00622739|Kirti Saxena|Baylor College of Medicine|832-822-4065|kxsaxen1@texaschildrens.org
6774|NCT00622869|Study Director|Novartis Pharmaceuticals|862 778-8300|
6775|NCT00622908|Timothy Comstock|Bausch & Lomb Incorporated|(585) 338-6631|timothy.comstock@bausch.com
6776|NCT00623103|Study Director|Novartis Pharmaceuticals|862-778-8300|
5781|NCT00855842|Lynn Borgatta, MD|Boston University|617-414-3440|lynn.borgatta@bmc.org
5782|NCT00855868|Chief Medical Officer|Avid Radiopharmaceuticals|215-298-0700|clinicaloperations@avidrp.com
5783|NCT00855894|Medical Communications|Genentech, Inc.|800 821-8590|
5784|NCT00855933|Jon Witt|The Procter & Gamble Co.|513-622-2963|witt.jj.2@pg.com
5785|NCT00855959|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
5786|NCT00856024|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClincialTrialsDisclosure@merck.com
5787|NCT00856050|Dr. Suzanne George|Dana-Farber Cancer Institute|617-632-5204|sgeorge2@partners.org
5899|NCT00728884|Clinical Research Manager|Biomet 3i LLC|5617766722|cristina.matthews@biomet.com
5900|NCT00728923|Dr. Carolyn Rodriguez|New York State Psychiatric Institute|212-543-5637|cr2163@columbia.edu
5901|NCT00728962|Clinical Research Manager|Biomet 3i LLC|5617766722|cristina.matthews@biomet.com
5902|NCT00728988|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5903|NCT00729248|Lorenzo Gallon, MD - Study Principal Investigator|Northwestern University|312-695-4457|l-gallon@northwestern.edu
5904|NCT00729326|Chief Medical Officer|Eli Lilly and Company|1-800-LILLYRX|clinicaltrials@amylin.com
5905|NCT00729469|Shionogi Clinical Trials Administrator|Shionogi Inc.|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
5906|NCT00729482|Dr. Yoon-Koo Kang|Asan Medical Center|+82-2-3010-3210|ykkang@amc.seoul.kr
5907|NCT00729560|Dr. John Nestler|Virginia Commonwealth University|804-828-3389|jnestler@mcvh-vcu.edu
5908|NCT00729651|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5909|NCT00729677|Victoria Rosenwald, RN MPH|Beth Israel Cancer Center|212 844-8285|vrosenwa@chpnet.org
5910|NCT00729690|Asokumar Buvanendran|Rush University|(312) 942-3685|asokumar@aol.com
5911|NCT00729781|David Hodge, Project Manager|Medtronic Xomed, Inc.|(+1-904) 281-2774|david.l.hodge@medtronic.com
5984|NCT00723645|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
5985|NCT00723697|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
5986|NCT00723710|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
5987|NCT00723736|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
5988|NCT00723749|Global Medical Director|RB Pharmaceuticals|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com
6100|NCT00762268|Beth Murphy MD|McLean Hospital|617-855-2297|BMurphy5@partners.org
6101|NCT00762320|Laura Clarke-Steffen, PhD, RN|Phoenix Children's Hospital|602-933-0234|lclarke@choenixchildrens.com
6102|NCT00762359|Sr. VP Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
6103|NCT00762385|Kurt Moody, OD FAAO|Vistakon|904-443-3088|
6104|NCT00762411|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6105|NCT00762450|William De Vizio|Colgate Palmolive Co.|732-878-7901|William_Devizio@colpal.com
6106|NCT00762463|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6107|NCT00762476|Dr. Ronald Turner|University of Virginia|(434) 243-9864|RBT2N@hscmail.mcc.virginia.edu
6108|NCT00808405|Connie Celum, MD, MPH|University of Washington|206-520-3824|ccelum@uw.edu
6109|NCT00808444|GSK Response Center|GlaxoSmithKline|866-435-7343|
6110|NCT00808509|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
6111|NCT00808639|Toni Choueiri, MD|Dana-Farber Cancer Institute|617-632-5456|toni_choueiri@dfci.harvard.edu
6112|NCT00808769|John Mcrorie, PhD, FACG, AGAF|The Procter & Gamble Company|513-622-1423|mcrorie.jw@pg.com
6113|NCT00808808|Seth Toback, MD|MedImmune, LLC|301-398-0000|tobacks@medimmune.com
6114|NCT00808834|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
6870|NCT00666679|Vice President, Late stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6871|NCT00666705|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
6872|NCT00666718|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6873|NCT00666757|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6874|NCT00666848|Nancy J. Brown, M.D.|Vanderbilt University School of Medicine|615-343-8701|nancy.j.brown@vanderbilt.edu
6443|NCT00731198|Zhaoshen Li M.D.|Changhai Hospital, Second Military Medical University, Shanghai, China|86-21-81873271|zhaoshenlismmu@gmail.com
6444|NCT00731341|Joy Benson, CRA|Galil Medical|651-287-5112|joy.benson@galilmedical.com
6445|NCT00731484|Dr. Benjamin Sullivan|TearLab, Inc.|855-832-7522|bdsulliv@TearLab.com
6446|NCT00731640|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6447|NCT00731653|Maurizio Fava, MD|Massachusetts General Hospital|617-724-2513|mfava@partners.org
6448|NCT00731666|Clinical Trials Manager|Coloplast Corp|612-302-4990|usdibe@coloplast.com
6449|NCT00731679|David Sorscher|Salix|919-862-1827|david.sorscher@salix.com
6450|NCT00731783|Stephanie A. Fritz, M.D., M.S.C.I.|Washington University|314-454-6050|fritz_s@kids.wustl.edu
6451|NCT00731822|GSK Response Center|GlaxoSmithKline|866-435-7343|
6452|NCT00731939|Clinical Trial Manager|Coloplast Corp|612-302-4990|usdibe@coloplast.com
6453|NCT00732030|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6454|NCT00732069|Dr. Nancy J. Brown|Vanderbilt University|615-343-8701|nancy.j.brown@vanderbilt.edu
6455|NCT00732225|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6456|NCT00732381|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
6457|NCT00732472|GSK Response Center|GlaxoSmithKline|866-435-7343|
6777|NCT00623181|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
6778|NCT00623194|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
6779|NCT00623233|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6780|NCT00623428|Medical Communications|Hoffman-LaRoche|800-821-8590|
6781|NCT00623441|Sofia Pateraki, MSc - Sr. Clinical Research Specialist|Medtronic Bakken Research Center|+31 43 3566785|sofia.pateraki@medtronic.com
6782|NCT00623467|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
6783|NCT00623480|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
6784|NCT00623506|Christine E. Marx, MD|Durham VA Medical Center|919 286-0411 ext 7426|marx0001@mc.duke.edu
6967|NCT00667381|Arnold Seto|University of California, Irvine|714-456-6699|aseto@uci.edu
6968|NCT00667394|Dr. Howard Fine|National Cancer Institute, National Institutes of Health|301-402-6383|hfine@mail.nih.gov
6969|NCT00667420|David P. Ryan|MassGH|617-724-0245|dpryan@partners.org
6970|NCT00667446|Global Medical Services|AbbVie, (prior sponsor, Abbott)|800-633-9110|
6971|NCT00667459|Clinical Department|Medtronic Spinal|1800-876-3133 ext 6068|msbkclinicalresearch@medtronic.com
6972|NCT00667563|Jeannette Y. Lee|AMC|5015266712|jylee@uams.edu
6973|NCT00667576|Global Medical Services|Abbott Japan Co., Ltd.|800-633-9110|
6974|NCT00667589|Hae Bae|Northwestern University|312-695-6829|j-bae@northwestern.edu
6975|NCT00667602|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
6976|NCT00667732|Dr. Matthew Riddle|Oregon Health and Science University|503-494-0557|riddlem@ohsu.edu
6977|NCT00667745|Dr. Andrew Nierenberg, Director of the Bipolar Trials Network|Bipolar Clinic and Research Program at|617-724-0837|ANIERENBERG@PARTNERS.ORG
6978|NCT00667992|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
5912|NCT00729833|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5913|NCT00729859|Stephanie T. Page, MD, PhD|University of Washington|206-616-0483|page@u.washington.edu
5914|NCT00729937|David A. Talan, MD|Olive View-UCLA Medical Center|818-364-3107|dtalan@ucla.edu
5915|NCT00730015|Doug Levine, MD|Ironwood Pharmaceuticals|617.374.3906|dlevine@ironwoodpharma.com
5916|NCT00730041|David Hodge|Medtronic Xomed, Inc.|904-281-2774|david.l.hodge@medtronic.com
5917|NCT00730132|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
5918|NCT00730236|Mark Sumeray, MD, Chief Medical Officer|Aegerion Pharmaceuticals|617-500-7867|msumeray@aegerion.com
5919|NCT00730275|Vice President, Late Stage Development Group Leader|Merck Sharpe & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5920|NCT00730691|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
5921|NCT00730730|Michele Masters|Medtronic Vascular|4848948925|michele.masters@medtronic.com
6033|NCT00779025|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|Johnson & Johnson Consumer and Personal Products Worldwide|928-277-0715|jhauze@its.jnj.com
6034|NCT00779038|Study Responsible Physician|Janssen-Cilag Belgium|003214649584|
6035|NCT00779116|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6036|NCT00779142|Dr. Shree Kurup|Wake Forest Baptist Health Eye Center|336-716-4091|skurup@wakehealth.edu
6037|NCT00779155|Allen S. Braswell CEO|Pico-Tesla Magnetic Therapies, LLC|303-795-3222|abraswell@pico-tesla.com
6038|NCT00779246|Marci Drees, MD, MS|Christiana Care Health System|302-733-5602|mdrees@christianacare.org
6039|NCT00779259|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
6040|NCT00779285|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6041|NCT00779311|Vice President of Scientific Affairs|Accelerated Community Oncology Research Network, Inc.|901-435-5570|mwalker@acorncro.com
5708|NCT00857649|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
5709|NCT00857766|GSK Response Center|GlaxoSmithKline|866-435-7343|
5710|NCT00692692|Jason Wendel, MD|Vanderbilt University Medical Center|615-936-0160|jason.wendel@vanderbilt.edu
5711|NCT00692913|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
5712|NCT00693017|Antonio Laurenza, MD, Executive Director|Eisai Inc|1 201 949-4157|antonio_laurenza@eisai.com
5713|NCT00693160|James C. Eisenach, M.D.|Wake Forest School of Medicine|336-716-4498|jimeisenach@gmail.com
5714|NCT00693225|Dr. Yvonne Romero|Mayo Clinic|507-266-9156|romero.yvonne@mayo.edu
5715|NCT00693238|Randal Henderson, MD, MBA|University of Florida|904-588-1800|rhenderson@floridaproton.org
5716|NCT00693303|Deborah Marr ScD, OTR/L|Shenandoah University|540-678-4312|dmarr@su.edu
5717|NCT00693420|Therapeutic Area Head|Allergan, Inc.|(714)246-4500|clinicaltrials@allergan.com
5718|NCT00693485|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
10023|NCT01134315|Global Medical Services|AbbVie|800-633-9110|
10024|NCT01195831|Malin Jaernkrants|Leo Pharma|+4544945888|malin.jaernkrants@leo-pharma.com
10025|NCT01195844|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10026|NCT01196026|GSK Response Center|GlaxoSmithKline|866-435-7343|
10027|NCT01196052|Medical Communications|Hoffmann-La Roche|800 821-8590|genentech@druginfo.com
10028|NCT01196442|Dr. Craig W. Swainey|Virginia Commonwealth University|804-828-9723|cswainey@mcvh-vcu.edu
10029|NCT01196975|GSK Response Center|GlaxoSmithKline|866-435-7343|
10030|NCT01196988|GSK Response Center|GlaxoSmithKline|866-435-7343|
10031|NCT01197508|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6458|NCT00732641|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6459|NCT00732680|Rizwan Siwani, MBBS|Mayo Clinic|507-284-9155|siwani.rizwan@mayo.edu
6460|NCT00732875|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
6461|NCT00732940|GSK Response Center|GlaxoSmithKline|866-435-7343|
6462|NCT00732992|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6463|NCT00733005|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
6464|NCT00733096|Steven P. Cohen|Johns Hopkins School of Medicine|410-955-1822|scohen40@jhmi.edu
6465|NCT00733135|Director of Medical Communications|Covidien|763-591-3047|jean.ahlstrom@covidien.com
6671|NCT00819741|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
6672|NCT00819767|Study Director|Novartis Pharmaceuticals|862 778-8300|
6673|NCT00819780|Study Director|Amgen Inc.|866-572-6436|
6674|NCT00819832|Dawid Schellingerhout, MD/Asst. Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
6675|NCT00819910|Ahmad Slim, MD|Brooke Army Medical Center|2109164717|ahmad.slim@us.army.mil
6676|NCT00820222|GSK Response Center|GlaxoSmithKline|866-435-7343|
6677|NCT00820534|Head of Clinical Research|Novartis Consumer Health|+4122363311|
6678|NCT00820573|Eugenio Cersosimo, MD PhD|University of Texas HSC at San Antonio|210 358 7200|Eugenio.cersosimo@uhs-sa.com
6679|NCT00820612|B. Joseph Elmunzer, MD.|University of Michigan|735 615 6652|badihe@umich.edu
6680|NCT00820664|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
6681|NCT00820755|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
6682|NCT00821041|Study Coordinator|University of Manitoba|204-787-5098|NVincent@exchange.hsc.mb.ca
6979|NCT00668200|Study Director|Novartis Pharmaceuticals|8627788300|
6980|NCT00523419|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6981|NCT00523549|Study Director|Novartis Pharmaceuticals|862-778-8300|
6982|NCT00523614|Juergen Dinger, MD, PhD, Principal Investigator|Berlin Center for Epidemiology and Health Research, Germany|+49 30 94510145|dinger@zeg-berlin.de
6983|NCT00523640|Theodore Karrison, PhD|University of Chicago|773-702-9326|tkarrison@health.bsd.uchicago.edu
6984|NCT00523705|Ellen Freeman, Principal Investigator|University of Pennsylvania|215 662-3329|freemane@mail.med.upenn.edu
6985|NCT00523744|Study Director|Novartis Pharmaceuticals|862-778-8300|
6986|NCT00523809|Naoto Ueno, MD / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
6987|NCT00523848|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
6988|NCT00523939|Dr. David Rizzieri|Duke University Medical Center|919-668-1040|rizzi003@mc.duke.edu
6989|NCT00523978|Linda Nelson, RN, BSN, MBA - AF Solutions Clinical Operations Director|Medtronic AF Solutions|(763)526-2891|linda.k.nelson@medtronic.com
6580|NCT00782483|Dr. Gal Shafirstein|University of Arkansas for Medical Sciences/Arkansas Children's Hospital|501-364-7546|jboswell@uams.edu
6581|NCT00782496|Jeanellen Fullam, BS, CCRA|Bayer Diabetes Care|914-333-6245|jeanellen.fullam.b@bayer.com
6582|NCT00782509|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6583|NCT00782639|Usha Halemane|Bracco Diagnostics, Inc|609-514-2578|usha.halemane@diag.bracco.com
6584|NCT00782717|Director of Alcon Clinical|Alcon Research, Ltd.|888.451.3937 and  817.568.6725|medinfo@alconlabs.com
6585|NCT00782834|Margaret von Mehren, M.D., Director of Sarcoma Oncology|Fox Chase Cancer Center|215-728-2814|margaret.vonMehren@fccc.edu
6586|NCT00783094|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6587|NCT00783198|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6042|NCT00779506|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6043|NCT00779675|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6044|NCT00779766|GSK Response Center|GlaxoSmithKline|866-435-7343|
6045|NCT00779779|GSK Response Center|GlaxoSmithKline|866-435-7343|
6046|NCT00779857|Jim Lucky|AtriCure, Inc.|1-513-755-4101|jlucky@atricure.com
6047|NCT00780273|Dr. George Romanos|University if Rochester Medical Center|585-276-4149|GeorgiosRomanos@urmc.rochester.edu
6048|NCT00780403|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6049|NCT00780416|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
6050|NCT00780455|Medical Affiars Therapeutic Area Head|Bayer Healthcare AG||clinical-trials-contact@bayerhealthcare.com
6051|NCT00825630|Dr. Haim Shirin|Sharon Hospital|0097239372231|haims3@clalit.org.il
6052|NCT00825812|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6053|NCT00825825|Tara Lauriat, Ph.D.|Steward St. Elizabeth's Medical Center|617-789-2404|tara.lauriat@steward.org
6054|NCT00825916|Denise Lamon, Director of Regulatory Affairs|Capstone Therapeutics|800-937-5520 ext 5206|dlamon@capstonethx.com
5627|NCT00659581|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5628|NCT00659607|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5629|NCT00659724|Jeffrey R. Shideman PhD|Gambro Renal Products, Inc.|952-835-4018|Jeff.Shideman@us.gambro.com
5630|NCT00659737|Michael Green|Drexel university|215-762-1524|micheal.green@drexelmed.edu
5631|NCT00659815|Gerard Cairns|Bausch & Lomb Incorporated|(585) 338-5170|gerard.cairns@bausch.com
5632|NCT00659945|Manuel C. Vallejo, MD|University of Pittsburgh|412-641-4260|vallejomc@anes.upmc.edu
5633|NCT00660010|Global Medical Services|Abbott Laboratories|800-633-9110|
10298|NCT01004510|Todd Sheppard, MD|Rochester General Hospital|585-922-4409|todd.sheppard@rochestergeneral.org
10299|NCT01004614|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10300|NCT01004705|Natalia Oudovenko|Ferrer Internacional S.A.|+34 93 509 32 82|noudovenko-research@ferrergrupo.com
10301|NCT01004770|Rubin Sheng, MD|GE Healthcare|1-609-514-6899|rubin.sheng@ge.com
10302|NCT01004874|Dr. Annick Desjardins, MD, FRCPC|Duke University Medical Center|9196846173|annick.desjardins@duke.edu
10303|NCT01004939|GSK Response Center|GlaxoSmithKline|866-435-7343|
10304|NCT01005251|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
10305|NCT01005290|Natalia Oudovenko|Ferrer Internacional S.A.|+34 93 509 32 82|noudovenko-research@ferrergrupo.com
10306|NCT01005329|Wendy Seiferheld|Radiation Therapy Oncology Group (RTOG)||wseiferheld@gmail.com
10307|NCT01005355|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
10308|NCT01163292|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
10309|NCT01163617|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
10310|NCT01163656|John Fiadjoe, MD|The Children's Hospital of Philadelphia|215-590-3916|fiadjoej@email.chop.edu
10311|NCT01163721|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
10312|NCT01163747|Medical Communications|Hoffman-LaRoche|800-821-8590|
10313|NCT01163760|Kurt Moody OD, FAAO|Vistakon|904-443-3088|
10314|NCT01163916|Global Medical Services|Abbott|800-633-9110|
10315|NCT01163955|W. Brian Monroe, Doctor of Physical Therapy|Glinn and Giordano Physical Therapy|661-832-9737|tandbmonroe@hotmail.com
10316|NCT01164137|Allan Bailey, M.D.; Study Principal Investigator|Westview Physician Collaborative|(780)-975-1131|baileymd@telusplanet.net
10317|NCT01164475|Trial Transparency Team|Sanofi||Contact-us@sanofi.com
6683|NCT00821093|Study Director|Novartis Pharmaceuticals|862 778-8300|
6684|NCT00821119|Jucille Meneses|Instituto Materno Infantil prof. Fernando Figueira|55 (81) 2122-4100 ext 4135|jmeneses@elogica.com.br
6685|NCT00821184|John T. Stoffel, MD|Lahey Clinic|781-744-5481|John.T.Stoffel@lahey.org
6686|NCT00821236|Brigette Ellis|Durrie Vision|913-491-3330 ext 7255|bellis@durrievision.com
6687|NCT00821509|Tapani Hovi, Project Leader|National Institute for Health and Welfare|+358 400 517299|tapani.hovi@thl.fi
6688|NCT00821587|Roberto J. Firpi-Morell, MD|University of Florida|352-273-9500 ext 9466|firpirj@medicine.ufl.edu
6689|NCT00829010|GSK Response Center|GlaxoSmithKline|866-435-7343|
6690|NCT00829036|David A. Ross|Atlanta VA Rehab R&D Center of Excellence|404-321-6111 ext 6817|ross0128@bellsouth.net
6691|NCT00829049|Vice President, Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
6692|NCT00829166|Medical Communications|Hoffmann-La Roche|800 821-8590|
6693|NCT00829179|John S. Sundy M.D. PhD|Duke University Medical Center|(919) 668-2169|john.sundy@duke.edu
6875|NCT00666926|Mitchell Keegan|Verastem, Inc.|617-252-9300|mkeegan@verastem.com
6876|NCT00666965|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
6877|NCT00667095|Dr. Steven P. Petrou|Mayo Clinic|904-953-7330|peterou.steven@mayo.edu
6878|NCT00667186|Michael S. Lyons|University of Cincinnati College of Medicine|513-558-0890|lyonsme@ucmail.uc.edu
6879|NCT00667225|Dean Morrell|University of North Carolina, Chapel Hill|919-843-5539|morrell@med.unc.edu
6880|NCT00667251|GSK Response Center|GlaxoSmithKline|866-435-7343|
6881|NCT00667277|Dr. Ronald Hoffman|Icahn School of Medicine at Mount Sinai|(212) 241-2297|ronald.hoffman@mssm.edu
6882|NCT00671879|David Ginsberg, DO Sr Dir Medical Scientific Affairs|Meda Pharma US|732 564 2347|david.ginsberg@meda.us
6883|NCT00671918|Dr. Frederick Cope|Navidea Biopharmaceuticals|614-793-7500 ext 140|fcope@navidea.com
6588|NCT00783224|Head, Clinical Trials Regisry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
6589|NCT00783263|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6590|NCT00783432|William Wheeler, PhD|Meda Pharmaceuticals|732-564-2351|wwheeler@medapharma.us
6591|NCT00783614|Dr. Jason Baker|Minneapolis Medical Foundation|612-873-2705|baker459@umn.edu
6592|NCT00783692|Medical Director|Millennium Pharmaceuticals Inc|800-778-2860|clinicaltrialregistry@tpna.com
6593|NCT00783718|Medical Director|Millennium Pharmaceuticals Inc|800-778-2860|clinicaltrialregistry@tpna.com
6594|NCT00783796|Ellen Travis|Abbott Vascular|408-845-3000|Ellen.Travis@av.abbott.com
6595|NCT00783835|Medical Manager|Janssen-Cilag Farmaceutica Ltda|+55 11 30302738|
6596|NCT00784147|Stanley T. Lewis, Jr., MD|TaiMed Biologics, Inc.|949-769-6543 ext 108|stlewis@taimedbiologics.com
6597|NCT00784238|Senior Clinical research Associate|Clinical Research Team, Medical Affairs Korea|82-2-2094-4804|
6598|NCT00784277|Senior Director, Clinical Leader|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|609-730-4537|
6599|NCT00784368|Director, Established Products|Global Medical Organization; Janssen R&D|(609) 730-7674|
6600|NCT00828516|Dr Beverley de Valois|Lynda Jackson Macmillan Centre|+44(0)1923-844456|beverley.devalois@nhs.net
6601|NCT00828568|Medical Director|Taro Pharmaceuticals USA|(914) 345-9001 ext 6427|medical.affairs@taro.com
6785|NCT00623636|VP, Scientific Affairs|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|650-386-3100|dkellerman@mappharma.com
6786|NCT00623714|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
6787|NCT00623727|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
6788|NCT00623766|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
6789|NCT00623779|Gerard Lynch|AstraZeneca|+44 1509 645895|aztrial_results_posting@astrazeneca.com
6790|NCT00623805|Medical Communications|Hoffmann-La Roche|800 821-8590|
5634|NCT00660075|Patrick Couture|Laval University|418-654-2106|patrick.couture@crchul.ulaval.ca
5635|NCT00660179|Parisa Danaietash|Actelion Pharmaceuticals Ltd||parisa.danaietash@actelion.com
5636|NCT00660309|Study Director|Novartis Pharmaceuticals|862-778-8300|
5637|NCT00660400|Teresa Field, M.D., Ph.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-7202|teresa.field@moffitt.org
5638|NCT00660504|Dr.Sunyan|Cancer Hospital of Chinese Academy of Medical Sciences|86-10-87788519|suny@csco.org.cn
5639|NCT00660517|David Ginsberg, D.O.|Meda Pharmaceuticals|7325642364|david.ginsberg@meda.us
5640|NCT00660595|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
5641|NCT00660816|Dr. Afshin Dowlati|CCCC|216-844-1228|afshin.dowlati@uhhospitals.org
5642|NCT00660829|William Wheeler, PhD|Meda Pharmaceuticals|732-564-2393|WWheeler@medapharma.us
5643|NCT00660907|Eva Johnsson|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
5644|NCT00660985|Michael Graeber, MD, Head of Global Clinical Project Management and US Development|Galderma|609-860-8201|michael.graeber@galderma.com
5645|NCT00661089|Dr. Christina Marciniak|The Rehabilitation Institute of Chicago|312-238-1000|cmarciniak@ric.org
5646|NCT00661362|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
5647|NCT00661479|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
5648|NCT00661544|Muzaffar H. Qazilbash, MD / Associate Professor|U.T. M.D. Anderson Cancer Center|713-745-3458|
5649|NCT00661570|Prof. Dr. F.J.M. Hilgers|Netherlands Cancer Institute|+31-20-5122550|f.hilgers@nki.nl
5788|NCT00856193|Study Director|Novartis Pharmaceuticals|862-778-8300|
5789|NCT00856232|Dr. Boris Veysman|UMDNJ|732-235-8717|veysmabo@umdnj.edu
5790|NCT00856284|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
5791|NCT00856297|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
6115|NCT00770913|Tomoki Kubota,  Study Director|Eisai Co.,Ltd. Eisai Product Creation Systems|+81-3-3817-3908|t2-kubota@hhc.eisai.co.jp
6116|NCT00771264|Susan Holman, Cheif Operating Officer|Uroplasty, Inc.|952-426-6143|susan.holman@uroplasty.com
6117|NCT00771277|Dr. Linda O. Nichols|VA Medical Center Memphis|901 523-8990 ext 5082|linda.nichols@va.gov
6118|NCT00771316|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6119|NCT00817778|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6120|NCT00817804|Adam Seiver|Respironics California|760-703-6993|adam.seiver@philips.com
6121|NCT00817843|Professor F.L.J. Visseren, MD PhD|UMC Utrecht|0031-88-7555555|f.l.j.visseren@umcutrecht.nl
6122|NCT00817999|Tammy Burns, PharmD|Creighton University|402-280-4292|TammyBurns@creighton.edu
5696|NCT00857220|CNS Medical Director|Sunovion|866-503-6357|
5697|NCT00857233|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
5698|NCT00857259|Study Director|Novartis Pharmaceuticals|862-778-8300|
5699|NCT00857272|John McGowan, Associate Director, Clinical Research|Braintree Laboratories, Inc.|781-843-2202|jmcgowan@braintreelabs.com
5700|NCT00857285|Senior Director, Regulatory Operations|Daiichi Sankyo, Inc.|732-590-5000|hmkessler@dsus.com
5701|NCT00857311|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme||ClinicalTrialsDisclosure@merck.com
5702|NCT00857415|Chief Medical Officer|Avid Radiopharmaceuticals|215-298-0700|clinicaloperations@avidrp.com
5703|NCT00857454|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
5704|NCT00857506|Chief Medical Officer|Avid Radiopharmaceuticals, Inc.|215-298-0700|clinicaloperations@avidrp.com
5705|NCT00857532|Chief Medical Officer|Avid Radiopharmaceuticals, Inc.|215-298-0700|clinicaloperations@avidrp.com
5706|NCT00857584|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
5707|NCT00857623|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6884|NCT00671931|Mohamed Mahmoud, MD Principal Investigator|Cincinnati Children's Hospital|513 636-7426|mohamed.mahmoud@cchmc.org
6885|NCT00671970|Dr. David Reardon|Dana Farber Cancer Institute|(617) 632-2166|David_Reardon@DFCI.HARVARD.EDU
6886|NCT00672100|Craig T. Hartrick, MD|William Beaumont Hospital|248-964-3440|chartrick@beaumont.edu
6887|NCT00672178|John Kirkpatrick, MD, PhD|Duke University Medical Center|919 668-7342|kirkp001@mc.duke.edu
6888|NCT00672204|Bernhard J. Hering, M.D.|University of Minnesota|612-626-5735|bhering@umn.edu
6889|NCT00672243|David A. Reardon, MD|The Preston Robert Tisch Brain Tumor Center at Duke|(919) 668-1409|reard003@mc.duke.edu
6890|NCT00672256|Joseph McClernon|Duke University Medical Center|919-668-3987|mccle011@mc.duke.edu
6891|NCT00672490|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6892|NCT00672555|Lukas Marti; principal investigator|Department of surgery, Cantonal hospital of St. Gallen|0041794120153|lukas.marti@kssg.ch
6893|NCT00672594|Dr. Daniel George|Duke University|919-668-4615|daniel.george@duke.edu
6894|NCT00672620|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
6895|NCT00672633|Dr. Stavroula Osganian, Principal Investigator|Boston Children's Hospital|8572184728|stavroula.osganian@childrens.harvard.edu
6896|NCT00672646|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6897|NCT00672841|Kimberly E. Hanson, MD, MHS|University of Utah|801.585.2867|kim.hanson@hsc.utah.edu
6489|NCT00781508|Robert C. Bahler, MD|MetroHealth Medical Center|216 778-2431|rbahler@metrohealth.org
6490|NCT00781599|Dr. Nikki Nollen|University of Kansas Medical Center|(913) 588-3784|NNOLLEN@kumc.edu
6491|NCT00781859|Aniz Girach|ThromboGenics|+32 16751310|aniz.girach@thrombogenics.com
6492|NCT00781937|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
6493|NCT00782184|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6791|NCT00623935|Dr. Gregory Yanik, M.D.|University of Michigan Comprehensive Cancer Center|734-936-8785|gyanik@umich.edu
6792|NCT00623974|Mimi Hu, MD / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
6793|NCT00671502|David Ginsberg, MD Sr Medical Director|Meda Pharma US|732 564 2364|david.ginsberg@meda.us
6794|NCT00671528|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6795|NCT00671554|Joe Stephenson, MD|Greenville Hospital System|864-455-3600|joe.stephenson@usoncology.com
6796|NCT00671606|Dr. Michael Frumovitz, ND/Assistant Professor|UT MD Anderson Cancer Center||tjohnsto@mdanderson.org
6797|NCT00671671|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6798|NCT00671788|Jessalyn Reboy|Gynecologic Oncology Group Statistical and Data Center|716-845-7738|reboyj@nrgoncology.org
6799|NCT00671853|Dr. Kemp Gao|University Hospitals Case Medical Center|216-844-2865|keming.gao@UHhopsitals.org
6800|NCT00631007|Chief Executive Officer|InteKrin Therapeutics|650-941-5501|Info@intekrin.com
6801|NCT00631189|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6802|NCT00631358|Alcon Clinical|Alcon Labs|1-888-451-3937; 1-817-568-6725|medinfo@alconlabs.com
6803|NCT00631371|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6804|NCT00631410|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6805|NCT00631449|Hiroyu Hatano|University of California, San Francisco|415-476-4082 ext 122|hhatano@php.ucsf.edu
6806|NCT00631475|Isabelle Leconte, PhD/Data Science Group Leader, Director|Actelion Pharmaceuticals Ltd|+ 41 61 565 64 18|isabelle.leconte@actelion.com
7013|NCT00531843|M. Margaret Knudson, MD|UCSF/SF General Hospital|415.205.4623|pknudson@sfghsurg.ucsf.edu
7014|NCT00531934|Medical Communications|Hoffmann- LaRoche|800-821-8590|genentech@druginfo.com
7015|NCT00531947|Kim Portland, Ph.D.|Mylan Specialty L.P.|908.542.2636|kimberly.portland@mylan.com
5792|NCT00856323|Dr. Cathy Reback|Friends Research Institute, Inc.|323-463-1601|reback@friendsresearch.org
5793|NCT00857818|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
5794|NCT00857896|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5795|NCT00857948|Medical Director|Sanofi Topaz||RegistryContactUs@sanofipasteur.com
5796|NCT00857961|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
5797|NCT00858143|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
5798|NCT00858208|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5799|NCT00858247|Seema Kumar, MD|Mayo Clinic|507-284-3300|kumar.seema@mayo.edu
5800|NCT00858390|G Hergenroeder, Principal Investigator|The University of Texas Health Science Center at Houston|7135006130|Georgene.W.Hergenroeder@uth.tmc.edu
5801|NCT00858403|Eric Haura, M.D., via Moffitt Cancer Center|H. Lee Moffitt Cancer Center and Research Institute|813-745-6827|eric.haura@moffitt.org
5802|NCT00858468|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
5803|NCT00858494|James A Taylor|University of Washington|206-616-1206|uncjat@uw.edu
5804|NCT00858702|Howard Kessler|Daiichi Sankyo|732-590-5032|hmkessler@dsi.com
5805|NCT00858780|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5806|NCT00858832|Patrick Teefey MD|USF Health Department of Obstetrics and Gynecology|813-259-8680|ObGynClinicalResearch@health.usf.edu
5807|NCT00858845|Dr. Holly R. Middlekauff|University of California, Los Angeles (UCLA)|310-206-6672|hmiddlekauff@mednet.ucla.edu
5808|NCT00858962|R. Douglas Bruce, MD, MA|Yale University AIDS Program|(203) 737-6133|robert.bruce@yale.edu
5809|NCT00727909|Gene W. Bratt, Ph.D.|VA TVHS|615-873-6068|gene.bratt@va.gov
5810|NCT00727961|Head, Clinical Trials Registry & results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@socorp.com
5922|NCT00730756|GSK Response Center|GlaxoSmithKline|866-435-7343|
10032|NCT01197521|Dave Goldstraw|AstraZeneca|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
10033|NCT01197534|Dave Goldstraw|AstraZeneca Pharmaceuticals|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
10034|NCT01197560|Anne McClain|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
10035|NCT01147627|Dr. Jianping Weng|The Third Affiliated Hospital of Sun Yat-sen University|86-20-85253162|wjianp@mail.sysu.edu.cn
10036|NCT01147822|GSK Response Center|GlaxoSmithKline|866-435-7343|
10037|NCT01211184|Robert Hahn|Södertälje Hospital|+46855024670 ext 4670|robert.hahn@sodertaljesjukhus.se
10038|NCT01211535|Jami Kern, Ph.D.|Alcon Global Medical Affairs|1-888-451-3937|
10039|NCT01211665|Biogen Idec Study Medical Director|Biogen Idec||clinicaltrials@biogenidec.com
10040|NCT01211769|José Carlos Fernandes Galduróz|UNIFESP|55 11 21490168|galduroz@psicobio.epm.br
10041|NCT01211873|Pierre Desché, MD - VP Development, Medical and Regulatory Affairs|Guerbet|+33 1 45 91 50 00|pierre.desche@guerbet-group.com
10042|NCT01212185|Dr. Cort Pedersen|UNC_ChapelHill|919-966-4447|cort_pedersen@med.unc.edu
10043|NCT01212302|Dr Horst Neubauer|Cardiology Dep, Ruhr-University Bochum|+49-234-509-2326|Horst.Neubauer@rub.de
10044|NCT01212445|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10045|NCT01212757|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
10160|NCT01292070|Nolan Sigal, MD, PhD, CEO, Tunitas Therapeutics|Tunitas Therapeutics|(650) 887-4747|nsigal@tunitastherapeutics.com
10161|NCT01292135|Thorsten Graef, MD|Pharmacyclics|855.427.8846|medinfo@pcyc.com
10162|NCT01292187|Dr. David Krause, Chief Medical Officer|Tarsa Therapeutics, Inc.|1-267-273-7940|dkrause@tarsatherapeutics.com
10163|NCT01292239|Director|Janssen Pharmaceutical K.K., Japan|81 3 44115639|
10164|NCT01292265|Study Director|UCB, Inc.|+1 887 822 9493|
10165|NCT01292473|Medical Communications|Genentech, Inc|800 821-8590|
6494|NCT00782210|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6495|NCT00782340|Chief Scientific Officer|Chelsea Therapeutics Inc.|704-973-4202|hewitt@chelsearx.com
6496|NCT00782379|Dr. Scott Solomon|Blood and Marrow Transplant Group of Georgia|404-255-1930|ssolomon@bmtga.com
6497|NCT00715559|Dr. James Murrough|Mount Sinai School of Medicine|212-241-7574|james.murrough@mssm.edu
6498|NCT00715676|Hector F. DeLuca, President and Chief Executive Officer|Deltanoid Pharmaceuticals|608-238-7710|info@deltanoid.com
6499|NCT00715741|Harriet Hopf, MD|University of Utah|801-205-1013|Harriet.Hopf@hsc.utah.edu
6500|NCT00715754|Laurie Moyer-Mileur|University of Utah|801/587-7488|Laurie.Moyer-Mileur@hsc.utah.edu
6501|NCT00715884|Amy Orlick, Associate Director Clinical Research|Cordis|908-541-4347|AOrlick@its.jnj.com
6502|NCT00715910|GSK Response Center|GlaxoSmithKline|866-435-7343|
6503|NCT00716079|Professor Craig Anderson|The George Institute for Global Health|+612 9993 4521|canderson@georgeinstitute.org.au
6504|NCT00716092|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6505|NCT00716417|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6506|NCT00716443|Ron W. Gottschalk, MD / Medical Director|Galderma Laboratories, L.P.|817-961-5358|ron.gottschalk@galderma.com
6507|NCT00716482|Research Coordinator|SuperSonic Imagine|+33 442 99 24 24|sharon.bruce@supersonicimagine.fr
6508|NCT00716742|Vice President, Global Health Outcomes Strategy and Research|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
6509|NCT00716807|Jon Levine MD, PhD|UCSF|415-476-5108|jon.levine@ucsf.edu
6510|NCT00716859|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6694|NCT00829244|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
6695|NCT00829309|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
7016|NCT00532155|Trial Transparency Team|Sanofi-aventis||Contact-Us@sanofi.com
7017|NCT00532259|Director Clinical Resaerch|CureTech Ltd.|+972-8-9324000|talh@curetechbio.com
7018|NCT00532298|GSK Response Center|GlaxoSmithKline|866-435-7343|
7019|NCT00532493|Dr. Murray Rasknd|VA Puget Sound Health Care System|(206) 764-2702|Murray.Raskind@va.gov
7020|NCT00532883|Harvey Luksenburg|NHLBI|301-435-0050|luksenburgh@mail.nih.gov
7021|NCT00674765|Dr. Kyle Kampman|University of Pennsylvania|215-222-3200 ext 109|kampman@mail.med.upenn.edu
7022|NCT00674986|Medical Communications|Hoffman-LaRoche|800-821-8590|
7023|NCT00675103|Chief Medical Officer|Savient Pharmaceuticals, Inc.|732-418-9300|
7024|NCT00675428|Biogen Idec Study Medical Director|Biogen Idec||clinicaltrials@biogenidec.com
7025|NCT00675441|Amin Alousi, MD / Assisstant Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
7026|NCT00675506|Steven K. Grinspoon MD|Massachusetts General Hospital|617-726-3890|sgrinspoon@partners.org
7027|NCT00675558|Paul D. Berk, MD|Columbia University Medical Center|2120-305-4491|pb2158@columbia.edu
7028|NCT00675584|Vernon M. Chinchilli, PhD|Penn State Hershey College of Medicine|717-531-4262|vchinchi@psu.edu
7029|NCT00675792|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
7030|NCT00675909|Eileen Klein, MD, MPH|Seattle Children's Hospital|206-987-2599|eileen.klein@seattlechildrens.org
7031|NCT00675922|David Herndon, MD|University of Texas Medical Branch|409-770-6731|dherndon@utmb.edu
7032|NCT00675948|Mr Richard Potts, Clinical Operations Director|GW Pharma LTD.|00 44 1223 266 800|rp@gwpharm.com
7033|NCT00675987|Mark A. Creager, MD|Brigham and Women's Hospital|617-732-5267|mcreager@partners.org
7034|NCT00676091|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7035|NCT00676130|Daniel J. Pallin, MD, MPH|Brigham and Women's Hospital|617-525-6614|dpallin@partners.org
5923|NCT00768053|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5924|NCT00768118|Fazlul Sarkar, Ph.D.|Barbara Ann Karmanos Cancer Institute|(313) 576-8327|sarkarf@karmanos.org
5925|NCT00768222|Xiaowei SUN, MD PhD|J&J Medical, China Ltd.|86 10 5952 3103|xsun5@its.jnj.com
5926|NCT00737282|Jennifer Wike|Repros Therapeutics Inc.|2817193402|jwike@reprosrx.com
5927|NCT00737360|Dr. Anne Tsao, Principal Investigator|The University of Texas M.D, Anderson Cancer Center|713-792-6363|
5928|NCT00737529|Senior Manager, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialsdisclosure@celgene.com
5929|NCT00737568|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
5930|NCT00737633|Wesley W Day, PhD|Vivus, Inc|650-934-5200|day@vivus.com
5931|NCT00738049|K. Lance Gould, MD|University of Texas Medical School at Houston|713-500-6611|K.Lance.Gould@uth.tmc.edu
5932|NCT00738062|Chief Scientific Officer|Chelsea Therapeutics Inc.|704-973-4202|hewitt@chelsearx.com
5933|NCT00738400|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
5934|NCT00738426|Dr. Robert F. Jackson|Cosmetic Surgery|765-662-8303|rjlipodr@comteck.com
5935|NCT00738543|Alejandro Macias|University of Guanajuato|52 477 7145859 ext 400|aaeemmhh@yahoo.com
5936|NCT00738673|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
5937|NCT00777608|Vice President of Late Stage Development|Merck Sharp and Dohme Corp||ClinicalTrialsDisclosure@merck.com
5938|NCT00777634|Study Coordinator|McLean Hospital|617-855-2984|eryan@mclean.harvard.edu
5939|NCT00777764|Medical Communications|Genentech, Inc.|800-821-8590|
5940|NCT00777790|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
5941|NCT00777803|Matthias Zerm|Merz Pharmaceuticals GmbH|+49 69 1503 ext 865|matthias.zerm@merz.de
5942|NCT00777855|Leslie Benet|UCSF|(415) 476-3853|leslie.benet@ucsf.edu
10410|NCT01093976|Jon E. Grant|University of Minnesota|612-273-9800|grant045@umn.edu
10411|NCT01094171|GSK Response Center|GlaxoSmithKline|866-435-7343|
10412|NCT01094704|Scott Donaldson|UNC-Chapel Hill|919-966-9198|scott_donaldson@med.unc.edu
10413|NCT01094730|John R. Buch, O.D., M.S.,  F.A.A.O., Principal Research Optometrist|Johnson & Johnson Vision Care|1-904-443-1707|jbuch@its.jnj.com
10414|NCT01094743|Huan Sheng, MD, PhD|Johnson & Johnson Vision Care|1-904-443-3440|HSheng2@its.jnj.com
10415|NCT01094808|Dr. Michael Camilleri|Mayo Clinic|507-266-2305|camilleri.michael@mayo.edu
10416|NCT01094886|VP Medical Affairs, Internal Medicine|Janssen Scientific Affairs, LLC|1 908 218-7250|
10417|NCT01095094|David Peereboom, MD|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|216-445-6068|peerebd@ccf.org
10418|NCT01095497|Chief Scientific Officer|ViroPharma|610-458-7300|
10419|NCT01095510|Jennifer Schranz, MD|Shire|484-595-8940|jschranz@shire.com
10420|NCT01231581|GSK Response Center|GlaxoSmithKline|866-435-7343|
10421|NCT01231607|GSK Response Center|GlaxoSmithKline|866-435-7343|
10422|NCT01231841|Jaroslaw Maciejewski, MD PhD, Principal Investigator|Cleveland Clinic Foundation|216-445-5962|maciejj@ccf.org
10423|NCT01231984|Laurence Hirsch, MD|Becton Dickinson|201-847-6513|Laurence_Hirsch@bd.com
10424|NCT01232127|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
10425|NCT01232205|Yuditiya Purwosunu|Dept Obstetrics Gynecology Indonesia University|+44 753 870 6897|yudi@med.showa-u.ac.jp
10426|NCT01232465|Dennis Marchesi|North Shore|516-562-1761|dmarches@nshs.edu
10427|NCT01232491|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
10428|NCT01232569|Medical Communications|Hoffmann-La Roche|800 821-8590|
10429|NCT01232790|Cenk Tek MD, Associate Professor of Psychiatry; Director, Psychosis Program, CMHC|Yale University School of Medicine, Department of Psychiatry|(203) 974-7500|cenk.tek@yale.edu
6696|NCT00829426|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
6697|NCT00829452|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
6698|NCT00829504|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
6699|NCT00829530|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
6700|NCT00829621|Brett Crist, MD|University of Missouri, Department of Orthopaedics|573-882-6562|cristb@health.missouri.edu
6701|NCT00829673|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
6702|NCT00829686|Gillian Schmitz, MD|Wilford Hall Medical Center|919-724-9185|gillianmd@gmail.com
6703|NCT00829712|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
6704|NCT00829738|Medical Responsible|Nycomed Deutschland GmbH|+49 7531 3666 0|clinicaltrials@nycomed.com
6705|NCT00829764|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
6706|NCT00829790|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
6707|NCT00829868|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
6708|NCT00829985|Associate Director, Clinical Research Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
6709|NCT00829998|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
6710|NCT00830024|Manger, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
6711|NCT00830076|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6712|NCT00830115|Medical Responsible|Nycomed Deutschland GmbH|+49 7531 3666 0|clinicaltrials@nycomed.com
6713|NCT00830128|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6714|NCT00830167|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6602|NCT00828711|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
6603|NCT00828750|GSK Response Center|GlaxoSmithKline|866-435-7343|
6604|NCT00828841|Vice President of Scientific Affairs|Accelerated Community Oncology Research Network, Inc.||mwalker@acorncro.com
6605|NCT00828945|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6606|NCT00718120|GSK Response Center|GlaxoSmithKline|866-435-7343|
6607|NCT00718237|Vice President of Late Stage Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6608|NCT00718640|Director, Medical Affairs Oncology|Janssen Inc., Canada|416-382-5078|
6609|NCT00718770|Joshua Klopper, MD|University of Colorado School of Medicine|303-724-3921|joshua.klopper@ucdenver.edu
6610|NCT00718861|Study Director|Novartis Pharmaceuticals|8627788300|
6611|NCT00756093|Alcon Clinical|Alcon Research Ltd|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6612|NCT00756314|Ana Laura Carneiro Gomes Ferreira - MD|IMIP - Instituto Materno Infantil Prof. Fernando Figueira|+558121224779|analaura@imip.org.br
6613|NCT00756444|Study Director|Amgen Inc.|866-572-6436|
6614|NCT00756457|Jeff Houck, PhD|Ithaca College|585-340-9619|jhouck@ithaca.edu
6615|NCT00756548|John McGowan, Director, Clinical Research|Braintree Laboratories, Inc.|781-843-2202|jmcgowan@braintreelabs.com
6616|NCT00756561|Mara Roth, MD|University of Washington, Dept. of Medicine|(206) 221-0519|mylang@u.washington.edu
6617|NCT00756574|Dr. Mark Loeb|McMaster University|905-525-9140 ext 26066|loebm@mcmaster.ca
6618|NCT00756678|Vice President Medical Affairs|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
6619|NCT00756730|Dr. Daniel Skiest|Community Research initiavte|413 794 5376|Daniel.Skiest@baystatehealth.org
6620|NCT00756886|Ayesha S. Bryant, MD|Surgery - Cardiovascular/Thoracic|(205) 996-7561|abryant@uab.edu
6621|NCT00756938|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5943|NCT00777946|Study Director|Novartis Pharmaceuticals|862-778-8300|
5944|NCT00778167|Dr. David R. Camidge|University of Colorado Denver|720-848-0449|ross.camidge@ucdenver.edu
6055|NCT00825994|Marlene Freeman, MD|Massachusetts General Hospital|617-643-6403|mfreeman@partners.org
6056|NCT00826007|Tamra Dukatz, CRNA, MSN|William Beaumont Hospital|2489924741|tdukatz@beaumont.edu
6057|NCT00826111|Tara Lauriat, Ph.D.|Steward St. Elizabeth's Medical Center of Boston, Inc.|617-789-2404|tara.lauriat@steward.org
6058|NCT00826176|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6059|NCT00826228|Thomas J Schnitzer|Northwestern University Feinberg School of Medicine|3125032315|tjs@northwestern.edu
6060|NCT00613314|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6061|NCT00613327|Clinical Research Associate|Medical Affairs, Janssen Korea|+82-2-2094-4935|
6062|NCT00613366|Dr. Alison Edelman|Oregon Health & Science University|503.494.5949|edelmana@ohsu.edu
6063|NCT00613379|Clinical Project Manager|Progenics Pharmaceuticals, Inc.|914-784-1868|trawls@progenics.com
6064|NCT00613405|Aimee  McRae-Clark, PharmD|Medical University of South Carolina|843-792-5126|mcraeal@musc.edu
6065|NCT00613509|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
6066|NCT00613574|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6067|NCT00613730|Study Director|Amgen Inc.|866-572-6436|
6068|NCT00613925|Alison Edelman, Associate Professor|Oregon health & Science University|503-418-2585|edelmana@ohsu.edu
6069|NCT00613938|Senior Director, Clinical Leader|Johnson & Johnson Pharmaceutical Research & Development|609-730-4537|
6070|NCT00614120|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
6071|NCT00614198|Lennart Pedersen|Center for Autisme|44982355|lpe@centerforautisme.dk
6072|NCT00614315|John Reviere, Director, Clinical Affairs|Bard Peripheral Vascular, Inc.|480-303-2644|John.Reviere@crbard.com
6308|NCT00842075|Dr. H. Peter Chase|UColorado|303-724-2323|peter.chase@ucdenver.edu
6309|NCT00842153|GSK Response Center|GlaxoSmithKline|866-435-7343|
6310|NCT00842231|Director of Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6311|NCT00842244|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6312|NCT00842335|Jane Fisher, Senior Manager, Regulatory Affairs|Jubilant Clinsys Inc.|+1 (919) 518-8786|jfisher@clinsys.com
6313|NCT00842543|J. Atilio Canas MD|Nemours Children's Clinic|9046973600 ext 3674|jcanas@nemours.org
6314|NCT00842751|John Amory, MD|University of Washington, Dept. of Medicine|(206) 616-1727|jamory@u.washington.edu
6315|NCT00842829|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
6316|NCT00842946|Dr. Erica England|Department of Veterans Affairs (formerly Drexel University)|207-239-6323|elengland02@yahoo.com
6317|NCT00842985|Mehmet Sofuoglu, M.D., Ph.D.|Yale University|203-937-4809|mehmet.sofuoglu@yale.edu
6318|NCT00843024|GSK Response Center|GlaxoSmithKline|866-435-7343|
6319|NCT00843050|Dr. Alan Hatfield|Piramal Healthcare Limited|02230275000 ext 5002|alan.hatfield@piramal.com
6320|NCT00843115|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
6321|NCT00843180|Dr. Wolf Mehling, MD|UCSF|415-353 9506|mehlingw@ocim.ucsf.edu
6322|NCT00843284|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
6323|NCT00843310|Hearn J. Cho, MD|NYU Cancer Institute|212-263-9274|hearn.jay.cho@med.nyu.edu
6324|NCT00843349|Dr. Myles Wolf, Associate Professor of Medicine, Chief-Division of Nephrology and Hypertension|University of Miami|305-243-7745|mwolf@med.miami.edu
6325|NCT00843479|Dr. Bruno Geloneze|Laboratory of Investigation on Metabolism and Diabetes - LIMED / State University of Campinas - Brazil|+55 19 35218589|bgeloneze@terra.com.br
6326|NCT00843492|GSK Response Center|GlaxoSmithKline|866-435-7343|
6715|NCT00830206|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
6898|NCT00672854|Guillermo Umpierrez|Emory University|404-778-1665|geumpie@emory.edu
6899|NCT00672932|Richard W. Price, M.D.|UCSF|415-206-4487|rwprice@sfgh.ucsf.edu
6900|NCT00672958|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
6901|NCT00672984|Gerald Tremblay, MD|Shire Pharmaceutical||gtremblay@shire.com
6902|NCT00673049|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6903|NCT00673075|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|Forest Laboratories|1-201-427-8259|John.Whalen@frx.com
6904|NCT00673114|Dr. Joanne Kurtzberg|Duke University Medical Center|919-668-1100|kurtz001@mc.duke.edu
6905|NCT00673179|Peter M. Anderson, MD, PHD / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
6906|NCT00673231|Eva Johnsson|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
6907|NCT00673257|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
6908|NCT00673361|Michael A Morse, M.D.|Duke University Medical Center|919-681-3480|morse004@mc.duke.edu
6909|NCT00633087|Dr. Robert DiPaola, MD|Rutgers Cancer Institute of New Jersey|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
6910|NCT00633126|David Friedland, MD|Cerexa, Inc.|510-285-9200|clinicaltrials@cerexa.com
6911|NCT00633139|Norman Barton|Shire Human Genetic Therapies, Inc|781-482-9297|nbarton@shire.com
6912|NCT00633152|Vice President, Clinical Sciences|Cerexa, Inc.|510-285-9200|clinicaltrials@cerexa.com
6913|NCT00633217|GSK Response Center|GlaxoSmithKline|866-435-7343|
6914|NCT00633243|R. Douglas Bruce|Yale University|(203) 737-6133|robert.bruce@yale.edu
6915|NCT00633256|James Poling, Ph.D.|Yale University|203-937-4830|james.poling@yale.edu
6916|NCT00673400|Ulrich Beutner PhD|Cantonal Hospital St. Gallen, Department of Surgery|+41 71 494 1111|ulrich.beutner@kssg.ch
6622|NCT00756964|A. Ahsan Ejaz, M.D.|University of Florida|3522735328|ejazaa@medicine.ufl.edu
6623|NCT00756977|John McGowan|Braintree Laboratories|781-843-2202|jmcgowan@braintreelabs.com
6624|NCT00757172|Dr. A. Craig Lockhart|Washington University School of Medicine|314-454-8306|alockhar@dom.wustl.edu
6807|NCT00631488|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6808|NCT00631540|Scott Snyder, PhD|Cook Incorporated|765-463-7537|ssnyder@medinst.com
6809|NCT00631657|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6810|NCT00631670|Bridget Fitzgerald, Clinical trials coordinator|University of Florida, Dept. of Radiation Oncology|352-265-0680 ext 87829|fitzgb@shands.ufl.edu
6811|NCT00631696|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6812|NCT00631748|Andre Tapp, MD|VA Puget Sound Health Care System|253-589-4176|andre.tapp@va.gov
6813|NCT00631917|Study Director|Novartis Pharmaceuticals|862-778-8300|
6814|NCT00631969|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
6815|NCT00632099|Dr. Suzette Evans|New York State Psychiatric Institute|646-774-6136|se18@columbia.edu
6816|NCT00632203|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6817|NCT00632229|Dr. Eric Storch|University of South Florida|727-767-8230|estorch@health.usf.edu
6818|NCT00632281|Bridget Fitzgerald, Clinical Research Coordinator|University of Florida|352-265-0680 ext 87829|fitzgb@shands.ufl.edu
6819|NCT00632424|Name/Official Title: BMS Study Director|Organization: Bristol-Myers Squibb||Clinical.Trials@bms.com
6820|NCT00632463|Chief Medical Officer|ADMA Biologics|201-478-5552|agrossman@admabio.com
6821|NCT00632619|James G Waxmonsky|Florida International University|305 348 3258|jwaxmons@fiu.edu
6822|NCT00632736|GSK Response Center|GlaxoSmithKline|866-435-7343|
6823|NCT00632814|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
6073|NCT00614380|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6074|NCT00614406|Allison Edelman, MD, MPH|Oregon Health and Sciences University|503-494-5949|edelmana@ohsu.edu
6075|NCT00614445|Michael Gallo|Duchesnay, Inc.|450-433-7734|mgallo@duchesnay.com
6076|NCT00614458|Professor of Medicine, Director Translational Research IGHID|UNC Chapel Hill|919 966 6388|dmargo@med.unc.edu
5650|NCT00661609|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
5651|NCT00661687|Gerard Cairns|Bausch & Lomb Incorporated|(585)338 - 5170|gerard.cairns@bausch.com
5652|NCT00661726|Nancy Gee, TCRN Network Manager|NERI|617-972-3295|ngee@neriscience.com
5653|NCT00661778|Medical Communications|Hoffmann-La Roche|800 821-8590|
5654|NCT00806078|Medical Affairs Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
5655|NCT00806195|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
5656|NCT00806260|Wesley W Day, PhD|Vivus, Inc.|650-934-5200|day@vivus.com
5657|NCT00806351|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5658|NCT00806390|Stephen Gottlieb|UMaryland|410-328-8788|sgottlie@medicine.umaryland.edu
5659|NCT00806403|Lars Grip|Sahlgren's University Hospital/S, Gothenburg||lars.grip@vgregion.se
5660|NCT00806416|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
5661|NCT00806494|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
5662|NCT00806546|Mark Pierce, MD, PhD|NuPathe Inc.|484-567-0130|mpierce@nupathe.com
5663|NCT00806585|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDevelopment@merck.com
5664|NCT00806598|Tapan Kadia, MD/Assistant Professor|The University of Texas MD Anderson Cancer Center|713-563-3534|eharriso@mdanderson.org
5665|NCT00807001|John Z. Sullivan-Bolyai, MD, MPH|Idenix Pharmaceuticals, Inc.|877-433-6491|
6327|NCT00843622|Dr Karl Fagerström|Fagerström Consulting AB||karl.fagerstrom@swipnet.se
6328|NCT00843778|UCB Clinical Trial Call Center|UCB|+1 877 822 ext 9493|
6329|NCT00843986|Medical Director|Astellas Pharma Global Development||clinicaltrials@us.astellas.com
6330|NCT00844090|Cyrus Desouza MD|Omaha VA Medical Center|402-995-5506|cyrus.desouza@va.gov
6331|NCT00844194|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6332|NCT00844376|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
6333|NCT00844415|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6334|NCT00846521|Tania Burgurt, MD|Yale University School of Medicine|203-785-7152|tania.burgurt@yale.edu
6335|NCT00846547|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|Seaside Therapeutics|617-374-9009 ext 1015|pwang@seasidetherapeutics.com
6336|NCT00846573|Dr. Mitchell Albert|UMass Medical School|(617) 875-2141|albertmi@tbh.net
6337|NCT00846586|Study Director|Novartis Pharmaceuticals|862 778-8300|
6338|NCT00846651|Sonia Vaida|Penn State Milton S. Hershey Medical Center|7175318433|svaida@hmc.psu.edu
6339|NCT00846768|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6340|NCT00846807|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6341|NCT00846846|Lisa Bousquette, Director Clinical Research Coronary and Renal Denervation|Medtronic Cardiovascular||lisa.r.bousquette@medtronic.com
6342|NCT00846885|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
6343|NCT00847002|Sunday Hoy, Director of Clinical Research|Tactile Systems Technology, Inc|612.355.5100|
6344|NCT00847197|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
6345|NCT00847210|Sr. VP Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
6917|NCT00673439|Goetz H Kloecker, MD, MSPH|James Graham Brown Cancer Center|502/562-4358|ghkloe01@exchange.edu
6918|NCT00673452|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6919|NCT00673595|Dr. John H. Eisenach|Mayo Clinic|507-266-8715|eisenach.john@mayo.edu
6920|NCT00673660|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6511|NCT00717054|Michael Green, DO|Drexel University College of Medicine|215-762-7798|michael.green@drexelmed.edu
6512|NCT00717067|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
6513|NCT00717093|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6514|NCT00717197|Erin M. Dunbar, MD|University of Florida|(352) 273-9000|edunbar@neurosurgery.ufl.edu
6515|NCT00717236|UCB (Study Director)|UCB Clinical Trial Call Center|+1 887 822 9493|
6516|NCT00717275|Dr. Erin M. Dunbar|University of Florida|352-273-9000|edunbar@neurosurgery.ufl.edu
6517|NCT00717288|Kathleen Dungan, MD|The Ohio State University|614-292-3800|kathleen.dungan@osumc.edu
6518|NCT00717418|Vice President, GHOSR|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
6519|NCT00717522|Associate Director, Clinical Trial Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
6520|NCT00717756|Howard Safran, MD|BrUOG|4018633000|Hsafran@lifespan.org
6521|NCT00717860|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6522|NCT00717977|Roy W. Beck, M.D., Ph.D.|Jaeb Center for Health Research|813-975-8690|rbeck@jaeb.org
6523|NCT00718042|Associate Director Clincal Affairs|Abbott Laboratories|847-937-8702|barbara.kaesdorf@abbott.com
6524|NCT00724932|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
6525|NCT00724945|Thomas Karkkainen OD|Vistakon|904-443-3402|tkarkkai@its.jnj.com
6526|NCT00724958|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialDisclosure@merck.com
6824|NCT00632931|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|clinicaltrialsdisclosure@merck.com
6825|NCT00633009|Stewart Nielsen|Nielsen BioSciences, Inc.|858.571.2726|stewart@nielsenbio.com
6826|NCT00633074|GSK Response Center|GlaxoSmithKline|866-435-7343|
6827|NCT00640562|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
6828|NCT00640601|Gerard Lynch|AstraZeneca|441625 518062|aztrial_results_posting@astrazeneca.com
6829|NCT00640822|Torsten Skov|LeoPharma|+4520736294|torsten.skov@leo-pharma.com
6990|NCT00523991|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6991|NCT00524030|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6992|NCT00524043|Clinical Team Leader, Paliperidone|Johnson & Johnson Pharmaceutical Research & Development|609 730-2436|
6993|NCT00673387|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
6994|NCT00530257|Dr. Nathan Blum|The Children's Hospital of Philadelphia|215-590-6336|blum@email.chop.edu
6995|NCT00530270|Karen Kesler, PhD|Rho Federal Systems Division|919-408-8000 ext 244|karen_kesler@rhoworld.com
6996|NCT00530335|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6997|NCT00530439|Dr. Christina Vinter|Odense University Hospital|+45 21782118|c.vinter@dadlnet.dk
6998|NCT00530712|Director Clincal Affairs|Covidien||Julie.Messer@covidien.com
6999|NCT00530764|Matthew Hersch, Senior Clinical Project Manager|GW Pharma Ltd.|+44 1353 616600|mhersch@gwpham.com
7000|NCT00530777|Dr. Carey Farquhar|University of Washington|206-543-4278|cfarq@uw.edu
7001|NCT00530790|GSK Response Center|GlaxoSmithKline|866-435-7343|
7002|NCT00530842|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7003|NCT00530920|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5666|NCT00807014|GSK Response Center|GlaxoSmithKline|866-435-7343|
5667|NCT00807092|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
5668|NCT00807209|Executive Medical Director|Pacira Pharmaceuticals, Inc.|203-837-6500|ErolOnel@pacira.com
5669|NCT00807235|Robert Segal, MD|Discovery Laboratories, Inc.|215-488-9300|rsegal@discoverylabs.com
5670|NCT00807248|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
5671|NCT00807885|George Harb, MD, MPH|Baxter Healthcare Corporation||george_harb@baxter.com
5672|NCT00807937|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
5811|NCT00728130|Director of Clinical Trials|Simmons Cancer Institute at Southern Illinois University School of Medicine|217-545-1946|krobinson@siumed.edu
5812|NCT00728182|Roberta Anderson, Vice President of Clinical Development|NoNO Inc.|613 833-1020|randerson@nonoinc.ca
5813|NCT00728416|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
5814|NCT00728481|Dr. Amy Foxx-Orenstein, D.O., Associate Prof. of Medicine, College of Medicine|Mayo Clinic|480-301-8806|foxx-orenstein.amy@mayo.edu
5815|NCT00728494|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
5816|NCT00728689|Annie Frimm, Vice President, Regulatory Affairs|Siga Technologies, Inc.|951-303-8797|afrimm@siga.com
5817|NCT00728754|Clinical Research Manager|Biomet 3i LLC|5617766722|cristina.matthews@biomet.com
5818|NCT00728845|Dr. Joseph Aisner|Cancer Institute of New Jersey|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu
5819|NCT00695669|GSK Response Center|GlaxoSmithKline|866-435-7343|
5820|NCT00695903|Medical Director|Cubist Pharmaceuticals||ellie.hershberger@cubist.com
5821|NCT00695955|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
5822|NCT00696241|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
6346|NCT00847288|OptiVol Care Pathway Clinical Team|Medtronic Cardiac Rhythm Disease Management|1-800-328-2518|medtronicCRMtrials@medtronic.com
6347|NCT00847405|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
6348|NCT00847509|Edward M. Aten, M.D.|Certus International, Inc.|603.627.1212|eaten@certusintl.com
6349|NCT00847535|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|Cook|765-463-7537|ssnyder@medinst.com
6350|NCT00847561|Dr. Golda Ginsburg|The Johns Hopkins University School of Medicine|410-955-1544|gginsbu@jhmi.edu
6351|NCT00847587|Kirtly Parker Jones|UUtah|801-581-3834|kirtly.jones@hsc.utah.edu
6352|NCT00847613|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6353|NCT00730847|GSK Response Center|GlaxoSmithKline|866-435-7343|
6354|NCT00730912|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6355|NCT00730925|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6356|NCT00730964|Rubin Sheng, MD|GE Healthcare|1-609-514-6899|Rubin.Sheng@ge.com
6357|NCT00731042|Chou Eyberg|3M Company|651-737-0934|cieyberg1@mmm.com
6358|NCT00731120|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
6359|NCT00731133|Dr. Alison Oliveto|UAMS|501-526-8441|olivetoalison@uams.edu
6360|NCT00699153|Laura Trusso, MS.|Bausch & Lomb, Inc.|(585) 338-5561|laura.trusso@bausch.com
6361|NCT00699192|Study Director|Novartis Pharmaceuticals|862 778-8300|
6362|NCT00699335|Medical Responsible|Nycomed Deutschland GmbH|+49 7531 3666 0|clinicaltrials@nycomed.com
6363|NCT00699374|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6364|NCT00699400|Mary C. Mahony, PhD, HCLD (AAB)|EMD Serono, Inc.|781.681.2438|mary.mahony@emdserono.com
6365|NCT00699582|Eisai Inc.|Eisai Call Center|888-422-4743|
6527|NCT00724984|Dr. Thorsten Graef|Pharmacyclics|855-427-8846|pharmacyclics@medcomsol.com
6528|NCT00725010|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6529|NCT00725049|Clinical Research Manager|Biomet 3i LLC|5617766722|cristina.matthews@biomet.com
6530|NCT00725101|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
6531|NCT00725153|Jessie Lemp, MS|Alcon Research, Ltd.|817-615-2739|Jessie.Lemp@alconlabs.com
6532|NCT00725205|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6533|NCT00725296|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6716|NCT00595465|Senior Manager Clinical Research|Intercell AG|+43 1 206 20 ext 1175|kdubischar-kastner@intercell.com
6717|NCT00595504|David C. Henderson, M.D.|Massachusetts General Hospital|617-912-7800|dchenderson@partners.org
6718|NCT00595517|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6719|NCT00595556|Albert J. Arias, M.D.|UCHC|8606794423 ext 4423|alarias@uchc.edu
6720|NCT00595582|Dr. James Patterson/Professor|LSU Health Sciences Center, Shreveport LA|318-813-2070|jpatte@lsuhsc.edu
6721|NCT00595790|Senior Manager Clinical Research|Intercell AG|+43 1 206 20 ext 0|kdubischar-kastner@intercell.com
6722|NCT00595868|John R. Hughes, MD|University of Vermont|802-656-3195|john.hughes@uvm.edu
6723|NCT00595881|Jennifer Marin|Children's Hospital of Pittsburgh|412-692-7692|jennifer.marin@chp.edu
6724|NCT00595959|Thomas M. Rasmussen V.P. Clinical Affairs|Spectranetics Inc|719-447-2471|thomas.rasmussen@spnc.com
6725|NCT00596011|Nagi Kumar, Ph.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-6885|nagi.kumar@moffitt.org
6726|NCT00596102|Katrin Dubischar-Kastner|Valneva Austria GmbH|+43 1 20620 ext 0|info@valneva.com
6727|NCT00596271|Katrin Dubischar-Kastner|Valneva Austria GmbH|+43 1 206 20 ext 0|info@valneva.com
6728|NCT00639002|Study Director|Incyte Corporation|855 463-3463|
7004|NCT00530946|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
7005|NCT00531011|Maria Jose' M. Lopera|Abbott Vascular, Italy|+39-02-516251|mariajose.lopera@av.abbott.com
7006|NCT00531050|Study Director|Novartis Pharmaceuticals|862-778-8300|
7007|NCT00531206|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
7008|NCT00531427|Clinical Leader, Executive Medical Director|Purdue Pharma|800-733-1333|
7009|NCT00531453|Dr. Helgi van de Velde|Johnson & Johnson Pharmaceutical Research & Development||HVDVELDE@ITS.JNJ.COM
7010|NCT00531479|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
7011|NCT00531661|Jordan Bauman|CardioMEMS, Inc.|4043458235|jbauman@cardiomems.com
7012|NCT00531817|Medical Communications|Hoffmann-La Roche|800-821-8590|
6625|NCT00757237|Mark Bresnik, MD, Director, Clinical Research|Gilead Sciences, Inc.|(650) 522-5934|mark.bresnik@gilead.com
6626|NCT00757588|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
6627|NCT00757601|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6628|NCT00757627|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
6629|NCT00757705|Medical Director|Janssen Research & Development|886 2 23762155|
6630|NCT00757783|Vice President, Tibotec Therapeutics Clinical Affairs|Tibotec Therapeutics Clinical Affairs (TTCA), Division of Centocor Ortho Biotech Services, LLC|877-732-2488|
6631|NCT00757848|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
6632|NCT00758043|Robert Kauffman, MD, PhD|Vertex Pharmaceuticals Incorporated|617-444-6158|Robert_Kauffman@vrtx.com
6633|NCT00763256|William DeVizio, DMD|Colgate Palmolive Co.|732-878-7901|william_devizio@colpal.com
6634|NCT00763269|William De Vizio|Colgate Palmolive Co.|732-878-7901|William_Devizio@colpal.com
6635|NCT00763321|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
5823|NCT00735969|High Dose Ribavirin in Combination With Peginterferon for Patients With Chronic Hepatitis C Genotype|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|(301) 402-5115|mg228m@nih.gov
5824|NCT00736034|Dr. V. Vakhapova|Sourazky Tel-Aviv Medical Center|972-3-6973698|vedanicek@gmail.com
5825|NCT00736073|Dr. Martin Poleski|DUMC|9196841817|martin.poleski@dm.duke.edu
5826|NCT00736099|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
5827|NCT00736125|Dr. Terri Monk|Duke University Medical Center|919-286-6938|terri.monk@duke.edu
5828|NCT00736190|Eduardo Bruno Martins, MD, DPhil, Sr. Director, Medical Affairs - Hepatitis|Gilead Sciences, Inc.|650-522-5792|eduardo.martins@gilead.com
5829|NCT00736242|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
5830|NCT00736255|Scott Kollins, PhD|DukeUMC|9196810014|kolli001@mc.duke.edu
5831|NCT00736333|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
5832|NCT00736489|Carin Jorup, MSD|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
5945|NCT00778310|Steven R. Pliszka MD|University of Texas Health Science Center at San Antonio|210-567-5475|pliszka@uthscsa.edu
5946|NCT00778336|DeeAnn Tinjum|MEDRAD Interventional / Possis|763-450-8707|deeann.tinjum@possis.com
5947|NCT00778622|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
5948|NCT00778648|Dr. Stephanie Roll|Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie , Charité - Universitätsmedizin Berlin, Germany|+49  30  450 529023|stephanie.roll@charite.de
5949|NCT00778817|Walter M. Stadler, MD|The University of Chicago|(773) 702-6149|wstadler@medicine.bsd.uchicago.edu
5950|NCT00778869|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
5951|NCT00778895|GSK Response Center|GlaxoSmithKline|866-435-7343|
5952|NCT00778921|Study Director|Novartis Pharmaceuticals|862-778-8300|
5953|NCT00778999|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
6366|NCT00738972|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6367|NCT00739024|Pat Barrodale, RN|Swedish Headache Center|206-215-3502|pat.barrodale@swedish.org
6368|NCT00739050|Vice President of Late Stage Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
6369|NCT00739063|Ana Gonzalez-Angulo, MD, MS / Associate Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
6370|NCT00739102|Patricia Schleckser, Director Medical Affairs|Cordis Corporation, a Johnson & Johnson company|908-541-4564|pschleck@its.jnj.com
6371|NCT00739297|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
6372|NCT00739583|Simon C Mears|Johns Hopkins University|410-550-0101|smears1@jhmi.edu
6373|NCT00739596|Study Director|Novartis Pharmaceuticals|862-778-8300|
6374|NCT00739648|Jeff Loutit, MD; Chief Medical Officer|Rempex Pharmaceuticals|858.875.6665|jloutit@rempexpharma.com
6375|NCT00739661|Medical Communications|Genentech, Inc|800-821-8590|
6376|NCT00739674|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
6377|NCT00739882|Medical Responsible|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|+49 6151 72 5200|service@merckgroup.com
6378|NCT00739908|Mahnaz Asgharnejad, Pharm.D.; Daniel Burch, M.D.|CeNeRx BioPharma Inc.|(919) 655 1435; (919) 674 6041|masgharnejad@cenerx.com; danburch@cenerx.com
6379|NCT00739934|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
6380|NCT00739973|Study Director|Novartis Pharmaceuticals|862 778-8300|
6381|NCT00739999|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
6382|NCT00740051|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6383|NCT00740181|James Butera|Brown Univeristy Oncology Research Group|401-863-3000|Kayla_Rosati@brown.edu
6384|NCT00740207|Usha Halemane|Bracco Diagnostics Inc.|609-514-2578|usha.halemane@diag.bracco.com
6729|NCT00639093|Benoît Girard|GRAP, Clinique de Psychologie au Travail|418-542-2030|g.r.a.p@videotron.ca
6730|NCT00639158|Global Medical Services|Abbott|800-633-9110|
6731|NCT00639223|Steven Halbert MD, MSCE|U. of Pennsylvania Health System|215 510 2221|shalbert@mail.med.upenn.edu
6732|NCT00639379|Kurt Moody, OD|Vistakon|904-443-3088|
6733|NCT00639418|Chris Ambrose|MedImmune LLC|301-398-0000|ambrosec@medimmune.com
6734|NCT00639457|Kevin Yarasheski, PhD|Washington Univ Med Sch|3143628173|key@wustl.edu
6735|NCT00639509|Ghassan K. Abou-Alfa, MD|Memorial Sloan-Kettering Cancer Center|646-888-4184|abou-alg@mskcc.org
6736|NCT00639678|GSK Response Center|GlaxoSmithKline|866-435-7343|
6737|NCT00639717|Dr. John Levine|University of Michigan Comprehensive Cancer Center|734-936-8456|jelevine@umich.edu
6738|NCT00639769|Barbara Murphy, M.D.|Vanderbilt-Ingram Cancer Center||barbara.murphy@vanderbilt.edu
6921|NCT00673673|Dr. Jill Lacy|Yale University|203-737-1600|jill.lacy@yale.edu
6922|NCT00673738|Alberto Chiappori, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-3050|alberto.chiappori@moffitt.org
6923|NCT00673764|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6924|NCT00673816|Catherine Meyerle, MD|National Eye Institute|301-435-7821|meyerlec@nei.nih.gov
6925|NCT00673855|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6926|NCT00673881|Michael H. Davidson, MD FACC|Radiant Research|312-494-2220 ext 2220|michaeldavidson@radiantresearch.com
6927|NCT00673933|Dr Ashish Bhatia|Dermatology Institute|630-942-5040|acbhatia@gmail.com
6928|NCT00673959|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6929|NCT00674115|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
6930|NCT00674128|Gregory Altemose MD|Mayo Clinic|480-301-8000|altemose.gregory@mayo.edu
6636|NCT00763360|Director of Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
6637|NCT00763386|Kacy Arnold, Associate Director, Clinical Affairs|Zimmer|574-371-8336|kacy.arnold@zimmer.com
6638|NCT00763698|Director, Clinical Affairs|St. Jude Medical|(408) 522-6410|tshipman@sjm.com
6639|NCT00763750|Howard Safran, MD|BrUOG|4018633000|Hsafran@lifespan.org
6640|NCT00763867|Jenny Ibarra|Duke University|919.236.3291|jenny.ibarra@duke.edu
6641|NCT00763919|Christopher Bialko|University Hospitals Case Medical Center|216-286-4362|Christopher.Bialko@UHhospitals.org
6642|NCT00763958|Dr. Karen Cropsey|University of Alabama at Birmingham|205-917-3786 ext 205|kcropsey@uab.edu
6643|NCT00763971|Study Physician|Shire Pharmaceutical|1 866-842-5335|
6644|NCT00764309|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
6645|NCT00764361|John Abernethy, MD - Medical Director|Nanotherapeutics, Inc.|386-462-9663 ext 326|jabernethy@nanotherapeutics.com
6646|NCT00764504|Manager of Clinical Affairs|DJO Surgical|512-832-9500 ext 6323|jane.jacob@djosurgical.com
6647|NCT00764673|Manager of Clinical Affairs|DJO Surgical|512-832-9500 ext 6323|jane.jacob@djosurgical.com
6830|NCT00640835|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|Reckitt Benckiser Pharmaceuticals, Inc.|804-379-1090 ext 7089|ed.johnson@reckittbenckiser.com
6831|NCT00640926|Eric Burak, PhD|Rib-X Pharmaceuticals, Inc.|203-848-6293|eburak@rib-x.com
6832|NCT00640978|Milind Javle, MD/Associate Professor|UT MD Anderson Cancer Center|713-792-2828|mjlim@mdanderson.org
6833|NCT00641043|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6834|NCT00641056|Chief Medical Officer|Eli Lilly and Company|1-800-LILLYRX|clinicaltrials@amylin.com
6835|NCT00641537|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
6836|NCT00641563|Dr. M. Hänggi|University Hospital Bern, Switzerland|0316323029|matthias.haenggi@insel.ch
6837|NCT00641641|Sean Emery|University of New South Wales|9385 0900|semery@kirby.unsw.edu.au
5954|NCT00661830|A. Kaiser|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|++49(0)6131-179921|kaiser@izks-mainz.de
5955|NCT00661895|Tammy Burns, PharmD, Research Manager|Creighton Cardiac Center|402-280-4292|TammyBurns@creighton.edu
5956|NCT00661999|Dr. Charles L. Loprinzi|Mayo Clinic Rochester|507-284-8666|cloprinzi@mayo.edu
5957|NCT00515697|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
5958|NCT00515827|Clinicaltrials.gov Coordinator|Center for Biostatistics for AIDS Research, Harvard School of Public Health|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
5959|NCT00516048|Chief Medical Officer|Eli Lilly and Company|1-800-LILLYRX|clinicaltrials@amylin.com
5960|NCT00516074|Chief Medical Officer|Eli Lilly and Company|1-800-LILLYRX|clinicaltrials@amylin.com
5961|NCT00516139|GSK Response Center|GlaxoSmithKline|866-435-7343|
5962|NCT00516269|Carmen Escalante, MD / Professor|UT MD Anderson Cancer Center||RABaker@mdanderson.org
5963|NCT00516295|Results Reporting Coordinator|Children's Oncology Group|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org
5964|NCT00516321|GSK Response Center|GlaxoSmithKline|866-435-7343|
5965|NCT00516386|Madhu Misra, MD|Massachusetts General Hospital|617-724-5602|mmisra@partners.org
5966|NCT00516737|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
6077|NCT00614484|David Bush MD|Professor of Radiation Medicine, Loma Linda University Medical Center|909-558-4280|dbush@llu.edu
6078|NCT00614523|Study Director|Amgen Inc.|866-572-6436|
6079|NCT00614575|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
6080|NCT00614614|GSK Response Center|GlaxoSmithKline|866-435-7343|
6081|NCT00614874|Dr. Tammy Wichman|Creighton University School of Medicine|402-449-4486|wichman@creighton.edu
6082|NCT00614913|David Bush MD|Radiation Medicine - Loma Linda University Medical Center|909-558-4280|dbush@dominion.llumc.edu
6083|NCT00614926|Judith Rabkin, PhD|Columbia University|212 543 5762|jgr1@columbia.edu
10914|NCT00996736|Dr. Thomas Lietman|F.I. Proctor Foundation, University of Califonia, San Francisco|415-502-2662|tom.lietman@ucsf.edu
10915|NCT00996775|Michael A. Cucciare, Ph.D.|Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System|501-257-1068|michael.cucciare@va.gov
10916|NCT00996801|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372 ext N/A|clincaltrialsdisclosure@merck.com
10917|NCT00996918|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10918|NCT00996931|Carol Parise, PhD|Sutter Institute for Medical Research|916-733-4413|PariseC@sutterhealth.org
10919|NCT00996944|GSK Response Center|GlaxoSmithKline|866-435-7343|
10920|NCT00996996|GSK Response Center|GlaxoSmithKline|866-435-7343|
10921|NCT00997113|James Miner|Minneapolis Medical Reseach Foundation|6128738791|miner015@umn.edu
10922|NCT00997139|Clinical Trials Unit Coordinator|Northwestern University Department of Dermatology|312-695-6829|j-bae@northwestern.edu
10923|NCT00997204|Alan Kimura, MD,PhD|Shire Human Genetic Therapies, Inc|781-482-0738|akimura@shire.com
10924|NCT00997243|Alison Walker, MD|Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center|614-293-3196|Alison.Walker@osumc.edu
10925|NCT00997321|James Miner|MinneapolisMRF|612-873-3000|miner015@umn.edu
10926|NCT00997516|Jonathan T. Carter, MD, FACS|University of California, San Francisco|415-476-0974|jonathan.carter@ucsfmedctr.org
10927|NCT00997555|John Alfred Carr, MD|Hurley Medical Center|810-262-4993|heartandbones@yahoo.com
10928|NCT00997594|Dr. Koichiro Yamakado|Mie University|+81-59-231-5029 ext 5630|yama@clin.medic.mie-u.ac.jp
10929|NCT00997672|Dr. Francesco Saccà|University Federico II, Naples, Italy|3470734774 ext +39|francesco.sacca@unina.it
10930|NCT00997984|Jonathan Rubin, M.D.|Shire Pharmaceutical||jrubin@shire.com
10931|NCT00998023|J Mocco, M.D.|University of Florida|352-273-9000|jmocco@neurosurgery.ufl.edu
11137|NCT00885638|Professor Bo Ahrén|Lund University|+46462220758|Bo.Ahren@med.lu.se
10823|NCT00996203|Medical Communications|Hoffmann- LaRoche|800-821-8590|genentech@druginfo.com
10824|NCT00996216|GSK Response Center|GlaxoSmithKline|866-435-7343|
10825|NCT00996281|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
10826|NCT00996307|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
10827|NCT00996372|VP, Clinical Development|Sprout Pharmaceuticals|9198820850|clinicaltrials@sproutpharma.com
10828|NCT00996437|Adam R. Glassman|Diabetic Retinopathy Clinical Research Network|813-975-8761|drcrstat4@jaeb.org
10829|NCT00996476|DIrector|Janssen Pharmaceutical K.K., Japan|81 3 44115639|
10830|NCT00996580|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
10831|NCT00996593|GSK Response Center|GlaxoSmithKline|866-435-7343|
10832|NCT00902174|Study Director|Novartis Pharmaceuticals|862-778-8300|
10833|NCT00952705|JA Sliman, MD, MPH, Director, Clinical Development|MedImmune, LLC|301-398-0000|SlimanJ@medimmune.com
10834|NCT00952822|Wing-Yen Wong, MD, Global Sr Medical Dir Hemophilia|Baxter Healthcare Corporation||wing_yen_wong@baxter.com
10835|NCT00952848|Thomas J. Smith, MD, FACP|Virginia Commonwealth University|410-955-2091|tsmit136@jhmi.edu
10836|NCT00953017|Dr. Michael Hjelkrem|Fort Belvoir Community Hospital|531-231-2015|mhjelkrem@yahoo.com
10837|NCT00953043|Dr. Michael Camilleri, Professor of Medicine and Physiology, Gastroenterology|Mayo Clinic|507-266-2305|camilleri.michael@mayo.edu
10838|NCT00953056|Vice President, Late Stage Development Group Leader|Merck Sharp and Dohme||ClinicalTrialsDisclosure@merck.com
10839|NCT00953121|Dr. Annick Desjardins|Preston Robert Tisch Brain Tumor Center at Duke University Medical Center|919-684-1691|annick.desjardins@duke.edu
10840|NCT00953147|Respiratory Medical Director|Sunovion|1-866-503-6351|
10841|NCT00953160|Ayse Turley, Clinical Development Researcher|Cutera Inc.|415-657-5665|aturley@cutera.com
11023|NCT01064167|Guyan Wang|Cardiovascular Institute & Fuwai Hospital|86-10-88398377|guyanwang2006@163.com
10208|NCT01391312|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
10209|NCT01391325|Vice President, Clinical Research and Development|Ardea Biosciences, Inc.|858.652.6587|sbaumgartner@ardeabio.com
10210|NCT01391507|Associate Director Biostatistics|Janssen Research & Development, LLC||ClinicalTrialDisclosure@its.jnj.com
10211|NCT01391559|Donald A. Mahler, M.D.|Dartmouth-Hitchcock|603 650-5533|Donald.a.mahler@hitchcock.org
10212|NCT01391663|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
10213|NCT01160770|Email contact via H. Lundbeck A/S|Lundbeck LLC||LundbeckClinicalTrials@lundbeck.com
10214|NCT01160822|Study Director|Novartis Pharmaceuticals|862-778-8300|
10215|NCT01160848|Project Director|Photocure ASA|+47 22062210|pf@photocure.no
10216|NCT01161407|Kathleen M. Hill Gallant|Purdue University|765-494-0101|hillgallant@purdue.edu
10217|NCT01161472|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10218|NCT01161537|Medical Monitor|Vertex Pharmaceuticals Incorporated|617-341-6777|medicalinfo@vrtx.com
10219|NCT01161563|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|Watson Laboratories, Inc.|801-588-6641|gary.hoel@watson.com
10220|NCT01161771|Vice President, Global Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
10221|NCT01162122|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
10222|NCT01162135|Jianqing Lin, MD|Thomas Jefferson University|215-955-8874|Jianqing.Lin@jefferson.edu
10223|NCT01162733|Deb Marco|Christiana Care Health System|302 733-4130|dmarco@christianacare.org
10224|NCT01163097|Medical Program Director|Swedish Orphan Biovitrum|+46 8 697 20 00|clinical@sobi.com
10225|NCT01163162|Dr. Rajiv Agarwal|Indiana University|317 988 2241|ragarwal@iu.edu
10226|NCT01163266|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
10227|NCT01176032|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
10441|NCT01235195|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10442|NCT01235338|Patrick Martin, MD|Shire Pharmaceutical||pmartin@shire.com
10443|NCT01235403|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
10444|NCT01235442|Study Director|Amgen Inc.|866-572-6436|
10445|NCT01235598|UCB Clinical Trials Call Center|UCB|+1 877 822 9493|
10446|NCT01235715|Dr. Mark P. Figgie|Hospital for Special Surgery|212-606-1932|figgiem@hss.edu
10447|NCT01235728|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10448|NCT01250171|Study Director|Novartis Pharmaceuticals|862 778-8300|
10449|NCT01250418|Gildasio De Oliveira MD|Northwestern University|312-472-3573|g-jr@northwestern.edu
10450|NCT01250509|Jennifer Daubenmier, PhD|University of California, San Francisco|415-514-8601|jennifer.daubenmier@ucsf.edu
10451|NCT01250717|Glenn Bubley MD, Director of GU ONC|BIDMC|617-735-2062|gbubley@bidmc.harvard.edu
10452|NCT01250730|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10453|NCT01250756|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10454|NCT01250769|Director of Clinical Operations|Philips Healthcare, Office of Medical and Health Affairs|425 908-1208|wendy.jenkins@philips.com
10455|NCT01250899|Dr Jordan Lake|University of California, Los Angeles|310-557-2273|jlake@mednet.ucla.edu
10456|NCT01251042|Emma Tällberg, Clinical Research Manager|Wellspect HealthCare|+46313764000|
10457|NCT01251146|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
10458|NCT01251315|Dr .Naureen Tareen|Charles R Drew University of Medicine and Science|323-568-3359|aaant@aol.com
10459|NCT01251770|Dr Facundo Jorro Barón|Hospital General de Niños Pedro de Elizalde|00541143632100 ext 2035|jorrobox@yahoo.com.ar
10460|NCT01251952|Zaid Al-Kadhimi, M.D.|Barbara Ann Karmanos Cancer Institute|(313) 576-8022|alkadhiz@karmanos.org
11138|NCT00885742|Clinical Trial Disclosure Manager|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
11139|NCT00885768|Mohammad Reza Khatami MD|Kidney Reasearch Center, Tehran University of Medical Sciences|00982161192659|khatami@hbi.ir
11140|NCT00885846|Guan-Cheng Sun, PhD|Bastyr University|425-602-3389|gsun@bastyr.edu
11141|NCT00886119|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
11142|NCT00886288|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11143|NCT00886340|Robin Whittemore, PhD|Yale School of Nursing|203-737-2351|robin.whittemore@yale.edu
11144|NCT00886483|L. Eugene Arnold, M.D. M.Ed.|The Ohio State University|614-685-6708|L.Arnold@osumc.edu
11145|NCT00886600|Executive Vice President, Clinical and Quantitative Sciences|Merck & Co., Inc.|1-800-672-6372|
11146|NCT00886613|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11147|NCT00886626|Aaron S. Kelly, Ph.D.|University of Minnesota|612-626-3492|kelly105@umn.edu
11148|NCT00886639|Dr. Klaus Kenn|Schön Klinik BGL|0865293 ext 1540|iheinzelmann@schoen-kliniken.de
11149|NCT00886704|Clemens von Schacky, Head, Preventive Cardiology, University of Munich|Ludwig Maximilians-University Munich|+498951600 ext 2165|clemens.vonschacky@med.uni-muenchen.de
11150|NCT00886769|Study Director|Novartis Pharmaceuticals|862-778-8300|
11151|NCT00886834|Dr. David Turok|University of Utah, Department of Obstetrics and Gynecology|801-581-7647|david.turok@hsc.utah.edu
11152|NCT00886899|VP, Clinical Affairs|BridgePoint Medical|763-225-8500|jschultz@bridgepointmedical.com
11153|NCT00886938|Dr. Jay F Piccirillo|Washington University|(314) 362-8641|piccirilloj@ent.wustl.edu
11154|NCT00887224|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
11155|NCT00887250|Executive Vice President, Clinical and Quantitative Sciences|Merck & Co., Inc.|1-800-672-6372|
11156|NCT00887289|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11024|NCT01064297|GSK Response Center|GlaxoSmithKline|866-435-7343|
11025|NCT01064310|GSK Response Center|GlaxoSmithKline|866-435-7343|
11026|NCT01064362|GSK Response Center|GlaxoSmithKline|866-435-7343|
11027|NCT01064414|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|Janssen Research & Development, LLC|1-800-526-7736|
11028|NCT01064739|Dr. Emily Garland|Vanderbilt University|615 936 1748|emily.garland@vanderbilt.edu
11029|NCT01064817|Elizabeth G. Trehu, MD|Promedior, Inc.|781-538-4203|btrehu@promedior.com
11030|NCT01064830|Aida Lugo-Somolinos MD|University of North carolina-Chapel Hill|919-843-9447|alugosom@med.unc.edu
11031|NCT01064882|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
11032|NCT01064947|Leon H. Kircik, M.D.|DermResearch, PLLC|502-451-9000|wedoderm@yahoo.com
11033|NCT01065051|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
11034|NCT01065350|Nathan J. Smischney, MD|Mayo Clinic|507-255-6032|smischney.nathan@mayo.edu
11035|NCT01065428|Dr. Haibo Qiu; Dr. Christer Sinderby|Department of Critical Care Medicine, Nanjing Zhong-Da Hospital, Southeast University School of Medicine, China|008613951965301|haiboq2000@yahoo.com.cn
11036|NCT01065454|Therapeutic Area Head|Bayer||clinical-trials-contact@bayerhealthcare.com
11037|NCT01065558|Dr. Richard Chipkin|Psyadon Pharmaceuticals|301-919-2020|rchipkin@psyadonrx.com
11038|NCT01065714|Leon Kircik, M.D.|DermResearch, PLLC|502-451-9000|wedoderm@yahoo.com
11039|NCT01065766|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-888-577-8839|ClinicalTrialsDisclosure@merck.com
11040|NCT01065779|Vice President, Late Stage Development Group Leater|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
11041|NCT01066039|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
11042|NCT01066520|Dr. Istvan Zatik|Biologische Heilmittel Heel GmbH|+4972215013192|istvan.zatik@heel.com
11043|NCT01066546|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10228|NCT01176240|Chief Scientific Officer|Chelsea Therapeutics Inc.|704-973-4202|hewitt@chelsearx.com
10341|NCT01179399|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
10342|NCT01179490|Toshihiko Nagase|Symbio Pharmaceuticals|81-3-5472-1127|tnagase.331@symbiopharma.com
10343|NCT01179516|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
10344|NCT01247090|Anjali Ganda, MD - Principal Investigator|Columbia University Medical Center||ag355@columbia.edu
10345|NCT01247272|Associate Director, Biopharmaceutics|Teva Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
10346|NCT01247285|Associate Director, Biopharmaceutics|Teva Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
10347|NCT01247428|Dennis Donohoe, MD, Chief Medical Advisor|Micell Technologies|919-313-2102|ddonohoeconsult@gmail.com
10348|NCT01248013|Charles D. Gerson, M.D.|Mind-Body Digestive Center|212 496 6161|cgerson@yahoo.com
10349|NCT01248065|Tonya S. King, PhD|Penn State University Dept. of Public Health Sciences|717-531-7178|tking@psu.edu
10350|NCT01248130|Gagan Joshi, MD|Massachusetts General Hospital|617-726-4651|lkfeinberg@mgh.harvard.edu
10351|NCT01248221|Dr. Adil E. Bharucha|Mayo Clinic|507-284-2687|bharucha.adil@mayo.edu
10352|NCT01248364|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10353|NCT01248468|Clinical Project Leader|Novartis Consumer Health|973-503-8000|
10354|NCT01248780|Associate Director, Clinical Research|Janssen Research & Development|610-500-3369|
10355|NCT01248793|Associate Director, Clinical Research|Janssen Research & Development|610-500-3369|
10356|NCT01248884|GSK Response Center|GlaxoSmithKline|866-435-7343|
10357|NCT01249092|Claudia O. Zein, MD|Cleveland Clinic|216-444-0421|zeinc@ccf.org
10358|NCT01249261|Grexan J. Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
10359|NCT01249651|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
10461|NCT01252095|Director of Clinical Development|Progen Pharmaceuticals Ltd|+61 7 32739133|
10462|NCT01330381|Study Physician|Shire Development LLC|+1 866 842 5335|
10463|NCT01330394|Dr. Ester Miyuki Nakamura-Palacios|Federal University of Espírito Santo|+55 27 7775-7337|emnpalacios@gmail.com
10464|NCT01330420|Kathleen Miller, RN|Massachusetts General Hospital|781-485-6176|kmiller16@partners.org
10465|NCT01331109|Robert Palmer, MD|Forest Research Institute|1-201-427-8200 ext 8218|robert.palmer@frx.com
10466|NCT01331213|Dr. Michael Camilleri|Mayo Clinic|507-266-2305|camilleri.michael@mayo.edu
10467|NCT01331304|Dr. Andrew Nierenberg|Massachusetts General Hospital|617-724-0837|anierenberg@mgh.harvard.edu
10468|NCT01331681|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
10469|NCT01331694|GSK Response Center|GlaxoSmithKline|866-435-7343|
10470|NCT01332071|GSK Response Center|GlaxoSmithKline|866-435-7343|
10471|NCT01332292|GSK Response Center|GlaxoSmithKline|866-435-7343|
10472|NCT01332305|XenoPort Call Center|XenoPort, Inc.|877-936-6778|
10473|NCT01332318|XenoPort Call Center|XenoPort, Inc.|877-936-6778|
10474|NCT01332357|GSK Response Center|GlaxoSmithKline|866-435-7343|
10475|NCT01332435|GSK Response Center|GlaxoSmithKline|866-435-7343|
10476|NCT01060059|Vice President, Research and Development|Amylin Pharmaceuticals, LLC||clinicaltrials@amylin.com
10477|NCT01060072|Tuyen Ong, MD, MRCOphth|Bausch & Lomb Incorporated|(973) 360-6389|tuyen.ong@bausch.com
10478|NCT01060111|Clinical Research Associate|Medical Affairs / Janssen-Cil Korea|82-2-2094-4837|
10479|NCT01060124|CRA|Medical affairs, Janssen Korea, Ltd.|82220944835|
10480|NCT01060150|Clinical Research Director|Medical Affairs / Janssen-Cil Korea|82-2-2094-4518|
10481|NCT01060540|Corrine Voils, PhD|Durham VA Medical Center|919-286-0411 ext 5196|corrine.voils@va.gov
11157|NCT00887315|Dr. Sang Mee Lee|Department of Health Studies, University of Chicago|773-834-6765|slee@health.bsd.uchicago.edu
11158|NCT00954733|Gildaasio De Oliveira, M.D.|Northwestern University|312-472-3573|gjr@northwestern.edu
10730|NCT01009346|Shanthi Marur, MD|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UAD Program|410-502-3820|smarur1@jhmi.edu
10731|NCT01009463|GSK Response Center|GlaxoSmithKline|866-435-7343|
10732|NCT01009619|Prof. Dr. GM Verleden|Katholieke Universiteit Leuven and University Hospital Leuven|+32 16 34 68 08|geert.verleden@uzleuven.be
10733|NCT01009645|Kenzie Cameron, PhD, MPH|Northwestern University|312-503-3910|kcameron@northwestern.edu
10734|NCT01009762|Professor Anders Fomsgaard|Statens Serum Institut|+45-32683460|afo@ssi.dk
10735|NCT01077323|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
10736|NCT01077362|Senior Director, Clinical Research|Janssen Research & Development, LLC|1-800-526-7736|
10737|NCT01077375|Allan Spera, Director, Clinical Development|Forest Research Institute|(201) 427-8399|Allan.Spera@frx.com
10738|NCT01077596|GSK Response Center|GlaxoSmithKline|866-435-7343|
10739|NCT01077622|GSK Response Center|GlaxoSmithKline|866-435-7343|
10740|NCT01077739|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
10741|NCT01077804|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
10742|NCT01077817|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@Merck.com
10743|NCT01077830|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10744|NCT01077960|EMD Serono Medical Information|EMD Serono|1-888-ASK-SERO (275-7376)|
10745|NCT01077973|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10746|NCT01078090|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
10747|NCT01078116|Global Medical Services|Abbott|1-800-633-9110|
11044|NCT01066585|Medical Director|Sanofi Topaz||RegistryContactUs@sanofipasteur.com
11045|NCT01066780|Kenneth Ripley, Director of Clinical Research|Advanced Bionics, LLC|1.661.362.1400|clinical.research@advancedbionics.com
11295|NCT01008618|Director, Clinical Research|Janssen Research & Development, L.L.C. USA|1 609 730-3387|
11296|NCT01102803|Dr. Jasper Smits|Southern Methodist University|214-768-4125|jsmits@smu.edu
11297|NCT01102972|GSK Response Center|ViiV Healthcare|866-435-7343|
11298|NCT01103063|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11299|NCT01103232|ILHAN KARACAN|Vakif Gureba Training and Research Hospital|+ 90 212 4531700|ilhankaracan@hotmail.com
11300|NCT01103271|Dr. Maurizio Fava|Massachusetts General Hospital|617-724-0838|mfava@partners.org
11301|NCT01103323|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
11302|NCT01103362|Krista Barbour, Ph.D.|Sprout Pharmaceuticals|9198820850|kbarbour@sproutpharma.com
11303|NCT01103414|Dr. Jerry Colca, President & CSO|Mstabolic Solutions Company. LLC|269.343.6732|jcolca@msdrx.com
11304|NCT01103466|Dr. Lis Hentze Poulsen|Coloplast A/S|4549111111|dklhp@coloplast.com
11305|NCT01103479|Kenzie A. Cameron|Northwestern University|312-503-3910|k-cameron@northwestern.edu
11306|NCT01103492|Jeffrey Marks, MD|University Hospitals Case Medical Center|216-983-4930|Jeffrey.Marks@uhhospitals.org
11307|NCT01103960|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11308|NCT01104103|Dr. Richard Bradley|The University of Texas Health Science Center at Houston|713-500-7878|Richard.N.Bradley@uth.tmc.edu
11309|NCT01104246|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|Watson Laboratories, Inc.|801-588-6641|gary.hoel@watson.com
11310|NCT01104285|Yizhak Kupfer MD|Maimonides Medical Center|718-283-8380|ykupfer@maimonidesmed.org
11311|NCT01104493|Dr. Robert Gasser|MedImmune, LLC|301-398-0000|gasserr@medimmune.com
11312|NCT01104558|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
10360|NCT01249664|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
10361|NCT01249872|Dr Anastasia Zotou|University Hospital Of Patras, Greece|0026130603341|anzotou@hotmail.com
10362|NCT01250002|Gildasio De Oliveira, MD|Northwestern University|312-926-8373|g-jr@northwestern.edu
10363|NCT01250054|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|CIBA VISION|1-678-415-3343|Joseph.Rappon@cibavision.com
9955|NCT00509288|Dr. Steven Rosenberg|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
9956|NCT00509366|Neal Ready, MD, PhD|Duke University|919-681-6932|neal.ready@duke.edu
9957|NCT00509496|Dr. Steven Rosenberg|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
9958|NCT00509600|Robert J. Wells, MD / Professor|UT MD Anderson Cancer Center|713-792-6620|
9959|NCT00509769|Medical Communications|Genentech, Inc.|800 821-8590|
9960|NCT00509795|Clinical Trials Administrator|Regeneron Pharmaceuticals||clinicaltrials@regeneron.com
9961|NCT00509873|Therapeutic Area Head|Allergan, Inc.|(714) 246-4500|clinicaltrials@allergan.com
9962|NCT00553644|Vicki Morrison, M.D.|Veterans Affairs Medical Center/University of Minnesota||morri002@umn.edu
9963|NCT00553787|Wesley W Day PhD|Vivus, Inc|650-934-5200|day@vivus.com
9964|NCT00554099|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
9965|NCT00554190|Marcee Maroney, VP Clinical Affairs|Carbylan BioSurgery Inc.|650 855 6774|mmaroney@carbylan.com
9966|NCT00554216|Wesley W. Day PhD|Vivus, Inc.|650-934-5200|day@vivus.com
9967|NCT00554229|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
9968|NCT00554294|Dr. Mathilde Kersting|Research Institute of Child Nutrition, Dortmund|0049 231 79221013|kersting@fke-do.de
9969|NCT00554619|GSK Response Center|GlaxoSmithKline|866-435-7343|
9970|NCT00554749|Dr. Hanne Kristensen|Centre for Child and Adolescent Mental Health, Eastern and Southern Norway|+4722586000|hanne.kristensen@r-bup.no
10482|NCT01060592|John O'Dea PhD|Crospon|+353-91-519880|jodea@crospon.com
10483|NCT01061008|Dr. Jamie Macdonald|UWalesBangor|+441248383272|j.h.macdonald@bangor.ac.uk
10484|NCT01061034|Dr. Keren Doenyas-Barak|Assaf Harofeh medical center|972-57-7346651|kerendoenyas@gmail.com
10485|NCT01061333|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10486|NCT01061359|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10487|NCT01061476|Dr. Susheel Patil|Johns Hopkins University|410-550-0574|spatil@jhmi.edu
10488|NCT01061567|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10489|NCT01061866|Julio Sotelo|National Institute of Neurology and Neurosurgery of Mexico|5255-5652-8285|jsotelo@unam.mx
10490|NCT01062061|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10491|NCT01062074|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10492|NCT01062113|Pfizer Clinical Trials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
10493|NCT01062165|Ronald Hall|Texas Tech UHSC|214-654-9404|ronald.hall@ttuhsc.edu
10494|NCT01062256|Pfizer Clinical Trials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com
10495|NCT01062269|Harold E. Bays, MD|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|502-515-5672|HBaysMD@aol.com
10496|NCT01062308|Jeyaraj D Pandian|Christian Medical College and Hospital, Ludhiana, Punjab, India|09915784750|jeyarajpandian@hotmail.com
10497|NCT01062763|Dr. Ib A. Jacobsen|Dept. of Endocrinology, Odense University Hospital|+45 27203135|ib.abildgaard@rsyd.dk
10498|NCT01063036|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
10499|NCT01063049|Dr. David Gerard|Gastroenterology Services|630 969 1167|davidpgerard@comcast.net
10500|NCT01063062|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
10748|NCT01078207|Fran Haury, RRT Research Coordinator, Clinical Affairs|Covidien|303 305-2314|fran.haury@covidien.com
10749|NCT01078220|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10750|NCT01099397|Mariellen Moore|University of Florida|352-273-6381|marielm@ufl.edu
10751|NCT01099579|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
10752|NCT01099709|Stephen C. Harris, MD|Purdue Pharma LP|203-588-7592|Stephen.Harris@pharma.com
10932|NCT00998049|Dr. Shaji Kumar|Mayo Clinic||kumar.shaji@mayo.edu
10933|NCT00998309|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10934|NCT00998374|Dr. Mitchell Roslin|Lenox Hill Hospital|212-434-3285|MRoslin@NSHS.edu
10935|NCT00998517|Indi Trehan|Washington University in St. Louis|5039284634|itrehan@wustl.edu
10936|NCT01063712|Alexandra Heath MD Ph.D|Cardiology Medical Center  "Kardiozentrum"|005912 2785037|draheath@gmail.com
10937|NCT01063764|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
10938|NCT01063855|CDTL, Cardiovascular and Metabolism|Janssen Research & Development, LLC|1 908 704-4648|
10939|NCT00950651|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
10940|NCT00950664|BS Jeon|Seoul National University Hospital|+82220722876|brain@snu.ac.kr
10941|NCT00950690|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
10942|NCT00950729|François Cabana|Centre hospitalier universitaire de Sherbrooke (CHUS)|1-819-346-1110 ext 14233|francois.cabana@usherbrooke.ca
10943|NCT00950742|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10944|NCT00950755|GSK Response Center|GlaxoSmithKline|866-435-7343|
10945|NCT00950807|GSK Response Center|GlaxoSmithKline|866-435-7343|
10946|NCT00950859|GSK Response Center|ViiV Healthcare|866-435-7343|
11313|NCT01104636|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11314|NCT01104701|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
11315|NCT01105091|Wade Benton, PharmD, Director of Medical Affairs|Actelion Pharmaceuticals, US|650-808-6562|wade.benton@actelion.com
11316|NCT01105117|Wade Benton, PharmD, Director of Medical Affairs|Actelion Pharmaceuticals, US|650-808-6562|wade.benton@actelion.com
10842|NCT00953290|Ayse Turley, Clinical Development Researcher|Cutera Inc.|415-657-5665|aturley@cutera.com
10843|NCT00953329|Shirley Blalock|DukeUMC|919-668-0999|shirley.blalock@duke.edu
10844|NCT00953407|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
10845|NCT00953524|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
10846|NCT00953615|Keith D. Lindor, M.D.|Mayo Clinic|507-284-2969|lindor.keith@mayo.edu
10847|NCT00953654|Matthew P. Herring, PhD|The University of Georgia|706-542-4381|mph8@uga.edu
10848|NCT00953680|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
10849|NCT00953706|Medical Monitor|Vertex|617-444-6777|medicalinfo@vrtx.com
10850|NCT00953719|Sam Himden|DePuy Orthopaedics, Inc.|574-372-7231|shimden@its.jnj.com
10851|NCT00953927|Bernard Landry|Aeras|301-547-2919|blandry@aeras.org
10852|NCT00954122|Gerard Lynch|AstraZeneca|4415 09645895|clinicaltrialtransparency@astrazeneca.com
10853|NCT00954187|Julio Narvaez, MD|Loma Linda University|9095589408|thamilton@llu.edu
10854|NCT00954356|Vice President Clinical|Xenon Pharmaceuticals Inc.|6044843300|pgoldberg@xenon-pharma.com
10855|NCT00954421|Dr. Kelly Foote|University of Florida|352-273-5550|foote@neurosurgery.ufl.edu
10856|NCT00954447|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10857|NCT00954538|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9971|NCT00554970|VP, Scientific Affairs|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|650-386-3100|dkellerman@mappharma.com
9972|NCT00555009|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
9973|NCT00555061|GSK Response Center|GlaxoSmithKline|866-435-7343|
9974|NCT00555321|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
9975|NCT00555438|Pr patrick MISMETTI|CHU SAINT-ETIENNE|33(1)477127788|patrick.mismetti@chu-st-etienne.fr
9976|NCT00555464|Beth Drolet, MD|Medical College of Wisconsin|414-955-2817|sjoachim@mcw.edu
9977|NCT00555477|Dr. Norah Lynn Henry|University of Michigan Comprehensive Cancer Center|734-936-4991|norahh@umich.edu
10092|NCT01121549|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10093|NCT01121562|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10094|NCT01121900|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
10095|NCT01183390|Associate Director, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
10096|NCT01183481|Dr. Edward Chow|Sunnybrook Health Sciences Centre|416-480-4998|edward.chow@sunnybrook.ca
10097|NCT01183650|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
10098|NCT01183975|Birgit Temiz|Ethicon, Inc.|+49 (0) 40 5297 3144|btemiz@its.jnj.com
10099|NCT01184014|Dr. Richard Bergenstal|International Diabetes Center|952-993-3796|richard.bergenstal@parknicollet.com
10100|NCT01184079|Chyongchiou Jeng Lin, PhD|University of Pittsburgh Department of Family Medicine|412/383-2360|cjlin@pitt.edu
10101|NCT01184417|Jonathan Rosenson MD|Alameda County Medical Center|510-407-6743|jonrosenson@yahoo.com
10102|NCT01184846|Clinical Trial Disclosure Manager|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
10103|NCT01184859|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
10104|NCT01184872|Study Director|Novartis Pharmaceutical|862 778 8300|
10501|NCT01063153|Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD|Massachusetts General Hospital|(617)-724-0006|jbiederman@partners.org
10502|NCT01095757|Dr. Edmund Waller|Winship Cancer Institute Emory University|404-727-4995|ewaller@emory.edu
10503|NCT01095796|Christophe Beraud, Director, Regulatory Affairs|Gilead Sciences, Inc.|(650) 522-5093|christophe.beraud@gilead.com
10504|NCT01095978|Global Medical Services|Abbott|1-800-633-9110|
10505|NCT01096017|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
10506|NCT01096056|GSK Response Center|GlaxoSmithKline|866-435-7343|
10507|NCT01096316|Wayne Katon MD, Professor and Vice Chair|Dept Psychiatry University of Washington|206-5437177|wkaton@uw.edu
10508|NCT01096342|Shaji Kumar, M.D.|Mayo Clinic Cancer Center||kumar.shaji@mayo.edu
10509|NCT01096550|Dr. Shannon Gwin Mitchell|Friends Research Institute|410-837-3977 ext 238|smitchell@friendsresearch.org
10510|NCT01096589|Prof. Christine Moffatt, Principal Investigator|Centre for Reasearch and Implementation of Clinical Practice (CRICP)|+44 20 73 51 14 11|christine.moffatt@cricp.org.uk
10511|NCT01096680|Timothy Whitaker, MD|Shire Pharmaceutical||twhitaker@shire.com
10512|NCT01096771|Dr. William Carlos|Indiana University School of Medicine|3178807819|wcarlos@iu.edu
10513|NCT01096875|Prof. A. Ruchan Akar MD., FRCS(CTh).|Ankara University Medical Faculty, Department of Cardiovascular Surgery|+90 533 646 06 84|akarruchan@gmail.com
10514|NCT01097343|Dr. Joseph S. Rossi|St. Vincent Medical Group|765 482 0656|jrossi@thecaregroup.com
10515|NCT01097421|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10516|NCT01097616|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10517|NCT01097629|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10518|NCT00891813|Global Medical Services|Abbott|1-800-633-9110|
10519|NCT00891904|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
10947|NCT00950872|Noreen Fahey, Director, Clinical Program Management|Covidien|203-821-4716|noreen.fahey@covidien.com
10948|NCT00950911|Study Director|Amgen Inc.|866-572-6436|
10949|NCT00950937|Pedro Dall'Ago|Hospital de Clínicas de Porto Alegre|555133038751|pdallago@pq.cnpq.br
10950|NCT00950963|Raymond Estaico, MD|Denver Health|303-860-9900|Ray.Estacio@cpcmed.org
10951|NCT00951015|GSK Response Center|ViiV Healthcare|866-435-7343|
10952|NCT00951093|Carlos AS Madalosso, Director of Department of Metabolic and Bariatric Surgery|Clinica Gastrobese|+55(54)3045-4070|madalosso@gastrobese.com.br
10953|NCT00951171|Andrew S Blazar, MD  Principal Investigator|WIHRI|401-274-1122 ext 8461|ablazar@WIHRI.org
10954|NCT00951275|Medical Communications|Hoffmann- LaRoche|800-821-8590|genentech@druginfo.com
11159|NCT00954915|Anastasia Daifotis, M.D.|MacroGenics, Inc.||info@macrogenics.com
11160|NCT00954941|Jorge Cortes, MD / Professor|The University of Texas MD Anderson Cancer Center|713-794-5783|eharriso@mdanderson.org
11161|NCT00955032|Dr. Hubert Fernandez|Center for Neurological Restoration Cleveland Clinic|(216) 445-1108|fernandez@neurology.ufl.edu
11162|NCT00955110|Endo Clinical Trials Response Center|Endo Pharmaceuticals Inc.|1-800-462-3636|clinicaltrials@endo.com
11163|NCT00955279|Senior Director|Johnson & Johnson Pharmaceutical Research & Development||ClinicalTrialDisclosure@its.jnj.com
11164|NCT00955357|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
11165|NCT00955513|Clinical Project Leader Pain category|Novartis Consumer Health|+41223635528|
11166|NCT00955617|Emilie Huchet|Guerbet|+33 1 45 91 50 00 ext 7688|emilie.huchet@guerbet-group.com
11167|NCT01009840|Global Medical Affairs|Otsuka Pharmaceutical Development and Commercialization|800 562-3974|
11168|NCT01009983|Dr. Julia Lawrence|Wake Forest University Health Sciences|336-716-5772|jlawren@wakehealth.edu
11169|NCT01010009|Emma Wightman|Northumbria university|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk
11170|NCT01010061|Medical Communications|Hoffman-LaRoche|800-821-8590|
10858|NCT00954707|Amy Orlick, Associate Director|Cordis Corporation, a Johnson & Johnson company|908-541-4347|aorlick@its.jnj.com
10859|NCT01167023|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
10860|NCT01167140|Francis Rogers Palmer III, MD|Myoscience|650-474-2600|thenry@myoscience.com
10861|NCT01167153|Study Director|Novartis Pharmaceuticals|862-778-8300|
10862|NCT01167257|Dr. Hann-Chorng Kuo|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|886-3-8561825 ext 2113|hck@tzuchi.com.tw
10863|NCT01167426|Thomas Smith, MD|Teva Pharmaceuticals Medical Affairs|816-508-5128|tom.smith@tevapharm.com
10864|NCT01167504|Professor Peter Wilde|Institute of Food Research|+441603255258|peter.wilde@ifr.ac.uk
11046|NCT01067105|Respiratory Medical Director|Sunovion|1-866-503-6351|
11047|NCT01067326|Dr. Amir Lerman|Mayo Clinic|507-255-4152|lerman.amir@mayo.edu
11048|NCT01078298|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11049|NCT01078376|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
11050|NCT01078389|Medical Director, Clinical Science|Takeda|+1-877-825-3327|clinicaltrialregistry@tpna.com
11051|NCT01078402|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
11052|NCT01078545|Global Medical Services|Abbott|1-800-633-9110|
11053|NCT01078571|Global Medical Services|Abbott|1-800-633-9110|
11054|NCT01078584|Global Medical Services|Abbott|800-633-9110|
11055|NCT01078753|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
11056|NCT01078805|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
11057|NCT01078922|Research Manager|Oncology Specialists, SC|847-410-0658|ktolzien@oncmed.net
11058|NCT01079130|Study Director|Novartis Pharmaceuticals|862-778-8300|
10105|NCT01184885|Margaret Kasner, MD|Thomas Jefferson University|215-955-8874|Margaret.Kasner@jefferson.edu
10106|NCT01184898|Margaret Kasner, MD|Thomas Jefferson University|215-955-8874|Margaret.Kasner@jefferson.edu
10107|NCT01184989|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10108|NCT01185028|Dr. Shyam Kottilil|NIAID/NIH|301-435-0936|skottilil@niaid.nih.gov
10109|NCT01185249|Dr. Alice Siehoff, Nurse Scientist|Central DuPage Hospital|1-630-858-0260|asiehoffrn@msn.com
10110|NCT01185288|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
10111|NCT01185301|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
10112|NCT01185704|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
10113|NCT01185782|Merck KGaA Communication Center|Merck Serono Co., Ltd., Japan, an affiliate of Merck KGaA, Darmstadt, Germany|+49-6151-72-5200|service@merckgroup.com
10114|NCT01185834|Sameena Haque-Khan, PhD, BSc(Hons)Optom, MCOptom, FAAO|Alcon Research, Ltd.|1-800-241-7629|
10229|NCT01176448|J. Jared Christophel MD|University of Virginia Dept of Otolaryngology Head and Neck Surgery|434-243-9391|jjchristop@gmail.com
10230|NCT01176513|Paul Gordon, PhD|GE Healthcare|011-47-2318-5822|Paul.Gordon@ge.com
10231|NCT01176773|Medical Monitor|Allergan Medical|(805) 961-5000|devicetrials@allergan.com
10232|NCT01176877|Dr. Steven Nwe, Clinical Research Fellow|Northwestern University, Feinberg School of Medicine, Department of Dermatology|312-695-4625|steven.nwe@northwestern.edu
10233|NCT01176955|Brad Yentzer|Wake Forest Baptist Medical Center|336-716-4735|byentzer@wakehealth.edu
10234|NCT01177098|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
10235|NCT01177228|Medical Director|Millennium Pharmaceuticals Inc|1-800-778-2860|clinicaltrialregistry@tpna.com
10236|NCT01177293|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10237|NCT01177384|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10520|NCT00891982|Alessandra Alio|Stiefel, a GSK company|1 919 990-6122|alessandra.b.alio@stiefel.com
10521|NCT00892008|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
10522|NCT00892151|Carmine Greene, Clinical Research Scientist|Bayer Healthcare, Diabetes Care|574-257-3040|carmine.greene.b@bayer.com
10523|NCT00892281|Ronald W. Gottschalk, MD / Medical Director|Galderma Laboratories, L.P.|817-961-5358|ron.gottschalk@galderma.com
10524|NCT00892723|Denise Lamon|Capstone Therapeutics|800-937-5520 ext 5206|dlamon@capstonethx.com
10525|NCT00892957|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery|BAXTER INNOVATIONS GmbH||edith_hantak@baxter.com
10526|NCT00893737|Rebecca Browning|Clinvest|(417) 841-3664|rbrowning@clinvest.com
10527|NCT00893789|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
10528|NCT00893997|Guillermo Garcia-Manero, MD / Associate Professor|UT MD Anderson Cancer Center|713-792-7305|eharriso@mdanderson.org
10529|NCT01235741|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
10530|NCT01235897|Jo Chien, MD|University of California, San Francisco|415-885-7577|crss@ucsf.edu
10531|NCT01235923|Robin Ohls|University of New Mexico|505-272-6410|rohls@salud.unm.edu
10532|NCT01311687|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|
10533|NCT01312129|Kent Hutchison, Ph.D.|The Mind Research Network|720-663-0745|khutchison@mrn.org
10534|NCT01312272|Dr. Michael C. Davis|VISN 22 Mental Illness Research, Education, and Clinical Center|3104783711 ext 49234|mcdavis@mednet.ucla.edu
10535|NCT01312428|Director of Clinical Research|Stryker Orthopedics|201-831-5401|ellen.axelson@stryker.com
10536|NCT01312519|Senior Director of Science and Clinical|Vidacare Corporation|210-375-8500|thomas.philbeck@vidacare.com
10537|NCT01312766|Dr. Barbara Cometti, Senior Clinical Research Manager, IBSA|IBSA Institut Biochimique SA|+41 58 360 10 00|barbara.cometti@ibsa.ch
10538|NCT01312948|Alison Wimms|ResMed Ltd|+6188842583|alison.wimms@resmed.com.au
11171|NCT01010230|Kirsten K. Ness, PT, PhD|St. Jude Children's Research Hospital|866-278-5833|kiri.ness@stjude.org
11172|NCT01010282|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
11173|NCT01010399|Franco Felizarta, MD|Franco Felizarta, MD|661-324-3128|felizarta@pol.net
11174|NCT01010477|Jill Williams, MD, Principal Investigator|Rutgers-Robert Wood Johnson Medical School|7322354341|Jill.williams@rutgers.edu
11175|NCT01010503|Medical Communications|Hoffmann- LaRoche.|800-821-8590|genentech@druginfo.com
11176|NCT01010555|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
11177|NCT01010633|Tuyen Ong, MD, MRCOphth|Bausch & Lomb Incorporated|(973) 360-6389|tuyen.ong@bausch.com
11178|NCT01010750|Gerald Tremblay, M.D.|Shire Pharmaceutical||gtremblay@shire.com
11179|NCT01010776|Medical Group Manager|Jan-Cil Brazil|55 11 3030-2770|
11180|NCT01010971|Respiratory Medical Director|Sunovion|1-866-503-6351|
11181|NCT01011049|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
10753|NCT01099774|Therapeutic Area Head|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
10754|NCT01100073|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10755|NCT01100086|Stephen Harris, M.D.|Purdue Pharma L.P.|203-588-7592|Stephen.Harris@Pharma.com
10756|NCT01100112|Michael Huang, MD, Senior Medical Director, Clinical Research|Santarus, Inc.|8583145700|contact@santarus.com
10757|NCT01100268|Dr. Carolyn Rodriguez|Columbia University Department of Psychiatry|(646) 774-8061|cr2163@columbia.edu
10758|NCT01100307|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10759|NCT01100320|Stephen Harris, MD|Purdue Pharma L.P.|203-588-7592|Stephen.Harris@Pharma.com
10760|NCT01100437|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10761|NCT01100606|Robert Winkler, MD, VP, Clinical Development and Operations|Aptalis Pharma US, Inc.|1-800-472-2634|
11059|NCT01079143|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
11060|NCT01079195|Global Medical Services|Abbott|1-800-633-9110|
11061|NCT01079299|Oscar M. Alvarez / Principal Investigator|Center for Curative and Palliative Wound Care Calvary Hospital|718-518-2577|oalvarez@calvaryhospital.org
11062|NCT01079806|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
11063|NCT01079832|Dr. Charles Kunos|Case Comprehensive Cancer Center|330-375-4485|kunosc@summahealth.org
11064|NCT01079949|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
11065|NCT01079962|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
11066|NCT01079988|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|+49-6151-72-5200|service@merckgroup.com
11067|NCT01080118|Dr. Gildasio DeOliveira|Northwestern University Feinberg School of Medicine|312-472-3573|g-jr@northwestern.edu
11068|NCT01080131|Study Director|Novartis Pharmaceuticals|862 778-8300|
11250|NCT00887965|Study Director|Amgen Inc.|866-572-6436|
11251|NCT00887978|Kevin Laliberte, PharmD|United Therapeutics Corporation|919-425-8350|klaliberte@unither.com
11252|NCT00888238|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
11253|NCT00888329|Javier Magrina MD|Mayo Clinic|480-301-8000|magrina.javier@mayo.edu
11254|NCT00888355|Executive Vice President, Clinical and Quantitative Sciences|Merck & Co., Inc.|1-800-672-6372|
11255|NCT00942851|Codrin Lungu, MD|Office of the Clinical Director, NINDS, NIH|301-496-5295|lunguci@ninds.nih.gov
11256|NCT00942903|Prof. Dr. F.J.M. Hilgers|The Netherlands Cancer Institute|+31-20-5122550|f.hilgers@nki.nl
11257|NCT00942994|Study Director|Novartis Pharmaceuticals|862-778-8300|
11258|NCT00943072|Clinical Trials Administrator|Regeneron Pharmaceuticals|914 847 5385|clinicaltrials@regeneron.com
11259|NCT00943098|Barbara Gugliotta, Clincial Research Manager|IBSA Institut Biochimique|+41 58 360 10 00|barbara.gugliotta@ibsa.ch
10135|NCT01199744|GSK Response Center|GlaxoSmithKline|866-435-7343|
10136|NCT01199861|Study Director|Novartis Pharmaceuticals|862-778-8300|
10137|NCT01199939|SENIOR MEDICAL DIRECTOR|Janssen Pharmaceuticals|1 609 730-2931|
10251|NCT01178385|Dr. Eric Storch|University of South Florida|727-767-8230|estorch@health.usf.edu
10252|NCT01178762|Yan-Ming Chen / Yu-Chih Hou|National Taiwan University Hospital|886-2-2312-3456 ext 62131|louice1070@gmail.com
10253|NCT01178827|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
10254|NCT00938457|Dr. Robert C. Miller|Mayo Clinic|507-284-2669|miller.robert@mayo.edu
10255|NCT00938548|Dr. So Yeon Kim|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|82-2-2227-3642|kimsy326@hanmail.net
10256|NCT00938639|Clinical Trial Disclosure Manager|CSL Limited|Use email contact|csl.clinicaltrials@csl.com.au
10257|NCT00938704|Vice President Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
10258|NCT00938717|Doug Levine, MD|Ironwood Pharmaceuticals|617.374.3906|dlevine@ironwoodpharma.com
10259|NCT00938860|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
10260|NCT00939003|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
10261|NCT00939029|Dr. Jon Ebbert|Mayo Clinic|507-284-4736|ebbert.jon@mayo.edu
10262|NCT00939055|Senior Director Clinical Affairs|EndoGastric Solutions|650-823-9093|gsahyun@endogastricsolutions.com
10263|NCT00939094|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
10264|NCT00939107|Tom Petersen|Back and Rehabilitation Center Copenhagen|+45 35304974|tom.petersen@suf.kk.dk
10265|NCT00939185|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
10266|NCT00992459|Tristen Moors-Associate Director, Clinical Operations|Hyperion Therapeutics|650-745-7840|tristen.moors@hyperiontx.com
10267|NCT00992589|PORTFOLIO/CDT LEADER|Janssen R&D US|1 609 730-2548|
10539|NCT01313039|Judith Hurley MD|University of Miami Sylvester Comprehensive Cancer Center|305-243-6462|JHurley@med.miami.edu
10540|NCT01313078|Elise Kohn, M.D.|National Cancer Institute, National Institutes of Health|301-496-9336|kohne@mail.nih.gov
10541|NCT01313182|Dr. Michael Phillips|New York University School of Medicine|212 263 4316|michael.phillips@nyumc.org
10542|NCT01313208|Study Director|Amgen Inc.|866-572-6436|
10543|NCT01313221|Study Director|Amgen Inc.|866-572-6436|
10544|NCT01313494|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
10545|NCT01313520|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
10546|NCT01313624|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
10547|NCT01313637|GSK Response Center|GlaxoSmithKline|866-435-7343|
10548|NCT01313650|GSK Response Center|GlaxoSmithKline|866-435-7343|
10549|NCT01313663|GSK Response Center|GlaxoSmithKline|866-435-7343|
10550|NCT01313728|David Lineberry, Associate Director, Clinical Operations|Valeant Pharmaceuticals International Inc|949-973-1153|David.Lineberry@valeant.com
10551|NCT01314014|Paul M. Barr, MD|James P. Wilmot Cancer Center, University of Rochester|585-273-3258|Paul_Barr@urmc.rochester.edu
10552|NCT01314417|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|National Institutes of Health|301-402-3254|senh@nei.nih.gov
10553|NCT01314443|Richard Bruno, PhD, RD|Ohio State University|614-292-5522|bruno.27@osu.edu
10554|NCT01314703|Jennifer Raeder-Devens|CareFusion|847-454-4939|jennifer.raeder-devens@carefusion.com
10555|NCT01314716|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
10556|NCT01332461|GSK Response Center|GlaxoSmithKline|866-435-7343|
10557|NCT01332487|GSK Response Center|GlaxoSmithKline|866-435-7343|
10558|NCT01332500|GSK Response Center|GlaxoSmithKline|866-435-7343|
10762|NCT01100658|Alicia Kunin-Batson|Masonic Cancer Center, University of Minnesota|612-624-6931|kunin003@umn.edu
10763|NCT01100762|Gad Alon, PhD, PT|University of Maryland, Baltimore|410-706-7733|galon@som.umaryland.edu
10764|NCT01100853|Dr. Helen Pettinati|University of Pennsylvania|215-222-3200 ext 139|helenp@mail.med.upenn.edu
10765|NCT01100931|Dr. Giuseppe Giaccone|National Cancer Institute, National Institutes of Health|301-496-4916|giacconeg@mail.nih.gov
10766|NCT01101022|Study Physician|Shire Pharmaceutical|1 866-842-5335|
10767|NCT01101165|Stephen Harris, MD|Purdue Pharma L.P.|203-588-7592|Stephen.Harris@Pharma.com
10768|NCT01101178|Clinical Leader|Purdue Pharma L.P.|800-733-1333|
10769|NCT01165996|Yogen Saunthararajah, MD|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|216-444-8170|saunthy@ccf.org
10770|NCT01166126|Ragini Kudchadkar, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-8581|ragini.kudchadkar@moffitt.org
10771|NCT01166178|Study Director|Novartis|41 61 324 1111|
10772|NCT01166230|H. Barton Grossman, MD|The University of Texas|713-563-7456|hbgrossman@mdanderson.org
10773|NCT01166750|Michael A. Rapoff, PhD., Principal Investigator|University of Kansas Medical Center|913-588-6323|mrapoff@kumc.edu
10774|NCT01166763|Bruce F. Kimler, Ph.D.|University of Kansas Medical Center|913-588-4523|bkimler@kumc.edu
10955|NCT00951561|Charles Tepper|Another Way Products|917-538-6894|charles_tepper@yahoo.com
10956|NCT00951808|Hae-Young Kim|New England Research Institutes|617-972-3251|hkim@nerisicence.com
10957|NCT00951899|Dr. Adrian Vella|Mayo Clinic|507-284-3289|vella.adrian@mayo.edu
10958|NCT00951912|Dr. Yan-bin Ye|the First Affiliated Hospital of Sun Yat-sen University|8620-87755766 ext 8179|yanbinye72@163.com
10959|NCT00952068|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
10960|NCT00952081|Alex Bekker, MD, PhD|UMDNJ|973-972-5007|bekkeray@umdnj.edu
10961|NCT00952133|Jeanna Blitz, MD|NYU Langone Medical Center|212-263 ext 0667|jeanna.viola@nyumc.org
11260|NCT00943111|Trial Transparency Team|Sanofi||Contact-us@sanofi.com
11261|NCT00943124|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
11262|NCT00943150|Robert Swain, PhD|Medtronic Surgical Technologies|(+1-603) 294-5428|robert.e.swain@medtronic.com
11263|NCT00943202|Sharon E. Frey, M.D.|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|314-977-5500|freyse@slu.edu
11264|NCT00943397|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
11265|NCT00943436|Emily Jokisch|Healthy Eating and Activity Laboratory- University of Tenneessee|865-974-0754|ejokisch@utk.edu
11266|NCT00943488|Patricia Winokur, MD|Carver College of Medicine, University of Iowa|319-384-1735|patricia-winokur@uiowa.edu
11267|NCT00943579|Glen R. Elliott, Ph.D., MD|Children's Health Council|650.688.3649|gelliott@chconline.org
11268|NCT00952484|Alexion Pharma International Sàrl|Alexion Pharma International Sàrl||ClinicalTrials@alxn.com
11269|NCT00952523|David Lineberry, Associate Director, Clinical Operations|Valeant Pharmaceuticals International Inc|949-973-1153|David.Lineberry@valeant.com
11270|NCT00952588|James J. Armbrust|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
11271|NCT00952614|Glenn J. Jaffe, MD|Duke University Medical Center|919-684-4458|jaffe001@mc.duke.edu
10865|NCT01167582|Jeffrey Carson|Rutgers University|732-235-7122|jeffrey.carson@rutgers.edu
10866|NCT01167608|Dr. Roseanne Dobkin, Associate Professor of Psychiatry|Rutgers-Robert Wood Johnson Medical School|732-235-4051|dobkinro@rutgers.edu
10867|NCT01167829|John Amory, MD|University of Washington, Dept. of Medicine|(206) 616-1727|jamory@u.washington.edu
10868|NCT01167881|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10869|NCT01168427|RIO Clinical Research Specialist.|Medtronic - CRDM|1-800-328-2518 ext 63277|MedtronicCRMtrials@medtronic.com
10870|NCT01168596|Irene A. Malaty, MD|University of Florida Center for Movement Disorders and Neurorestoration|352-273-5550|Irene.Malaty@neurology.ufl.edu
10871|NCT01168687|Jennifer Mitchell, Clinical Project Director|Ernest Gallo Clinic and Research Center, UCSF|510-985-3100|jmitchell@gallo.ucsf.edu
10371|NCT00994422|Medical Director|Sanofi Topaz||RegistryContactUs@sanofipasteur.com
10372|NCT00994448|Keith Heinzerling MD|UCLA|310-794-0619|KHeinzerling@mednet.ucla.edu
10373|NCT00994461|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10374|NCT00994760|Medical Responsible|Nycomed Deutschland GmbH|+49 7531 3666 ext 0|clinicaltrials@nycomed.com
10375|NCT00995020|Investigator: MJCamargo [Camargo Maria José]    Official Title: PHD|Affiliation: Oswaldo Cruz Foundation|00552199777009|mariaj.camargo@hotmail.com
10376|NCT00995085|Jonathan Rubin, MD, MBA|Alcobra Inc|610-504-7814|jrubin@alcobra-pharma.com
10377|NCT00995345|Dr. Diane Plotkin, Sr. Director Clinical Development|ActivX Biosciences|858-558-5558|dianep@activx.com
10378|NCT00995371|Lois A. Davis|Coastal Orthopedics & Sports Medicine|941-782-1353|ldavis@coastalorthopedics.com
10379|NCT00995449|Nestor A. Molfino, MD., MSc|KaloBios Pharmaceuticals, Inc.|650-243-3103|nmolfino@kalobios.com
10380|NCT00995488|Dr. Maha Hussain|University of Michigan Comprehensive Cancer Center|734-647-8903|mahahuss@umich.edu
10381|NCT00995566|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10382|NCT00995761|Gyeong-Won Lee M.D.Ph.D.|Gyeongsang National University Hospital|82-55-750-8066|brightree@lycos.co.kr
10383|NCT00995774|Peter Lum, PhD|Washington DC Veterans Affairs Medical Center|202-319-5181|lum@cua.edu
10384|NCT00995904|VP, Scientific Affairs|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|650-386-3100|dkellerman@mappharma.com
10385|NCT01058993|David D. Dale, MD|University of Washington|206-543-7215|dcdale@u.washington.edu
10386|NCT01059565|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
9978|NCT00555620|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9979|NCT00555672|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9980|NCT01118845|Toshihiko Nagase|Symbio Pharmaceuticals|81-3-5472-1127|tnagase.331@symbiopharma.com
10559|NCT01332721|Dr Charles Theuer|TRACON Pharmaceuticals|8585500780 ext 233|ctheuer@traconpharma.com
10560|NCT01333436|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10561|NCT01333722|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
10562|NCT01333813|GSK Response Center|GlaxoSmithKline|866-435-7343|
10563|NCT01334229|Dr. Patrick Couture MD, PhD, FRCP|Laval University|418-654-2106|patrick.couture@crchul.ulaval.ca
10564|NCT01334606|Laurence J. Hirsch.  Medical Director|BD Medical - Diabetes Care|201-847-6513|laurence_hirsch@bd.com
10565|NCT01334710|Dr. Bassel El-Rayes|Emory University|404-778-1900|belraye@emory.edu
10566|NCT01334723|GSK Response Center|GlaxoSmithKline|866-435-7343|
10567|NCT01334866|Kristin Lawman|Medtronic, Inc.|763-514-9809|kristin.j.lawman@medtronic.com
10568|NCT01334918|Senior Medical Director, Medical Affairs|Astellas Scientific and Medical Affairs, Inc. / Astellas Pharma Global Development, Inc.||ClinicalTrials.Disclosure@us.astellas.com
10569|NCT01334944|Dr. Amy Rock|Cumberland Pharmaceutical Inc.|615-255-0068|arock@cumberlandpharma.com
10570|NCT01334957|Dr. Amy Rock|Cumberland Pharmaceuticals Inc.|615-255-0068|arock@cumberlandpharma.com
10571|NCT01335191|Dr. Gideon Goldstein|Thymon LLC|(973) 467-9558|gidgold@gmail.com
10572|NCT01335230|Mohamed Tarek M. shata|University of Cincinnati, Associate Prof., PI.|(513) 558-6110|mohamed.shata@uc.edu
10573|NCT01335724|Clinical project Leader|Novartis Consumer Health|+41223635528|
10574|NCT01335750|Dr. Gary Andrasko, MS|Erdy/Searcy Group|(614) 459-3363|gandrask@columbus.rr.com
10575|NCT01335789|Aimee McRae-Clark, Pharm.D., BCPP|Medical University of South Carolina|843-792-5216|mcraeal@musc.edu
10576|NCT01336140|Rami Doukky|Rush University Medical center|312-942-4655|rami_doukky@rush.edu
10577|NCT01336569|Doug Hubatsch, Global Brand Medical Affairs Leader, Glaucoma|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
10578|NCT01336738|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10962|NCT00952276|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
10963|NCT00952289|Study Director|Incyte Corporation|855 463-3463|
10964|NCT00952341|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10965|NCT00952367|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10966|NCT00952419|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
10967|NCT01236001|UCB (Study Director)|UCB Clinical Trial Call Center|+1 887 822 9493|
10968|NCT01236053|GSK Response Center|GlaxoSmithKline|866-435-7343|
10969|NCT01236105|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
10970|NCT01236339|Arthur Scott / Clinical Study Manager|W.L. Gore and Associates, Inc.|623.234.5263|artscott@wlgore.com
10971|NCT01236378|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10972|NCT01237080|Mogens Ydemann|Department of Anaesthesiology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark|+4531155995|clinicaltrials@ydemann.dk
10973|NCT01237197|Aaron S. Kelly, Ph.D.|University of Minnesota|612-626-3492|kelly105@umn.edu
10974|NCT01237223|Study Director|Novartis Pharmaceuticals|862-778-8300|
10975|NCT01237301|Dr. Richard Bergenstal|International Diabetes Center|952-993-3796|richard.bergenstal@parknicollet.com
10976|NCT01237327|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10977|NCT01237340|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
11182|NCT01011153|Joanna Adrian, Director of Clinical Operatons and Medical Affairs|MELA Sciences, Inc.|914-591-3783 ext 732|adrian@melasciences.com
11183|NCT01011179|Dr. Jennifer Stinson|The Hospital for Sick Children|416-813-7654 ext 304514|jennifer.stinson@sickkids.ca
11184|NCT01011283|Erhan Berrack, M.D.|Eisai Inc.|888-422-4743|
11185|NCT01011309|Jill Ashman, MSc, Associate Director of Clinical Operations|IDRI|206-858-6041|jill.ashman@idri.org
10872|NCT01168934|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10873|NCT01168999|Dr. Joel Bialosky|University of Florida|352-273-8636|bialosky@phhp.ufl.edu
10874|NCT01169038|Wonder Drake|Vanderbilt University|615-322-2035|wonder.drake@vanderbilt.edu
10875|NCT01169103|Madhusmita Misra|Massachusetts General Hospital|617-724-5602|mmisra@partners.org
10876|NCT01169519|Dr. Kevin Hill|Duke University Medical Center|919-668-8305|kevin.hill@duke.edu
10877|NCT01169610|Mark A. Frye, MD|Mayo Clinic|507-255-9391|mfrye@mayo.edu
10878|NCT01169675|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10879|NCT01170091|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10880|NCT01170208|Dr. Richard Bergenstal|International Diabetes Center|952-993-3796|richard.bergenstal@parknicollet.com
10881|NCT01170221|Philippe Prokocimer, MD|Cubist Pharmaceuticals, Inc.|858-452-0370 ext 241|Philippe.Prokocimer@cubist.com
10882|NCT01170533|Dominick J. Angiolillo, MD, PhD|University of Florida-Jacksonville|904-244-3933|dominick.angiolillo@jax.ufl.edu
10883|NCT01170546|Shih-Wei Chou, MD, PhD|Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital|88633281200 ext 3846|h0711@ms13.hinet.net
10884|NCT01170598|Sara O'Neill|University Health Network|416-597-3422 ext 7860|o'neill.sara@torontorehab.on.ca
10885|NCT00988117|Dr. Bruce Miller|UCaliforniaSF|415-476-5569|bmiller@memory.ucsf.edu; kpossin@memory.ucsf.edu
10886|NCT00988143|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
11069|NCT00896051|Senior Director|Tibotec|+32 (0) 14 641 265|
11070|NCT00896168|Director of Medical Affairs|Xian-Janssen Pharmaceutical Ltd|(8610) 5821 8359|
11071|NCT00896233|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
11072|NCT00896337|Angela Schutt|Boston Scientific|763-494-2166|schutta@bsci.com
10238|NCT01177410|Vice President of Clinical Operations|Salix Pharmaceuticals, Inc.|919-862-1000|enoch.bortey@salix.com
10239|NCT01177553|Research Coordinator|University of South Florida|813-259-8680|obgynclinicalresearch@health.usf.edu
10240|NCT01177670|Edward Evantash, MD|Hologic, Inc.|508-263-8475|edward.evantash@hologic.com
10241|NCT01177722|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
10242|NCT01177800|Senior Therapeutic Area Physician|Beijing, China R&D|+86 010 58218358|
10243|NCT01177813|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10244|NCT01177943|Chief Medical Officer|Eli Lilly and Company|1-800-545-5979|
10245|NCT01177956|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
10246|NCT01177969|Dr. Eric Storch|University of South Florida|727-767-8230|estorch@health.usf.edu
10247|NCT01178099|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
10248|NCT01178125|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
10249|NCT01178138|W. Brooks Gentry, MD|University of Arkansas for Medical Sciences|501 686 6119|gentrywilliamb@uams.edu
10250|NCT01178281|Anne McClain|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
10364|NCT01250145|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
10365|NCT00993473|Trial Transparency Team|sanofi-aventis||Contact_US@sanofi.com
10366|NCT00993616|Melissa Leventhal|Gynecologic Oncology Group Statistical and Data Center|716-845-4030|mleventhal@gogstats.org
10367|NCT00993668|UCB Clinical Trial Call Center|UCB, Inc|+1 877 822 9493|
10368|NCT00993824|Roger Mazze PhD|International Diabetes Center|952-993-3796|rmazze@aol.com
10369|NCT00993915|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10370|NCT00994318|Medical Information|Vifor Pharma|41 58 851 8222|medinfo@viforpharma.com
10579|NCT01109056|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
10580|NCT01109147|Dr. Eric Fakra|Hopital Sainte Marguerite - APHM - Service du Pr. Azorin||eric.fakra@ap-hm.fr
10581|NCT01109173|Dana Sager, Clinical Manager Group Leader|Alcon Research|1-817-551-8603|dana.sager@alconlabs.com
10582|NCT01109316|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
10583|NCT01109381|Medical Director|Synergy Pharmaceuticals Pte Ltd|+64 9 522 4278|damian@pethica.net
10584|NCT01063595|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|Octapharma USA|201 604-1155|michael.eppolito@octapharma.com
10585|NCT00882557|Ed Campanaro/Vice President, Clinical Operations|Cubist Pharmaceuticals, Inc.|781-860-8318|ed.campanaro@cubist.com
10586|NCT00882778|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
10587|NCT00882908|Global Clinical Development Manager|Jan-Cil France||ClinicalTrialDisclosure@its.jnj.com
10588|NCT00882921|Arian Pano|Shire|+1 866 842 5335|
10589|NCT00883090|Clinical Trial Disclosure Manager|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
10590|NCT00883103|Oz Harmanli, MD|Baystate Medical Center|4137945608|oz.harmanli@baystatehealth.org
10591|NCT00883116|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
10592|NCT00883168|David Ginsberg,D.O.|Meda Pharmaceuticals, Inc.|732 564-2364|david.ginsberg@meda.us
10593|NCT00883233|Jean-Charles Dhuin|Galderma|+33492952921|jean-charles.dhuin@galderma.com
10594|NCT00883337|Trial Transparency Team|sanofi-aventis||Contact_US@sanofi.com
10595|NCT00883389|Dr. Jeffrey C. Fink, Associate Professor, Nephrology|University of Maryland, School of Medicine|410-328-5720|jfink@medicine.umaryland.edu
10596|NCT00883493|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
10597|NCT00883558|Vice President, Endocrinology Clinical Development|Halozyme Therapeutics, Inc.|858-794-8889|
10598|NCT00883675|Michael Mann, MD|Maestro|650-380-9579|michael.mann@ucsfmedctr.org
11186|NCT01321749|Xunming Ji, M.D.,Ph.D.|XuanWu Hospital, Capital Medical University|8683198127|jixm70@hotmail.com , Jixm@ccmu.edu.cn
11187|NCT01322360|Anton (Tony) Amann, PhD, Executive Director, Drug Regulatory and Medical Affairs|Roxane Laboratories, Inc|614-272-4785|Tony.Amann@boehringer-ingelheim.com
11188|NCT01322594|Ed Piper|MedImmune, Limited|+44 (0) 1223 471 471|pipered@medimmune.com
11189|NCT01322633|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11190|NCT01322945|Andrew S. Little, MD|Barrow Neurological Institute|602-406-3181|heidi.jahnke@dignityhealth.org
11191|NCT01323140|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|Watson Laboratories, Inc.|801-588-6641|gary.hoel@watson.com
11192|NCT01323192|Medical Director|Janssen Pharm KK Japan|+81-3-4411-5509|
11193|NCT01323478|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
11194|NCT01323595|Chairman, Department of Urology|Weill Cornell Medical College|212 746-5491|pnschleg@med.cornell.edu
11195|NCT01323621|GSK Response Center|GlaxoSmithKline|866-435-7343|
11196|NCT01323634|GSK Response Center|GlaxoSmithKline|866-435-7343|
11197|NCT01323660|GSK Response Center|GlaxoSmithKline|866-435-7343|
11198|NCT01323673|GSK Response Center|GlaxoSmithKline|866-435-7343|
11199|NCT01323920|Dr. John Koreth|Dana Farber Cancer Institute|617-632-2949|John_Koreth@dfci.harvard.edu
11200|NCT01323998|GSK Response Center|GlaxoSmithKline|866-435-7343|
11201|NCT01324128|Medical Information|Vifor Pharma|41 58 851 8222|medinfo@viforpharma.com
11202|NCT01101191|Stephen Harris, MD|Purdue Pharma L.P.|203-588-7592|Stephen.Harris@Pharma.com
11203|NCT01101308|Stephen Harris, MD|Purdue Pharma L.P.|203-588-7592|Stephen.Harris@Pharma.com
11204|NCT01101321|Clinical Leader|Purdue Pharma L.P.|800-733-1333|
10775|NCT01166958|Neil Binkley, MD|University of Wisconsin Osteoporosis Clinical Research Program|608-265-6410|uwosteoporosis@gmail.com
11073|NCT00897104|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
11074|NCT00897390|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
11075|NCT00897897|Director, Clinical and Regulatory Affairs|Philips Healthcare|425-487-7665|sarah.baxter@philips.com
11076|NCT01240746|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
11077|NCT01240811|Sharon Achilles, MD, PhD|University of Pittsburgh|412-641-1403|achisx@upmc.edu
11078|NCT01241240|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11079|NCT01241539|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11080|NCT01241565|Noreen Fahey|Covidien|203-821-4716|noreen.fahey@covidien.com
11081|NCT01241591|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11082|NCT01241760|Compound Development Team Leader|Janssen Infectious Diseases BVBA|32 14 64 13 70|
11083|NCT01241903|Dr. Susan S. Smyth|University of Kentucky|(859) 323-2274|ssmyt2@uky.edu
11084|NCT01318070|General Manager|Japan Development Center, Pharmaceutical Development Division|+81-6-6204-5257|clinicaltrialregistry@tpna.com
11085|NCT01318083|General Manager|Japan Development Center, Pharmaceutical Development Division|+81-6-6204-5257|clinicaltrialregistry@tpna.com
11086|NCT01318109|General Manager|Japan Development Center, Pharmaceutical Development Division|+81-6-6204-5257|clinicaltrialregistry@tpna.com
11087|NCT01318122|General Manager|Japan Development Center, Pharmaceutical Development Division|+81-6-6204-5257|clinicaltrialregistry@tpna.com
11088|NCT01318135|General Manager|Japan Development Center, Pharmaceutical Development Division|+81-6-6204-5257|clinicaltrialregistry@tpna.com
11089|NCT01318382|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
11090|NCT01318499|Dana Sager, Clinical Manager Group Leader|Alcon Research|1-817-551-8603|dana.sager@alconlabs.com
11317|NCT01105247|Danelle James|Pharmacyclics|855-427-8846|medinfo@pcyc.com
10268|NCT00992719|Geeta K. Swamy, M.D.|Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, Duke University School of Medicine|919-681-5220|geeta.swamy@duke.edu
10269|NCT00992784|GSK Response Center|GlaxoSmithKline|866-435-7343|
10270|NCT00992836|Melissa Allen, Director, IMPAACT Operations Center|Family Health International (FHI 360)|919-405-1429|mallen@fhi360.org
10271|NCT00992927|Sun Gun Chung/Professer|Seoul National University Hospital|+82-2-2072-3954|suncg@snu.ac.kr
10272|NCT00992992|GSK Response Center|GlaxoSmithKline|866-435-7343|
10387|NCT01059617|GSK Response Center|GlaxoSmithKline|866-435-7343|
10388|NCT01059773|EMEA THERAPEUTIC AREA LEADER|Janssen-Cilag France|+33 6 15167408|
10389|NCT01059851|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10390|NCT01059864|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10391|NCT01059903|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
10392|NCT01005602|Dr. Robert J. DiDomenico|University of Illinois at Chicago|(312) 413-4654|rdidom1@uic.edu
10393|NCT01005680|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
10394|NCT01005719|Vice President of Late Stage Development|Merck, Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
10395|NCT01005732|Loren Engrav|University of Washington|206-744-3209|engrav@u.washington.edu
10396|NCT01005745|Amod Sarnaik, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-8581|amod.sarnaik@moffitt.org
10397|NCT01005875|Dr. Kimberly Keene|University of Alabama at Birmingham|2-5-934-5670|kkeene@uab.edu
10398|NCT01005888|Chief Scientific Officer|ViroPharma|610-458-7300|
10399|NCT01005901|Study Director|Novartis Pharmaceuticals|862-778-8300|
10400|NCT01005966|GSK Response Center|GlaxoSmithKline|866-435-7343|
10401|NCT01092923|Dr Phil Peyton|Austin Health|9496 5000 ext 5704|phil.peyton@austinhealth.org.au
10599|NCT00883740|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10600|NCT00883753|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
10601|NCT00884039|Marianne Price, PhD|Cornea Research Foundation of America|317-814-2990|mprice@cornea.org
10602|NCT00884065|Martín Eusebio Barra López|Catalan Institut of Health - Servei de Rhb Sant Ildefons||martinbarra@gmail.com
10603|NCT00884221|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
10604|NCT00884273|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
10605|NCT00884325|Leon H. Kircik, M.D.|DermResearch, PLLC|502-451-9000|wedoderm@yahoo.com
10606|NCT00884390|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10607|NCT00884585|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
10608|NCT00884754|Philip Jones|London Health Sciences Centre|519-685-8500 ext 36306|philip.jones@lhsc.on.ca
10609|NCT00884793|Steven Yukl|UCSF|415-221-4810 ext 3930|steven.yukl@ucsf.edu
10610|NCT00884806|Director of Alcon Clinical|Alcon Research, Ltd.|1-888-451-3937|medinfo@alconlabs.com
10611|NCT00884832|Dr. Adil E. Bharucha|Mayo Clinic|507-266-9156|bharucha.adil@mayo.edu
10612|NCT00894127|Maria Zannes|bioAffinity|505-400-9747|mz@bioaffinitytech.com
10613|NCT00894166|Jed E. Rose, Ph.D.|Duke University Medical Center|919-668-5055|jed.rose@duke.edu
10614|NCT00894244|Dr. Murad Alam|Northwestern University|(312) 695-6785|m-alam@northwestern.edu
10615|NCT00894322|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
10616|NCT00894361|Terence J. Gioe, M.D.|Minneapolis Veterans Affairs Medical Center (VAMC)|612-467-1780|tjgioe@gmail.com
10617|NCT00894387|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
10618|NCT00894517|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
10776|NCT01166971|Director of Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
10777|NCT01113580|Clinical Trial Disclosure Manager|CSL Limited|Use email contact|csl.clinicaltrials@csl.com.au
10778|NCT01113710|UCB (Study Director)|UCB Clinical Trial Call Center|+1 887 822 9493|
10779|NCT01113749|Laura C. Hanson, MD, MPH|University of North Carolina Chapel Hill|9199665945|lhanson@med.unc.edu
10780|NCT00985985|GSK Response Center|GlaxoSmithKline|866-435-7343|
10781|NCT00986102|VP MEDICAL AFFAIRS ASIA PACIFIC|Jan-Cil Singapore|+65 6827 6753|
10782|NCT00986180|Vice President, Medical Affairs, Internal Medicine|Janssen Pharmaceuticals|1 908 218-7250|
10783|NCT00986232|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10784|NCT00986245|BS Jeon|Seoul National University Hospital|82-2-2072-2876|brain@snu.ac.kr
10785|NCT00986258|Dr. Ilona Steigerwald|Grünenthal GmbH|+49 241 569 3223|clinical-trials@grunenthal.com
10786|NCT00986362|Dr. Aniz Girach|ThromboGenics NV|+32 16751310|aniz.girach@thrombogenics.com
10787|NCT00986401|Vice President, Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
10788|NCT00986427|Julian Mackay-Wiggan, MD|Columbia University Dept of Dermatology|212-305-6953|jc299@columbia.edu
10789|NCT00986453|Robert Swain, PhD|Medtronic Surgical Technologies|+1 (603) 294-5428|robert.e.swain@medtronic.com
10790|NCT00986544|Marcello Picchio|Department of Surgery, Hospital “P. Colombo”, Via Orti Ginnetti 7, 00049 Velletri (Rome), Italy|+39696102228|marcellopicchio@libero.it
10791|NCT00986570|Priscilla Padilha, MD|Biolab Sanus Farmacêutica Ltda.|55(11)35736335|ppadilha@biolabfarma.com.br
10792|NCT00986674|Study Statistician|ECOG Statistical Office|617-632-3012|
10793|NCT00986856|Anders Rhod Larsen, Scientific advisor|LEO Pharma|+45 72262990|anders.larsen@leo-pharma.com
10794|NCT00986921|Director of Clinical Research|Boston University Department of Obstetrics and Gynecology|617-414-5175|rstudy@bmc.org
10795|NCT00986960|Dr. Robert Zivadinov|Buffalo Neuroimaging Analysis Center|716-859-7031|rzivadinov@bnac.net
11318|NCT01105377|Nilofer S. Azad, M.D.|Johns Hopkins Oncology Center||nazad2@jhmi.edu
11319|NCT01170663|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
11320|NCT01170884|Vice President, Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
11321|NCT01171612|Anna Rodriguez-Pont|Corporacion Sanitaria y Universitaria Parc Tauli|0034937231010 ext 21283|anna.r.pont@gmail.com
11322|NCT01171677|John Rotrosen|NYUMED|212 951 3294|john.rotrosen@nyumc.org
11323|NCT00934947|Samuel McLean|UNC Department of Anesthesiology|919-966-7315|smclean@aims.unc.edu
11324|NCT00935064|Dr. Raelene E. Maser|University of Delaware/Christiana Care Health System|302-831-8400|rmaser@udel.edu
11325|NCT00935220|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11326|NCT00935259|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11327|NCT00935272|Heather M Corey|Medicis Global Services|480-291-5981|hcorey@medicis.com
11328|NCT00935311|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
11329|NCT00935493|Christopher van Dyck|Yale University|203-764-8100|christopher.vandyck@yale.edu
11330|NCT00989014|Michael Graeber, MD|Galderma|609-860-8201|michael.graeber@galderma.com
11331|NCT00989092|Study Director|Amgen Inc.|866-572-6436|
11332|NCT00989157|Dr. James Roerig|NRIFargo|701 365 4919|jroerig@nrifargo.com
11333|NCT00989196|Dr. Sigurd Knaub|Octapharma AG|+41 554512141|sigurd.knaub@octapharma.com
11334|NCT00989235|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
11335|NCT00989664|GSK Response Center|GlaxoSmithKline|866-435-7343|
11336|NCT00989768|Juliana de Souza|Brazilian Center for Studies in Dermatology|+55 51 3026 2633|pesquisa@cebd.org.br
11337|NCT00989833|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
9981|NCT01118949|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
9982|NCT01118962|UCB (Study Director)|UCB Clinical Trial Call Center|+1 887 822 9493|
9983|NCT01118975|Michelle Medeiros|University of Maryland|410-328-1160|mmedeiros@umm.edu
9984|NCT01119040|Jeffrey Marks, MD/Principal Investigator|University Hospitals Case Medical Center|216-983-4930|jeffrey.marks@UHhospitals.org
9985|NCT01119118|Dr. Glenn Liu|University of Wisconsin Carbone Cancer Center|608-265-8689|gxl@medicine.wisc.edu
9986|NCT01119222|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9987|NCT01119287|Head, Alcon Clinical|Alcon Research|1-888-451-3937|
9988|NCT01119443|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9989|NCT01119625|GSK Response Center|GlaxoSmithKline|866-435-7343|
9990|NCT01119703|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9991|NCT01119716|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9992|NCT01119755|George S Stergiou, Associate Professor of Internal Medicine and Hypertension|Hypertension Center, Third Department of Medicine, University of Athens, Greece|+302107763117|gstergi@med.uoa.gr
9993|NCT01119768|Gerard Lynch|AstraZeneca||az_trials_posting@astrazeneca.com
9994|NCT01119859|Medical Communications|Hoffmann-La Roche|800 821-8590|
9995|NCT01119937|Study Director|Novartis Pharmaceuticals|862-778-8300|
9996|NCT01119950|Study Director|Novartis Pharmaceuticals|41 61 324 1111|
9997|NCT01120093|Clinical Project Leader and Trial Manager|Almirall S.A.|+34 93 291 3200|
9998|NCT01120197|Professor, Ph. D, Researcher. Astrid Bergland.|Faculty of Health Sciences, Oslo University College, Oslo, Norway|+4722452507|astrid.bergland@hf.hio.no
9999|NCT01120210|Senior Director Translational Medicine|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|858.320.3408|wradzisz@its.jnj.com
10619|NCT00894543|Dr. Ellen W. Freeman|University of Pennsylvania School of Medicine|215-349-5521|freemane@mail.med.upenn.edu
10620|NCT00894556|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
10621|NCT00894647|Vice President Medical Affairs|Graceway Pharmaceuticals|267-948-0400|Sharon.levy@gracewaypharma.com
10622|NCT00894699|Pamela Palmer, MD, PhD|AcelRx Pharmaceuticals, Inc.|650-216-3504|ppalmer@acelrx.com
10623|NCT00894790|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10624|NCT00894803|Dr Arthur Pancioli|University of Cincinnati|513-558-8087|arthur.pancioli@uc.edu
10625|NCT00895011|Wesley W Day, PhD|Vivus, Inc.|650-934-5200|medaffairs@vivus.com
10626|NCT00895193|Julie-Ann Dutton, MS, RD|University of Kansas Medical Center|(913) 588-4064|jdutton@kumc.edu
10627|NCT00895284|Dr. Rosanne Kho|Mayo Clinic|408-301-5811|kho.rosanne@mayo.edu
10628|NCT00895453|Armin Witt MD|Vienna Medical School|+43140400 ext 2821|armin.witt@meduniwien.ac.at
10629|NCT00895583|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10630|NCT00895817|Dr. Fouad J Moawad|Walter Reed Army Medical Center|(301) 295-4600|fouad.moawad@us.army.mil
10631|NCT00895830|Dr Gabriel Fox|Acacia Pharma Ltd||gabrielfox@acaciapharma.com
10632|NCT00895843|Mr Sin L Yong|University of Manchester|01612756806|sin.l.yong@manchester.ac.uk
10633|NCT00895895|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10634|NCT00895947|Martin J. Cummins|Amarillo Biosciences, Inc.|806-376-1741 ext 14|mcummins@amarbio.com
10635|NCT00896025|William M. Lee, MD|University of Texas Southwestern Medical Center|214-645-6111|william.lee@utsouthwestern.edu
10636|NCT00949715|Rachael Rose|Medtronic CRDM|763-526-2332|rachael.k.rose@medtronic.com
10637|NCT00949884|Robert Dubiel, PharmD|Daiichi Sankyo, Inc.|973-944-2963|bdubiel@dsi.com
10638|NCT00949975|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
10796|NCT00986986|Dominic Chow|University of Hawaii at Manoa|(808)737-2751|dominicc@hawaii.edu
10978|NCT01237353|Dr. Leslie Benet|University of California San Francisco|415-476-3853|leslie.benet@ucsf.edu
10979|NCT01238211|Guido Marcucci, M.D.|The Ohio State University||Guido.Marcucci@osumc.edu
10980|NCT01238471|Professor Imad Makhoul|Rambam Medical Center|972-4-8542219|makhoul@rambam.health.gov.il
10981|NCT01238640|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|Johnson & Johnson Consumer and Personal Products Worldwide|928-277-0715|jhaue@its.jnj.com
10982|NCT01238822|Jeff Epstein|Cincinnati Children's Hospital Medical Center||jeff.epstein@cchmc.org
10983|NCT01238848|Maria I. Espelt, MD|Hospital General de Niños Pedro de Elizalde|541146136968|cespelt@fibertel.com.ar
10984|NCT01239043|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
10985|NCT01239212|Dr. Stephanie Merhar|Cincinnati Children's Hospital Medical Center|513-636-4200|stephanie.merhar@cchmc.org
10986|NCT01239511|Melanie Huang|Sinphar Pharmaceutical Co., Ltd.|886-2-27603688 ext 2190|wthuang@sinphar.com.tw
10987|NCT01239680|Charles W. Van Way, III, M.D.|Truman Medical Center|816.235.2553|vanwayc@umkc.edu
10988|NCT01239745|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10989|NCT01239992|Klaus G. Parhofer|University Munich|+49-89-7095-3010|klaus.parhofer@med.uni-muenchen.de
10990|NCT01240122|Senior Manager, Clinical Research|Abbott Medical Optics|714.247.8723|eugenia.kao@amo.abbott.com
10991|NCT01240135|Director of Alcon Clinical|Alcon Research, Ltd.|1-888-451-3937|medinfo@alconlabs.com
10992|NCT01240330|Director of Quality Assurance & Operations|Venous Health Systems, Inc.|(650)646-3327 ext 104|rlaguna@venoushealth.com
10993|NCT01240382|General Manager of Clinical Development Group|Santen Pharmaceutical Co., Ltd.|+81-6-4802-9341|clinical@santen.co.jp
10994|NCT01052844|Felipe Melo Cruz|Faculdade de Medicina do ABC|+55+11+27595914|felipemcruz@yahoo.com.br
10995|NCT01052948|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11338|NCT00989950|Arie Ashkenasi, MD|CoxHealth|011 972 50 3007477|ashkenasi1@gmail.com
11339|NCT00989989|Study Director|Novartis Pharmaceuticals|41 61 324 1111|
11340|NCT00990093|Kristine Gjødsbøl, PhD|Coloplast|+4549113557|dkkg@coloplast.com
10887|NCT00988156|Director R&D|BIAL - Portela & Cª, S.A.|351-22-9866100|clinical.trials@bial.com
10888|NCT00988208|Senior Manager , Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
10889|NCT00988221|Medical Communications|Hoffman-La Roche|800 821-8590|
10890|NCT00988247|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
10891|NCT00988429|Head of Clinical Research|Bial - portela & Cª, S.A.|+351 22 986 6100|clinical.trials@bial.com
10892|NCT00988533|Medical Director|Sanofi Topaz||RegistryContactUs@sanofipasteur.com
10893|NCT00988637|Ronald W. Gottschalk, MD / Medical Dierctor|Galderma Laboratories, L.P.|817-961-5358|ron.gottschalk@galderma.com
10894|NCT00988832|Vice President, Late Stage Development Group Leader|Merck Sharp and Dohme Corp||ClinicalTrialsDisclosure@merck.com
10895|NCT01050530|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
10896|NCT01050543|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
10897|NCT01050569|Dorothy Hatsukami|University of Minnesota|612 626-2121|hatsu001@umn.edu
10898|NCT01050582|Clinical Leader|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|609-730-6581|
10899|NCT01050634|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10900|NCT01050673|Dr Robert D Galiano, Assistant Professor of Surgery|Northwestern Medical Faculty Foundation|312-695-6022|rgaliano@nmh.org
10901|NCT01050816|Lee Gyeong Tae|Eulji General Hospital|+82-11-214-3323|lkt2408@hanmail.net
10902|NCT01051440|Tara Lauriat|Steward St. Elizabeth's Medical Center|617-789-2404|tara.lauriat@steward.org
10903|NCT01051466|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
10115|NCT01186744|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10116|NCT01186848|Dr. Murad Alam|Northwestern University|312-695-4761|m-alam@northwestern.edu
10117|NCT01197755|Dave Goldstraw|AstraZeneca Pharmaceuticals|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
10118|NCT01197794|Alison Holt|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
10119|NCT01197833|David Wright MB FRCS|BTG International Inc|610-278-1660|david.wright@btgplc.com
10120|NCT01197898|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|Healthpoint, Ltd.|817-302-3914|jaime.dickerson@healthpoint.com
10121|NCT01198275|Dr. Savina Nodari|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|00390303996 ext 587|nodari@med.unibs.it
10122|NCT01198327|Peter Campocahiro|Wilmer Eye Institute|410-955-5106|pcampo@jhmi.edu
10123|NCT01198548|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
10124|NCT01198574|Dr. Min Kyaw Htet, Township Health Officer, Ministry of Health, Myanmar|South East Asia Ministers of Education Organization, Regional Center for Food and Nutrition|+62-857-27262672|kyawhtet@gmail.com
10125|NCT01198600|R. Alan Landers, O.D., M.S., F.A.A.O.|Alcon Research|1-800-241-7629|
10126|NCT01198691|Donna Lambers, MD|TriHealth|513-862-2828|donna_lambers@trihealth.com
10127|NCT01198756|GSK Response Center|GlaxoSmithKline|866-435-7343|
10128|NCT01198769|GSK Response Center|GlaxoSmithKline|866-435-7343|
10129|NCT01198795|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|Forest Research Institute|201-427-8000 ext 58124|carl.gommoll@frx.com
10130|NCT01198873|Trial Transparency Team|Sanofi||Contact_US@sanofi.com
10131|NCT01199237|Rachel Eshima McKay|University of California, San Francisco|415-502-1715|eshimar@anesthesia.ucsf.edu
10132|NCT01199471|Global Medical Services|Abbott|800-633-9110|
10133|NCT01199601|Dr. Catherine Todd|Columbia University|212-305-4805|cst2121@columbia.edu
10134|NCT01199705|Clinical Trial Disclosure Manager|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
10639|NCT00950599|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
10640|NCT01314742|Dr. Beatrice Stefanescu|Vanderbilt University Sch of Medicine|6159365933|beatrice.stefanescu@Vanderbilt.edu
10641|NCT01315028|Professor Andrew Gumley|University of Glasgow|0044 141 211 3927|andrew.gumley@glasgow.ac.uk
10642|NCT01315249|Study Director|Novartis|41 61 324 1111|
10643|NCT01316055|Herbert Henney, PharmD|Vice President - Clinical Development & Medical Affairs (CDMA)|(914) 347-4300 ext 5138|hhenney@acorda.com
10644|NCT01316315|Janice M. Troha|N30 Pharmaceuticals Inc.|720-945-7714|janice.troha@n30pharma.com
10645|NCT01316341|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage@boehringer-ingelheim.com
10646|NCT01316380|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10647|NCT01316575|Dr. William McKay|University of Saskatchewan|306-655-1202|william.mckay@saskatoonhealthregion.ca
10648|NCT01316887|GSK Response Center|GlaxoSmithKline|866-435-7343|
10649|NCT01316900|GSK Response Center|GlaxoSmithKline|866-435-7343|
10650|NCT01316913|GSK Response Center|GlaxoSmithKline|866-435-7343|
10651|NCT01316926|GSK Response Center|GlaxoSmithKline|866-435-7343|
10652|NCT01097863|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
10653|NCT01098071|Vice President, Late Stage Development Group Leader|Merck, Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
10654|NCT01098097|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
10655|NCT01098162|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
10656|NCT01098240|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10657|NCT01098253|Dr. Hillary R Bogner|University of Pennsylvania, Perelman School of Medicine|215-746-4181|hillary.bogner@uphs.upenn.edu
10658|NCT01098461|GSK Response Center|GlaxoSmithKline|866-435-7343|
10996|NCT01053078|Elizabeth Seaquist|University of Minnesota|612 624 9176|seaqu001@umn.edu
10997|NCT01053156|Randi J. Hagerman MD, Medical Director of the MIND Institute|MIND Institute, University of California Davis Medical Center|916-703-0247|randi.hagerman@ucdmc.ucdavis.edu
10998|NCT01053312|Paul Sherwin, MD|GE Healthcare|1-609-514-6820|paulsherwin@ge.com
10999|NCT01053429|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11205|NCT01101464|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
11206|NCT01101477|Dr. Ting-Yu Lin|Chang Gung Memorial Hospital|886 3 3281200 ext 5108|yuebaoyuebao@yahoo.com.tw
11207|NCT01101542|GSK Response Center|GlaxoSmithKline|866-435-7343|
11208|NCT01101841|Sailaja Bhaskar, Executive Director, Clinical Research|Noven Therapeutics, LLC|(212) 287-0798|sbhaskar@noven.com
11209|NCT01101867|Dr. Kathleen Dungan|The Ohio State University|614-685-3333|kathleen.dungan@osumc.edu
11210|NCT01101958|Prof. Dr. F.J.F. Herth|ThoraxKlinik, University of Heidelberg|650-216-0176|Felix.Herth@thoraxklinik-heidelberg.de
11211|NCT01102218|Christina Kahn, Senior Manager of Clinical Trials|Fresenius Medical Care North America|615-345-5542|christina.meng@fmc-na.com
11212|NCT01102257|Dr. Penny Asbell|Mount Sinai School of Medicine|(212) 241-7977|penny.asbell@mssm.edu
11213|NCT01102491|TK Kim|Joint Reconstruction Center, Seoul National University Bundang Hospital|82-31-787-7196|osktk@snubh.org
11214|NCT00932022|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11215|NCT00932126|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11216|NCT00932165|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
11217|NCT00932321|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
11218|NCT00932477|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
11219|NCT00932620|Prof Moses Elisaf|University of Ioannina|+302651007509|egepi@cc.uoi.gr
10904|NCT01051570|Ulka N. Vaishampayan, M.D.|Barbara Ann Karmanos Cancer Institute|313-576-8718|vaishamu@karmanos.org
10905|NCT01051778|Usama .M .Fouda|Cairo university|+20123595106|umfrfouda@yahoo.com
10906|NCT01051921|Vice President, Clinical Development|Conatus Pharmaceuticals Inc.|(858) 457- 7227|MHuyghe@conatuspharma.com
10907|NCT01051986|Ki-Bong Kim|Seoul National University Hospital|+82-2-2072-3482|kimkb@snu.ac.kr
10908|NCT01052038|Dr. Robert J. McCarthy|Northwestern University Feinberg School of Medicine|312-926-9015|r-mccarthy@northwestern.edu
10909|NCT01052207|Dr. Kiran Hebbar|CHOA/Emory|404-785-6135|khebbar@emory.edu
11091|NCT01318733|Michael Graeber, MD|Galderma|609-860-8201|michael.graeber@galderma.com
11092|NCT01318876|Gaston De Serres|Laval University|418-666-7000 ext 274|gaston.deserres@ssss.gouv.qc.ca
11093|NCT01319318|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11094|NCT01319396|Paul Phillips|BiancaMed Ltd|+353 1 716 3755|paul.phillips@biancamed.com
11095|NCT01319500|Dr Juergen Dinger|Center for Epidemiology and Health Research Berlin|+49 (0)30 945 10145|dinger@zeg-berlin.de
11096|NCT01319617|Felipe Medeiros|UCSD|858 82245-92|fmedeiros@glaucoma.ucsd.edu
11097|NCT01319773|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
11098|NCT01320826|Dr. Michael Kolber|University of Alberta|(780) 616-8411|mkolber@ualberta.ca
11099|NCT01321008|Bouthaina Dabaja, MD / Associate Professor, Radiation Oncology|University of Texas MD Anderson Cancer Center|713-563-2300|CR_Study_Registration@mdanderson.org
11100|NCT01321697|Sandy Annis|University of Arkansas for Medical Sciences|5016868274|amannis@uams.edu
11101|NCT01321710|Kathryn Lee, RN, PhD|University of California, San Francisco|415-476-4442|kathryn.lee@nursing.ucsf.edu
11102|NCT01321723|Nozer Mehta, PhD.  Chief Scientific Officer|Unigene Laboratories, Inc.|(973) 265-1100|nmehta@unigene.com
11103|NCT00874887|Vice President, Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
11104|NCT00875017|Gerald Tremblay, M.D.|Shire Pharmaceutical||gtremblay@shire.com
6288|NCT00519194|Sue Walgren, Manager Sr.,  Clinical Project|St. Jude Medical|6517563210|swalgren@sjm.com
6289|NCT00519285|Trial Transparency Team|Sanofi||Contact-Us@sanofi.com
6290|NCT00519376|GSK Response Center|GlaxoSmithKline|866-435-7343|
6291|NCT00519532|UCB Clinical Trial Call Center|UCB|+18778229493|
6292|NCT00564265|Dr. Marcelo A. Beltran|Hospital de La Serena|56 - 51 - 485923|beltran_01@yahoo.com
6293|NCT00564447|Director of Clinical Research|Inspire Pharmaceuticals, Inc.|010-941-9777|kkuhn@inspirepharm.com
6294|NCT00564486|Mike Royal, MD, JD, MBA.Vice President Clinical Development- Analgesics|Cadence Pharmaceuticals, Inc.|858-436-1400|mroyal@cadencepharm.com
6295|NCT00564629|Mike Royal, MD, JD, MBA. Vice President Clinical Development- Analgesics|Cadence Pharmaceuticals|858-436-1400|mroyal@cadencepharm.com
6296|NCT00564681|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
6297|NCT00564850|Medical Director, Endocrinology|Ipsen||clinical.trials@ipsen.com
6298|NCT00564876|Neal Ready, MD|Duke University Medical Center|919-668-6688|neal.ready@duke.edu
6299|NCT00564889|Dr. Shaji Kumar|Mayo Clinic||kumar.shaji@mayo.edu
6300|NCT00564902|Dr. Stuart P. Richer|James A. Lovell Federal Health Care Center|224-610-5440|Stuart.Richer1@va.gov
6301|NCT00564954|Study Director|Novartis Pharmaceuticals|862-778-8300|
6302|NCT00565045|Dr. Jayme Knutson|MetroHealth Medical Center|216-778-8364|jsk12@case.edu
6303|NCT00565084|Senior Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
6304|NCT00565136|Paul Below, Clinical Trial Manager|American Medical Systems|952-930-6089|paul.below@ammd.com
6305|NCT00565266|Vernon M. Chinchilli, PhD|Penn State Hershey College of Medicine|717-531-4262|vchinchi@psu.edu
6306|NCT00565448|International Clinical Development, Clinical Study Director|sanofi-aventis||GV-Contact-us@sanofi-aventis.com
6307|NCT00811252|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
10659|NCT01098500|GSK Response Center|GlaxoSmithKline|866-435-7343|
10660|NCT01098539|GSK Response Center|GlaxoSmithKline|866-435-7343|
10661|NCT01098747|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10662|NCT01098812|Kristen Featherstone|Abbott Medical Optics|714-247-8621|kristen.featherstone@amo.abbott.com
10663|NCT01098851|Fran Haury|Covidien|303 305-2314|fran.haury@covidien.com
10664|NCT01099111|Dr. Ahmed Al Omair|KFMC|+96612889999 ext 8771|aalomair@kfmc.med.sa
10665|NCT01099202|Jorge Cortes M.D./Professor|The University of Texas M. D. Anderson Cancer Center|713/794-5783|eharriso@mdanderson.org
10666|NCT01099215|Eric Goldberg, MD, Sr. Medical Director|Shire Regenerative Medicine|(858) 754-5705|egoldberg@shire.com
10667|NCT01099267|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
10668|NCT01109524|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
10669|NCT01109979|Ellen Seely, MD|Brigham and Women's Hospital|617-732-5012|eseely@partners.org
10670|NCT01110187|Jerzy P. Szaflarski, MD|University of Alabama at Birmingham|205-934-3866|szaflaj@uab.edu
10671|NCT01110200|GSK Response Center|GlaxoSmithKline|866-435-7343|
10672|NCT01110239|Sebastian Koch|University Miami|305 243-6733|skoch@med.miami.edu
10673|NCT01110252|João Tadeu Ribeiro Paes|Labcel|55 18 3302 5800 ext 5856|labcel.tronco@gmail.com
10674|NCT01110330|Director Infectious Diseases|Jan-Cil Switzerland|41 41 7673477|
10675|NCT01110382|Therapeutic Areas Director|Janssen R&D US||ClinicalTrialDisclosure@its.jnj.com
10676|NCT01110408|Therapeutic Areas Director|Janssen R&D US||ClinicalTrialDisclosure@its.jnj.com
10677|NCT01110421|Therapeutic Areas Director|Janssen R&D US||ClinicalTrialDisclosure@its.jnj.com
10678|NCT01110499|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11220|NCT00932646|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11221|NCT00932659|Patrick Pun, MD, MHS|Duke University|919-660-6865|patrick.pun@duke.edu
11222|NCT00932893|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11223|NCT00933166|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
11224|NCT00933335|GSK Response Center|GlaxoSmithKline|866-435-7343|
11225|NCT00933543|Project director Per Fuglerud|Photocure|+47 22 06 16 54|pf@photocure.no
11226|NCT00933686|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merck.de
10797|NCT00987337|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10798|NCT00987402|Stephan Harbarth MD|University Hospital, Geneva|+41-22-372.3357|stephan.harbarth@hcuge.ch
10799|NCT00987467|Dr.Esen Akpek, MD. Associate professor of ophthalmology Wilmer eye institute|Johns Hopkins University, Wilmer Eye Institute|410-955-5214|esakpek@jhmi.edu
10800|NCT00987623|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
10801|NCT00987727|Vice President Medical Affairs|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
10802|NCT00988065|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
10803|NCT00988091|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
10804|NCT00940537|Gary Skolnick|Washington University School of Medicine|314-362-5292|gskolnic@wustl.edu
10805|NCT00940927|Kathryn Blake, Pharm.D.|Nemours Children's Clinic|904 858 3806|kblake@nemours.org
10806|NCT00941070|Dr. Charles Kunos|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|330-375-4485|kunosc@summahealth.org
10807|NCT00941655|Dr. Udo Rudloff|National Cancer Institute, National Institutes of Health|301-496-3098|Udo.Rudloff@nih.gov
10808|NCT00941668|Willliam DeVizio-DMD|Colgate Palmolive|732-878-7901|William_DeVizio@colpal.com
11105|NCT00875212|Fabio Correia Sampaio  (research leader)|Federal University of Paraiba|+55 83 3216 7795|fabios@ccs.ufpb.br
11106|NCT00875394|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
11107|NCT00875420|Program Director|Radius Health, Inc.|(617) 551-4700|info@radiuspharm.com
11108|NCT00875433|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11109|NCT00875485|GSK Response Center|GlaxoSmithKline|866-435-7343|
11110|NCT00875615|Lynn Feun MD|University of Miami Sylvester Comprehensive Cancer Center|305-243-4981|lfeun@med.miami.edu
11111|NCT00875797|Lidija Kompan, principal Investigator|UMCLjubljana|0038651301781|lidija.kompan@gmail.com
11112|NCT00875979|Medical Communications|Hoffmann-La Roche|800 821-8590|
11113|NCT00876265|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com
11272|NCT00952653|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11273|NCT01006018|Mary Rhee, M.D.|Emory University|404-778-1666|mrhee@emory.edu
11274|NCT01006122|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11275|NCT01006135|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11276|NCT01006356|Medical Director|Medical department / Korea|+82-2-2094-4518|
11277|NCT01006590|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
11278|NCT01006603|Boaz Hirshberg , MSD|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
11279|NCT01006629|Global Medical Services|Abbott|800-633-9110|
11280|NCT01006655|Prof Lea Bentur|Rambam medical Center|xx 972 4 854 3263 ext 0502062400|l_bentur@rambam.health.gov.il
11281|NCT01006980|Medical Communications|Hoffman-LaRoche|800-821-8590|
11282|NCT01007110|Kathleen Gustafson, Ph.D.|University of Kansas Medical Center|(913) 588-0065|kgustafson@kumc.edu
10430|NCT01232894|Study Director|Novartis|41 61 324 1111|
10431|NCT01233076|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|CIBA VISION|1-678-415-3343|Joseph.Rappon@cibavision.com
10432|NCT01233258|Therapeutic  Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
10046|NCT01212770|Anne McClain|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
10047|NCT01213043|Benjamin King, PhD|Grifols Therapeutics Inc.||ben.king@grifols.com
10048|NCT01213173|Gerard Lynch|AstraZeneca|+44 1625 518062|aztrial_results_posting@astrazeneca.com
10049|NCT01213264|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10050|NCT01213329|Dr. Lorenzo Gallon|Northwestern University|312-695-8900|l-gallon@northwestern.edu
10051|NCT01213589|Richard Jonkers, PhD|Medtronic|800-217-1617 ext 3727|richard.jonkers@medtronic.com
10052|NCT01213706|Adam Wanner, MD|University of Miami|(305) 243-2568|awanner@med.miami.edu
10053|NCT01213836|Gerard Lynch|Astra Zeneca||ClinicalTrailTransparency@astrazeneca.com
10054|NCT01214109|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10055|NCT01214174|Wendy Murahashi, MD|Icon Bioscience, Inc.|650-369-4049|wendymurahashi@iconbioscience.com
10056|NCT01214239|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10057|NCT01214252|Annie Choi|Covidien|781-839-1756|annie.choi@covidien.com
10058|NCT01214395|Dr Kerry Carson Trial Manager|PathWest Laboratory Medicine WA|+61 8 93464092|kerry.carson@uwa.edu.au
10059|NCT01214434|Medical Information Center|Promius Pharma, LLC|888 966-8766|product-complaints@promiuspharma.com
10060|NCT01214616|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10061|NCT01214720|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
10062|NCT00555750|Dr. John Winkelman, MD, PhD|Brigham and Women's Hospital|617-278-0061|jwwinkelman@partners.org
10679|NCT01110915|Advisa MRI Clinical Research Specialist|Medtronic, Inc|800-328-2518 ext 62813|medtronicCRMtrials@medtronic.com
10680|NCT01110967|Cristina Faria|Medtronic Spinal & Biologics|+41 (0)21 802 70 00|cristina.faria@medtronic.com
10681|NCT01111110|Dr.Sreekala Prabhakaran. Clinical Assistant Professor Pediatrics|University of Florida|352-273-8381|sprabhakaran@peds.ufl.edu
10682|NCT01111149|Dr. S. Hossein Fatemi|University of Minnesota|612-626-3633|fatem002@umn.edu
10683|NCT01111318|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10684|NCT01111331|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10707|NCT00939471|Laura England, Manager-Clinical|Acclarent, Inc.|650-687-4466|lenglan1@its.jnj.com
10708|NCT00939510|Dr. Robert Dreicer|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|216-445-4623|dreicer@ccf.org
10709|NCT00939536|Kedar Joshi|Accutest Research Laboratories Pvt. Ltd.|+91 22 27780718|
10710|NCT00939562|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
10711|NCT00939692|Walter A Parham|Gateway Medical Research, Inc.|(314) 663-4550|
10712|NCT00939705|Walter A Parham|Gateway Medical Research, Inc.|(314) 663-4550|
10713|NCT00939731|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10714|NCT00939783|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10715|NCT00939796|Director of Clinical Research|Acclarent|650-687-5888|lenglan1@its.jnj.com
10716|NCT00939809|Jessalyn Reboy|Gynecologic Oncology Group Statistical and Data Center|716-845-7738|reboyj@nrgoncology.org
10717|NCT00939952|Katie Cardone|Albany College of Pharmacy and Health Sciences|518-694-7875|katie.cardone@acphs.edu
10718|NCT00939991|Katherine Peters, MD, PhD|Duke University Medical Center|919-684-3914|katherine.peters@dm.duke.edu
10719|NCT00940017|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
10809|NCT00941681|Project Manager|Cytokinetics, Inc.|650-624-2918|
10810|NCT00941720|Dr. Ronald Sobecks|CCCC|216-444-6833|sobeckr@ccf.org
10811|NCT00941798|Study Director|Novartis Pharmaceuticals|862-778-8300|
10812|NCT00941863|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
10813|NCT00941928|Anna Franklin, MD, Assistant Professor|University of Texas MD Anderson Cancer Center|713-792-3497|rnjackso@mdanderson.org
10814|NCT00941993|Clinical Director|Acclarent|650-687-5888|lenglan1@its.jnj.com
10815|NCT00942084|P. Brian Smith, MD MPH MHS|Duke Clinical Research Institute|919-668-8951|brian.smith@duke.edu
10816|NCT00942149|Brian Smith|Duke University Medical Center|9196688951|brian.smith@duke.edu
10817|NCT00942175|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
10818|NCT00942266|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
11000|NCT01053507|Dr. Roger K. Cady|Clinvest/A Division of Banyan Group, Inc.|417-841-3673|jtarrasch@clinvest.com
11001|NCT01053819|Boni Elewski, MD|University of Alabama at Birmingham|205-502-9960|beelewski@gmail.com
11002|NCT01053897|Gerri Henwood, CEO|Garnet BioTherapeutics, Inc.|484-395-2440|ghenwood@garnetbio.com
11003|NCT01053988|GSK Response Center|GlaxoSmithKline|866-435-7343|
11004|NCT01054170|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
11005|NCT01054222|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11006|NCT01054339|Jeffrey D. Chulay, MD|Applied Genetic Technologies Corp.|386-462-2204 ext 205|jchulay@agtc.com
11007|NCT01054404|Dr. John F. Bebawy, Assistant Professor of Anesthesiology & Neurological Surgery|Northwestern University|312-695-0061|j-bebawy@northwestern.edu
11008|NCT01054573|Medical Leader|Janssen Research & Development, LLC|1 609 730-3174|
11009|NCT01054586|GSK Response Center|GlaxoSmithKline|866-435-7343|
11283|NCT01007149|Study Director|Novartis Pharmaceuticals|862-778-8300|
11284|NCT01007253|Dr. Robert M. Naclerio, MD|The University of Chicago|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu
11285|NCT01007396|Won-Jung Koh|Samsung Medical Center|82-2-3410-3429|wjkoh@skku.edu
11286|NCT01007435|Medical Communications|Hoffmann-La Roche|800 821-8590|
11287|NCT01007643|Dr Erika Persson|University of Manitoba|780-492-4752|epersson@ualberta.ca
11288|NCT01007656|Dr. Choo-Aun Neoh|PingTung Christian Hospital Ruiguang Branch|886-8-736-8686 ext 5310|neohca@gmail.com
11289|NCT01007812|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
11290|NCT01007838|Danielle Kirkman|UWalesBangor|00 44 1248 388254|pepa03@bangor.ac.uk
11291|NCT01007916|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
11292|NCT01008449|Principal Investigator|UAB|205-934-3411|dana_figueroa_marzilli@hotmail.com
11293|NCT01008553|Director, Clinical Research|Janssen Research & Development, L.L.C. USA|1 609 730-3387|
11294|NCT01008605|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9932|NCT01145391|Amy Huebschmann|University of Colorado Denver School of Medicine|303-724-2268|amy.huebschmann@ucdenver.edu
9933|NCT01145417|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9934|NCT01145495|Peter Martin, M.D.|Weill Cornell Medical College||pem9019@med.cornell.edu
9935|NCT01145508|Study Statistician|ECOG Statistical Office|617-632-3012|
9936|NCT01145560|Justin Lindemann|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
9937|NCT01145625|Study Director|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|(973) 385-3203|
9938|NCT01145755|Gerard Lynch|AstraZeneca|645895 ext +44 1509|aztrial_results_posting@astrazeneca.com
9939|NCT01145898|Alon Harris|Indiana University|317-278-00177|alharris@indiana.edu
10063|NCT00555997|Dr. George Papakostas|Massachusetts General Hospital|617-726-6697|gpapakostas@partners.org
10064|NCT00556075|Jennifer L. Wike|Repros Therapeutics Inc.|2817193402|jwike@reprosrx.com
10065|NCT00556140|Dr. John Matthews|Massachusetts General Hospital|617-724-0847|jmatthews@partners.org
10066|NCT00556400|Dr. Pamela Stratton|NICHD|301 496-9079|strattop@mail.nih.gov
10067|NCT00556426|John Reviere, Director of Clinical Affairs|C.R. Bard|480-303-2644|john.reviere@crbard.com
10068|NCT00556504|Dr. Ya-Chun Wang, EVP/CSO|TCM Biotech International|886-2-26581677 ext 733|yachunwang@tcmbio.com
10183|NCT00947544|Tristen Moors-Associate Director, Clinical Operations|Hyperion Therapeutics|650-745-7840|tristen.moors@hyperiontx.com
10184|NCT00947752|Thomas Smith, MD, VP, Medical Affairs|Teva Neuroscience, Inc.|816-508-5000|tom.smith@tevapharm.com
10185|NCT00947765|Dr. Chetan Muralidhara Rao Dojode, MBBS,MS(Ortho)|Dr. Chetan Muralidhara Rao Dojode. Resident in Orthopaedics and Traumatology.|91 9844592532|docchetanmd@yahoo.co.in
10186|NCT00947856|Chief Medical Officer|Seattle Genetics, Inc.|855-473-2436|medinfo@seagen.com
10187|NCT00948090|Global Medical Affairs|Otsuka Pharmaceutical Development and Commercialization, Inc.|800 562-3974|
10188|NCT00948246|Medical Monitor|Allergan Medical|(805) 961-5000|devicetrials@allergan.com
10189|NCT00948389|BMS Study Director|Bristol-Myers Squibb||clinical.trials@bms.com
10190|NCT00948506|Joy Wan|University of Pennsylvania|2157466364|joy.wan@uphs.upenn.edu
10191|NCT00948675|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
10192|NCT00948766|Study Director|Novartis Pharmaceuticals|862 778-8300|
10193|NCT00948792|Doug Dannaway|University of Oklahoma Health Sciences Center|4052715215 ext 42048|douglas-dannaway@ouhsc.edu
10194|NCT00948818|Paul F.C. Eng Ph.D Director, Clinical Development|Forest Research Institute|201-427-8071|Paul.Eng@frx.com
10195|NCT00948857|Dr. Norbert Gleicher|Center for Human Reproduction|212-994-4400|ngleicher@thechr.com
10196|NCT00949117|Cristina Burroughs, Clinical Research Coordinator|SunCoast CCOP Research Base|(813) 396-9237|Cristina.Burroughs@epi.usf.edu
10720|NCT00940108|Clinical Trial Disclosure Manager|CSL Limited|Use email contact|csl.clinicaltrials@csl.com.au
10721|NCT00940290|Carlos A. Cuello-García|ITESM|+52 (81)88882154|carlos.cuello@gmail.com, carlos.cuello@itesm.mx
10722|NCT01008696|Clinical Research Associate|Medical Affairs, Seoul, Korea|82-2-2094-4835|
10723|NCT01008904|Thomas J. Smith, MD|Virginia Commonwealth University|410-955-2091|tsmit136@jhmi.edu
10724|NCT01008969|Youngho Seo, PhD|University of California, San Francisco|415-353-9464|youngho.seo@ucsf.edu
10725|NCT01008995|Director, Clinical Research|Janssen R&D US|1 215-793-7646|
10726|NCT01009034|Tony Antoniou|Maple Leaf Research|4164657936|tantoniou@smh.toronto.on.ca
10727|NCT01009047|Senior Director, Clinical Leader|Janssen Research & Development, LLC|+1-609-730-2436|
10728|NCT01009086|Director, Clinical Research|Janssen Research & Development, LLC|1-800-526-7736|
10729|NCT01009333|Maureen McGuire, Sr. Program Manager|Medtronic Neuromodulation|763-526-8425|maureen.mcguire@medtronic.com
11114|NCT00876343|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ld.|+81-3-6361-7366|
11115|NCT00876447|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11116|NCT00876694|Study Director|Novartis Pharmaceuticals|862-778-8300|
11117|NCT00876928|Mayer B. Davidson, MD|Charles R. Drew University|323 357-3439|mayerdavidson@cdrewu.edu
11118|NCT00877006|Manager|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
11119|NCT00877058|Professor Synneve Dahlin-Ivanoff (Research leader)|Göteborg University|+46317865733|synneve.dahlin-ivanoff@gu.se
11120|NCT00877370|Bruce A. Mueller|University of Michigan|(734) 615-4578|muellerb@umich.edu
11121|NCT00877383|Study Director|Novartis Pharmaceuticals|862 778-8300|
11122|NCT00877448|Tamar Ben-Yedidia, PhD|BiondVax Pharmaceuticals Ltd.|972-8-9302529|benyedidia@BiondVax.com
11123|NCT00877487|Timothy Whitaker, MD|Shire Pharmaceutical||twhitaker@shire.com
11010|NCT01054625|Eva Järlid Westerberg, VP Clinical Operations|Genmab A/S|+45 7020 2728|E.Westerberg@genmab.com
11011|NCT01054703|Laura England, Manager-Clinical Research|Acclarent|650-687-4466|lenglan1@its.jnj.com
11012|NCT00873873|Head, Pediatric Clinical Pharmacology|National Jewish Health|303-398-1193|szeflers@njhealth.org
11013|NCT00873912|Elissa Malkin, DO|MedImmune, LLC|301-398-0000|malkine@medimmune.com
11014|NCT00874029|Laura Kemp, Sr. VP Clinical Affairs|Halt Medical, Inc|408-375-1465|lkemp@haltmedical.com
11015|NCT00874094|Anthony P Sclafani, MD|NY Eye & Ear Infirmary|212-979-4200|asclafani@nyee.edu
11016|NCT00874120|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
11017|NCT00874250|Bill Caldwell|W.L. Gore and Associates|6232345687|bicaldwe@wlgore.com
11018|NCT00874276|Dr. Peter Stacpoole/Principal Investigator|University of Florida|1-352-273-9023|pws@ufl.edu
11019|NCT00874549|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
11020|NCT00874822|Jason Shiffermiller, MD, MPH|University of Nebraska Medical Center|402-559-7299|jshiffermiller@unmc.edu
11021|NCT01063868|Senior Director, Clinical Leader|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|609-730-4537|
11022|NCT01063881|Sr. Director CDTL, RA CVM Urology|Janssen Research & Development, LLC|1 908 704-4648|
11227|NCT00933933|Barbara Kaesdorf, Associate Director Clinical Affairs|Abbott Diagnostic Division|847-937-8702|barbara.kaesdorf@abbott.com
11228|NCT00934102|Craig Woods, PhD, FAAO / Research Manager|University of Waterloo|1-519-888-4742|cclr2@uwaterloo.ca
11229|NCT00934141|Dr. David H Gustafson|University of Wisconsin - Madison|608-890-1436|dhgustaf@wisc.edu
11230|NCT00934180|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
11231|NCT00934362|Dr. Scott Donaldson|University of North Carolina at Chapel Hill|919-966-9198|scott_donaldson@med.unc.edu
11232|NCT00934375|Anita Murthy, Study Director|Eisai Inc.|201-692-1100|
11233|NCT00934544|Clinical Disclosure Office|Novartis Pharmaceuticals|862-778-8300|
9940|NCT01146275|Head of Medical Affairs|Q-Med AB|+46 (0) 18 4749000|reception.SEUPP@galderma.com
9941|NCT01146600|Lynn Marie Trotti, MD, MSc|Emory University School of Medicine|404-728-4752|lbecke2@emory.edu
9942|NCT01146613|Megan Ryan, M.B.A.|NIAAA|301-443-4225|mryan1@mail.nih.gov
9943|NCT01146782|Andrea Brown, Director, Clinical Affairs|ApniCure, Inc.|650-361-9000 ext 122|abrown@apnicure.com
9944|NCT01146860|Dr. Rainer Jund, Specialist in Otorhinolaryngology|ENT practice|+49 89 804880|RainerJund@gmx.de
9945|NCT01146912|Melissa Stockwell, MD MPH|Columbia University|212-342-5372|mss2112@columbia.edu
9946|NCT01146951|Eisai Inc.|Eisai Call Center|888-422-4743|
9947|NCT01147055|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9948|NCT01147068|Dr. Ruvim Izikson, M.D.|Protein Sciences Corporation|203-599-6064 ext 163|rizikson@proteinsciences.com
9949|NCT01147341|Michael schiff|michael schiff|303 773 8429|michael.schiff@me.com
9950|NCT01147406|Janice M Troha|N30 Pharmaceuticals Inc.|720-945-7714|janice.troha@n30pharma.com
9951|NCT01147458|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9952|NCT01147497|Eva Lathrop, MD, MPH|Emory University|404-778-1379|elathro@emory.edu
9953|NCT00509236|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9954|NCT00509262|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10069|NCT00556543|John Mayberry, MD|Oregon Health & Science University|503-494-5300|mayberrj@ohsu.edu
10070|NCT00556673|Study Director|Novartis Pharmaceuticals|862-778-8300|
10071|NCT00556972|Thais Benjamin N. Christensen, Senior Clinical Project Manager|Coloplast A/S|+4549112668|dkthc@coloplast.com
10072|NCT00556998|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10073|NCT00557310|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
10197|NCT00949650|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10198|NCT00949702|Medical Communications|Hoffmann-La Roche|800-821-8590|
10199|NCT01390415|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10200|NCT01390779|Mona Moshtaghi|UCSD|858 534-6290|momoshta@ucsd.edu
10201|NCT01390857|GSK Response Center|GlaxoSmithKline|866-435-7343|
10202|NCT01390870|GSK Response Center|GlaxoSmithKline|866-435-7343|
10203|NCT01390909|GSK Response Center|GlaxoSmithKline|866-435-7343|
10204|NCT01391013|Therapeutic Area Medical Manager|Jan-Cil Italy|39 02 2510589 ext NA|
10205|NCT01391273|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
10318|NCT01164501|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10319|NCT01164644|Dr. Scott R. Chaiet|University of Wisconsin School of Medicine and Public Health|(608) 263-1092|scottchaiet@yahoo.com
10320|NCT01164865|Jami Kern, Ph.D.|Alcon Global Medical Affairs|1-888-451-3937|
10321|NCT01165021|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
10322|NCT01165047|Katernie Slotke|Aurora Health Care|414-649-2615|katherine.Slotke@aurora.org
10323|NCT01165138|GSK Response Center|GlaxoSmithKline|866-435-7343|
10324|NCT01165216|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
10325|NCT01165281|Medical Director|Janssen Pharm KK Japan|＋81-3-5509|
10326|NCT01165320|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10327|NCT01165424|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
10328|NCT01165541|Mary Brunette, MD|Geisel School of Medicine At Dartmouth|603-271-7642|mary.brunette@dartmouth.edu
11124|NCT00877877|GSK Response Center|GlaxoSmithKline|866-435-7343|
11125|NCT00877890|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
11126|NCT00877929|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11127|NCT00878228|Dr. David Kim|Hospital for Special Surgery|212-606-1206|KimD@hss.edu
11128|NCT00878501|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
11129|NCT00878553|Dr. Christine Blumhardt, Chief Regulatory Officer|Somnus Therapeutics, Inc|617-710-0928|cblumhardt@somnusthera.com
11130|NCT00931996|Dr. Jeffrey Bishop|Ullinois|312-413-3495|jbishop@uic.edu
11131|NCT01067352|Medical Responsible|Merck Serono S.p.A., Italy, an affiliate of Merck KGaA, Darmstadt, Germany|+49-6151-72-5200|service@merckgroup.com
11132|NCT01067716|Amelia Saliba|Abbott Medical Optics|408-273-4158|amelia.saliba@amo.abbott.com
11133|NCT01067768|Dr. María Victoria Restrepo|Hospital Pablo Tobón Uribe|57-4-4459315|mrestrepo@hptu.org.co
11134|NCT01067781|Head Clinical Developement|Valneva Austria GmbH|0043120620 ext 0|info@valneva.com
11135|NCT01067846|Clint Kilts, PhD|Brain Imaging Research Center|526-8163|CDKilts@uams.edu
11136|NCT01068158|Medical Director|Sanofi Topaz||RegistryContactUs@sanofipasteur.com
10685|NCT01111851|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
10686|NCT01112241|Dr. Giovanni Barisione, MD|Azienda Ospedaliera Universitaria San Martino, Genova, Italy|+39 010 5553367|giovanni.barisione@hsanmartino.it
10687|NCT01112267|Therapeutic area Scientist|Janssen Korea/ Seoul|+82-2-2094-4802|
10688|NCT01112514|Andrew T. Chan|Massachusetts General Hospital|617 726 3212|achan@partners.org
10689|NCT01112670|Christina Aquilante, Pharm.D.|University of Colorado|303-724-6126|christina.aquilante@ucdenver.edu
10690|NCT01112683|Dr. Alberto Costa|University of Colorado School of Medicine|303-724-6007|Alberto.Costa@ucdenver.edu
10691|NCT01112696|Scott Lee M.D.|Medtronic|818-576-4204|scott.w.lee@medtronic.com
11234|NCT00934596|Dr. Bansi Koul MD, PhD, Principal Investigator|Cardiothoracic Surgery, Skåne University Hospital Lund|+46 46 171649|bansi.koul@skane.se
11235|NCT00934622|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
11236|NCT00934635|Medical Development Manager;  Medical and Scientific Affairs|Janssen Cilag|0049-2137-955-1240|
11237|NCT00934648|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
11238|NCT00934791|Dr. Patrick G. Dean|Mayo Clinic|507-266-6953|dean.patrick2@mayo.edu
11239|NCT00934843|Dr. Eric Graham|Medical University of South Carolina|843-792-8704|grahamem@musc.edu
11240|NCT00934921|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
11241|NCT00887458|Dr. Michael Carducci|Johns Hopkins University|410-614-3977|carducci@jhmi.edu
11242|NCT00887471|Nira A Goldstein, MD|SUNY Downsate Medical Center|718-270-1638|ngoldstein@downstate.edu
11243|NCT00887484|GSK Response Center|GlaxoSmithKline|888-435-7343|
11244|NCT00887510|Rhonda M Cooper-DeHoff|University of Florida|352 273-6184|dehoff@cop.ufl.edu
11245|NCT00887549|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
11246|NCT00887640|Dr. Andrew Armstrong|Duke University Medical Center|919-668-8108|andrew.armstrong@dm.duke.edu
11247|NCT00887679|Dr. Ashwin A Patkar Associate Professor|Duke University Medical Center|919-668-3626|ashwin.patkar@duke.edu
11248|NCT00887744|E. Wülfert, Medical Affairs & Clinical Operations Director|Medtronic Spinal & Biologics Europe and Central Asia||inca.studyregistration@medtronic.com
11249|NCT00887913|Hanit Brenner-Lavie|Syneron Medical Ltd|972-73-244-2200 ext 581|hanitb@syneron.com
10819|NCT00942448|Barbara Gugliotta|IBSA Institut Biochimique|+41 58 360 1000|barbara.gugliotta@ibsa.ch
10820|NCT00942604|Dr. Torsten Skov|LEO Pharma|+4520736294|torsten.skov@leo-pharma.com
10821|NCT00996125|GSK Response Center|GlaxoSmithKline|866-435-7343|
10822|NCT00996164|Krista Barbour, Ph.D.|Sprout Pharmaceuticals|9198820850|kbarbour@sproutpharma.com
10074|NCT00557323|Timothy Whitaker, M.D.|Shire Pharmaceutical||twhitaker@shire.com
10075|NCT00557362|Tom M/ Lietman|University of California San Francisco Proctor Foundation|4155022662|tom.lietman@ucsf.edu
10076|NCT00557440|Study Director|Novartis Pharmaceuticals|862-778-8300|
10077|NCT00557466|Study Director|Novartis Pharmaceuticals|862-778-8300|
10078|NCT00557505|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10079|NCT00557622|GSK Response Center|GlaxoSmithKline|866-435-7343|
10080|NCT00603382|GSK Response Center|GlaxoSmithKline|866-435-7343|
10081|NCT00603473|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10082|NCT00603512|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10083|NCT00603525|GSK Response Center|GlaxoSmithKline|866-435-7343|
10084|NCT00603538|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10085|NCT00603564|Roberto Cosentini, MD|IRCCS Fondazione Po.Ma.Re, Milan, Italy|00390255033602|roberto.cosentini@policlinico.mi.it
10086|NCT00603590|Mansoor Rastegarpanah|Tehran University of Medical Sciences|+989121255960|rastegar@sina.tums.ac.ir
10087|NCT00603642|Study Director|Amgen Inc.|866-572-6436|
10088|NCT00603746|GSK Response Center|GlaxoSmithKline|866-435-7343|
10089|NCT00603798|Sharon F Levy, MD|Graceway Pharmaceuticals|267-948-0400|sharon.levy@gracewaypharma.com
10090|NCT01121263|Deborah Ascheim, MD|Icahn School of Medicine at Mount Sinai|212-659-9567|deborah.ascheim@mssm.edu
10091|NCT01121484|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10206|NCT01391286|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
10207|NCT01391299|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
10329|NCT01165554|Dr. Paul Sherwin|GE Healthcare|1-609-514-6820|paulsherwin@ge.com
10330|NCT01165684|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
10331|NCT01230814|Shelly Lensing, MS|University of Arkansas for Medical Sciences|501-686-8203|sylensing@uams.edu
10332|NCT01231321|Global Medical Services|Abbott|800-633-9110|
10333|NCT01231334|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
10334|NCT01231373|David Wright MBBS|BTG International Inc.|610-278-1660|david.wright@btgplc.com
10335|NCT01231464|GSK Response Center|GlaxoSmithKline|866-435-7343|
10336|NCT01231516|GSK Response Center|GlaxoSmithKline|866-435-7343|
10337|NCT01178853|Roger Morgan, MD, FACS|Kowa Research Institute, Inc.|919-433-1600|RMorgan@KowaUS.com
10338|NCT01179191|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10339|NCT01179334|Therapeutic Area Head|Bayer||clinical-trials-contact@bayerhealthcare.com
10340|NCT01179347|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10433|NCT01233284|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10434|NCT01233817|Aga Lewelt MD, Principal Investigator|Department of Physical Medicine and Rehabilitation, School of Medicine, University of Utah|801-518-4572|aga@genetics.utah.edu
10435|NCT01233921|Dr. Paul J. Martin|Fred Hutchinson Cancer Research Cetner|206-667-4798 ext NA|pmartin@fhcrc.org
10436|NCT01233999|Dr. Suephy Chen|Emory University|404-778-3084|schen2@emory.edu
10437|NCT01234714|Dr Dimitri Aristotle Raptis, Principal Investigator|University of Zurich|+41442553300|dimitri.raptis@usz.ch
10438|NCT01234831|Dr. David C. Hooper|Massachusetts General Hospital|617-726-2036|dhooper@partners.org
10439|NCT01234870|Dr. James Carr|Northwestern University|(312)695-4218|jcarr@northwestern.edu
10440|NCT01234883|Drew Jones, M.D.|Baxter Healthcare|224-270-2659|Drew_Jones@baxter.com
10692|NCT01112865|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10693|NCT01113385|Asha Moudgil MD, Professor of Pediatrics|Children's National|202-476-5058|amoudgil@childrensnational.org
10694|NCT01113541|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10695|NCT00884910|Prof Dr FJM Hilgers|Netherlands Cancer Institute|+31 20 512 2550|f.hilgers@nki.nl
10696|NCT00884949|BioMarin Medical Information Services|BioMarin Pharmaceutical Inc.|800-983-4587|medinfo@bmrn.com
10697|NCT00885079|Mr. Kyoji Imaoka|Otsuka Pharmaceutical Co., Ltd.|-81-6-6943-7722|
10698|NCT00885092|Director of Alcon Clinical|Alcon Research, Ltd.|1-888-451-3937|medinfo@alconlabs.com
10699|NCT00885105|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
10700|NCT00885118|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10701|NCT00885352|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
10702|NCT00885365|Chiesi Clinical Trials|Chiesi Farmaceutici S.p.A.||clinicaltrials_info@chiesi.com
10703|NCT00885378|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
10704|NCT00939211|Gerard Lynch|AstraZeneca|+441509645895|clinicaltrialtransparency@astrazeneca.com
10705|NCT00939341|Gerard Lynch|AstraZeneca|+44 1625 518062   ext 28062|aztrial_results_posting@astrazeneca.com
10706|NCT00939367|Kedar Joshi|Accutest Research Laboratories Pvt. Ltd.|+91 22 27780718|
10910|NCT01052272|Louis . J. Dell'Italia, M.D|University of Alabama at Birmingham|205-934-3969|Dell'Italia@PHYSIOLOGY.UAB.EDU
10911|NCT01052428|Louis J. Dell'Italia, M.D.|University of Alabama at Birmingham|205-934-0850|loudell@uab.edu
10912|NCT00996632|Prof. Nicolò de Manzini|University of Trieste|+390403994152|nicolo.demanzini@aots.sanita.fvg.it
10913|NCT00996658|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9184|NCT01395901|Salvatore Chessari|Helsinn Healthcare SA|+41 91 985 21 21|salvatore.chessari@helsinn.com
9185|NCT01396005|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6327|ClinicalTrialsDisclosure@merck.com
9186|NCT01396044|Dr. Curtis Weiss|Northwestern University|(312) 695-6439|curtisweiss@northwestern.edu
9187|NCT01396057|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
9188|NCT01396226|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
9189|NCT01416142|Dr. William Reindel|Bausch & Lomb Incorporated|(585) 338-8129|william.reindel@bausch.com
9190|NCT01416571|GSK Response Center|GlaxoSmithKline|866-435-7343|
9191|NCT01417104|Sanjay Rajagopalan, MD|The Ohio State University|614-247-7760|sanjay.rajagopalan@osumc.edu
9192|NCT01417195|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
9193|NCT01418209|Hadine Joffe, MD, MSc|Brigham and Women's Hospital|617-732-4906|hjoffe@partners.org
9194|NCT01418365|Study Physician|Shire Pharmaceutical|1 866-842-5335|
9195|NCT01419028|Alexion Pharmaceuticals|Alexion International Sarl||clinicaltrials@alxn.com
9196|NCT01419171|Peter Maurer, Director Clinical Trials|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com
9197|NCT01419197|Medical Communications|Hoffmann-La Roche|800 821-8590|
9198|NCT01419249|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
9199|NCT01419314|Roberto Sandoval PT|Texas Woman's University|713-859-9351|rsandoval@mail.twu.edu
9200|NCT01420289|Oscar M. Alvarez PhD, Director Center for Curative and Palliative Wound Care|Calvary Hospital|718-518-2577|oalvarez@calvaryhospital.org
9201|NCT01420848|Leonice Fumiko Sato Kurebayashi|University of São Paulo|(5511 991126023)|fumie_ibez@yahoo.com.br
9202|NCT01421277|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6327|ClinicalTrialsDisclosure@merck.com
9203|NCT01421355|Joshua Beckman, MD|Brigham and Women's Hospital|617-732-6320|jbeckman@partners.org
9791|NCT01366417|Jennifer Raeder-Devens|CareFusion|847-454-4939|jennifer.raeder-devens@carefusion.com
9792|NCT01366443|Dr. Michael Draper, MD University of Utah Medical Center, Dept. of OB/GYN|University of Utah Medical Center, Dept. of OB/GYN|801-581-7647|mike.draper@hsc.utah.edu
9793|NCT01366638|Director|Janssen Pharmaceutical K.K., Japan|81 3 44115639|
9794|NCT01366872|Dr. John G. Anderson|Orthopaedic Associates of Michigan, PC|616-459-7101 ext 797|John.Anderson@oamichigan.com
9389|NCT01142115|Trine Møller Kruse|Clinical Regulatory Development, Global R&D|+4549112174|dktrm@coloplast.com
9390|NCT01142128|Phillip Toskes, M.D.|University of Florida|352-273-9493|phillip.toskes@medicine.ufl.edu
9391|NCT01142193|Bob Anders, Sr. Director of Clinical Operations|Upsher-Smith Laboratories, Inc.|763-315-2000|Bob.Anders@upsher-smith.com
9392|NCT01142323|Dr. Cynthia Levy|University of Miami|305-243-2147|clevy@med.miami.edu
9393|NCT01142466|Medical Responsible|Merck Serono GmbH, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|+49 6151 72 5200|service@merckgroup.com
9394|NCT01142661|Prash Gopalakrishna|Eisai Inc.|888-422-4743|
9395|NCT01143051|Stephen A. Campbell, Esq.|Amphastar Pharmaceuticals, Inc.|(909) 980-9484 ext 2016|stephenc@amphastar.com
9396|NCT01143077|Medical Director, CNS|Sunovion Pharmaceuticals|1-866-503-6351|
9397|NCT01143090|Medical Director, CNS|Sunovion Pharmaceuticals Inc|1-866-503-6351|
9398|NCT01143207|Vera Halpern, MD|FHI 360|919-54-7040 ext 11390|vhalpern@fhi360.org
9399|NCT01143259|Matthew Peters RN MS|Intermountain Healthcare|801-442-3703|matthew.peters@imail.org
9400|NCT01143324|Christel Van Dam|MedtronicSpineECA|+31433566523|christel.van.dam@medtronic.com
9401|NCT01143610|Adriana Campos Passanezi Sant'Ana|School of Dentistry at Bauru - USP|00 55 14 3235-8278|acpsantana@usp.br
9402|NCT01143714|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|Healthpoint, Ltd.|817-302-3914|jaime.dickerson@healthpoint.com
9403|NCT01143727|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|Healthpoint, Ltd.|817-302-3914|jaime.dickerson@healthpoint.com
9404|NCT01143766|Gregory A. Cote|Indiana University|317-944-2740|gcote@iupui.edu
9702|NCT01275066|BioMarin Medical Information Services|BioMarin Pharmaceutical Inc.|(800) 983-4587|medinfo@bmrn.com
9703|NCT01275092|Giora Weisz, MD; Director of Clinical Resarch Center for Interven tional Vascular Therapy|Columbia University Medical Center, New York, NY, 10032|212-305-7060|gweisz@crf.org
9704|NCT01275131|Vice President, Endocrinology Clinical Development|Halozyme Therapeutics, Inc|(858)794-8889|
9705|NCT01275625|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9706|NCT01276054|Victoria Soto, Project Specialist, Clinical Investigations Support Office|USC Norris Comprehensive Cancer Center|323-226-6384|victoria.soto@med.usc.edu
9862|NCT00663858|Herbert Sindermann|Aeterna Zentaris|+49 69 42602 3429|HSindermann@aezsinc.com
9863|NCT00663923|Mohammad R sedghipour,MD|Tabriz University of Medical Sciences|+98 411 3306619|sedghipm@yahoo.com
9864|NCT00664066|Timothy Whitaker, MD|Shire Pharmaceutical||twhitaker@shire.com
9865|NCT00664105|Vicki Keedy, M.D.|Vanderbilt-Ingram Cancer Center|(615) 322-4967|
9866|NCT00664326|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
9867|NCT00664430|Global Medical Services|Abbott|800-633-9110|
9868|NCT00664534|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
9869|NCT01345123|David R Veroff, MPP, SVP Analytic Development|Health Dialog|617-406-5219|dveroff@healthdialog.com
9870|NCT01345162|Dr Massimo Allegri|IRCCS Policlinico S Matteo|00390382502627|massimo.allegri@unipv.it
9871|NCT01345240|GSK Response Center|GlaxoSmithKline|866-435-7343|
9872|NCT01345721|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
9873|NCT01345786|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
9874|NCT01346085|Dr Lorenzo Piemonti|Ospedale San Raffaele|+390226432706|piemonti.lorenzo@hsr.it
9875|NCT01346592|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
9876|NCT01346852|GSK Response Center|GlaxoSmithKline|866-435-7343|
8729|NCT01378195|Bruno Kajiyama|Photozig, Inc.|650-694-7496|info@photozig.com
8730|NCT01378221|Dr. Armin Zittermann|Heart and Diabetes Center North Rhine-Westphalia, Germany|+49 5731 97 ext 1912|azittermann@hdz-nrw.de
8731|NCT01378325|Sahar Siddik-Sayyid|AUBMC|9611350000 ext 6380|ss01@aub.edu.lb
8732|NCT01378416|Yufang Lu, MD PhD|Eisai Inc.|1-888-422-4743|
8733|NCT01378429|Respiratory Medical Director|Sunovion|866-503-6351|
8734|NCT01378520|Donald A. Mahler, M.D.|Dartmouth-Hitchcock|603 650-5533|Donald.a.mahler@hitchcock.org
8735|NCT01379183|Dr. Jeff L. Fidler|Mayo Clinic|507-284-5010|fidler.jeff@mayo.edu
8736|NCT01379651|Dr. Iride Dello Iacono|Unit of Pediatrics, Fatebenefratelli Hospital, Benevento, Italy|+39 824 771111|iridedello@hotmail.com
8737|NCT01379703|Global Medical Services|Abbott|1-800-633-9110|
8738|NCT01134393|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8739|NCT01134627|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
8740|NCT01134705|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
8741|NCT01134900|Allison B. McCoy, PhD|The University of Texas Health Science Center at Houston (UTHealth)|713-500-6931|allison.b.mccoy@uth.tmc.edu
8742|NCT01135017|Trial Transparency Team|Sanofi||Contact_US@sanofi.com
8743|NCT01135134|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
8744|NCT01135368|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
8745|NCT01135381|Dr. Christine Ritchie|University of California San Francisco (UCSF); University of Alabama at Birmingham (UAB)|415-514-0605|christine.ritchie@ucsf.edu; critchie@uab.edu
8746|NCT01135511|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8747|NCT01135524|Clinical Leader, Medical Director|Purdue Pharma L.P.|800-733-1333|
9204|NCT01421511|Philippe Prokocimer, MD|Cubist Pharmaceuticals, Inc.|858-452-0370 ext 241|philippe.prokocimer@cubist.com
9205|NCT01421589|Hideo Makimura, MD, PhD|Massachusetts General Hospital|617-726-8277|hmakimura@partners.org
9206|NCT01421641|Paula Bednarek|Oregon Health & Science University|(503) 418-4500|bednarek@ohsu.edu
9207|NCT01421654|Amy Blase/Clinical Research Manager|ResMed|858-836-6715|amy.blase@resmed.com
9208|NCT01422213|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
9209|NCT01422239|Andrea Weinberger, Ph.D.|Yale University School of Medicine|203-974-7598|andrea.weinberger@yale.edu
9210|NCT01422304|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9211|NCT01422356|Associate Professor Marcus Chen|Melbourne Sexual Health Centre, Alfred Health|+61 3 9341 6260|mchen@mshc.org.au
9212|NCT01422369|Roger Morgan, MD FACS|Kowa Research Institute, Inc|919-433-1600|RMorgan@kowaus.com
9213|NCT01422382|Roger Morgan, MD FACS|Kowa Research Institute, Inc|919-433-1600|RMorgan@kowaus.com
9214|NCT01422434|Clinical trial disclosure manager|LEO Pharma A/S|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com
9215|NCT01422538|Lisa Misell, Ph.D., VP, Clinical and Medical Affairs|Ulthera, Inc.|480-619-4069|
9216|NCT01255137|Dr. Tito Fojo|National Cancer Institute, National Institutes of Health|301-496-2631|FojoT@mail.nih.gov
9217|NCT01255306|Mia Zoric Geber, MD|University Hospital "Sestre milosrdnice"|+385 1 3787 354|mia.zoric-geber@zg.t-com.hr
9218|NCT01255423|Clinical Project Leader|Novartis Consumer Health|0041223635528|
9219|NCT01255436|Dr. Lia M. Palileo|University of the Philippines Manila|6325679740|liapalileo@gmail.com
9220|NCT01255449|Dr. Giovanni Barisione|IRCCS Azienda Ospedaliera Universitaria San Martino IST - Genova, Italy|+39010555 ext 3367|giovanni.barisione@hsanmartino.it
9221|NCT01255761|(UCB) Study Director|UCB Clinical Trial Call Center|+1 887 822 9493|
9222|NCT01255787|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
9405|NCT01205646|Ulka Vaishampayan, M.D.|Barbara Ann Karmanos Cancer Institute|(313) 576-8718|vaishamu@karmanos.org
9406|NCT01205685|Dr. Ingrid Mayer|Vanderbilt-Ingram Cancer Center|615-936-2033|ingrid.mayer@vanderbilt.edu
9407|NCT01224015|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
9408|NCT01224171|Medical Director|Millennium Pharmaceuticals Inc.|800-778-2860|clinicaltrialregistry@tpna.com
9409|NCT01224431|Angelique Ferayorni|Phoenix Children's Hospital|602-546-1910|aferayorni@phoenixchildrens.com
9410|NCT01224626|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9411|NCT01224782|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
9594|NCT01271712|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
9595|NCT01271907|James Yang, M.D.|National Cancer Institute, National Institutes of Health|301-496-1574|jamesyang@mail.nih.gov
9596|NCT01271946|Debra Cogan, Director of Quality, Regulatory and Clinical|Arstasis|650-261-8073|dcogan@arstasis.com
9597|NCT01272076|Carmelina Gordon, MD|TLC Eyecare and Laser Centers|(517) 7821213|shellie.fuentes@tlcmi.com
9598|NCT01210144|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
9599|NCT01210443|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9600|NCT01210716|Sr. Mgr. Clinical Affairs|Fenwal, Inc|847-550-5620|carrie.pineda@fenwalinc.com
9601|NCT01210807|PD Dr. med. Peter Szurman|University Eye Clinic, Tubingen, Germany|49-7071-29-84915|peter.szurman@med.uni-tuebingen.de
9602|NCT01210820|Carrie Garufis|AMO Development, LLC|714-566-3728|carrie.garufis@amo.abbott.com
9603|NCT01286558|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9604|NCT01286740|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
9605|NCT01286805|Dr. Jacques YaDeau|Hospital for Special Surgery|212-606-1206|yadeauj@hss.edu
9606|NCT01287065|GSK Response Center|GlaxoSmithKline|866-435-7343|
9877|NCT01347034|Alberto Chiappori, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-3050|alberto.chiappori@moffitt.org
9878|NCT01347060|GSK Response Center|GlaxoSmithKline|866-435-7343|
9879|NCT01347112|Dr. Richard Hurt|Mayo Clinic|507-284-7313|rhurt@mayo.edu
9880|NCT01347632|Andrea Thurman|CONRAD|757-446-7444|thurmaar@evms.edu
9881|NCT01347840|Amy Mahanes|Ethicon Endo-Surgery, Inc.|513-337-8366|amahanes@its.jnj.com
9882|NCT01347879|Dr David Pariser|Virginia Clinical Research, Inc.|757-625-0151|dpariser@pariserderm.com
9883|NCT01348100|Study Director|Novartis Pharmaceuticals|862 778-8300|
9884|NCT01348139|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
9885|NCT01348165|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9503|NCT01207934|Samuel Klein, MD|Washington University School of Medicine|3143628708|sklein@wustl.edu
9504|NCT01208220|Dr. Stanley McCallon|LSUShreveport|318-813-2996|smccal@lsushc.edu
9505|NCT01208961|Douglas Kling, Vice President, Clinical Development & Project Management|Omthera Pharmaceuticals, Inc.|908-741-4193|dkling@omthera.com
9506|NCT01209260|Jonathan Hsu, MD, MAS|University of California San Diego|415-476-5706|jonathan.hsu@ucsd.edu
9507|NCT01209624|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9508|NCT01209689|Medical Communications|Hoffmann-La Roche|800 821-8590|
9509|NCT01209702|Medical Communications|Hoffman-LaRoche|800-821-8590|
9510|NCT01209767|Dr. Murad Alam|Northwestern University|312-695-4761|m-alam@northwestern.edu
9511|NCT01209780|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
9512|NCT01209949|Norman Preston|Galderma Laboratories, L.P.|817-961-5360|Norman.Preston@galderma.com
9513|NCT01210001|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8748|NCT01136226|Heather Thomas, Administrator|Chesapeake Urology Research Associates|443.471.5742|hthomas@cua.md
8749|NCT01136291|Fernanda Garanhani de Castro Surita|Department of Obstetrics and Gynecology - University of Campinas|+551935219304|surita@unicamp.br
8750|NCT01136382|Geoff Gilmartin|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
8865|NCT01218594|Ming Chen|Sun Yat-Sen University Cancer Center|86-20-87343640|chenming@sysucc.org.cn
8866|NCT01218646|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
8867|NCT01218958|Bernard L. Silverman, VP, Clinical Development|Alkermes, Inc.|781-609-6000|bernard.silverman@alkermes.com
8868|NCT01218971|Bernard L. Silverman, MD|Alkermes, Inc.|781-609-6000|bernard.silverman@alkermes.com
8869|NCT01218984|Bernard L. Silverman, VP, Clinical Development|Alkermes, Inc.|781-609-6000|bernard.silverman@alkermes.com
8870|NCT01218997|Bernard L. Silverman|Alkermes, Inc.|781-609-6000|bernard.silverman@alkermes.com
8871|NCT01219881|Dr. Joseph Werner|The Ohio State University|614-293-8487|Joseph.Werner@osumc.edu
8872|NCT01219985|Pr. Marc-Etienne Meyer|Centre Hospital-Universitaire d'Amiens|+33 3 22 45 59 64|meyer.marc-etienne@chu-amiens.fr
8873|NCT01220180|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8874|NCT01220401|Dr. Noelle Balliett|University of Tulsa|918-631-3976|noelle-balliett@utulsa.edu
8875|NCT01220466|Amelia Saliba, Sr. Manager, Clinical Research|Abbott Medical Optics|408-273-4158|amelia.saliba@amo.abbott.com
8876|NCT01220557|Norbert Hermanns, PhD|Forschungsinstitut der Diabetes Akademie Mergentheim|+49 7931 594 ext 553|hermanns@diabetes-zentrum.de
8877|NCT01296646|James C.  Garbutt, M.D., Professor of Psychiatry|University of North Carolina at Chapel Hill|919-966-4652|jc_garbutt@med.unc.edu
8878|NCT01296698|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|Johnson & Johnson Consumer and Personal Products Worldwide|928-277-0715|jhauze@its.jnj.com
8879|NCT01296841|Roy Soetikno, Chief of Endoscopy, Principal Investigator|VA Palo Alto|650-493-5000 ext 64800|roy.soetikno@va.gov
8880|NCT01297062|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
9223|NCT01256034|Dr. Katsunori Furukawa|Chiba University Graduate School of Medicine|+81-43-226-2269|k-furukawa@umin.ac.jp
9224|NCT01256086|Prof. Dr. Leslie Hendeles|University of Florida, Department of Pharmacotherapy and Tanslational Research, 100486 Gainesville, FL 32610|+1 352 279 ext 6027|hendeles@cop.ufl.edu
9225|NCT01256164|Paul Frohna, Chief Medical Officer|ProFibrix, Inc|206-499-6462|p.frohna@profibrix.com
9226|NCT01256190|Paul Frohna, Chief Medical Officer|ProFibrix, Inc|206-499-6462|p.frohna@profibrix.com
9227|NCT01337076|Dr. Colin Driscoll|Mayo Clinic, Rochester|507 266 1965|driscoll.colin@mayo.edu
9228|NCT01337115|Dr Raul Carvalho|Centro Hospitalar do Porto|+351226176114|raul@meo.pt
9229|NCT01337297|Dr. Ester Miyuki Nakamura-Palacios|Federal University of Espírito Santo|+55 27 7775-7337|emnpalacios@gmail.com
9230|NCT01337336|GSK Response Center|GlaxoSmithKline|866-435-7343|
9231|NCT01337609|Dr. Maurizio Fava|Massachusetts General Hospital|617-724-2513|mfava@partners.org
9232|NCT01337739|Paul Fitzgerald|Northwestern University|312-472-3539|p-fitzgerald2@northwestern.edu
9233|NCT01338025|Clinictrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
9234|NCT01338610|Christian Leisner|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
9235|NCT01338649|Aleksandar Videnovic|Northwestern University|3126234033|aleksvidenovic@gmail.com
9236|NCT01338792|Jacek Pinski, MD|USC Norris Comprehensive Cancer Center|323-865-3900|pinski_j@ccnt.usc.edu
9237|NCT01338818|Study Director|Novartis Pharmaceuticals|8627788300|
9238|NCT01338870|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9239|NCT01339013|Dr Louise Walther Sturesson|Region Skane, Lund University Hospital, Lund, Sweden|+46 46 171953|louise.waltersturesson@skane.se
9240|NCT01339091|Michael Zelasky|Durata Therapeutics|203-871-4616|mzelasky@duratatherapeutics.com
9241|NCT01339247|GSK Response Center|GlaxoSmithKline|866-435-7343|
9607|NCT01287117|Medical Communications|Genentech, Inc.|800 821-8590|
9608|NCT01287208|Anne Thorndike, MD, MPH|Massachusetts General Hospital|617-724-4608|athorndike@partners.org
9609|NCT01287221|Dr. Phillip A. Low|Mayo Clinic|507-284-3375|low@mayo.edu
9610|NCT01287364|Respiratory Medical Director|Sunovion|1-866-503-6351|
9611|NCT01287403|Dr Maurice Beaumont, MD, PhD|Clinical Development Unit / Metabolic Unit|+41217858054|maurice.beaumont@rdls.nestle.com
9612|NCT01287416|Shay-Lee Bolton|University of Manitoba|204-787-5082|sbolton@hsc.mb.ca
9613|NCT01287611|Dr. Cem Turan|DrLutfi|00905323513423|cemturan@gmail.com
9614|NCT01287832|Leonard Johnson MD|St. John Hospital and Medical Center|3133438823|leonard.johnson@stjohn.org
9615|NCT01288079|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
9616|NCT01288209|Manager|Janssen Pharmaceutical K.K., Japan|81 3 44115639|
9795|NCT01367080|Cheol-Hee Lim. Clinical Research Manager (CRM)|Dong Wha Pharm. Co. Ltd.|+82-2-2021-9300 ext 551|cheolhee.lim@dong-wha.co.kr
9796|NCT01367119|Dr. Keith G. Rassmussen|Mayo Clinic|507-284-2933|rasmussen.keith@mayo.edu
9797|NCT01367249|James Gow|Bausch & Lomb Incorporated|949-788-6000|james.gow@bausch.com
9798|NCT01367704|Dr. Elizabeth Miller|Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center|412-692-8504|elizabeth.miller@chp.edu
9799|NCT01367860|Dr. Alexandre Cristante Fogaça|IOT/HC University of SãoPaulo|+55 11 2661-6951|aacristante@uol.com.br
9800|NCT01368042|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
9801|NCT01368081|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9802|NCT01368185|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9803|NCT01368211|Dr. Pär Johansson|Transfusion Service Rigshospitalet - Dept of Immunology, Copenhagen Denmark|+45 35452030|per.johansson@rh.regionh.dk
9804|NCT01368406|Cecilia Attux|Programa de Esquizofrenia PROESQ UNIFESP|551155733599|cattux@gmail.com
9514|NCT01210079|Margaret (Peggy) Compton, RN PhD|School of Nursing, University of California, Los Angeles|(310) 206-2825|pcompton@sonnet.ucla.edu
9515|NCT01210118|Professor Panagiotis Behrakis|Hellenic Anticancer Society|00302106470056|pbehraki@hsph.harvard.edu
9516|NCT01422720|Director R&D|BIAL – Portela & Cª S.A.|+351-229866100|clinical.trials@bial.com
9517|NCT01422850|Christer Lundell-Ek, Project Manager - Clinical Development|CytoVac A/S||cle@cytovac.dk
9518|NCT01423162|Trinidad P. Trinidad|Food and Nutrition Research Institute|6328372071 ext 2281|trinidadtp@yahoo.com.ph
9519|NCT01423773|Head, Clinical Trial Management|Alcon Research|1-800-241-7629|
9520|NCT01424072|Leonice Fumiko Sato Kurebayashi|University of São Paulo|5511 991126023|fumie_ibez@yahoo.com.br
9521|NCT01424228|Study physician|Shire Development LLC|+1 866 842 5335|
9522|NCT01424644|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
9523|NCT01424930|Senior Director|Janssen R&D US||ClinicalTrialDisclosure@its.jnj.com
9524|NCT01155167|Andrew Boyle MD|UCSF|4153533817|aboyle@medicne.ucsf.edu
9525|NCT01155323|Wakana Katabami|Johnson and Johnson K.K.|81-34411-8040 ext 22025|wkatabam@its.jnj.com
9707|NCT01289782|Global Clinical Development Manager|Jan-Cil France||ClinicalTrialDisclosure@its.jnj.com
9708|NCT01289821|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
9709|NCT01289990|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdf@boehringer-ingelheim.com
9710|NCT01290224|Dr. Charles L. Loprinzi|Mayo Clinic|507-284-2511|cloprinzi@mayo.edu
9711|NCT01290341|Stefan Plaum, MD Associate Medical Director|Merz Pharmaceuticals, LLC|800-334-0514|clinicaltrials@merzusa.com
9712|NCT01290484|Dr. Alfred Lane|Stanford University|650-721-7170|alfred.lane@stanford.edu
9713|NCT01290627|Richard Komistek, Ph. D.|The University of Tennessee|86598744159|rkomiste@utk.edu
9714|NCT01290640|Dr. Richard Komistek, Professor|The University of Tennessee|865-974-4159|rkomiste@utk.edu
8881|NCT01297257|Frank van Leeuwen, M.D.|Clinical Research Director|+31433566622|frank.van.leeuwen@medtronic.com
8882|NCT01297283|Dr Françoise Hidden-Lucet|Hôpital de la Pitié-Salpêtrière|+33 1 42 16 00 00|francoise.hidden-lucet@psl.aphp.fr
8883|NCT01297348|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com
8884|NCT01297465|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
8885|NCT01297504|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
8886|NCT01297517|Matt Walker, PhD, Clinical Project Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
9002|NCT00605540|Renata Ferrari|HC/FMB-Unesp|55 14 38116213|renataferrarifisio@gmail.com
9003|NCT00605657|V. Koneti Rao, MD|NIAID|301-496-6502|korao@niaid.nih.gov
9004|NCT00605722|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
9005|NCT00605813|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9006|NCT00605839|Aaron E. Carroll|Indiana University School of Medicine|3172780552|aaecarro@iupui.edu
9007|NCT00605865|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9008|NCT00605904|Markus Heilig|NIAAA, NIH|301.435.9386|mheilig@mail.nih.gov
9009|NCT00605917|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9010|NCT00606008|Dr. Edward Pan|H. Lee Moffitt Cancer Center and Research Institute|813-745-3871|edward.pan@moffitt.org
9011|NCT00606021|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
9012|NCT00606034|Dr. Wendy Lane, Director of Clinical Research|Mountain Diabetes and Endocrine Center|828-258-2404 ext 314|mountaindiabetes@msn.com
9013|NCT00606086|Clinical Operations Manager|GlobeImmune, Inc.|3036252700|Alicia.Mattson@globeimmune.com
9014|NCT00606177|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
9015|NCT00606229|Director of Clinical Research and Development|Otsuka Pharmaceutical CO., Ltd.|+81-3-6361-7366|
9242|NCT01339299|Prof, M.D. Peter Humaidan|Fertility Clinic Regional Hospital Skive|+45 78445760|peter.humaidan@viborg.rm.dk
9243|NCT01361464|Jeffrey Lancet, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-6841|jeffrey.lancet@moffitt.org
9244|NCT01361568|Frédérique Menzaghi, PhD; Vice President, Research & Development|Cara Therapeutics|203-567-1502|fmenzaghi@caratherapeutics.com
9245|NCT01361620|Dr. Timothy McCaffrey|George Washington University|(202) 994-8919|mcc@email.gwu.edu
9246|NCT01361633|Gretchen Diefenbach, Ph.D.|Anxiety Disorders Center, Institute of Living/Hartford Hospital|860-545-7685 ext 5-7396|gdiefen@harthosp.org
9247|NCT01362296|GSK Response Center|GlaxoSmithKline|866-435-7343|
9248|NCT01362439|Therapeutic Area Medical Manager|Janssen-Cilag SpA, Cologno Monzese, Milan - Italy|+39 0225101|
9249|NCT01362491|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9250|NCT01362517|Medical Affairs Director|Crucell Switzerland AG|+41(0)319806111|info@crucell.com
9251|NCT01362530|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9252|NCT01362894|Stacie Cummings, O.D.|Alcon Research, Ltd.|1-800-241-7629|
9253|NCT01362907|Joachim Nick, Dipl. Ing. (FH)|Alcon Research|+49 6022 240 520|joachim.nick@cibavision.com
9254|NCT01363050|David Bregman, M.D., Ph.D.|Luitpold Pharmaceuticals, Inc.|610-650-4200 ext 828|dbregman@lpicrd.com
9255|NCT01363076|David Bregman, M.D., Ph.D.|Luitpold Pharmaceuticals, Inc.|610-650-4200|dbregman@lpicrd.com
9256|NCT01363349|Dr. Arnon Aharon|BioLineRx LTD|972-2-548-9100 ext 135|arnona@biolinerx.com
9257|NCT01363492|Study Physician|Shire Development LLC|+1 866 842 5335|
9258|NCT01363661|Jacques Bruhwyler, Project Manager|ECSOR|3267444093 ext None|Jacques.Bruhwyler@ecsor.com
9259|NCT01363713|General Manager of Clinical Development Group|Santen Pharmaceutical Co., Ltd.|+81-6-4802-9341|clinical@santen.co.jp
9260|NCT01363765|Anete Trajman|InCo-TB project, Gama Filho University|5521-82189194|atrajman@gmail.com
9805|NCT01368536|Study Director|Novartis Pharmaceuticals|862-778-8300|
9806|NCT01368835|Lisa Misell, Ph. D, VP, Medical & Clinical Affairs|Ulthera, Inc.|480-619-4069|
9807|NCT01368874|Lisa Misell, Ph.D., VP, Clinical and Medical Affairs|Ulthera, Inc.|480-619-4069|
9808|NCT01368900|Lisa Misell, Ph.D.|Ulthera, Inc.|480-619-4069|
9809|NCT01368965|Lisa Misell, Ph.D., VP, Clinical and Medical Affairs|Ulthera, Inc.|480-619-4069|
9810|NCT01369030|Lori W Barrentine, MS, PA-C, Director of Clinical Affairs|Pamlab, Inc.|985-867-5788|lbarrentine@pamlab.com
9811|NCT01369485|John Lombard, Manager Clinical Research|Ethicon Surgical Care|908 218 2877|Jlombar8@its.jnj.com
9812|NCT01369641|David Cognetti, MD|Thomas Jefferson University|215-955-6670|David.Cognetti@jefferson.edu
9813|NCT01369680|Dr. Amy-Lee Bredlau|Medical University of South Carolina|843-792-2957 ext 62872|bredlau@musc.edu
9814|NCT01411592|Dr. Martin Sasse, D.M.D., Assistant Professor|University of Kiel|+494315972874|sekretariat@proth.uni-kiel.de
9815|NCT01411696|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
9816|NCT01411891|Dr. Kristopher Schroeder|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|608-263-8100|kmschro1@wisc.edu
9412|NCT01224821|GSK Response Center|GlaxoSmithKline|866-435-7343|
9413|NCT01225029|Dr. Annemarie Stroustrup|Icahn School of Medicine at Mount Sinai|212-241-6186|annemarie.stroustrup@mssm.edu
9414|NCT01225068|Thomas J Schnitzer|Northwestern University Feinberg School of Medicine|3125032315|tjs@northwestern.edu
9415|NCT01225289|The Study of the Effects of Vitamin A Supplementation on Immune System and Th1/Th2 Balance in Patien|Tehran University of Medical Sciences|+98 912 2182815|sjafarirad@gmail.com
9416|NCT01225354|Jack Arkins, Data Manager|DeNova Research|312-335-2070|jack@drdayan.com
9417|NCT01225822|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9418|NCT01225835|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
9715|NCT01290679|Global Clinical Development Manager|Jan-Cil France||ClinicalTrialDisclosure@its.jnj.com
9716|NCT01290731|Manager|Janssen Pharmaceutical K.K., Japan|81 3 44115639|
9717|NCT01290757|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9718|NCT01290796|Jaime Ritter, MPH, CCRP, CIC|Bard Medical Division|770-784-6437|jaime.ritter@crbard.com
9719|NCT01290978|Dr. Gary Grove|cyberDERM Clinical Studies|610-325-0112|
9720|NCT01291108|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
9721|NCT01408862|Dr. Carlos Jose Pirola|Institute of Medical Research (UBA-CONICET)|541145148701 ext 167|cpirola@ciudad.com.ar
9722|NCT01408992|Dr. Kwanchanok Yimtae|Khon Kaen University|66-43348396|kwayim@kku.ac.th
9723|NCT01409213|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9724|NCT01409239|Kathleen Dungan|The Ohio State University|614-685-3333|kathleen.dungan@osumc.edu
9725|NCT01409291|Kathleen Packard, PharmD, MS, BCPS (AQ Cardiology)|Creighton University|402-481-3915|kathleenpackard@creighton.edu
9726|NCT01409564|Prof. Jung Seok Choi|Seoul National University Hospital|82-2-870-3461|choijs@neuroimage.snu.ac.kr
9727|NCT01409707|Dr. Scott Coffey|University of Mississippi Medical Center|601-815-5588|scoffey@umc.edu
9728|NCT01409837|Dr. Anthony Mbah, Principal investigator|University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu|2348051519065|cmd_unth@yahoo.com
9909|NCT01129583|Eric Swart, MD|Columbia University Medical Center|212-305-3912|efs2129@columbia.edu
9910|NCT01129622|Robert F Casper|Mount Sinai Hospital|416-972-0777|casper@lunenfeld.ca
9911|NCT01129765|Mary Margaret Thorne|Advanced Pediatrics|703-938-5555|mthorne@pop.powweb.com
9912|NCT01129921|Eric Grigsby, MD|Napa Pain Institute|707-252-9660|egrig@aol.com
9913|NCT01129960|Director R&D|BIAL - Portela & Cª, S.A.|351-22-9866100|clinical.trials@bial.com
9914|NCT01130051|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
9016|NCT00606281|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
9017|NCT00606320|Director of Clinical Research and Development|Otsuka Pharmaceutical Co, Ltd.|+81-3-6361-7366|
9018|NCT00606489|Amy Rock, Doctor of Philosophy (Ph.D.)|Cumberland Pharmaceuticals|6152550068|arock@cumberlandpharma.com
9019|NCT00606502|Medical Monitor|Allos Therapeutics, Inc|303-426-6262|gweems@allos.com
9020|NCT00606554|Allan Walkey, MD, MSc|Boston University School of Medicine|617-638-4860|alwalkey@bu.edu
9021|NCT00606580|Division of Regulated Activies and Compliance|US Army Medical Materiel Development Activity (USAMMDA)|301-619-0317|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil
9022|NCT00606593|Pascal Charef/Clinical Trial Leader|Actelion Pharmaceuticals Ltd|+41 61 565 65 65|
9023|NCT00606632|Roman Bartz|Wilex AG|+49 89413138 ext 52|roman.bartz@wilex.com
9024|NCT00606684|GSK Response Center|GlaxoSmithKline|866-435-7343|
8614|NCT01280981|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
8615|NCT01281124|Greg Otterson|The Ohio State University Comprehensive Cancer Center|614-293-2887|Greg.Otterson@osumc.edu
8616|NCT01281501|Khrongwong Musikatavorn, MD|Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital.|+662-256-4000 ext 4553-5|kmusikatavorn@yahoo.com
8617|NCT01281839|Global Clinical Development Manager|Jan-Cil France||ClinicalTrialDisclosure@its.jnj.com
8618|NCT01282086|Global Medical Services|Abbott (Ukraine)|1-800-633-9110|
8619|NCT01370590|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8620|NCT01370603|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8621|NCT01370863|Study Physician|Shire Development LLC|+1 866 842 5335|
8622|NCT01371539|Stacie Cummings, O.D.|Alcon Research, Ltd.|1-800-241-7629|
8623|NCT01371552|Joachim Nick, Dipl. Ing.|Alcon Research, Ltd.|+49 6022 240 520|joachim.nick@cibavision.com
9261|NCT01363843|William Sikov, MD and Kimberly Perez, MD|BrUOG|4018633000|kayla_rosati@brown.edu
9262|NCT01363986|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
9263|NCT01364207|Dr. Louis R. Pasquale|Massachusetts Eye and Ear Infirmary|617-573-4240 ext 4240|aliya_jiwani@meei.harvard.edu
9264|NCT01364298|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
9265|NCT01364558|Dr. James Cloyd, Director for Center for Orphan drug research|University of Minnesota|612-624-4609|cloyd001@umn.edu
9266|NCT01364922|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
9267|NCT01365039|Robert Steffen, OD, MS|Bausch & Lomb Incorporated|(585) 338-6399|robert.steffen@bausch.com
9268|NCT01365052|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
9269|NCT01365091|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
9270|NCT01396265|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9271|NCT01396512|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
9272|NCT01396525|Maureen Kennedy|AbbottVascular|+1 408-845-0597|Maureen.Kennedy@av.abbott.com
9273|NCT01397084|James Armbrust|AstraZeneca||aztrial_results_posting@astrazeneca.com
9274|NCT01397591|Jeff Donovan|OHSU Knight Investigational Cancer Services|503-494-7702|mastersj@ohsu.edu
9275|NCT01397890|Nongluk Yimsuan|AstraZeneca|66 2 7397400 ext 429|ClinicalTrialTransparency@astrazeneca.com
9276|NCT01398176|Dr. Susan S. Percival|UFlorida|352-392-1991 ext 201|percival@ufl.edu
9277|NCT01398514|Dr. Naomi Simon|Massachusetts General Hospital|617-726-7913|nsimon@partners.org
9278|NCT01398787|Sharon Holden Thomas, Sr. Principal Clinical Scientist|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
9279|NCT01398839|Bob Gibson|Topcon Medical Systems|(201) 599-5121|RGIBSON@TOPCON.COM
9280|NCT01398852|Bob Gibson|Topcon Medical Systems|(201) 599-5121|RGIBSON@TOPCON.COM
9419|NCT01225926|Manoj Venkiteshwar, Brand Lead, Global Medical Affairs|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
9420|NCT01225952|Omid Khodai, OD,RAC|Bausch & Lomb Incorporated|(949) 521-7894|omid.khodai@bausch.com
9421|NCT01225991|Dr. Helen Lavretsky,|University of California, Los Angeles|310-794-4619|hlavretsky@mednet.ucla.edu
9422|NCT01226043|Trial Transparency Team|Sanofi||Contact-US@sanofi.com
9423|NCT01226095|Global Medical Services|Abbott|800-633-9110|
9424|NCT01226121|F. Thomas D. Kaplan|Indiana Hand to Shoulder Center|3178759105|tdk@hand.md
9425|NCT01226420|Corey S. Cutler, MD, MPH, FRCP(C)|Dana-Farber Cancer Institute|617-632-5946|cscutler@partners.org
9426|NCT01301066|Roger Morgan, MD, FACS|Kowa Research Institute, Inc.|919-433-1600|RMorgan@kowaus.com
9427|NCT01301274|Dr Facundo Jorro Barón|Intensive Care Unit - Hospital Pedro de Elizalde|00541143632100 ext 2035|jorrobox@yahoo.com.ar
9428|NCT01301742|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9429|NCT01301950|Sam Himden, Clinical Portfolio Leader|DePuy Synthes|574-372-7231|shimden@its.jnj.com
9430|NCT01301963|Hien Duong, MD|CCCC|216-445-5531|duongh@ccf.org
9431|NCT01302054|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9432|NCT01302067|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9433|NCT01302119|Sheryl Baldwin, RN/Associate Director|Anacor Pharmaceuticals, Inc.|650-223-8597|clinicaltrials@anacor.com
9617|NCT01288781|Mr Justin Stevan Lawley|UWalesBangor|00441248382810|pepa16@bangor.ac.uk
9618|NCT01288859|Prof. Vincenzo Fogliano|University of Naples|+39 0812539356|fogliano@unina.it
9619|NCT01289015|Stefan Plaum, MD  Associate Medical Director|Merz Pharmaceuticals, LLC|800-334-0514|clinicaltrials@merzusa.com
9620|NCT01289119|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
8653|NCT01149434|Sunil Sharma, MD|Huntsman Cancer Institute Unversity of Utah|801-585-0255|sunil.sharma@hci.utah.edu
8654|NCT01149460|Associate Director, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
8655|NCT01149473|Associate Director, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
8656|NCT01149486|Associate Director, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
8657|NCT01149733|Associate Director, Biopharmaceutics|Teva Pharmaceuticals USA|866-384-5525|clinicaltrialqueries@tevausa.com
8658|NCT01149785|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8774|NCT01217476|Mr. Akira Kondo, Manager, Clinical R&D|Olympus France S.A.S|+33-1-4560-6849|akira.kondo@olympus.fr
8775|NCT01217515|Dr C Jordan, Head of Clinical Operations|S.L.A. Pharma UK Ltd|44 01923 681001|cjordan@slapharma.com
8776|NCT01217892|Eva Johnsson|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
8777|NCT01217944|Study Director|Novartis Pharmaceuticals|862-778-8300|
8778|NCT01218100|Manfred Stapff, MD, PhD|Forest Research Institute|201-427-8000|Manfred.stapff@frx.com
8779|NCT00511355|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
8780|NCT00511433|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
8781|NCT00511472|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8782|NCT00511667|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8783|NCT00511706|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
8784|NCT00511797|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
8785|NCT00511836|Bernard L. Silverman|Alkermes, Inc.|781-609-6000|bernard.silverman@alkermes.com
8786|NCT00511862|Director of Clinical Operations|BTG International Canada Inc.|613-801-1880|TheraSphereClinical@btgplc.com
8624|NCT01371565|Medical Director|Corcept Therapeutics|650-327-3270|info@corcept.com
8625|NCT01371786|Respiratory Medical Director|Sunovion|1-866-503-6351|
8626|NCT01371838|Melnick, David A / Exec Dir Med Science|AstraZeneca Pharmaceuticals|+1 302 886 5627|David.Melnick@astrazeneca.com
8627|NCT01372410|GSK Response Center|GlaxoSmithKline|866-435-7343|
8628|NCT01372813|Marston Linehan, M.D.|National Cancer Institute, National Institutes of Health|301-496-6353|linehanm@mail.nih.gov
8629|NCT01372878|Ravit Peled / Biostatistics and Data Management Manager|Given Imaging|+972 (4) 909-7894 ext 7894|ravit.peled@givenimaging.com
8630|NCT01373346|Seung Ho Choi, M.D., Ph.D.|Gangnam severance hospital|82-2-2019-3374|choish@yuhs.ac
8631|NCT01373450|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8632|NCT01374269|Dr. Fabio Salinas Duran|Grupo Rehabilitacion en Salud|5742196475|fabios@une.net.co
8633|NCT01374919|Dr. Michael Auerbach|Auerbach Hematology Oncology Assoc|410-780-4050|mauerbachmd@abhemonc.com
8634|NCT01374971|Nathan Wei, MD|Nathan Wei, MD, PA dba Arthritis Treatment Center|301-694-5800|nwei@arthritistreatmentcenter.com
8635|NCT01375049|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
8751|NCT01151137|Trial Transparency Team|sanofi-aventis||Contact_US@sanofi.com
8752|NCT01151215|Dr Serban Ghiorghiu|Astrazeneca||ClinicalTrialTransparency@astrazeneca.com
8753|NCT01151280|Alexis James, Clinical Project Manager|Boston Scientific Corporation|508-683-4074|jamesa@bsci.com
8754|NCT01151345|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8755|NCT01151371|Kathy Lorenz-Osborn, OD|Vistakon|+1 904 443-1032|kosborn@its.jnj.com
8756|NCT01151436|Ma May|Galderma|+33 4 92 38 67 33|may.ma@galderma.com
8757|NCT01151553|Dr. Heather Bloom|Emory University|404-321-6111 ext 6391|heather.bloom@emory.edu
8758|NCT01151904|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
9281|NCT01399008|Mary Jean Stempien, M.D., Acting Chief Medical Officer|Metabolex|510-293-8800|mjstempien@metabolex.com
9282|NCT01399125|Study Director|Novartis Pharmaceuticals|8627788300|
9283|NCT01399229|Jack McCrary|Reproductive Research Technologies, LP|7136800200|jmc@innovalp.com
9284|NCT01399788|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9285|NCT01400425|Chief Medical Officer|Avid Radiopharmaceuticals|215-298-0700|clinicaloperations@avidrp.com
9286|NCT01400451|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
9287|NCT01400698|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merck.de
9288|NCT01139047|Ronald W. Gottschalk, MD / Medical Director|Galderma Laboratories, L.P.|817-961-5358|ron.gottschalk@galderma.com
9289|NCT01139515|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9290|NCT01139580|GSK Response Center|GlaxoSmithKline|866-435-7343|
9291|NCT01139658|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9292|NCT01139762|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
9293|NCT01139814|Vice President, Clinical and Regulatory Affairs|Catheter Robotics, Inc.|973-426-0300|research@catheterrobotics.com
9294|NCT01140048|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9295|NCT01140295|Petar Mamula|The Children's Hospital of Philadelphia|215-590-9146|mamula@email.chop.edu
9296|NCT01140477|Johnson Varughese|Bausch & Lomb, a division of Valeant Corporation|908-541-2179|Johnson.Varughese@valeant.com
9297|NCT01401023|Dr. Gary Stein, Pharm D|Michigan State University|517-353-5126|steing@msu.edu
9298|NCT01401153|Prof. Dr. Mathilde Kersting|Research Institute of Child Nutrition|+49-231-792210-18|kersting@fke-do.de
9299|NCT01401361|Nancy Ouch|St. Jude Medical|+19497695041|NOuch@sjm.com
9300|NCT01401465|Respiratory Medical Director|Sunovion|1-866-503-6351|
9621|NCT01289392|Dr Teresa Cristina Barros Schutz|Associação Fundo de Incentivo à Pesquisa|55-21-99868033|schutzferraz@gmail.com
9622|NCT01289418|Gaston De Serres|Laval University|418-666-7000 ext 274|gaston.deserres@ssss.gouv.qc.ca
9623|NCT01289548|Hua zheng|Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology|00862783663173|huaz1980@hotmail.com
9624|NCT01289574|Charles CY Shih, PhD|AndroScience Corp|(858) 638-7230|cyshih@androscience.com
9625|NCT01407523|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
9626|NCT01408277|Jaime E Dickerson, Jr, PhD|Smith & Nephew Biotherapeutics|817-302-3914|jaime.dickerson@smith-nephew.com
9627|NCT01408485|Nancy Ouch, Senior Clinical Project Manager|St. Jude Medical|949-769-5000|NOuch@sjm.com
9628|NCT01408719|Dr. Nancy Ames|Agriculture and Agri-food Canada|204-474-7187|nancy.ames@agr.gc.ca
9629|NCT01152190|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
9630|NCT01152294|Karen Sepucha, Ph.D.|Massachusetts General Hospital|617-724-3350|ksepucha@partners.org
9631|NCT01152307|Dr. Karen Sepucha|Massachusetts General Hospital|617-724-3350|ksepucha@partners.org
9632|NCT01152385|Gerard Lynch|AstraZeneca|+44 1625 518062|aztrial_results_posting@astrazeneca.com
9633|NCT01152437|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9634|NCT01152450|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9635|NCT01152554|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
9636|NCT01152580|Dr. Paula Witt-Enderby, Professor of Pharmacology and Toxicology|Duquesne University|412-396-4346|wittp@duq.edu
9637|NCT01152697|Martha Sajatovic, Professor of Psychiatry|University Hospitals of Cleveland|2168442808|martha.sajatovic@uhhospitals.org
9638|NCT01152788|Dr. Janet Dancey|NCIC Clinical Trials Group|1-613-533-6430|jdancey@ctg.queensu.ca
9817|NCT01412086|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
9915|NCT01130103|Franklin Schneier MD|Research Foundation for Mental Hygiene|212-543-5368|frs1@columbia.edu
9916|NCT01130168|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9917|NCT01130532|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
9918|NCT01130831|Study Physician|Shire Development LLC|+1 866 842 5335|
9919|NCT01130883|Global Medical Services|Abbott|1-800-633-9110|
9920|NCT01130974|Robert Steffen|Bausch & Lomb Inc.|(585) 338-6399|robert.steffens@bausch.com
9921|NCT01131130|Dr. Robert Steffen|Bausch + Lomb|585-338-6399|robert.steffen@bausch.com
9922|NCT01131182|Vice President, Late Stage Development Group Leader|Merck Sharpe & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9923|NCT01131494|Natalie Argolo Ponte|University Federal of Bahia|55 31 3274 5579|natyargolo@hotmail.com
9924|NCT01131507|Robert Winkler, MD, VP, Clinical Development and Operations|Aptalis Pharma US, Inc.|1-800-472-2634|
9925|NCT01144416|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
9926|NCT01144442|Peter Argenta, MD|Masonic Cancer Center|612-626-3111|argenta@umn.edu
9927|NCT01144598|Global Medical Services|Abbott|1-800-633-9110|
9928|NCT01144624|Justin Lindemann|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
9929|NCT01144949|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|Watson Laboratories, Inc.|801 588-6641|gary.hoel@watson.com
9930|NCT01145053|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9931|NCT01145352|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9526|NCT01155336|Dr. Robert Block|University of Rochester|585 275-3356|robert_block@urmc.rochester.edu
9527|NCT01155531|Monica Tettamanti, MSc|Theracos, Inc|617-643-5696|mtettamanti@ccib.mgh.harvard.edu
9528|NCT01155570|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
8759|NCT01215721|Thomas Ahlering, MD|UC Irvine|714-456-6068|tahlerin@uci.edu
8760|NCT01215734|Natasha Halasa, Associate Professor of Pediatrics|Vanderbilt University|615-322-3346|natasha.halasa@vanderbilt.edu
8761|NCT01215786|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
8762|NCT01215929|Michael J Mancino MD|UAMS|501-526-8440|mjmancino@uams.edu
8763|NCT01215955|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8764|NCT01216072|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
8765|NCT01216163|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8766|NCT01216241|Dr. Robert F. Betts|University of Rochester|585-275-5871|robert_betts@urmc.rochester.edu
8767|NCT01216397|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8768|NCT01216410|Ashraf Habib|Duke University Medical Center|919 668 6266|habib001@dm.duke.edu
8769|NCT01216761|Laraine Washer, MD|University of Michigan Health System|734-936-5205|laraine@med.umich.edu
8770|NCT01216943|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
8771|NCT01217112|Mr Richard Potts, Clinical Operations Director|GW Research Ltd.|0044 1223266800|rp@gwpharm.com
8772|NCT01217229|Medical Monitor|Plexxikon Inc.|510-647-4000|info@plexxikon.com
8773|NCT01217463|Mr. Akira Kondo, Manager, Clinical R&D|Olympus France S.A.S|+33-1-4560-6849|akira.kondo@olympus.fr
8887|NCT01297595|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8888|NCT00558571|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8889|NCT00558636|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
8890|NCT00558753|Asokumar Buvanendran, M.D.|Rush University Medical Center|(312) 942-3685|asokumar@aol.com
8891|NCT00558792|Usha Halemane, Executive Director of Medical Biometrics and Medical Writing|Bracco Diagnostics Inc|609-514-2578|usha.halemane@diag.bracco.com
9301|NCT01401478|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
9302|NCT01401517|Tony Giordano|TheraVasc Inc.|318-349-3851|tgiordano@theravasc.com
9303|NCT01402102|Dr. Dal-Sik Kim|Clinical trial center for Functional Food in Chonbuk Nat'l University Hospital|82-63-250-1793|dskim@chonbuk.ac.kr
9304|NCT01402115|Dr. Dal-Sik Kim, MD|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|82-63-276-8284|dskim@chonbuk.ac.kr
9305|NCT01402128|Dr. Soo-Wan Chae, MD|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|82-63-276-8284|soowan@jbnu.ac.kr
9306|NCT01402141|Dr. Baek-Hwan Cho, MD|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|82-63-250-1579|chobh@jbnu.ac.kr
9307|NCT01402427|Istvan Hizoh, MD, PhD / Senior Consultant|State Health Center, Hungary|+36 1 4651800 ext 71773|ihizoh@web.de
9308|NCT01402869|Dr. Lauren Gutenberg|Loma Linda University|909-558-4690|lgutenberg@llu.edu
9309|NCT01402947|Study Physician|Shire Pharmaceutical|1 866-842-5335|
9310|NCT01403051|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
9311|NCT01403090|Luis Angel, MD|BiO2 medical|2102139778|langel@bio2medical.com
9312|NCT01403194|Dr. Seema Kumar|Mayo Clinic|507-538-2724|kumar.seema@mayo.edu
9313|NCT01403376|Trial Transparency Team|Sanofi||Contact_US@sanofi.com
9314|NCT01403805|Dr. Masahiro Hatta|Department of Dentistry, Yubari Kibounomori, Japan|+81-123-52-4339|masahiro.hatta@hotmail.co.jp
9315|NCT01403987|Brian Jacobson, MD, Principal Investigator|Boston Medical Center|617-6386563|brian.jacobson@bmc.org
9316|NCT01404234|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
9317|NCT01404429|Varun Dhir, Assistant Professor, Internal Medicine|PGIMER, India|+91-8872229998|varundhir@gmail.com
9318|NCT01404572|BMS Study Director|Bristol-Myers Squibb (BMS)||Clinical.Trials@bms.com
9319|NCT01404832|Stuart Spechler|Dallas VAMC|214-374-7799|sjspechler@aol.com
9818|NCT01412151|Steven M. Hersch, MD, PhD|Massachusetts General Hospital|617-726-1254|hersch@helix.mgh.harvard.edu
9819|NCT01412281|Medical Affairs Director|Crucell Switzerland|+41(0)319806111|info@crucell.com
9820|NCT01412801|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
9821|NCT01412983|Dr. Robert Steffen|Bausch & Lomb|1 585 338 6399|robbert.steffen@bausch.com
9822|NCT01413204|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
9823|NCT01413958|Vice President, Late Stage Development Group|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9824|NCT01414166|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@Merck.com
9825|NCT01414205|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
9826|NCT01414413|Dr Peter MacPherson|Liverpool School of Tropical Medicine|0044151 705 3100|p.macpherson@liv.ac.uk
9827|NCT01415232|Dr. Manuel Vallejo|UPittsburgh`|4126414260|vallejomc@anes.upmc.edu
9828|NCT01415349|Study Physician|Shire Pharmaceutical|1 866 842 5335|
9829|NCT01415401|Doug Hubatsch, Global Brand Leader|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
9830|NCT01415453|Dr Ronald Silverman|Columbia University Medical Center|2123055484|rs3072@columbia.edu
9831|NCT01415518|Goran Eckerwall|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
9832|NCT01415531|Tatjana Lukic, MD, MSc|Forest Research Institute|(201) 427-8649|tanya.lukic@frx.com
9833|NCT01415986|Gal Shafirstein, D.Sc.|Roswell Park Cancer Institute|716-845-4025|Gal.Shafirstein@RoswellPark.org
9834|NCT01416129|Jason Highsmith|University of South Florida|813-974-3806|mhighsmi@health.usf.edu
9835|NCT01143792|Natasha Slesnick|The Ohio State University|614 247-8469|slesnick.5@osu.edu
9836|NCT01143818|Global Medical Services|Abbott|800-633-9110|
9837|NCT01143883|Jorge E. Marcet, M.D.|University of South Florida|813-844-4545|jmateka@health.usf.edu
8478|NCT01186939|CL Beach|Celgene Corporation||CLBeach@celgene.com
8479|NCT01187004|Dr Daniela Pasero|UTurin|00390116335511|daniela.pasero@unito.it
8480|NCT01187043|Jennifer L. Wike|Repros Therapeutics Inc.|281-719-3402|jwike@reprosrx.com
8481|NCT01187355|Director of Alcon Clinical|Alcon Research, Ltd.|1-888-451-3937|medinfo@alconlabs.com
8482|NCT01187498|Kathryn L. Burgio, PhD|Birmingham VA Medical Center|205-558-7064|kburgio@uabmc.edu
8483|NCT01187550|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
8484|NCT01187914|Dr. Kavitha Damal, Clinical research Manager|Arrhythmia Research Center, University of Utah|8012133775|kavitha.damal@carma.utah.edu
8485|NCT01188343|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
8486|NCT01188538|Farzaneh SIDOU|Galderma|00 33 4 93 95 70 51|farzaneh.sidou@galderma.com
8487|NCT01188551|Joseph D. Tobias, MD|Nationwide Children's Hospital|614-722-4200|Joseph.Tobias@nationwidechildrens.org
8488|NCT01188603|Sprout Pharmaceuticals|Sprout Pharmaceuticals|1-919-882-0850|clinicaltrials@sproutpharma.com
8489|NCT01188655|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8490|NCT01188668|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8491|NCT01260948|Associate Director, Biopharmaceutics|Teva Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
8492|NCT01261052|Dr. W Kenneth Ward|Legacy Health System|503-413-5171|kenward503@msn.com
8493|NCT01261507|Matthew T. Freedman, MD|Georgetown University Medical Center|4105429680|freedmmt@georgetown.edu
8494|NCT01261559|Dr. Claire Sandstrom|University of Washington|206-744-3561|cks13@uw.edu
8495|NCT01261624|Clinical R&D Director|Italfarmaco S.p.A.|026443 ext 2584|p.bettica@italfarmaco.com
8496|NCT01261975|Omid Khodai|Bausch & Lomb|(949) 521-7894|Omid.Khodai@bausch.com
8497|NCT01262092|Dr. Alison Oliveto|University of Arkansas for Medical Sciences|501-526-8441|olivetoalison@uams.edu
8892|NCT00558831|Amy Paller, MD|Northwestern University|312-695-6829|apaller@nmff.org
8893|NCT00558896|Dr. Martha Lacy|Mayo Clinic||lacy.martha@mayo.edu
8894|NCT00559013|Lesa Hobright-Turner, Director of Clinical Affairs|Synovis|651-796-7506|lesa.hobrightturner@synovissurgical.com
8895|NCT00559364|Robert Winkler, MD, VP, Clinical Development and Operations|Aptalis Pharma US, Inc.|1-800-472-2634|
8896|NCT00559507|Clifford Hudis, MD|Memorial Sloan-Kettering Cancer Center|646-888-4551|hudisc@mskcc.org
8897|NCT00559585|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
8898|NCT00559936|Dr. Reza Dana|Massachusetts Eye and Ear Infirmary|617-573-3313|cornea_research@meei.harvard.edu
8899|NCT00559962|Mark Sumeray, MD, Chief Medical Officer|Aegerion Pharmaceuticals|617-500-7867|
8900|NCT00559988|Crystal Miller|Biotronik, Inc|503-451-8051|crystal.miller@biotronik.com
8901|NCT00560066|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
8902|NCT00560235|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8903|NCT00560313|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
8904|NCT00560352|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
8905|NCT00560391|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
8906|NCT00560417|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8907|NCT00560508|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8908|NCT00560560|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8909|NCT00560573|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9025|NCT00606801|Mehmet Sofuoglu, M.D., Ph.D.|Yale University|203-937-4809|mehmet.sofuoglu@yale.edu
9026|NCT01190085|Dr. Lorenzo Leggio|Brown University|401-863-1000|Lorenzo_Leggio@Brown.edu
9342|NCT01342471|Jeremy Steeves Ph.D.|National Cancer Institute|(865)-308-3506|jeremy.steeves@nih.gov
9343|NCT01113931|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
9344|NCT01114581|Gail Solomon, Director, Clinical Development|Reckitt Benckiser Inc.|973-404-2752|gail.solomon@rb.com
9345|NCT01114672|Mary Schanler, Principal Investigator|Winthrop University Hospital|5156639028|mschanler@winthrop.org
9346|NCT01114724|Kalyan Obalampalli|Medtronic Inc|7075413158|kalyan.obalampalli@medtronic.com
9347|NCT01114828|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
9348|NCT01114880|Global Medical Services|Abbott|1-800-633-9110|
9349|NCT01114893|Alcon Clinical|Alcon Research, Lt.d|888.451.3937 ext 817.568.67|medinfo@alconlabs.com
9350|NCT01115101|Dr. Max Dieterich|University of Rostock|+493814401 ext 4500|max.dieterich@uni-rostock.de
9351|NCT01365130|Howard Safran, MD|BrUOG|4018633000|Hsafran@lifespan.org
9352|NCT01365273|Joan Wilson, MSN, MHA, RN|Monlycke Health Care|706 504 8997|joan.wilson@molnlycke.com
9353|NCT01365494|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
9354|NCT01365585|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9355|NCT01365611|David Bregman, M.D., Ph.D.|Luitpold Pharmaceuticals, Inc.|610-650-4200 ext 828|dbregman@lpicrd.com
9356|NCT01125917|Clinical Leader, Medical Director|Purdue Pharma L.P.|800-733-1333|
9357|NCT01125930|Dr. Lisa Maier|University of Michigan|734-936-4192|maierl@med.umich.edu
9358|NCT01126060|Dr. Man Ki Chung|Samsung medical center|82-2-3410-1845|manki.chung@samsung.com
9359|NCT01126359|Dr. Erik Kubiak|Department of Orthopaedics|801-587-5404|Erik.Kubiak@hsc.utah.edu
9360|NCT01126424|Associate Medical Director Urology|Astellas Pharma Europe Ltd.||clinicaltrials@us.astellas.com
9361|NCT01126437|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9838|NCT01144026|Dr. Gideon Goldstein|Thymon LLC|(973) 467-9558|gidgold@gmail.com
9839|NCT01144052|Claudio Globbi, Dr. med.|Ospedale Civico|+41 91 811 6921|claudio.gobbi@eoc.ch
9434|NCT01115166|Joachim Zdolsek|Department of Anaestesilogy and Intensive Care|+46101030000|joachim.zdolsek@lio.se
9435|NCT01115569|Kevin Romanko|Zogenix|(510) 550-8323|kromanko@zogenix.com
9436|NCT01115660|Dr. Cheryl Bushnell|Wake Forest School of Medicine|(336) 716-2357|cbushnel@wakehealth.edu
9437|NCT01115673|Joyce Hauze, RPS Sr Specialist, Clinical Research Operations|Johnson & Johnson Consumer and Personal Products Worldwide|928-277-0715|jhauze@its.jnj.com
9438|NCT01115699|Michelle Skime, Supervisor - Senior Clinical Research Coordinator|Mayo Clinic|507-255-0501|skime.michelle@mayo.edu
9439|NCT01115738|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
9440|NCT01115933|Aarthi Raman, PhD|Abbott Vascular|408 845-0942|aarthi.raman@abbott.com
9441|NCT01115998|Director of Sponsored Programs|University of Oklahoma Health Sciences Cetner|405-271--2090|mary-cotter@ouhsc.edu
9442|NCT01116102|George Harb, MD, MPH|Baxter Healthcare Corporation||george_harb@baxter.com
9443|NCT01116232|Zaid Al-Kadhimi, M.D.|Barbara Ann Karmanos Cancer Institute|313-576-8022|alkadhiz@karmanos.org
9444|NCT01116687|Jonathan Strosberg, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-7257|jonathan.strosberg@moffitt.org
9445|NCT01116882|Katherine Agule|Harvard Clinical Research Institute|617-307-5200|kagule@hcri.harvard.edu
9446|NCT01117051|Study Physician|Movetis|+1 866 842 5335|
9447|NCT01117090|Felicia R. Cochran, PhD, Principal Clinical Research Specialist|Medtronic Neuromodulation|763-526-8139|felicia.r.cochran@medtronic.com
9448|NCT01117181|Anne Casper, MA|Johns Hopkins|410-955-8183|ashankli@jhsph.edu
9449|NCT01117311|Dr. Adrian Vella|Mayo Clinic|507-284-3289|vella.adrian@mayo.edu
9450|NCT01117337|Mohamed Ismail, Chief Consultant, Moulana Hospital, Perianthalmanna|Moulana Hospital|0091-9447128511|drgargpankaj@yahoo.com, mdismail13@gmail.com
9451|NCT01117350|Trial Transparency Team|sanofi||Contact-us@sanofi.com
8787|NCT00511901|Jeffrey L Carson, MD|University of Medicine and Dentistry of New Jersey|732-235-7122|carson@umdnj.edu
8788|NCT00511914|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
8789|NCT00512096|Cherie A. Perez|UT MD Anderson Cancer Center||caperez@mdanderson.org
8790|NCT00512148|Sunita Sheth, MD - Chief Medical Officer|Tengion|610 292 8364|info@tengion.com
8791|NCT00512252|Geoffrey L. Uy, M.D.|Washington University School of Medicine|314-454-8304|guy@dom.wustl.edu
8792|NCT00512798|Jeffrey Sosman, M.D.|Vanderbilt-Ingram Cancer Center||jeff.sosman@vanderbilt.edu
8793|NCT00557830|Vice President of Scientific Affairs|Accelerated Community Oncology Research Network, Inc.||mwalker@acorncro.com
8794|NCT00557947|John Lombard|Ethicon Inc|908-218-2877|Jlombar8@its.jnj.com
8795|NCT00558025|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8910|NCT00605085|Senior Manager Clinical Research|Intercell AG|+43 1 206 20 ext 1175|kdubischar-kastner@intercell.com
8911|NCT00605176|Sharon F. Levy, MD|Graceway Pharmaceuticals LLC|267-948-0400|sharon.levy@gracewaypharma.com
8912|NCT00605202|Janne Hukkanen|Oulu University Hospital, Department of Internal Medicine|+358-8-315 6212|janne.hukkanen@oulu.fi
8913|NCT00605267|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
8914|NCT00605280|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8915|NCT01124617|Manager|Neuroscience department, clinical science department, R&D in Janssen Japan, Chiyodaku, Tokyo 101-0065 Japan|+81-3-4411-5509|
8916|NCT01124643|Study Physician|Shire Development LLC|+1 866 842 5335|
8917|NCT01124786|VP Clinical Development|Clovis Oncology, Inc.|415-409-5440|clinicaltrialinfo@clovisoncology.com
8918|NCT01124955|Tatiana Molinas Hasegawa|Federal University of São Paulo|55 115576 4239|tatianamolinas@hotmail.com
8919|NCT01125514|Study Director|Novartis Pharmaceuticals|862-778-8300|
9027|NCT01190124|Doroana, Maria Manuela, M.D.|Hospital de Santa Maria - Centro Hospitalar Lisboa Norte|351 217938043|manuela.doroana@hsm.min-saude.pt
9028|NCT01190150|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
9029|NCT01190215|GSK Response Center|GlaxoSmithKline|866-435-7343|
9030|NCT01190254|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9031|NCT01190267|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9032|NCT01190306|Robert Gibson|Topcon Medical Systems|(201) 599-5121|RGIBSON@TOPCON.COM
9033|NCT01190436|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
9034|NCT01190514|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
9035|NCT01191320|Jennifer L. Wike|Repros Therapeutics Inc.|281-719-3402|jwike@reprosrx.com
9036|NCT01191398|Craig J. Huang, MD|University of Texas Southwestern Dallas Medical Center|214-456-6371|craig.huang@utsouthwestern.edu
9037|NCT01191476|Global Medical Services|Abbott|800-633-9110|
9038|NCT01191723|VP, Scientific Affairs|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|650-386-3100|dkellerman@mappharma.com
9039|NCT01191736|David Drachman|Maricopa Integrated Health System|602-344-5161|david.drachman@mihs.org
9040|NCT01191762|Kenneth R. Phelps, M.D.|Kenneth R. Phelps, M.D.|518-626-5641|kenneth.phelps@va.gov
9041|NCT01191788|Katherine Watkins|RAND Corporation|(310) 393-0411 ext 6509|kwatkins@rand.org
9042|NCT01265615|Dr. Alexander Kharlamov|Ural Institute of Cardiology, Ural State Medical Academy|+79638547663|drskharlamov@gmail.com
9043|NCT01265823|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
9044|NCT01265966|Dr. Jordan Pinsker|Tripler Army Medical Center|808-433-6338|jordan.pinsker@us.army.mil
9045|NCT01265992|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
9046|NCT01266148|Study director|Novartis Pharmaceuticals|862-778-8300|
9362|NCT01126541|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
9363|NCT01126619|Global Medical Services|Abbott|800-633-9110|
9364|NCT01126671|Dr. Sarah Pitts|Boston Children's Hospital|617-355-3732|sarah.pitts@childrens.harvard.edu
9729|NCT01410240|Maurice Bagot D'Arc, MD, Sr Medical Director Medical Affairs , BioSurgery|Baxter BioScience||maurice_bagot_d'arc@baxter.com
9730|NCT01410474|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
9731|NCT01410604|M.D. Maria L. Evia-Viscarra|Hospital Regional de Alta Especialidad del Bajio|+52 (477) 267-2000 ext 1405|evialola@hotmail.com
9732|NCT01410773|Jane Wallace|Bayer Healthcare, Diabetes Care|574-257-3063|jane.wallace@bayer.com
9733|NCT01411215|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9734|NCT01302418|Tony Lam|QIAGEN|301-944-7090|tony.lam@qiagen.com
9735|NCT01302444|James R Klinger, MD|Rhode Island Hospital||jklinger@lifespan.org
9736|NCT01302548|Richard F Petrik, MD|University of Florida|352-265-5911|rpetrik@ufl.edu
9737|NCT01302899|Study Director|Novartis Pharmaceuticals|862-778-8300|
9738|NCT01302938|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9739|NCT01303224|Angela Capriati MD PhD, Corporate Director of Clinical Research|Menarini Ricerche S.p.A.|+39 055 5680 ext 9933|acapriati@menarini-ricerche.it
9740|NCT01303445|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9741|NCT01303510|Medical Affairs Director|Crucell Switzerland AG|+41(0)319806111|info@crucell.com
9742|NCT01303627|Derya Özkan MD|Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital 1. Anesthesiology|0903125962553|derya_z@yahoo.com
9743|NCT01303861|Dr. Jed E. Rose|Duke University Medical Center - Duke Center for Smoking Cessation|919-668-5055|jed.rose@dm.duke.edu
9744|NCT01304238|GSK Response Cente|GlaxoSmithKline|866-435-7343|
9745|NCT01304277|Study Physician|Shire Development LLC|+1 866 842 5335|
9452|NCT01117766|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9453|NCT01117857|Dr. Marlene Freeman, MD|Massachusetts General Hospital|617-643-6403|mfreeman@partners.org
9454|NCT01117948|Director of Clinical Trials|JSW-Lifesciences|0043316 258111 ext 310|office@jsw-lifesciences.com
9455|NCT01118091|Dr. Steven Rosenberg|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
9456|NCT01118273|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
9639|NCT01152996|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
9640|NCT01153009|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
9641|NCT01153269|Global Medical Services|Abbott|1-800-633-9110|
9642|NCT01153347|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
9643|NCT01153503|Irina Gasanova, MD, PhD|University of Texas Southwestern Medical Center|214-590-0064|Irina.Gasanova@UTSouthwestern.edu
9644|NCT01153620|Medical Affairs Manager|B. Braun Medical, Centre of Excellence|+41 58 258 55 47|
9645|NCT01153633|Medical Scientific Affairs Manager|B. Braun Medical AG|+41 58 258 55 47|
9646|NCT01153685|GSK Response Center|GlaxoSmithKline|866-435-7343|
9647|NCT01153698|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9648|NCT01153711|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9649|NCT01153724|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9650|NCT01153763|GSK Response Center|GlaxoSmithKline|866-435-7343|
9651|NCT01153815|GSK Response Center|GlaxoSmithKline|866-435-7343|
9652|NCT01153893|GSK Response Center|GlaxoSmithKline|866-435-7343|
9653|NCT01182207|Associate Director, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
9529|NCT01155726|Director of Clinical Trials|Alcon Research|1-800-241-7629|
9530|NCT01155869|Peter Friedmann|Providence VA Medical Center|401-273-7100 ext 6240|peter.friedmann@va.gov
9531|NCT01156051|Thomas A Rugino MD|Children's Specialized Hospital|732-797-3826|trugino@childrens-specialized.org
9532|NCT01156480|Dr. Brandy Frost|NorthShore University HealthSystem|847-570-2033|bfrost@northshore.org
9533|NCT01156532|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
9534|NCT01156571|Meredith Todd - Sr. Director Program Management|The Medicines Company|+1.973.290.6088|meredith.todd@themedco.com
9535|NCT01156701|GSK Response Center|GlaxoSmithKline|866-435-7343|
9536|NCT01156844|Study Director|Novartis Pharmaceuticals|862-778-8300|
9537|NCT01157065|Mehdi Hosseini, Clinical Trial Manager|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
9538|NCT01157078|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
9539|NCT01157169|Associate Director, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
9540|NCT01157182|Associate Director, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
9541|NCT01157377|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
9542|NCT01157533|Ara Vaporciyan, MD, BS/ Professor|The University of Texas (UT) MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
9543|NCT01157845|R. Todd Stravitz|Virginia Commonwealth University|804-828-8514|rstravit@vcu.edu
9544|NCT01179672|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
9545|NCT01179737|Study Director|Novartis Pharnaceuticals|862-778-8300|trialandresults.registries@novartis.com
9546|NCT01180244|Dr. Jeffrey B. Hargrove|Department of Mechanical Engineering, Kettering University||jhargrov@kettering.edu
9547|NCT01180296|David McKenna|Fetal Medicine Foundation?USA|937-208-4005|dsmckenna@mvh.org
9548|NCT01180400|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
9047|NCT01266824|Dr. Amy Cohen|Children's Hospital of Philadelphia|215-590-1000|cohenam@email.chop.edu
9048|NCT01266967|GSK Response Center|GlaxoSmithKline|866-435-7343|
9049|NCT01267136|Andrea Postier/Clinical Research Program Manager|Children's Hospitals and Clinics of Minnesota|612-813-6409|andrea.postier@childrensmn.org
9050|NCT01267175|Harold Torunsky|Medtronic Diabetes|(818) 576 5445|harold.torunsky@medtronic.com
9051|NCT01267201|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9052|NCT01267227|Dr. Daniel Riche|University of Mississippi|601-984-2640|driche@umc.edu
9053|NCT01205581|Jon McCullers, MD|St. Jude Children's Research Hospital|866-278-5833|info@stjude.org
9054|NCT01282138|Head, Global Medical Affairs|Alcon Research|1-800-862-5266|medinfo@alconlabs.com
9055|NCT01282203|Global Medical Services|AbbVie (prior sponsor Abbott)|1-800-633-9110|
9056|NCT01282424|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
9057|NCT01282710|Jack McCrary|Reproductive Research Technologies, LP|7136800200|jmc@innovalp.com
9058|NCT01282723|Jack McCrary|Reproductive Research Technologies, LP|7136800200|jmc@innovalp.com
9059|NCT01282801|Associate Director, Biopharmaceutics|Teva Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
9060|NCT01282814|Associate Director, Biopharmaceutics|Teva Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
9061|NCT01282866|Suzanne Kilmer, MD|Laser & Skin Surgery Medical Group Inc.|916-456-0400|Study@skinlasers.com
9062|NCT01283022|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
9063|NCT01283464|Dr. Anna L. Chien|Johns Hopkins Dermatology|4105027546|ctrep@jhmi.edu
9064|NCT01283516|Study Director|Novartis Pharmaceuticals|862-778-8300|
9065|NCT01283555|Jessica Cohen|PATH|206-285-3500|jcohen@path.org
9066|NCT01283581|Dr. Eugene Sun|Rib-X Pharmaceuticals||esun@Rib-x.com
9746|NCT01304329|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9747|NCT01304589|Dr. Candace Brown|University of Tennessee Health Science Center|901-412-4341|csbrown@uthsc.edu
9748|NCT01304641|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9749|NCT01304693|Georges Weissgerber, Executive Director, Novartis Pharma AG|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
9750|NCT01304966|Dr.Pavinee Intakorn|Queen Sirikit Nation Institute of Thailand|06623548333 ext 2301|pintakorn@yahoo.com
9320|NCT01404936|Anas Younes, MD / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
9321|NCT01405768|L. Stewart Massad, M.D.|Washington University School of Medicine|314-362-3181|massadl@wudosis.wustl.edu
9322|NCT01405950|Herbert Henney, PharmD|Acorda Therapeutics, Inc.|914-347-4300 ext 5138|hhenney@acorda.com
9323|NCT01406990|Dr. Katie Packard, PharmD|Creighton University|402-280-4566|kathleenpackard@creighton.edu
9324|NCT01339416|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9325|NCT01339936|Dr Michel Guillon|Optometric Technology Group|+44 2072224224|mguillon@otg.co.uk
9326|NCT01340014|Doug Hubatsch, Global Brand Leader, Medical Affairs|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
9327|NCT01340066|Dr. John McMichael|Beech Tree Labs, Inc.|518-872-1144|
9328|NCT01340209|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9329|NCT01340573|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
9330|NCT01340625|Associate Director, Biopharmaceutics|Teva Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
9331|NCT01340651|Study Director|Incyte Corporation|855 463-3463|
9332|NCT01340664|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|Janssen Research & Development, LLC|1 908 927-5775|
9333|NCT01340768|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9654|NCT01182428|Ellen Travis, Clinical Science|Abbott Vascular|408-845-3000|Ellen.Travis@av.abbott.com
9655|NCT01182610|Vice Presidnet of Scientific Affairs|Accelerated Community Oncology Research Network, Inc.||mwalker@acorncro.com
9656|NCT01182727|Dr. Robert Buchanan, M.D.|Maryland Psychiatric Research Center|410-402-7876|rwbuchanan@mprc.umaryland.edu
9657|NCT01182805|Theodore J. Kolias, MD|University of Michigan|(734) 615-4907|tkolias@umich.edu
9658|NCT01183013|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9659|NCT01183234|Patrick Martin, M.D.|Shire Pharmaceutical||pmartin@shire.com
9660|NCT01183312|Dr. Lynn Marie Trotti|Emory University School of Medicine|404-728-4752|lbecke2@emory.edu
9661|NCT01256294|Study Director|Novartis Pharmaceuticals|862-778-8300|
9840|NCT01144286|Vladimir Dvorak|Privatni gynekologicka ambulance|+420 542 221 661|ssgcr@ti.cz
9841|NCT01144299|GSK Response Center|GlaxoSmithKline|866-435-7343|
9842|NCT00615056|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9843|NCT00662025|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9844|NCT00662363|Christina Marciniak|Rehabilitation Institute of Chicago|312-238-1000|cmarciniak@ric.org
9845|NCT00662389|Eve Conner, Ph.D. Consultant|Apsara Medical Corporation|510 566-2495|eaconner@sbcglobal.net
9846|NCT00662532|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|OraPharma|215-420-4064|bpatel@orapharma.com
9847|NCT00662545|Anne Luetkemeyer|UCSF SFGH|415 476 4082 ext 130|aluetkemeyer@php.ucsf.edu
9848|NCT00662558|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
9849|NCT00662649|Study Director|Novartis Pharmaceuticals|862 778-8300|
9850|NCT00662675|Director, Clinical Team Leader|Johnson & Johnson Pharmaceutical Research & Development, LLC|609-730-3158|
9851|NCT00662818|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8498|NCT01262105|Sean Self|Nimbic Systems|281-565-5700|self@nimbicsystems.com
8499|NCT01262118|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8500|NCT01262131|Allen S. Braswell CEO|Pico-Tesla Magnetic Therapies, LLC|303 795-3222|abraswell@pico-tesla.com
8636|NCT01375127|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8637|NCT01376037|Mark S. Nestor, M.D., Ph.D|Center for Clinical and Cosmetic Research|305-933-6716|nestormd@ADMCORP.com
8638|NCT01376089|Lauren Lim, PharmD|GE Healthcare|1-626-356-1937|lauren.lim@ge.com
8639|NCT01376245|GSK Response Center|GlaxoSmithKline|866-435-7343|
8640|NCT01376362|Hatice Nida Sen, Principal Investigator, National Eye Institute|National Institutes of Health|(301) 402-3254|senh@nei.nih.gov
8641|NCT01147874|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8642|NCT01147900|GSK Response Center|GlaxoSmithKline|866-435-7343|
8643|NCT01147926|Study Physician|Shire|+1 866 842 5335|
8644|NCT01148017|Posting Director|Novartis Vaccines||RegistryContactVaccinesUS@novartis.com
8645|NCT01148420|Anita Nelson|Harbor - UCLA Medical Center|310-222-3871|anitanelsonwhc@earthlink.net
8646|NCT01148511|Study Director|Novartis Pharmaceuticals|862 778-8300|
8647|NCT01148524|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
8648|NCT01148537|Executive Medical Director|Purdue Pharma L.P.|800-733-1333|
8649|NCT01148693|Dr. Rasoul sotoudehmanesh|Tehran medical university of science|(+98 21) 82414000 ext 82415000|r.sotudemanesh@gmail.com
8650|NCT01148745|Dr. Toros Kapoian, M.D., F.A.C.P.|Dialysis Clinic, Inc.|732-940-8368|Toros.Kapoian@dciinc.org
8651|NCT01148771|Joseph L. Kuti, Pharm.D. / Associate Director, Clinical and Economic Studies|Center for Anti-Infective Research and Development, Hartford Hospital|860-545-3612|jkuti@harthosp.org
8652|NCT01149148|Dr. Wei C. Lau|UmichiganHS|734 9369479|weiclau@med.umich.edu
9067|NCT01283971|Medical Communications|Hoffman-LaRoche|800-821-8590|
9068|NCT01284114|Dr. Yoshiyuki Morishita|Division of Nephrology, Department of Internal Medicine, Jichi Medical University|81-285-58-7346|ymori@jichi.ac.jp
9069|NCT01284296|Ronald D. Miller|University of California, San Francisco|415 476-9034|millerr@anesthesia.ucsf.edu
9070|NCT01284491|Robert Swain, PhD|Medtronic Surgical Technologies|(+1-603) 294-5428|robert.e.swain@medtronic.com
9071|NCT01284517|Medical Director, CNS|Sunovion|1-866-503-6351|
9072|NCT01284621|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9073|NCT01284634|Richard Potts|GW Research Ltd|0044 1223 266800|rp@gwpharm.com
9074|NCT01284959|Prof. Youngchul Chung|Chonbuk National University Hospital|+82-63-250-2185|chungyc@chonbuk.ac.kr
9075|NCT01285076|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9076|NCT01285310|Anne McClain|Celgene Corporation|888-260-1599|clinicaltrialdisclosure@celgene.com
9077|NCT01285427|Deanna Vella, Staff Regulatory Engineer|Life Technologies|760-918-3000|deanna.vella@lifetech.com
9078|NCT01285492|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
9079|NCT01285713|Dr. Kari Posner|New York University, Langone Medical Center|212-263-7300|kariposner@gmail.com
9080|NCT01285843|Ing. Elisa Bonacina, Clinical Data Manager|Medacta International|+41 91 696 60 60|bonacina@medacta.ch
9081|NCT01153958|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
9082|NCT01153971|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
9083|NCT01154036|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9084|NCT01154127|Study Director|Novartis Pharmaceuticals|862-778-8300|
9085|NCT01154153|Trial Transparency Team|sanofi-aventis||Contact-US@sanofi.com
9086|NCT01154166|GSK Response Center|GlaxoSmithKline|866-435-7343|
9334|NCT01341067|Mark Sulik, PharmD CCRP|Rocky Mountain Diabetes and Osteoporosis Center|208-528-9642|mark@idahomed.com
9335|NCT01341782|Global Medical Services|Abbvie (prior sponsor, Abbott)|800-633-9110|
9336|NCT01341912|VP of Clinical Research and Development|Octapharma|+41 554512141|sigurd.knaub@octapharma.com
9337|NCT01341977|Alcon Clinical|Alcon Research, Ltd.|888.451.3937; 817.568.6725|medinfo@alconlabs.com
9338|NCT01341990|Director of Alcon Clinical|Alcon Research, Ltd.|1-888-451-3937|medinfo@alconlabs.com
9339|NCT01342107|Director of Alcon Clinical|Alcon Research, Ltd.|1-888-451-3937|medinfo@alconlabs.com
9340|NCT01342341|Dr. Jennifer Mitchell, Clinical Project Director|Ernest Gallo Clinic and Research Center|510-985-3921|jmitchell@gallo.ucsf.edu
9341|NCT01342445|Dr. Lisa Weyandt|University of Rhode Island|(401)874-2087|lisaweyandt@uri.edu
9549|NCT01180660|Gildasio De Oliveira MD|Northwestern University|312-472-3573|g-jr@northwestern.edu
9550|NCT01180777|Michael S. Mayers, O.D., FAAO|Johnson & Johnson Vision Care|1-904-443-3252|MMayers@its.jnj.com
9551|NCT01180790|Kevin Kucharski, VP Clinical Operations|Achillion Pharmaceuticals, Inc.|203-624-7000|Kkucharski@achillion.com
9552|NCT01180985|John Buch, OD, MS, FAAO|Johnson & Johnson Vision Care|1 904 443-1707|jbuch@its.jnj.com
9553|NCT01180998|Kathy Osborn, OD|Johnson & Johnson Vision Care|1-904-443-1032|KOsborn@its.jnj.com
9554|NCT01181011|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257 ext Option 4|clintriage.rdg@boehringer-ingelheim.com
9555|NCT01181050|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
9556|NCT01181128|Biogen Idec Study Medical Director|Biogen Idec||clinicaltrials@biogenidec.com
9557|NCT01181323|Mark Steinhoff, MD|Cincinnati Children’s Hospital Medical Center|513-636-2791|Mark.steinhoff@cchmc.org
9558|NCT01181349|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
9559|NCT01181492|Zhang Xianwei|Huazhong University of Science&Technology|027 83662853|ourpain@163.com
9560|NCT01181531|Study Director|Amgen Inc.|866-572-6436|
9852|NCT00662831|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9853|NCT00662909|Medical Director, Medical Sciences|Astellas Pharma Global Development, Inc.||ClinicalTrials.Disclosure@us.astellas.com
9854|NCT00663026|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9855|NCT00663052|Pfizer ClinicalTrials.gov Call Center|Wyeth, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9856|NCT00663117|Jill P Smith, MD Professor of Medicine, Gastroenterology Division|Pennsylvania State University, College of Medicine Hershey, PA 17033|717-531-3694|jsmith2@psu.edu
9857|NCT00663169|Study Director|Novartis Pharmaceuticals|862-778-8300|
9858|NCT00663403|Bruce A. Mueller|University of Michigan College of Pharmacy|7347636629|muellerb@umich.edu
9859|NCT00663702|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||clinical.trials@bms.com
9860|NCT00663793|John K Amory, MD, MPH|University of Washington|206-616-1727|jamory@u.washington.edu
9861|NCT00663819|Dr. Anthony Senagore|CMU College of Medicine|989-790-1001|anthony.senagore@cmich.edu
9457|NCT01118325|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
9458|NCT01118377|Medical Communications|Hoffmann-La Roche|800 821-8590|
9459|NCT01118455|Mark Bunker, PharmD, Sr. Director, Global Medical Affairs|Cyberonics, Inc.|281-228-7223|Mark.Bunker@cyberonics.com
9460|NCT01118624|Pankaj Sharma, MD|Spectrum Pharmaceuticals|949-743-9264|pankaj.sharma@sppirx.com
9461|NCT01128270|Peter W. Stacpoole,MD|University of Florida|(352) 273-9023|pws@ufl.edu
9462|NCT01128400|M. Yanina Pepino|Washington University School of Medicine|3143628113|ypepino@dom.wustl.edu
9463|NCT01128426|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9464|NCT01128543|GSK Response Center|GlaxoSmithKline|866-435-7343|
9465|NCT01128569|GSK Response Center|GlaxoSmithKline|866-435-7343|
9466|NCT01128595|GSK Response Center|GlaxoSmithKline|866-435-7343|
8920|NCT01125566|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8921|NCT01125605|Director of Clinical Trials|Pascoe pharmazeutische Praeparate GmbH|0049 641 7960100|klinische.forschung@pascoe.de
8922|NCT01125722|Michael Schwiers, Principal Biostatistician|Ethicon Endo-Surgery|513-337-1172|mschwier@its.jnj.com
8923|NCT01125813|Dr Sigurd Knaub|Octapharma AG|41 55 451 21 41|sigurd.knaub@octapharma.ch
8924|NCT01188772|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
8925|NCT01188798|Asha Pillai, MD|St. Jude Children's Research Hospital|1-866-278-5833|info@stjude.org
8926|NCT01188928|Clinical Trial Disclosure Manager|Leo Pharma A/S|+45 4494 5888|ctr.disclosure@leo-pharma.com
8927|NCT01189032|General Manager of Clinical Development Group|Santen Pharmaceutical Co., Ltd.|+81-6-4802-9341|clinical@santen.co.jp
8928|NCT01189110|Deborah Fritz FNP PhD|VAMC St. Louis MO|314-652-4100 ext 53692|deborah.fritz@va.gov
8929|NCT01189123|Dr. Keipp Talbot|Vanderbilt University Medical Center|6153222035|keipp.talbot@vanderbilt.edu
8930|NCT01189227|Director, Division of Regulatory Affairs|NSABP Foundation, Inc.|412-330-4600|
8931|NCT01189279|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
8501|NCT01262352|Medical Monitor|Vertex Pharmaceuticals Incorporated|617-341-6777|medicalinfo@vrtx.com
8502|NCT01262872|GSK Response Center|GlaxoSmithKline|866-435-7343|
8503|NCT01262989|GSK Response Center|GlaxoSmithKline|866-435-7343|
8504|NCT01263015|GSK Response Center|GlaxoSmithKline|866-435-7343|
8505|NCT01263028|John J. Sim, MD|Kaiser Permanente||john.j.sim@kp.org
8506|NCT01276353|Naoki Kubota|Clinical Development. JAC PCU. Eisai Co., Ltd.|+81-3-3817-5245|
8507|NCT01276457|Study director|Novartis Pharmaceuticals|862 778-8300|
8508|NCT01276639|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9087|NCT01154218|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9088|NCT01154322|June Mendoza|ResMed|1-800-424-0737|june.mendoza@resmed.com
9089|NCT01154634|Gerard Lynch|AstraZeneca|+44 1625 518062|aztrial_results_posting@astrazeneca.com
9090|NCT01155024|Applied Research Engineer|The Ohio Willow Wood Company|740-869-3377|mariag@owwco.com
9091|NCT01155063|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9092|NCT01155141|Dr. Richard Lafayette|Stanford University|650-498-6063|czar@stanford.edu
9093|NCT01220869|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
9094|NCT01221090|Dr. Samuel N. Forjuoh|Scott & White Hospital|(254) 771-7695|SFORJUOH@sw.org
9095|NCT01221272|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
9096|NCT01221285|Associate Director, Clinical Research Operations Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
9097|NCT01221350|Fernando R Siller Lopez, Ph.D.|Centro Universitario de Ciencias de la Salud, Mexico|523310585200 ext 33723|fsiller@cucs.udg.mx
9098|NCT01221727|Study Director|Amgen Inc.|866-572-6436|
9099|NCT01222195|Gautam Borthakur, MBBS / Assistant Professor|The University of Texas M. D. Anderson Cancer Center|713-792-7305|eharriso@mdanderson.org
9100|NCT01222286|Dr Renaud Buffet|Innate Pharma|33 4 30 30 30 32|renaud.buffet@innate-pharma.fr
9101|NCT01222507|Dr. Jay Piccirillo|Washington University|314-362-7508|piccirilloj@ent.wustl.edu
9102|NCT01222520|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9103|NCT01222533|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9104|NCT01222572|Raymond Mak, MD|Dana-Farber Cancer Institute/Brigham and Women's Hospital|6177328651|rmak@partners.org
9105|NCT01222585|Michael Cohen-Wolkowiez, MD|Duke Clinical Research Institute|919668-8812|michael.cohenwolkowiez@dm.duke.edu
9561|NCT01181609|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
9562|NCT01181726|Associate Director, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
9563|NCT01181778|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
9564|NCT01181804|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
9565|NCT01181895|GSK Response Center|GlaxoSmithKline|866-435-7343|
9566|NCT01181921|COUNTRY MEDICAL DIRECTOR|Jan-Cil Spain|+34 91 7228043|
9567|NCT01181986|Dr. Juraj Koska|Phoenix VA Health Care System|602-277-5551 ext 7685|juraj.koska@va.gov
9568|NCT01182103|Tiao-Lai Huang|Kaohsiung Chang Gung Memorial Hospital|886-7-7317123 ext 8753|a540520@adm.cgmh.org.tw
9569|NCT01182181|Associate Director, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
9570|NCT01182194|Associate Director, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
9571|NCT01193556|Robert Swain, PhD|Medtronic Surgical Technologies|(+1-603) 294-5428|robert.e.swain@medtronic.com
9751|NCT01305239|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9752|NCT01305265|Kolodzie, Kerstin M.D, PhD, Principal Investigator|Dept. of Anesthesia & Perioperative Care, UCSF San Francisco|4158853647|kolodziek@anesthesia.ucsf.edu
9753|NCT01305473|Dawn Heimer/Director, Clinical Affairs|C.R. Bard: Davol, Inc.|401-825-8681|dawn.heimer@crbard.com
9754|NCT01305772|Neal Ready,MD|Duke University Medical Center|919-681-6932|neal.ready@dm.duke.edu
9755|NCT01306162|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9756|NCT01306175|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9757|NCT01306201|Ulf Borg, Director of Clinical Affairs|Covidien|303-305-2400|ulf.borg@covidien.com
9758|NCT01306214|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9467|NCT01128738|GSK Response Center|GlaxoSmithKline|866-435-7343|
9468|NCT01128894|GSK Response Center|GlaxoSmithKline|866-435-7343|
9469|NCT01128946|GSK Response Center|GlaxoSmithKline|866-435-7343|
9470|NCT01128972|GSK Response Center|GlaxoSmithKline|866-435-7343|
9471|NCT01129011|Senior Vice President, Clinical Research|POZEN|919-913-1030|eorlemans@pozen.com
9472|NCT01129102|Department director of clinical development department 1|Nobelpharma|+81-5651-1177|murakami@nobelpharma.co.jp
9473|NCT01129128|James A Taylor, MD|University of Washington|206-616-1206|uncjat@uw.edu
9474|NCT01129245|Alison Edelman|Oregon Health and Science University|503-494-5949|edelmana@ohsu.edu
9475|NCT01129284|Dr. Andrew S. Bomback, MD, MPH|Columbia University Medical Center|212-305-0320|asb68@columbia.edu
9476|NCT01191944|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9477|NCT01192126|Dr. Robert Steffen OD|Bausch & Lomb Incorporated|585-338-6399|robert.steffen@bausch.com
9478|NCT01192139|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
9479|NCT01192152|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
9480|NCT01192178|GSK Response Center|GlaxoSmithKline|866-435-7343|
9662|NCT01256424|Vice President Research and Development|Photocure|+47 22062210|ifh@photocure.no
9663|NCT01256476|Roger Morgan, MD, FACS|Kowa Research Institute, Inc.|919-433-1600|RMorgan@KowaUS.com
9664|NCT01256502|Medical Monitor|Allergan, Inc.|(805) 961-5000|devicetrials@allergan.com
9665|NCT01256567|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
9666|NCT01256658|Study Director|Novartis|41 61 324 1111|
9667|NCT01256918|Dr. Praveen Kumar Malik|Dr. Ram Manohar Lohia Hospital|00919810405681|praveenk002@yahoo.com
9668|NCT01256983|Mrs. Hanna Burkahlter|University Hospital Zürich|0041 76 371 12 35|hanna.burkhalter@usz.ch
10012|NCT01132378|R. David Heekin MD, FACS|Heekin Institute for Orthopaedic Research|904-634-0640|drheekin@heekinortho.com
10013|NCT01132651|Elizabeth Damstetter, MD|Northwestern University|312-695-0287|e-damstetter@northwestern.edu
10014|NCT01132846|Kevin Anstrom|Duke University|919-668-8902|kevin.anstrom@dm.duke.edu
10015|NCT01133288|Eric Levey, M.D.|Kennedy Krieger Institute|443-923-9148|levey@kennedykrieger.org
10016|NCT01133626|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
10017|NCT01133704|Kathleen Picha|Dendreon Corporation|206-265-4545|kpicha@dendreon.com
10018|NCT01133860|Prof. Carlo Balduini|IRCCS Policlinico San Matteo Foundation|0039.0382.502580|c.balduini@smatteo.pv.it
10019|NCT01134016|Director of clinical trials|Golden Biotechnology Corp.|886-2808-6006|
10020|NCT01134042|GSK Response Center|GlaxoSmithKline|866-435-7343|
10021|NCT01134107|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
10022|NCT01134276|Sun-Whe Kim|Seoul National University College of Medicine|+82-2-2072-2315|sunkim@plaza.snu.ac.kr
10138|NCT01199965|VP, Scientific Affairs|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|650-386-3100|dkellerman@mappharma.com
10139|NCT01200160|Carlos A Gonzalez MD, PhD|Abbott Laboratories de México|(5255) 5809- ext 7576|carlos.gonzalez@abbott.com
10140|NCT01200368|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10141|NCT01200498|Alfonso Quintas-Cardama, MD/Assistant Professor|The University of Texas MD Anderson Cancer Center|713-745-4009|eharriso@mdanderson.org
10142|NCT01276301|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10143|NCT01276327|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10144|NCT01214811|Viktoria Ahlenius Körner|Molnlycke Health Care|0046 31 7223000|viktoria.ahleniuskorner@molnlycke.com
10145|NCT01214824|Director Global Clinical and EMEA Regulatory Affairs|Abbott Diabetes Care|01993863164|joe.bugler@abbott.com
9106|NCT01223469|Hendrik Lambert PhD, VP of Clinical and Regulatory Affairs|St. Jude Medical/Endosense||Hendrik.Lambert@endosense.com
9107|NCT01223703|Dr Savina Nodari|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|00390303996 ext 587|nodari@med.unibs.it
9108|NCT00606892|Mehmet Sofuoglu, M.D., Ph.D.|Yale University|203-937-4809|mehmet.sofuoglu@yale.edu
9109|NCT00606905|Mary D. Stephenson, M.D. MSc|University of Chicago|773 834-1167|mstephen@babies.bsd.uchicago.edu
9110|NCT00606931|Judith E Kalinyak, MD, PhD,   Medical Director|Naviscan Inc|858-587-3641 ext 108|jkalinyak@naviscan.com
9111|NCT01252134|Director of Medical Affairs|Alcon Research, Ltd.|888.451.3937|medinfo@alconlabs.com
9112|NCT01252147|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
9113|NCT01252238|Dr. Jonathan Williams|Brigham and Women's Hospital|617-278-0882|jwilliams5@partners.org
9114|NCT01252355|Trial Transparency Team|Sanofi||Contact-us@sanofi.com
9115|NCT01252810|Ruben Sheng, M.D.|GE Healthcare|609-514-6899|Rubin.Sheng@ge.com
9116|NCT01252940|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
9117|NCT01253174|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
9118|NCT01253187|Therapeutic Area Head|Bayer HealthCare AG||clinical-trials-contact@bayerhealthcare.com
9119|NCT01253343|Dr. Drew Barzman|Cincinnati Children's Hospital Medical Center|513-636-4788|drew.barzman@cchmc.org
9120|NCT01253408|Dr. Michael Camilleri|Mayo Clinic|507-266-2306|camilleri.michael@mayo.edu
9121|NCT01253525|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
9122|NCT01253824|Department director of clinical development department 1|Nobelpharama|+81-23-5651-1177|murakami@nobelpharma.co.jp
9123|NCT01253902|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
9124|NCT01253980|Dr Kate Balme|Poisons Information Centre, Red Cross War Memorial Children's Hospital and University of Cape Town|+27 21 658 5308|kh.balme@uct.ac.za
9125|NCT01254045|Scott S. Hall, PhD|Stanford University School of Medicine|650-498-4799|hallss@stanford.edu
9759|NCT01306253|Medical Affairs Director|Crucell Switzerland AG|+41(0)319806111|info@crucell.com
9760|NCT01258803|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
9761|NCT01259102|Executive Medical Director, Clinical Pharmacology|Purdue Pharma L.P.|800-733-1333|
9762|NCT01259115|Executive Medical Director, Clinical Pharmacology|Purdue Pharma L.P.|800-733-1333|
9763|NCT01259245|Dr Lorna Ng|Kwong Wah Hospital|(852) 23322311|ngl@ha.org.hk
9764|NCT01259284|Ara Vaporciyan, MD, BS / Professor|UT MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
9765|NCT01259297|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
9766|NCT01259492|Study  Director|Novartis Pharmaceuticals|8627788300|
9767|NCT01260272|Kathy Schmitz, Site Manager|L-MARC Research center|502 214 3990|kschmitz@lmarc.com
9768|NCT01260311|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9769|NCT01260324|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9770|NCT01260493|Professor Synneve Dahlin-Ivanoff ( Research leader)|Vårdalinstitute, University of Gothenburg|+46 31 7865733|synneve.dahlin-ivanoff@gu.se
9771|NCT01260584|Brian Baker|Daiichi Sankyo|973-944-2712|bbaker@dsi.com
9772|NCT01260688|Dr. Lillian Siu|Princess Margaret Cancer Centre|416-946-2911|lillian.siu@uhn.ca
9365|NCT01127087|Dr. John C. Lieske|Mayo Clinic|507-266-7960|lieske.john@mayo.edu
9366|NCT01127139|Global Medical Services|Abbott|1-800-633-9110|
9367|NCT01127165|Jihee Mun, Pharmacist, Medical Department manager|Eisai Korea Inc.|+82-2-3451-5531|jihee_mun@eisaikorea.com
9368|NCT01127256|Jihee Mun, Pharmacist, Medical Department manager|Eisai Korea Inc.|+82-2-3451-5531|jihee_mun@eisaikorea.com
9369|NCT01127321|David Close, Director, Clinical Development|MedImmune, LLC.|301-398-0000|closeda@medimmune.com
9370|NCT01127438|Eisai Inc.|Eisai Call Center|888-422-4743|
9669|NCT01257230|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9670|NCT01257425|Director, Uro-oncology|Ipsen|clinical.trials@ipsen.com|clinical.trials@ipsen.com
9671|NCT01257542|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9672|NCT01257750|Reza Dana, MD, MPH, MSc|Massachusetts Eye and Ear Infirmary|617-573-3313|Cornea_Research@meei.harvard.edu
9673|NCT01257880|Jill T. Jesurum, Ph.D.|Swedish Medical Center|206-683-1505|jill.jesurum@swedish.org
9674|NCT01258049|Dr Daryl Bendel|Xidea Solutions Limited||daryl@xideasolutions.com
9675|NCT01258387|Anthony Caggiano, MD, PhD|Acorda Therapeutics, Inc.|914-347-4300 ext 5150|tcaggiano@acorda.com
9676|NCT01258582|Rochelle P. Walensky, MD, MPH|Massachusetts General Hospital|(617) 724-8445|rwalensky@partners.org
9677|NCT01258595|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
9678|NCT01258660|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
9679|NCT01258790|Steve Wu, MD|Cincinnati Children's Hospital Medical Center|513-636-4222|steve.wu@cchmc.org
9680|NCT01272141|William Read, MD|Emory University School of Medicine|1-888-946-7447|william.l.read@emory.edu
9681|NCT01272180|Posting Director|Novartis Vaccines||RegistryContactVaccinesUS@novartis.com
9682|NCT01272284|Clinical Trials Manager|Coloplast Corp|612-302-4990|usdibe@coloplast.com
9683|NCT01272583|Dr. Josefine E. Schopman|Academic Medical Center|+31 20 5669111|j.e.schopman@amc.uva.nl
9684|NCT01272661|Lydia Furman MD, PI|UHospitalsCleveland; Rainbow Babies and CHildren's Hospital|216-844-8260|Lydia.Furman@uhhospitals.org
9886|NCT01348425|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|Cook|765-463-7537|ssnyder@medinst.com
9887|NCT01348607|Cristina Burroughs, Clinical Research Administrator|SunCoast CCOP Research Base|(813) 396-9237|Cristina.Burroughs@epi.usf.edu
9888|NCT01348776|Doran Rozen, Director of Clinical Affairs|Syneron Beauty|+972-54-7800260|Doran.Rozen@syneron.com
10146|NCT01214850|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
10147|NCT01214915|Study Physician|Shire Development LLC|+1 866 842 5335|
10148|NCT01215097|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10149|NCT01215292|Mara Roth, MD|University of Washington|206-221-0519|mylang@uw.edu
10150|NCT01215357|Dr. Richard Chipkin|Psyadon Pharmaceuticals|301-919-2020|rchipkin@psyadonrx.com
10151|NCT01215422|DR. JOAN ROBINSON|UNIVERSITY OF ALBERTA|780-248-5540|jr3@ualberta.ca
10152|NCT01215435|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
10153|NCT01215513|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
10154|NCT01291160|S.Sarangapani|Ogenix|7817026732|ssarangapani@ogenix.com
10155|NCT01291173|Study Physician|Shire Development LLC|1 866-842-5335|
10156|NCT01291264|Dr. Julius Schachter, Professor of Laboratory Medicine|University of California, San Francisco|415 824 5115|julius.schachter@ucsf.edu
10157|NCT01291498|Mr Radu Mihai|Oxford University Hospitals NHS Trust||radu.mihai@ouh.nhs.uk
10158|NCT01291784|Dr. John O. Mascarenhas|Icahn School of Medicine at Mount Sinai|212-241-6756|john.mascarenhas@mssm.edu
10159|NCT01292005|Dr. Santhi Swaroop Vege|Mayo Clinic|507-284-2175|vege.santhi@mayo.edu
10273|NCT00993044|Rajkumar Venkatramani|Children's Hospital Los Angeles|3233615504|rvenkatramani@chla.usc.edu
10274|NCT00993148|Dr. Babafemi Taiwo|Northwestern University|312-695-5085|b-taiwo@northwestern.edu
10275|NCT00993187|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|
10276|NCT00993200|Robert Pendleton|University of Utah|801 581 7818|robert.pendleton@hsc.utah.edu
10277|NCT00993265|Dr. Michael Bloch, MD, MS|Yale University, Child Study Center|203-737-4809|michael.bloch@yale.edu
10278|NCT00993291|Fenna Phibbs M.D.|Vanderbilt University|615-936-2025|fenna.phibbs@vanderbilt.edu
9126|NCT01254292|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
9127|NCT01254305|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|Forest Research Institute|201-427-8000 ext 8124|carl.gommoll@frx.com
9128|NCT01254344|Naimi Missoum|Merck Sharp & Dohme (China) Ltd.|+8621 2211 8546|naimi_missoum@merck.com
9129|NCT01254396|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9130|NCT01254604|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9131|NCT01254656|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9132|NCT01254721|Hui Jung Sin / Clinical Project Leader|SM&M Korea|82-2-2188-2165|ClinicalTrialTransparency@astrazeneca.com
9133|NCT01254747|Director of Alcon Clinical, Atlanta|Alcon Research|1-800-241-7629|
9134|NCT01254760|Director of Alcon Clinical|Alcon Research, Ltd.|1-800-241-7629|
9135|NCT01267929|Miss Namfon Mahasup|Postgraduate Studied Program, faculty of medicine, Thammasat University|+66 867733596|namfon_pt@yahoo.com
9136|NCT01268111|A J Vinaya Simha|Mayo Clinic|5072664321|simha.aj@mayo.edu
9137|NCT01268267|Carmine Greene|Bayer Healthcare, Diabetes Care|574-257-3040|carmine.greene@bayer.com
9138|NCT01268488|Maria Viggiani|Bayer Healthcare, Diabetes Care|914-333-6280|maria.viggiani@bayer.com
9139|NCT01268501|Director of Alcon Clinical|Alcon Research, Ltd.|1-800-241-7629|
9140|NCT01268683|Sven Jacobson|Remedy Pharmaceuticals, Inc.|212 586 2226 ext 225|sven@remedypharmaceuticals.com
9141|NCT01268891|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
9142|NCT01269125|Apostolos Kaponis, M.D.|Dept. of Ob/Gyn, Patra University School of Medicine, Greece|+30-2610999569|kaponisapostolos@hotmail.com
9143|NCT01269710|Linmarie Sikich, M.D.|The University of North Carolina at Chapel Hill|(919) 972-7499|lsikich@med.unc.edu
9144|NCT01270126|Prof. Bernhard A. Sabel|Otto-von-Guericke University of Magdeburg, Medical Faculty, Institute of Medical Psychology, Magdeburg, Germany|0049 3916721800|bernhard.sabel@med.ovgu.de
9371|NCT01127581|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
9372|NCT01127607|Dr. James Waxmonsky|Florida International University|717 531 8646|jwaxmons@fiu.edu
9373|NCT01127646|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
9374|NCT01127737|June Robinson, MD|Northwestern University|312-695-6624|june-robinson@northwestern.edu
9375|NCT01127763|Amy Tiersten, MD|Mt Sinai School of Medicine|212-249-3300|amy.tiersten@mssm.edu
9376|NCT01128114|Gerard Lynch|AstraZeneca||clinicaltrialtransparency@astrazeneca.com
9377|NCT01128153|Gerard Lynch|AstraZeneca|+44 1625 518062|aztrial_results_posting@astrazeneca.com
9378|NCT01128179|Study Physician|Shire Development LLC|+1 866 842 5335|
9379|NCT01140646|Dr. Amit Sood|Mayo Clinic|507-284-1623|sood.amit@mayo.edu
9380|NCT01140815|Knee Research Director|AORI|7036194423|nancylparks@gmail.com
9381|NCT01140867|Jihee Mun, Pharmacist, Medical Department manager|Eisai Korea Inc.|+82-2-3451-5531|jihee_mun@eisaikorea.com
9382|NCT01140880|Dr. Cathy J. Reback|Friends Research Institute, Inc.|323-463-1601|reback@friendsresearch.org
9383|NCT01140906|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
9384|NCT01141205|Dr Anders Fomsgaard|Statens Serum Institut|+45-32683460|afo@ssi.dk
9385|NCT01141283|Clinical Leader, Medical Director|Purdue Pharma LP|800-733-1333|
9386|NCT01141374|Leonice Fumiko Sato Kurebayashi|University of São Paulo|55-11-91126023|fumie_ibez@yahoo.com.br
9387|NCT01141595|Richard Frye|Arkansas Children's Hospital Reseach Insitute|501-364-5465|REFrye@uams.edu
9388|NCT01141660|Cristina Baldassari|Eastern Virginia Medical School|7576689853|baldassc@yahoo.com
9572|NCT01193582|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9573|NCT01193660|Minyoung Kim, MD, PhD|CHA Bundang Medical Center, CHA University|82-31-780-1872|kmin@cha.ac.kr
9889|NCT01348789|Dr. Jerome M. Garden|Northwestern Memorial Hospital|312-280-0891|j-garden@northwestern.edu
9890|NCT01348854|Carrie Garufis|Abbott Medical Optics|714-247-8200|carrie.garufis@amo.abbott.com
9891|NCT01349114|David A. Calhoun, MD|University of Alabama at Birmingham|205-934-4633|dcalhoun@uab.edu
9892|NCT01349231|Dr. Michael Bloch, MD, MS|Yale University, Connecticut Mental Health Center|203-737-4809|michael.bloch@yale.edu
9893|NCT01349829|Medical Affairs Director|Crucell Switzerland AG|+41(0)319806111|info@crucell.com
9894|NCT01118663|Amy Rock, PhD|Cumberland Pharmaceuticals Inc.|615-255-0068|arock@cumberlandpharma.com
9895|NCT01118741|Michael Carducci, MD|Johns Hopkins University|410-614-3977|carducci@jhmi.edu
9896|NCT01118780|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
9897|NCT01369732|Dr. Yon Hee Shim|Yonsei University College of Medicine|82220193547|tren125@yuhs.ac
9898|NCT01369745|Margaret Lee,PhD|Zalicus|617-301-7142|mlee@zalicus.com
9899|NCT01369875|Dr. Steven Rosenberg|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
9900|NCT01370005|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9901|NCT01370265|Dr. Panithaya Chareonthaitawee|Mayo Clinic|507-284-1648|chareonthaitawee.panithaya@mayo.edu
9902|NCT01370356|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9903|NCT01370460|Andrew Georgiadis, MD|Henry Ford Health System|313-916-7520|ageorgi1@hfhs.org
9904|NCT01370525|Gerard Lynch|AstraZeneca|1625 518062 ext +44|aztrial_results_posting@astrazeneca.com
9905|NCT01370538|Gerard Lynch|AstraZeneca|1625 518062 ext +44|aztrial_results_posting@astrazeneca.com
9906|NCT01129336|Study Director|Novartis Pharmaceuticals|862-778-8300|
9907|NCT01129531|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
9908|NCT01129557|Andrew Bomback, MD|Columbia University Medical Center, Division of Nephrology|212-305-5020|asb68@columbia.edu
10279|NCT00993317|Eun Young Cho, Clinical Trial Manager|Korea Otsuka Pharmaceutical|+82-2-3287-9233|hyerim@otsuka.co.kr
10280|NCT00993421|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
10281|NCT01002482|Dr. Pierre Kalfon|CH Chartres|003323730303073|pkalfon@ch-chartres.fr
10282|NCT01002989|George S. Stergiou, MD, FRCP, Associate Professor of Medicine|Hypertension Center, Third University Department of Medicine, Sotiria Hospital|+30 2107763117|gstergi@med.uoa.gr
10283|NCT01003080|Dr. Sun Jin Kim|Montefiore Medical Center|718-920-2060|sukim@montefiore.org
10284|NCT01003184|Chief Medical Officer|Eli Lilly and Company|1-877-285-4559|clinicaltrials@amylin.com
10285|NCT01003210|Dr. James Taylor|University of Washington|206-6165-1206|uncjat@uw.edu
10286|NCT01003275|Ian H. de Boer, MD, MS, Associate Professor of Medicine|University of Washington|2066165403|deboer@u.washington.edu
10287|NCT01003301|Sarbjit S. Saini|Johns Hopkins University|410-550-2129|ssaini@jhmi.edu
10288|NCT01003886|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
10289|NCT01003899|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
10290|NCT01003938|Franco Muggia, MD|NYU Cancer Institute|212-263-6485|franco.muggia@nyumc.org
10291|NCT01004146|Dr. Davide Cattano|University of Texas at Houston Medical School / Dept. of Anesthesiology|713-500-6235|davide.cattano@uth.tmc.edu
10292|NCT01004159|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
10293|NCT01004185|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
10294|NCT01004250|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8591|NCT01263483|General Manager|Japan Development Center, Pharmaceutical Development Division|+81-6-6204-5257|clinicaltrialregistry@tpna.com
8592|NCT01263496|General Manager|Japan Development Center, Pharmaceutical Development Division|+81-6-6204-5257|clinicaltrialregistry@tpna.com
8593|NCT01263509|General Manager|Japan Development Center, Pharmaceutical Development Division|+81-6-6204-5257|clinicaltrialregistry@tpna.com
9145|NCT01270139|Dr. Alexander Kharlamov|Ural Institute of Cardiology|0031627849118|drskharlamov@gmail.com
9146|NCT01270256|Dr. Robert M Naclerio|University of Chicago|773-702-0080|rnackeri@surgery.bsd.uchicago.edu
9147|NCT01270555|Timothy Wilens, MD|Massachusetts General Hospital|617-503-1053|twilens@partners.org
9148|NCT01270711|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9149|NCT01270802|Dr. Samir K. Gupta, Principal Investigator|Indiana University School of Medicine|317-274-7926|sgupta1@iu.edu
9150|NCT01270841|Jennifer L. Wike|Repros Therapeutics Inc.|281-719-3402|jwike@reprosrx.com
9151|NCT01270867|Cindy Jahans, BSc, Clinical Research Manager|Concentric Medical / Stryker Neurovascular Inc|510-413-2268|cindy.jahans@stryker.com
9152|NCT01270919|Director of Clinical Research|Stryker Orthopedics|201-831-5401|ellen.axelson@stryker.com
9153|NCT01270958|GSK Response Center|GlaxoSmithKline|866-435-7343|
9154|NCT01270971|Sheryl Baldwin, RN/Associate Director|Anacor Pharmaceuticals, Inc.|650-223-8597|clinicaltrials@anacor.com
9155|NCT01271036|Joyce Hauze, Sr. Specialist|Johnson & Johnson Consumer and Personal Products Worldwide|928-277-0715|jhauze@its.jnj.com
9156|NCT01271413|Dr. Miriam Mintzer|Johns Hopkins University School of Medicine|410 550-0529|mmintzer@jhmi.edu
9157|NCT01271452|Vice President, Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
9158|NCT01271543|Sonia Vaida|Penn State Milton S. Hershey Medical Center|7175318433|svaida@hmc.psu.edu
9159|NCT01361009|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9160|NCT01361048|Dr. Jane Schwebke|UAB|205-975-5665|schwebke@uab.edu
9161|NCT01361308|Sailaja Bhaskar, Executive Director, Clinical Research|Noven Therapeutics, LLC|(212) 287-0798|sbhaskar@noven.com
9162|NCT01285908|Dr. David S. Goldstein|National Institute of Neurological Disorders & Stroke||david.goldstein1@nih.gov
9163|NCT01285947|Dr. Murad Alam|Northwestern University|312-695-4761|m-alam@northwestern.edu
9574|NCT01193907|Dr. Audino Podda|Novartis Vaccines Institute for Global Health|+39 0577 243496|audino.podda@novartis.com
9575|NCT01193920|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
9576|NCT01194245|Vice President, Endocrinology Clinical Development|Halozyme Therapeutics, Inc.|858-794-8889|
9577|NCT01194258|Vice President, Endocrinology Clinical Development|Halozyme Therapeutics|858-794-8889|
9578|NCT01194297|Dr. Carl D'Angio|University of Rochester|585-275-2972|carl_dangio@urmc.rochester.edu
9579|NCT01194414|Medical Communications|Hoffman-LaRoche|800-821-8590|
9580|NCT01194427|Dr. Vered Stearns|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|4432876489|vstearn1@jhmi.edu
9581|NCT01194674|H. Nida Sen, Principal Investigator, National Eye Institute|National Institutes of Health|301-402-3254|senh@nei.nih.gov
9582|NCT01194830|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9583|NCT01194999|Joseph A Zadra, MD CM FRCSC|Barrie Urology Associates - The Male/Female Health and Research Centre|705-727-0551|joezadra@rogers.com
9584|NCT01195090|Dr. Sung-Chen Liu|Department of Internal Medicine, Mackay Memorial Hospital|886-2-2543-3535 ext 2174|pine3.tw@yahoo.com.tw
9585|NCT01195103|John B Leslie MD|Mayo Clinic|480-301-8000|leslie.john@mayo.edu
9586|NCT01195584|Wolfgang Senker, MD|General Hospital Amstetten|+43 7472 6040 ext 6611|wolfgang.senker@aon.at
9587|NCT01195597|Prof Riccardo Polosa|University of Catania|0957436413 ext 0039|polosa@unict.it, p.caponnetto@unict.it
9588|NCT01195623|Lena Blomgren MD PhD|Uppsala UH|+46851774173|lena.blomgren@karolinska.se
9589|NCT01195636|Dr. Paul Goldberg, VP Clinical Development|Xenon Pharmaceuticals Inc.|604-484-3300|pgoldberg@xenon-pharma.com
9590|NCT01195662|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
9591|NCT01195675|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9592|NCT01195779|GSK Response Center|GlaxoSmithKline|866-435-7343|
9481|NCT01192191|GSK Response Center|GlaxoSmithKline|866-435-7343|
9482|NCT01192282|Dr Shahila Tayib|Groote Schurr Hospital / University of Cape Town|0060195773376|syarq@yahoo.com
9483|NCT01192347|Study Physician|Shire Development LLC|+1 866 842 5335|
9484|NCT01192542|Brian Pall, O.D., M.S. F.A.A.O. Principal Research Optometrist|Johnson and Johnson Vision Care|1 904 443-1290|bpall@its.jnj.com
9485|NCT01193049|Vice President, Late Stage Development Group Leader|Merck Sharp and Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9486|NCT01193114|Dr. Natasha Slesnick|The Ohio State University|614 247-8469|slesnick.5@osu.edu
9487|NCT01193127|Chief Medical Officer|Omeros Corporation|(206) 676-5000|swhitaker@omeros.com
9488|NCT01193218|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9489|NCT01206101|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
9490|NCT01206387|Director, Clinical Research|Taro Pharmaceuticals U.S.A., Inc|914-345-9001|natalie.yantovskiy@taro.com
9491|NCT01206517|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9492|NCT01206595|Executive Medical Director|Pacira Pharmaceuticals, Inc.|203-837-6500|ErolOnel@pacira.com
9493|NCT01206608|Executive Medical Director|Pacira Pharmaceuticals, Inc.|203-837-6500|ErolOnel@pacira.com
9494|NCT01206660|Director, Clinical Research|Taro Pharmaceuticals U.S.A., Inc.|914-345-9001|natalie.yantovskiy@taro.com
9495|NCT01206738|Prof Shaun Treweek|University of Aberdeen||streweek@mac.com
9496|NCT01207401|Dr. Sheila Krishnan Mody|University of California, San Diego|(619)543-6777|smody@ucsd.edu
9497|NCT01207414|Study Director|Novartis Pharmaceuticals|862-778-8300|
9498|NCT01207466|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|CIBA VISION|1-678-415-3343|joseph.rappon@cibavision.com
9499|NCT01207570|Dr. Marco Pang|The Hong Kong Polytechnic University|85227667156|Marco.Pang@inet.polyu.edu.hk
8594|NCT01263639|Dr. Brent J. Morris Orthopaedic Resident|Vanderbilt Medical Center|615-835-0699|brent.j.morris@vanderbilt.edu
8595|NCT01263665|Keli Sapp|W.L. Gore & Associates|9288643964|kesapp@wlgore.com
8596|NCT01263691|Dr. Robert Hopkins|Emergent BioSolutions|(301) 944-0136|hopkinsr@ebsi.com
8597|NCT01263873|Brian Radesic|University Hospitals of Cleveland|3309725175|radesic@uakron.edu
8598|NCT01263925|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
8599|NCT01264016|Jane Wallace|Bayer Healthcare, Diabetes Care|574-257-3063|jane.wallace@bayer.com
8600|NCT01264770|Dave Goldstraw|AstraZeneca Pharmaceuticals|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
8601|NCT01264835|Michael Schwiers, Principal Biostatistician|Ethicon Endo-Surgery|513-337-1172|mschwier@its.jnj.com
8602|NCT01264939|Medical Communications|Genentech, Inc.|800 821-8590|
8603|NCT01265056|Jennifer Lassner|The University of Iowa|319-335-2123|jennifer-lassner@uiowa.edu
8604|NCT01265394|Dr. Paul Sherwin|GE Healthcare|1-609-514-6820|paulsherwin@ge.com
8605|NCT01265446|Clinical Project Leader|Novartis Consumer Health, Nyon, Switzerland|+41223633279|Rowland.Furcha@novartis.com
8606|NCT01265459|Head of Medical Affairs|Q-Med AB|+46 (0) 18 4749000|reception.SEUPP@galderma.com
8607|NCT01265524|Howard Dittrich, MD FACC|Sorbent Therapeutics|858-405-1429|hdittrich@sorbent.com
8608|NCT01350271|Dr Balachandran Kumarendran|University of Kelaniya|0094112961140|drbkumaran@gmail.com
8609|NCT01350583|Robert J. Gillies, Ph.D. - Principal Investigator|H. Lee Moffitt Cancer Center and Research Institute|813-745-8355|robert.gillies@moffitt.org
8610|NCT01350934|Senior Vice President, Global Clinical Development|Merck Sharpe & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8611|NCT01351090|David Bregamn, M.D., Ph.D.|Luitpold Pharmaceuticals, Inc.|610-650-4200 ext 828|dbregman@lpicrd.com
8612|NCT01352507|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8613|NCT01352585|Study Physician|Shire Development LLC|+1 866 842 5335|
9164|NCT01286012|Raymond Pratt, MD CMO|Rockwell Medical|248 960 9009|rd@rockwellmed.com
9165|NCT01286077|EMEA Medical Affairs Director|Janssen-Cilag Greece|+30 210 8090738|
9166|NCT01286129|Louis-Philippe Boulet, principal investigator|IUCPQ|418-656-4747|lpboulet@med.ulaval.ca
9167|NCT01286207|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
9168|NCT01286324|Suzanna M Zick|University of Michigan|734-998-9553|szick@umich.edu
9169|NCT01286454|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9170|NCT01286493|Dr.Suda Sibunruang|Queen Saovabha Memorial Institute|+66 2 2520161 ext 125|sudapunrin@gmail.com
9171|NCT01391858|Babatunde Ogunnaike|UTexas Southwestern Medical Center|(214) 590 ext 8536|Babatunde.Ogunnaike@UTSouthwestern.edu
9172|NCT01392378|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9173|NCT01392547|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
9174|NCT01392560|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9175|NCT01392677|Eva Johnsson|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
9176|NCT01392703|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
9177|NCT01394692|Dr. Christian Senft|Johann Wolfgang Goethe University|+49 69 63015939|c.senft@med.uni-frankfurt.de
9178|NCT01394926|Paul Sherwin, M.D.|GE Healthcare|1-609-514-6820|Paulsherwin@ge.com
9179|NCT01394991|Clinical Development Team Lead|Johnson and Johnson PRD|1 908 218 6097|
9180|NCT01395043|Dr Nils Bjerregaard|Aalborg Hospital|004522860649|niheb@rn.dk
9181|NCT01395368|Dr. Jay F. Piccirillo, Professor|Washington University in St. Louis|314 362-8641|piccirilloj@ent.wustl.edu
9182|NCT01395394|Kathryn Coakley|Emory University|404-778-1286|kcoakle@emory.edu
9183|NCT01395888|GSK Response Center|GlaxoSmithKline|866-435-7343|
9593|NCT01271686|Dr. John Liu|University of California, San Diego|858 534-7056|joliu@ucsd.edu
9773|NCT01260701|Study Statistician|SWOG Statistical Center|206-667-4623|
9774|NCT01260883|Anne Lynn MD|Seattle Children's Hospital|206 987-2518|anne.lynn@seattlechildrens.org
9775|NCT01260896|Associate Director, Biopharmaceutics|Teva Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
9776|NCT01260922|Associate Director, Biopharmaceutics|Teva Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
9777|NCT01342510|Dr. Kristopher Schroeder|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|608-263-8100|kmschro1@wisc.edu
9778|NCT01342523|Stevens Smith, PhD|University of Wisconsin|608-262-7563|sss@ctri.wisc.edu
9779|NCT01342666|Favorable effect of tomato consumption on HDL-c serum levels|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (INCMNSZ)|525555133891|shiverqks@hotmail.com
9780|NCT01342757|Jeffrey J. Olson, MD|Emory University School of Medicine|404-778-3091|jolson@emory.edu
9781|NCT01342913|GSK Response Center|GlaxoSmithKline|866-435-7343|
9782|NCT01343485|Zoe Unger, Research Program Coordinator|Planned Parenthood Federation of America|212-261-4702|zoe.unger@ppfa.org
9783|NCT01343823|Mike Pankratz, Associate Director, Clinical Operations|Dyax Corp.|16172252500|mpankratz@dyax.com
9784|NCT01344161|Dr.Farzad Shidfar|Tehran University of Medical Sciences|09123082922|f-shidfar@tums.ac.ir
9785|NCT01344369|Associate Director, Biopharmaceutics|Teva Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
9786|NCT01344629|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9787|NCT01276223|Director of Alcon Clinical|Alcon Research|1-888-451-3937|
9788|NCT01276288|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
9789|NCT01365624|David Bregman, M.D., Ph.D|Luitpold Pharmaceuticals, Inc.|610-650-4200 ext 828|dbregman@lpicrd.com
9790|NCT01365910|Dr. Jordan Berlin|Vanderbilt-Ingram Cancer Center|615-343-4128|jordan.berlin@vanderbilt.edu
9500|NCT01207583|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
9501|NCT01207596|Srinivas Nalamachu|International Clinical Research Institute|913-317-5300|nalamachu@yahoo.com
9502|NCT01207648|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
9685|NCT01272869|Director Medical Affairs|Coloplast A/S|4549111111|dkbir@coloplast.com
9686|NCT01272882|Gerard Fulda|ChristianaCHS|302-733-4260|gfulda@christianacare.org
9687|NCT01272908|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
9688|NCT01272921|Mark Kendall, M.D.|Northwestern University|312-695-2528|m-kendall@northwestern.edu
9689|NCT01272934|Clinical Project Leader|Novartis Consumer Health|0041223635228|
9690|NCT01272947|Clinical Project Leader|Novartis Consumer Health S.A.|+41 22 3635528|
9691|NCT01273038|Director of Medical Affairs|Coloplast A/S|4549111111|dkbir@coloplast.com
9692|NCT01273064|MiRa Huyghe, Vice President, Clinical Development|Conatus Pharmaceuticals Inc.|(858) 457-7227|mhuyghe@conatuspharma.com
9693|NCT01273181|Dr. Steven Rosenberg|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
9694|NCT01273519|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
9695|NCT01273597|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
9696|NCT01273766|Dr. Mary Ann Knovich|Comprehensive Cancer Center of Wake Forest University|336-716-7973|mknovich@wakehealth.edu
9697|NCT01274559|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
9698|NCT01274585|Does Percutaneous Tibial Nerve Stimulation (PTNS) Improve Outcomes in Patients|Massachusetts General Hospital|617-643-0541|lsavitt@partners.org
9699|NCT01274611|Dr. Murad Alam|Northwestern University|312-695-4761|m-alam@northwestern.edu
9700|NCT01274715|Aanand Naik, MD|Michael DeBakey VAMC|713-794-8541|anaik@bcm.edu
9701|NCT01274897|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
12922|NCT00921947|Dr. David N.Taylor|VaxInnate|609-860-2260|david.taylor@vaxinnate.com
12923|NCT00922194|Dr. Amulya R Sircar|Sircar Diabetes Clinic|+ 91 (522) 2324747|arsircar@yahoo.com
12924|NCT00922233|Dr. Vera Halpern|FHI360|9195447040|vhalpern@fhi360.org
12925|NCT00922272|Study Physician|Shire Pharmaceutical|1-866-842-5335|
12926|NCT00922623|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com
12927|NCT00922636|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12928|NCT00922701|Mario Bonomini, M.D.|University G. D'Annunzio|+39 0871 540120|m.bonomini@nephro.unich.it
12929|NCT00922766|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12930|NCT00922935|Kristina Espemar Holst, Senior Clinical Trial Manager|Straumann|+41 61 965 11 11|info@straumann.com
13043|NCT00984568|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
13044|NCT00984594|Director, Clinical Projects|RTI Biologics|386-418-8888 ext 4172|rwaite@rtix.com
13045|NCT00984659|GSK Response Center|GlaxoSmithKline|866-435-7343|
13046|NCT00984698|Dr. Patricia Haynes, Assistant Professor|University of Arizona|5206261855|thaynes@email.arizona.edu
13047|NCT00984815|Amy Y. Grahn, MS|Horizon Pharma|224-383-3012|agrahn@horizonpharma.com
13048|NCT00984867|Eva Johnsson|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
13049|NCT00985010|Hugo Mendieta Zerón|Materno-Perinatal Hospital of the State of Mexico|+52-722-2176605|mezh_74@yahoo.com
13050|NCT00985153|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
13051|NCT00985166|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13052|NCT00985231|William Reindel, OD, MS|Bausch & Lomb Incorporated|(585) 338-8129|william.t.reindel@bausch.com
13053|NCT00985257|Carmine Greene, Clinical Research Scientist|Bayer Healthcare, Diabetes Care|574-257-3040|carmine.greene.b@bayer.com
13577|NCT00977704|Head of Clinical Trials|Medicis R&D Clinical Research Department||ClinicalTrialsQuery@Medicis.com
13578|NCT00977769|Professor Leiv Arne Rosseland|Oslo University Hospital|+4723070000|lrossela@ous-hf.no
13579|NCT00977808|Boris Kovatchev, Ph.D./Principal Investigator|University of Virginia|434-982-6479|pcm9b@virginia.edu
13580|NCT00978029|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
13581|NCT00978042|Medical Monitor|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
13582|NCT00978120|Associate Director, Clinical Research Program|DAIT/NIAID|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov
13583|NCT00978341|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
13584|NCT01996904|Sang-Hoon Lhee|CM Chungmu Hospital|+82(2)2068/4525|cmirb@naver.com
13585|NCT01997216|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13586|NCT01997723|Bharati Prasad|UIllinois|3129968433|bpradsad@uic.edu
13587|NCT01997892|Study Director|Amgen Inc.|866-572-6436|
13977|NCT01444300|Dr. Michelle Cameron|Oregon Health & Science University|503-218-1971|cameromi@ohsu.edu
13978|NCT01444391|Director Clinical|Acclarent|650-687-5888|lenglan1@its.jnj.com
13979|NCT01444456|Study Director|Amgen Inc.|866-572-6436|
13980|NCT01444781|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
13981|NCT01444924|Dr. David Kushner|University of Wisconsin Hospitals and Clinics|608-263-0796|dmkushner@facstaff.wisc.edu
13982|NCT01445548|Wai T. Wong, MD, PhD|National Eye Institute|301-496-7566|wongw@nei.nih.gov
13983|NCT01445626|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13984|NCT01445652|Jami Kern, PhD|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13985|NCT01445769|Study Director|Incyte Corporation|855 463-3463|
13665|NCT01521845|Dr.Jamshid Salamzadeh|Shaheed Beheshti Medical University|00982188662334|j.salamzadeh@yahoo.com
13666|NCT01522131|Rosemary Thomas, DMD, MS|The University of Texas Health Science Center at Houston|713-486-4074|rosemary.thomas@uth.tmc.edu
13667|NCT01522339|Jean Tkach|Cincinnati Children's Hospital Medical Center|513-636-7166|jean.tkach@cchmc.org
13668|NCT01522924|Dr. Jacqueline Singleton|University of Louisville|502-852-2611|jasing02@louisville.edu
13669|NCT01523366|Tomas LG Andersson, MD, PhD|AstraZeneca|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com
13670|NCT01523392|Tomas LG Andersson, MD, PhD|AstraZeneca|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com
13671|NCT01523743|Pref. Emmanuel Chartier-kastler|Hopital Raymond poincare|+33 1 42 17 71 29|emmanuel.chartier-kastler@psl.aphp.fr
13672|NCT01523756|Marianne Raff|Coloplast A7S|+45 4911 2562|dkmr@oloplast.com
13673|NCT01523886|Mona R Gätke, MD, PH.D.|Herlev Hospital|004538662420|mona.gatke@regionh.dk
13674|NCT01523964|Chief Operating Officer|DART Therapeutics|415-341-5783|egoldstein@dartrx.com
13675|NCT01524198|Dr. Abdullah Alangari|King Saud University|966506287276|alangari100@gmail.com
13676|NCT01525173|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13677|NCT01525225|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
13678|NCT01525420|Jonathan B. Bricker, Ph.D.|Fred Hutchinson Cancer Research Center||jbricker@fhcrc.org
13679|NCT01526213|Mary F. Paine, RPh, PhD|UNC-Chapel Hill|919-966-9984|mpaine@unc.edu
13864|NCT01826370|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13865|NCT01829230|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|Vistakon USA|1 904 443-1245|xcheng6@its.jnj.com
13866|NCT01829243|Ashwin A. Patkar, MD|Duke University Medical Center|919-668-3626|ashwin.patkar@duke.edu
13867|NCT01829919|Sailaja Bhaskar, Executive Director, Clinical Research|Noven Therapeutics, LLC|(212) 287-0798|sbhaskar@noven.com
13868|NCT01830699|Matthew B. Carroll, MD|Keesler Medical Center|228-376-3629|matthew.carroll.1@us.af.mil
8950|NCT01202253|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8951|NCT01202279|Gail Solomon,MS; Director Clinical Development|Reckitt Benckiser Inc.|973-404-2752|gail.solomon@reckittbenckiser.com
8952|NCT01202565|Global Medical Services|AbbVie|800-633-9110|
8953|NCT01202578|Director of Clinical Research|Acclarent, Inc.|650-687-5888|lenglan1@its.jnj.com
8954|NCT01202747|Christy Stevens, OD|TearScience, Inc. (formerly Kolis Scientific)|919-459-4815|cstevens@tearscience.com
8524|NCT01279070|Dr. Aida Farreny|Parc Sanitari Sant Joan de Déu|+34 936406350 ext 2373|afarreny@pssjd.org
8525|NCT01279317|Drs. Jan-Willem van Dijk|Maastricht University Medical Centre|+31(0)433881394|janwillem.vandijk@maastrichtuniversity.nl
8526|NCT01279447|Lawrence Hsu, MD|Northwestern|312 9262000|larryphsu@gmail.com
8527|NCT01280110|Vital Paulino Costa|Departamento de Oftalmologia - Universidade Estadual de Campinas - Campinas - Brazil|55-19-35217396|vp.costa@uol.com.br
8528|NCT01280266|Dr. Eun Bong Lee|Seoul National University|+82 2 2072-3944|leb7616@snu.ac.kr
8529|NCT01280357|Ian How|Monica Healthcare Ltd|+44 (0)115912 ext 4540|ianhow@monicahealthcare.com
8530|NCT01280591|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
8531|NCT01280695|Jerry Colca, PhD|Metabolic Solutions Development Company|269.343.6732|jcolca@msdrx.com
8532|NCT01280968|Alexey G Mukhin, M.D., Ph.D.|Duke University Medical Center|Telephone:   919-668-5055|amukhin@duke.edu
8533|NCT01381471|GSK Response Center|GlaxoSmithKline|866-435-7343|
8534|NCT01381575|GSK Response Center|GlaxoSmithKline|866-435-7343|
8535|NCT01381679|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8536|NCT01381900|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|Janssen Research & Development, LLC|1-800-526-7736|
8537|NCT01381952|Dr. Söderman|Karolinska University Hospital|+46851774037|michael.soderman@karolinska.se
8538|NCT01382108|Kathy Dumbleton|Centre for Contact Lens Research|519-888-4567 ext 32694|kdumble@uwaterloo.ca
13054|NCT00985439|Steven Jensen|Iroko Pharmaceuticals, LLC|267-546-3003|sjensen@iroko.com
13055|NCT00985504|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13056|NCT00985543|Dr Marta Boffito|St Stephens Centre, Chelsea and Westminster Hospital|+44 2088 466 507|marta.boffito@chelwest.nhs.uk
13057|NCT00985673|GSK Response Center|GlaxoSmithKline|866-435-7343|
13058|NCT00985712|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13059|NCT00985725|Study Physician|Shire Pharmaceutical|1 866-842-5335|
13060|NCT00985790|GSK Response Center|GlaxoSmithKline|866-435-7343|
13061|NCT00985829|Zohreh Tehranchi-nia, assist. prof|skin research center|+989121029415|zohreh_tehranchi@yahoo.com
13062|NCT00985959|Director|Janssen Pharm KK Japan|+81-3-4411-5801|
13063|NCT01925170|Dr. Deborah Rhodes|Mayo Clinic|507-284-7971|rhodes.deborah@mayo.edu
13064|NCT01929135|Dra. Catherine Andrade|Universidad de los Andes|056-972862308|catherine.perio@gmail.com
13065|NCT01933776|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
13179|NCT01491607|Dr. Robert Hopkins|Emergent BioSolutions|(301) 944-0136|hopkinsr@ebsi.com
13180|NCT01491633|Dr. Peter Hammerman|Dana-Farber Cancer Institute|617-632-3000|phammerman@partners.org
13181|NCT01492439|Dr. Sean A. Kidd|Centre for Addiction and Mental Health|416-535-8501 ext 6295|sean.kidd@camh.ca
13182|NCT01493089|Dr. Richard Ng Kwet Shing|Norgine Ltd|+441895453584|RNg@Norgine.com
13183|NCT01493180|Director oof Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
13184|NCT01493427|Doug Hubatsch, Global Brand Leader, Medical Affairs|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13185|NCT01494298|Gina Ryan Clinical Professor|Mercer University College of Pharmacy|678.547.6222|ryan_gj@mercer.edu
13186|NCT01494545|Jami Kern, PhD|Alcon Research, Ltd|1-888-451-3937|alcon.medinfo@alcon.com
13986|NCT01445847|Effect of Intravenous Lidocaine on the Incidence of Post-Extubation Laryngospasm|Khalid Aljonaieh|966544300777|kaljonaieh@ksu.edu.sa
13987|NCT01445873|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13988|NCT01595854|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13989|NCT01596062|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
13990|NCT01596972|Director of Clinical Research and Training|Planned Parenthood League of Massachusetts|617.616.1600|agoldberg@pplm.org
13991|NCT01597843|Jeff Whittle, MD, MPH|Clement J Zablocki VA Medical Center|414-384-2000 ext 46444|jeffrey.whittle@va.gov
13992|NCT01598064|Dr. Po Lin Chen|National Cheng Kung University Hospital|886-2353535 ext 4733|n939492@mail.hosp.ncku.edu.tw
13993|NCT01598350|Julia Looper, PT PhD|University of Puget Sound|253 879 2895|jlooper@pugetsound.edu
13994|NCT01598610|Carmine Greene|Bayer Healthcare, Diabetes Care|574-257-3040|carmine.greene@bayer.com
13995|NCT01546922|A. P. van Beek, MD PhD|University Medical Center Groningen|00315036110388|a.p.van.beek@umcg.nl
13996|NCT01547247|Přemysl Falt MD|Digestive Diseases Center, Vítkovice Hospital, Ostrava, Czech Republic|+420602689561|faltprem@centrum.cz
13997|NCT01547598|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13998|NCT01548638|Dr. Rebecca Ashare|University of Pennsylvania Perelman School of Medicine|2157465789|rlashare@mail.med.upenn.edu
13999|NCT01548833|Jami Kern, PhD|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13543|NCT00914810|Ken Kunisaki, M.D.|Minneapolis VA Health Care System|612-467-4400|kunis001@umn.edu
13544|NCT00914862|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
13545|NCT00914966|Chief Scientific Officer|ViroPharma|610-458-7300|
13546|NCT00915278|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13547|NCT00915356|Gerard Lynch|AstraZeneca||clinicalTrialTransparency@astrazeneca.com
13869|NCT01830933|Celia P. Kaplan, Professor|University of California, San Francisco|415-502-5601|celia.kaplan@ucsf.edu
13870|NCT01832155|Corjena Cheung, Assistant Professor|University of Minnesota|612-624-5198|corjena@umn.edu
13871|NCT01833117|Michela Montecchi-Palmer, Clinical Project Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13872|NCT01833741|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13873|NCT01833845|Dr. Arnon Aharon|BioLineRx LTD|972-2-548-9100 ext 104|arnona@biolinerx.com
13874|NCT01834027|Sonia Vaida|Penn State Milton S. Hershey Medical Center|7175318433|svaida@hmc.psu.edu
13875|NCT01835743|Michael Coughlin, MD|Coughlin Foot and Ankle Clinic|208-367-3330|thefootmd@gmail.com
13876|NCT01835912|Panagiota Klentrou|BrockU|19056885550 ext 4538|nklentrou@brocku.ca
13877|NCT01836809|Keyur Shah, MD|Virginia Commonwealth University|804-828-4571|kshah@mcvh-vcu.edu
13878|NCT01837719|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
13879|NCT01838980|Medical Consultant|Motus GI Medical Technologies Ltd.|+972-4-6214446 ext 104|rose@motusgi.com
13880|NCT01839318|Jessie Lemp, GMA Brand Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13881|NCT01840319|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13882|NCT01843465|Dr Serge Boveda|Clinique Pasteur, Toulouse, France|(33) 5 62 21 16 45 ext 8819|sboveda@clinique-pasteur.com
13883|NCT01843660|Therapeutic Area Physician|Janssen China, Beijing|+86-10-58218709|
13884|NCT01845077|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13885|NCT01845155|Dr. Heike Argstatter|Deutsches Zentrum für Musiktherapieforschung (Viktor Dulger Institut) DZM e.V. - German Center for Music Therapy Research|+49-6221-7963960|heike.argstatter@dzm-heidelberg.de
14090|NCT01863433|bioCSL, Head of Clinical Operations|bioCSL PTY LTD|csl.clinicaltrials@csl.com.au|csl.clinicaltrials@csl.com.au
14091|NCT01866709|Henrik Rasmussen, MD, PhD|ZS Pharma, Inc|443-699-5230|hrasmussen@zspharma.com
8539|NCT01382225|Michela Montecchi-Palmer, Clinical Project Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
8540|NCT01382251|Dr. Gregory L Bryson|Department of Anesthesiology, The Ottawa Hospital|613.761.4169|glbryson@ottawahospital.on.ca
8541|NCT01382446|Tracy L. Thomas MSN RN CCRN ACNS-BC|SJHMC|602-406-2567|Tracy.Thomas007@dignityhealth.org
8542|NCT01382719|Jeffrey Edelson, MD, FRCPC|Palatin Technologies, Inc.|(609) 495-2200|jedelson@palatin.com
8543|NCT01382901|Marc Tokars|Luitpold Pharmaceuticals, Inc.|601-650-4200 ext 805|mtokars@lpicrd.com
8544|NCT01382940|Medical Communications|Hoffmann-La Roche|800 821-8590|
8545|NCT01383005|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
8546|NCT01383213|Dr Roberto Cosentini|IRCCS Fondazione Cà Granda Policlinico Milano|+390255033618 ext 3618|r.cosentini@gmail.com
8683|NCT00510653|David Gershenson, MD / Professor|The University of Texas (UT) MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
8684|NCT00510692|Dr Chris Jordan|S.L.A. Pharma (UK) Ltd|+44 (0)1923 681001|cjordan@slapharma.com
8685|NCT00510783|Brittney Copeland|Emory|404-616-0301|bcopel3@emory.edu
8686|NCT00510809|James Backes, PharmD|University of Kansas Medical Center|(913) 588-5324|JBACKES@kumc.edu
8687|NCT00510874|GSK Response Center|GlaxoSmithKline|866-435-7343|
8688|NCT00510887|Dr. David Rizzieri|Duke University Medical Center|919-668-1000|rizzi003@mc.duke.edu
8689|NCT00510952|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8690|NCT00511108|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
8691|NCT00511134|Andrea H. Weinberger, Ph.D.|Yale University|203-974-7598|andrea.weinberger@yale.edu
8692|NCT00511173|Christopher Destache|Creighton University|402-280-4744|destache@creighton.edu
8693|NCT00511199|Vice President of Late Stage Development, Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
8694|NCT00511238|Onyx Medical Information|Onyx Pharmaceuticals|1-877-ONYX-121|medinfo@onyx.com
13187|NCT01494584|GSK Response Center|GlaxoSmithKline|866-435-7343|
13188|NCT01494610|GSK Response Center|GlaxoSmithKline|866-435-7343|
13189|NCT01494649|GSK Response Center|GlaxoSmithKline|866-435-7343|
13190|NCT01494818|Renee Garofalo, OD, FAAO|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13191|NCT01494987|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
13192|NCT01495000|GSK Response Center|GlaxoSmithKline|866-435-7343|
13193|NCT01495286|Anita Mitchell PhD, coinvestigator|University of Arkansas|501-686-7021|AMitchell@uams.edu
13194|NCT01495572|Udai Kammula M.D.|National Cancer Institute|301-435-8606|kammulau@mail.nih.gov
13195|NCT01495858|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
13196|NCT01496287|Director of Clinical Research|Acclarent, Inc.|650-687-5888|lenglan1@its.jnj.com
13197|NCT01496352|Kent Allenby, MD, VP, Drug Development|Dr. Reddy's Laboratories, Inc.|609-375-9855|kallenby@drreddys.com
13198|NCT01497171|Dr. Emanuel C. Trabuco|Mayo Clinic|507-284-7519|trabuco.emanuel@mayo.edu
13199|NCT01497366|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
13200|NCT01497756|Mark Hauswald MD|uNewMexico|505-269-6699|markhauswald@gmail.com
13201|NCT01497938|Thomas Troub|Medtronic|(818) 576-3142|thomas.troub@medtronic.com
13202|NCT01498068|Compound Development Team Leader|Janssen Belgium|32 14 64 13 70|
13295|NCT01159912|GSK Response Center|GlaxoSmithKline|866-435-7343|
13296|NCT01159938|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13297|NCT01160237|GSK Response Center|GlaxoSmithKline|866-435-7343|
13298|NCT01160445|Dr. Steven Rosenberg|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
13299|NCT01160458|Dr. Raffit Hassan, M.D.|National Cancer Institute, National Institutes of Health|301-451-8742|hassanr@mail.nih.gov
13548|NCT00915473|Dr. David Dodick|Mayo Clinic|480-301-5797|dodick.david@mayo.edu
13549|NCT00915499|June Mendoza|ResMed|1-800-424-0737|june.mendoza@resmed.com
13550|NCT00915551|Dr. Torsten Skov|LEO Pharma|+4520736294|torsten.skov@leo-pharma.com
13551|NCT00965094|Study Director|Novartis Pharmaceuticals|862-778-8300|
13552|NCT00965146|Director of Clinical Research|Stryker Orthopaedics®|201-831-5401|ellen.axelson@stryker.com
13553|NCT00965237|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
13554|NCT00965250|Dr. Giuseppe Giaccone|National Cancer Institute, National Institutes of Health|301-496-4916|giacconeg@mail.nih.gov
13555|NCT00965484|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13556|NCT00965497|Meera Narasimhan, MD|University of South Carolina School of Medicine|803-434-1100|shardeman@uscmed.sc.edu
13557|NCT00925782|Omar Aljitawi, M.D., Assistant Professor of Medicine|University of Kansas Medical Center|913-588-6029|oaljitawi@kumc.edu
13558|NCT00925938|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
13559|NCT00925990|Vice President, Clinical Development|Conatus Pharmaceuticals Inc.|858-457-7227|mhuyghe@conatuspharma.com
13560|NCT00926029|William DeVizio - DMD|Colgate Palmolive|732-878-7901|william_devizio@colpal.com
13561|NCT00926211|Miguel Canales, M.D.|Restoration Robotics|650-965-3612 ext 206|miguel@restorationrobotics.com
13562|NCT00926263|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13563|NCT00976508|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13564|NCT00976521|Leah Hollins, Director of Clinical Affairs|Atrium Medical Corporation|603-880-1433 ext 5365|lhollins@atriummed.com
13588|NCT01998360|Peter S. Millard, MD, PhD|University of New England|2078663503|pmillard@mac.com
13772|NCT01438060|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
13773|NCT01438151|Dr. Shradha Agarwal|Mount Sinai|212-659-9261|shradha.agarwal@mssm.edu
14092|NCT01867164|Clinical Research Director|Global Clinical Operations Mexico|+52 55 5484 3184|
14093|NCT01868009|GSK Response Center|GlaxoSmithKline|866-435-7343|
14094|NCT01868035|GSK Response Center|GlaxoSmithKline|866-435-7343|
14095|NCT01869075|Artemis Diamantouros|Sunnybrook HSC|416-480-6100 ext 3654|artemis.diamantouros@sunnybrook.ca
14096|NCT01869686|Study Director|Amgen Inc.|866-572-6436|
14097|NCT01870999|Global Medical Affairs|Otsuka Pharmaceutical Development & Commercialization, Inc.|800-562-3974|
14098|NCT01873859|Dr. Saeed Alipour Parsa, director of clinical trial|Cardiovascular research center, Shahid Beheshti University of Medical Sciences|+9821 2208 3106|s_alipour@sbmu.ac.ir
14099|NCT01875510|Dr. Serdar Beken|Dr. Sami Ulus Children's Hospital|00903123056449|serbeken@gmail.com
14100|NCT01875978|Dr. Dalong Chen|China Medical University Hospital|+886-227919696 ext 1205|my686chen@gmail.com
14101|NCT01876732|Suzanne El-Sayegh|Staten Island University Hospital|718-226-6158|uviola@siuh.edu
14102|NCT01877161|Nam-Jong Paik|Seoul National University Bundang Hospital|031-787-7731 ext 7731|njpaik@snu.ac.kr
14103|NCT01877408|Dr. Peter Millard|University of New England|2078663503|pmillard@mac.com
14104|NCT01552876|Katherine Osborn OD, MS FAAO|Johnson & Johnson Vision Care|1 904 443-1032|kosborn@its.jnj.com
14105|NCT01552928|Study Physician|Shire Development LLC|+1 866 842 5335|
14106|NCT01553292|Dr Yahya Al Ethawi|University of Manitoba|0012049634721|yalethawi@hsc.mb.ca
14107|NCT01553539|Dr. William J. Petty|Wake Forest University Health Sciences|336-716-3313|wpetty@wakehealth.edu
14108|NCT01553708|Associate Prof. Pornanong Aramwit, Pharm.D., Ph.D.|Faculty of Pharmaceutical Sciences, Chulalongkorn University|+66-02-218-8409|paramwit@gmail.com
14109|NCT01554163|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
14110|NCT01554904|Richard B Berry, M.D.  Principal Investigator|University of Florida|3522621575|Richard.Berry@medicine.ufl.edu
14111|NCT01555073|Antoun Nader, MD|Northwestern University, Feinberg School of Medicine|312-695-3045|a-nader2@northwestern.edu
8695|NCT00511342|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
8696|NCT01353274|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8697|NCT01353664|Anne McClain|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
8698|NCT01353859|Medical Communications|Hoffmann- LaRoche|800-821-8590|genentech@druginfo.com
8699|NCT01353976|Candis Edwards|AmDerma Pharmaceuticals|631-974-7949|cedwards@amderma.com
8700|NCT01354028|Dr Richard W Hall MD, Professor of Neonatology|University of Arkansas for Medical Sciences|501-680-7894|HallRichardW@uams.edu
8701|NCT01354106|Dr. Gary Grove|cyberDERM|610-325-0112|GGrove@cyberderm-inc.com
8702|NCT01354223|William J. Gleason, O.D.|Foresight Regulatory Strategies, Inc.|978-658-6888 ext 151|
8703|NCT01354938|Esther Oppermann, Clinical Trial Manager|Abbott|49 511 6750 3954|
8704|NCT01354990|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8705|NCT01355068|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8819|NCT01123512|Barbara S. Lindsay, Vice President Clinical & Regulatory Affairs|Benvenue Medical, Inc.|408-454-9300|blindsay@benvenuemedical.com
8820|NCT01123889|Liz Clarke|Loma Linda University Orthopaedic Surgery|909-558-5592|eaclarke@llu.edu
8821|NCT01123928|Dr. Nathan Congdon|Zhongshan Ophthalmic Center|13925056342|ncongdon1@gmail.com
8822|NCT01123941|Dr. Audino Podda, MD|Novartis Vaccines Institute for Global Health|+39 0577 243496|audino.podda@novartis.com
8823|NCT01123980|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
8824|NCT01124045|Pam Kaur, PhD|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
8825|NCT01124097|Director R&D|BIAL – Portela & Cª S.A.|+351-229866100|clinical.trials@bial.com
8826|NCT01124149|Study Physician|Shire Development LLC|+1 866 842 5335|
13300|NCT01160484|Director, Clinical Operations|Oncotherapeutics|323-623-1200|lthulin@oncotherapeutics.com
13301|NCT01160614|Medical Services|Purdue Pharma L.P.|888-726-7535, option 1|
13302|NCT01226459|Study Director|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|(973) 385-3203|
13303|NCT01226511|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13304|NCT01227018|Dr. Dana Cardin|Vanderbilt-Ingram Cancer Center|615-936-8580|dana.cardin@vanderbilt.edu
13305|NCT01227395|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13306|NCT01227421|Marc Ayers|Romark Laboratories, L.C.|813-282-8544|Marc.Ayers@romark.com
13307|NCT01227629|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13308|NCT01227668|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
13309|NCT01227707|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
13310|NCT01227785|Paji Vitoff, Senior Clinical Manager|Guidant, a Boston Scientific Company|651-582-5415|paji.vitoff@bsci.com
13311|NCT01227824|GSK Response Center|GlaxoSmithKline|866-435-7343|
13312|NCT01227889|GSK Response Center|GlaxoSmithKline|866-435-7343|
13313|NCT01025154|Stefan Faderl, MD / Associate Professor|The University of Texas MD Anderson Cancer Center|713-745-4613|eharriso@mdanderson.org
13314|NCT01025271|Karin Byers, MD|University of Pittsburgh|412-648-6553|dlp5@pitt.edu
13315|NCT01025336|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13316|NCT01025635|Therapeutic Area Head|Bayer HealthCare Pharmaceuticals, Inc. (formerly Intendis GmbH)||clinical-trials-contact@bayerhealthcare.com
13317|NCT01025817|Study Director|Novartis|+1 (862) 778-8300|
13318|NCT01087970|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13319|NCT01088295|Jordan E. Lake, M.D., M.Sc.|University of California, Los Angeles|(310)557-1891|jlake@mednet.ucla.edu
13774|NCT01582139|Marc D Breton, Ph.D.|University of Virginia|434-982-6484|mb6nt@virginia.edu
13775|NCT01582178|Premysl Falt, MD|Vitkovice Hospital|+420595633 ext 205|faltprem@centrum.cz
13776|NCT01582282|John McRorie, PhD|Procter and Gamble|513-622-1423|mcrorie.jw@pg.com
13777|NCT01721070|Pamela Palmer, MD, PhD|AcelRx Pharmaceuticals, Inc.|650-216-3504|ppalmer@acelrx.com
13778|NCT01721317|GSK Response Center|GlaxoSmithKline|866-435-7343|
13779|NCT01721564|Prof David Celermajer|Royal Prince Alfred Hospital, Sydney, Australia|+61 2 9515 6519|david.celermajer@email.cs.nsw.gov.au
13780|NCT01721837|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13781|NCT01722435|Prof. Dr. Jens reimer|Centre for Interdisciplinary Addiction research of Hamburg University ZIS|+4940741057900|reimer@uke.de
13782|NCT01722734|Dr Günther Fink|Harvard School of Public Health|6174327389|gfink@hsph.harvard.edu
13783|NCT01723722|Dr Mark S Brown|Eastern Maine Medical Center|207-973-8670|mbrown@emh.org
13784|NCT01723904|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
13785|NCT01724216|Mark Charles DeLano, M.D., Principal Investigator|Spectrum Health|616-363-7339|delanom@msu.edu
13786|NCT01724359|GERENTE MEDICO REGIONAL|Jan-Cil Mexico|52 55 5237 3410|
13787|NCT01533493|Joseph Biederman|Massachusetts General Hospital|617-724-1743|jbiederman@partners.org
13788|NCT01533753|Dr. Justine Bruce|University of Wisconsin Carbone Cancer Center|608-263-7107|jybruce@medicine.wisc.edu
13789|NCT01534143|Zaid Al-Kahdimi, M.D.|Barbara Ann Karmanos Cancer Institute|(313) 576-8022|alkadhiz@karmanos.org
13790|NCT01534182|Study  Director|Novartis|+1 (862) 778-8300|
13791|NCT01534208|Jennifer Wike|Repros Therapeutics Inc.|2817193402|jwike@reprosrx.com
13792|NCT01534533|Dr. Zhiyong Zou|Peking University|+8610-13581525193|harveyzou2002@bjmu.edu.cn
13793|NCT01534637|James Lovato, MS|Comprehensive Cancer Center of Wake Forest University|336-713-4172|jlovato@wakehealth.edu
14112|NCT01555151|Clinical Disclosure Office|Novartis Pharmaceuticals|+1(862)778-8300|
13680|NCT01526902|Pete Kollbaum, OD, PhD, FAAO, FBCLA, Principal Investigator|Indiana University|812-856-0108|kollbaum@indiana.edu
13681|NCT01527370|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13682|NCT01528319|Department Chief, Clinical Development & PMS|Johnson & Johnson K.K. Medical Company|+81-3-4411-6789|yikeda5@its.jnj.com
13683|NCT01528332|Dr. Elke Naujokat|Philips Consumer Lifestyle|+31 (0) 631974213|elke.naujokat@philips.com
13684|NCT01528592|Darren Gitelman, MD|Northwestern University|312-908-8266|d-gitelman@northwestern.edu
13685|NCT01528605|Xiaoming Lin|Peking University|010-82805336|linbjmu@bjmu.edu.cn
13686|NCT01529203|Clinical Project Manager|Galderma|(33) 4 92 38 67 33|may.ma@galderma.com
13687|NCT01529632|Study Director|Novartis Pharmaceuticals|862-778-8300|
13688|NCT01529645|Posting Director|Novartis Vaccines||RegistryContactVaccinesUS@novartis.com
13689|NCT01530464|Dr. Thies Schroeder|Duke University Medical Center|919 681 4721|thies.schroeder@duke.edu
13690|NCT01530477|Yi Xia|GE Healthcare|1 (608) 221-1551 ext 500-3045|Yi.Xia@ge.com
13691|NCT01531205|Julio Pow-Sang, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-2226|julio.powsang@moffitt.org
13692|NCT01820559|Head of Clinical Research Section|BIAL - Portela & Ca, SA|351 22 986 6100|clinical.trials@bial.com
13693|NCT01820585|Head of Clinical Research Section|Bial - Portela & Cª, S.A.|+ 351 22 986 61 00|clinical.trials@bial.com
13694|NCT01821534|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13695|NCT01821807|Dr. Ruslan Abdullayev|Adiyaman University Research Hospital, Department of Anesthesiology and Reanimation|+905063010833|ruslan_jnr@hotmail.com
13696|NCT01821859|Tanja Pejovic|Oregon Health and Science University|503-494-5125|pejovict@ohsu.edu
13697|NCT01822665|GSK Response Center|GlaxoSmithKline|866-435-7343|
13698|NCT01822678|Head of Clinical Research Section|BIAL - Portela & Ca, SA|351 22 986 6100|clinical.trials@bial.com
8827|NCT01124162|Associate Director, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
8828|NCT01124175|Associate Director, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
8829|NCT01124292|Dr. Maysam Ghovanloo|Georgia Institute of Technology|404-385-7048|mgh@gatech.edu
8830|NCT01124305|Knee Project Director|AORI|7036194423|nparks@aori.org
8831|NCT01124422|GSK Response Center|GlaxoSmithKline|866-435-7343|
8832|NCT01124448|Dr. Juan M Rodríguez|Complutense University Madrid|34 91 3943837|jmrodrig@vet.ucm.es
8833|NCT01124604|Manager|Neuroscience Department, Clinical Science Department, R&D in Janssen Japan Chiyodaku, Tokyo 101-0065 Japan|+81-3-4411-5509|
8834|NCT01136408|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8835|NCT01136655|Göran Eckerwall, MSD|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
8836|NCT01136746|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8837|NCT01136876|Maria Luigia Storto, M.D.|Bracco Diagnostics Inc.|609-514-2262|MariaLuigia.Storto@diag.bracco.com
8838|NCT01136915|Maria Luigia Storto, M.D.|Bracco Diagnostics, Inc.|609-514-2262|MariaLuigia.Storto@diag.bracco.com
8839|NCT01136954|Eisai Inc.|Eisai Call Center|888-422-4743|
8840|NCT01137292|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8841|NCT01137370|Jae-Joon Yim|Department of Medicine and Lung Institute, Seoul National University College of Medicine|+82-2-2072-2059|yimjj@snu.ac.kr
8955|NCT01202955|Dr. Caryn Lerman|University of Pennsylvania|215-746-7141|clerman@mail.med.upenn.edu
8956|NCT01203046|Dr. Silvia M. Pinango L.|Dr. Silvia M. Pinango L|+584169267988|pinangosilvia@yahoo.com
8957|NCT01203319|Fengcai Zhu|Jiangsu Provincial Center for Disease Control and Prevention|#86-25-83759418|jszfc@vip.sina.com
8958|NCT01203644|Executive Medical Director|Pacira Pharmaceuticals, Inc.|203-837-6500|ErolOnel@pacira.com
8959|NCT01203917|Haiyi Jiang|AstraZeneca|+86 21 60302408|aztrial_results_posting@astrazeneca.com
13320|NCT01088399|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13321|NCT01088438|Dr. Alan Schwartz|University of Illinois at Chicago|312-996-2070|alansz@uic.edu
13322|NCT01088529|Senior Director|Janssen R&D US||ClinicalTrialDisclosure@its.jnj.com
13323|NCT01088646|Hilla Debby/Director of clinical affairs|Givenimaging|97249097774 ext 7774|hila.debby@givenimaging.com
13324|NCT01089023|Medical Communications|Hoffmann- LaRoche|800-821-8590|genentech@druginfo.com
13325|NCT01089062|VP, Scientific Affairs|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|650-386-3100|dkellerman@mappharma.com
13326|NCT01089127|Study Director|Novartis Pharmaceuticals|862 778-8300|
13327|NCT01089231|M. Sc. Simone Schmidt|Leibniz Universität Hannover|+49 (511) 762 5931|Schmidt@nutrition.uni-hannover.de
13328|NCT01089517|Jeffrey Nau|Ophthotech|646-573-7045|jeff.nau@ophthotech.com
13329|NCT01089543|Yoshiumi Okubo, Study Director|Eisai Inc.|+81-3-3817-3908|y4-okubo@hhc.eisai.co.jp
13330|NCT01089556|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13331|NCT01089582|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13332|NCT01089751|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13333|NCT01090011|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13334|NCT01090050|Jeanne Tarrasch|Clinvest/A Division of Banyan Group Inc.|417-841-3673|jtarrasch@clinvest.com
13335|NCT01090063|Dr. Alice Gottlieb|Tufts Medical Center|617-636-7462|Agottlieb@tuftsmedicalcenter.org
13336|NCT01090076|Mr Alvin Wong|Changi General Hospital|68504627|alvin_wong@cgh.com.sg
13337|NCT01090102|Dr. Ma Somsouk|University of California, San Francisco|415-206-6480|somsoukma@medsfgh.ucsf.edu
13338|NCT01090323|Study Director|Novartis Pharmaceuticals|862-778-8300|
13339|NCT01090453|GSK Response Center|GlaxoSmithKline|866-435-7343|
13794|NCT01534962|Angela Capriati MD PhD, Head of Corporate Clinical Research|Menarini Ricerche S.p.A|00390555680 ext 9933|acapriati@menarini-ricerche.it
14000|NCT01548885|Jane Wallace|Bayer HealthCare, LLC, Diabetes Care|574-257-3063|jane.wallace@bayer.com
14001|NCT01549041|Joseph P McEvoy, MD|DukeUMC|9198199295|JPMCEVOY@DUKE.EDU
14002|NCT01549340|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
14003|NCT01739803|Marie Chisholm-Burns|University of Tennessee College of Pharmacy|901-448-7141|mchisho3@uthsc.edu
14004|NCT01740362|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14005|NCT01740388|Johnson Varughese|Valeant Pharmaceuticals|908-541-2179|Johnson.Varughese@valeant.com
14006|NCT01741350|Dr. Michael M. Copenhaver, Ph.D.|University of Connecticut|860 208-3632|michael.copenhaver@uconn.edu
14007|NCT01742897|Medical Affairs Director|Medical Affairs, Janssen-Cilag (Thailand)|662-739-7200 ext 5888|
14008|NCT01743027|James Wheeler, Unit Head, Pharma|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
14009|NCT01745055|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14010|NCT01747330|Associate Director Clinical Services|Abbott||taco.baardman@abbott.com
14011|NCT01747343|Brian D. Greer, Ph.D.|University of Kansas|386-852-7171|brian.greer@unmc.edu
14012|NCT01747928|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14013|NCT01748071|Xianwei Zhang|Huazhong University of Science&Technology|027 83662853|ourpain@163.com
14014|NCT01748890|Anthony E. Samir|Massachusetts General Hospital|6178523241|asamir@partners.org
14015|NCT01749982|Megan N Hall|Columbia University|212-305-3161|mh2825@columbia.edu
14016|NCT01750242|Stephanie Salisbury|Medtronic Neuromodulation|763-526-8096|stephanie.salisbury@medtronic.com
14017|NCT01751113|GSK Response Center|GlaxoSmithKline|866-435-7343|
14018|NCT01751178|GSK Response Center|GlaxoSmithKline|866-435-7343|
13699|NCT01822899|GSK Response Center|GlaxoSmithKline|866-435-7343|
13700|NCT01823289|Director of Respiratory Department|Department of Respiratory Medicine, SHANGHAI First People’s Hospital Affiliated to SHANGHAI JiaoTong University|86-21-63071428|xzhou53@163.com
13701|NCT01823536|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
13886|NCT01732471|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
13887|NCT01732484|Prof. Dr. R. Menapace|Medical University of Vienna|+43 699 19660272|rupert.menapace@meduniwien.ac.at
13888|NCT01732692|Medical Director|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
13889|NCT01732757|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13890|NCT01733056|Dr. Robert Swerlick|Emory University|404-727-3669|rswerli@emory.edu
13891|NCT01733069|Jennifer Reid, Director of Clinical Affairs|Gen-Probe Incorporated|858-731-5985|jennifer.reid@hologic.com
13892|NCT01733277|Dr Jean-Pierre Pelletier|ArthroLab Inc.|15148908000 ext 26666|dr@jppelletier.ca
13893|NCT01733329|Dr. Flavio Hernández Castro|Hospital Universitario José Eleuterio González, Universidad Autónoma de Nuevo León|8112776459|flaviohernandezc@yahoo.com
13894|NCT01733745|Abayomi Ogundele, Pharm.D, Global Brand Medical Affairs Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13895|NCT01734239|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13896|NCT01734317|Joan Wilson|Mölnlycke Health Care|+1 706-650-1012|joan.wilson@molnlycke.com
13897|NCT01734395|Clinical Research Director|Jan-Cil Korea|82 2 2094 ext 4518|
13898|NCT01734772|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13899|NCT01734889|Medical Director|Swedish Orphan Biovitrum|+46 8 697 20 00|erik.brouwer@sobi.com
13900|NCT01735201|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13901|NCT01735877|Dr Jeyaraj D Pandian|Christian Medical College & Hospital|09915784750|jeyarajpandian@hotmail.com
8960|NCT01204255|Thomas J. Smith, MD|Virginia Commonwealth University|804-828-9723|tsmith5@mcvh-vcu.edu
8961|NCT01204294|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8962|NCT01204398|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8963|NCT01204671|GSK Response Center|GlaxoSmithKline|866-435-7343|
8964|NCT01204853|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8965|NCT01205126|Director, Established Products|Janssen Research & Development, LLC|+1 609 730 3387;|
8966|NCT01205230|GSK Response Center|GlaxoSmithKline|866-435-7343|
8967|NCT01205269|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
8968|NCT01205399|Dawn Heimer/Director, Clinical Affairs|C. R. Bard: Davol, Inc.|401-825-8681|dawn.heimer@crbard.com
8969|NCT01205451|GSK Response Center|GlaxoSmithKline|866-435-7343|
8970|NCT01297920|Matt Walker, PhD, Clinical Project Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
8971|NCT01298063|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8972|NCT01298128|Dr. Kimberly Liu|Mount Sinai Hospital|416-586-5367|kliu@mtsinai.on.ca
8973|NCT01298167|David Leffell, MD|Yale University|203 785 7999|david.leffell@yale.edu
8974|NCT01298518|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8975|NCT01298531|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8976|NCT01298544|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8977|NCT01298648|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
8547|NCT01383356|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8548|NCT01383486|Head Clinical and Medical Affairs|Bayer HealthCare LLC, Consumer Care||clinical-trials-contact@bayerhealthcare.com
13340|NCT01090479|Michael Murray, MD|Northwestern University|312-926-4444|m.murray8278@gmail.com
13341|NCT00862940|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
13342|NCT00863057|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
13343|NCT00863109|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13344|NCT00863343|Dennis Mertz, Director Regulatory and Clinical Affairs|Meso Scale Diagnostics, LLC.|240 631-2522 ext 2809|dmertz@mesoscale.com
13345|NCT00863356|V.P., Clinical Affairs|HemCon Medical Technologies|971.223.4904|jody.oyama@hemcon.com
13346|NCT00863551|Vice President, Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
13347|NCT00863655|Study Director|Novartis Pharmaceutical|862-778-8300|
13348|NCT00863707|Senior Medical Director, Medical Affairs|Astellas Pharma Global Development||clinicaltrials@us.astellas.com
13349|NCT00863746|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
13350|NCT00863798|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13351|NCT00864032|Dr. Robert J. Canter|University of California Davis Comprehensive Cancer Center|916-734-5907|robert.canter@ucdmc.ucdavis.edu
13352|NCT00864084|Ms Elizabeth Harvey|The University of Manitoba|204-977-5656|harveye@cc.umanitoba.ca
13353|NCT00864123|Eric Storch, Ph.D.|University of South Florida|727-767-8230|estorch@health.usf.edu
13354|NCT00864253|Anne McClain|Celgene Corporation|888-260-1599|clinicaltrialdisclosure@celgene.com
13355|NCT00864539|Dr. Tirang R. Neyestani|National Nutrition and Food Technology Research Institute|(+9821)22376471|neytr@yahoo.com
13356|NCT00864682|Joseph M. Neal, MD|Virginia Mason Medical Center|206-223-6980|anejmn@vmmc.org
13357|NCT00864708|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|NF/SG VA Medical Center, Gainesville Florida|(352) 376-1611 ext 5223|janis.daly@neurology.ufl.edu
13358|NCT00864851|Anna Wijatyk, MD, Medical Director|Shire Human Genetic Therapies, Inc. (Shire HGT)|781-482-9622|awijatyk@shire.com
14019|NCT01751867|SR DIR COMPD DEV TM LDR|Janssen R&D US|1 908 704-5197|
14020|NCT01754766|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
14021|NCT01755026|michael stitely|west virginia university|304-293-5631|mstitely@hsc.wvu.edu
14022|NCT01755637|GSK Response Center|GlaxoSmithKline|866-435-7343|
13589|NCT01998880|Medical Communications|Hoffman-LaRoche|800-821-8590|
13590|NCT01998919|Medical Communications|Hoffmann- LaRoche|800-821-8590|genentech@druginfo.com
13591|NCT01999894|Ephraim Katz, PhD / Associate Director|Forest Research Institute|201-427-8000 ext 8169|Ephraim.Katz@frx.com
13592|NCT02000973|Jun Wang|First Hospital of China Medical University|8602483283100|wjun2000@hotmail.com
13593|NCT02003534|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13594|NCT02003638|Dr. Emil deGoma|University of Pennsylvania|2156156521|emil.degoma@uphs.upenn.edu
13595|NCT02004132|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13596|NCT02004886|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13597|NCT02005484|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
13598|NCT02005549|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
13599|NCT02005692|Barrett Larson, MD, Chief Medical Officer|Leaf Healthcare, Inc.|650-701-3652|barrett.larson@leafhealthcare.com
13600|NCT02006836|Dr.Yu|Huazhong University of Science and Technology|862783662883|xfyu188@163.com
13601|NCT02010216|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
13602|NCT02012686|Dr Dong Woo Han|Department of Anesthesiology and Pain Medicine, Gangnam Severance Hospital, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-720, Republic of Korea|82-2-2019-3549|HANESTH@yuhs.ac
13603|NCT02013765|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
13604|NCT02013817|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
14117|NCT01556594|Dr. Claude Piche|AMG Medical|5144580175|claude.piche@amgmedical.com
14118|NCT01556763|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|EnVivo Pharmaceuticals, Inc.|617-225-4264|mgawryl@envivopharma.com
14119|NCT01556906|Chief Medical Officer|Aegerion Pharmaceutical|617-500-7867|
14120|NCT01557283|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14121|NCT01557322|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14122|NCT01557595|Dr. Rachel Fargason|UAB|205-934-5151|rfargason@uab.edu
14123|NCT01557868|Dr. Barton Mann|American Orthopaedic Society for Sports Medicine|847-292-4900|bart@aossm.org
14124|NCT01557894|Bogdan Tudor Tulbure|Babes-Bolyai University|+40745753061|btulbure@gmail.com
14125|NCT01557959|Dr. William J. Petty|Wake Forest Baptist Health|336-716-3313|wpetty@wakehealth.edu
14126|NCT01559012|Dr. Aldo Maina  M.D. Obstetric Medicine|Città della Salute e della Scienza  Ospedale Sant'Anna. Servizio di Medicina Interna|0039011313 ext 5735|amaina@cittadellasalute.to.it
14127|NCT01769339|Medical Affairs Manager|Janssen Philippines|+6328248935|
14128|NCT01770314|Emil Chiauzzi|Inflexxion|617-614-0429|echiauzzi@inflexxion.com
14129|NCT01770483|Prof. Faisal Masud|SIMS|00923004260213|faisalmasud@hotmail.com
14130|NCT01770652|Fernando Tricta, MD|ApoPharma Inc.|Phone: 416-401-7332|ftricta@apopharma.com
14131|NCT01878149|Sr. Director of Clinical Affairs|Baxano Surgical®|919.899.9760|teresa.schroeder@baxsurg.com
14132|NCT01878656|Dr. Chong Wha Baek|Chung-Ang University Hospital|82-2-6299-2579|nbjhwa@naver.com
14133|NCT01879410|GSK Response Center|GlaxoSmithKline|866-435-7343|
14134|NCT01879540|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
14135|NCT01879553|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
13725|NCT01711866|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
8549|NCT01383499|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8550|NCT01383681|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
8551|NCT01383993|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8552|NCT01384019|Dr. Chang-Hwan Yoon|Seoul national university Bundang hospital|+82-31-787-7052|changhwanyoon@snubh.org
8553|NCT01385033|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8554|NCT01385371|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
8555|NCT01385566|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8556|NCT01385579|Dr. Muriel Jean-Jacques, Assistant professor|Northwestern University|312-503-9642|mjean@nmff.org
8557|NCT01385696|Clinical Project Leader and Trial Manager|Almirall S.A.|+34 93 291 3200|
8558|NCT01385995|Dr. Susan Redline|Brigham and Women's Hospital|857-307-0352|sredline1@rics.bwh.harvard.edu
8559|NCT01147848|GSK Response Center|GlaxoSmithKline|866-435-7343|
8560|NCT00653523|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
8561|NCT00653861|Therapeutic Area Head|Allergan Medical|(805) 961-5500|devicetrials@allergan.com
8562|NCT00654004|Dr. Melanie Gillingham|Oregon Health & Science Univeristy|503-494-1682|gillingm@ohsu.edu
8563|NCT00654030|Dr. Edward Hirschowitz|University of Kentucky|859-323-5045|eahirs2@uky.edu
8564|NCT00654095|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
8565|NCT00654186|Sigrun Hallmeyer, MD|Oncology Specialists, SC|847-268-8200|shallmeyer@oncmed.net
8566|NCT00654329|Julia C. Finkel, MD|Children's National Medical Center|202-476-4867 ext 4867|jfinkel@cnmc.org
8567|NCT00654368|Study Director|Amgen Inc.|866-572-6436|
13359|NCT00864916|Samir K. Gupta, MD|Indiana University School of Medicine|317-274-7926|sgupta1@iu.edu
13360|NCT00865020|Study Director|Novartis Pharmaceuticals|862-778-8300|
13361|NCT00865098|Masataka Ota|Merck Serono Co., Ltd, Tokyo, Japan|+81 0 3 6853 8611|
13362|NCT00865306|Dina R. Hirshfeld-Becker, PhD|Massachusetts General Hospital|617-503-1408|dhirshfeld@partners.org
13363|NCT00865345|Scott Lee M.D.|Medtronic|818-576-4204|scott.w.lee@medtronic.com
13364|NCT00865514|Dr. Peter W. Stacpoole|University of Florida|(352) 273-9023|pws@ufl.edu
13365|NCT00865709|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
13366|NCT00923195|Dr. Steven Rosenberg|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
13367|NCT01460290|Martha Sajatovic, Professor of Psychiatry|University Hospitals of Cleveland|2168442808|martha.sajatovic@uhhospitals.org
13368|NCT01460342|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13369|NCT01460446|Medical Communications|Hoffmann-La Roche|800 821-8590|
13370|NCT01460732|George S. Stergiou|Hypertension Center, Third University Department of Medicine|0030 210 7763117|gstergi@med.uoa.gr
13371|NCT01460927|Alessandro Bizzarri|El.En. Electronic Engineering S.p.A.|+39 055 8826807|a.bizzarri@elen.it
13372|NCT01461369|Daniel Solorio, Executive Director of Clinical Operations|Iroko Pharmaceuticals, LLC|267-546-3150|dsolorio@iroko.com
13373|NCT01461655|Clinical Trial Disclosure Manager|LEO Pharma A/S|+45 4494 5888|ctr.disclosure@leo-pharma.com
13374|NCT01461733|Salmaan Kanji|The Ottawa Hospital Research Institute|613-737-8899 ext 78159|skanji@toh.on.ca
13375|NCT01461811|Mary Fahmy, OD, Clinical Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13376|NCT01462266|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13377|NCT01462370|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13378|NCT01462435|Daniel Solorio|Iroko Pharmaceuticals, LLC|267-546-3150|dsolorio@iroko.com
13605|NCT02013830|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
13606|NCT02014272|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13607|NCT02014480|GSK Response Center|GlaxoSmithKline|866-435-7343|
13608|NCT02016963|GSK Response Center|Human Genome Sciences Inc.|866-435-7343|
13609|NCT02020512|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13610|NCT02021461|Director R&D|BIAL - Portela & Cª, S.A.|351-22-9866100|clinical.trials@bial.com
13611|NCT02024867|Dr. Lucy Holmes|University at Buffalo|716-878-7277|LHolmes@upa.chob.edu
13795|NCT01535118|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13796|NCT01535222|Andreas van de Locht|The Medicines Company|+4989244180862|andreas.locht@themedco.com
13797|NCT01535326|Dr. Yu-Hsi Hsieh|Dalin Tzu Chi Hospital|88652648000 ext 5241|hsieh.yuhsi@msa.hinet.net
13798|NCT01535365|Adam Singer|Stony Brook U|631-444-7856|adam.singer@stonybrook.edu
13799|NCT01535560|Sally Schieb, Sr. Clinical Project Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13800|NCT01535599|Sally Scheib, Sr. Clinical Project Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13801|NCT01535664|Gustavo Suarez, MD|Acorda Therapeutics, Inc.|(914) 326-5394|gsuarez@acorda.com
13802|NCT01535976|Gildasio De Oliveira MD|Northwestern University|312-472-3573|g-jr@northwestern.edu
13803|NCT01536015|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
13804|NCT01582308|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13805|NCT01582477|Andrew Sternlicht, MD|St. Elizabeth's Medical Center|617-789-2777|andrew.sternlicht@steward.org
13806|NCT01582490|Erol Onel, MD|Pacira Pharmaceuticals, Inc.|858-625-2424|erol.onel@pacira.com
13807|NCT01583530|GSK Response Center|GlaxoSmithKline|866-435-7343|
14172|NCT01777126|Peter Declercq|Pharmacy Department, University Hospitals Leuven & Department of Pharmaceutical and Pharmacological Sciences, KULeuven, Belgium|003216342340|peter.declercq@uzleuven.be
14173|NCT01777334|GSK Response Center|GlaxoSmithKline|866-435-7343|
14174|NCT01777425|Prof. Dr. P. Hellings|UZ Leuven|+3216332340|peter.hellings@uzleuven.be
14175|NCT01777438|Dr Hellings|UZ Leuven|+32 16 332338|peter.hellings@uzleuven.be
14176|NCT01777581|David Marks, MD|Duke University Medical Center|919 668-2859|d.marks@duke.edu
14177|NCT01777620|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
14178|NCT01777763|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
14179|NCT01778296|Dr. Chao Chen|The Second Hospital of Tangshan|86-13700350471|ts_chenchao@163.com
14180|NCT01778530|Dr. Joohee Sul|National Cancer Institute|301-402-6298|Joohee_Sul@nih.gov
13702|NCT01823614|Dmitry Kireev|Central Research Institute for Epidemiology|+74959749646 ext 2227|dmitry.kireev@pcr.ru
13703|NCT01823653|Director of Clinical Programs|Solta Medical|510-259-5284|aloncaric@solta.com
13704|NCT01824446|Study Physician|Shire Development LLC|+1 866 842 5335|
13705|NCT01824498|Susan Raatz, PhD, RD|USDA, GFHNRC|701-795-8294|susan.raatz@ars.usda.gov
13706|NCT01824602|Head of Clinical Research Section|BIAL - Portela & Ca, SA|351 22 986 6100|clinical.trials@bial.com
13707|NCT01825837|Head of Clinical Research Section|BIAL - Portela & Ca, SA|351 22 986 6100|clinical.trials@bial.com
13708|NCT01431755|Head of Medical Affairs|Q-Med AB|+46 (0) 18 474 90 00|reception.SEUPP@galderma.com
13709|NCT01431950|GSK Response Center|GlaxoSmithKline|866-435-7343|
13710|NCT01431963|GSK Response Center|GlaxoSmithKline|866-435-7343|
13711|NCT01431976|GSK Response Center|GlaxoSmithKline|866-435-7343|
13712|NCT01431989|GSK Response Center|GlaxoSmithKline|866-435-7343|
8568|NCT00654381|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8706|NCT01355458|Michael Graeber, MD|Galderma|609-860-8201|michael.graeber@galderma.com
8707|NCT01355471|Michael Graeber, MD|Galderma|609-860-8201|michael.graeber@galderma.com
8708|NCT01355523|MD Melissa Voigt Hansen|Herlev Hospital, Department of Surgery|+45 20661119|melissa.voigt.hansen@regionh.dk
8709|NCT01355588|David Bregman, M.D., Ph.D.|Luitpold Pharmaceuticals, Inc.|610-650-4200 ext 828|dbregman@lpicrd.com
8710|NCT01355627|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
8711|NCT01356407|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
8712|NCT01356498|Chief Medical Officer|Savient Pharmaceuticals, Inc.|732-418-9300|
8713|NCT01356602|Study Director|Novartis Pharmaceuticals|862-778-8300|
8714|NCT01357148|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8715|NCT01357616|Mandy Ye, Head, Clinical Trial Management, Asia|Alcon Research, Ltd.|1-888-451-3739|alcon.medinfo@alcon.com
8716|NCT01357720|Medical Affairs Director|Crucell Switzerland AG|+41(0)319086111|info@crucell.com
8717|NCT01357889|GSK Response Center|GlaxoSmithKline|866-435-7343|
8718|NCT01357980|Medical Director Neurology|Ipsen|clinical.trials@ipsen.com|clinical.trials@ipsen.com
8719|NCT01358526|Clinical Leader|Purdue Pharma L.P.|800-733-1333|
8720|NCT01358708|Robert Winkler MD,  VP, Clinical Development and Operations|Aptalis Pharma US, Inc.|(908) 429-4479 ext 4175|rwinkler@aptalispharma.com
8721|NCT01359111|Courtney Jarrahian|PATH|206-285-3500|cjarrahian@path.org
8722|NCT01359150|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8723|NCT01359449|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
8724|NCT01376388|GSK Response Center|GlaxoSmithKline|866-435-7343|
13379|NCT01618240|Hooman Mirzakhani|Massachusetts General Hospital|617-291-9779|hmirzakhani@partners.org
13380|NCT01618838|Dr. Sean Collins|Georgetown University Hospital|202-444-3062|spc9@gunet.georgetown.edu
13381|NCT01618864|Director of Clinical Affairs|Iluminage|+972 547 800 260|doranr@iluminagebeauty.com
13382|NCT01618942|Xianwei Zhang|Huazhong University of Science&Technology|027 83662853|ourpain@163.com
13383|NCT01618955|Jonathan Jaffe, MD; Vice President-Clinical Development|Antares Pharma Inc.|609-359-3020 ext 324|jjaffe@antarespharma.com
13384|NCT01618968|Jonathan Jaffe, MD; Vice President Clinical Development|Antares Pharma Inc.|609-359-3020 ext 324|jjaffe@antarespharma.com
13385|NCT01620047|Director of Research|Gulf-to-Bay Anesthesiology Associates LLC|813-844-4413|rkarlnoski@fgtba.com
13386|NCT01620060|Medical Director, CNS|Sunovion|1-866-503-6351|
13387|NCT01621776|Janet Silverstein, MD|University of Florida|352-334-1390|silvejh@peds.ufl.edu
13388|NCT01622231|GSK Response Center|GlaxoSmithKline|866-435-7343|
13389|NCT01622257|Dr. Moustafa Ibrahim|Assistant professor of Obstetrics & Gynecology, Ain-shams faculty of medicine|00201001955996|mi_monem@yahoo.com
13390|NCT01622296|Dr. Susan Parveen Tavana|UCSF School of Dentistry|415-476-1891|susan.tavana@ucsf.edu
13391|NCT01622673|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13392|NCT01623479|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13393|NCT01625169|LaShonda Spencer|USC|323 226-6437|lspencer@usc.edu
13394|NCT01085500|Benjamin Zendejas, MD|Mayo Clinic|507-538-5413|zendejas.benjamin@mayo.edu
13395|NCT01085513|director of clinical affairs|Given Imaging|+972-4-9097774|Hila.debby@givenimaging.com
13396|NCT01085539|Fran Haury, RRT Research Coordinator|Covidien|303 305-2314|fran.haury@covidien.com
13397|NCT01085643|Edy Soffer, MD|Cedars-Sinai Medical Center|(310) 423-6143|edy.soffer@cshs.org
13398|NCT01085682|Kun-Ho Yoon, professor|The Catholic University of Korea|82-2-2258-8281|yoonk@catholic.ac.kr
13808|NCT01583647|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13809|NCT01584648|GSK Response Center|GlaxoSmithKline|866-435-7343|
13810|NCT01584843|GSK Response Center|GlaxoSmithKline|866-435-7343|
13811|NCT01585558|Shionogi Clinical Trials Administrator|Shionogi Inc.|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
13812|NCT01585597|Christopher Horn|Emory University|404 387 7320|cmhorn@emory.edu
13813|NCT01586364|Shionogi Clinical Trials Administrator|Shionogi Inc.|800-849-9707 ext 1454|shionogiclintrialsadmin@shionogi.com
13814|NCT01586962|Clinical Project Leader|Novartis|+41223633111|
13815|NCT01587014|Dr. Julie Dunn|Medical Center of the Rockies|970-624-1680|julie.dunn@uchealth.org
13816|NCT01587027|Gary Luckasen, M.D.|Medical Center of the Rockies|(970)624-1686|gary.luckasen@uchealth.org
13817|NCT01587651|Fred Lipkin|Daiichi Sankyo Medical Affairs|973-944-2216|flipkin@dsi.com
14023|NCT01598740|Howard Dittrich, MD|Sorbent Therapeutics, Inc.|858-405-1429|hdittrich@sorbent.com
14024|NCT01599234|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd.|0044 1223 266800|rp@gwpharm.com
14025|NCT01599741|Thijs Grunhagen|Philips|+31 6 11645166|thijs.grunhagen@philips.com
14026|NCT01600287|Dr G D Puri|Postgraduate Institute of Medical Education and Research|00919914209509|gdpuri007@hotmail.com
14027|NCT01600495|Prof. Alessandra Cristina Marcolin|University of São Paulo.|Tel.: (16) 36022587 ext 55 +|dralemar@uol.com.br
14028|NCT01600703|Dr. Gary Lewis|University Health Network|416-340-4270|gary.lewis@uhn.ca
14029|NCT01600729|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
14030|NCT01601132|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
14031|NCT01601782|Jon Jacobson, MD|University of Michigan|734-936-4365|jjacobsn@umich.edu
14032|NCT01601821|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13902|NCT01736215|Medical Affairs Director|Janssen Cilag Thailand|+6627927232|
13903|NCT01736527|Raphaële Siou-Mermet, MD, MS|Bausch & Lomb Incorporated|+33160871491|raphaele.siou-mermet@bausch.com
13904|NCT01736657|Ray Goodrich, Phd, VP Scientifc and Clinical Affairs|Terumo BCT, Inc.|303-205-2680|
13905|NCT01736696|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13906|NCT01736930|Roy W. Beck, MD, PhD|Jaeb Center for Health Resesarch|813-975-8690|jdrfapp2@jaeb.org
13907|NCT01737879|Study Director|Amgen Inc.|866-572-6436|
14159|NCT01770860|Associate Director, Clinical Research|Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.|973-385-7984|
14160|NCT01772134|GSK Response Center|GlaxoSmithKline|866-435-7343|
14161|NCT01772147|GSK Response Center|GlaxoSmithKline|866-435-7343|
14162|NCT01772550|Randall Jones, MD|Becton, Dickinson and Company|801 565-2843|randall_jones@bd.com
14163|NCT01773122|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
14164|NCT01773135|Mohamed Saied Eldein El-Safty, Lecturer of Obstetrics and Gynecology Faculty of Medicine - Ain Shams|Ain Shams University Maternity Hospital|01003922211 ext 002|dr.mai_elshahm@yahoo.com
14165|NCT01773889|Tyler Curiel, MD|The Cancer and Therapy Center at The University of Texas Health Science Center San Antonio|210-562-5287|CURIELT@UTHSCSA.EDU
14166|NCT01774045|Dr. Cheng-Ta Li|Taipei Veterans General Hospital|886-2-2871-2121 ext 7027|on5083@msn.com
14167|NCT01774084|Thomas Nyström MD, PhD|Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden;|+4686163211|thomas.nystrom@ki.se
14168|NCT01774305|Dr. Jeongsoo Lee|Yonsei Univ. Health System, Gangnam Severance Hospital|+82-2-2019-6092|ration99@yuhs.ac
14169|NCT01774903|Medical Affairs Director|Medical Affairs, Janssen-Cilag (Thailand)|662-792-7200|
14170|NCT01774929|Medical Affairs Director|Medical Affairs, Janssen-Cilag (Thailand)|662-792-7200 ext 5888|
14171|NCT01776645|Dr. Sean Mackey|Stanford University|650-724-2795|smackey@pain.stanford.edu
8725|NCT01376804|Medical Communications|Hoffman-LaRoche|800-821-8590|
8726|NCT01377194|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|Forest Research Institute|201-427-8000 ext 8124|carl.gommoll@frx.com
8727|NCT01378104|Dr. Kwon|the Catholic University of Korea|+82322805886|doctorkwon@catholic.ac.kr
8728|NCT01378117|Guillermo Umpierrez, MD|EUSOM|4047781665|geumpie@emory.edu
8842|NCT01137474|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
8843|NCT01137786|Maria Luigia Storto, M.D.|Bracco Diagnostics Inc.|609-514-2262|MariaLuigia.Storto@diag.bracco.com
8844|NCT01137812|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|Janssen Research & Development, LLC|1-800-526-7736|
8845|NCT01138007|GSK Response Center|GlaxoSmithKline|866-435-7343|
8846|NCT01138046|GSK Response Center|GlaxoSmithKline|866-435-7343|
8847|NCT01138098|GSK Response Center|GlaxoSmithKline|866-435-7343|
8848|NCT01138111|Juergen Hirschfeld, Senior Director Regulatory Affairs|Piramal Imaging|+49 30 461 1246 15|juergen.hirschfeld@piramal.com
8849|NCT01138124|GSK Response Center|GlaxoSmithKline|866-435-7343|
8850|NCT01138501|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
8851|NCT01138735|Michael Graeber, MD|Galderma|609-860-8201|michael.graeber@galderma.com
8852|NCT01138826|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8853|NCT01138969|Dr. Ping-I Hsu|KaohsiungVGH|886-7-3462121 ext 8233|pihsu@isca.vghks.gov.tw
8854|NCT01139008|Ronald W. Gottschalk, MD / Medical Director|Galderma Laboratories, L.P.|817-961-5358|ron.gottschalk@galderma.com
8855|NCT01200524|Heather Bryson|AstraZeneca||clinicaltrialtransparency@astrazeneca.com
8856|NCT01200602|Vilmarie Rodriguez, MD|Mayo Clinic|507-284-2695|rodriguez.vilmarie@mayo.edu
8857|NCT01200992|Zvi Cohen, PhD|Bioniche Life Sciences Inc|(514) 697-6636 ext 3386|zvi.cohen@bioniche.com
13399|NCT01085734|Raj K. Maturi, MD|Raj K. Maturi, MD, PC|317-817-1414|rmaturi@gmail.com
13400|NCT01085760|Dr. Jayant A. Talwalkar|Mayo Clinic|507-538--4877|talwalkar.jayant@mayo.edu
13401|NCT01085786|Dr. Ping-I Hsu|Kaohsiung Veterans General Hospital|886-7-3462121 ext 8233|pihsu@isca.vghks.gov.tw
13402|NCT01086033|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
13403|NCT01086384|GSK Response Center|GlaxoSmithKline|866-435-7343|
13404|NCT01086410|GSK Response Center|GlaxoSmithKline|866-435-7343|
13405|NCT01086761|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13406|NCT01086969|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
13407|NCT01087489|Dr. Ninel Gregori, MD|Miami Veterans Affairs Medical Center|305-575-7000 ext 3081|ngregori@med.miami.edu
13408|NCT01087502|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13409|NCT01087528|Hilla Debby/Director of clinical affairs|Givenimaging|972490977740 ext 77740|hila.debby@givenimaging.com
13410|NCT01087541|Cecilia Borau|Jordi Gol i Gurina Foundation|34 934824617|cborau@idiapjgol.org
13411|NCT01087736|David L. Pennington, PhD (Research Psychologist II)|University of California, San Francisco|415-221-4810 ext 4504|david.pennington2@va.gov
13412|NCT01087762|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
13413|NCT01087788|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
13414|NCT01087801|Edward Purich, Ph.D.|ChiRhoClin, Inc.|301-476-8388|mdoerr@chirhoclin.com
13415|NCT01087814|Ann Seguin|University of Minnesota|612-625-7472|segu0017@umn.edu
13416|NCT01087905|Stevens S. Smith, Ph.D.|University of Wisconsin School of Medicine and Public Health|608-262-7563|sss@ctri.medicine.wisc.edu
13417|NCT01087918|Hubertus van Hedel, PhD|UZurich|+41 44 762 52 91|hubertus.vanhedel@kispi.uzh.ch
13418|NCT01087957|Helen Rogers PT, PhD|Innovative Neurotronics|512-721-1922|hrogers@ininc.us
14033|NCT01602471|Edward M. Aten, M.D.|Certus International, Inc.|603.627.1212|eaten@certusintl.com
14034|NCT01602562|GSK Response Center|GlaxoSmithKline|866-435-7343|
14035|NCT01602744|Dvora Frankenthal|Tel Aviv University|0097235326835|shai_f@zahav.net.il
14036|NCT01603043|Yamini Patel, PhD, Clinical Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
14037|NCT01603394|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14038|NCT01603875|Dr. Terapong Tantawichien|Queen Saovabha Memorial Institute|66225201614 ext 125|terapong_tantawichien@hotmail.com
14039|NCT01604109|Thanya Sitthisettapong|ThammasatU|6629869213 ext 7150|thanyasang@yahoo.com
14040|NCT01604265|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd.|0044 1223 266800|rp@gwpharm.com
14041|NCT01604850|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
14042|NCT01605370|Marek Belohlavek, M.D., Ph.D.|Mayo Clinic|408-301-6694|belohlavek.marek@mayo.edu
14043|NCT01605617|Dr. Jeffrey L. Cornella|Mayo Clinic|480-342-2867|cornella.jeffrey@mayo.edu
14044|NCT01605669|LCDR William Bennett MD FACC|Naval Medical Center San Deigo|619-532-7400|william.bennett5@med.navy.mil
14045|NCT01605825|Study Director|Acorda Therapeutics, Inc.|914-347-4300|
13612|NCT01702311|Guillermo Umpierrez, MD|Emory University|404-778-1663|geumpie@emory.edu
13613|NCT01702363|GSK Response Center|GlaxoSmithKline|866-435-7343|
13614|NCT01702454|GSK Response Center|GlaxoSmithKline|866-435-7343|
13615|NCT01702532|GSK Response Center|GlaxoSmithKline|866-435-7343|
13616|NCT01703000|Peter Maurer, Director Clinical Trials|Boston Scientific|508-683-6678|Peter.Maurer@bsci.com
13617|NCT01705899|Amer Rajab, Associate Professor of Surgery|The Ohio State University|614-293-6322|Amer.Rajab@osumc.edu
13618|NCT01706159|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
13726|NCT01712178|Global Medical Services|AbbVie|800-633-9110|
13727|NCT01712334|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
13728|NCT01712685|Dr. Adam Metwalli|National Cancer Institute|301-435-6237|metwallia@mail.nih.gov
13729|NCT01712711|Professor Raika Jamali|Tehran University of Medical Sciences|00982163120000 ext 411|jamalira@tums.ac.ir
13730|NCT01712984|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
13731|NCT01713660|Carrie Garufis|AMO|7145663728|carrie.garufis@amo.abbott.com
13732|NCT01713933|Lisa Misell, Ph.D|Ulthera, Inc.|480-619-4069|medaffairs@ulthera.com
13733|NCT01713998|Lisa Misell, Ph.D., VP, Clinical and Medical Affairs|Ulthera, Inc.|480-619-4069|
13734|NCT01714232|Jane Wallace|Bayer HealthCare, Diabetes Care|574-257-3063|jane.wallace@bayer.com
13735|NCT01714492|Richard Komistek, Ph. D.|The University of Tennessee|8659744159|rkomiste@utk.edu
13736|NCT01714505|Boris Kovatchev, PhD|University of Virginia|434-924-5592|boris@virginia.edu
13737|NCT01714544|Director Clinical Operations|Promius Pharma|609-282-1404|jfraser@drreddys.com
13738|NCT01715064|Dr. Daniel Santa Mina|University of Guelph-Humber|416-798-1331 ext 6065|daniel.santamina@guelphhumber.ca
13739|NCT01715857|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
13740|NCT01716455|Study Physician|Shire Development LLC|+1 866 842 5335|
13741|NCT01716520|GSK Response Center|GlaxoSmithKline|866-435-7343|
13742|NCT01717287|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13743|NCT01717989|Study Director|Amgen Inc.|866-572-6436|
13744|NCT01718028|Abayomi Ogundele, Pharm.D.|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13745|NCT01718483|Study Physician|Shire Development LLC|+1 866 842 5335|
13746|NCT01718509|Study Physician|Shire Development LLC|+1 866 842 5335|
8858|NCT01201317|Heather Bryson|AstraZeneca||clinicaltrialtransparency@astrazeneca.com
8859|NCT01201343|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
8860|NCT01201772|Dominick Angiolillo|University of Florida|904-244-3933|dominick.angiolillo@jax.ufl.edu
8861|NCT01201785|Dominick J. Angiolillo, MD, PhD|University of Florida-Jacksonville|904-244-3933|dominick.angiolillo@jax.ufl.edu
8862|NCT01218243|Zhishun Liu, Director of the study|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|8610-010-88001124|liuzhishun@yahoo.com.cn
8863|NCT01218308|GSK Response Center|GlaxoSmithKline|866-435-7343|
8864|NCT01218477|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
8978|NCT01298661|Juliano Ferreira Arcuri|Universidade Federal de São Carlos|+55 (16) 33518343|julianoarcuri@gmail.com
8979|NCT01299077|Haibo Song|Eisai China Inc.|0086-21-24192864|songhaibo@eisai.com.cn
8980|NCT01299389|Medical director|Janssen Pharmaceutical K.K|+81-3-4411-5509|
8981|NCT01299571|GSK Response Center|GlaxoSmithKline|866-435-7343|
8982|NCT01299584|GSK Response Center|GlaxoSmithKline|866-435-7343|
8983|NCT01299805|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
8984|NCT01300234|GSK Response Center|GlaxoSmithKline|866-435-7343|
8985|NCT01300286|Dr. Ian Welsby|Duke University Medical Center|919-668-2699|ian.welsby@duke.edu
8986|NCT01300338|Dr. Frederick North|Mayo Clinic|507-284-5164|North.Frederick@mayo.edu
8987|NCT01300455|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8988|NCT01300546|Jeanne Tarrasch|Clinvest/A Division of Banyan Group Inc.|417-841-3673|jtarrasch@clinvest.com
8989|NCT01300559|Steven E. Hill, M.D.|Duke University Medical Center|681-6614|hill0012@mc.duke.edu
8990|NCT01300650|Benjamin Van Tassell|Virginia Commonwealth University|8049820997|bvantassell@vcu.edu
13419|NCT00902226|Study Director|H. Lundbeck A/S|email contact via ext Lundbeck|LundbeckClinicalTrials@lundbeck.com
13420|NCT00902265|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
13421|NCT00902304|Study Director|Novartis Pharmaceuticals|862-778-8300|
13422|NCT01090752|Zanchi Anne, MD|University Hospital Geneva and Lausanne, Switzerland|0041213140775|azanchidel@hotmail.com
13423|NCT01090973|Celeste Bello, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-8623|celeste.bello@moffitt.org
13424|NCT01091116|Clinical Research Director|Menarini-Ricerche|+39-055-56809990|
13425|NCT01091155|Eran Choman, VP Clinical Affairs & Statistics|novoGI|+972 9 8603000|eran.choman@novogi.com
13426|NCT01091246|Judy Falloon, MD/ Sr Director Clinical Development|MedImmune, LLC|301-398-0000|falloonj@medimmune.com
13427|NCT01091519|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13428|NCT01092338|Virginia Stallings|Children's Hospital of Philadephia|215-590-1664|stallingsv@email.chop.edu
13429|NCT01092507|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
13430|NCT01092546|Paul Sherwin, M.D.|GE Healthcare|609-514-6820|Paul.Sherwin@ge.com
13431|NCT01092559|Director of Clinical Development|GeNO, LLC|321-785-2613|matthew.rush@genollc.com
13432|NCT01092663|Carine Beysen, PhD|KineMed, Inc.|510-655-6525 ext 123|cbeysen@kinemed.com
13433|NCT01092702|J Taylor Hays. MD|Mayo Clinic|507-266-1944|nicotineresearch@mayo.edu
13434|NCT01092767|Kalyan Obalampalli|Medtronic, Inc|7075413158|kalyan.obalampalli@medtronic.com
13435|NCT00911612|Dr. Michael Camilleri|Mayo Clinic|507-266-2306|camilleri.michael@mayo.edu
13436|NCT00911742|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
13437|NCT00911768|Jae-Woo Park, KMD, PhD|Kyung Hee East-West Neo Medical Center|+082-02-440-6219|pjw2907@khu.ac.kr
13438|NCT00911807|Dr. Philipp Novak|EBEWE Pharma|01143-7665-8123 ext 733|philipp.novak@ebewe.com
13619|NCT01706328|GSK Response Center|GlaxoSmithKline|866-435-7343|
13620|NCT01706588|Prof. Thomas Dietrich|The School of Dentistry, University of Birmingham|+44-121-46 65494|t.dietrich@bham.ac.uk
13621|NCT01706770|William J. Gleason, O.D.|Foresight Regulatory Strategies, Inc.|(978) 658-6888 ext 151|
13622|NCT01707095|Thomas Robinson|University of Colorado|303-724-2728|thomas.robinson@ucdenver.edu
13623|NCT01707238|Graeme Young|Visioncare Research Ltd.|01252 718719 ext 207|g.young@visioncare.co.uk
13624|NCT01707654|Dr. Chao Chen|The Second Hospital of Tangshan|86-13700350471|ts_chenchao@163.com
13625|NCT01708057|Carin Jorup|AstraZeneca||aztrial_results_posting@astrazeneca.com
13626|NCT01708317|Dr. Fahd A Ahmad|Washington University School of Medicine|314-286-0298|ahmad_f@kids.wustl.edu
13627|NCT01708915|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13628|NCT01708967|Dr. Ki Tae Suk|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|+82-33-240-5826|ktsuk@hallym.ac.kr
13629|NCT01709422|Dr. Nisa Netinatsunton|Prince of Songkhla University|6674451965 ext 9|nisasan@yahoo.com
13630|NCT01710020|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13631|NCT01710033|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13632|NCT01520532|Jay Kelley, Director of Clinical Research|Medtronic AF Solutions|+1.760.827.0076|jay.l.kelley@medtronic.com
13633|NCT01520714|Research Manager|The Heart Hospital Baylor Plano|469-814-4712|natalie.settele@baylorhealth.edu
13634|NCT01520922|GSK Response Center|GlaxoSmithKline|866-435-7343|
13818|NCT01587885|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13819|NCT01589445|Dr. Masuma  Parvin|Ministry of Science and Technology, Government of the People's Republic of Bangladesh|88 01819141258|acmasuma@gmail.com
13820|NCT01589510|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13713|NCT01432262|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13714|NCT01432327|Karen Van Hoye|Katholieke Universiteit Leuven|0032498617141|Karen.Vanhoye@faber.kuleuven.be
13715|NCT01432457|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13716|NCT01432535|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
13717|NCT01432561|Dr. Ranjan Dohil, P.I.|University of California San Diego|619-471-9554|rdohil@ucsd.edu
13718|NCT01433016|Clinical Trials Manager|Exalenz Bioscience|+972-8-9737513|avrahamh@exalenz.com
13719|NCT01433042|Director of Clinical affairs|Given Imaging Ltd.|+972-4-9097774|Hila.Debby@givenimaging.com
13720|NCT01531725|Paul Vermeersch, MD, PhD|ZNA Middelheim Department Interventional Cardiology, Antwerpen, Belgium|+32 3 280 3211|paul.vermeersch@zna.be
13721|NCT01710514|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
13722|NCT01710800|Dr. Fouad J. Moawad|Walter Reed National Military Medical Center|(301) 400-1551|Fouad.Moawad@us.army.mil
13723|NCT01711424|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13724|NCT01711736|GSK Response Center|GlaxoSmithKline|866-435-7343|
13908|NCT01737931|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
13909|NCT01737944|Jonathan Jaffe, MD; Vice President Clinical Development|Antares Pharma|1-609-359-3020 ext 324|jjaffe@antarespharma.com
13910|NCT01738698|Study Physician|Shire|+1 866 842 5335|
13911|NCT01738750|Dr. Eric Scaife|University of Utah|801-662-2950|eric.scaife@imail2.org
13912|NCT01738971|Dr Lucy Michie|University of Edinburgh|0131 5361542|michieluc@yahoo.co.uk
13913|NCT01847443|GSK Response Center|GlaxoSmithKline|866-435-7343|
13914|NCT01847547|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13915|NCT01848847|cem celik|namik kemal university|905324205365|cemcel@yahoo.com
8991|NCT01300741|Director of Clinical Trials|Alcon Research|1-800-241-7629|
8992|NCT01300767|Director of Clinical Trials|Alcon Research|1-800-241-7629|
8993|NCT01300819|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
8994|NCT01400906|GSK Response Center|GlaxoSmithKline|866-435-7343|
8995|NCT01400932|GSK Response Center|GlaxoSmithKline|866-435-7343|
8996|NCT01400958|Peter A. Forsyth, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-3063|peter.forsyth@moffitt.org
8997|NCT01401010|Gary E Stein|Michigan State University|517-353-5126|Gary.Stein@hc.msu.edu
8998|NCT00605306|Study Director|Novartis Pharmaceuticals|862-778-8300|
8999|NCT00605384|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
9000|NCT00605423|Peter Campochiaro, M.D.|Johns Hopkins University||pcampo@jhmi.edu
9001|NCT00605475|Study Director|Novartis Pharmaceuticals|862 778 8300|
8569|NCT00654498|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8570|NCT00654511|Dexmedetomidine for Immediate Perioperative Analgesia in Pediatric Patients Undergoing Tonsillectomy|Children's National Medical Center|202-476-4867 ext 4867|jfinkel@cnmc.org
8571|NCT00654628|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
8572|NCT00654641|Michael L. Stitely, MD|West Viginia University|304-293-1566|mstitely@hsc.wvu.edu
8573|NCT00654654|Kevin Hennegan|CBR International Corp.|(720)746-1190|khennegan@cbrintl.com
8574|NCT00654745|James McCarthy|Daiichi Sankyo|732-590-3430|jmccarthy@dsi.com
8575|NCT00654784|Thomas Meier|Santhera|+4161 906 8964|thomas.meier@santhera.com
8576|NCT00654875|Study Director|Novartis Pharmaceuticals|862-778-8300|
8577|NCT00654901|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
13439|NCT00911898|Dr. Muralibhar Beeram|South Texas Accelerated Research Therapeutics|210-593-5921|murali.beeram@stoh.com
13440|NCT00911937|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13441|NCT00911989|Director of Clinical Operations|Ethicon-Endo Surgery|1.513.337.3079|SHelsing@its.jnj.com
13442|NCT00912002|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13443|NCT00912015|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
13444|NCT00912028|Carlos E Leite Arieta MD, PhD|University of Campinas, Brazil||ra-visus-clnclstds@its.jnj.com
13445|NCT00912093|Alan Kimura, MD, PhD|Shire|1-617-482-0738|akimura@shire.com
13446|NCT00912158|Dr. Maha K Ghanem, MD, FCCP|Chest Department, Faculty of Medicine, Assiut University- EGYPT|+ 2 0127694434|mahaghanem@hotmail.com
13447|NCT00912288|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13448|NCT00912301|Michael L. Camilleri, MD|Mayo Clinic|507-266-2306|camilleri.michael@mayo.edu
13449|NCT00923260|Dr. Miguel F Herrera|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|(+52) 55 54870208|miguelfherrera@gmail.com
13450|NCT00923273|Dr. Arun Rajan|National Cancer Institute|301-594-5322|rajana@mail.nih.gov
13451|NCT00923351|Dr. Crystal Mackall|National Cancer Institute, National Institutes of Health|301-402-5940|mackallc@mail.nih.gov
13452|NCT00923481|Dr. Shivaani Kummar|National Cancer Institute, National Institutes of Health|301-435-5402|kummars@mail.nih.gov
13453|NCT00923910|Dr. Terry Fry|National Cancer Institute|301-402-0215|fryt@mail.nih.gov
13454|NCT00923949|Giuseppe Giaccone M.D.|National Cancer Institute|301-496-4916|giacconeg@mail.nih.gov
13455|NCT00923975|Carmine Greene, Clinical Research Scientist|Bayer Healthcare, Diabetes Care|574-257-3040|carmine.greene.b@bayer.com
13456|NCT00924001|Steven Rosenberg|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
13457|NCT00924040|Robert J. Kreitman, M.D.|National Cancer Institute, National Institutes of Health|301-496-6947|kreitman@mail.nih.gov
13821|NCT01590212|Prof. Phil Wilson|University of Glasgow|+44 (0)1463 255892|p.wilson@abdn.ac.uk
13822|NCT01590264|Dr. Jay F. Piccirillo|Washington University in Saint Louis|314-362-8641|piccirilloj@ent.wustl.edu
13823|NCT01591317|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13824|NCT01591616|Tegwyn H. Brickhouse, DDS, PhD|Virginia Commonwealth University, School of Dentistry|(804) 827-2699|thbrickhouse@vcu.edu
13825|NCT01591681|Roy W. Beck, M.D., Ph.D.|Jaeb Center for Health Research|813-975-8690|jdrfapp2@jaeb.org
13826|NCT01591837|Clinical Trial Disclosure Manager|CSL Limited|Use email contact|csl.clinicaltrials@csl.com.au
13827|NCT01592071|Dr. John Lewis|University of Miami|(305) 243-6227|jelewis@miami.edu
13828|NCT01592708|Dr. Jay Anderson, PI|UNC Chapel Hill|919-966-5136|janderson@aims.unc.edu
13829|NCT01592786|Joel Trugman, MD|Forest Research Institute|201-427-8000 ext 8681|Joel.Trugman@frx.com
13830|NCT01592851|GSK Response Center|GlaxoSmithKline|866-435-7343|
13831|NCT01592864|GSK Response Center|GlaxoSmithKline|866-435-7343|
13832|NCT01536093|Dr. Juyoung Lee|Seoul National University College of Medicine|82-31-787-7301|lamb4122@snu.ac.kr
13833|NCT01536119|Jennifer Abbass Dick|University of Toronto||jennifer.abbass@mail.utoronto.ca
13834|NCT01536145|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13835|NCT01536171|Dr. Heather K. Vincent, PhD|University of Florida|352-273-7410|vincehk@ortho.ufl.edu
13836|NCT01536197|M. Yanina Pepino|Washington University School of Medicine|3143628113|ypepino@dom.wustl.edu
13837|NCT01536405|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13838|NCT01536561|GSK Response Center|GlaxoSmithKline|866-435-7343|
13839|NCT01536574|GSK Response Center|GlaxoSmithKline|866-435-7343|
13840|NCT01536587|GSK Response Center|GlaxoSmithKline|866-435-7343|
13916|NCT01850394|Dr. Paphon Sa-ngasoongsong|Faculty of Medicine, Ramathibodi Hospital, Mahidol University|66-2-2011589|chan3s@hotmail.com
13917|NCT01851655|Dr. Terese Chmielewski|University of Florida|352-273-6104|tchm@ufl.edu
13918|NCT01851876|Dr. Suleyman Guven, Director of clinical trial|Karadeniz Technical University, School of Medicine, Dept Obs and Gyn.|+904623775869|drsuleymanguven@yahoo.com
13919|NCT01852383|Dr. D.P. Devanand|New York State Psychiatric Institute|(646) 774-8658|dpd3@columbia.edu
13920|NCT01853215|Larry J. Miller, MD|Vidacare Corporation|210-375-8500|larry.miller@vidacare.com
13921|NCT01853254|Medical Communications|Hoffmann-La Roche|800 821-8590|
13922|NCT01853371|Dr. Nouran Aleyeidi|Ministry of Health|00966504304577|dr.nouran@live.com
13923|NCT01854281|Jakub Honek, MD|University Hospital Motol|+42022443 ext 4901|jakub.honek@gmail.com
13924|NCT01854593|Dr. Ayumu Manabe|Department of Ophthalmology, Surugadai Hospital of Nihon University|+81-3-3293-1711 ext 429|ayumu.m76@gmail.com
13925|NCT01438424|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
13926|NCT01438814|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13927|NCT01438996|Dr. Audino Podda|Novartis Vaccines Institute for Global Health|+39 0577 243496|audino.podda@novartis.com
13928|NCT01439204|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
13929|NCT01439724|Dr. Heliton Spindola Antunes|Instituto Nacional de Cancer|55 21 32076597|hspindola@inca.gov.br
13930|NCT01440049|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14113|NCT01555164|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
14114|NCT01555931|Dr. Gretchen Stuart|University of North Carolina School of Medicine|919-962-4880|gstuart@med.unc.edu
14115|NCT01556061|Dr. Davide Cattano MD PhD|University of Texas at Houston Medical School/ Dept. of Anesthesiology|713-500-6235|davide.cattano@uth.tmc.edu
14116|NCT01556451|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8578|NCT00654927|Andrew Blight, PhD Chief Scientific Officer|Acorda Therapeutics, Inc.|914-347-4300 ext 4102|ablight@acorda.com
8579|NCT00654940|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
8580|NCT00654953|Alison Oliveto, Ph.D.|UAMS|501-526-8441|olivetoalison@uams.edu
8581|NCT00654992|Effect of erythropoietin in kidney after cardiac surgery|Seoul National University Bundang Hospital|82-31-787-7014|kyna@snubh.org
8582|NCT00655083|Angela Capriati, Clinical research Director|Menarini Group- Clinical Research|+ 39-055 56809990|acapriati@menarini-ricerche.it
8583|NCT00655356|Kevin Hennegan|CBR International Corp.|720-746-1190|khennegan@cbrintl.com
8584|NCT00655486|UCB Clinical Trial Call Center|UCB, Inc|+1 877 822 9493|
8585|NCT00655551|UCB Clinical Trial Call Center|UCB, Inc|+1 877 822 9493|
8586|NCT00655564|Steven Feldman, MD, PhD|Wake Forest University Health Sciences|336-716-3775|sfeldman@wakehealth.edu
8587|NCT01263132|Medical Responsible|Merck S.A. de C.V., Mexico, an affiliate of Merck KGaA, Darmstadt, Germany|+49-6151-72-5200|service@merckgroup.com
8588|NCT01263301|Ling-Chih Wu MD|Mennonite Christian Hospital|88638241234 ext 1810|lingchihwu@yahoo.com
8589|NCT01263444|Doug Hubatsch, Global Brand Leader, Medical Affairs|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
8590|NCT01263470|General Manager|Japan Development Center, Pharmaceutical Development Division|+81-6-6204-5257|clinicaltrialregistry@tpna.com
12885|NCT00908960|Jeffrey Zwicker, MD|Beth Israel Deaconess Medical Center|617-667-9299|jzwicker@bidmc.harvard.edu
12886|NCT00909038|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12887|NCT00909181|Kaushik Dave|Antares Pharma|609 359 3020|kdave@antarespharma.com
12888|NCT00909324|Study Director|Novartis Pharmaceuticals|862 778-8300|
12889|NCT00909389|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
12890|NCT00909480|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
13458|NCT00924053|Yuan-Di Halvorsen|Theracos, Inc|617 726-4236|yhalvorsen@ccib.mgh.harvard.edu
13459|NCT00924066|Antonio Fojo, M.D.|National Cancer Institute|301-496-2631|fojot@mail.nih.gov
13460|NCT00924209|Dr. Giuseppe Giaccone|National Cancer Institute, National Institutes of Health|301-402-3415|giacconeg@mail.nih.gov
13461|NCT00924287|Steven A. Rosenberg|National Cancer Institute, National Institutes of Health|301-496-4164|sar@mail.nih.gov
13462|NCT00924313|Dr. Peter L. Choyke|National Cancer Institute, National Institutes of Health|301-402-8409|pchoyke@mail.nih.gov
13463|NCT00924469|Senior Director, Clinical Research|Janssen Research & Development, LLC 10990 Wilshire Blvd, Suite 1200 Los Angeles, CA 90024|(310) 914-2917|
13464|NCT00924482|Arthur Wallace, M.D., Ph.D.|University of California San Francisco|415-750-2069 ext 3732|wallacea@anesthesia.ucsf.edu
13465|NCT00924508|John Koo, MD|UCSF|415-476-6281|john.koo@ucsfmedctr.org
13466|NCT00924638|Medtronic CRDM clinical trial manager|Medtronic, Inc.|763-505-6000|medtronicCRMtrials@medtronic.com
13467|NCT00924729|Walter J. Stark, M.D./Professor of Ophthalmology|Johns Hopkins University|410-955-5490|wstark@jhmi.edu
13468|NCT00924781|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
13469|NCT00924833|Gianfranco Parati, Professor|Istituto Auxologico Italiano|+3961911 ext 2949|gianfranco.parati@unimib.it
13470|NCT00924950|Tina Bhutani|UCSF|4154763396|tinabhutanimd@gmail.com
13471|NCT00925288|Dr. Brandon Brown|Johns Hopkins University|949-266-4401|bbrown@jhsph.edu
13472|NCT00925353|Colleen K. Lambertz, MBA, MSN, FNP|St. Luke's Mountain States Tumor and Medical Research Institute|208 463 6018|lambertc@slhs.org
13473|NCT00925548|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
13474|NCT00925587|Study Director|Amgen Inc.|866-572-6436|
13475|NCT00925704|Gerald Tremblay, M.D.|Shire Pharmaceutical||gtremblay@shire.com
13476|NCT01625221|VP of Clinical Affairs|Torax Medical, Inc.|651-361-8900|aderosier@toraxmedical.com
14046|NCT01606137|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd.|0044 1223 266800|rp@gwpharm.com
14047|NCT01606176|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd.|0044 1223 266800|rp@gwpharm.com
14048|NCT01606189|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd.|0044 1223 266800|rp@gwpharm.com
14049|NCT01606202|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd.|0044 1223 266800|rp@gwpharm.com
14050|NCT01606228|Medical Affairs Director, CNS, Asia Pacific|Janssen China|8610 5821 8766|
14051|NCT01756274|Jeanellen Fullam|Bayer Medical Care|862-404-6245|jeanellen.fullam@bayer.com
14052|NCT01756976|Clinical Project Manager|Haemonetics|781-356-9595|michael.dioguardi@haemonetics.com
14053|NCT01757704|Dr. Bansi Koul|Lunds University|+4646171649|bansi.koul@skane.se
14054|NCT01759160|Dr. Xia Feng|First Affiliated Hospital of Sun Yat-sen University|008613688877856|fengxiar@yahoo.cn
14055|NCT01759368|Anna-Leena Orsama|VTT Technical Research Centre of Finland|+358408485966|anna-leena.orsama@vtt.fi
14056|NCT01759420|Peter Moffett MD|Carl R Darnall Army Medical Center|254-288-8302|peter.m.moffett.mil@mail.mil
14057|NCT01759602|Michael Levy, MD, PhD|Johns Hopkins University|443-287-4412|mlevy@jhmi.edu
14058|NCT01760889|Study Physician|Shire|+1 866 842 5335|
14059|NCT01760993|Study Physician|Shire|+1 866 842 5335|
14060|NCT01761279|Dr Pete Basford, Endoscopy Research Fellow|Portsmouth Hospitals NHS Trust|+447890990445|petebasford@hotmail.com
14061|NCT01762722|Dr David MacLeod|Duke University Medical Center|919-812-3201|david.macleod@duke.edu
14062|NCT01762904|Alejandro E. Macías|Universidad de Guanajuato|+52 477 7 14 58 59 ext 4644|aaeemmhh@yahoo.com
14063|NCT01762982|GSK Response Center|GlaxoSmithKline|866-435-7343|
14064|NCT01766050|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
14065|NCT01766466|Jayne Prats, PhD - VP, Global Knowledge Management|The Medicines Company|888.779.MDCO ext 1510|jayne.prats@themedco.com
10402|NCT01093027|Virgilio Evidente MD|Mayo Clinic|480-301-8000|evidente.virgilio@mayo.edu
10403|NCT01093222|Study Statistician|SWOG|206-667-4623|
10404|NCT01093417|Grace McComsey, MD|University Hospitals Case Medical Center|2168443607|gam9@case.edu
10405|NCT01093534|Director Medical Affairs – Urology|Astellas Pharma Europe Ltd.||clinicaltrials@us.astellas.com
10406|NCT01093625|Katherine E. Osborn|Vistakon||clinicalstudies@its.jnj.com
10407|NCT01093651|Kevin Yarasheski, PhD|Washington Univ Med Sch|3143628173|key@wustl.edu
10408|NCT01093690|Suthinee Ithimakin, MD|Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University|6624197000 ext 4489|aesi105@yahoo.co.th
10409|NCT01093794|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme||ClinicalTrialsDisclosure@merck.com
10000|NCT01120379|Aarthi Raman, PhD|Abbott Vascular|408-845-3000|aarthi.raman@av.abbott.com
10001|NCT01120405|Yannick LE MANACH, MD, PhD|Population Health Research Institute - Mc Master University, Hamilton CANADA|0012892606840|Yannick.Lemanach@phri.ca
10002|NCT01120691|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
10003|NCT01120717|Study Director|Novartis Pharmaceuticals|862 778-8300|
10004|NCT01120782|Ross Franklin, OD|Johnson & Johnson Vision Care|1-904-443-1379|RFrankl1@its.jnj.com
10005|NCT01120899|Catherine Cukras, MD, PhD, Principal Investigator, NEI|National Institutes of Health|301-435-5061|cukrasc@nei.nih.gov
10006|NCT01120990|George S Stergiou, MD|Hypertension Center, Third University Department of Medicine, University of Athens|+30 210 7763117|gstergi@med.uoa.gr
10007|NCT01131585|Study Director|Novartis Pharmaceuticals|41 61 324 1111|
10008|NCT01131884|K.Rao Poduri, M.D., Chair of Physical Medicine & Rehab|University of Rochester|585-275-6978|kr_poduri@urmc.rochester.edu
10009|NCT01132118|Dr. Daniel H. Solomon|Brigham and Women's Hospital|617-525-8127|dsolomon@partners.org
10010|NCT01132144|Dr. Wellington P Martins|University of Sao Paulo|55162231|wpmartins@gmail.com
10011|NCT01132326|Chief Scientific Officer|Chelsea Therapeutics Inc.|704-973-4202|hewitt@chelsearx.com
12891|NCT00909532|Medical Monitor|Vertex|617-444-6777|medicalinfo@vrtx.com
12892|NCT00909545|Tanya Simuni, MD|Feinberg School of Medicine, Northwestern University|312-503-2970|TSimuni@nmff.org
12893|NCT00909610|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12894|NCT00909649|Elnakeeb Ayman|Mansoura university hospital|0106752021|elnakeebayman@yahoo.com
12895|NCT00909727|Medical Monitor|Vertex|617-444-6777|medicalinfo@vrtx.com
12896|NCT00909753|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12897|NCT00909779|Respiratory Medical Director|Sunovion|1-866-503-6351|
12898|NCT00909792|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
12899|NCT00909857|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
12900|NCT00909870|Mollie Carter, MD, Medical Director|Shire Regenerative Medicine|(858) 754-5678|mcarter@shire.com
12901|NCT00910039|David Peereboom, MD|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|216-445-6068|peerebd@ccf.org
12902|NCT00910299|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12903|NCT00910520|Therapeutic Area Head,|Allergan, Inc|714-246-4500 ext:|clinicaltrials@allergan.com
12904|NCT00910624|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
12905|NCT00919854|Senior Director R&D|Janssen R&D US|1 609 730-7548|
12906|NCT00919867|Gerald Tremblay, M.D.|Shire Pharmaceutical||gtremblay@shire.com
12907|NCT00919893|Dr. F.M.E. Wagenlehner|Clinic for urology and pediatric urology, JL-University, Giessen, Germany|0049 641 9944518|wagenlehner@AOL.com
13021|NCT00973349|Posting Director|Novartis Vaccines and Diagnostics||RegContactVacUS.nvdit@Novartis.com
13022|NCT00973479|Director Clinical Research|Centocor, Inc.|1-800-457-6399|
13023|NCT00973622|Christine Sheffer, PhD|University of Arkansas for Medical Sciences|212 650 6860|csheffer@med.cuny.edu
13477|NCT01625910|Steven D. Stovitz, MD, MS|University of Minnesota, Department of Family Medicine and Community Health|612-310-2344|sstovitz@umphysicians.umn.edu
13478|NCT01626118|Daniel Solorio|Iroko Pharmaceuticals, LLC|267-546-3150|dsolorio@iroko.com
13479|NCT01626391|Dr. Jiri Hardlund|TauRx Therapeutics Ltd|+44 (0)1224438550|JHH@taurx.com
13480|NCT01626820|GSK Response Center|GlaxoSmithKline|866-435-7343|
13481|NCT01627002|ProtAffin Biotechnologie AG|ProtAffin Biotechnologie AG|Not Available|office@protaffin.com
13482|NCT01627327|GSK Response Center|GlaxoSmithKline|866-435-7343|
13483|NCT01627860|Medical Director|Janssen-Cilag Taiwan|886 2 23762155|
13484|NCT01628588|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13485|NCT01628601|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13486|NCT01628614|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13487|NCT01628848|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6131-7366|
13488|NCT01628926|Director of Clinical Research and Development|Otsuka Pharmaceutical Co, Lts.|+81-3-6361-7366|
13489|NCT01628965|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
13490|NCT01629134|Medical Monitor|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
13491|NCT01629589|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
13492|NCT01629771|Clinical Trials Unit Coordinator|Northwestern University|312-695-6829|j-bae@northwestern.edu
13493|NCT01629784|Hae Bae, CRCC|Northwestern University|312-695-6829|j-bae@northwestern.edu
13494|NCT01629797|Hae Bae|Northwestern University|312-695-6829|j-bae@northwestern.edu
13495|NCT01630109|Dr. Steven Brooks|Genesys Regional Medical Center Office of Research|8106067722|Steven.Brooks@genesys.org
13496|NCT01630135|GSK Response Center|GlaxoSmithKline|866-435-7343|
14066|NCT01767103|Fernando Tricta, MD|ApoPharma Inc.|416-401-7332|ftricta@apopharma.com
14067|NCT01768013|Clinical trial disclosure manager|LEO Pharma A/S|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com
14068|NCT01549392|Barbara Fisher|London Health Sciences Hospital|519-685-8650|barbara.fisher@lhsc.on.ca
13635|NCT01521026|Elizabeth Twamley, PhD|UCSD|6195436684|etwamley@ucsd.edu
13636|NCT01521260|Y.C.M. de Waal|University Medical Center Groningen - Center for dentistry and oral hygiene|+31 50-3639051|y.c.m.de.waal@umcg.nl
13637|NCT01521364|Dr. J.W.C. Alffenaar|University of Groningen, University Medical Center Groningen|+31-50-3614070 ext 40378|j.w.c.alffenaar@umcg.nl
13638|NCT01521780|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13639|NCT01579916|Raburn Mallory, MD/Senior Director Clinical Development|MedImmune, LLC|301-398-0000|malloryr@medimmune.com
13640|NCT01580423|Donald A. Mahler|Dartmouth-Hitchcock Medical Center|603 650-5533|Donald.a.mahler@hitchcock.org
13641|NCT01580488|Clinical Trial Disclosure Manager|LEO Pharma A/S|+45 4494 5888|ctr.disclosure@leo-pharma.com
13642|NCT01581021|Dr. Lawrence Haber|University of Mississippi Medical Center|601-984-6525|lhaber@umc.edu
13643|NCT01581658|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13644|NCT01581684|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13645|NCT01581931|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13646|NCT01809197|Jessie Lemp, GMA Brand Lead - Vision Care|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13647|NCT01809262|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13648|NCT01809834|Lyndon Jones, PhD, FCO|School of Optometry, University of Waterloo|519-888-4742|ljones@uwaterloo.ca
13649|NCT01809938|Dr. Sam Hillyard|GuysThomasNHSTrust / Rockingham General Hospital|+61424055820|sghillyard@yahoo.co.uk
13650|NCT01810042|Ji Eun Lee|Pusan National University Hospital|+82-51-240-7957|jlee@pusan.ac.kr
8509|NCT01276756|Dr. Hany Shehab|Cairo University|00201111111071|h.shehab@drshehab.com
8510|NCT01276821|Dr. Aayush Khanal|Department of Child Health, Tribhuvan University Teaching Hospital, Institute of Medicine.|977-1-4421532|aayush_khanal@yahoo.com
8511|NCT01276847|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8512|NCT01277042|GSK Response Center|GlaxoSmithKline|866-435-7343|
8513|NCT01277211|Senior Vice President, Global Clinical Development|Merck Sharpe & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8514|NCT01277302|Medical Communications|Genentech, Inc.|800 821-8590|
8515|NCT01277549|Jerome R Bill, M.D.|Terumo BCT|303-231-4729|jerry.bill@terumobct.com
8516|NCT01277822|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8517|NCT01277861|Girish P. Joshi, MD|University of Texas Southwestern Medical Center at Dallas|214-590-7259|girish.joshi@utsouthwestern.edu
8518|NCT01278030|John Gill|St. Jude Medical|818-493-2609|jgill@sjm.com
8519|NCT01278160|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
8520|NCT01278342|Study Director|Novartis Pharmaceuticals|862-778-8300|
8521|NCT01278394|Sheryl Baldwin, RN/Associate Director|Anacor Pharmaceuticals, Inc.|650-223-8597|clinicaltrials@anacor.com
8522|NCT01278485|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8523|NCT01278797|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8659|NCT01149863|Dr. Harvey|Emory University|404-778-4381|rdharve@emory.edu
8660|NCT01150097|Study Director|Novartis Pharmaceuticals|862-778-8300|
8661|NCT01150461|Michael A. Fifer, MD|Massachusetts General Hospital|617 726-1832|mfifer@partners.org
8662|NCT01150500|Hiroko Ookubo|Study Manager|+81-3-6430-7017|hiroko.ookubo@medtronic.com
8663|NCT01150760|Director Medical Writing and Scientific Communications|Adolor Corporation|484-595-1942|arachfal@adolor.com
13024|NCT00973700|Posting Director|Novartis Vaccines and Diagnostics||RegContactVacUS.nvdit@Novartis.com
13025|NCT00973765|Gillian Schmitz, MD|Washington Hospital Center|919-724-9185|gillianmd@gmail.com
13026|NCT00973921|Giora Weisz MD|Columbia University Medical Center|212-305 7060|gw2128@mail.cumc.columbia.edu
13027|NCT00974051|Dr. H Peter Chase|UColorado|303-724-2323|peter.chase@ucdenver.edu
13028|NCT00974090|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
13029|NCT00974311|Lynn Seely, MD, Chief Medical Officer|Medivation, Inc.|415-829-4106|lynn.seely@medivation.com
13030|NCT00974480|Annie Levesque|Innovaderm Research Inc|514-521-4285 ext 222|alevesque@innovaderm.ca
13031|NCT00974571|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
13032|NCT00975130|Vice President, Late Stage Development Group Leader|Merck Sharpe & Dohme Corp||ClinicalTrialsDisclosure@merck.com
13033|NCT00975143|Julia Chan, RAC|Cipher Pharmaceuticals Inc.|905-602-5840 ext 326|jchan@cipherpharma.com
13034|NCT00975156|Elizabeth Noser|Mischer Neuroscience Institute, Memorial Hermann-TMC||elizabeth.noser@memorialhermann.org
13035|NCT00975481|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13036|NCT00975507|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13037|NCT00975585|Sheila Hickson-Curran, MCOptom/ Director, Medical Affairs|Vistakon|904-443-1754|
13038|NCT00975611|Dr. David Henderson|Massachusetts General Hospital Schizophrenia Research Program|(617) 912-7800|dchenderson@partners.org
13039|NCT00984295|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13040|NCT00984334|Dr C Jordan, Head of Clinical Operations|S.L.A. Pharma UK Ltd|44 01923 681001|cjordan@slapharma.com
13041|NCT00984490|Ingrid Mayer, MD|Vanderbilt-Ingram Cancer Center|615-936-2033|ingrid.mayer@vanderbilt.edu
13042|NCT00984542|Leora Horn, MD|Vanderbilt-Ingram Cancer Center|615-936-2033|leora.horn@vanderbilt.edu
13497|NCT01987752|Vice President  GSE,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13498|NCT01987765|Vice President  GSE,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13499|NCT01989572|Study Statistician|ECOG Statistical Office|617-632-3012|
13500|NCT01993238|Director of Clinical Programs|Solta Medical|510-259-5284|aloncaric@solta.com
13501|NCT01994876|Director of Clinical Affairs|Coloplast A/S|+45 4911 25 23|dkdac@coloplast.com
13502|NCT01996332|Medical Communications|Hoffmann- LaRoche|800-821-8590|genentech@druginfo.com
13503|NCT01996813|Alexander Tauchen, MD|Loyola University Medical Center|708-216-9000|atauchen@lumc.edu
13504|NCT00902538|Bettina Ammentorp|Daiichi Sankyo Europe GmbH|0049 89 7808 0 ext 585|bettina.ammentorp@daiichi-sankyo.eu
13505|NCT00902564|Study Director|H. Lundbeck A/S|Email contact via ext Lundbeck|LundbeckClinicalTrials@lundbeck.com
13506|NCT00902668|Laurie W. Cuttino, MD|Virginia Commonwealth University|804-828-7232|LCuttino@mcvh-vcu.edu
13507|NCT00902746|Department director of clinical development department 1|Nobelpharma|+81-3-5651-1177|murakami@nobelpharma.co.jp
13508|NCT00903331|Parisa Danaietash|Actelion Pharmaceuticals Ltd||parisa.danaietash@actelion.com
13509|NCT00903344|Dr. Leigh Eck|University of Kansas Medical Center|913-588-6022|leck2@kumc.edu
13510|NCT00903357|Bok Yang Pyun, M.D.|Department of Pediatrics, Soonchunhyang University Hospital|+82-2-709-9339|bypyun@hanmail.net
13511|NCT00903383|Joel Freiman, MD, MPH|Lexicon Pharmaceuticals, Inc.|281-863-3070|
13512|NCT00903409|GSK Response Center|GlaxoSmithKline|866-435-7343|
13513|NCT00903448|John Mcrorie, PhD, FACG, AGAF|The Procter & Gamble Company|513-622-1423|mcrorie.jw@pg.com
13514|NCT00903682|EMEA Medical Affairs Director Virology|Janssen-Cilag EMEA|+31 6 542 454 37|
13515|NCT00903695|Marilee Monnot, PhD|UOklahoma Health Sciences Center|405-456-5773 ext 5773|marilee-monnot@ouhsc.edu
13516|NCT00904007|Dr. B. Price Kerfoot|Veterans Affairs Boston Healthcare System|7742869230|price.kerfoot@gmail.com
13651|NCT01810302|Dr. Spiros Blackburn|University of Florida|(352) 273-9000|spiros.blackburn@neurosurgery.ufl.edu
13652|NCT01811303|Rungano Munyuki (Clinical Project Manager)|RSSL|0118 9184034|
13653|NCT01812655|Debra Jeffs, PhD, RN, Principal Investigator|Arkansas Children's Hospital|501-364-3239|jeffsda@archildrens.org
13654|NCT01812681|Dr. Serdar Beken|Dr. Sami Ulus Children's Hospital|00903123056449|serbeken@gmail.com
13655|NCT01814397|Dr. Norah Lynn Henry|University of Michigan Comprehensive Cancer Center|734-936-4991|norahh@med.umich.edu
13656|NCT01814774|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13841|NCT01536704|GSK Response Center|GlaxoSmithKline|866-435-7343|
13842|NCT01536860|Rungano Munyuki|RSSL|+44 118 918 4166|rungano.munyuki@rssl.com
13843|NCT01537081|Gail Solomon,MS; Director Clinical Development|Reckitt Benckiser LLC|973-404-2752|gail.solomon@rb.com
13844|NCT01537120|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13845|NCT01537185|Dr. Royce Morrison|Comprehensive Clinical Development Northwest|206 285 3500|ckeech@path.org
13846|NCT01537367|Lytt I. Gardner, Ph.D., CDC Project Officer|Division of HIV/AIDS (Epidemiology Branch), National Center for HIV/Hepatitis/STD/Tuberculosis Prevention, Centers for Disease Control and Prevention|(404) 639-6163|lig0@cdc.gov
13847|NCT01537666|Taneli Jouhikainen, MD, MBA; Chief Operating Officer|Savara Inc.|(888) 302-4876|info@savarapharma.com
13848|NCT01538472|Issa Khouri, MD / Professor, Stem Cell Transplant|University of Texas (UT) MD Anderson Cancer Center|713-745-2803|CR_Study_Registration@mdanderson.org
13849|NCT01539070|MPH. Gloria Oliva Martínez Andrade|Instituto Mexicano del Seguro Social|5556059862 ext 21075|gloria_olivam@hotmail.com
13850|NCT01725217|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
13851|NCT01725282|Vice President, Clinical Development Administration|Astellas Pharma Inc.||clinicaltrials@us.astellas.com
13852|NCT01725451|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13853|NCT01726335|Medical Group Manager|Janssen-Cilag Ltd.|+55 11 30302738|
8664|NCT01150903|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8665|NCT01150981|Samir Malkani, MD|University of Massachusetts Medical School|5088563800|samir.malkani@umassmemorial.org
8666|NCT01151085|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8667|NCT01151098|Clinical Leader, Executive Medical Director|Purdue Pharma L.P.|800-733-1333 OR 800-745-7445|
8668|NCT00655629|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
8669|NCT00655642|Dr. Tyler Barrett|Vanderbilt University|6159360253|tyler.barrett@vanderbilt.edu
8670|NCT00655668|Associate Director, Clinical Trial Disclosure|Celgene|1-888-260-1599|clinicaltrialdisclosure@celgene.com
8671|NCT00655733|Hua Mu,Senior Vice President of Clinical Research and Development|Hutchison MediPharma|861 3564487805|huam@hmplglobal.com
8672|NCT00655746|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
8673|NCT00655824|GSK Response Center|GlaxoSmithKline|866-435-7343|
8674|NCT00509899|Study Director|Incyte Corporation|1-855-463-3463|
8675|NCT00509925|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
8676|NCT00510068|Study Director|Novartis Pharmaceuticals|862-778-8300|
8677|NCT00510146|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8678|NCT00510224|Charles J. Ryan, MD|UCSF|415-353-9279|ryanc@medicine.ucsf.edu
8679|NCT00510276|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8680|NCT00510289|David Rizzieri, MD|Duke University Medical Center|919-668-1014|David.Rizzieri@duke.edu
8681|NCT00510484|Sven Voet - Global Communication|Solvay Pharmaceuticals|+32 (0)2 509 69 77|sven.voet@solvay.com
8682|NCT00510510|Study Director|Novartis Pharmaceuticals|862-778-8300|
8796|NCT00558064|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13156|NCT01952301|Dr. Michael K. McGuire|Perio Health Professionals, PLLC|713-783-5442|mkmperio@swbell.net
13157|NCT01955083|Dr. Hsueh-Yu Li|Chang Gung Memorial Hospital|886-3-3281200 ext 3967|hyli38@adm.cgmh.org.tw
13158|NCT01957384|Marian Dyreborg Sinvani, Clinical Manager|Coloplast A/S|+45 4911 2356|dkmards@coloplast.com
13159|NCT01957397|Birte Petersen Jakobsen, MD|Coloplast A/S|+45 4911 1395|dkbir@coloplast.com
13160|NCT01957462|Daniel Carter|Coloplast|+45 49222523|dkdac@coloplast.com
13161|NCT01957475|Daniel Carter|Coloplast|+45 49112523|dkdac@coloplast.com
13162|NCT01957488|Medical Director|Coloplast|+45 4911 1395|dkbir@coloplast.com
13163|NCT01957553|Dr. Birte P.Jakobsen|Coloplast|+45 4911 1395|dkbir@coloplast.com
13164|NCT01959685|Jennifer Wike|Repros Therapeutics Inc.|2817193402|jwike@reprosrx.com
13165|NCT01963091|Dr. Moran-Santa Maria|MUSC|843-792-8187|moranm@musc.edu
13166|NCT01963767|Dr. Brent Small|University of South Florida|813-974-9746|bsmall@usf.edu
13167|NCT01964547|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd.|0044 1223 266800|rp@gwpharm.com
13168|NCT01965067|Kyo Sang Kim, MD, PhD|Department of Anesthesiology and Pain Medicine, Hanyang University Hospital|+82-2-2290-8680|kimks@hanyang.ac.kr
13169|NCT01966042|Dr. Nelson Americo Hossne Junior|Federal University of Sao Paulo (UNIFESP)|+55 11 5571-2719|nelson.hossne@gmail.com
13170|NCT01966926|Dr. Jennifer Linde|University of Minnesota|612-624-0065|linde074@umn.edu
13171|NCT01967121|Tracey Covassin|Michigan State University|517-353-2010|covassin@msu.edu
13172|NCT01972659|Assistant Professor Dr Z Ipek ARSLAN AYDIN|Kocaeli University Medical Faculty|00905325011339|zehraipek48@gmail.com
13173|NCT01973413|Marc Breton, PhD|Univeristy of VIrginia|434-982-6484|mb6nt@virginia.edu
13174|NCT01973439|Trial manager|MRC Clinical Trials Unit at UCL|02076704825|silvia.forcat@ucl.ac.uk
13175|NCT01490294|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
13517|NCT00904150|Professor Anne MacGregor|Centre for Neuroscience and Trauma, Queen Mary, University of London|+44 7774 868628|e.macgregor@qmul.ac.uk
13518|NCT00904215|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13519|NCT00904371|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13520|NCT00904618|Louis-Olivier Gagnon|Centre Hospitalier Universitaire de Sherbrooke|1-819-437-4965|louis.olivier.gagnon@gmail.com
13521|NCT00904670|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13522|NCT00904748|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13523|NCT00904826|Dr. Sean J. Pittock|Mayo Clinic|507-284-4741|pittock.sean@mayo.edu
13524|NCT00904943|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
13525|NCT00904995|Jorge Cortes, MD / Professor|The University of Texas MD Anderson Cancer Center|713-745-5783|eharrison@mdanderson.org
13526|NCT00905021|Dr. Mothaffar Rimawi|Baylor College of Medicine|713-798-1311|rimawi@bcm.edu
13527|NCT00905125|Shital M. Patel, M.D.|Medicine and Molecular Virology & Microbiology, Baylor College of Medicine|713-798-3793|shitalp@bcm.edu
13528|NCT00905164|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
13529|NCT00905346|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
13530|NCT00912509|Marianne O. Price, PhD|Cornea Research Foundation of America|317-814-2990|mprice@cornea.org
13531|NCT00912782|Monnie Wasse MD/MPH / Associate Professor of Medicine|Emory University|404-727-1598|hwasse@emory.edu
13532|NCT00912808|Kathryn Chung, MD|Oregon Health & Science University|503 220 8262 ext 51091|chungka@ohsu.edu
13533|NCT00912925|Genzyme Medical Information|Genzyme Corporation||medinfo@genzyme.com
13534|NCT00912964|Medical Director, Global Medical Sciences|Astellas Pharma Global Development, Europe||ClinicalTrials.Disclosure@us.astellas.com
13535|NCT00913133|Director of Clinical Trials|Canyon Pharmaceuticals|888-434-7003|info@canyonpharma.com
13854|NCT01727895|Drs. Jenneke Leentjens|Radboud UMC|0031-243668420|Jenneke.Leentjens@radboudumc.nl
13855|NCT01728246|Medical Affairs Manager|Janssen Pharmaceutica|+632-8247901|
13856|NCT01728337|Dr Doris Hexsel|CBED|30262633|cbed@cbed.com.br
13857|NCT01729247|Nancy Herje, BSN, RN, MBA|Aerocrine, Inc.|919-449-8873|Nancy.Herje@aerocrine.com
13858|NCT01732263|Study Physician|Shire Development LLC|+1 866 842 5335|
13859|NCT01593852|Lukas Dekker, MD, PhD|Catharina Hospital Eindhoven|+31 40 239 7000|lukas.dekker@catharina_ziekenhuis.nl
13860|NCT01594294|Renee Garofalo, OD, FAAO|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13861|NCT01594411|May Yau, Sr. Director Clinical Operations|CardioDx, Inc.|650-475-2724|llittleford@cardiodx.com
13862|NCT01594970|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13863|NCT01595282|Principal Investigator|PPLM|617-616-1600|
14069|NCT01549405|Dr Derya Özkan|Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital|00903125962553|derya_z@yahoo.com
14070|NCT01549613|George J. Shaw, MD, PhD|University of Cincinnati, Dept. of Emergency Medicine|513-558-8098|shawge@ucmail.uc.edu
14071|NCT01549977|Sr. VP, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
14072|NCT01550549|Chief Medical Officer|Avid Radiopharmaceuticals|215-298-0700|clinicaloperations@avidrp.com
14073|NCT01550809|Francisco Javier Ampudia Blasco|Departamento de Endocrinología y Nutrición, Hospital Clínico Universitario de Valencia, Universitat de València, Valencia, Spain|+34 96 3862665|Francisco.J.Ampudia@uv.es
14074|NCT01551173|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
14075|NCT01551303|Dr. Elizabeth Hoge|Massachusetts General Hospital|617-724-0859|ehoge@partners.org
14076|NCT01552603|Kenneth Ward|Legacy Health System|971-570-2632|kenward503@msn.com
14077|NCT01552772|Global Medical Affairs|Otsuka Pharmaceutical Development and Commercialization, Inc.|800 562-3974|
14078|NCT01854905|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
8797|NCT00558103|GSK Response Center|GlaxoSmithKline|866-435-7343|
8798|NCT00558246|Phyllis Britnell|Ethicon|1 908 218-3060|pbritnel@its.jnj.com
8799|NCT00558259|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8800|NCT00558272|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
8801|NCT00558285|Study Director|Novartis Pharmaceuticals|862-778-8300|
8802|NCT00558363|GSK Response Center|GlaxoSmithKline|866-435-7343|
8803|NCT00558428|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8804|NCT00558467|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
8805|NCT00558558|Ying Guo, MD - Associate Professor|UT MD Anderson Cancer Center|713-745-2327|jaallo@mdanderson.org
8806|NCT01359748|Angel Pons Ferré|Aguiflai Iberica, SL|+34 93 7540370|calidad@keito.com
8807|NCT01360021|Goran Eckerwall, MD|Astrazeneca||aztrial_results_posting@astrazeneca.com
8808|NCT01121913|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
8809|NCT01121926|Director of Regulatory Affairs|Labopharm Inc.|1 450 686 1017|
8810|NCT01121991|Medical Responsible|EMD Serono Canada Inc., an affiliate of Merck KGaA, Darmstadt, Germany|+1-888-737-6668 ext 5248|david.sciberras@emdserono.com
8811|NCT01122108|Harold E. Bays, MD|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|502-515-5672|kschmitz@lmarc.com
8812|NCT01122160|Beverly Clevidence|USDA|301-504-8367|beverly.clevidence@ars.usda.gov
8813|NCT01122264|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
8814|NCT01122511|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
8815|NCT01122576|Quintus Ngumah, OD, PhD|Bausch & Lomb Incorporated|(973) 360-6450|Quintus.Ngumah@bausch.com
8816|NCT01122680|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13176|NCT01490931|Elliot V Hersh DMD, MS, PhD  Professor of Pharmacology|Univeristy of Pennsylvania School of Dental Medicine|215-898-9686|evhersh@pobox.upenn.edu
13177|NCT01491113|UCB Clinical Trials Call Center|UCB|+1 877 822 9493|
13178|NCT01491490|Mr Colin Stott|GW Research Ltd.|+44 (0)1980 557000|cgs@gwpharm.com
13272|NCT01455012|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
13273|NCT01455064|Shridhara A. Karinka, Ph.D., Director of Clinical Affairs|Abbott Diabetes Care|510-749-6393|SHRIDHARA.ALVA@ABBOTT.COM
13274|NCT01455545|Dr. Carlos Almonacid|SESCAM - HOSPITAL UNIVERSITARIO DE GUADALAJARA|+34 655 53 44 75|caralmsan@gmail.com
13275|NCT01456130|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
13276|NCT01456169|Sr. VP, Clinical Science|Takeda GlobalResearch and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
13277|NCT01456299|Dr.Kim|Ajou University|82-32-460-3400|kjyeop@ajou.ac.kr
13278|NCT01457339|Study Physician|Shire Development LLC|1 866-842-5335|
13279|NCT01457950|GSK Response Center|GlaxoSmithKline|866-435-7343|
13280|NCT01458171|Clinical Trial Disclosure Manager|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
13281|NCT01458275|Respiratory Medical Director|Sunovion|1-866-503-6351|
13282|NCT01458587|Anna Houlihan|DUSA Pharmaceuticals, Inc.|9147608796|houlihana@dusapharma.com
13283|NCT01459068|Courtland Robinson|Johns Hopkins Bloomberg School of Public Health|4104155266|crobinso@jhsph.edu
13284|NCT01459588|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13285|NCT01158378|Michael Carnahan, PhD|HyperBranch Medical Technology, Inc|919-433-3329|michaelc@hyperbranch.com
13286|NCT01158534|Dr. Brian Rini|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|216-444-9567|rinib2@ccf.org
13287|NCT01158716|Theodoros Zografos|Cardiovasular RS|+306956161001|theodoroszografos@gmail.com
13288|NCT01159171|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
13536|NCT00913380|Kyoung Ho Lee|Seoul National University Bundang Hospital|82-31-787-7607|kholeemail@gmail.com
13537|NCT00913458|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13538|NCT00913510|Dikran Shamoun|Wellspect HealthCare|+46313764000|
13539|NCT00913523|Joyce Hauze, RPS Senior Specialist, Clinical Research Operations|Johnson & Johnson Consumer and Personal Products Worldwide|928-277-0715|jhauze@its.jnj.com
13540|NCT00913692|Jeffrey I. Cohen, MD|National Institute of Allergy and Infectious Diseases, Laboratory of Infectious Diseases|(301) 496-5265|jcohen@niaid.nih.gov
13541|NCT00913744|Dr. Aniz Girach|ThromboGenics NV|+32 16 751 447|aniz.girach@thrombogenics.com
13542|NCT00914186|Fred Henry MS, MPH,|Taisho Pharmaceutical R&D Inc.|973-898-6200|F-Henry@taihso-rd.com
13565|NCT00976599|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13566|NCT00976677|Study Statistician|ECOG Statistical Office|617-632-3012|
13567|NCT00976703|Kelly S Gibson, MD|Metrohealth Medical Center|216-778-5498|kgibson@metrohealth.org
13568|NCT00976716|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13569|NCT00976950|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13570|NCT00977080|Global Medical Services|Abbott|800-633-9110|
13571|NCT00977106|Medical Communications|Hoffmann- LaRoche|800-821-8590|genentech@druginfo.com
13572|NCT00977171|Chief Scientific Officer|Chelsea Therapeutics Inc.|704-973-4202|hewitt@chelsearx.com
13573|NCT00977184|David H. Benninger, MD|Department of Neurology, Centre Hospitalier Universitaire Vaudois||David.Benninger@chuv.ch
13574|NCT00977548|Rami Komrokji, Principal Investigator|H. Lee Moffitt Cancer Center and Research Institute|813-745-4692|rami.komrokji@moffitt.org
13575|NCT00977561|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13576|NCT00977613|Victoria Rosenwald|Beth Israel Cancer Center|212 844-8285|vrosenwa@chpnet.org
14079|NCT01855074|Medical Manager Neurosciences|Janssen. Pharmaceutical Companies of Johnson and Johnson|+507-3989740|dmuschet@its.jnj.com
14080|NCT01856530|Dr. Stefan G. Hofmann|Boston University|617-353-9233|shofmann@bu.edu
14081|NCT01856686|Dr. Moises Aguilar|Spanish Foundation for Neurometrics Development|+34 634 54 87 20|moises.aguilar@gmail.com
14082|NCT01857063|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
14083|NCT01857297|bioCSL, Head of Clinical Operations|bioCSL PTY LTD|csl.clinicaltrials@csl.com.au|csl.clinicaltrials@csl.com.au
14084|NCT01857531|Dr. Jed E. Rose|Duke Center for Smoking Cessation|919-668-5055|jed.rose@duke.edu
14085|NCT01859702|Abayomi Ogundele, Global Medical Affairs Brand Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
14086|NCT01860521|Dr. Umberto Leone Roberti Maggiore|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|00393289461340|ulrm@libero.it
14087|NCT01861704|Tanya Arbogast, Study Principal Investigator|InSound Medical, Newark, California|510-792-4000|Srikant.Mantha@phonak.com
14088|NCT01861925|Dr. Lucio Robledo, Clinical Trials Biometry|Haag Streit AG|+41 31 978 01 11 ext 209|lucio.robledo@haag-streit.com
14089|NCT01863134|Miroslaw Wilczynski|First Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland|+48 32 20 24 025|miroslaw.wilczynski@cardiosurg.pl
13657|NCT01814878|Clinical Research Director|Janssen Korea/25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|82-2-2094-4518|
13658|NCT01815671|Leonard Weinstock, MD|Specialists in Gastroenterology, LLC|314-997-0554 ext 102|lw@gidoctor.net
13659|NCT01816243|Medical Affairs Director|Medical Affairs, Janssen-Cilag (Thailand)|662-792-7200|
13660|NCT01816451|Ph.D. Laura Castro de Garay|University of Trás-os-Montes and Alto  Douro|+55 21 22275084|laura@virtualsoftware.com.br
13661|NCT01817764|GSK Response Center|GlaxoSmithKline|866-435-7343|
13662|NCT01817790|GSK Response Center|GlaxoSmithKline|866-435-7343|
13663|NCT01819415|Dr. Flavio Rezende|Maisonneuve-Rosemont Hospital|514-867-2990|frezendef@hotmail.com
13664|NCT01819935|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8817|NCT01122862|GSK Response Center|GlaxoSmithKline|866-435-7343|
8818|NCT01123395|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
8932|NCT01189461|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8933|NCT01189487|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8934|NCT01189500|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8935|NCT01189604|Gerard Lynch|Astrazeneca||aztrial_results_posting@astrazeneca.com
8936|NCT01189617|Joyce Hauze, Sr. Specialist|Johnson & Johsnon Consumer and Personal Products Worldwide|9285-277-0715|jhauze@its.jnj.com
8937|NCT01189747|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
8938|NCT01189760|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
8939|NCT01189812|Director of Clinical Operations|Columbia Northwest Pharmaceuticals|425.453.0404|jhobus@nwcrc.net
8940|NCT01189890|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
8941|NCT01190007|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
8942|NCT01201798|Head, Alcon Clinical|Alcon Research, Ltd.|1-888-451-3937|medinfo@alconlabs.com
8943|NCT01201811|Anne McClain|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
8944|NCT01201915|Medical Communications|Genentech, Inc.|800 821-8590|genentech@druginfo.com
8945|NCT01201967|Jeff C. Huffman, MD|Massachusetts General Hospital|6177242910|jhuffman@partners.org
8946|NCT01202071|Masaharu Yokoyama, Director|Eisai Co., Ltd.|+81-3-3817-3908|m-yokoyama@hhc.eisai.co.jp
8947|NCT01202162|Gildasio De Oliveira, M.D.|Northwestern University|312-926-8371|g-jr@northwestern.edu
8948|NCT01202188|Study Director|Novartis Pharmaceuticals|862-778-8300|
8949|NCT01202227|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13289|NCT01159431|Dr. Christopher DeGiorgio|UCLA|310-206-3753|cmd@mednet.ucla.edu
13290|NCT01159600|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13291|NCT01159665|Dr. Aniz Girach|ThromboGenics|+32 16751310|aniz.girach@thrombogenics.com
13292|NCT01159691|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
13293|NCT01159743|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
13294|NCT01159769|Director of Medical Affairs|Alcon Research, Ltd.|800-862-5266|medinfo@alconlabs.com
12908|NCT00920075|Deborah A Bowlby, Asst.Professor, Pediatric Endocrinology|Medical University of South Carolina|843-792-6807 ext none|bowlbyd@musc.edu
12909|NCT00920140|GSK Response Center|GlaxoSmithKline|866-435-7343|
12910|NCT00920309|Dr. Neera Dahl|Yale University School of Medicine|203-785-4184|neera.dahl@yale.edu
12911|NCT00920374|GSK Response Center|GlaxoSmithKline|866-435-7343|
12912|NCT00920647|MedINfo|Shire Human Genetic Therapies Medical Information|1-866-888-0660 ext 2|US_ShireHGT_Medicalinformation@shire.com
12913|NCT00920686|Thomas Lategan, PhD|NeurAxon, Inc|417 673 6697|tlategan@neuraxon.com
12914|NCT00920790|Project Management Department, Development Division|Kyowa Hakko Kirin||clinical.info@kyowa-kirin.co.jp
12915|NCT00920816|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12916|NCT00920855|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
12917|NCT00920907|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
12918|NCT00921518|Judith Kristeller|Wilkes University|570-408-4272|judith.kristeller@wilkes.edu
12919|NCT00921687|Paul Drawz, MD, MHS, MS|Louis Stokes Cleveland VA Medical Center|6126255423|draw0003@umn.edu
12920|NCT00921895|Robert Sambusky, MD|Rapid Pathogen Screening, Inc.|941-556-1853|sambursky@rpsdetectors.com
12921|NCT00921934|Dr. med. Martin Schencking|Department for Complementary and Alternative Medicine|+0049-2602-684-614|
12867|NCT01659853|Dr. Warren Winkelman|Galerma Laboratories|817-961-5494|warren.winkelman@galderma.com
12868|NCT01660230|Kent Pryor, PhD, MBA, Chief Operating Officer|ZZ Biotech, LLC||kpryor@zzbiotech.com
12869|NCT01660321|Director, Quality and Regulatory|ParaPro|317-810-6205|kerrym@parapro.com
12870|NCT01660334|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12871|NCT01660698|Dr Maurice Beaumont, Principal Investigator|Clinical Development Unit / Metabolic Unit|+41217858054|maurice.beaumont@rdls.nestle.com
12872|NCT01660763|Pamela Palmer, MD, PhD|AcelRx Pharmaceuticals, Inc|650-216-3504|ppalmer@acelrx.com
12873|NCT01660815|Chief Medical Officer|Avid Radiopharmaceuticals, Inc.|215-298-0700|clinicaloperations@avidrp.com
12874|NCT01661621|Dr. Hann-Chorng Kuo|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|886-3-8561825 ext 2113|hck@tzuchi.com.tw
12875|NCT01662310|Senior Director Clinical Leader|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.||ClinicalTrialDisclosure@its.jnj.com
12876|NCT01662362|Barbara Kaesdorf, Associate Director Clinical Affairs|Abbott|847-937-8702|barbara.kaesdorf@abbott.com
12877|NCT01662648|Regional Medical Franchis Director AP|Janssen China|+86 10 582 187 66|
12878|NCT01083485|Maggie Wilson|Mundipharma Research|+ 4401223 424444 ext 2303|
12879|NCT01083576|Director, Division of Regulated Activites and Compliance|US Army Medical Materiel Development Activity (USAMMDA)|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil
12880|NCT01083693|Global Medical Services|Abbott|1-800-633-9110|
12881|NCT01083810|Global Medical Services|Abbott|1-800-633-9110|
12882|NCT01083901|Catherine M. Jankowski|University of Colorado Denver|303-724-7383|catherine.jankowski@ucdenver.edu
12883|NCT01084005|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12884|NCT01084148|Clinical Project Manager|Orfagen|0033 5 34 50 64 62|caroline.miklaszewski@orfagen.com
12999|NCT00911443|Roberto Camerini|R&D Department - Sigma-Tau SpA|+390691393562|roberto.camerini@sigma-tau.it
11949|NCT00978757|MD|Francisco C. Bonofiglio|541149590200 ext 4949|francisco.bonofiglio@hospitalitaliano.org.ar
11950|NCT00979017|Katherine B. Peters, MD, PhD|Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center|(919) 684-6173|katherine.peters@duke.edu
11951|NCT00979199|Dr. Danilo Neglia|CNR Institute of Clinical Physiology, Pisa, Italy and Fondazione Toscana G. Monasterio, Pisa, Italy|+390503152019 ext 2019|dneglia@ifc.cnr.it
11952|NCT00979420|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11953|NCT00979459|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11954|NCT00979615|Maria J. Tort, PhD|Alcon Research, Ltd.|(817) 302-5968|Maria.Tort@alconlabs.com
11955|NCT00979628|Guillermo Umpierrez|EUSOM|4047781665|geumpie@emory.edu
11956|NCT00979875|Vice President, Endocrinology Clinical Development|Halozyme Therapeutics, Inc.|(858) 794-8889|
11957|NCT00979901|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
11958|NCT00980005|GSK Response Center|GlaxoSmithKline|866-435-7343|
11959|NCT00980174|Study Director|Amgen Inc.|866-572-6436|
11960|NCT01040780|Yan Sun, M.D.|Cancer Hospital, Chinese Academy of Medical Sciences|0086-010-87788519|zhangheping@csco.org.cn
11961|NCT01040793|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11962|NCT01040832|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
11963|NCT01040845|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
11964|NCT01040871|Dr. Helgi van de Velde|Johnson & Johnson Pharmaceutical Research & Development||HVDVELDE@ITS.JNJ.COM
11965|NCT01041209|Dr. Fernando Torres|Hospital General de Niños Pedro de Elizalde|+54 11 43070140|slaip@intramed.net
11966|NCT01041573|Senior Manager Clinical Research|Valneva Austria GmbH|+43 1 206 20 ext 1175|katrin.dubischar-kastner@valneva.com
11967|NCT01041859|Director, Clinical Leader|Janssen Research&Development|609-730-6777|
12628|NCT01050257|Medical Communications|Hoffman-LaRoche|800-821-8590|
12629|NCT00869960|Jennifer King|UAB|205-934-2696|jenking@uab.edu
12630|NCT01498458|Dr. Andreas Schneeweiss|University Hospital Heidelberg|+49 (0)6221 56 36051|andreas.schneeweiss@med.uni-heidelberg.de
12631|NCT01498653|GSK Response Center|GlaxoSmithKline|866-435-7343|
12632|NCT01498679|GSK Response Center|GlaxoSmithKline|866-435-7343|
12633|NCT01498692|Ruth M. Starzyk, PhD|Boston Scientific|508-683-6577|ruth.starzyk@bsci.com
12224|NCT01072448|Study Director|Novartis Pharmaceuticals|862 778-8300|
12225|NCT01072643|Dr. Aruna T. Nathan|The Children's Hospital of Philadelphia|215-590-1858|nathan@email.chop.edu
12226|NCT01072669|Dr. Soumya Chatterjee|Cleveland Clinic|216-444-9945|chattes@ccf.org
12227|NCT01072773|Dr. Shaji Kumar|Mayo Clinic||kumar.shaji@mayo.edu
12228|NCT01072877|David Wright MB FRCS|BTG International Inc|610-278-1660|david.wright@btgplc.com
12229|NCT01073163|Manager|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12230|NCT01073449|Dr. Giosue Mascioli|Dept. of Arrhythmology - Cliniche Humanitas Gavazzeni|+39 035 4204159|giosuemascioli@mac.com
12231|NCT01073462|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
12232|NCT01073566|Vice President Clinical Affairs|Calibra Medical|650-298-4750|ddreon@calibra.com
12233|NCT01073605|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12234|NCT01073618|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12235|NCT01073631|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12236|NCT01073865|An Open Label Study of ZOLADEX in Pre-menopausal Women with ER Positive Advanced Breast Cancer|AstraZeneca|+44 1509 645895|clinicaltrialtransparency@astrazeneca.com
12237|NCT01073930|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
14142|NCT01447121|Ann Tideman|Bayer HealthCare, Diabetes Care|574-257-3062|ann.tideman@bayer.com
14143|NCT01447433|Prof. Donglian Cai|Changhai Hospital|86 21 81873168|nutrition1226@126.com
14144|NCT01447511|Dr. Richard Brundage|University of Minnesota|612-624-3115|brund001@umn.edu
14145|NCT01447719|Chief Medical Officer|Avid Radiopharmaceuticals|215-298-0700|clinicaloperations@avidrp.com
14146|NCT01447849|Dr. Jerzy Sarosiek, Director, Mol. Medicine Research|TexasTech|915-215-5255|jerzy.sarosiek@ttuhsc.edu
14147|NCT01447927|Dr. Amitabh Chak|University Hospitals of Cleveland, Case Medical Center|216-844-5385|Amitabh.chak@case.edu
14148|NCT01448213|Marianne O. Price, PhD|Cornea Research Foundation of America|317-814-2990|mprice@cornea.org
14149|NCT01448356|Dr Andrea Petznick|Singapore Eye Research Institute|+65 6322 ext 4512|andrea.petznick@seri.com.sg
14150|NCT01448486|Prof. Bruce Brew|St. Vincent's Hospital, Sydney|61 2 8382 1111 ext 4100|b.brew@unsw.edu.au
14151|NCT01448525|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
14152|NCT01449305|Mirror Hsieh|isRed Pharma & Biotech Research Corporation|886-8-7628188|mingrong@bioisred.com
14153|NCT01449734|Christiane Hartog, MD|CSCC Germany, Jena University Hospital|+49 3641 9323171|christiane.hartog@med.uni-jena.de
14154|NCT01449929|GSK Response Center|GlaxoSmithKline|866-435-7343|
14155|NCT01449955|Dr. Alina Suris|UT Southwestern/VA North Texas|214-857-0334|alina.suris@va.gov
14156|NCT01450397|Scott W. Wolfe|Hospital for Special Surgery|212-606-1529|WolfeS@hss.edu
14157|NCT01450631|Jill Twardowski, Director of Clinical Operations|KCI USA, Inc.|210-515-4166|jill.twardowski@kci1.com
14158|NCT01450683|Associate Professor of Medicine (Oncology)|Stanford University Medical Center|650-725-2078|sandysri@stanford.edu
12796|NCT01083186|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
12797|NCT01083472|Sandra VanGuldener|LifeCell|310612504695|svanguldener@lifecell.com
12798|NCT00860067|Judith Falloon, MD/ Sr. Dir. Clinical Development|MedImmune LLC, an affiliate of AstraZeneca AB|301-398-0000|falloonj@medimmune.com
13000|NCT00911495|Dr. Helen Thackray, Vice-president Clinical Development|GlycoMimetics, Inc|240-243-1201|hthackray@glycomimetics.com
13001|NCT00911547|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com
13002|NCT00961636|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13003|NCT00961649|Matt Walker, PhD, Clinical Project Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13004|NCT00961805|Andreia S Baptista, PT|Federal University of Sao Paulo|551155764239|deiasalvador1@yahoo.com.br
13005|NCT00962000|Richard A. Ward, Ph.D.|University of Louisville Kidney Disease Program|502-852-5757|richard.ward@louisville.edu
13006|NCT00962013|Director of Clinical Research|Stryker Orthopaedics|201-831-5401|Ellen.Axelson@stryker.com
13007|NCT00962065|Joel P. Freiman, MD, MPH|Lexicon Pharmaceuticals, Inc.|281-863-3000|
13008|NCT00962104|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13009|NCT00962208|Prof Pauline Cho|The Hong Kong Polytechnic University|(852) 2766-6100|sopaulin@polyu.edu.hk
13010|NCT00962585|Rick Schwen, PhD, DABT, RAC / Vice President of Regulatory Affairs|Ausio Pharmaceuticals, LLC|513-731-0222|rick@ausiopharma.com
13011|NCT00962650|Michael Schwiers, Principal Biostatistician|Ethicon Endo-Surgery, Inc.|513-337-1172|mschwier@its.jnj.com
13012|NCT00962741|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13013|NCT00923117|Dr. Teri Kreisl|National Cancer Institute, National Institutes of Health|301-402-3423|kreislt@mail.nih.gov
13014|NCT00923156|Study Director|Novartis Pharmaceuticals|862-778-8300|
13015|NCT00972595|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
13016|NCT00972621|Nicholas Tarantino, O.D., Head, Worldwide Clinical Research|Abbott Medical Optics, Inc.|714-247-8613|nick.tarantino@amo.abbott.com
13017|NCT00972738|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
13018|NCT00972777|Tuyen Ong, MD, MRCOphth|Bausch & Lomb Incorporated|(973) 360-6389|tuyen.ong@bausch.com
11968|NCT01042093|David F. Dalury, MD|Towson Orthopaedic Associates|410-337-7900 ext 1221|ddalury@gmail.com
11969|NCT01042145|Dr. Jane Garbutt|Washington University School of Medicine|314-454-8613|jgarbutt@dom.wustl.edu
11970|NCT01042236|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11971|NCT01042392|Study Director|Novartis Pharmaceuticals|862-778-8300|
11972|NCT01042600|Joaquim Pinheiro, MD, MPH|Albany Medical Center|518-262-5421|pinheij@mail.amc.edu
11996|NCT01634555|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
11997|NCT01634620|Nancy Herje, BSN, RN, MBA|Aerocrine, Inc.|919-449-8873|Nancy.Herje@aerocrine.com
11998|NCT01634659|Jami Kern, MBA, PhD|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
11999|NCT01635218|Dr. Emma del Carmen Macías-Cortés|Hospital Juárez de México|+52 55 5747 7605|ecmc2008@hotmail.es
12000|NCT01635439|Ahmed Abdelaziz|NWAFH|0096644411088|webmaster@nwafh.med.sa
12001|NCT01635855|Merz Pharmaceuticals North America|Merz Pharmaceuticals North America|800-334-0514|clinicaltrials@merzusa.com
12002|NCT00957723|Director of Clinical Research|Stryker Orthopaedics|201-831-5401|Ellen.Axelson@Stryker.com
12003|NCT00957944|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
12004|NCT00958009|Fernando Dangond, MD|EMD Serono, Inc.|781-681-2348|Fernando.dangond@emdserono.com
12005|NCT00958035|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
12006|NCT00958126|Clinical Trials Disclosure Manager|CSL Limited|Use email contact|csl.clinicaltrials@csl.com.au
12007|NCT00958191|Director of Clinical Research|Stryker Orthopaedics|201-831-5401|Ellen.Axelson@stryker.com
12008|NCT00958243|Dr Russell Basser|CSL Limited|61393891569|russell.basser@csl.com.au
12009|NCT00958308|Dr. Serge Carrière|Bio-K+ International. Inc.|450-978-2465|scarriere@biokplus.com
12010|NCT00958334|Ronald Wiehle, PhD|Repros Therapeutics, Inc|281.719.3406|rwiehle@reprosrx.com
12238|NCT01073943|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com
12239|NCT01074164|Hae Bae|Northwestern University Department of Dermatology|312-695-6829|j-bae@northwestern.edu
12240|NCT01074229|Gildasio De Oliveira, MD|Northwestern University|312-926-8373|g-jr@northwestern.edu
12241|NCT01074242|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12242|NCT01074255|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12243|NCT01074307|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
12244|NCT01074437|Jonathan Perkins, Prinicipal Investigator|Seattle childrens research institute|206-987-1927|jonathan.perkins@seattlechildrens.org
12245|NCT01074450|Associate Director, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12429|NCT01642589|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
12430|NCT01642602|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
12431|NCT01643044|Steven Ondersma, PhD|Wayne State University|313-444-9797|sondersm@med.wayne.edu
12432|NCT01643616|Dr. Ronald Seidel|HELIOS-Kliniken Schwerin, Germany|0049 385 5204251|ronald.seidel@helios-kliniken.de
12433|NCT01643798|Joseph Taylor|Medical University of South Carolina|8437295729|taylorjj@musc.edu
12434|NCT01643876|Dr. Elham Emami|Université de Montréal|5143436111 ext 6053|elham.emami@umontreal.ca
12435|NCT01644058|Elham Emami, DDS, MSc, PhD|Université de Montréal|514-343-6111 ext 6053|elham.emami@umontreal.ca
12436|NCT01644292|Ed Giesbrecht|University of Manitoba|204-977-5630|Ed.Giesbrecht@med.umanitoba.ca
12437|NCT01644396|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
12438|NCT01644695|Dr. Andrew Elkwood, MD|Institute For Advanced Reconstruction|732-741-0970|aelkwood@hotmail.com
12439|NCT01644734|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12799|NCT00860249|Kenzie A. Cameron, PhD, MPH|Northwestern University, Department of General Internal Medicine|312-503-3910|K-Cameron@northwestern.edu
12800|NCT00860262|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12801|NCT00860314|Tim Risius, MD|University Hospital Hamburg-Eppendorf, Heart Center|+49-40-42803 ext 4142|risius@uke.uni-hamburg.de
12802|NCT00860405|Professor Dr. Martin Westphal, Chief Medical Officer|Fresenius Kabi Aktiengesellschaft, Else-Kröner-Str. 1, 61352 Bad Homburg, Germany|+49 6172 686 7280|martin.westphal@fresenius-kabi.com
12803|NCT00860457|Dr. Chaitra Ujjani|Lombardi Comprehensive Cancer Center, Georgetown University Hospital|202-444-1212|csu@georgetown.edu
12804|NCT00860535|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12805|NCT00860795|James A Taylor, MD|University of Washington|206-616-1206|uncjat@u.washington.edu
12806|NCT00861146|Ned L. Cooney, PhD|Yale University School of Medicine|860-594-6339|ned.cooney@yale.edu
12807|NCT00861263|Dr. Peter Draganov MD|University of FLorida|352-273-9472|peter.draganov@medicine.ufl.edu
12808|NCT00861471|Anna Ferrari, MD|New York University Cancer Institute|212-731-5389|anna.ferrari@nyumc.org
12809|NCT00861601|GSK Response Center|GlaxoSmithKline|866-435-7343|
12810|NCT00861744|GSK Response Center|GlaxoSmithKline|866-435-7343|
12811|NCT00861757|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12812|NCT00861913|Amy M. Weise, D. O.|Karmanos Cancer Institute, Wayne State University|313-576-8952|
12813|NCT00862082|Director of Clinical Development|Proacta, Inc.|858-642-0386|clinicalops@proacta.com
12814|NCT00862121|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
12815|NCT00862134|Director of Clinical Development|Proacta, Inc.|858-642-0386|clinicalops@proacta.com
12816|NCT00862186|Catherine Fiona Macpherson, PhD|Seattle Children's Hospital|206-987-2032|catherine.macpherson@seattlechildrens.org
12817|NCT00862251|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13019|NCT00972816|Posting Director|Novartis Vaccines and Diagnostics||RegContactVacUS.nvdit@Novartis.com
13020|NCT00972959|Prof. M. A. Dimopoulos|Department of Clinical Therapeutics, University of Athens School of Medicine, “Alexandra” General Hospital of Athens,|0030 210 3381511|mdimop@med.uoa.gr
13133|NCT01035138|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13134|NCT01035333|Dr Margaret Malone|Albany College of Pharmacy and Health Sciences|518 694 7275|margaret.malone@acphs.edu
13135|NCT01035346|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13136|NCT01035905|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
13137|NCT01035944|Dr. Jody Oyama|HemCon Medical Technolgoies|503.245.0459|jody.oyama@hemcon.com
13138|NCT01036165|Fernando Dangond, MD|EMD Serono, Inc.|781-681-2348|Fernando.dangond@emdserono.com
13139|NCT01036438|Ann Larkö|Molnlycke Health Care AB|+46 722 3338|ann.larko@molnlycke.com
13140|NCT01036529|Valerie Lucero-Cimmarusti|Boston Scientific|661-949-4745|Valerie.Lucero-Cimmarusti@bsci.com
13141|NCT01036724|Dr. Tina Hunter, Consulting Statistician to Biosense Webster|CTI Clinical Trials and Consulting|513-619-5541|tinah@s2stats.com
13142|NCT01036763|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13143|NCT01036802|Kenneth I. Ataga, MD|University of North Carolina, Chapel Hill|919-843-7708|kataga@med.unc.edu
13144|NCT01037088|Dr. Barth Wilsey, MD|UCaliforniaDavis|916-843-9082|blwilsey@ucdavis.edu
13145|NCT01037114|GSK Response Center|GlaxoSmithKline|866-435-7343|
13146|NCT01037127|GSK Response Center|GlaxoSmithKline|866-435-7343|
13147|NCT01934231|GSK Response Center|GlaxoSmithKline|866-435-7343|
13148|NCT01935622|Antonio Abbate|Virginia Commonwealth University|8048280513|aabbate@vcu.edu
13149|NCT01944878|Dr. Chang Seok Bang|Hallym University College of Medicine, Chuncheon Sacred Heart Hospital|+82-33-240-5000|cloudslove@naver.com
12011|NCT00958347|Director of Clinical Research|Stryker Orthopaedics|201-831-5401|ellen.axelson@stryker.com
12012|NCT00958568|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12013|NCT00958828|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
12014|NCT00958880|Jasper Smits, Ph.D.|Southern Methodist University|214-768-4310|jsmits@smu.edu
12015|NCT00958893|Jennifer Wike|Repros Therapeutics Inc.|2817193402|jwike@reprosrx.com
12016|NCT01012622|Clinical Research Associate|Janssen Korea MAF, Korea|82-2-2094-4837|
12017|NCT01012661|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com
12018|NCT01012739|Study Director|Novartis Pharmaceuticals|862 778-8300|
12019|NCT01012765|Study Director|Novartis Pharmaceuticals|862-778-8300|
12020|NCT01012947|Dr. Kang Soo Lee|Ajou University|821087812077|kpsimon@hanmail.net, antiaging@ajou.ac.kr
12021|NCT01012973|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
12022|NCT01013207|Alison Wimms|ResMed Ltd|+61 8884 2583|alison.wimms@resmed.com.au
12023|NCT01013740|GSK Response Center|GlaxoSmithKline|866-435-7343|
12024|NCT01013753|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12025|NCT01013844|June Robinson, MD|Northwestern University Department of Dermatology|312-695-6624|june-robinson@northwestern.edu
12026|NCT01013883|Dr Rajender singh|Darlington Memorial Hospital|01325380100 ext 3444|drrsdogra@yahoo.com
12027|NCT01014013|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
12028|NCT01014143|William DeVizio - DMD|Colgate Palmolive|732-878-7901|william_devizio@colpal.com
12029|NCT01014169|Dr Caroline Kistin|Boston University School of Medicine/Boston Medical Center|617-414-3642|caroline.kistin@bmc.org
12030|NCT00968838|Dr. Emil J. Freireich MD/Professor|The University of Texas M D Anderson Cancer Center|713-792-2660|eharriso@mdanderson.org
12440|NCT01645059|Dr. Santiago González Santiago|Hospital San Pedro Alcántara||santidatvs@hotmail.com
12441|NCT00908141|Robert Dreicer MD|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|216-445-4623|dreicer@ccf.org
12442|NCT00908232|EMEA Medical Affairs Director Oncology|Janssen-Cilag Germany|+49 2137 955-492|
12443|NCT00908310|Debra Mansfield|GE Healthcare|609-514-6329|debra.mansfield@ge.com
12444|NCT00908375|K Malik|Nortthwestern University|3129262280|kmalikmd@yahoo.com
12445|NCT00908388|Abe Letter|W.L. Gore & Associates|928-864-3113|aletter@wlgore.com
12446|NCT00908596|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
12447|NCT00908648|Dr Vittorio Terruzzi, Director of Gastroenterology Unit|Gastroenterology Unit, Valduce Hospital - Como - Italy|+39031324009|vterruzzi@valduce.it
12448|NCT00908687|Head Clinical Development|Valneva Austria GmbH|0043120620 ext 0|info@valneva.com
12449|NCT00908895|Dr Stéphane Pelet, MD, PhD|Département d'orthopédie, CHA-Pavillon Enfant-Jésus Québec|418-649-0252 ext 3165|stephane.pelet.ortho@gmail.com
12450|NCT00908908|Eisai Inc.|Eisai Call Center|888-422-4743|
12451|NCT00958919|Donald A. Mahler, M.D.|Dartmouth-Hitchcock|603 650-5533|Donald.a.mahler@hitchcock.org
12634|NCT01499199|GSK Response Center|GlaxoSmithKline|866-435-7343|
12635|NCT01499303|Bernadette Weidman|AstraZeneca|800-456-3669|ClinicalTrialTransparency@astrazeneca.com
12636|NCT01499576|Dr. Kyung Ho SONG, Assistnat Professor of Konyang University|Konyang University Hospital||postit2@daum.net, postit@kyuh.ac.kr
12637|NCT01499667|Study Director|Novartis Pharnaceuticals|862-778-8300|
12638|NCT01499810|Dr. Stanislav Pekarskiy|Research Institute of Cradiology, Siberian Branch of Russian Academy of Sciences|+73822558122|pekarski@cardio-tomsk.ru
12639|NCT01662882|Chief Medical Officer|Avid Radiopharmaceuticals, Inc.|215-298-0700|clinicaloperations@avidrp.com
12640|NCT01662999|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
12641|NCT01663285|Dr. Ajjai Alva|University of Michigan Comprehensive Cancer Center|734-647-8921|ajjai@umich.edu
12931|NCT00922987|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12932|NCT00923091|Bettina Ammentorp|Daiichi Sankyo Europe, GmbH|00498978080|bettina.ammentorp@daiichi-sankyo.eu
12933|NCT00930787|Dr Michael Franz|LifeCell|908094701100|mfranz@lifecell.com
12934|NCT00930969|ST Detect Study Team|Medtronic Cardiac Rhythm Disease Management|1-800-328-2518|medtronicCRMtrials@medtronic.com
12935|NCT00930982|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
12936|NCT00931164|Dr. Kathryn Swoboda|University of Utah|801-585-9717|taran@genetics.utah.edu
12937|NCT00931242|Alice B Gottlieb, MD, PhD|Tufts Medical Center|617 636 4802|agottlieb@tuftsmedicalcenter.org
12938|NCT00931268|Head of Clinical Development|Q-Med AB|+46 (0)18 4749000|reception.SEUPP@galderma.com
12939|NCT00931307|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
12940|NCT00931359|Kathy O'Shaughnessy, PhD|Miramar Labs|408-940-8700|kathyo@miramarlabs.com
12941|NCT00931385|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12942|NCT00931411|Annie Levesque|Innovaderm Research|514-521-4285 ext 222|alevesque@innovaderm.ca
12943|NCT00931463|Prof Sean Emery|The Kirby Institute|+61293850900|semery@kirby.unsw.edu.au
12944|NCT00931515|Director of Regulatory and Clinical Affairs|Pioneer Surgical Technology|906-225-5602|emilydowns@pioneersurgical.com
12945|NCT00931710|Study Director|Novartis Pharmaceuticals|862-778-8300|
12946|NCT00931723|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
12947|NCT00931801|Calvin J. Cohen MD, MSc, Director of Research|Community Research Initiative of New England|617-502-1700|ccohen@crine.org
12948|NCT00983827|Dr. Steven Edgley|University of Utah|801-581-4695|carma.hyde@hsc.utah.edu
12949|NCT00983853|Medical Monitor|Vertex Pharmaceuticals Incorporated|1-617-444-6777|medicalinfo@vrtx.com
12950|NCT00983905|Medical Affairs Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
13150|NCT01946425|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
13151|NCT01946438|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
13152|NCT01948050|Helena Knotkova, PhD|Beth Israel Medical Center|212-844-8541|hknotkov@chpnet.org
13153|NCT01948375|Zhishun Liu, Director of the study|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|8610-010-88001124|liuzhishun@aliyun.com.cn
13154|NCT01949051|GSK Response Center|GlaxoSmithKline|866-435-7343|
13155|NCT01951950|John F. Bebawy, MD, Principal Investigator|Northwestern University|312-695-0061|j-bebawy@northwestern.edu
11455|NCT01055262|Pfizer Clinical Trials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com
11456|NCT01055704|Dr Michael Camilleri|Mayo Clinic|5072662305|camilleri.michael@mayo.edu
11457|NCT01055769|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11458|NCT01055782|Lene Hendel MD|Specialist Doctors Rolighedsvej|+4545819090|lene@hendel.dk
11459|NCT00999544|Dr. Sharon Walsh|University of Kentucky|859-257-6485|sharon.walsh@uky.edu
11460|NCT00999596|Sarah Baxter or Linda Jalbert|Philips Healthcare|425-487-7665 / 978-659-7434|sarah.baxter@philips.com, linda.jalbert@philips.com
11461|NCT00999661|Michael Schwiers, Principal  Biostatistician|Ethicon Endo-Surgery, Inc.|513-337-1172|mschwier@its.jnj.com
11462|NCT00999687|Lin Yin-Ku MD.Ph.D.|Chang Gung Memorial Hospital|886-2-24313131 ext 2127|lin1266@adm.cgmh.org.tw
11463|NCT00999908|Study Director|Novartis Pharmaceuticals|862 778-8300|
11464|NCT01000311|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
11465|NCT01000324|GSK Response Center|GlaxoSmithKline|866-435-7343|
11466|NCT01000337|Argyro Fassoulaki|Aretaieio Hospital, University of Athens|+30210 7286334|fassoula@aretaieio.uoa.gr
11467|NCT01000376|Dr. Peter Tarassoff|Eisai|888-422-4743|
11468|NCT01000480|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12031|NCT01025830|Jayne Byakika Tusiime|University of California Berkeley|1 510 219 7567|tusiimej@berkeley.edu
12032|NCT01026038|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12033|NCT01026103|Noreen Fahey|Covidien|203-821-4716|noreen.fahey@covidien.com
12034|NCT01026194|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
12035|NCT01026389|Post M. A. Clinical Unit Manager|Guerbet|+33 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com
12036|NCT01026454|Connie Celum, MD, MPH|University of Washington|206-520-3800|ccelum@uw.edu
12037|NCT01026805|John Vozella, V.P. Clinical & Regulatory Affairs|Interlace Medical, Inc.|508-875-1343 ext 112|john@interlacemedical.com
12038|NCT01026818|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12039|NCT01026831|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12040|NCT01026844|Lecia Sequist, MD|Massachusetts General Hospital|617-724-4000|lvsequist@partners.org
12041|NCT01026948|Professor Zarko Alfirevic|University of Liverpool|00 44(1)51 702 ext 4100|zarko@liverpool.ac.uk
12042|NCT01026974|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
12043|NCT01027195|Wael K Barsoum, MD|The Cleveland Clinic|216-444-7515|barsouw@ccf.org
12044|NCT01027273|Carol R Horowitz, MD, MPH|Icahn School of Medicine at Mount Sinai|212-659-9567|carol.horowitz@mountsinai.org
12045|NCT01027286|Wael K Barsoum, MD|The Cleveland Clinic|216-444-7515|barsouw@ccf.org
12046|NCT01027351|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
12047|NCT01027364|Biogen Idec Study Medical Director|Biogen Idec Inc.||clinicaltrials@biogenidec.com
12048|NCT01027468|Assoc.Prof.PD.Dr.Stefan Sacu|Medical University of Vienna|+43404001 ext 7937|stefan.sacu@meduniwien.ac.at
12049|NCT01027650|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
12050|NCT01027780|Dr. Jan Moynihan|University of Rochester|585-275-4648|jan_moynihan@urmc.rochester.edu
12642|NCT01663714|GSK Response Center|GlaxoSmithKline|866-435-7343|
12643|NCT01664624|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
12644|NCT01664806|Dr. Thomas Robinson|University of Colorado School of Medicine|303-724-2728|thomas.robinson@Ucdenver.edu
12645|NCT01665157|Han-Mo Chiu, M.D., Ph.D.|National Taiwan University Hospital||hanmochiu@ntu.edu.tw
12646|NCT01665807|Brenda L. Coleman, PhD,|Mount Sinai Hospital, IDERU|416-586-4800 ext 4538|bcoleman@mtsinai.on.ca
12647|NCT01665911|Frank Lippert|Indiana University School of Dentistry|317-274-8822|flippert@iu.edu
12648|NCT01666197|Clinical Project Leader|Novartis Consumer Health SA|41223635293|
12649|NCT01667224|Dr. Soo-Wan Chae|Clinical Trial Center for Functional Food in Chonbuk National University Hospital|82-63-250-2348|soowan@jbnu.ac.kr
12650|NCT01667848|Dr. Bettina Klugsberger|LudwigBoltzmannIOL|+43 732 7806 2133|Bettina.Klugsberger@akh.linz.at
12651|NCT01668654|GSK Response Center|GlaxoSmithKline|866-435-7343|
12652|NCT01669629|Kathy Osborn, OD, MS, FAAO, FBCLA Senior Principal Research Optometrist|Vistakon|904 443-1032|kosborn@its.jnj.com
12653|NCT01669785|Jeffery L. Milleman, DDS, MPA|Salus Research, Inc.|260-755-1099|
12654|NCT01670201|Dr Nicole Gibran|Harborview Medical Center / Seattle, Washington|206-744-3140|nicoleg@uw.edu
12655|NCT01671839|Lisa Misell, Ph.D., VP, Clinical and Medical Affairs|Ulthera, Inc. 1840 South Stapley Drive, Mesa, AZ 85204|480-619-4069|l.misell@ulthera.com
12656|NCT01672827|Paul Sherwin, M.D.|GE Healthcare|1-609-514-6820|paulsherwin@ge.com
12246|NCT01074463|Associate Director, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12247|NCT01074502|Aida Lugo-Somolinos MD-PI|UNC Chapel Hill|919-843-9447|alugosom@med.unc.edu
12248|NCT01076153|Global Medical Services|Abbott|1-800-633-9110|
12249|NCT01076166|Global Medical Services|Abbott|1-800-633-9110|
12250|NCT01076244|Timothy Deer|Center for Pain Relief|(304) 347-6144|Diana.tolentino@stfh.net
12951|NCT00983918|Jaime Ortiz, MD|Baylor College of Medicine|713-873-2860|jaimeo@bcm.edu
12952|NCT00983931|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
12953|NCT00984009|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
13066|NCT01933880|Director - CNS & Pain, CDMA, China R&D and SA|Xi’an Janssen Pharmaceutical Ltd.|+86 10 5821-8307|
13067|NCT02159118|Chatchawin Assanasen, MD|The University of Texas Health Science Center|210-567-7456|assanasen@uthscsa.edu
13068|NCT02159482|Dr. Michael Morse|Duke University|919-681-3480|morse004@mc.duke.edu
13069|NCT02160977|Dr. Jia-Kuo Yu|Peking University Third Hospital|86-10-82267392|yujiakuo@126.com
13070|NCT02162680|Julia Aucoin, DNS|Duke University Medical Center|1 919 613 6406|julia.aucoin@dm.duke.edu
13071|NCT02162979|Tonya Hamilton, reszearch Compliance Auditor|Loma Linda University|909-558-4908|thamilton@llu.edu
13072|NCT02170064|Head of Clinical Research|BIAL - Portela & Cª, SA|+351-22 9866100|clinical.trials@bial.com
13073|NCT02170077|Head of Clinical Research|BIAL – Portela & Cª, SA|+351 22 9866100|clinical.trials@bial.com
13074|NCT02170519|Neil MacIntyre, MD|Duke University Medical Center|919-681-2720|neil.macintyre@dm.duke.edu
13075|NCT02170532|Neil MacIntyre, MD|Duke University Medical Center|(919) 681-2720|macin001@mc.duke.edu
13076|NCT02170662|Dr. Elise Olsen|Duke University Medical Center|919-668-5613|elise.olsen@dm.duke.edu
13077|NCT02171247|Daniel T Boll, MD|Duke University Medical Center|919-684-2711|daniel.boll@duke.edu
13078|NCT02185183|Dr. Elazar Rabbani|ENZO|2125830100|erabbani@enzo.com
13079|NCT01479764|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
13080|NCT01479777|Dr. Cristina Sadowsky|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|443-923-9210|sadowsky@kennedykrieger.org
13081|NCT01480219|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13082|NCT01480284|GSK Response Center|GlaxoSmithKline|866-435-7343|
11469|NCT01000805|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
11470|NCT01000818|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
11471|NCT01000974|GSK Response Center|GlaxoSmithKline|866-435-7343|
11472|NCT01001052|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
11473|NCT01001195|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11474|NCT01001208|Study Director|Amgen Inc.|866-572-6436|
11475|NCT01001221|Trial Transparency Team|sanofi-aventis||Contact-US@sanofi.com
11476|NCT01001234|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11477|NCT01001325|Dr. Brenda Coleman|Mount Sinai Hospital|416-586-4800 ext 4161|bcoleman@mtsinai.on.ca
11591|NCT01069939|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
11592|NCT01070043|Study Director|Novartis Pharmaceuticals|862 - 778- 8300|
11593|NCT01070173|Dr. Jordan Pinsker|Tripler Army Medical Center|808-433-6338|jordan.pinsker@us.army.mil
11594|NCT01070303|Global Medical Services|Abbott|800-633-9110|
11595|NCT01070329|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
11596|NCT01227902|GSK Response Center|GlaxoSmithKline|866-435-7343|
11597|NCT01227928|GSK Response Center|GlaxoSmithKline|866-435-7343|
11598|NCT01227993|Catherine Meyerle, MD|National Eye Institute|301-435-7821|meyerlec@nei.nih.gov
11599|NCT01228019|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11600|NCT01228071|Peter B. Langmuir, MD|Endo Pharmaceutical Clinical Development & Medical Science|+1-484-216-7514|langmuir.peter@endo.com
11601|NCT01228084|Joshi Alumkal, MD|Oregon Health & Science University, Knight Cancer Institute|503-494-1091|
12051|NCT01027819|Dr. Dongwook Kim|Seoul National University Hospital|821067395311|daljookim@gmail.com
12052|NCT01027897|Prasad Abraham|Grady Health System|404-616-3246|pabraham@gmh.edu
12053|NCT01028014|Dr. William Jerod Greer|University of Alabama at Birmingham|205-934-7874|wjgreer@uab.edu
12054|NCT01028027|Tuyen Ong, MD|Bausch & Lomb Incorporated|(973) 360-6389|tuyen.ong@bausch.com
12055|NCT01028053|Paul Sherwin M.D.|GE Healthcare|16095146820|Paul.Sherwin@ge.com
12056|NCT01028131|Steven J. Ondersma|Wayne State University|313-577-6680|s.ondersma@wayne.edu
12057|NCT01042678|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
12058|NCT01042938|Julie L Ryan, PhD, MPH (PI)|University of Rochester Medical Center|585-276-3862|julie_ryan@urmc.rochester.edu
12059|NCT01042977|Eva Johnsson|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
12060|NCT01043094|Roger Morgan, MD, FACS|Kowa Research Institute, Inc.|919-433-1600|RMorgan@KowaUS.com
12061|NCT01043133|Ronald W. Gimbel|USUHS|301-295-3077|rgimbel@usuhs.mil
12062|NCT01043146|Gary Peters, MD, Managing Director|Corimmun, GmbH|001-215 628-5257|gpeters7@its.jnj.com
12063|NCT01043185|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
12064|NCT01043393|Director, Clinical Research|Taro Pharmaceuticals U.S.A., Inc.|914-345-9001|natalie.yantovskiy@taro.com
12065|NCT01043523|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
12066|NCT01043926|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12067|NCT01043939|Cindy K. Blair, MPH|Masonic Cancer Center, University of Minnesota|612-624-9668|blair016@umn.edu
12068|NCT01044056|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12069|NCT01044264|Manager|Perrigo Company|718-960-0119|jonathan.schwartz@perrigo.com
12070|NCT01044459|Cynthia F. Caracta, MD FCCP|Forest Research Institute|201-427-8000|cynthia.caracta@frx.com
12284|NCT00926783|Ellen Harris, Sr. Clinical Research Associate, Clinical Operations|Biosense Webster EMEA|(800) 729-9010|eharris@its.jnj.com
12285|NCT00926796|Shelly Lensing|University of Arkansas for Medical Sciences|501-686-8203|sylensing@uams.edu
12286|NCT00926887|Elvira Walls, Clinical Consultant|Regulatory Insight, Inc.|615-712-9743|elvira@reginsight.com
12287|NCT00926952|Annie Levesque|Innovaderm Research Inc.|514-521-4285 ext 222|alevesque@innovaderm.ca
12288|NCT00927069|Annie Levesque|Innovaderm Research, Inc.|514 521 4285 ext 222|alevesque@innovaderm.ca
12289|NCT00927160|Dr. William Hung|Icahn School of Medicine at Mount Sinai|718-584-9000|william.hung@mssm.edu
12290|NCT00927186|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12291|NCT00927251|Model 4296 Left Ventricular (LV) Lead Study Sr. CRS|Medtronic, Bakken Research Center|+31-43-3566602|margriet.kruijshoop@medtronic.com
12475|NCT00970294|Patricia Kluding PT PhD|University of Kansas Medical Center|913-588-6918|pkluding@kumc.edu
12476|NCT00970606|Gordon R. Bernard, MD, Associate Vice Chancellor for Research|Vanderbilt University Medical Center|615-343-0077|gordon.bernard@vanderbilt.edu
12477|NCT00970632|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12478|NCT00970684|Nathan Pennell MD|Case Comprehensive Cancer Center|216-445-9285|penneln@ccf.org
12479|NCT00970814|Megan Ryan - Clinical Trials Project Manager|NIAAA|301-443-4225|mryan1@mail.nih.gov
12480|NCT00970853|Dr. Jerilynn Radcliffe|Children's Hospital of Philadelphia|215-590-7446|radcliffe@email.chop.edu
12481|NCT00970944|Joseph T Giacino, PhD|Spaulding Rehabilitation Hospital|617-573-2757|jgiacino@partners.org
12482|NCT00971048|Jaime Dickerson, PhD|Smith & Nephew Biotherapeutics|817-302-3914|jaime.dickerson@smith-nephew.com
12483|NCT00971243|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
12484|NCT00971282|Florence Paliargues|Galderma|0033 4 92 95 29 57|Florence.Paliargues@Galderma.com
12485|NCT00971425|GSK Response Center|GlaxoSmithKline|866-435-7343|
13083|NCT01481376|Docteur Dieter BIRK|Surgical Department of the Protestant Hospital|06332 422120|
13084|NCT01481558|Claudia Kimie Suemoto|University of Sao Paulo|551130618249|cksuemoto@usp.br
13085|NCT01481896|Robert H. Hopper, Jr., PhD|Anderson Orthopaedic Research Institute|(703) 619-4411|research@aori.org
13086|NCT01481935|Anthony D. Harris, MD MPH|University of Maryland School of Medicine|410-706-0064|aharris@epi.umaryland.edu
13087|NCT01482312|Director of Alcon Clinical|Alcon Research|1-800-241-7629|
13088|NCT01482429|Liliane Barbosa da Silva Passos|Federal University of Uberlândia|553432182150|lilibsp@yahoo.com.br
13203|NCT01021683|Clinical Research Associate|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|+82-2-2094-4879|
13204|NCT01021761|Frank A. Bucci, Jr., MD|Bucci Laser Vision|570-825-5949|Buccivision@aol.com
13205|NCT01021813|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13206|NCT01022112|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
13207|NCT01022190|Study director|Radboud University Nijmegen Medical Centre|+31 24 36 13918|
13208|NCT01022242|Monica Wiig|Uppsala University Hospital||monica.wiig@akademiska.se
13209|NCT01022398|Cardiology Research Manager|Creighton University|402-280-4566|tammyburns@creighton.edu
13210|NCT01022502|Yin-Ku Lin, MD. PhD.|Chang Gung Memorial Hospital|886-2-24313131 ext 2127|lin1266@adm.cgmh.org.tw
13211|NCT01022762|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
13212|NCT01023035|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13213|NCT01023217|Professor Young-Suk Lim|Asan Medical Center|+82-2-3010-5933|limys@amc.seoul.kr
13214|NCT01023256|Roman Korolkiewicz|MorphoSys|+498989927 ext 208|Roman.Korolkiewicz@morphosys.com
13215|NCT01023516|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
11602|NCT01228435|Lecia Sequist|Massachusetts General Hospital|617-726-7812|lvsequist@partners.org
11603|NCT01228591|Brian Pall, O.D., M.S., F.A.A.O. Principal Research Optometrist|Johnson & Johnson Vision Care|1 904 443-1290|bpall@its.jnj.com
11604|NCT01228968|Gary Skolnick|Washington University School of Medicine|3143625292|gskolnic@wustl.edu
11605|NCT01229176|Dr. Audino Podda|Novartis Vaccines Institute for Global Health|+39 0577 243496|audino.podda@novartis.com
11606|NCT01229228|Steven Jensen|Iroko Pharmaceuticals, LLC|267-546-3003|sjensen@iroko.com
11607|NCT01229371|Medical Affairs Director|Crucell Switzerland AG|+41(0)319806111|info@crucell.com
11608|NCT01229397|Medical Affairs Director|Crucell Switzerland AG|+41(0)319806111|info@crucell.com
11609|NCT01229410|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11610|NCT01229423|Vice President, Medical Affairs|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
11611|NCT01229436|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11612|NCT01229462|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11613|NCT01229527|Dr. Massimo Agostoni|Department of Anesthesia and Intensive Care|+39.02.2643.2656|agostoni.massimo@hsr.it
11725|NCT01309737|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11726|NCT01309828|Medical Director, Clinical Science|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
11727|NCT01310127|Melissa Toyos, MD|Discover Vision Centers|816-478-1230|mtoyos@discovervision.com
11728|NCT01310400|Medical Affairs Director|Crucell Switzerland AG|+41(0)319806111|info@crucell.com
11729|NCT01310413|GSK Response Center|GlaxoSmithKline|866-435-7343|
11730|NCT01310582|Kirtanaa Voralu, Associate Director Research Management|Clinical Research Group|215-255-7878 ext 7878|kirtanaa.voralu@drexelmed.edu
11731|NCT01328080|Ginette Okoye, MD, Director of Ethnic Skin Program|Johns Hopkins Dermatology|410-502-7546|ctrep@jhmi.edu
12071|NCT01044498|Medical Communications|Hoffmann-La Roche|800 821-8590|
12072|NCT01044706|Bang Qian Xu, Ph.D., Director of Biopharmaceutics|Kremers Urban Development Company|812-523-5453|Bang.xu@ucb.com
12073|NCT01045096|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
12074|NCT01045187|Kelly W Elliott RN, MS|Xoft, Inc.|408-419-2428|Kelliott@xoftinc.com
12075|NCT01045265|Tony Antoniou|Maple Leaf Research|4164657936|tantoniou@smh.toronto.on.ca
12076|NCT01045798|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12077|NCT01045967|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12078|NCT00866034|Ouijdane Hamdine, MD|UMC Utrecht|+31-88-7557524|O.Hamdine@umcutrecht.nl
12079|NCT00866047|Chief Medical Officer|Seattle Genetics, Inc.|855-473-2436|medinfo@seagen.com
12080|NCT00866294|GSK Response Center|GlaxoSmithKline|866-435-7343|
12081|NCT00866320|Dr. Brian Rini|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|216-444-9567|rinib2@ccf.org
12082|NCT00866359|Anne McClain|Celgene Corporation|888-260-1599|ClinicalTrialDisclosure@Celgene.com
12083|NCT00866606|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12084|NCT01635881|Andrey Nersesov, Clinical Trial Manager|Boston Scientific|1-508-683-4988|Andrey.Nersesov@bsci.com
12085|NCT01635920|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
12086|NCT01635933|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
12087|NCT01636102|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
12088|NCT01636258|Adam M. Bernstein MD|The Cleveland Clinic|216-448-8538|bernsta2@ccf.org
12089|NCT01636362|Joan Wilson|Molnlycke Health Care AB|706 504 8997|joan.wilson@molnlycke.com
12090|NCT01636713|GSK Response Center|GlaxoSmithKline|866-435-7343|
12251|NCT01076283|Lorenzo Leggio, MD|Brown University|401-863-1000|lorenzoleggio@gmail.com
12252|NCT01076348|Stefanie Lorinser, Sr. Clinical Research Specialist|Medtronic, Inc.|763-526-2742|stefanie.lorinser@medtronic.com
12253|NCT01076452|Frances M. Weaver, Ph.D|Hines Veterans Affairs Hospital Center for Management of Complex Chronic Care|708-202-8387 ext 25866|frances.weaver@va.gov
12254|NCT01076686|Executive Medical Director|Pacira Pharmaceuticals|203-837-6500|erolo@pacira.com
12255|NCT01076959|Global Medical Services|Abbott|800-633-9110|
12256|NCT01076972|Global Medical Services|Abbott|800-633-9110|
12257|NCT01076985|Global Medical Services|Abbott|800-633-9110|
12258|NCT01077024|Dr. Theresa Winhusen|University of Cincinnati Addiction Sciences Division|513-585-8227|winhust@ucmail.uc.edu
12259|NCT01077050|Director of Clinical Operations|SciBase|+46841062001|per.svedenhag@scibase.se
12260|NCT01077063|Daniel Laheru, MD|Sidney Kimmel Comprehensive Cancer Center at JHMI|410-955-8974|laherda@jhmi.edu
12261|NCT01077076|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
12262|NCT01077128|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
12263|NCT01077193|Michael L. Schwiers|Ethicon-Endo Surgery, Inc.|513-337-1172|mschwier@its.jnj.com
12264|NCT01077258|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
12265|NCT01077271|Global Medical Services|Abbott|1-800-633-9110|
12266|NCT01077284|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
12267|NCT00915655|Medical Leader|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|+1 609 730-7548|
12268|NCT00915759|Principal Investigator|Warfighter Refractive Eye Surgery Program and Research Center at FT Belvoir|571-231-1600|rose.sia@us.army.mil
12452|NCT00959049|Program Director, Clinical Research and Development|CSL||csl.clinicaltrials@csl.com.au
12453|NCT00959374|Amy Pollack M.D. Vice President Medical Affairs, STI|Covidien|203-821-4719|amy.pollack@covidien.com
13216|NCT01023581|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
13217|NCT01023659|Dr. Peter Selby|Centre for Addiction and Mental Heatlh|416-535-8501 ext 4946|peter.selby@camh.ca
13218|NCT01023672|Dr. Bradley F. Boeve|Mayo Clinic|507-266-4106|bboeve@mayo.edu
13219|NCT01023724|Frank A. Bucci, Jr., MD|Bucci Laser Visiosn|570-825-5949|Buccivision@aol.com
13220|NCT01023815|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
13221|NCT01023841|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13222|NCT01024036|DIRECTOR CLINICAL RESEARCH|Janssen R&D US||ClinicalTrialDisclosure@its.jnj.com
13223|NCT01024244|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13224|NCT01024335|Adam Bisaga|NYS Psychiatric Institute|646-774-6155|amb107@columbia.edu
13225|NCT01024608|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
12818|NCT00862277|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
12819|NCT00919191|David Lineberry, Associate Director, Clinical Operations|Valeant Pharmaceuticals International, Inc|949-973-1153|David.Lineberry@valeant.com
12820|NCT00919633|Study Trial Manager|Medtronic, Inc.|763-505-4594|sarah.mische@medtronic.com
12821|NCT00919711|Study Director|Amgen Inc.|866-572-6436|
12822|NCT00919724|Samir K. Gupta, MD, MS|Indiana University School of Medicine|317-274-7926|sgupta1@iu.edu
12823|NCT00919763|Michael Graeber, MD, Head of Global Clinical Project Management and US Development|Galderma|609-860-8201|michael.graeber@galderma.com
12824|NCT00872898|Ephraim Katz, PhD / Associate Director|Forest Research Institute|201-427-8000 ext 8169|Ephraim.Katz@frx.com
12825|NCT00873015|Dr. Edward Oldfield|University of Virginia Medical Center|(434) 982-0059|EHO4U@hscmail.mcc.virginia.edu
12826|NCT00873041|Study Director|Novartis Pharmaceuticals|862-778-8300|
12827|NCT00873327|Brian Smith, MD. MPH|Duke University Medical Center|919-668-8951|brian.smith@duke.edu
11732|NCT01328184|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11733|NCT01328379|Vice President - Clinical Development & Medical Affairs|Acorda Therapeutics|(914) 347- 4300 ext 5138|hhenney@acorda.com
11734|NCT01328405|Dr. Kristopher Schroeder|University of Wisconsin School of Medicine and Public Health|608-263-8100|kmschro1@wisc.edu
11735|NCT01328431|Steven L. Bernstein, MD|Yale University|203-737-3574|steven.bernstein@yale.edu
11736|NCT01328444|GSK Response Center|GlaxoSmithKline|866-435-7343|
11737|NCT01328717|Dr. Daniel Brown|Bayer Healthcare, Diabetes Care|574-256-7754|daniel.brown@bayer.com
11738|NCT01328782|Gaia Georgopoulos, MD|Children's Hospital Colorado|720-777-2588|Gaia.Georgopoulos@childrenscolorado.org
11739|NCT01328964|GSK Response Center|GlaxoSmithKline|866-435-7343|
11740|NCT01329185|Dr. Priya Verghese, Director of Pediatric Kidney Transplantation|University of Minnesota|6126262922 ext 0|pverghes@umn.edu
11741|NCT01329198|Assistant Director of Clinical Trials|University of Florida Center for Movement Disorders & Neurorestoration|352-294-5000|stacy.merritt@neurology.ufl.edu
11742|NCT01329419|GSK Response Center|GlaxoSmithKline|866-435-7343|
11743|NCT01329562|Dr. Roger Cady|Clinvest/A Division of Banyan Group Inc.|417-890-7888|jtarrasch@clinvest.com
11744|NCT01329978|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
11745|NCT01330017|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Company||ClinicalTrialsDisclosure@merck.com
11746|NCT01330108|Robert C Bourge|University of Alabama at Birmingham|205-934-3624|bbourge@uab.edu
11861|NCT01108341|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
11862|NCT01108523|Jaime Dickerson, PhD|Smith & Nephew Biotherapeutics|817-302-3914|jaime.dickerson@smith-nephew.com
11863|NCT01108718|Diana Vu|Beth Israel Medical Center|212-844-6747|dvu@bethisraelny.org
11864|NCT01108796|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12091|NCT01636765|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
12092|NCT01636986|Jami Kern, PhD|Alcon Research, Ltd.|1-888-452-3937|alcon.medinfo@alcon.com
12093|NCT01637246|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
12094|NCT01637935|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
12095|NCT01639222|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
12096|NCT01639729|Pamela Palmer|AcelRx|650-216-3500|ppalmer@acelrx.com
12097|NCT01639833|Michael Rohan|Covidien|781-839-1757|Michael.Rohan@Covidien.com
12098|NCT01640054|Dave Goldstraw|AstraZeneca Pharmaceuticals|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
12099|NCT01640171|Steven Cohen|Retina Vitreous Associates of Florida|7274459110|scohen@health.usf.edu
12100|NCT02028676|Professor Ann Sarah Walker|Medical Research Council|+44 20 7670 4726|rmjlasw@ucl.ac.uk
12101|NCT02028754|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
12102|NCT02029521|Clark Bishop|Intermountain Healthcare|385 224 7343|clark.bishop@imail.org
12103|NCT02029989|Dr. Mark E. Schneiderhan|UMN, College of Pharmacy|8452540458|meschnei@d.umn.edu
12104|NCT02033213|Maja Karaman Ilić, MD PhD|KBC Zagreb|00385 1 2385 122|majakilic1@gmail.com
12105|NCT02042872|William A. Bauman, M.D.|James J. Peters VA Medical Center|718-584-9000 ext 5428|william.bauman@va.gov
12106|NCT02043145|Vice President  GSE,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
12107|NCT02046772|Antonio Rodríguez Miguel|Hospital Universitario Príncipe de Asturias|+34 91 887 81 00 ext 2610|antonio.hupa@gmail.com
12108|NCT02055404|Joachim Nick, Dipl. Ing.|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
12109|NCT02055430|dr Mohammed Said ElSheemy|Cairo University|01006117755|mohammedshemy@yahoo.com
12110|NCT02056834|Clinical Research Scientist Biomaterials|Synthes GmbH|0041327204465|clinicalaffairs.emea@synthes.com
12474|NCT00970281|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12657|NCT01672996|Rubin Sheng, MD|GE Healthcare|609-514-6899|Rubin.Sheng@ge.com
12658|NCT01017731|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12659|NCT01017874|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12660|NCT01017952|GSK Response Center|GlaxoSmithKline|866-435-7343|
12661|NCT01018030|GSK Response Center|GlaxoSmithKline|866-435-7343|
12662|NCT01018056|Dr. Harvey S. Singer|Johns Hopkins University|410-955-7212|hsinger@jhmi.edu
12663|NCT01018095|Patricia Kissinger, PhD|Tulane University|5049887320|kissing@tulane.edu
12664|NCT01018134|Director, Clinical Research|Taro Pharmaceuticals U.S.A., Inc.|914-345-9001|natalie.yantovskiy@taro.com
12665|NCT01018186|GSK Response Center|GlaxoSmithKline|866-435-7343|
12666|NCT01018394|Dr. Jon Ebbert|Mayo Clinic|507-266-1944|nicotineresearch@mayo.edu
12667|NCT01018420|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
12668|NCT01018680|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12669|NCT01018732|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
12670|NCT01018810|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12671|NCT01018862|Sr.Director Medical Scientific Affairs|Meda Pharmaceuticals Inc|732 564 2200|David.ginsberg@meda.us
12672|NCT01019317|Elias Joseph Jabbour MD/Assistant Professor|University of Texas (UT) MD Anderson Cancer Center|713-792-4764|eharriso@mdanderson.org
12673|NCT01019694|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12674|NCT01019707|Edythe D London|University of California Los Angeles|310 825 0606|elondon@mednet.ucla.edu
12675|NCT01019928|Gerard Lynch|AstraZeneca|+44 1625 518062|aztrial_results_posting@astrazeneca.com
12828|NCT00873457|Daphne Friedman, MD|Duke University Medical Center|919-684-9220|daphne.friedman@dm.duke.edu
12829|NCT00873730|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
12830|NCT00873821|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12831|NCT00928746|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12832|NCT00928889|Study Director|Novartis Pharmaceuticals|862 778-8300|
12833|NCT00929071|Susan H. Weinkle, MD|Susan H. Weinkle, MD|941-794-5432|sweinkle@aol.com
12834|NCT00929110|Study Director|Novartis Pharmaceuticals|862 778-8300|
12835|NCT00929162|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
12836|NCT00929201|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
12837|NCT00929305|Elvira Walls, Clinical Consultant|Regulatory Insight, Inc.|615-712-9743|elvira@reginsight.com
12838|NCT00929331|GSK Response Center|GlaxoSmithKline|866-435-7343|
12839|NCT00929357|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12840|NCT00929383|David Hess, Manager Clinical Affairs|Stryker Neurovascular|1-510-413-2642|david.hess@stryker.com
12954|NCT00984022|David Drachman|Maricopa Integrated Health System|602-344-5161|david.drachman@mihs.org
12955|NCT00984061|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
12956|NCT00984139|GSK Response Center|GlaxoSmithKline|866-435-7343|
12957|NCT00984204|Nabil Kanaan|St. Jude Medical|949-769-5000|nkanaan@sjm.com
12958|NCT00984256|Michelle Mathers|US Army Medical Materiel Development Activity (USAMMDA)|301-619-8061|Michelle.mathers@us.army.mil
12959|NCT00984282|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
12960|NCT01673126|Aurore Thibaut and Pr Steven Laureys|Coma Science Group, University of Liège|003243662362|athibaut@ulg.ac.be
11865|NCT01108809|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11866|NCT01175824|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
11867|NCT02026206|Professor Yong-Il Shin|Pusan Natinal University Yangsan Hospital|82-55-360-2872|rmshin01@gmail.com
11868|NCT01462929|Clinical Project Leader and Trial Manager|Almirall|+34 93 291 3200|
11869|NCT01463293|Dr James Dekker|Fonterra Research Centre|+64 6 350 6323|james.dekker@fonterra.com
11870|NCT01463384|Principal Investigator|Huntington Medical Research Institutes|6263975840|mrs@hmri.org
11871|NCT01463527|Dr. Melissa Langhan|Yale University|203-737-7413|melissa.langhan@yale.edu
11872|NCT01463683|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11873|NCT01463878|Dr Paul Marik|Eastern Virginia Medical School|757-446-8910|marikpe@evms.edu
11874|NCT01464021|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
11875|NCT01464190|Medical Information|Vifor Pharma|41 58 851 8222|medinfo@viforpharma.com
11876|NCT01464255|Thao N Yeh, O.D.|Clinical Research Center, University of California, Berkeley, School of Optometry|(510) 642-9649|thaoyeh@berkeley.edu
11877|NCT01464424|Doug Hubatsch, Global Brand Leader, Medical Affairs|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
11878|NCT01464840|Amelia Sutton, M.D., Ph.D.|University of Alabama at Birmingham|205-934-5612|alsutton@uab.edu
11879|NCT01465048|Dr Susanne Sheehy|University of Oxford||susanne.sheehy@balliol.ox.ac.uk
11880|NCT01466062|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
11881|NCT01466075|Jane Wallace|Bayer Healthcare, Diabetes Care|574-257-3063|jane.wallace@bayer.com
11882|NCT01466348|GSK Response Center|GlaxoSmithKline|866-435-7343|
11883|NCT01466361|GSK Response Center|GlaxoSmithKline|866-435-7343|
11478|NCT01001377|Study Director|Amgen Inc.|866-572-6436|
12111|NCT01014351|John D. Hainsworth, M.D.|SCRI Development Innovations LLC|615-329-7274|asksarah@scresearch.net
12112|NCT01014455|David O. Warner MD|Mayo Clinic|5072846277|warner.david@mayo.edu
12113|NCT01014585|Joel Trugman, MD|Forest Research Institute, Inc., a subsidiary of Forest Laboratories, Inc.|201-427-8681|joel.trugman@frx.com
12114|NCT01014624|Brian Baker|Daiichi Sankyo, Inc.|973-944-2712|bbaker@dsi.com
12115|NCT01014689|Florence Paliargues / CPM|Galderma|+33492952957|florence.paliargues@galderma.com
12116|NCT01014728|Dr. Robert Naclerio|University of Chicago|773-702-0080|rnacleri@surgery.bsd.uchicago.edu
12117|NCT01014871|Florence Paliargues / CPM|Galderma|+33492952957|florence.paliargues@galderma.com
12118|NCT01015131|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12119|NCT01015287|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12120|NCT01015326|Hae Bae|Northwestern University|312-695-6829|j-bae@northwestern.edu
12121|NCT01015534|Carlos Gamboa Vignolle/ Radiation Oncologist|Instituto Nacional de Cancerologia de Mexico|0155556280400 ext 441|cswgamboa@yahoo.com
12122|NCT01015560|Study Statistician|SWOG Statistical Center|206-667-4623|
12123|NCT01015638|GSK Response Center|GlaxoSmithKline|88-435-7343|
12124|NCT01015703|SVP Clinical Development|BTG International Inc.|610-278-1660|angela.ogden@btgplc.com
12125|NCT01015820|Dr. Michael B. Wallace|Mayo Clinic|904-953-6970|wallace.michael@mayo.edu
12126|NCT01015976|James L. Roerig PharmD, BCPP|University of North Dakota - Neuropsychiatric Research Institute|701 365 4919|jroerig@nrifargo.com
12127|NCT01016106|Hae Bae|Northwestern University|312-695-6829|j-bae@northwestern.edu
12128|NCT01016132|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
12129|NCT01016652|Thomas R. Karkkainen OD, MS, FAAO Senior Principal Research Optometrist|Johnson & Johnson Vision Care|(904)443-3402|TKarkkai@its.jnj.com
12130|NCT01016691|Brian Schwam MD|Vistakon|1-904-443-1482|bschwam@its.jnj.com
12486|NCT00971633|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
12487|NCT00971750|Dr. Shanu Kothari|Gundersen Lutheran Health System|608-775-2331|snkothar@gundluth.org
12488|NCT00971789|Dr. Arun Rajan|National Cancer Institute, National Institutes of Health|301-594-5322|rajana@mail.nih.gov
12489|NCT00971841|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
12490|NCT00971932|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
12491|NCT00971997|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12492|NCT00972023|Elaina Gartner|Barbara Ann Karmanos Cancer Institute|800-527-6266|egartner@seagen.com
12493|NCT00972088|samuel n adler md, director of clinical trial|bikur holim hospital|972 2 6464206|nasnadler@gmail.com
12494|NCT00972153|Sean Self|Nimbic Systems|281-565-5715|self@nimbicsystems.com
12495|NCT00981825|William DeVizio - DMD|Colgate Palmolive|732-878-7901|william_devizio@colpal.com
12496|NCT00982007|Marc Tokars|Luitpold Pharmaceuticals, Inc.|610-650-4200|mtokars@lpicrd.com
12497|NCT00982137|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
12681|NCT01020786|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12682|NCT01020799|Gerard Lynch|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
12683|NCT01020877|Associate Director, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12684|NCT01021007|William DeVizio - DMD|Colgate Palmolive|732-878-7901|william_devizio@colpal.com
12685|NCT01080261|Ruth Starzyk, Ph.D.|Boston Scientific Corporation|508-683-6577|ruth.starzyk@bsci.com
12686|NCT01080300|Head of R&D|Depomed|510-744-8000|msweeney@depomed.com
12687|NCT01032382|Director, Division of Regulated Activites and Compliance|US Army Medical Materiel Development Activity (USAMMDA)|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil
12688|NCT01032694|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12961|NCT01673425|Lewis Radonovich|VA National Center for Occupational Health & Infection Control|352-376-1611 ext 4988|Lewis.radonovich@va.gov
12962|NCT01673568|Mette W. Christoffersen|Hvidovre Hospital University of Copenhagen|38625826|mette.willaume@gmail.com
12963|NCT01673802|John V. Thomas, MD; Principal Investigator|University of Alabama at Bimringham|205-996-4132|jvthomas@uabmc.edu
12964|NCT01675453|Dr. Evgeny Fominskiy|Academician EN Meshalkin State Budget Research Institute of Circulation Pathology|+79139538754|evfominskiy@gmail.com
12965|NCT01676298|Dr. Chris Harder|Spartan Bioscience Inc.|613-228-7756 ext 778|chris.harder@spartanbio.com
12966|NCT01677299|Senior Director, Development|Elcelyx Therapeutics, Inc|858-876-1814|info@elcelyx.com
12967|NCT01677936|Kathy Schmitz RN|Louisville Metabolic and Atherosclerosis Research Center|502.515.5672 ext o|kschmitz@lmarc.com
12968|NCT01678313|Dr. Hann-Chorng Kuo|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|886-3-8561825 ext 2113|hck@tzuchi.com.tw
12969|NCT01678885|Corby Martin, Ph.D.|Pennington Biomedical Research Center|225-763-2585|corby.martin@pbrc.edu
12970|NCT01679236|James M. Davis MD, Assistant Professor, Duke University|University of Wisconsin|608-217-9405|jjamesdavis@hotmail.com
12971|NCT01680016|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
12972|NCT01680328|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
12973|NCT01681121|Yuan Lu, MS|Jazz Pharmaceuticals|650 496 2855|yuan.lu@jazzpharma.com
12974|NCT01681511|Dr. Shantha Sarangapani|ICET, Inc.|781-769-6064|Shantha@icetinc.com
12975|NCT01499862|Dr. Nancy N. Byl|Department of Physical Therapy and Rehabilitation, University of California San Francisco|415-514-4816|byln@ptrehab.ucsf.edu
13089|NCT01483378|Dr. Elisabeth J. Cohen|NYU Langone Medical Center|212-263-3262|elisabeth.cohen@nyumc.org
13090|NCT01483625|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13091|NCT01483651|Kenneth Ward|Legacy Health System|971-570-2632|kenward503@msn.com
13092|NCT01483937|Karen L. Atkins PhD PT|BalanceSense LLC|407 625 9680|atkins.balancesense@gmail.com
11479|NCT01001390|Kirsten K. Ness, PT, PhD|St. Jude Children's Research Hospital|866-966-5934|info@stjude.org
11480|NCT01001403|CW Jung|Seoul National University Hospital|82-2-2072-2467 ext 9|spss@snuh.org
11481|NCT01001494|Clinical Project Leader and Trial Manager|Almirall SA|+34 93 291 3200|
11482|NCT01001520|Caryn Lerman, PhD|University of Pennsylvania|215-746-7141|clerman@mail.med.upenn.edu
11483|NCT01001559|Dr. Lawrence Ginsberg|Red Oak Psychiatry Associates|281-893-4111 ext 151|larrydg@earthlink.net
11484|NCT01001572|Study Director|Novartis Pharmaceuticals|862 778-8300|
11485|NCT01001702|Global Medical Affair|Otsuka Pharmaceutical Development and Commercialization|800 562-3974|
11486|NCT01001767|Grace McComsey, MC|University Hospitals Case Medical Center|216-844-3607|mccomsey.grace@clevelandactu.org
11487|NCT01011387|Jenny Thorell|Mölnlycke Health Care AB|0046 31 7223000|jenny.thorell@molnlycke.com
11488|NCT01011465|Dr. Laura Kubzansky|Harvard School of Public Health|617-432-3589|lkubzans@hsph.harvard.edu
11489|NCT01011556|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
11490|NCT01011634|Karen Meckstroth, MD|UCSF|415 206-8713|meckstrothk@obgyn.ucsf.edu
11491|NCT01011673|Benjamin Friedman, MD|Montefiore Medical Center, Albert Einstein College of Medicine|718-920-6626|BEFRIEDM@montefiore.org
11492|NCT01011816|Jeff Doerzbacher|formerly Spinal Restoration, Inc||jdoerzbacher@renascentmed.com
11493|NCT01011829|Steve Shoptaw PhD|University of California, Los Angeles|310 794 0619 ext 225|sshoptaw@mednet.ucla.edu
11494|NCT01011907|Jennifer Mitchell, Clinical Project Director|UCSF: EGCRC|510-985-3100|jmitchell@gallo.ucsf.edu
11495|NCT01011933|Melissa Leventhal|Gynecologic Oncology Group Statistical and Data Center|716-845-4030|mleventhal@gogstats.org
11496|NCT01012037|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11497|NCT01012219|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12131|NCT01016834|Judith Myers, Senior Director Clinical Operations|Zogenix|510-550-8300|jmyers@zogenix.com
12132|NCT01016964|David Michaels|Lexington International, LLC|5614170200|las@hairmax.com
12133|NCT01071915|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
12134|NCT01072136|Shelly Lensing|University of Arkansas for Medical Sciences|501-686-8203|sylensing@uams.edu
12135|NCT01072149|GSK Response Center|GlaxoSmithKline|866-435-7343|
12136|NCT01072175|GSK Response Center|GlaxoSmithKline|866-435-7343|
12137|NCT01072188|William DeVizio - DMD|Colgate Palmolive|732-878-7901|william_devizio@colpal.com
12138|NCT01072201|William De Vizio, DMD|Colgate Palmolive Co|732-878-7901|William_Devizio@colpal.com
12139|NCT01028352|Dr. Norah L. Henry|University of Michigan Comprehensive Cancer Center|734-936-4991|norahh@umich.edu
12140|NCT01028391|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
12141|NCT01028820|Linmarie Sikich, M.D.|The University of North Carolina at Chapel Hill|(919) 972-7499|lsikich@med.unc.edu
12142|NCT01028911|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12143|NCT01029340|Therapeutic Area Head|BAYER||clinical-trial-contact@bayerhealthcare.com
12144|NCT01029535|Medical Monitor|Allergan Medical|(805) 961-5000|devicetrials@allergan.com
12145|NCT01029652|Study Director|Novartis Pharmaceuticals|862 778-8300|
12146|NCT01029704|Yuan-Di C. Halvorsen, PhD|Theracos, Inc.|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu
12147|NCT01029795|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12148|NCT01029886|Chief Medical Officer|Eli Lilly and Company|1-877-285-4559|clinicaltrials@amylin.com
12149|NCT01075087|Gildasio De Oliveira MD,MS|Northwestern University|312-472-3573|g-jr@northwestern.edu
12150|NCT01075152|Dr. David R Boulware|University of Minnesota|6126249996|boulw001@umn.edu
12454|NCT00959699|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
12455|NCT00959751|Thomas Lategan, PhD|NeurAxon, Inc.|417-673-6697|tlategan@neuraxon.com
12456|NCT00959764|Dr. David Krause, Chief Medical Officer|Tarsa Theapeutics, Inc.|1-267-273-7940|dkrause@tarsatherapeutics.com
12457|NCT00959907|Débora Zechmeister do Prado|CBED|55 51 30262633|cbed@cbed.org.br
12458|NCT00959920|Dr Linda Brubaker|Loyola University Medical Center|708-216-3960|lbrubaker@lumc.edu
12459|NCT00959946|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12460|NCT00960076|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
12461|NCT00960141|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
12462|NCT00960154|Robert Swain, PhD|Medtronic Surgical Technologies|(+1-603) 294-5428|robert.e.swain@medtronic.com
12463|NCT00960193|Medical Drector|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
12464|NCT00960206|Director of Clinical Research|Stryker Orthopaedics|201-831-5401|Ellen.Axelson@stryker.com
12465|NCT00960297|David R. Spigel, M.D.|Study Chair|1-877-MY-1-SCRI|David.Spigel@scresearch.net
12466|NCT00960323|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
12467|NCT00960440|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12468|NCT00969228|GSK Response Center|GlaxoSmithKline|866-435-7343|
12469|NCT00969280|Tae-Hun Kim, Researcher|Korea Institute of Oriental Medicine|82-10-6532-5524|rockandmineral@gmail.com
12470|NCT00969501|Arnold Weil, MD|Georgia Institute for Clinical Research, LLC|770-421-2030|research@lowbackpain.com
12471|NCT00969618|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12472|NCT00969709|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|Forest Research Institute|201-427-8000 ext 8124|carl.gommoll@frx.com
12473|NCT00970268|Cynthia F. Caracta, MD FCCP|Forest Research Institute|201-427-8000|cynthia.caracta@frx.com
13093|NCT01484028|Dr. Michael Mayers, O.D., FAAO, Senior Research Optometrist|Vistakon, Johnson and Johnson Vision Care|1 904 443 3252|mmayers@its.jnj.com
13094|NCT00962754|Dr. J. Bekhof|Princess Amalia Children's Clinic, Isala Klinieken|0031-38-4245050|j.bekhof@isala.nl
13095|NCT00963157|Lisa Jackson, MD, MPH|Group Health Research Institute|206-442-5216|
13096|NCT00963235|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
13097|NCT00963430|Lisa Jackson, MD, MPH|Group Health Research Institute|206-442-5216|
13098|NCT00963469|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
13099|NCT00963482|M. Sc. S. Müller (Site-investigator) Prof. G. A. Wiesbeck (PI)|Divsion Substance Use Disorder, Psychiatric Hospital of the Univeristy of Basel|+41 61 325 53 33|sandra.mueller@upkbs.ch
13100|NCT00963508|Director, Clinical Research|Taro Pharmaceuticals U.S.A., Inc.|914 -345-9001|natalie.yantovskiy@taro.com
13101|NCT00963560|Director of Alcon Clinical|Alcon Research, Ltd.|888-451-3937; 817-568-6725|medinfo@alconlabs.com
13102|NCT00963599|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
13103|NCT00963638|Catherine Coleman, RN, BSN|William Beaumont Hospitals|248-655-5865|cjcoleman@beaumont.edu
13104|NCT00963677|Ru-Ping Dai, B.Sc(Med), PhD, Associate Professor|The Second Xiangya Hospital of Central South University|86-731-85295970|Ruping_dai@yahoo.com.cn
13105|NCT00963859|John W. Davis, MD / Assistant Professor|The University of Texas (UT) MD Anderson Cancer Center||CR_Study_Registration@mdanderson.org
13106|NCT00963924|Dr. Donald C Goff|Nathan Klein Institute for Psychiatric Research|646-754-4843|donald.goff@nyumc.org
13107|NCT00963937|GSK Response Center|GlaxoSmithKline|866-435-7343|
13108|NCT00964223|Lou Barbato, MD|Stiefel, a GSK company|678-731-5592|lou.barbato@stiefel.com
13109|NCT00964366|GSK Response Center|GlaxoSmithKline|888-435-7343|
13110|NCT00964431|Steven Jensen|Iroko Pharmaceuticals, LLC|267-546-3003|sjensen@iroko.com
13226|NCT01024738|William DeVizio - DMD|Colgate Palmolive|732-878-7901|william_devizio@colpal.com
11498|NCT01012245|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
11499|NCT01012258|Junliang Cai, Medical Responsible|Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd.|+86 2161131298 ext 173|Junliang.Cai@merckgroup.com
11500|NCT01012336|Pf Duk-Soo Bae|Samsung Medical Center|82-2-3410-3519|huna0@naver.com
11614|NCT01229722|Dr. Vikram Kumar|Dimagi Inc.|6176492214|information@dimagi.com
11615|NCT01229891|T Neyestani|National nutrition and food technology institute|0982122376471|neytr@yahoo.com
11616|NCT01230021|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
11617|NCT01230060|Jon Hayashida|Bausch & Lomb Incorporated|(949) 521-7876|jon.hayashida@bausch.com
11618|NCT01230502|Professor William Burlingham, PhD|University of Wisconsin|(608) 263-0119|BURLINGHAM@SURGERY.WISC.EDU
11619|NCT01230749|Director, Translational Medicine|Janssen R&D US|1 908 927-7881|
11620|NCT01230788|Dr. Todd Cooper|Emory University|404-785-3000|tmcoope@emory.edu
11621|NCT01306305|Medical Affairs Director|Crucell Switzerland AG|+41(0)319806111|info@crucell.com
11622|NCT01306968|Dr. R. Scott Miller, M.D.|Uniformed Services University of Health Sciences|301-816-8424|robert.s.miller@us.army.mil
11623|NCT01245387|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11624|NCT01245413|Dr. Claus Hyldahl|Lægehuset, Skodsborg Strandvej 125A, 2942 Skodsborg, Denmark|4545801331|hyldahl@info.dk
11625|NCT01245647|Dr. Bob Cook|University of Florida|352-273-5869|cookrl@ufl.edu
11626|NCT01245738|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11627|NCT01245751|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11628|NCT01245764|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11629|NCT01246011|Research Manager|Massachusetts General Hospital|617 726 2612|imcnulty@partners.org
12151|NCT01075178|Global Medical Services|Abbott|800-633-9110|
12152|NCT01075191|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
12153|NCT01075204|Esther Oppermann, Clinical Trial Manager|Abbott|49 511 6750 3954|esther.oppermann@abbott.com
12154|NCT01075217|Usha Halemane|Bracco Diagnostics Inc|609.514.2578|Usha.Halemane@diag.bracco.com
12155|NCT01075256|GSK Response Center|GlaxoSmithKline|866-435-7343|
12156|NCT01075347|We-Li Chen , MD|Natinal Taiwan University Hospital|886-2-2356 ext 5206|chenweili@ntu.edu.tw
12157|NCT01075399|Edward M. Aten, MD, President|Certus International, Inc.|603.627.1212|eaten@certusintl.com
12158|NCT01075685|Juliette Guillemont|Inpes|+331 49 33 22 55|juliette.guillemont@inpes.sante.fr
12159|NCT01075763|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
12160|NCT01075815|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
12161|NCT01075958|Dr Philippa Jackson|Northumbria University|+44 191 204 8818|philippa.jackson@northumbria.ac.uk
12162|NCT01075971|Head, Clinical Trials Registry & Results Disclosure Group|Schering-Plough||ClinicalTrialsDisclosure@spcorp.com
12163|NCT01075984|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12164|NCT01076075|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12165|NCT01076088|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12166|NCT00866697|GSK Response Center|GlaxoSmithKline|866-435-7343|
12167|NCT00866788|Medical Communications|Hoffmann-LaRoche|800-821-8590|
12168|NCT00866814|Dawn Heimer/Director, Clinical Affairs|C.R. Bard: Davol, Inc.|401-825-8681|dawn.heimer@crbard.com
12169|NCT00867009|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12676|NCT01019980|Study Director|Novartis Pharmaceuticals|862-778-8300|
12677|NCT01020006|Dr. Laurence Elias|Pharmacyclics|855-427-8846|pharmacyclics@medcomsol.com
12678|NCT01020123|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
12679|NCT01020747|Monica Tettamanti|Massachusetts General Hospital|617-643-5696|mtettamanti@ccib.mgh.harvard.edu
12680|NCT01020773|Department of Respiratory Medicine|Beijing Shijitan Hospital|86-010-63926385|mayingmin@hotmail.com
12269|NCT00915772|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12270|NCT00915902|Dr. Samuel Gidding|Nemours Alfred I. duPont Hospital for Children|302-651-6607|sgidding@nemours.org
12271|NCT00916006|Dr. Torsten Skov|LEO Pharma|+4520736294|tosdk@leo-pharma.com
12272|NCT00916032|Brigitt Abbuehl, MD, Medical Director, Hematology/Hemophilia|Baxter||brigitt_abbuehl@baxter.com
12273|NCT00916136|William Obremskey MD MPH|Vanderbilt|615-936-0112|william.obremskey@vanderbilt.edu
12274|NCT00916344|Dr. Evelyn Diessel|BIOTRONIK SE & Co.KG|+49 (0) 30 68905 ext 1231|evelyn.diessel@biotronik.com
12275|NCT00916357|Vice President, Endocrinology Clinical Development|Halozyme|858-794-8889|
12276|NCT00869557|Clinical Trial Disclosures|Gilead Sciences, Inc||ClinicalTrialDisclosures@gilead.com
12277|NCT00869947|Dr. Alena Grabowski|Eastern Colorado Healthcare System|303-492-5208|alena.grabowski@va.gov
12278|NCT00926289|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12279|NCT00926328|William De Vizio, DMD|Colgate Palmolive|732-878-7901|William_Devizio@colpal.com
12280|NCT00926367|GSK  Response Center|GlaxoSmithKline|866-435-7343|
12281|NCT00926393|Gerard Lynch|AstraZeneca||AZTrial_Results_Posting@astrazeneca.com
12282|NCT00926497|Martin Stocker, MD|Children's Hospital of Lucerne|0041412051288|martin.stocker@ksl.ch
12283|NCT00926575|Dhara Patel, Clinical Coordinator|Soligenix, Inc.|609-538-8200|dpatel@soligenix.com
13227|NCT01024751|William Reindel, OD, MS|Bausch & Lomb Incorporated|(585) 338-8129|william.reindel@bausch.com
13228|NCT01024855|Nick Tarantino, Head, Clinical Research and Development|Abbott Medical Optics, Inc.|714-247-8613|nicholas.tarantino@amo.abbott.com
13229|NCT01024959|Jennifer Reid, Director of Clinical Affairs|Gen-Probe, Incorporated|858-731-5985|jennifer.reid@hologic.com
13230|NCT01037192|Anna Yuen, BSc. Pharm|Fraser Health Authority|604-520-4005|anna.yuen@fraserhealth.ca
13231|NCT01037218|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
13232|NCT01037244|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
13233|NCT01037452|Head New Therapeutic Opportunities|Novartis|973-503-8000|
13234|NCT01038128|Study Coordinator|McLean Hospital|617-855-2984|eryan@mclean.harvard.edu
13235|NCT01038609|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
13236|NCT01038869|Leon Kircik, M.D.|DermResearch, PLLC|502-451-9000|wedoderm@yahoo.com
13237|NCT01038921|Dr. Abinav Goyal|Emory University|404-727-8758|agoyal4@emory.edu
13238|NCT01039428|Study Director|KDL|818058844243|toiawase@advance-cro.co.jp
13239|NCT01039584|Jonathan Schwartz|Perrigo|718-960-9900|jonathan.schwartz@perrigo.com
13240|NCT01039675|GSK Response Center|GlaxoSmithKline|866-435-7343|
13241|NCT01040052|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
13242|NCT01040130|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13243|NCT01040169|William DeVizio - DMD|Colgate Palmolive|732-878-7901|william_devizio@colpal.com
13244|NCT01040260|Dr. Timothy Carmody|University of California, San Francisco|(415) 221-4810 ext 6344|Timothy.Carmody@ucsf.edu
13245|NCT01040351|Usama M.Fouda, M.D, PhD|Cairo university|+20123595106|umfrfouda@yahoo.com
13246|NCT01040689|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11630|NCT01246349|Beverly Walpole|The Hospital for Sick Children|416. 813 7654 ext 328363|bwalpole@uoguelph.ca
11631|NCT01246713|Michael Ganetsky, MD|BIDMC|6177542323|mganetsk@bidmc.harvard.edu
11632|NCT01246791|Department director of clinical development department 1|Nobelpharma|+81-3-5651-1177|murakami@nobelpharma.co.jp
11633|NCT01247064|Todd Florin|Cincinnati Children's Hospital Medical Center|513-636-7966|todd.florin@cchmc.org
11634|NCT01324310|Senior Manager|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
11635|NCT01324323|Senior Manager, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
11747|NCT01330290|UCB Clinical Trials Call Center|UCB|+1 877 822 9493|
11748|NCT01330303|GSK Response Center|GlaxoSmithKline|866-435-7343|
11749|NCT01330355|Johnson Varughese|Valeant Pharmaceuticals|908-541-2179|Johnson.Varughese@valeant.com
11750|NCT01105533|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11751|NCT01106040|Dr. Frederick Cope|Navidea Biopharmaceuticals|614-793-7500 ext 140|fcope@navidea.com
11752|NCT01106248|Dr. Peter Tarassoff|Eisai|888-422-4743|
11753|NCT01106287|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11754|NCT01106326|Maria Fagnano|University of Rochester|5852758220|maria_fagnano@urmc.rochester.edu
11755|NCT01106391|Amy Berman, Associate Director Clinical Research|Cordis Corp.|908-541-4347|AOrlick@its.jnj.com
11756|NCT01106404|Mark Sun, Senior Clinical Research Manager|Neuromodulation Emerging Therapy Clinical Research, Medtronic, Inc|763-526-8098|mark.sun@medtronic.com
11757|NCT01106430|Study Physician|Shire Development LLC|+1 866 842 5335|
11758|NCT00882102|Gautam Borthakur, MD/Associate Professor|The University of Texas MD Anderson Cancer Center|713-563-1586|eharriso@mdanderson.org
11759|NCT00882362|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
11760|NCT00882440|Executive Vice President, Clinical and Quantitative Sciences|Merck & Co., Inc.|1-800-672-6372|
12170|NCT00867035|Milton Robert Wirthlin, DDS, MS|Department of Orofacial Sciences, University of California, San Francisco|415-476-1731|m.robert.wirthlin@ucsf.edu;  ddsmmr@att.net
12171|NCT00867139|Michael Boeckh MD|FHCRC|206 667 6706|mboeckh@fhcrc.org
12172|NCT00867165|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12173|NCT00867451|Richard Gilman, Ph.D.|Cincinnati Children's Hospital Medical Center|513-636-8172|richard.gilman@cchmc.org
12174|NCT00867490|Study Director|Novartis Pharmaceuticals|862 778-8300|
12175|NCT00867503|Dr. Setsuko K Chambers|University Of Arizona|520/626-0950|schambers@azcc.arizona.edu
12176|NCT00867659|Dr Fady Sharara|Virginia Center for Reproductive Medicine|7034377722|fsharara@vcrmed.com
12177|NCT00868101|Marcos Alves Pavione|Universidade de Sao Paulo|55 79 9199 9576|mapavione@hotmail.com
12178|NCT00868231|Clinical Project Leader and Trial Manager|Almirall S.A.|+34 93 291 3200|
12202|NCT02081183|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
12203|NCT02083107|Dr. Mohamed S. Sweed, Dr.Mourad M.El-Said, Dr.Amgad E. Abou-Gamrah, Dr.Mohamed M. Abd-El-Hamid|AinShams University|01001222047 ext +2|drmsweed@gmail.com
12204|NCT02083263|Maria Cecilia Rodriguez Hortal|Karolinska University Hospital|0046709558699|cecilia.rodriguez-hortal@karolinska.se
12205|NCT02085720|Dr Susanna Ng SS|Chinese University of Hong Kong|85226322211|drsssng123@yahoo.com.hk
12206|NCT02087670|Jesus Alberto Plata Contreras|Universidad de Antioquia|5742196478|rehabilitacionsalud@siu.udea.edu.co
12207|NCT02087774|Rebecca Hayes, M.D.|Marshall University|3046173570|hayes79@live.marshall.edu
12208|NCT02090855|Paul Sherwin, M.D.|GE Healthcare|1-609-514-6489|Paul.Sherwin@ge.com
12209|NCT02092311|Dr.Navid Pooyan|OMID FERTILITY CENTER|00989124474032|navidpooyan@yahoo.com
12210|NCT02092857|Dr. Tom Clandinin|University of Alberta|7804925188|tclandin@ualberta.ca
12211|NCT02092961|Dave Goldstraw|AstraZeneca Pharmaceuticals|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
12689|NCT01032733|Stephen Anton|University of Florida|352-273-7514|santon@ufl.edu
12690|NCT01032837|Medical Communications|Hoffman-LaRoche|800-821-8590|
12691|NCT01033071|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
12692|NCT01033383|Dr. Manisha Juthani-Mehta|Yale University|(203)785-7571|manisha.juthani@yale.edu
12693|NCT01033565|Howard Needelman MD|University of Nebraska|4025594097|hneedelm@unmc.edu
12694|NCT01033747|Study Director|Novartis Pharmaceuticals|862 778-8300|
12695|NCT01033825|Respiratory Medical Director|Sunovion|1-866-503-6351|
12696|NCT01033851|Dr. Elizabeth Hoge|Massachusetts General Hospital|6177240859|ehoge@partners.org
12697|NCT01034111|Vice President, Late Stage Development Group Leader|Merck, Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12698|NCT01034358|Jeanne Tung, MD|Mayo Clinic|507-266-0114|tung.jeanne@mayo.edu
12699|NCT01034462|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|Forest Research Institute|201-427-8000 ext 8124|carl.gommoll@frx.com
12700|NCT01034540|Dr. Kevin Maki, Chief Science Officer|Biofortis Clinical Research (formerly Provident)|630-516-3800|kevin.maki@mxns.com
12701|NCT00859027|Pamela Taxel MD|University of Connecticut Health Center|860-679-4743|taxel@nso.uchc.edu
12702|NCT00859040|Patrick Y. Wen, MD|Dana-Farber Cancer Institute / Brigham & Women's Hospital|617-632-2166|pwen@partners.org
12703|NCT00859313|Dr. Pamela Palmer|AcelRx Pharmaceuticals, Inc.|650-216-3504|ppalmer@acelrx.com
12292|NCT00927355|Dr. George Beck|Emory|404-686-1000|gbeck@emory.edu
12293|NCT00927394|Study Directors|Novartis Pharmaceuticals|862-778-8300|
12294|NCT00927472|Director, Clinical Research|Taro Pharmaceuticals U.S.A.,|914-345-9001|Natalie.Yantovskiy@Taro.com
12295|NCT00927563|Dr. Jon Grant|University of Chicago|773-834-1325|jongrant@uchicago.edu
12296|NCT00927758|Study Director|Sandoz|609-627-8889|yaping.zhu@sandoz.com
13247|NCT01040728|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13248|NCT00862459|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
12841|NCT00929474|Manager of Clinical Studies|St. Jude Medical|818-493-2522|klee3@sjm.com
12842|NCT00929526|GSK Response Center|GlaxoSmithKline|866-435-7343|
12843|NCT00929643|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12844|NCT00929708|Carin Jorup, MSD|AstraZeneca||clinicaltrialtransparency@astrazeneca.com
12845|NCT00929773|Elvira Walls, Clinical Consultant|Regulatory Insight, Inc.|615-712-9743|elvira@reginsight.com
12846|NCT00929864|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
12847|NCT00929981|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12848|NCT00930722|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12849|NCT00930761|Dr. Arnaldo Prata Barbosa|Instituto de Puericultura e Pediatria Martagão Gesteira - UFRJ|+55 21 25904891|arnaldoprata@globo.com
12850|NCT00930774|Dr. Gabrielle H Saunders|National Center for Rehabilitative Auditory Research, Portland VA Medical Center|503-220-8262 ext 56210|gabrielle.saunders@va.gov
12851|NCT01651351|Leman Yel, MD, Medical Director, Biotherapeutics|Baxter Healthcare Corporation||leman_yel@baxter.com
12852|NCT01652495|Milva Battaglia, Director of Clinical Trials|Istituto Ortopedico Rizzoli|0516366026 ext 0039|milva.battaglia@ior.it
12853|NCT01653158|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12854|NCT01653509|GSK Response Center|GlaxoSmithKline|866-435-7343|
12855|NCT01654536|Respiratory Medical Director|Sunovion|1-866-503-6351|
12856|NCT01654549|Dr Raika Jamali|Tehran University of Medical Sciences|982163120000 ext 411|jamalira@tums.ac.ir
12857|NCT01654601|Won-myung Bahk. M.D. PhD.|The Catholic university of Korea|82-2-3779-1051|wmbahk@catholic.ac.kr
11761|NCT00882518|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
11762|NCT00935532|Chief Medical Officer|Eli Lilly and Company|1-877-285-4559|clinicaltrials@amylin.com
11763|NCT00935649|David M Harris, PhD, Research Director|PathoLase|510-502-3345|bmcinc@comcast.net
11764|NCT00935701|Lana Warren|Kennedy Krieger Institute|4439239312|WarrenL@kennedykrieger.org
11765|NCT00935818|Dr. Jon Ebbert|Mayo Clinic|507-284-4736|ebbert.jon@mayo.edu
11766|NCT00935857|Rajesh N. Keswani|Northwestern University|312-695-5620|raj-keswani@northwestern.edu
11767|NCT00936065|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11768|NCT00936208|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11769|NCT00936455|Dr Brett Meyer|University of California San Diego|619-543-7760|bcmeyer@ucsd.edu
11884|NCT01466387|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
11885|NCT01466595|Clinicaltrials.gov Coordinator|Center for Biostatisticis in AIDS Research, Harvard School of Public Health|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
11886|NCT01466673|Medical Affairs Director|Medical Affairs, Janssen-Cilag (Thailand)|662-739-7200 ext 5888|
11887|NCT01467570|Hanna Szajewska, Malgorzata Piescik-Lech|The Medical University of Warsaw|+48-22-45-23-309|hania@ipgate.pl
11888|NCT01467934|Melissa Stockwell|Columbia University|212-342-5732|mss2112@columbia.edu
11889|NCT01467960|Sarah Dassati|Villa Melitta|+39 0471 471 ext 471|sarahdassati@yahoo.it
11890|NCT01468350|Vice President - Clinical Development & Medical Affairs|Acorda Therapeutics, Inc.|914-347-4300|hhenney@acorda.com
11891|NCT01468558|VP, Scientific Affairs|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|650-386-3100|dkellerman@mappharma.com
11892|NCT01469052|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11893|NCT01469065|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12212|NCT02095561|Silvina Arrossi, Phd|INSTITUTO NACIONAL DEL CÁNCER, ARGENTINA|541152390562|silviarrossi2020@gmail.com
12213|NCT02099838|Dr. Yu|Huazhong University of Science and Technology|027-83662883|xfyu188@163.com
12214|NCT02100410|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
12215|NCT02101359|Medical director|Laboratoires Thea|33-4-73-98-14-36|p.pouliquen@laboratoires-thea.fr
12216|NCT02107274|Dr. Albert Iruthiaraj L. Anthony|Ministry of Health of Malaysia|+60174633410|albert5409@yahoo.com
12217|NCT02108223|Fatma yazıcı yılmaz|Sisli etfal training anf research hospital|+905079234033|fatmayazc@gmail.com
12218|NCT02115581|Giv Heidari-Bateni MD/MPH|Children's Medical Center|3142991984|givhb@yahoo.com
12219|NCT01472380|VP, Clinical Development and Medical Affairs|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
12220|NCT01472822|Dr. Jeong-Hwan Seo, MD|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|82-63-276-8284|vivaseo@jbnu.ac.kr
12221|NCT01072331|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
12222|NCT01072396|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12223|NCT01072409|Teresa Zwolan, Ph.D.|University of Michigan|(313) 618-9669|zwolan@umich.edu
12588|NCT01031095|Dr.Hasan ARI|Bursa Postgraduate Hospital|00902243605050 ext 1739|hasanari03@yahoo.com
12589|NCT01031446|Ingrid A. Mayer, MD|Vanderbilt-Ingram Cancer Center|615-936-2033|ingrid.mayer@vanderbilt.edu
12590|NCT01031498|Jorge Cortes, MD / Professor|UT MD Anderson Cancer Center|713-745-5783|eharrison@mdanderson.org
12591|NCT01031550|Yuriy Gubenko, MD|UMDNJ|973 972-5007|yuriygubenko@yahoo.com
12592|NCT01031628|Research Project Manager|SARC|(734) 930-7600|sarc@sarctrials.org
12593|NCT01031680|Eva Johnsson|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
12594|NCT01031706|Dr. Scott H. Donaldson|University of North Carolina at Chapel Hill|919-966-9198|scott_donaldson@med.unc.edu
13949|NCT01542255|Marc Ernstoff|Dartmouth-Hitchcock|603-650-5534|marc.s.ernstoff@hitchcock.org
13950|NCT01542645|Glenn Murphy, MD|NorthShore University HealthSystem|847-570-2760|dgmurphy2@yahoo.com
13951|NCT01542684|Zeev Estrov, MD/Professor|The University of Texas MD Anderson Cancer Center|713-794-1675|eharriso@mdanderson.org
13952|NCT01542788|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
13953|NCT01543581|Dr. Abel Torres, PI|Loma Linda University Health, Department of Dermatology|(909) 558-2055|atorres@llu.edu
14181|NCT01778985|David D. Rahn, M.D.|University of Texas Southwestern Medical Center|214-648-6430|david.rahn@utsouthwestern.edu
14182|NCT01779648|Principal Investigator|SMG-SNU Boramae Medical Center|+82-10-9988-2691|turejsreal@hanmail.net
14183|NCT01780389|David Marks, MD|Duke University Medical Center|619 668-2859|d.marks@duke.edu
14184|NCT01780584|Dr Eva M Marwali, Principal Investigator|Pediatric Cardiac ICU National Cardiovascular Center Harapan Kita|+62215684085 ext 2807|evamarwali@yahoo.com
14185|NCT01450787|Kenneth A Beckman, MD|Coa Research Foundation|614-506-4720|kenbeckman22@aol.com
14186|NCT01450800|Dr. Alexis Dieter|Duke University Medical Center|919-401-1006|alexis.dieter@duke.edu
14187|NCT01451424|Jennifer Wike|Repros Therapeutics Inc.|2817193402|jwike@reprosrx.com
14188|NCT01451541|Respiratory Medical Director|Sunovion|1-866-503-6351|
14189|NCT01451554|Jon O. Ebbert, MD|Mayo Clinic|507-255-3965|ebbert.jon@mayo.edu
14190|NCT01451645|Clinical Trials Administrator|Regeneron|914 847 5385|clinicaltrials@regeneron.com
14191|NCT01451723|Jesus Lovera MD|Louisiana Health Sciences Center-New Orleans|50-903 9302|jlover@lsuhsc.edu
14192|NCT01451762|Gildasio De Oliveira MD|Northwestern University|312-472-3573|g-jr@northwestern.edu
14193|NCT01451775|Boehringer Ingelheim Call Center|boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
14194|NCT01452347|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
14195|NCT01452854|Dr. Mitchell Rosen|UCSF|415-353-7394|thomas.remble@ucsfmedctr.org
12858|NCT01655329|Matthew T. Freedman|Georgetown University Medical Center|4105429680|MTFreedman@verizon.net
12859|NCT01656031|Dr. Bayard Powell|Comprehensive Cancer Center of Wake Forest University|336-716-7970|bpowell@wakehealth.edu
12860|NCT01656304|Ulka Vaishampayan, M.D.|Barbara Ann Karmanos Cancer Institute|(313) 576-8718|vaishamu@karmanos.org
12861|NCT01656486|David Iannitti, MD|Carolinas Medical Center|704-446-2772|david.iannitti@carolinashealthcare.org
12862|NCT01657032|Hanna Szajewska, Malgorzata Pieścik-Lech|The Medical University of Warsaw|+48-22-45-23-309|hania@ipgate.pl
12976|NCT01500031|Director Clinical Trials|Boston Scientific|708-771-4737|Pamela.Grady@bsci.com
12977|NCT01500252|Dr. Lauren Beaupre|UAlberta|780-407-3945|lauren.beaupre@albertahealthservices.ca
12978|NCT01500317|Dr. Michael Camilleri|Mayo Clinic|507-284-6218|camilleri.michael@mayo.edu
12979|NCT01500434|Ruth Starzyk, PhD|Boston Scientific|508-683-6577|ruth.starzyk@bsci.com
12980|NCT01500629|Daniel Qi, MD, PhD, Director, Clinical Research|Johnson & Johnson Consumer and Personal Products Worldwide|973 385-2260|dqi6@its.jnj.com
12981|NCT01500746|Dr. Elliot Hirsch|Northwestern University|312-695-6022|elliot-hirsch@md.northwestern.edu
12982|NCT01502423|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
12983|NCT01505647|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12984|NCT01505881|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12985|NCT01506362|Dr. Arnon Aharon|BioLineRx LTD|972-2-548-9100 ext 135|arnona@biolinerx.com
12986|NCT00910663|Associate DIrector, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12987|NCT00910689|Kenneth Holroyd|Ohio University|(740) 593-1085|holroyd@ohio.edu
12988|NCT00910715|Dr.Dasa Stupica|UMC Ljubljana, Department of Infectious Diseases|+386 1 522 2110|cerar.dasa@gmail.com
12989|NCT00910845|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11894|NCT00905424|Timothy Whittaker, M.D.|Shire Pharmaceuticals, Ltd.||twhitaker@shire.com
11895|NCT00905437|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11896|NCT00905489|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11897|NCT00905515|Director of Clinical Trials|East Carolina University|252-744-3773|parkerk@ecu.edu
11898|NCT00905554|Vittorio Terruzzi, MD|Valduce Hospital - Como - Italy|+39031324009|vterruzzi@valduce.it
11899|NCT00955916|Rami Komrokji, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-4291|rami.komrokji@moffitt.org
11900|NCT00955955|Dr. George Papakostas- Director of Treatment Resistant Depression Studies|Massachusetts General Hospital- Depression Clinical and Research Program|617-726-6697|gpapakostas@partners.org
11901|NCT00956254|Larry Dillaha, M.D., Chief Medical Officer|Insys Therapeutics, Inc.|602 910-2617|ldillaha@insysrx.com
11902|NCT00956293|Study Director|Novartis Pharmaceuticals|+1 (862) 778-1873|
11903|NCT00956540|Dr. Gonzalo Hernández|Hospital Virgen de la Salud|0034629625428|ghernandezm@telefonica.net
11904|NCT00956592|Michael Aziz|Oregon Health & Science University|503-494-5581|azizm@ohsu.edu
11905|NCT00956631|VP of Clinical, Regulatory and Quality|Vertos Medical|9493490008 ext 216|cmyers@vertosmed.com
11973|NCT01042613|Luis Trujillo Huaccho, MD|St. Jude Children's Research Hospital|1-866-278-5833|info@stjude.org
11974|NCT01469182|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
11975|NCT01469234|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
11976|NCT01469637|Study Physician|Shire Development LLC|+1 866-842-5335|
11977|NCT01470118|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11978|NCT01470469|Study Physician|Shire Development LLC|+1 866 842 5335|
11979|NCT01471171|Clinical Project Leader and Trial Manager|Almirall S.A.|+34 93 291 3200|
12595|NCT01031810|Dr. Patrick J. McGrath|New York State Psychiatric Institute|(646) 774-8076|mcgrath@nyspi.columbia.edu
12596|NCT01031914|Dr. David P. White|Philips|724 387 4554|Dr.DavidWhite@philips.com
12597|NCT01031953|Dr. Joseph Bubalo|Oregon Health & Science University|503-494-8007|bubaloj@ohsu.edu
12598|NCT01032018|Karina W Davidson, PhD|Columbia University Medical Center|212-342-4493|kd2124@cumc.columbia.edu
12599|NCT01032070|Senior Medical Director, Medical Oncology|Astellas Pharma Global Development, Inc||ClinicalTrials.Disclosure@us.astellas.com
12600|NCT01032174|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12601|NCT01032265|Dr. Eva Samuelsson|Umeå University, Umeå, Sweden|+46706966440|eva.samuelsson@jll.se
12602|NCT01032291|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
12603|NCT01046695|Deborah J. Engen, OT, CMT|Mayo Clinic|507-255-5504|engen.deborah@mayo.edu
12604|NCT01046903|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12605|NCT01047189|Steven Feldman, MD, PhD|Wake Forest University Health Sciences|336-716-3775|sfeldman@wfubmc.edu
12606|NCT01047241|Sponsor's contact person Bettina Nygaard Nielsen|Copenhagen University Hospital, Rigshospitalet|+45 35459546|bettina.nygaard.nielsen@regionh.dk
12607|NCT01047436|Dr D Bendel|Xidea Solutions Limited||daryl@xideasolutions.com
12608|NCT01047553|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
12609|NCT01047709|Devin Brown, MD|University of Michigan|7349369075|devinb@umich.edu
12610|NCT01048333|Gerard Lynch|Astra Zeneca|+44 1509 645895|ClinicalTrialTransparency@astrazeneca.com
12179|NCT00868296|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
12180|NCT00868309|Walter Garcia|Instituto Bioclon S.A. de C.V.|+52 (55)54883700 ext 3785|wgarcia@silanes.com.mx
12181|NCT00868348|Karen V Andersen|Aarhus University Hospital|51263173 ext 0045|karenand@rm.dk
12182|NCT00868374|Dr. Keming Gao|University Hospitals Case Medical Center|216-844-2865|keming.gao@UHhospitals.org
14196|NCT01453023|GSK Response Center|GlaxoSmithKline|866-435-7343|
14197|NCT01453036|Dr. Jin Il Kim|The Catholic University of Korea|+82-2-3779-2382|jikim@catholic.ac.kr
14198|NCT01453049|GSK Response Center|GlaxoSmithKline|866-435-7343|
14199|NCT01453166|Dr. Otavio Berwanger|Instituto de Ensino e Pesquisa do Hospital do Coração|+ 55 11 30536677 ext 8201|oberwanger@hcor.com.br
14200|NCT01453296|GSK Response Center|GlaxoSmithKline|866-435-7343|
14201|NCT01606254|Medical Director|Janssen Pharm KK Japan|81-3-4411 ext 5509|
14202|NCT01606735|Wendy Murahashi, MD|Icon Bioscience, Inc|6503694049|wendymurahashi@iconbioscience.com
14203|NCT01607112|GSK Response Center|GlaxoSmithKline|866-435-7343|
13749|NCT01433081|Gildasio De Oliveira MD|Northwestern University|312-472-3573|g-jr@northwestern.edu
13750|NCT01433107|Clinical Project leader|Novartis|+41223633111|
13751|NCT01433159|Jaime Dickerson, PhD|Smith & Nephew Biotherapeutics|817-302-3914|jaime.dickerson@smith-nephew.com
13752|NCT01433549|R. Alan Landers, O.D., M.S., F.A.A.O.|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13753|NCT01434030|Boris P Kovatchev, Ph.D.|University of Virginia|434-924-5592|bpk2u@virginia.edu
13754|NCT01434121|Alpha A. Fowler, III, MD|Virginia Commonweath University|804-628-5710|afowler@mcvh-vcu.edu
13755|NCT01434680|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
13756|NCT01434693|Vice President Clinical Operations|Coronado Biosciences|781.652.4516|nsilver@coronadobio.com
13757|NCT01435174|Bruce A. Mueller|University of Michigan College of Pharmacy|7346154578|muellerb@umich.edu
13758|NCT01435265|Steven Feldman, MD, PhD|Wake Forest University Health Sciences|336-716-7740|sfeldman@wakehealth.edu
13759|NCT01435460|Tuyen Ong|Bausch & Lomb, Incorporated|(973) 360-6389|tuyen.ong@bausch.com
13760|NCT01435577|Director of Clinical Trials|Grünenthal GmbH|+241 569 3223|
12990|NCT00910858|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
12991|NCT00910871|Medical Leader|Janssen Infectious Diseases – Diagnostics BVBA|1 609 730-7768|
12992|NCT00910988|Julie Schweiger/Michael Yingling|Washington University|3143623153/5735791412|schweigj@psychiatry.wustl.edu/yinglinm@psychiatry.wustl.edu
12993|NCT00911144|GSK Response Center|GlaxoSmithKline|866-435-7343|
12994|NCT00911157|GSK Response Center|GlaxoSmithKline|866-435-7343|
12995|NCT00911170|Study Director|Amgen Inc.|866-572-6436|
12996|NCT00911274|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12997|NCT00911300|GSK Response Center|GlaxoSmithKline|866-435-7343|
12998|NCT00911326|Dr. Frederick O. Cope, Chief Scientific Officer|Navidea Biopharmaceuticals|614-793-7500 ext 140|fcope@navidea.com
13111|NCT00964444|David B. Peisner MD|Pinnacle Health|717-231-8472|dpeisner@pinnaclehealth.org
13112|NCT00964496|Zhizheng Ge, MD. Ph.D.   Director of the Clinical Trials|Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine|86-21-68383015|zhizhengge@yahoo.com.cn
13113|NCT00964548|Susanne Muehlschlegel, MD, MPH, Principal Investigator|UMASS Medical School|508-856-4667|susanne.muehlschlegel@umassmemorial.org
13114|NCT00964743|Edward Pan, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-3871|edward.pan@moffitt.org
13115|NCT00964860|Holly Eynon|Procter and Gamble|513-622-2920|eynon.ha@pg.com
13116|NCT00965081|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13117|NCT01021020|Medical Affairs Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
13118|NCT01021423|Associate Director, Clinical Trials Disclosure|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
13119|NCT01021618|Gary V Heller, MD, PhD|Hartford Hospital|860-545-5527|aahlber@harthosp.org
13120|NCT00975689|Dr. Forbes D Porter, Senior Investigator|National Institute of Child Health and Human Development; NIH|(301) 435-4432|fdporter@mail.nih.gov
13121|NCT00975715|Study Director|Novartis|41 61 324 1111|
11980|NCT01471197|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
11981|NCT01471379|Dr. Spencer Dorn  Associate Professor|UNC Chapel Hill|919-966-0141|sdorn@med.unc.edu
11982|NCT01471626|Dr Marie Bruyneel|CHU St Pierre|003225354219|marie_bruyneel@tpierre-bru.be
11983|NCT01631071|Medical Affairs Director|Crucell Switzerland AG|+41(0)319806111|info@crucell.com
11984|NCT01631110|Medical Affairs Director|Crucell Switzerland AG|+41(0)319806111|info@crucell.com
11985|NCT01631227|Associate Director Clinical Services|Abbott||taco.baardman@abbott.com
11986|NCT01631812|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
11987|NCT01631825|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
11988|NCT01632215|Dr. Rioko K. Sakata|Federal University of São Paulo|055 11 5084 7463|riokoks.dcir@epm.br
11989|NCT01632267|Joel Winner, MD|AssureRx|513-234-0510|jwinner@assurerxhealth.com
11990|NCT01632423|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11991|NCT01633320|Dr Emmanuel Boselli|Edouard Herriot hôspital Anaesthesia and intensive care|+334711689|emmanuel.boselli@chu-lyon.fr
11992|NCT01634100|Boehringer Ingelheim Call center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11993|NCT01634243|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
11994|NCT01634256|Dr. Sang-Wook Kim, MD|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|82-63-276-8284|clickm@jbnu.ac.kr
11995|NCT01634360|Eisai Inc.|Eisai Call Center|888-422-4743|
11906|NCT00956657|Gavin H. Taylor, Clinical Psychologist|NHS Greater Glasgow & Clyde|0141 211 2134|gavin.taylor@ggc.scot.nhs.uk
11907|NCT00956709|Dr Pham Dang|CHU de Nantes|33 2 53 48 24 15|charles.phamdang@chu-nantes.fr
11908|NCT00956839|Professor Eesh Bhatia|Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow|00915222494382|ebhatia@sgpgi.ac.in
11909|NCT00956943|Robert A. Schnoll, Ph.D.|University of Pennsylvania|215-746-7143|schnoll@mail.med.upenn.edu
12183|NCT00868452|Medical Director, CNS|Sunovion|1-866-503-6351|
12184|NCT00868530|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12185|NCT00868699|Medical Director, CNS|Sunovion|1-866-503-6351|
12186|NCT00868712|Todd C. Villines, MD|Walter Reed Army Medical Center, Cardiology Service|301-295-7839|todd.villines@us.army.mil
12187|NCT00868959|Medical Director, CNS|Sunovion|1-866-503-6351|
12188|NCT00869089|Neil J. Korman, MD Principal Investigator|University Hospitals Case Medical Center|216-844-7164|neil.korman@UHHospitals.org
12189|NCT00869128|D. Garfinkel ,  MD|Shoham Geriatric Medical Center, Pardes Hana, Israel|Tel: 972-4-6375667|dorong@shoham.health.gov.il
12190|NCT00869167|Brandon Lu, M.D., M.S.|California Pacific Medical Center|415-923-3421|lubs@sutterhealth.org
12191|NCT00869362|Deborah J. Wexler MD|Massachusetts General Hospital Diabetes Center|617-726-8722|dwexler@partners.org
12192|NCT00869375|J. Emilio Exaire MD|OUHSC|405 271 4742 ext 44744|jose-exaire@ouhsc.edu
12193|NCT00869518|Brian S. Schwartz, MD|University of California, San Francisco|415-476-5767|brian.schwartz@ucsf.edu
12194|NCT02058290|Erol Onel, MD|Pacira Pharmaceuticals, Inc.|858-625-2424|erol.onel@pacira.com
12195|NCT02061683|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
12196|NCT02062177|Professor Testoni Pier Alberto|Università Vita-Salute San Raffaele|+390226432756|testoni.pieralberto@hsr.it
12197|NCT02064231|Birte Petersen Jakobsen, MD|Coloplast A/S|+45 4911 1395|dkbir@coloplast.com
12198|NCT02072421|Katherine Agule|Harvard Clinical Research Institute|617-307-5200|kagule@hcri.harvard.edu
12199|NCT02075632|GSK Response Center|GlaxoSmithKline|866-435-7343|
12200|NCT02079519|Medical Communications|Hoffmann-La Roche|800 821-8590|
12201|NCT02080780|Ventrus|Ventrus Biosciences|646-706-5208|VEN307@ventrusbio.com
12406|NCT00981214|Robert Winkler, MD, VP, Clinical Development and Operations|Aptalis Pharma US, Inc.|1-800-472-2634|
13761|NCT01435928|Medical Director, CNS|Sunovion|1-866-503-6351|
13762|NCT01436071|GSK Response Center|GlaxoSmithKline|866-435-7343|
13763|NCT01436110|GSK Response Center|GlaxoSmithKline|866-435-7343|
13764|NCT01436253|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13765|NCT01436370|Jack Stapleton, MD|Department of Internal Medicine, University of Iowa|319-356-3168|jack-stapleton@uiowa.edu
13766|NCT01436526|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
13767|NCT01436643|Study Director|Novartis Pharmaceuticals|862-778-8300|
13768|NCT01436799|Dr.HJ Kwak|Gachon University Gil Medical Center|82-32-460-3400|hyun615@gilhospital.com
13769|NCT01437111|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13770|NCT01437267|Dr. Audino Podda|Novartis Vaccines Institute for Global Health|+39 0577 243496|audino.podda@novartis.com
13771|NCT01437501|Thomas W. Kensler, PhD|Johns Hopkins Bloomberg School of Public Health|410-955-1292|tkensler@jhsph.edu
13954|NCT01543685|Daniel Solorio|Iroko Pharmaceuticals, LLC|267-546-3150|dsolorio@iroko.com
13955|NCT01543828|Study Director|Novartis Pharmaceuticals|862-778-8300|
13956|NCT01543958|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|617-432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
13957|NCT01544361|Joseph M. Parker, Director, Clinical Development|MedImmune, LLC.|301-398-0000|parkerj@medimmune.com
13958|NCT01545388|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
13959|NCT01545518|Dr. Charles M. Epstein|Emory University|404-778-3633|cepstei@emory.edu
13960|NCT01545700|Glenn S. Murphy, MD|NorthShore University HealthSystem|847-570-2760|dgmurphy2@yahoo.com
13961|NCT01545765|Farzaneh Sidou Clinical Project Manager)|Galderma|00.33.4.93.95.70.70|farzaneh.sidou@galderma.com
13962|NCT01546207|Dr. Vivek Y. Reddy|Icahn School of Medicine at Mount Sinai|212-241-7114|vivek.reddy@mountsinai.org
13122|NCT00975780|Vincent James Quagliarello MD, Professor of Medicine (Infectious Diseases); Clinical Chief, Infectio|Yale University School of Medicine|(203) 785-7571|vincent.quagliarello@yale.edu
13123|NCT00976027|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
13124|NCT00976209|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
13125|NCT00976248|Steven P. Treon, MD, PhD|Dana-Farber Cancer Institute|617-632-2681|steven_treon@dfci.harvard.edu
13126|NCT00976274|Dr. Jae-Yong Shim|Department of Family Medicine, Yonsei University College of Medicine|(+82) 2-2019-3480|hope@yuhs.ac
13127|NCT00976391|GSK Response Center|GlaxoSmithKline|866-435-7343|
13128|NCT00976404|Baiba Berzins, MPH|Northwestern University|312-695-5012|baiba@northwestern.edu
13129|NCT01034579|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
13130|NCT01034709|Kevin Modarress, PhD Senior Manager Regulatory Affairs Operations NA, Regulatory Affairs|QIAGEN|301-944-7103|kevin.modarress@qiagen.com
13131|NCT01035047|Erin Harper|Wake Forest Baptist Medical Center|336-716-2059|erharper@wakehealth.edu
13132|NCT01035060|Dr. Thomas Buford|University of Florida|352-273-5918|tbuford@ufl.edu
13249|NCT00862537|Allen S. Braswell CEO|Pico-Tesla Magnetic Therapies, LLC|303 795-3222|abraswell@pico-tesla.com
13250|NCT00862641|Senior Medical Director, Medical Affairs|Astellas Pharma Global Development||clinicaltrials@us.astellas.com
13251|NCT00862654|Farzi Sidou, Clinical Project Manager|Galderma|+33 4 93 95 70 51|farzaneh.sidou@galderma.com
13252|NCT00862745|Dr. Jeanette Brown|University of California, San Francisco|415-353-9751|brownj@obgyn.ucsf.edu
13253|NCT00862784|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
13254|NCT00862810|Emmanuel Walter MD, MPH|Duke University Health System|919-620-5346|walte002@mc.duke.edu
13255|NCT00862823|Jennifer King|University of Alabama at Birmingham|205-934-2696|jenking@uab.edu
13256|NCT00862836|Gerard Lynch|AstraZeneca||clinicaltrialtransparency@astrazeneca.com
11910|NCT00957008|Project director|University of South Carolina|8037773881|msui@mailbox.sc.edu
11911|NCT00957021|Director of Clinical Research|Stryker Orthopaedics|201-831-5401|Ellen.Axelson@Stryker.com
11912|NCT00957034|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
11913|NCT00957047|Head of Clinical Research Section|Bial - Portela & Cª, S.A.|+ 351 22 986 61 00|clinical.trials@bial.com
11914|NCT00957242|Imre Noth, MD, Associate Professor of Medicine|University of Chicago Hospital|773-834-1832|inoth@medicine.bsd.uchicago.edu
11915|NCT00957372|Head of Clinical Research Section|Bial - Portela & Cª, S.A.|+ 351 22 986 61 00|clinical.trials@bial.com
11916|NCT00957528|Randall Urban, M.D., Professor of Medicine|The University of Texas Medical Branch at Galveston|409- 772-1176|rurban@utmb.edu
11917|NCT00957593|Joanne N. Quinones MD MSCE|Lehigh Valley Health Netword|6104021221|joanne_n.quinones@lvhn.org
11918|NCT00957658|Director of Clinical Research|Stryker Orthopaedics|201-831-5401|Ellen.Axelson@stryker.com
11919|NCT00957684|Head of Clinical Research Section|BIAL - Portela & Ca, SA|351 22 986 6100|clinical.trials@bial.com
11920|NCT00965523|Tatsuo Watanabe, Study Director|Eisai|+81-3-3817-5252|
11921|NCT00965718|Moonjae Chung, MD|Yonsei university|82-2-2228-2274|MJCHUNG@yuhs.ac
11922|NCT00965731|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11923|NCT00965848|Medical Affairs Director|Medical Affairs, Janssen-Cilag Ltd.,Thailand|662-792-7200|
11924|NCT00966186|Jung-Won Hwang|Seoul National University Bundang Hospital|82-31-787-7499|jungwon@snubh.org
11925|NCT00966238|Dr. David N. Taylor|VaxInnate|609-860-2260|david.taylor@vaxinnate.com
11926|NCT00966264|Ritva Hurskainen|Helsinki University|+23845872267|ritva.hurskainen@hus.fi
11927|NCT00966940|Director of Medical Affairs|Alcon Research, Ltd.|1-800-862-5266|medinfo@alconlabs.com
11928|NCT00966953|William DeVizio - DMD|Colgate Palmolive|732-878-7901|william_devizio@colpal.com
11929|NCT00967018|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com
12407|NCT00981227|Head of Clinical Research Section|Bial-Portela & Cª, S.A.|+351 22 986 6100|clinical.trials@bial.com
12408|NCT00981292|Emma Wightman|Northumbria university|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk
12409|NCT00981409|GSK Response Center|GlaxoSmithKline|866-435-7343|
12410|NCT00981461|David Michaels|Lexington International, LLC|5614170200|dm@hairmax.com
12411|NCT00981630|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
12412|NCT00981669|Alexander Roberto Precioso|Instituto Butantan|+5511-2627-9372 ext 9372|alexrp@butantan.gov.br
12413|NCT01478256|George John|George John MD|5028949757|grjohn777@yahoo.com
12414|NCT01478958|Professor Julie Lovegrove|University of Reading|+44 (0)118 3786418|j.a.lovegrove@reading.ac.uk
12415|NCT01478971|Medical Director|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
12416|NCT01479374|Abhijit Narvekar, MS, MBBS|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
12417|NCT01479530|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com
12418|NCT01479543|Esther Matencio Hilla|Hero Institute for Infant Nutrition|+0034 968 89 89 00|esther.matencio@hero.es
12419|NCT01640197|Emma Wightman|Northumbria University|(+44) 0191 2437253|emma.l.wightman@northumbria.ac.uk
12420|NCT01640314|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
12421|NCT01640327|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
12422|NCT01640340|Rachel Layman, MD|Ohio State University Medical Center|614-293-0066|Rachel.Layman@osumc.edu
12423|NCT01641237|GSK Response Center|GlaxoSmithKline|866-435-7343|
12424|NCT01641640|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
12425|NCT01641692|GSK Response Center|GlaxoSmithKline|866-435-7343|
12426|NCT01641991|David Bernstein, MD, MA|Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center|513-636-7625|david.bernstein@cchmc.org
13963|NCT01546285|Jeffrey Conner - Global Research Manager|GE Healthcare|414.721.2423|Jeffrey.Conner@ge.com
13964|NCT01546402|Aniruddha Agarwal|Post Graduate Institute of Medical Education and Research|+911722756111|aniruddha9@gmail.com
13965|NCT01546636|Glenn Murphy, MD, Director of Clinical Research|NorthShore University HealthSystem|847-570-2760|gmurphy@northshore.org
13966|NCT01546688|Eisai Inc.|Eisai Call Center|888-422-4743|
13967|NCT01441843|Dr. M. Klimek|Erasmus University Medical Centre|+31107033713|m.klimek@erasmusmc.nl
13968|NCT01442064|Genentech|Genentech||ctg-post-d@gene.com
13969|NCT01442103|Joan wilson|Molnlycke Health Care|+1 706-650-1012|joan.wilson@molnlycke.com
13970|NCT01442376|Spinelli Tulla|Helsinn Healthcare SA|+4191985 21 21|tulla.spinelli@helsinn.com
13971|NCT01442688|Study Physician|Shire Pharmaceutical|1 866-842-5335|
13972|NCT01442779|Lorenz Lutherer, MD, PhD|Texas Tech University Health Sciences Center|806-743-2532|Lorenz.Lutherer@ttuhsc.edu
13973|NCT01442844|Dr. Alexandra Kimball|Massachusetts General Hospital|617-726-5066|harvardskinstudies@partners.org
13974|NCT01443494|Jingyuan Xu|Intensive Care Unit, Zhongda Hospital, Southeast University|86-025-83262550|xujingyuanmail@163.com
13975|NCT01443858|Dr. Jed E. Rose|Duke Center for Smoking Cessation|919-668-5055|jed.rose@duke.edu
13976|NCT01444287|Noel Brennan|Vistakon|1 904 4433494|nbrenna2@its.jnj.com
14136|NCT01879852|Dr. Terese Chmielewski|University of Florida|(352)273-6104|tchm@ufl.edu
14137|NCT01880697|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
14138|NCT01880723|Courtney Wheatley|University of Arizona|507-266-2696|wheatley.courtney@mayo.edu
14139|NCT01446289|Posting Director|Novartis vaccines||RegistryContactVaccinesUS@novartis.com
14140|NCT01446796|Michel Khouri, MD|Duke University Medical Center|919 684 8111|michel.khouri@duke.edu
14141|NCT01447017|Dr. Pekka Koskinen|Centre for Clinical Studies in Malmö|+46 (0)40 97 12 60|pekka@clsm.se
13257|NCT00862849|Vice President, Endocrinology Clinical Development|Halozyme Therapeutics, Inc.|858-794-8889|
13258|NCT01976806|Dr. Asghar Naqvi|Beth Israel Deaconess Medical Center|617-667-2117|anaqvi@bidmc.harvard.edu
13259|NCT01981057|Nadja Haiden M.D.|Medical University of Vienna|+4314040032320|nadja.haiden@meduniwien.ac.at
13260|NCT01981616|Medical Director|Millennium Pharmaceuticals Inc.|800-778-2860|clinicaltrialregistry@tpna.com
13261|NCT01987583|Dr. Nouran Aleyeidi|Ministry of Health|00966504304577|dr.nouran@live.com
13262|NCT01453348|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
13263|NCT01453413|Dr. Steven Edelman, MD|Taking Control of Your Diabetes|858-755-5683|svedelman@vapop.ucsd.edu
13264|NCT01453855|Theresa A Landry, PhD|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13265|NCT01453894|David W. Baker, MD, MPH|Northwestern University Feinberg School of Medicine|312-503-6400|dbaker1@nmff.org
13266|NCT01453998|GSK Response Center|GlaxoSmithKline|866-435-7343|
13267|NCT01454063|Chief Medical Officer|Omeros Corporation|(206) 676-5000|swhitaker@omeros.com
13268|NCT01454414|Dr. Meagan Vaughn|University of North Carolina at Chapel Hill|9196986208|meagan.vaughn@unc.edu
13269|NCT01454505|Terri Pasquine, Clinical Project Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13270|NCT01454583|Professor Dr. Uwe Zeymer|Foundation Stiftung Institut fuer Herzinfarktforschung Ludwigshafen, Germany|+49 621 503 2813|Uwe.Zeymer@t-online.de
13271|NCT01454726|Dr. Jianping JIA|Xuan Wu Hospital of Capital Medical University|0086-10-83198899 ext 8650|jiajp@vip.sina.com
12863|NCT01657877|GSK Response Center|GlaxoSmithKline|866-435-7343|
12864|NCT01658020|Principal Investigator|Asan Midical Center|+82-2-3010-3136|ymoh55@amc.seoul.kr
12865|NCT01658839|Theresa Landry, Project Head, Clinical Trial Management|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
12866|NCT01659268|Cesar Eduardo Pedersoli|College of Nursing at Ribeirão Preto, University of Sao Paulo|55(16)3602-3421|cesinhajardel@ig.com.br
11930|NCT00967044|Yasuhiro Oki, MD / Assistant Professor, Lymphoma/Myeloma|University of Texas MD Anderson Cancer Center|713-792-2860|CR_Study_Registration@mdanderson.org
11931|NCT00967447|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11932|NCT00967473|Director of Alcon Clinical|Alcon Research, Ltd.|888-451-3937; 817-568-6725|medinfo@alconlabs.com
11933|NCT00967486|Ali Fawazi AbuRahma MD|Vascular center of excellence (CAMC medical staff-with admitting privileges)|304-388-9973|
11934|NCT00967551|Hugo Costa-Ribeiro|Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Bahia, Brasil||hugocrj@ufba.br
11935|NCT00967668|Laura Damschroder|VA Center for Clinical Management Research|734-845-3603|laura.damschroder@va.gov
11936|NCT00967694|Dr. Eric Fox|University of Utah Department of Anesthesiology|775-340-0219|ericbfox@yahoo.com
11937|NCT00968019|Mayda Lopez-Belmonte, PhD|Johnson and Johnson Medical Iberia|+34 91 7228481|tlopezbe@its.jnj.com
11938|NCT00968032|Christof Schmeer|pfm medical ag|+49 6873 9011 ext 41|christof.schmeer@pfmmedical.com
11939|NCT00968071|Gautam Borthakur M.D./Associate Proffesor|The University of Texas M. D. Anderson Cancer Center|713-563-1586|eharriso@mdanderson.org
11940|NCT00968149|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
11941|NCT00968201|Vice President of Late Stage Development|Merck Sharp & Dohme Corp|1-800-672-6372|
11942|NCT00968617|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
11943|NCT00968669|Joe Parker, MD|MedImmune|301-398-0000|parkerJ@medimmune.com
11944|NCT00968708|Medical Director|Takeda|800-778-2860|clinicaltrialregistry@tpna.com
11945|NCT00968799|Sascha Müller, MD|Cantonal Hospital St.Gallen|+41 71 494 1317|ulrich.beutner@kssg.ch
11946|NCT00968812|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|Janssen Research & Development, LLC|1-800-526-7736|
11947|NCT00978445|Dr. Heather Gornik|Cleveland Clinic Foundation|216-445-3689|gornikh@ccf.org
11948|NCT00978731|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
12427|NCT01642147|Xiao-Yu Yang|Huashan Hospital Fudan University|086-021-52889999 ext 7693|xiaoyuyangfudan@gmail.com
12428|NCT01642485|Dr Jorg Taubel|Richmond Pharmacology Ltd|+44(0)2086645200|j.taubel@richmondpharmacology.com
12611|NCT01048424|Alison Huang, MD|University of California, San Francisco|415-353-9751|ahuang@medicine.ucsf.edu
12612|NCT01048541|Kristine Gjødsbøl, PhD|Coloplast|+4549113557|dkkg@coloplast.com
12613|NCT01048593|VP, Clinical Development|Icon Bioscience|408-492-9515|wendymurahashi@iconbioscience.com
12614|NCT01048606|Pr Isabelle Dionne, Ph.D., vice-dean to research and graduate studies|Université de Sherbrooke|1-819-821-8000 ext 63327|isabelle.dionne@usherbrooke.ca
12615|NCT01048671|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12616|NCT01048697|Ronald Hall|Texas Tech UHSC|214-654-9404|ronald.hall@ttuhsc.edu
12617|NCT01048723|Jonathan Zager, M.D.|H. Lee Moffitt Cancer Center and Research Institute|813-745-1085|jonathan.zager@moffitt.org
12618|NCT01048788|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
12619|NCT01048879|Bruce A. Mueller|University of Michigan|7346154578|muellerb@umich.edu
12620|NCT01049217|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12621|NCT01049243|Steven Feldman, MD, PhD|Wake Forest University Health Sciences|336-716-1877|sfeldman@wfubmc.edu
12622|NCT01049373|Dr. Gabriele Weiss|PASCOE pharmazeutische Präparate GmbH|0049/641/7960-0|klinischeforschung@pascoe.de
12623|NCT01049503|Dr. Marília Buzalaf|Bauru Dental School/University of São Paulo|+55 14 32358346|mbuzalaf@fob.usp.br
12624|NCT01049776|Sachdev Thomas, M.D.|Illinois CancerCare, P.C.|309-243-3000|sthomas@illinoiscancercare.com
12625|NCT01050062|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12626|NCT01050153|Ernest E. Moore|Denver Health Medical Center|303.602.1820|Ernest.Moore@dhha.org
12627|NCT01050218|U. S. Contact Center|Wyeth||clintrialresults@wyeth.com
11374|NCT00998868|Tai Ryoon Han, MD, PhD./Professor|Seoul National University Hospital|+82-2-2072-3218|tairyoon@snu.ac.kr
11375|NCT00998881|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
11376|NCT00999141|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery|Baxter Innovations, GmbH||edith_hantak@baxter.com
11377|NCT00897910|Zaid S. Al-Kadhimi, M.D.|Barbara Ann Karmanos Cancer Institute|313-576-8022|alkadhiz@karmanos.org
11378|NCT00897949|Senior Vice President,Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11379|NCT00898443|Marsha Wakefield, M.D.|UAB|205-934-4696|mwakefield@uab.edu
11380|NCT00898677|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11381|NCT00898807|Anne Casper|Johns Hopkins|410-955-8183|ashankl1@jhu.edu
11382|NCT00899353|Dr. W. Elaine Hardman|Marshall University Joan C. Edwards School of Medicine|304-696-3721|hardmanw@marshall.edu
11383|NCT00899379|Senior Vice President, Global Clinical  Development|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11384|NCT00899392|Joel A Friedlander|Children's Hospital of Philadelphia/OHSU/Doernbecher Children's Hospital|503-494-1078|friedlan@ohsu.edu
11385|NCT00899470|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
11523|NCT01242527|Douglas Kling, Vice President, Clinical Development & Project Management|Omthera Pharmaceuticals, Inc.|908-741-4193|dkling@omthera.com
11524|NCT01243112|James Collins, MD|Scott & White Healthcare|254-724-7508 ext 0612|jbcollins@swmail.sw.org
11525|NCT01243242|Dr Yaron Daniely CEO|Alcobra|972-072-2204662|yaron@alcobra-pharma.com
11526|NCT01243294|Pia Nordmand, Clinical Trial Manager|Coloplast A/S|+4549113250|dkpialn@coloplast.com
11527|NCT01243567|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11528|NCT01243671|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
11529|NCT01244061|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14460|NCT01701414|Francesca Beaudoin MD, MS|Dept of Emergency Medicine, Rhode Island Hospital|401-444-2577|fbeaudoin@lifespan.org
14461|NCT01701622|Debbie Minor|University of Mississippi Medical Center|601-984-6888|DMinor@umc.edu
14462|NCT01702298|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
14463|NCT01569464|Study Director|UCB Clinical Trial Call Center|+1 887 822 9493|
14464|NCT01569529|Dr. Robin Mermelstein|University of Illinois at Chicago, Institute for Health Research and Policy|312 996-1469|robinm@uic.edu
14465|NCT01570309|Dr Seth I Sokol|Jacobi Medical Center|718-918-5735|seth.sokol@nbhn.net
14466|NCT01570634|Richard scruggs|Salient Pharmaceuticals Incorporated|7135899859|rscruggs@salientpharmaceuticals.com
14467|NCT01570686|Study Director|Novartis Pharmaceuticals|862-778-8300|trialandresults.registries@novartis.com
14468|NCT01572740|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
14469|NCT01573000|GSK Response Center|GlaxoSmithKline|866-435-7343|
14470|NCT01573325|Rebecca Duke DNP, MSN, NP-BC Transplant Surgery Nurse Practitioner|Northwestern Memorial Hospital|3126951686|rduke@nmh.org
14471|NCT01574079|Principle investigator|University of Mississippi Medical Center|601-984-6369|lbarnes@umc.edu
14472|NCT01574105|Mark Rosin|Saskatoon Health Region|306-655-2128|mark.rosin@sasktoonhealthregion.ca
14473|NCT01574612|David Ginsberg, DO|Meda Pharmaceutical|732 564 2200|ginsberg.david@gmail.com
14474|NCT01574651|Study Director|Novartis Pharnaceuticals|862-778-8300|trialandresults.registries@novartis.com
14475|NCT01575080|Carmine Greene|Bayer Healthcare, Diabetes Care|574-257-3040|carmine.greene@bayer.com
14340|NCT01689324|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
14341|NCT01689350|Lingyan CHEN, Master candidate|School of Pharmaceutical Sciences, Sun Yat-sen University|+8615018706960|chlingy@mail2.sysu.edu.cn
14342|NCT01689649|Medical Director|Janssen-Cilag Taiwan|886 2 23762155|
14343|NCT01689857|Dr. Chanyeong Heo|Seoul National University Bundang Hospital|82317877222|lionheo@snu.ac.kr
12331|NCT01478087|Jeffrey Lawrence Winters, MD|Mayo Clinic|507-538-1707|winters.jeffrey@mayo.edu
12332|NCT01074931|Global Medical Services|Abbott|1-800-633-9110|
12333|NCT01075074|Gildasio De Oliveira, MD|Northwestern University|312-926-8373|g-jr@northwestern.edu
12334|NCT00905567|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12335|NCT00905580|Dr. So Yeon Kim|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|82-2-2227-3642|kimsy326@hanmail.net
12336|NCT00905606|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12337|NCT00906074|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12520|NCT01046643|Dr. Yolanda Smith|The University of Michigan|(734) 936-7401|ysmith@med.umich.edu
12521|NCT01046682|Grace McComsey, MC|UHospitalsCleveland|216-844-3607|mccomsey.grace@clevelandactu.org
12522|NCT01484054|Michael Mayers, OD, FAAO|Johnson & Johnson Vision Care|904-443-3252|mmayers@its.jnj.com
12523|NCT01484197|Study Director|Novartis Pharmaceuticals|862-778-8300|
12524|NCT01484561|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12525|NCT01484652|Director Clinical Research|Mallinckrodt Pharmaceuticals|314-654-3913|thomas.barrett@mallinckrodt.com
12526|NCT01484912|Justine Tang|Sinphar Pharmaceutical Co., Ltd. Taiwan||justine@sinphar.com.tw
12527|NCT01484938|Jami Kern, Ph.D., Global Medical Affairs|Alcon Research, Ltd.|800-862-5266|
12528|NCT01484951|Abayomi Ogundele, Pharm.D|Alcon Global Medical Affairs|1-888-451-3937|
12529|NCT01486238|Victor Gonzalez, MD|Valley Retina Institute, PA|956-631-8875|research@vritx.com
12530|NCT01486446|Dr. Y Paul Goldberg|Xenon Pharmaceuticals Inc.|604 484 3300|pgoldberg@xenon-pharma.com
12531|NCT01486615|Dr Krishna Pokharel|B. P. Koirala Institute of Health Sciences|0977-9841986321|drkrishnapokharel@gmail.com
12532|NCT01486966|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
11530|NCT01244425|Ildiko Szabo, MD, MBA Medical Director, Biosurgery|BAXTER INNOVATIONS GmbH||ildiko_szabo@baxter.com
11531|NCT01244490|Study Physician|Shire Development LLC|+1 866 842 5335|
11532|NCT01244516|Kathy Osborn, OD|Johnson & Johnson Vision Care|1-904-443-1032|KOsborn@its.jnj.com
11533|NCT01244529|Kathy Osborn, OD|Johnson & Johnson Vision Care|1-904-443-1032|kosborn@its.jnj.com
11534|NCT01244620|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11535|NCT01244815|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11536|NCT01244893|Brian Pall, O.D., M.S., F.A.A.O.  Senior Research Optometrist|Johnson & Johnson Vision Care|(904) 443-1290|BPALL@its.jnj.com
11537|NCT01244984|GSK Response Center|GlaxoSmithKline|866-435-7343|
11538|NCT01245062|GSK Response Center|GlaxoSmithKline|866-435-7343|
11539|NCT01245270|Dr Nigel Hoggard|University of Aberdeen Rowett Institute of Nutrition and Health|[+44] (0) 1224 438700|N.Hoggard@abdn.ac.uk
11540|NCT01245374|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
11541|NCT01055834|Kenya Nakai, Study Director|Eisai Co., Ltd.|+81-3-3817-3865|k3-nakai@hhc.eisai.co.jp
11542|NCT01056107|Dr. Michael Camilleri|Mayo Clinic|507-266-2305|camilleri.michael@mayo.edu
11543|NCT01056198|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|Healthpoint Biotherapeutics|817-302-3914|jaime.dickerson@healthpoint.com
11544|NCT01056263|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11659|NCT00880165|Samuel T. Kuna, MD|Philadelphia VA Medical Center|215-823-4400|Samuel.Kuna@va.gov
11660|NCT00880230|Beaux S. Alexander - Director of Clinical Affairs|Medtronic EndoVascular Therapies|(707) 591-7291|beaux.s.alexander@medtronic.com
11661|NCT00880256|Dr. David Kearney|VA Puget Sound Health Care System|206-764-2285|david.kearney@va.gov
11662|NCT00880334|Toni Choueiri, MD|Dana-Farber Cancer Institute|617-632-5456|toni_choueiri@dfci.harvard/edu
14344|NCT01690052|Juan F. Yepes DDS, MD, MPH, MS, DrPH, Associate Professor|Indiana University School of Dentistry|317-944-9601|jfyepes@iupui.edu
14345|NCT01691326|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
14346|NCT01691339|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
14347|NCT01691482|GSK Response Center|GlaxoSmithKline|866-435-7343|
14348|NCT01691560|GSK Response Center|GlaxoSmithKline|866-435-7343|
14349|NCT01693185|Dr. Tae-Yop Kim, Professor of Anesthesiology|Konkuk University Medical Center|82-2-2030-5445|taeyop@gmail.com
14350|NCT01694667|Stephen Bent|University of California, San Francisco|415-221-4810 ext 3457|Stephen.Bent@ucsf.edu
14351|NCT01799590|Group Manager|Janssen Pharmaceutical KK Japan|+81-3-4411-5072|
14352|NCT01799720|Dr. Elena García García|Universidad Miguel Hernández|965222025 ext 2025|egarcia@umh.es
14353|NCT01800890|Marian Sinvani|Coloplast A/S|+45 4911 2356|dkmards@coloplast.com
14354|NCT01800903|Trine Møller Senior Clinical Manager|Coloplast A/S|+45 4911 2174|dktrm@coloplast.com
14355|NCT01800916|Marian Sinvani|Coloplast A/S|+45 49112356|dkmards@coloplast.com
14356|NCT01801124|Mark Kronefeld, MD|Maimonides Medical Center|(718) 283-8816|
14357|NCT01801436|Medical Affairs Director|Janssen Pharmaceutical Taiwan|+886-2-23762155|
14358|NCT01802554|Brent T Mausbach, PhD|University of California San Diego|858-822-7529|BMausbach@ucsd.edu
14359|NCT01803737|David O. Garcia, PhD|University of Arizona|520-626-4641|davidogarcia@email.arizona.edu
14360|NCT01804673|Head|Clinic for Anaesthesiology, Intensive Care Unit and Pain Therapy at the Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Str. 33, 48149 Munster.|+49 251 / 83 - 4 72 52|
14361|NCT01804881|Principal Investigator|North York Family Health Team|4164943003 ext 130|dsouthgate@nyfht.com
14362|NCT01805323|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
14476|NCT01575899|Dr. Ming-Cheh, Chen|Buddhist Tzu Chi General Hospital|+886-910-521003|MingCheh_chen@tzuchi.com.tw
12533|NCT01488071|H. Lundbeck A/S|H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@lundbeck.com
12534|NCT01488188|Dr. Jae Seung Yang|International Vaccine Institute|82-2-881-1198|jsyang@ivi.int
12535|NCT01488448|Dr. Alyssa Silver|Children's Hospital at Montefiore/Albert Einstein College of Medicine|718-741-2304|alysilve@montefiore.org
12536|NCT01488578|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12537|NCT01488877|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12538|NCT01489670|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
12539|NCT01489891|Dr. Felipe de la Morena|Hospital Universitario Infanta Cristina|0034659716030|felipe_de_la_morena@hotmail.com
12540|NCT01490125|Study director|Novartis|41 61 324 1111|
12541|NCT01490190|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
12542|NCT01649791|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
12750|NCT01648790|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12751|NCT01648920|Nancy Herje, BSN, RN, MBA.  Director, Clinical Development and Medical Affairs|Aerocrine, Inc.|919-449-8873|nancy.herje@aerocrine.com
12752|NCT01649232|Dr. Moises Aguilar-Domingo, Chairman of Spanish Neurometrics Foundation|Spanish Neurometrics Foundation|+34 634548720|moises.aguilar@gmail.com
12753|NCT01649362|Dr Manon Bache|Centre Hospitalier de Luxembourg|+352 4411 3157|manon.bache@hotmail.com
12754|NCT01649505|Dr. Juliana Hansen|Oregon Health and Science University|503-494-4834|hansenju@ohsu.edu
12755|NCT02115984|Dr. Sergey S. Bogachev|Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences|+7-963-946-57-69|labmolbiol@mail.ru
12756|NCT02120443|Garret T. Bonnema|ivWatch, LLC|1.855.489.2824 ext 7018|garret.bonnema@ivwatch.com
12757|NCT02123745|Garret T. Bonnema|ivWatch, LLC|1.855.489.2824 ext 7018|garret.bonnema@ivwatch.com
12758|NCT02126306|Dr Gadi Lalazar|HMO|97226777337|lalazar@hadassah.org.il
11663|NCT00880360|Dr. Tyler Curiel|University of Texas Health Science Center at San Antonio|210-450-1000|curielt@uthscsa.edu
11664|NCT00880425|Jessica Ailani, MD/ Headache Fellow|Thomas Jefferson University|631-807-8194|Jessica.Ailani@gmail.com
11665|NCT00880542|William Tap, MD|University of Calicornia Los Angeles (UCLA)|888-798-0719|wtap@mednet.ucla.edu
11666|NCT00880568|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11667|NCT00880685|Dr. Jon Grant|University of Chicago|773-834-1326|jongrant@uchicago.edu
11668|NCT00880750|Gerald Tremblay, M.D.|Shire Pharmaceutical||gtremblay@shire.com
11669|NCT00880906|Michael Vaezi, MD, PhD|Vanderbilt University|615-322-3739|michael.vaezi@vanderbilt.edu
11670|NCT00881205|Study Director|Novartis Pharmaceuticals|862-778-8300|
11671|NCT00881335|Zhang Xiangyu|Shanghai Tenth People's Hospital, Tongji University|86-21-66307174|xiangyu62@126.com
11672|NCT00881530|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11673|NCT00881608|Jennifer Wike|Repros Therapeutics|2817193402|jwike@reprosrx.com
11674|NCT00881647|Thomas C. Neylan, MD|University of California, San Francisco|415-750-6961|thomas.neylan@ucsf.edu
11675|NCT00881868|Ronald W. Gottschalk, MD / Medical Director|Galderma Laboratories, L.P.|817-961-5358|ron.gottschalk@galderma.com
11676|NCT00881894|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
11677|NCT01070381|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|CIBA VISION|1-800-241-7629|priya.janakiraman@cibavision.com
11678|NCT01070693|Dr. Georgios Pierides|Helsinki University Central Hospital|+358 9 4711|georgios.pierides@hus.fi
11679|NCT01070784|Goran Eckerwall, MSD|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
11680|NCT01070953|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11793|NCT00890682|Executive Medical Director|Pacira Pharmaceuticals, Inc|203-837-6500|ErolOnel@pacira.com
14477|NCT01576042|Sana M. Al-Khatib, MD, MHS|Duke Clinical Research Institute|919-668-8649|sana.alkhatib@dm.duke.edu
14478|NCT01576809|Clinical project Leader|Novartis Consumer Health|41223633111|
14479|NCT01577160|Medical Director|Janssen Research & Development|886 2 23762155|
14480|NCT01577186|Medical Director|Janssen Research & Development|886 2 23762155|
14481|NCT01577732|GSK Response Center|GlaxoSmithKline|866-435-7343|
14482|NCT01578187|Doran Rozen, Director of Clinical Affairs|Syneron Beauty|+972-54-7800260|Doran.Rozen@syneron.com
14483|NCT01578785|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
14484|NCT01578980|Boris Kovatchev, PhD|University of Virginia|434-924-5592|bpk2u@virginia.edu
14485|NCT01578993|Ulla Wallin, Director of Clinical Research|Semprus BioSciences|1-617-577-2205|ulla.wallin@semprusbio.com
14486|NCT01579084|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
14487|NCT01579305|Medical Monitor|Allergan, Inc.|805 961 5000|devicetrials@allergan.com
14488|NCT01579565|Chief Medical Officer|Omeros Corporation|(206) 676-5000|swhitaker@omeros.com
14489|NCT01579578|Dr Serban Ghiorghiu|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
14490|NCT01579747|Nicholas Lam|Univeristy of New Mexico|505 272 2610|nlam@salud.unm.edu
14491|NCT01506908|GSK Response Center|GlaxoSmithKline|866-435-7343|
14492|NCT01506960|Iris McNulty|Massachusetts General Hospital|617 726 2612|imcnulty@partners.org
14493|NCT01507051|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
14494|NCT01507220|Sergio Bergese, MD|The Ohio State University|(614) 293-9027|bergese.1@osu.edu
14495|NCT01507233|Keith Candiotti, MD|University of Miama/Jackson Memorial Hospital|305-585-5332|info@jhsmiami.org
14496|NCT01507246|Stephen Cohen, MD|Atlanta Colon and Rectal Surgery|770-997-1975|klong@atlantacolon.com
12759|NCT02127372|Gordana Vlahovic, MD|Duke University Medical Center|919-681-4047|Gordana.vlahovic@dm.duke.edu
12760|NCT02133534|Research Practice Manager|Duke University Medical Center|919 681 6819|bixby001@duke.edu
12761|NCT02135016|Dr. Jun Wang|First Hospital of CMU|8602483283100|wjun2000@hotmail.com
12762|NCT02138461|John A. Hovanesian, MD|MDbackline, LLC|949 951 9248|jhovanesian@mdbackline.com
12763|NCT02139982|Dr. Ting Li|The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University|008613587876896|liting1021@aliyun.com
12764|NCT02141217|GSK Response Center|GlaxoSmithKline|866-435-7343|
12765|NCT02150044|Director of Clinical Research|Acclarent, Inc.|650-687-5888|lenglan1@its.jnj.com
12766|NCT02150954|Chad Grotegut ,  MD|Duke University Medical Center||chad.grotegut@dm.duke.edu
12767|NCT02154048|Steve Melton, MD|Duke University|919.668.2047|steve.melton@duke.edu
12768|NCT02157116|Richard Riedel, MD|Duke University|919-681-6932|richard.riedel@duke.edu
12769|NCT02158247|Dr. Oh Saecheol|The Catholic University of Korea|+88-42-220-9046|oscane0822@gmail.com
12770|NCT01080625|Chul-Woo Jung/ Assistant professor|SNUH|82-2-2072-0640|spss@snuh.org
12771|NCT01080768|Study Director|Novartis Pharmaceuticals|862-778-8300|
12772|NCT01080807|Vice President, Medical Affairs|Cephalon, Inc.|610-727-6353|
12338|NCT00906243|Dr. Johannes Vieweg|University of Florida|352 273-6815|j.vieweg@urology.ufl.edu
12339|NCT00906347|Dr. April Bleich|University of Texas Southwestern Medical Center|214-648-2316|april.bleich@gmail.com
12340|NCT00906399|Biogen Idec Study Medical Director|Biogen Idec||clinicaltrials@biogenidec.com
12341|NCT00906425|Michael Hotze, PhD|Institut Straumann|+4161965 ext 1235|michael.hotze@straumann.com
12342|NCT00906698|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12343|NCT00906776|Prof Philippe Bouchard|Rotschild hospital|+33614656947|phbouch@noos.fr
11794|NCT00890695|Dr James Berkley|KEMRI/Wellcome Trust Research Programme|+254 41 522535|jberkley@kilifi.kemri-wellcome.org
11795|NCT00890721|Executive Medical Director|Pacira Pharmaceuticals, Inc.|203-837-6500|ErolOnel@pacira.com
11796|NCT00890981|Study Director|Amgen Inc.|866-572-6436|
11797|NCT00891020|Medical Communications|Hoffman-LaRoche|800-821-8590|
11798|NCT00891176|GSK Response Center|GlaxoSmithKline|866-435-7343|
11799|NCT00891202|Trial Transparency Team|Sanofi||Contact-us@sanofi.com
11800|NCT00891293|GSK Response Center|GlaxoSmithKline|866-435-7343|
11801|NCT00891436|James N. Moy, M.D.|Rush University Medical College|312-942-6176|jmoy@rush.edu
11802|NCT00891462|Cynthia F. Caracta, MD FCCP|Forest Research Institute|201-427-8000|cynthia.caracta@frx.com
11803|NCT00891657|Global Director, Clinical Affairs - BioSurgery|Confluent Surgical|781.839.1770|jennifer.doyle@covidien.com
11804|NCT00891735|Medical Communications|Genentech, Inc.|800-821-8590|
11805|NCT00891774|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|Johnson & Johnson Consumer and Personal Products Worldwide|928-277-0715|jhauze@its.jnj.com
11806|NCT00945815|SWOG Leukemia Statistician|SWOG Statistical Center|206-667-4408|
11807|NCT00945854|Riccardi Gabriele|Federico II University|+390817462117|riccardi@unina.it
11808|NCT00945893|Raburn Mallory, MD Senior Director Clinical Development|MedImmune, LLC|301-398-0000|malloryr@medimmune.com
11809|NCT00945906|Clinical Trial Disclosure Manager|CSL Behring|Use email contact|clinicaltrials@cslbehring.com
11810|NCT00945945|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
11811|NCT00946101|Elissa Malkin, D.O.|MedImmune, LLC an affiliate of AstraZeneca AB|301-398-0000|malkine@medimmune.com
11812|NCT00946114|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11813|NCT00946478|Dr. Tissa Hata|UCSD Dermatology|858-657-8390|ucsddermstudies@gmail.com
14497|NCT01507493|Xianwei Zhang|Huazhong University of Science&Technology|13037154560|znpain@sina.com
14498|NCT01508052|Dr.Kwak|Gachon University|82324603400|hyun615@gilhospital.com
14204|NCT01607398|GSK Response Center|GlaxoSmithKline|866-435-7343|
14205|NCT01607411|GSK Response Center|GlaxoSmithKline|866-435-7343|
14206|NCT01607593|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14207|NCT01607853|Clinical Trial Disclosure Manager|Leo Pharma A/S|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com
14208|NCT01608659|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
14209|NCT01608672|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
14210|NCT01608815|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
14211|NCT01609010|Medical Communications|Hoffman-LaRoche|800-821-8590|genentech@druginfo.com
14212|NCT01609478|Clinical Disclosure Office|Novartis Pharmaceuticals|+1(862)778-8300|
14213|NCT01610167|Jeffery L. Milleman, DDS, MPA|Salus Research, Inc.|(260) 755-1099|
14214|NCT01780922|Boon P. Chew|Washington State Unviversity|5093351427|boonchew@wsu.edu
14215|NCT01781169|Dr. Ji-Chang Zhou|Shenzhen Center for Chronic Disease Control|86-755-25503842|jichangzhou@gmail.com
14216|NCT01781962|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
14217|NCT01782482|Sharon Thomas, O.D., Sr. Principal Clinical Scientist|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
14218|NCT01559064|Medical Monitor|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
14219|NCT01559675|Dr. Phillip Fleshner|Cedars Sinai Medical Center|310-289-9224|pfleshner@aol.com
14220|NCT01560507|Dr. Jed Rose|Duke University Medical Center|919-668-5055|jed.rose@duke.edu
14221|NCT01560819|Dr. Sachin Kunde|Helen DeVos Children's Hospital of Spectrum Health Hospitals|616-267-2100|sachin.kunde@helendevoschildrens.org
12344|NCT00906789|Matthew T. Freedman|Georgetown University Medical Center|4105429680|MTFreedman@verizon.net
12345|NCT00906971|Carlos André Gomes Silva|Universidade Federal de Pernambuco|+55 83 9913-4949|carlosandrejpa@hotmail.com
12346|NCT00907088|Dr. Patricia Parkin|The Hospital for Sick Children|416-813-7654 ext 301544|patricia.parkin@sickkids.ca
12347|NCT00907218|Dr. Timothy Wilens|MassGH|617-724-5226|twilens@partners.org
12348|NCT00907257|David Lineberry|Valeant Pharmaceuticals International, Inc|949-973-1153|David.Lineberry@valeant.com
12349|NCT00907335|David Lineberry, Associate Director, Clinical Operations|Valeant Pharmaceuticals International, Inc|949-973-1153|David.Lineberry@valeant.com
12350|NCT00907374|Mayer B. Davidson, MD|Charles R. Drew University|323 357-3439|mayerdavidson@cdrewu.edu
12351|NCT00907426|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
12352|NCT00907738|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12353|NCT00907803|Annie Frimm, Vice President, Regulatory Affairs|SIGA Technologies, Inc.|951-303-8797|afrimm@siga.com
12354|NCT00907881|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12355|NCT00907907|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12356|NCT00908115|GSK Response Center|GlaxoSmithKline|866-435-7343|
12357|NCT00908128|Manager, Biopharmaceutics|TEVA Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12358|NCT00916370|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|Abbott Vascular|408-845-8265|robert.smithjr@av.abbott.com
12359|NCT00916643|Kevin Minnich|B. Braun Medical, Inc.|610 596 2358|kevin.minnich@bbraun.com
12543|NCT01650324|Dr. Yi-Jen Chen|Taipei Medical University - Wanfang Hospital|886-2-2930-7930 ext 2543|yjchen@tmu.edu.tw
12544|NCT01650519|Amy Rock, PhD|Cumberland Pharmaceutical Inc.|615-255-0068|arock@cumberlandpharma.com
12545|NCT01650779|Trial Transparency Team|Sanofi||Contact-us@sanofi.com
11814|NCT01310777|Matt Walker, PhD, Clinical Project Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
11815|NCT01311024|Arto Palmu, MD, PhD Research manager,|head of Clinical Research Unit, National Institute for Health and Welfare|+358295247910|arto.palmu@thl.fi
11386|NCT00899574|Sylvia Adams, MD|NYU Cancer Institute|212-263-6485|sylvia.adams@nyumc.org
11387|NCT00899600|Dr. Randy Loftus|Dartmouth-Hitchcock Medical Center|6036504642|randy.w.loftus@hitchcock.org
11388|NCT00899678|UCB Clinical Trial Call Center|UCB|+1 877 822 9493|
11389|NCT00899717|Urbano Santana Penín|University of Santiago de Compostela|0034647344093|urbano.santana@usc.es
11390|NCT00900146|Study Director|Novartis Pharmaceuticals|862-778-8300|
11391|NCT00900666|Krisanne B. Chapin, PhD|Mary Free Bed Rehabilitation Hospital|616-493-9831|krisanne.chapin@maryfreebed.com
11392|NCT00900731|Study Director|Novartis Pharmaceuticals|862 778-8300|
11393|NCT00900757|Mary Lou Affronti|Duke University Medical Center|919-684-6239|mary.affronti@dm.duke.edu
11394|NCT00900796|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11395|NCT00900822|Clinial Trial Manager|Institut Straumann AG|+41 61 965 11 11|info@straumann.com
11396|NCT00901017|Marc Quirynen, Professor|Institut Straumann AG|+4161965 ext 1235|michael.hotze@straumann.com
11397|NCT00901186|Study Director|Novartis Pharmaceuticals|1-862-778-8300|
11398|NCT00901225|Mitchell E Horwitz, MD, Principal Investigator|Duke University Medical Center|919-668-1045|mitchell.horwitz@duke.edu
11399|NCT00901459|Jed E. Rose, Ph.D.|Duke Center for Nicotine and Smoking Cessation Research|919-668-5055|jed.rose@mc.duke.edu
11400|NCT00901576|Gerald Tremblay, MD|Shire Pharmaceutical||gtremblay@shire.com
11401|NCT00901628|Tae Kyun Kim|Joint Reconstruction Center, Seoul National University Bundang Hospital|82-31-787-7196|osktk@snubh.org
11402|NCT00901901|Therapeutic Area Head|BAYER||clinical-trial-contact@bayerhealthcare.com
11403|NCT00902161|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
14222|NCT01561313|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
14223|NCT01561469|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14224|NCT01561560|Jami Kern, PhD|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
14225|NCT01561716|Dr. Isabel D Fernandez|University of Rochester|585-275-9554|Diana_Fernandez@URMC.Rochester.edu
14226|NCT01561898|Medical Director|Janssen Pharm KK Japan|03-4411-5067|
14363|NCT01805687|W. James Alexander, MD, MPH|Cornerstone Therapeutics, Inc.|919-678-6925|jim.alexander@chiesi.com
14364|NCT01807000|Study Physician|Shire Development LLC|+1 866 842 5335|
14365|NCT01808066|Chief Medical Officer|CogCubed|612-250-9737|monika@cogcubed.com
14366|NCT01808248|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
14367|NCT01808339|GSK Response Center|GlaxoSmithKline|866-435-7343|
14368|NCT01808755|D. Porru|Divisione Urologia IRCCS Policlinico San Matteo Pavia, Italy|39-0382-503868/503872|danieleporru@tin.it
14369|NCT01808963|Dr. Neal Fleming|UC Davis Medical Center|916-734-5394|nwfleming@ucdavis.edu
14370|NCT01809054|Kevin Bliden|Sinai Center for Thrombosis Research|4106014795|kbliden@lifebridgehealth.org
14371|NCT01425203|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
14372|NCT01425528|Kathryn Swoboda MD|University of utah|801-585-9717|Swoboda@genetics.utah.edu
14373|NCT01426230|Head of R&D|Depomed|510-744-8000|msweeney@depomed.com
14374|NCT01426269|Elizabeth M Nieman|Galderma Laboratories, L.P.|817-961-5130|elizabeth.nieman@galderma.com
14375|NCT01426360|Dr. Liu Hongchun|Sun Yat-sen University|86-0-13826189071|hongchun751@sina.com
14376|NCT01426763|Chief Scientific Officer|ViroPharma|610-458-7300|
14377|NCT01426854|Terence Li, Clinical Research Manager, Development & Medical Affairs, China|Alcon (China) Ophthalmic Product Co., Ltd.|+86 10 5829 1452|Terence.li@alcon.com
12546|NCT01650831|Avraham Hershkowitz, Clinical Trials Manager|Exalenz.Bioscience Ltd.|+972-8-9737513|avrahamh@exalenz.com
12547|NCT01651104|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
12548|NCT01651208|Ana M. Palacio|University of Miami|3052439754|apalacio2@med.miami.edu
12549|NCT00960570|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
12550|NCT00960622|Dr. Donald Phillip Kotler|St Luke's Roosevelt Hospital New York|212 523 3670|dkotler@chpnet.org
12551|NCT00960661|Vice President, Research and Development|Amylin Pharmaceuticals, LLC||clinical.trials@BMS.com
12552|NCT00960687|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
12553|NCT00960843|Michael Schwiers Principal Biostatistician|Ethicon Endo-Surgery Inc.|513-337-1172|mschwier@its.jnj.com
12554|NCT00960856|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clincialtrials@urlmutual.com
12555|NCT00960934|Vice President, Late Stage Development Group Leader|Merck, Sharpe and Dohme Corporation|1-800-672-6372 ext N/A|ClinicalTrialDisclosure@merck.com
12556|NCT00960986|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12557|NCT00961051|Eugenia Thomas, O.D.|Abbott Medical Optics|714-247-8723|eugenia.thomas@amo.abbott.com
12558|NCT00961116|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
12559|NCT00961181|Prof. Dr. Christoph Hehrlein|University Medical Center, Freiburg i.Br., Germany|+49 761 270 ext 6095|christoph.hehrlein@uniklinik-freiburg.de
12560|NCT00961233|Evan S. Dellon, MD MPH|University of North Carolina School of Medicine|919-966-2511|edellon@med.unc.edu
12561|NCT00961259|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
12562|NCT00961298|Alicia Kaplan MD|Allegheny General Hospital|412-330-4069|akaplan@wpahs.org
12563|NCT00961311|K. Bogdanovich|Medtronic Cardiovascular||rs.medtroniccardiovascularclinicaltrials@medtronic.com
12564|NCT00961441|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
11404|NCT01171820|Ellen Travis|Abbott Vascular|408-845-1512|Ellen.Travis@av.abbott.com
11405|NCT01171963|GSK Response Center|GlaxoSmithKline|866-435-7343|
11406|NCT01171976|Study Director|Novartis Pharmaceuticals|862-778-8300|
11407|NCT01172145|Laura L. Frakey|Brown University|401-729-3163|lfrakey@gmail.com
11408|NCT01172184|Dr. Shih-Hung Hsiao|Kaohsiung veterans general hospital|886-7-3422121 ext 1518|irb@vghks.gov.tw
11545|NCT01056289|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11546|NCT01056315|Study Director|Grünenthal|+49 (0)-241-569-3223|clinical-trials@grunenthal.com
11547|NCT01056328|Nicole Glowacki, Clinical Project Manager|St. Jude Medical|651-756-3432|NGlowacki@sjm.com
11548|NCT01056341|Dr. Jean-Jacques VOISARD - General Manager -|Pierre Fabre Dermatologie|+33 5 63 58 88 00|jean.jacques.voisard@pierre-fabre.com
11549|NCT01056484|Aleksandra Zgierska, MD PhD|University of Wisconsin Madison|(608) 263-7882|aleksandra.zgierska@fammed.wisc.edu
11550|NCT01056601|Arkaduisz Dudek, M.D.|Masonic Cancer Center, University of Minnesota|612-624-0123|dudek002@umn.edu
11551|NCT01056640|Dr. Paul Takahashi|Mayo Clinic|507-284-2511|takahashi.paul@mayo.edu
11552|NCT01056913|Bernhard Dauser (MD)|St John of God Hospital Vienna|+43121121 ext 5098|bernhard.dauser@gmail.com
11553|NCT01057017|Howard Safran, MD|BrUOG|4018633000|Hsafran@lifespan.org
11554|NCT01057251|Manfred Stapff, MD, PhD|Forest Research Institute|201-427-8000 ext 8686|manfred.stapff@frx.com
11555|NCT01057433|Roger Morgan, MD, FACS|Kowa Research Institute, Inc.|919-433-1600|RMorgan@KowaUS.com
11556|NCT01057589|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
11557|NCT01057693|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11558|NCT01057888|Dr. Peter Szilagyi|University of Rochester, Deparentment of Pediatrics|585 275-5798|peter_szilagyi@urmc.rochester.edu
11559|NCT01057901|Krista Barbour, Ph.D.|Sprout Pharmaceuticals|9198820850|kbarbour@sproutpharma.com
14378|NCT01426867|Matt Walker, PhD, Clinical Project Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
14379|NCT01923389|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14380|NCT01924767|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
14381|NCT01924871|Dr. Chong Wha Baek|Chung-Ang University Hospital|82-2-6299-2579|nbjhwa@naver.com
14382|NCT01694771|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
14383|NCT01695369|Jan Bergmanson, OD,PhD|University of Houston, College of Optometry, TERTC|713-743-1950|jbergmanson@uh.edu
14384|NCT01696071|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
14499|NCT01508169|Cecilia de Morais Barbosa|Hospital de Clinicas da Universidade Estadual de Campinas (Unicamp)|+55-19-35217113|cecimbarbosa@gmail.com
14500|NCT01508455|Dr. Marcelo Garcia da Rocha|Hospira|224-212-4424|marcelo.rocha@hospira.com
14501|NCT01508832|Ronald D Miller, MD|University of California San Francisco|415 476-9034|millerr@anesthesia.ucsf.edu
14502|NCT01509053|Medical Affairs|Otsuka Pharmaceutical Development & Commercialization, Inc.|800-562-3974|
14503|NCT01509638|Marylise Boutrous, MD|Cleveland Clinic Florida|954-659-5000|canedoj@ccf.org
14504|NCT01509664|Dr Allan Geliebter|New York Obesity Nutrition Research Center|212-523-4184|ag58@columbia.edu
14505|NCT01509807|Jorge Marcet, MD|University of South Florida|813-844-4545|jmarcet@health.usf.edu
14506|NCT01510145|Doug Hubatsch, Global Brand Leader, Medical Affairs|Alcon Research, Ltd|1-888-451-3937|alcon.medinfo@alcon.com
14507|NCT01510327|Ruth Starzyk, PhD|Boston Scientific|508-683-6577|ruth.starzyk@bsci.com
14508|NCT01510379|Kyle A. Perry, MD|The Ohio State University|614-293-5815|kyle.perry@osumc.edu
14509|NCT01510704|Dr Gabriel Fox|Acacia Pharma Ltd||gabrielfox@acaciapharma.com
14510|NCT01510834|Laurel King, PhD|Pacific Health Research and Education Institute|808-564-5711|laurel.king@va.gov
12727|NCT00871403|GSK Response Center|GlaxoSmithKline|866-435-7343|
12728|NCT00871429|Ann Cameron Haley|Northwestern University|312-695-6624|a-haley@northwestern.edu
12729|NCT00871494|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12730|NCT00871689|Michael Verneris, M.D.|Masonic Cancer Center, University of Minnesota|612-626-2961|verneris@umn.edu
12731|NCT00871728|Clinical Research Associate|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|+82-2-2094-4879|
12732|NCT00871819|Nitzan Mekel-Bobrov, Ph.D.|Boston Scientific|(661) 949-4537|Nitzan.Mekel-Bobrov@bsci.com
12733|NCT00871871|Vice President of Late Stage Development|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
12734|NCT00872001|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
12735|NCT00872079|Michael Brier|University of Louisville|502-852-0246|mbrier@louisville.edu
12736|NCT00872170|Nancy Gee|New England Research Institutes|617-972-3295|ngee@neriscience.com
12737|NCT00872339|Felicia Trachtenberg|New England Research Institutes|6179723120|ftrachtenberg@neriscience.com
12738|NCT00872430|Dr. Paulo Dornelles Picon|Hospital de Clínicas de Porto Alegre|55 xx 51 21018752|paulopicon@gmail.com
12739|NCT00872521|Regional Medical Affairs Director Asia Pacific|Jan-Cil Australia|61 427564369|
12740|NCT00872599|Nancy J. Brown, M.D.|Vanderbilt University|615-343-8701|nancy.j.brown@vanderbilt.edu
12741|NCT00872833|Eric Gerstenberger|New England Research Institutes, Inc.|6179237747|egerstenberger@neriscience.com
12742|NCT01645709|Stephen Snowdy, PhD|CaloSyn Pharma Inc.|404-863-8892|ssnowdy@ansleyvc.com
12743|NCT01646151|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
12744|NCT01646385|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12745|NCT01646398|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11560|NCT01058005|Biogen Idec Study Medical Director|Biogen Idec||clinicaltrials@biogenidec.com
11561|NCT01058070|VP of Clinical Affairs|Torax Medical, Inc.|651-361-8900|aderosier@toraxmedical.com
11562|NCT01058265|Larry Bergstrom, MD|Mayo Clinic in Arizona|480-301-7108|bergstrom.larry@mayo.edu
11563|NCT01058356|Korea Association for the Study of Intestinal Disease (KASID)|Pharmbio Korea Co., Ltd.|82-2-587-2551|pharmbio@hotmail.com
11564|NCT00878826|Dr. Deirdre Lyell|Stanford University|650-736-1191|dlyell@stanford.edu
11565|NCT00878878|Ruben Sheng, M.D.|GE Healthcare|1-609-514-6899|Rubin.Sheng@ge.com
11566|NCT00879229|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
11567|NCT00879411|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11681|NCT01070966|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11682|NCT01070979|Grexan Wulff, Manager Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
11683|NCT01071044|Joel L. Young, MD|Rochester Center for Behavioral Medicine|248-608-8800 ext 261|jyoung@rcbm.net
11684|NCT01071070|Global Medical Services|Abbott|800-633-9110|
11685|NCT01071083|Biogen Idec Medical Director|Biogen Idec Inc|1-617-679-2000|neurologyclinicaltrials@biogenidec.com
11686|NCT01071096|Jeanne Tarrasch|Clinvest|417-841-3673|jtarrasch@clinvest.com
11687|NCT01071200|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
11688|NCT01071278|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11689|NCT00888381|Clinical Trial Disclosure Manager|CSL Limited|Use email contact|csl.clinicaltrials@csl.com.au
11690|NCT00888433|Murray Esler, Principal Investigator|Baker IDI Heart and Diabetes Institute||murray.esler@bakeridi.edu.au
11691|NCT00888459|Jon O. Ebbert|Mayo Clinic|507-266-1944|ebbert.jon@mayo.edu
14511|NCT01510912|Daniel Solorio, Executive Director of Clinical Operations|Iroko Pharmaceuticals, LLC|267-546-3150|dsolorio@iroko.com
14512|NCT01511939|Manager, Clinical Research Department|Arthritis Treatment Center|301-624-1168|tgillis@arthritistreatmentcenter.com
14513|NCT01512108|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
14514|NCT01512160|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14515|NCT01682031|Senior Administrator, Compliance - Clinical Research Services|Roswell Park Cancer Institute|716-845-2300|
14516|NCT01682460|Research Manager|CCLR|519-888-4742|cclr2@sciborg.uwaterloo.ca
14517|NCT01682538|Medical Director|Swedish Orphan Biovitrum|+4686972000|erik.brouwer@sobi.com
14227|NCT01562548|GSK Response Center|GlaxoSmithKline|866-435-7343|
14228|NCT01562613|Taco Baardman|Abbott||taco.baardman@abbott.com
14229|NCT01562743|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-6361-7366|
14230|NCT01562886|Dr Borja Mora Peris|Imperial College London|020 3312 6789|b.mora-peris@imperial.ac.uk
14231|NCT01563081|GSK Response Center|GlaxoSmithKline|866-435-7343|
14232|NCT01563978|Dave Goldstraw|AstraZeneca Pharmaceuticals|+44-1625-512415|dave.goldstraw@astrazeneca.com
14233|NCT01564706|Chief Medical Officer|Avid Radiopharmaceuticals|215-298-0700|clinicaloperations@avidrp.com
14234|NCT01564758|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14235|NCT01565291|Chief Medical Officer|Avid Radiopharmaceuticals|215-298-0700|clinicaloperations@avidrp.com
14236|NCT01565330|Chief Medical Officer|Avid Radiopharmaceuticals|215-290-0700|clinicaloperations@avidrp.com
14237|NCT01565343|Chief Medical Officer|Avid Radiopharmaceuticals|215-298-0700|clinicaloperations@avidrp.com
14238|NCT01565356|Chief Medical Officer|Avid Radiopharmaceuticals|215-298-0700|clinicaloperations@avidrp.com
14239|NCT01565369|Chief Medical Officer|Avid Radiopharmaceuticals|215-798-0700|clinicaloperations@avidrp.com
12746|NCT01646827|Global Medical Affairs|Otsuka Pharmaceutical Development & Commercialization, Inc|800 562-3974|
12747|NCT01648101|GSK Response Center|GlaxoSmithKline|866-435-7343|
12748|NCT01648452|Paul A Sieving, MD, PhD|National Eye Institute|301-496-2234|ps261o@nih.gov
12749|NCT01648699|Medical Affairs Manager|Janssen Philippines|+632-8248935|
12360|NCT00916721|A. Eden Evins, MD, MPH, Director Center for Addiction Medicine|Massachusetts General Hospital|617-643-4679|a_eden_evins@hms.harvard.edu
12361|NCT00916929|Tamara Shipman|St Jude Medical|408 522-6410|tshipman@sjm.com
12362|NCT00917124|Zeljko Colak|University Hospital Center Zagreb|00385915624189|zcolak2000@yahoo.com
12363|NCT00917267|Chief Medical Officer|Eli Lilly and Company|1-877-285-4559|clinicaltrials@amylin.com
12364|NCT00917579|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
12365|NCT00917644|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
12366|NCT00917852|Tab Bonny|W.L. Gore and Associates|9288644275|tbonny@wlgore.com
12367|NCT00917865|David Schuster, MD|Emory University|404-712-4859|dschust@emory.edu
12368|NCT00918125|Dr. Kevin Thomas|Duke University Medical Center|919-668-7857|kevin.thomas@dm.duke.edu
12369|NCT00918138|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
12370|NCT00918255|Global Medical Services|Abbott|800-633-9110|
12371|NCT00918281|Matthew Miller|GE Healthcare|011-44-1494-543981|matthew.miller@ge.com
12372|NCT00918346|Auli Ropo|Santen Oy|+358405012416|auli.ropo@santen.fi
12373|NCT00918580|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12374|NCT00918671|Professor Knut Hagen|NTNU|+4772575080|knut.hagen@ntnu.no
12375|NCT00918736|Shu-Fen Sun|Veterans General Hospital, Kaohsiung, Taiwan|886-73422121 ext 4210|sfsun.tw@yahoo.com.tw
11692|NCT00888849|Sheryl Helsinger/Clinical Affairs Director|Ethicon Endo Surgery, Inc|513-337-3079|shelsing@its.jnj.com
11693|NCT00888940|Alistair Wheeler, MD MFPM, Senior Director Clinical Research|Cubist Pharmaceuticals, Inc.|781-860-8660|awheeler@cubist.com
11694|NCT00889252|Brian Pall OD MS FAAO|Vistakon|904-443-1290|
11695|NCT00889265|Dr Hai Bo Wen, Director of Research|Zimmer Dental|760-929-4312|haibo.wen@zimmer.com
11696|NCT00889330|Arthur Shedden, MD|Johnson & Johnson Vision Care, Inc.|904-443-1557|ashedden@its.jnj.com
11697|NCT00889421|Dr. Eric Suhler|Oregon Health & Science University|503-494-5023|suhlere@ohsu.edu
11698|NCT00889603|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11699|NCT00889681|Dana Wigert- Sr. Clinical Research Specialist|Medtronic- AF Solutions|763-526-2802|dana.wigert@medtronic.com
11700|NCT00889707|Chief Medical Officer|Sophiris Bio Corp (formerly Protox Therapeutics)|858-255-4711|richard@sophiris.com
11701|NCT00889720|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11702|NCT00889863|Study Director|Novartis Pharmaceuticals|862-778-8300|
11816|NCT01311102|Dr. Anita Nelson|Harbor-UCLA Medical Center|310-222-3871|anitanelsonwhc@earthlink.net
11817|NCT01311505|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11818|NCT01311661|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11819|NCT01386008|Meng Lin, OD, PhD|Clinical Research Center (CRC) UC Berkeley School of Optometry|(510) 642-9731|
11820|NCT01386125|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
11821|NCT01386944|UCB Clinical Trial Call Center|UCB|++1 877 822 9493|
11822|NCT01386983|GSK Response Center|GlaxoSmithKline|866-435-7343|
11823|NCT01387074|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11824|NCT01387178|GSK Response Center|GlaxoSmithKline|866-435-7343|
14240|NCT01565382|Chief Medical Officer|Avid Radiopharmaceuticals|215-298-0700|clinicaloperations@avidrp.com
14241|NCT01565538|Dr. Si-Yu Wang|Sun Yat-sen University Cancer Center|020-87343439|wsysums@163.net
14242|NCT01610687|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd.|0044 1223 266800|rp@gwpharm.com
14243|NCT01610700|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd.|0044 1223 266800|rp@gwpharm.com
14244|NCT01610713|Mr Richard Potts, Clinical Operations Director|GW Pharma Ltd.|0044 1223 266800|rp@gwpharm.com
14245|NCT01610791|Medical Communications|Hoffmann- LaRoche|800-821-8590|genentech@druginfo.com
14246|NCT01611571|Marcella Walker MD|Columbia University Medical Center|212-342-5351|mad2037@columbia.edu
14247|NCT01612494|Dr. Angela Lumba-Brown|Washington University School of Medicine|314-362-4325|lumba_a@kids.wustl.edu
14248|NCT01612702|Dr. TK Kim|Joint Reconstruction Center, Seoul National University Bundang Hospital|82-31-787-7196 ext 7200|osktk@snubh.org
14249|NCT01613326|Study Director|Novartis Pharmaceuticals|4 161 324 1111|
14385|NCT01696760|Joel Mayerson, MD|The Ohio State University Comprehensive Cancer Center|614-293-4420|joel.mayerson@osumc.edu
14386|NCT01512368|Dr. Daniel Cuevas-Ramos|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|525554870900 ext 2407|shiverqks@hotmail.com
14387|NCT01512849|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
14388|NCT01512979|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
14389|NCT01513122|Prof Sean Emery|The Kirby Institute|+61293850900|semery@kirby.unsw.edu.au
14390|NCT01513148|Dr. Todd Telemeco|Shenandoah University|540-545-7398|ttelemec@su.edu
14391|NCT01513330|Director of Clinical Trials|Coloplast A/S|+45 4911 3595|dkbir@coloplast.com
14392|NCT01514318|Dr. Jane M. Jacob|DJO Surgical|512-834-6323|jane.jacob@djoglobal.com
14393|NCT01514734|Doug Hubatsch, Global Brand Leader, Medical Affairs|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
12376|NCT00918749|Grexan Wulff, Manager, Regulatory Affairs|Warner Chilcott|973-442-3376|gwulff@wcrx.com
12377|NCT00918866|Dana Washburn, M.D.|Lantheus Medical Imaging|978-671-8686|dana.washburn@lantheus.com
12378|NCT00918879|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
12379|NCT00918931|Srdan Verstovsek M.D./Associate Professor|Organization: The University of Texas M. D. Anderson Cancer Center|713-792-7305|eharriso@mdanderson.org
12380|NCT00918957|Clinical Disclosure Office|Novartis Pharmaceuticals|862-778-8300|
12381|NCT00919035|Sigrun Hallmeyer, MD|Oncolgy  Specialists, SC|847-268-8200|shallmeyer@oncmed.net
12382|NCT00919113|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|Watson Laboratories, Inc.|801 588-6641|gary.hoel@watson.com
12565|NCT00961532|Andrew M Naidech|Northwestern Medicine|312-503-3335|a-naidech@northwestern.edu
12566|NCT01016977|GSK Response Center|GlaxoSmithKline|866-435-7343|
12567|NCT01017003|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
12568|NCT01017042|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
12569|NCT01017120|GSK Response Center|GlaxoSmithKline|866-435-7343|
12570|NCT01017146|GSK Response Center|GlaxoSmithKline|866-435-7343|
12571|NCT01017237|Jay Anderson, DDS, MD|University of North Carolina School of Dentistry|919-966-1126|janderson@aims.unc.edu
12572|NCT01017250|John Kirkpatrick, MD, PhD|Duke University Radiation Oncology|919 668-7342|robert.clough@dm.duke.edu
12573|NCT01017263|Scott Kollins, PhD|Duke UMC|9196810014|scott.kollins@dm.duke.edu
12574|NCT01017549|Michael A. Patz  MBA, RAC, Senior Director Clinical Affairs|iCAD, Inc. Xoft, Inc|603-882-5200 ext 7308|mpatz@icadmed.com
12575|NCT01017653|Annick Desjardins|Preston Robert Tisch Brain Tumor Center||annick.desjardins@dm.duke.edu
12576|NCT00972205|Susan S. Bates, M.D.|National Cancer Institute (NCI), National Institutes of Health (NIH)|301-402-0984|Batess@mail.nih.gov
12577|NCT00972244|Eva Johnsson|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
11825|NCT01387230|GSK Response Center|GlaxoSmithKline|866-435-7343|
11826|NCT01387347|Nabila Turjman, PhD, Executive Director, Regulatory Affairs and Drug Safety|RegeneRx Biopharmaceuticals, Inc.|301-208-9191 ext 108|nturjman@regenerx.com
11827|NCT01387542|Medical Affairs Director|Janssen-Cilag Ltd.:  106 Moo 4 Lad Krabang Industrial Estate, Chalongkrung Rd., Lamplatew, Lad Krabang, Bangkok 10520|+66 2 7397200 ext 5888|
11828|NCT01387737|Clinical Trials, Information Desk|Mitsubishi Tanabe Pharma Corporation||cti-inq-ml@ml.mt-pharma.co.jp
11829|NCT01387789|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
11830|NCT01388491|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
11831|NCT01388790|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
11832|NCT01388816|Kent Allenby, MD|Proprietary Products, Dr. Reddy's Laboratories, Inc.|609-375-9855|kallenby@drreddys.com
11833|NCT01388920|Senior Medical Advisor|Theratechnologies|514-336-7800|jmamputu@theratech.com
11834|NCT01389102|Jim Joffrion|KV Pharmaceutical Company|314-645-6600 ext 3410|jjoffrion@kvph.com
11835|NCT01389284|Head Medical Affairs|Bayer HealthCare LLC, Consumer Care||clinical-trials-contact@bayerhealthcare.com
11836|NCT01389882|Dr. Juyoung Lee|Seoul National University Hospital|lamb4122@snu.ac.kr|lamb4122@snu.ac.kr
11837|NCT01390233|Meg Hill, MBBS|University of Arizona (Investigator has changed institutions - study completed at University of South Carolina)|520 626 6174 ext -|meghanhill@obgyn.arizona.edu
11409|NCT01172353|Vitor Osório Gomes, MD, PhD|Hospital Sao Lucas|55 51 33203494|pesquisa@cardiarte.com.br
11410|NCT01172418|George W. Burke, M.D.|University of Miami|305-355-5315|gburke@med.miami.edu
11411|NCT01172808|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11412|NCT01172821|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11413|NCT01172873|Moira A. Rynn, M.D.|New York State Psychiatric Institute/Columbia University|646-774-5805|RynnM@nyspi.columbia.edu
11414|NCT01172938|Anne McClain, Senior Manager|Celgene Corporation|888-260-1599|clinicaltrialdisclosure@celgene.com
14394|NCT01515306|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
14395|NCT01515345|Univ.Prof. Dr Günter Christ|Kaiser Franz Josef Hospital|+43160191 ext 2508|guenter.christ@wienkav.at
14396|NCT01515410|Head of R&D|Depomed|510-744-8000|msweeney@depomed.com
14397|NCT01515488|Madhumita Sinha, MD, MHSM|Maricopa Integrated Health System|602-344-5404|madhumita_sinha@dmgaz.org
14398|NCT01515540|Javeria Ali Hashmi|Northwestern University|3125037991|j-hashmi@northwestern.edu
14399|NCT01515566|David Hui, MD, MSc, FRCPC / Asst. Professor, Palliative Care and Rehabilitation Medicine|University of Texas MD Anderson Cancer Center|713-792-6085|CR_Study_Registration@mdanderson.org
14400|NCT01515696|Nadja Haiden M.D.|Medical University of Vienna|+431404003232|nadja.haiden@meduniwien.ac.at
14401|NCT01516008|Clinical Leader|Janssen Research & Development, L.L.C.||ClinicalTrialDisclosure@its.jnj.com
14402|NCT01516034|David J. Friedman, Principal Investigator|Dr David Friedman Laser & Skin Center|+972-2-5635673|drfriedmanlaser@gmail.com
14403|NCT01516268|Dr. Laleh Eslamian|Tehran University of Medical Sciences|0098218490 ext 2415|leslamian@tums.ac.ir
14404|NCT01516749|Kieron S. Leslie, MD|University of California, San Francisco|415-206-4777|lesliek@derm.ucsf.edu
14405|NCT01517074|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|National Institutes of Health|301-402-3254|senh@nei.nih.gov
14406|NCT01518192|Franc Strle|Department of Infectious Diseases, University Medical Center Ljubljana|+386 1 522 2610|franc.strle@kclj.si
14250|NCT01613339|Dr. Anette Forsberg|Orebro county council|+46-19-602 5788|anette.forsberg@orebroll.se
14251|NCT01614509|Dr. Min Sagong|Yeungnam University College of Medicine|82-53-620-4191|msagong@ynu.ac.kr
14252|NCT01614574|Bjorn Mellgard, MD, PhD|Shire|+41 22 419 4110|bmellgard@shire.com
14253|NCT01614600|Jami Kern, MBA, PhD|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
14254|NCT01614613|Carmine Greene|Bayer Healthcare, Diabetes Care|574-257-3040|carmine.greene@bayer.com
14255|NCT01614769|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12578|NCT00972322|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
12579|NCT00972374|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
12580|NCT00972530|Dr Tomas Weitoft|Department of Research and Development County Council of Gavleborg/Uppsala University|+46 26 154388|tomas.weitoft@lg.se
12581|NCT00972543|Medical Responsible|Merck Serono S.A., a division of Merck KGaA|+49-6151-75-5200|service@merckgroup.com
12582|NCT01030458|Prof. Dr. Jan A Staessen|University of Leuven|+32 16 34 7104|jan.staessen@med.kuleuven.be
12583|NCT01030666|Prof. Dr. Peter Eickholz|JWGUniversity|+496963015642|eickholz@med.uni-frankfurt.de
12584|NCT01030718|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
12585|NCT01030952|Study Director|Novartis Pharmaceuticals|+1-800-244-7668|
12586|NCT01030965|GSK Response Center|GlaxoSmithKline|866-435-7343|
12587|NCT01031004|John Buch/Principal Research Optometrist|Vistakon|904-443-1707|
12773|NCT01081041|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12774|NCT01081132|Study Physician|Shire Development LLC|+1 866 842 5335|
12775|NCT01081145|Study Physician|Shire Development LLC|+1 866 842 5335|
12776|NCT01081301|Dr. Wendy Duggleby|University of Alberta|780-492-8660|wendy.duggleby@ualberta.ca
12777|NCT01081626|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
12778|NCT01081665|Global Medical Services|Abbott|1-800-633-9110|
12779|NCT01081795|Group Manager|Janssen Pharmaceutical KK Japan|+81-3-4411-5072|
12780|NCT01081834|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|Janssen Research & Development, LLC|1-800-526-7736|
12781|NCT01081873|Global Medical Services|Abbott|800-633-9110|
12782|NCT01081886|Robert Swain, PhD|Medtronic Surgical Technologies|(+1-603) 294-5428|robert.e.swain@medtronic.com
11415|NCT01173029|Paulo Robeto Benchimol Barbosa|Universidade Gama Filho|+55-21-95320182|ecgar@yahoo.com
11416|NCT01173120|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
11417|NCT01173211|Shital M. Patel, M.D.|Baylor College of Medicine|713-798-3793|shitalp@bcm.edu
11418|NCT01173471|Stuart McIntosh|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com
11419|NCT01173653|Benjamin  Heavrin, MD|Vanderbilt University Emergency Medicine Department|615-936-0253-|benjamin.heavrin@vanderbilt.edu
11420|NCT01173718|Debby Pfile, Clinical Research Associate|W. L. Gore & Associates|623-234-5226|dpfile@wlgore.com
11421|NCT01174004|Roger Mills, MD|ACADIA Pharmaceuticals Inc.|858-202-7563|rmills@acadia-pharm.com
11422|NCT01174030|Michael Graeber, MD|Galderma|609-860-8201|michael.graeber@galderma.com
11423|NCT01174342|Amit Meshi|Meir Medical Center|+972523580222|amitmeshi@gmail.com
11424|NCT01174446|Brigitt Abbuehl, MD, Global Medical Director, Hematology/Hemophilia|Baxter Innovations GmbH||brigitt_abbuehl@baxter.com
11425|NCT01174459|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11426|NCT01174576|Dr. Mary Yannakoulia|Harokopio University|00302109549175|myianna@hua.gr
11427|NCT01174784|Patty Hevey|Avinger Inc.|650.241.7900|phevey@avinger.com
11428|NCT01175005|Amanda Kasem|Phoenixchildrens|6025461910|akasem@phoenixchildrens.com
11429|NCT01175317|Kostan Reisinger|Maastricht University Medical Center|0031433881494|k.reisinger@maastrichtuniversity.nl
11430|NCT01175369|Dr. Jill Halterman|University of Rochester|5852755798|jill_halterman@urmc.rochester.edu
11431|NCT01175434|Dr. Jill Halterman|University of Rochester|5852755798|jill_halterman@urmc.rochester.edu
11568|NCT01001806|Frank A. Bucci, Jr., MD|Bucci Laser Vision|570-825-5949|Buccivision@aol.com
11569|NCT01001832|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
11570|NCT01001975|Vice President, Late Stage Development Group Leader|Merck Sharpe & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
14256|NCT01615263|Dr Jean S. Bussières, anesthesiologist, director of research|Institut universitaire de cardiologie et de pneumologie de Québec, Laval University|418 656-4870|jbuss@criucpq.ulaval.ca
14257|NCT01615328|Jin-Sup Yeom|Seoul National University Bundang Hospital|82-31-787-7190|highcervical@gmail.com
14258|NCT01616459|GSK Response Center|GlaxoSmithKline|866-435-7343|
14259|NCT01616576|Cedric Navarro, Vice President of Regulatory/Clinical Affairs and Quality|Advanced Bionics, LLC|(661) 362-1963|Clinical.Research@advancedbionics.com
14260|NCT01617577|Professor Juan Sanchez-Ramos|University of South Florida|813-974-5841|jsramos@health.usf.edu
14261|NCT01617603|Prof. Stephen Atkin, Principal Investigator|Medical School, Michael White Diabetes Centre, 220-236, Anlaby Road,|+44(0)1482 675312|Stephen.Atkin@hyms.ac.uk
14262|NCT01618019|Dr. Yongsoon Park|Hanyang University|82-2-2220-1205|yongsoon@hanyang.ac.kr
14263|NCT01618214|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
14264|NCT01881776|Dr.Admir Hadzic|StLukeNY|212-665-1400|admir@nysora.com
14265|NCT01885104|Senior Vice President, Global Clinical Development|Merck Sharpe & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
14266|NCT01885117|Posting Director|Novartis Vaccines and Diagnostics||RegistryContactVaccinesUS@novartis.com
14267|NCT01889563|Audrey Borghi e Silva|Federal university of Sao Carlos|+55 163351-8952|audrey@ufscar.br
14268|NCT01890343|Chief Medical Officer|Avid Radiopharmaceuticals|215-298-0700|clinicaloperations@avidrp.com
14269|NCT01565551|Geoffrey Manley, MD, PhD|University of California, San Francisco|415-206-8300|manleyg@neurosurg.ucsf.edu
14270|NCT01565993|Dra Elvira Quintanilla|Hospital Universitario Severo Ochoa|34 914818000 ext 8326|elviramquintanilla@hotmail.com
14271|NCT01566084|Dr. Kristen Jablonski|University of Colorado Denver|303-724-4842|KRISTEN.NOWAK@UCDENVER.EDU
14407|NCT01518244|Doug Hubatsch, Global Brand Leader, Medical Affairs|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
14408|NCT01426958|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
14409|NCT01427309|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
12783|NCT01081912|Kevin Romanko|Zogenix|(510) 550-8323|kromanko@zogenix.com
12784|NCT01081951|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
12785|NCT01082159|VP Clinical Research|Vertos Medical|949-349-0008 ext 216|cmyers@vertosmed.com
12786|NCT01082328|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
12787|NCT01082380|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12788|NCT01082575|Fran Haury Clinical Program Manager II|Covidien|303 305-2314|fran.haury@covidien.com
12789|NCT01082588|Dr. David Henderson|Massachusetts General Hospital|617-912-7800|dchenderson@partners.org
12790|NCT01082640|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
12791|NCT01082939|William G. Wierda, MD, PhD, BS / Associate Professor|The University of Texas MD Anderson Cancer Center|713-745-0428|eharriso@mdanderson.org
12792|NCT01082952|Dr. Rabih Halwani|King Saud University|00966551307134|rhalwani@ksu.edu.sa
12793|NCT01082965|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12794|NCT01083121|Global Medical Services|AbbVie (prior sponsor, Abbott)|800-633-9110|
12795|NCT01083160|Global Medical Services|Abbott|1-800-633-9110|
12383|NCT00919126|Prof. Dr. Med Berthold BEIN|University Hospital Schleswig-Holstein|+49(0)431-5973 739|bein@anasthesie.uni-kiel.de
12384|NCT00968890|GSK Response Center|GlaxoSmithKline|866-435-7343|
12385|NCT00969150|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|Forest Research Institute|201-427-8000 ext 8124|carl.gommoll@frx.com
12386|NCT00927992|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12387|NCT00928057|Kenneth Kassler-Taub, MD|BD Medical, Medical Affairs|201 847 6729|kenneth_kassler-taub@bd.com
12388|NCT00928070|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11571|NCT01002287|Sue Duggan|Covidien|781-577-5819|susan.duggan@covidien.com
11572|NCT01068600|Study Director|Novartis Pharmaceuticals|862-778-8300|
11573|NCT01068626|Kristjan Karason|University of Gothenburg|+46 31 342 7554|kristjan.karason@gu.se
11574|NCT01068652|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
11575|NCT01068717|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
11576|NCT01068730|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
11577|NCT01068743|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
11578|NCT01068769|Dr. Suzanne George|Dana-Farber Cancer Institute|617-632-5204|sgeorge2@partners.org
11579|NCT01068821|Dr. Mary Ellen Wechter|Mayo Clinic, Florida|904 412 7351|wechter.mary@mayo.edu
11580|NCT01068860|Dr. Tom Thuren/Global Brand Medical Director|Novartis Pharmaceuticals|862-778-1828|tom.thuren@novartis.com
11581|NCT01068912|Dr. Carol Epstein, Chief Medical Officer|MediVector, Inc., managing member MDVI, LLC|617-439-4500|cepstein@medivector.com
11582|NCT01068964|Therapeutic Area Head|Allergan, Inc.|714-246-4500|clinicaltrials@allergan.com
11583|NCT01069120|Jennifer Wike|Repros Therapeutics Inc.|2817193402|jwike@reprosrx.com
11584|NCT01069172|Luis Atiles, Manager, Clinical Research|AMO Development, LLC|214 537-6784|luis.atiles@amo.abbott.com
11585|NCT01069289|Gerard Lynch|AstraZeneca||aztrial_results_posting@astrazeneca.com
11586|NCT01069341|Dr. Neelakshi Bhagat|The University of Medicine and Dentistry of New Jersey|973-972-2032|bhagatne@umdnj.edu
11587|NCT01069523|Steven R.Pliszka MD|University  of Texas Health Science Center at San Antonio|210-567-5475|pliszka@uthscsa.edu
11588|NCT01069562|Puri GD|Post Graduate Institute of Medical Education and Research|91-9914209509|gdpuri007@hotmail.com
11589|NCT01069627|Medical Communications|Hoffmann-LaRoche|800-821-8590|genentech@druginfo.com
11590|NCT01069861|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14410|NCT01427504|Dr. Jennifer Kiser|University of Colorado|303-724-6131|jennifer.kiser@ucdenver.edu
14411|NCT01427517|Mary Holmay|University of Minnesota|612-812-5854|holma101@umn.edu
14412|NCT01427803|Head Medical Affairs|Bayer HealthCare LLC, Consumer Care||clinical-trials-contact@bayerhealthcare.com
14413|NCT01427920|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
14414|NCT01427933|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
14415|NCT01428076|David Wright MB FRCS|BTG International Inc.|610-278-1660|david.wright@btgplc.com
14416|NCT01428128|Chul S. Ha, MD, Professor and Chair|The University of Texas Health Science Center at San Antonio, Department of Radiation Oncology|210-450-1109|hac@uthscsa.edu
14417|NCT01428713|Dr. Lakshmi Srivaths|Baylor College of Medicine/TCH|832-822-1514|lvsrivat@txch.org
14418|NCT01428765|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
14419|NCT01429051|Medical Director|Takeda|+1-800-778-2860|clinicaltrialregistry@tpna.com
14420|NCT01429077|Leora R. Cherney, PhD|Rehabilitation Institute of Chicago|312-238-1117|Lcherney@ric.org
14421|NCT01429532|Prof. Yizhi Liu|SunYat-senU|+86-20-87330341|Reviewborad_SYsU@163.com
14422|NCT01429584|Dr. Elizabeth Thackeray|University of Utah Department of Anesthesiology|(801) 581-6393|elizabeth.thackeray@hsc.utah.edu
14423|NCT01430091|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
14424|NCT01430104|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
14425|NCT01430325|Lindell K. Weaver, MD|Intermountain Healthcare|801-408-3623|lindell.weaver@imail.org
14426|NCT01430585|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14427|NCT01430611|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
14428|NCT01430819|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
14429|NCT01431014|Lun-Jou Lo, MD,Hye-Young Kim, MD|Chang Gung Memorial Hospital||lunjoulo@cgmh.org.tw
12389|NCT00928304|Dr. Juergen Hirschfeld|Piramal Imaging|49 30 461 1246 15|juergen.hirschfeld@piramal.com
12390|NCT00928395|Clinical Study Manager|Uroplasty, Inc|952-426-6153|megan.otoole@uroplasty.com
12391|NCT00928408|Study Director|Amgen Inc.|866-572-6436|
12392|NCT00928421|David Wright MB FRCS|BTG International Inc|610-943-3513|david.wright@btgplc.com
12393|NCT00928668|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12394|NCT00928694|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
12395|NCT00928720|Ann Gill Taylor, Professor Nursing|University of Virginia School of Nursing|434-924-0113|agt@virginia.edu
12396|NCT00980200|GSK Response Center|GlaxoSmithKline|866-435-7343|
12397|NCT00980330|Global Clinical Development Manager|Jan-Cil France||ClinicalTrialDisclosure@its.jnj.com
12398|NCT00980655|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12399|NCT00980746|Head of Clinical Research Section|BIAL – Portela & Ca, SA|351 22 986 6100|clinical.trials@bial.com
12400|NCT00980798|EMEA Medical Affairs Director Analgesia|Janssen-Cilag Ireland|0035 878 339174|
12401|NCT00980980|Dr. Susan Huang|University of California, Irvine|949-824-5073|sshuang@uci.edu
12402|NCT00981019|Dr. Odette Wegwarth|Max Planck Institute for Human Development, Harding Center for Risk Literacy|+49-30-82406 ext 695|wegwarth@mpib-berlin.mpg.de
12403|NCT00981045|Marc Tokars|Luitpold Pharmaceuticals, Inc.|610-650-4200|mtokars@lpicrd.com
12404|NCT00981084|Dr. Jared Bruce|University of Missouri - Kansas City|401-499-4043|brucejm@umkc.edu
12405|NCT00981175|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
11341|NCT00990106|Murray Raskind, MD|VA Puget Sound Health Care System|206-277-3797|Murray.Raskind@va.gov
11342|NCT00990184|Steven E. Kahn|SIBCR|206-277-5515|skahn@u.washington.edu
11343|NCT00990340|Thomas Smith, MD, VP, Medical Affairs|Teva Neuroscience|816-508-5000|tom.smith@tevapharm.com
11703|NCT00889915|John S. March, MD, MPH|Duke Clinical Research Institute - Duke University School of Medicine|919-668-7818|john.march@duke.edu
11704|NCT01307020|Dr Angela Capriati, Corporate Clinical Research Director|Menarini Ricerche S.p.A.|+39 055 5680 9933|acapriati@menarini-ricerche.it
11705|NCT01307033|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11706|NCT01307046|Vice President, Late Stage Development Group Leader|Merch Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11707|NCT01307423|Anne McClain|Celgene Corporation|1-888-260-1599|clinicaltrialdisclosure@celgene.com
11708|NCT01307787|G.Breedland|UMCG||g.breedland@cvr.umcg.nl
11709|NCT01308424|Dr. John McMichael|Beech Tree Labs, Inc.|518-872-1144|
11710|NCT01308450|Calvin R. Sumner, MD, CMO, Sr. VP for Clinical Development|BioBDx|978-431-5103|calvin_sumner@biobdx.com
11711|NCT01308476|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11712|NCT01308619|Dr. Warren Winkelman|Galderma Laboratories|817-961-5494|warren.winkelman@galderma.com
11713|NCT01308762|Clinical Trials Co-ordinator|Immodulon Therapeutics, The London Clinic Cancer Centre, London W1G 6JA,|+44 (0)203 219 3568/3572|Ilda@immodulon.com
11714|NCT01308788|Alon Harris|Indiana University|3170278-0177|alharris@indiana.edu
11715|NCT01308918|Nathalie Gagne|Institut universitaire de cardiologie et de pneumologie de Quebec|418 656-8711 ext 2645|nathalie.gagne@criucpq.ulaval.ca
11716|NCT01309100|Dr. Robert Steffen|Bausch & Lomb|585 338 6399|robert.steffen@bausch.com
11717|NCT01309204|Matt Walker, PhD, Clinical Project Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
11718|NCT01309243|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
11719|NCT01309308|Ayse Parlakgumus|Baskent University|00903224586868 ext 2102|ayseparlakgumus@yahoo.de
11720|NCT01309360|Dr.med.Ronald Seidel|Helios-Kliniken Schwerin|0049 (0)385 520-4251|ronald.seidel@helios-kliniken.de
11721|NCT01309386|Manager|Neuroscience department, Clinical science department, R&D in Janssen, Chiyodaku, Tokyo 101-0065, Japan|+81-3-4411-5509|
14272|NCT01566149|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
14273|NCT01566526|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
14274|NCT01566604|Study Director|Novartis|862-778-8300|
14275|NCT01567163|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
14276|NCT01567839|Dr. John Nusstein|The Ohio State University, Division of Endodontics|614-292-9412|nusstein.1@osu.edu
14277|NCT01568008|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
14278|NCT01568892|GSK Response Center|GlaxoSmithKline|866-435-7343|
14279|NCT01569074|Dave Goldstraw|AstraZeneca Pharmaceuticals|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
14280|NCT01569126|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
14281|NCT01783860|Dr. Mohsen Bahmani-Kashkouli|Rasoule-Akram Hospital|00982166558811|bahmanik@eyeplasticsurgeries.com
14282|NCT01785628|The chief, Department of Neurology|China Medical University Hospital|8864-22052121 ext 5035|d8079@mail.cmuh.org.tw
14283|NCT01786109|Dr. Michael Camilleri|Mayo Clinic|507-266-2306|camilleri.michael@mayo.edu
14284|NCT01786629|John McGowan, Director Clinical Research|Braintree Laboratories, Inc.|781-843-2202|jmcgowan@braintreelabs.com
14285|NCT01786707|Dr. Rodolfo Alejandro|University of Miami School of Medicine|3052435324|ralejand@med.miami.edu
14286|NCT01786876|Study Physician|Shire Development LLC|+1 866 842 5335|
14287|NCT01787838|Rebecca Culver Clark|Carilion Clinic|540-588-8184|rcclark@carilionclinic.org
14288|NCT01790750|Curt DeGroff|University of Florida|(352) 273-7831|degroffc@peds.ufl.edu
14289|NCT01791413|Dr. Weena Krutsawad|Mahidol University|66812070264|vna_fe2@hotmail.com
14290|NCT01793285|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14291|NCT01795898|Medical Affairs Manager|Janssen Philippines|+632-8247901|
13747|NCT01718535|Azar Azad|Mount Sinai Services Inc.|416-856-8545|aazad@mtsinai.on.ca
13748|NCT01719172|Julie Totten|Covidien|781-839-1729|Julie.Totten@Covidien.com
13931|NCT01440322|Sharon Holden Thomas, Sr. Principal Clinical Scientist|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
13932|NCT01440387|GSK Response Center|GlaxoSmithKline|866-435-7343|
13933|NCT01440517|Arnold Jacobson, M.D.|GE Healthcare|1-609-514-6325|Arnold.Jacobson@ge.com
13934|NCT01440543|Premysl Falt MD|Digestive Diseases Center, Vitkovice Hospital, Ostrava, Czech Republic|+420602689561|faltprem@centrum.cz
13935|NCT01440634|Dr. Carlos H Timaran|UT Southwestern Medical Center|2146450533|timaran1@msn.com
13936|NCT01440647|Abbot R. Laptook, MD, Professor of Pediatrics The Warren Alpert Medical School of Brown University M|Women & Infants Hospital of Rhode Island|401-274-1122 ext 7404|ALaptook@WIHRI.org
13937|NCT01440881|Dr. Thomas Beaver|University of Florida|352-273-5501|thomas.beaver@surgery.ufl.edu
13938|NCT01440959|Dr. Yoon-Koo Kang|Asan Medical Center|+82-2-3010-3210|ykkang@amc.seoul.kr
13939|NCT01441180|Dr. Shyam Kottilil|NIAID/NIH|301-435-0936|skottilil@niaid.nih.gov
13940|NCT01539538|Pamela Palmer|AcelRx|650-216-3500|ppalmer@acelrx.com
13941|NCT01539642|Pamela Palmer, MD, PhD|AcelRx Pharmaceuticals, Inc|650-216-3504|ppalmer@acelrx.com
13942|NCT01540370|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
13943|NCT01540487|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
13944|NCT01541254|Mary Schmitz|MicroVention, Inc.|714-247-8025|mary.schmitz@microvention.com
13945|NCT01541371|Therapeutic Area Manager|CDMA, Beijing|00861058218352|
13946|NCT01541553|Clinical trial disclosure|LEO Pharma A/S|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com
13947|NCT01541735|PhD. Manuel González Ortiz|Instituto Mexicano del Seguro Social|33 36176000 ext 31494|uiec@prodigy.net.mx
13948|NCT01541930|Clinical Project Manager|Galderma K.K.|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com
11344|NCT00990509|Chelsea Kidwell, MD|University of Arizona|(520) 626-7159|ckidwell@neurology.arizona.edu
11345|NCT00990561|John Koo, Principle Investigator|UCSF|415-476-4701|john.koo@ucsfmedctr.org
11346|NCT00990652|Jeffrey Raizer, MD|Northwestern University|312-503-4724|jraizer@nmff.org
11347|NCT00990704|Global Medical Services|Abbott|800-633-9110|
11348|NCT00990769|Dr. Heather Frederick|Duke University Medical Center|919-812-6204|heather.frederick@duke.edu
11349|NCT00990821|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11350|NCT00990964|Attain Success Clinical Trial Leader|Medtronic, Inc.|800-328-2518 ext 62864|medtronicCRMtrials@medtronic.com
11351|NCT00943592|Dr. Andrew Artz|University of Chicago|773-834-8980|aartz@medicine.bsd.uchicago.edu
11352|NCT00943605|Robert Swain, PhD|Medtronic Surgical Technologies|(+1-603) 294-5428|robert.e.swain@medtronic.com
11353|NCT00943631|Karen Kotloff, MD|Center for Vaccine Development, University of Maryland|401-706-5328|kkotloff@medicine.umaryland.edu
11354|NCT00943670|Medical Communications|Hoffman-LaRoche|800-821-8590|
11355|NCT00943683|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
11356|NCT00943735|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11357|NCT00943787|Mary Oliveri|University of Virginia|434-982-0602|mc7m@virginia.edu
11358|NCT00943826|Medical Communications|Hoffman-LaRoche or Genentech, Inc.|800-821-8590|
11359|NCT00943852|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
11360|NCT00943878|Sharon E. Frey, M.D.|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|314-977-5500|freyse@slu.edu
11361|NCT00943917|Michelle Baron MD|Intarcia Therapeutics, Inc|510-782-7800|clinicaltrials@intarcia.com
11362|NCT00944073|Karen Kotloff, MD|Center for Vaccine Development, University of Maryland|401-706-5328|kkotloff@medicine.umaryland.edu
11722|NCT01309581|James Murrough|Mount Sinai School of Medicine|212 241 7574|James.Murrough@mssm.edu
11723|NCT01309646|GSK Response Center|GlaxoSmithKline|866-435-7343|
11724|NCT01309659|Harvey J Cohen, MD|Duke University Medical Center|919-660-7502|harvey.cohen@dm.duke.edu
11838|NCT01390259|Marc Breton, Ph.D.|University of Virginia|434-982-6484|mb6nt@virginia.edu
11839|NCT01390389|Cara McCabe|McLean Hospital|617-855-2410|cfmccabe@partners.org
11840|NCT01106586|Christophe Beraud, Director, Regulatory Affairs|Gilead Sciences, Inc|(650) 522-5093|christophe.beraud@gilead.com
11841|NCT01106625|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|Janssen Research & Development, LLC|1 800 526 7736|
11842|NCT01106651|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|Janssen Research & Development, LLC|1-800-526-7736|
11843|NCT01106677|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|Janssen Research & Development, LLC|1 800 526 7736|
11844|NCT01106690|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|Janssen Research & Development, LLC|1-800-526-7736|
11845|NCT01106859|Clinical Leader|Purdue Pharma LP|800-733-1333|
11846|NCT01106950|Jeffrey S. Miller, M.D.|Masonic Cancer Center, University of Minnesota|612-625-7409|mille011@umn.edu
11847|NCT01107197|Dr. Federico D'Andrea|Department of Clinical Nutrition and Dietetics, Azienda Ospedaliera “Maggiore della Carità”|+39 0321.373.3275|dietologia@maggioreosp.novara.it
11848|NCT01107353|Anton (Tony) Amann, PhD., Executive Director, DRAMA|Roxane Laboratories, Inc.|614-272-4785|tony.amann@boehringer-ingelheim.com
11849|NCT01107379|Clinical Director|Acclarent, Inc.|650-687-5888|lenglan1@its.jnj.com
11850|NCT01107392|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11851|NCT01107405|Tuyen Ong, MD MRCOphth|Bausch & Lomb Incorporated|(973) 360-6389|tuyen.ong@bausch.com
11852|NCT01107535|Global Medical Services|Abbott|1-800-633-9110|
11853|NCT01107743|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
14292|NCT01796548|Medical Affairs Director|Medical Affairs, Janssen-Cilag (Thailand)|662-792-7200 ext 5888|
14293|NCT01797380|Harold Goforth, M.D.|Duke University Health Systems|216-636-3999|goforth@ccf.org
14294|NCT01797783|Stacie Cummings, O.D.|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
14430|NCT01431079|Dr. Manoj Sharma, PI|University of Cincinnati|513-556-3878|manoj.sharma@uc.edu
14431|NCT01431144|Henry Greenwell, Principal Investigator|University of Louisville|502-852-6928|henry.greenwell@louisville.edu
14432|NCT01431300|Charles Kim|Duke University Medical Center|919-684-7284|charles.kim@duke.edu
14433|NCT01431339|Michael Zelasky|Durata Therapeutics|203-871-4616|mzelasky@duratatx.com
14434|NCT01431508|Vice President, late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
14435|NCT01518257|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
14436|NCT01518270|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
14437|NCT01518322|Nancy Herje|Aerocrine, Inc.|919-449-8873|Nancy.Herje@aerocrine.com
14438|NCT01518530|Dr. Yaron River|Hillel Yaffe Medical Center|972-523-756-446|yaronr@hy.health.gov.il
14439|NCT01518946|Study Physician|Shire|+1 866-842-5335|
14440|NCT01519206|Lisa Misell, Ph.D., VP, Clinical and Medical Affairs|Ulthera, Inc.|480-619-4069|
14441|NCT01519245|Dr. Kelsey Brose, Primary Investigator|University of Saskatchewan|306-655-1483|kelsey.brose@saskcancer.ca
14442|NCT01519427|Jeff Sosman, MD|Vanderbilt-Ingram Cancer Center|615-936-3048|jeff.sosman@vanderbilt.edu
14443|NCT01519648|Professor Galina A Klyasova|National Hematological Society|+7(495)6125181|klyasova.g@blood.ru
14444|NCT01519713|Medical Director|Sanofi Pasteur Inc.||RegistryContactUs@sanofipasteur.com
14445|NCT01519882|UCB Clinical Trial Call Center|UCB|+1 877 822 9493 (UCB)|
14446|NCT01519934|Lisa Misell, PhD, VP Clinical Affairs|Ulthera, Inc.|4806194069|
12297|NCT00927823|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12298|NCT00927849|ayman elnakeeb|Mansoura university hospital|0020106752021|elnakeebayman@yahoo.com
12299|NCT00927862|Dr. Jeffrey L. Anderson, Director of CV Research and Professor of Medicine|Intermountain Healthcare|801-507-4704|jeffrey.anderson@imail.org
12300|NCT00927901|Study Director|Novartis Pharmaceuticals|862 778-8300|
12301|NCT00927927|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
12302|NCT00927940|Hiroko Okubo|Medtronic Japan Co.,Ltd|+81-3-6430-7017|rs.medtroniccardiovascularclinicaltrials@medtronic.com
12303|NCT00927953|Medical Officer|MacroGenics, Inc.||info@macrogenics.com
12304|NCT01472835|Steven Cohen|Johns Hopkins|410-955-1818|scohen40@jhmi.edu
12305|NCT01472874|Dr. Schilsky|Yale|203-785-2565|michael.schilsky@yale.edu
12306|NCT01472939|Study Physician|Shire Development LLC|+1 866 842 5335|
12307|NCT01473160|Joachim Nick, Dipl. Ing.|Alcon Research, Ltd.|+49 6022 240 520|joachim.nick@cibavision.com
12308|NCT01473381|Suresh Durgam, MD Clinical Asset Lead for Vilazodone - Senior Director – Clinical Development|Forest Research Institute|201 427-8000 ext 8172|suresh.durgam@frx.com
12309|NCT01473394|Carl Gommoll|Forest Research Institute, Inc.|201 427-8000|
12310|NCT01473745|Dr. Yi Hsuan Chen|ChangGungMH|+886227135211 ext 3533|acantehr@gmail.com
12311|NCT01473836|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
12312|NCT01473953|Public Access to Clinical Trials|Novo Nordisk A/S||clinicaltrials@novonordisk.com
12313|NCT01474213|Dr. Jiang Hong|Department of Anaesthetics, Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine|86-21-13512122883|hr310@vip.sina.com.cn
12314|NCT01474317|Jeannellen Fullam, CCRA|Bayer Healthcare, Diabetes Care|914-333-6245|jeannellen.fullam@bayer.com
12498|NCT00982189|Dr. Jason Baker|Minneapolis Medical Foundation|612-873-2705|baker459@umn.edu
12499|NCT00982280|Dr. Ilona Steigerwald|Grünenthal GmbH|+49 241 569 0|Clinical-Trials@grunenthal.com
11363|NCT00944450|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
11501|NCT01012388|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com
11502|NCT01012414|David Whellan MD|Thomas Jefferson University|215 955 5050|david.whellan@jefferson.edu
11503|NCT01084239|Pearl Zakroysky|Massachusetts Genderal Hospital Biostatistics Center|617 724 0309|pzakroysky@partners.org
11504|NCT01084265|Merck KGaA Communication Center|Merck Serono, a division of Merck KGaA|+49-6151-72-5200|service@merckgroup.com
11505|NCT01084278|Sr. VP, Clinical Science|Takeda Global Research and Development Center, Inc.|800-778-2860|clinicaltrialregistry@tpna.com
11506|NCT01084538|Global Medical Services|Abbott|1-800-633-9110|
11507|NCT01084551|Director of Clinical Research and Development|Otsuka Pharmaceutical Co., Ltd.|+81-3-6361-7366|
11508|NCT01084603|Joyce Hauze, Sr Specialist, Clinical Research Operations|J&J Consumer and Personal Products Worldwide|928-277-0715|jhauze@its.jnj.com
11509|NCT01084668|Global Medical Services|Abbott|800-633-9110|
11510|NCT01084707|Joyce Hauze, Sr. Specialist, Clinical Research Operations|J&J Consumer and Personal Products Worldwide|928-277-0715|jhauze@its.jnj.com
11511|NCT01085006|Dr. Laleh Eslamian|Tehran University of Medical Sciences|+982184902415|leslamian@tums.ac.ir
11512|NCT01085201|Dr. Joshua J. Field|BloodCenter of Wisconsin|414-937-3848|joshua.field@bcw.edu
11513|NCT01085318|Fernando Dangond, MD FAAN|EMD Serono, Inc.|781-681-2348|fernando.dangond@emdserono.com
11514|NCT01175590|Tuyen Ong, MD, MRCOphth|Bausch & Lomb Inc.|(973) 360-6389|tuyen.ong@bausch.com
11515|NCT01175668|Rachana Singh, MD|Baystate Medical Center|413-794-2400|rachana.singhmd@bhs.org
11516|NCT01175798|Anita Mehrotra MD|Icahn School of Medicine at Mount Sinai|2122415153|anita.mehrotra@mssm.edu
11517|NCT01175811|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
11518|NCT01241916|Dr. David Ring|Massachusetts General Hospital|617-724-3953|dring@partners.org
11519|NCT01242085|Steven T Woolson, MD|VA Palo Alto HCS|650-493-5000 ext 66101|steven.woolson@va.gov
11854|NCT01107886|Boaz Hirshberg MD, MBA|AstraZeneca LP|1 302 885 4997 ext NA|ClinicalTrialTransparency@astrazeneca.com
11855|NCT01107899|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
11856|NCT01107912|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
11857|NCT01107925|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
11858|NCT01108185|Global Medical Services|Abbott|1-800-633-9110|
11859|NCT01108237|Sam Himden|DePuy Orthopaedics, Inc.|574-372-7231|SHimden@its.jnj.com
11860|NCT01108263|Dr. John Steinberg, Principal Investigator|Georgetown University|202-444-0793|zr40@georgetown.edu
11432|NCT00991081|Sean P. David, MD, SM, DPhil|Stanford University|650-498-4687|spdavid@stanford.edu
11433|NCT00991185|brian smith|duke|919668951|brian.smith@duke.edu
11434|NCT00991276|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11435|NCT00991289|Clinicaltrials.gov Coordinator|Center for Biostatistics in AIDS Research, Harvard School of Public Health|(617) 432-2829|CBAR.ClinicalTrials.Gov@sdac.harvard.edu
11436|NCT00991458|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11437|NCT00991510|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|215-591-3000|ustevatrials@tevapharm.com
11438|NCT00991809|Dr. D. Andrew Tompkins|Johns Hopkins University, School of Medicine|410-550-5953|dtompki1@jhmi.edu
11439|NCT00991939|Susan F. Assmann, PhD|New England Research Institutes, Inc.|617-923-7747 ext 548|sassmann@neriscience.com
11440|NCT00991952|Dr. Yelena Janjigian|Memorial Sloan-Kettering Cancer Center|646-888-4186|janjigiy@mskcc.org
11441|NCT00992017|Melissa Allen, Director, IMPAACT Operations Center|Family Health International (FHI 360)|919-405-1429|mallen@fhi360.org
11442|NCT00992056|Richard A Preston MD MSPH MBA|University of Miami|305 243 5930|rpreston@med.miami.edu
11443|NCT00992186|Senior Director, Early Clinical Development Global Leader|Centocor Research & Development, Inc., PA, USA|+1-908-927-3159|
11444|NCT00992264|Jennifer McClure|Group Health Research Institute|206-287-2737|mcclure.j@ghc.org
14447|NCT01520402|Dr. Daniella Kadian-Dodov|Mount Sinai School of Medicine|(212) 241-9454|daniella.kadian-dodov@mssm.edu
14448|NCT01696968|Paul F. Pinsky, Ph.D.|Early Detection Research Group, NCI, NIH|301-496-8544|pinskyp@mail.nih.gov
14449|NCT01696981|Paul F. Pinsky, Ph.D.|Early Detection Research Group, NCI, NIH|301-496-8544|pinskyp@mail.nih.gov
14450|NCT01697345|Dr. Melissa A Dahir|Creighton University|402-657-2847|melissadahir@creighton.edu
14451|NCT01697969|Danyel Crout Carr, MS, CCRA|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
14452|NCT01698502|Michael Lund|University of Copenhagen|+45 3532 7519|michaeltl@sund.ku.dk
14295|NCT01798264|Michelle Braon|Intarcia|510-782-7800|
14296|NCT01799239|Camilla Felsvang Vibjerg, Senior Clinical manager|Coloplast A/S|+45 4911 1990|dkcfv@coloplast.com
14297|NCT01890512|Giovanni Raciti|Guidant Europe SA/NV A Boston Scientific Company|+39 02 26983213|giovanni.raciti@bsci.com
14298|NCT01890785|Study Physician|Shire Development LLC|+1 866 842 5335|
14299|NCT01892657|Elizabeth M. Nieman, Medical Information Specialist|Galderma Laboratories, L.P.|817-961-5130|elizabeth.nieman@galderma.com
14300|NCT01893567|Senior Clinical Project Manager|Galderma Laboratories, L.P.|817-961-5000|jay.mashburn@galderma.com
14301|NCT01894984|Medical affairs director|XIAN-JANSSEN PHARMACEUTICAL|86-10-58218307|
14302|NCT01895062|Dr. Richard Rose|5i Sciences|858-759-2205|rrose@5isciences.com
14303|NCT01896687|Dr. Angela Starkweather|Virginia Commonwealth University|8048283986|astarkweathe@vcu.edu
14304|NCT01897285|Mrs Gwenneth Lawrence|Arrowe Park Hospital|0151 678 5111 ext 8362|gwen.lawrence@nhs.net
14305|NCT01897727|Dr. Eric Judd|University of Alabama at Birmingham|205 934-9281|ejudd@uab.edu
14306|NCT01899677|Ozge Serce (Investigator, MD)|Zeynep Kamil Maternity and Children's Education Training Hospital|+905323270375|ozge_serce@hotmail.com
14307|NCT01901250|Dr. Suchitra Nelson|Case Western Reserve University|216-368-3469|sxn15@case.edu
14308|NCT01903148|Dr. Alberto Martínez Castelao|Hospital de Bellvitge|610 459 262|albertomcastelao@gmail.com
12500|NCT00982553|Dr Alan Winston|Imperial College|+44 (0)20 3312 1603|a.winston@imperial.ac.uk
12501|NCT00982735|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
12502|NCT00982995|Susan Urba|University of Michgan Comprehensive Cancer Center|734-615-4762|surba@umich.edu
12503|NCT00983073|Dr. Ilona Steigerwald|Grünenthal GmbH|+49 241 569 3223|clinical-trials@grunenthal.com
12504|NCT00983216|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
12505|NCT00983242|Medical Affairs Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlpharma.com
12506|NCT00983281|Kenneth Proctor, PhD|University of Miami|305-243-4694|kproctor@med.miami.edu
12507|NCT00983294|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
12508|NCT00983372|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clinicaltrials@urlmutual.com
12509|NCT00983385|Dr. Ilona Steigerwald|Grünenthal GmbH|+49 241 569 3223|Clinical-Trials@grunenthal.com
12510|NCT00983437|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12511|NCT00983489|Dr Kanchan Sharma|Deen Dayal Upadhaya Hospital, New Delhi|919417938224|psaiims@yahoo.co.in
12512|NCT00983515|Medical Director|Mutual Pharmaceutical Company, Inc.|215-697-1743|clincialtrials@urlmutual.com
12513|NCT00983801|BMS Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
12514|NCT01045993|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com
12515|NCT01046084|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12516|NCT01046136|Gail Solomon, MS; Director Clinical Development|Reckitt Benckiser Inc.|973-404-2752|gail.solomon@reckittbenckiser.com
12517|NCT01046253|Manager, Biopharmaceutics|TEVA Pharmaceuticals, USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12518|NCT01046396|Ronald W. Gottschalk, MD / Medical Director|Galderma Laboratories, L.P.|817-961-5358|ron.gottschalk@galderma.com
11520|NCT01242176|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11521|NCT01242371|Dr. Faith Dickerson|Sheppard Pratt|410-938-4359|fdickerson@sheppardpratt.org
11522|NCT01242514|Dave Goldstraw|AstraZeneca Pharmaceuticals|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com
11636|NCT01324349|Vice President, Medical Affairs|Covidien|203-500-4256|amy.pollack@covidien.com
11637|NCT01324440|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11638|NCT01324882|Joseph Anderson|UConn Health Center|8022959362 ext 6003|joseph.anderson@dartmouth.edu
11639|NCT01325181|Jang Won Heo|Seoul National University Hospital|82220720836|hjw68@snu.ac.kr
11640|NCT01325337|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11641|NCT01325350|Therapeutic  Area Head,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
11642|NCT01325870|Clinical Research Associate|Advanced Circulatory|651-403-5606|nburkhart@advancedcirculatory.com
11643|NCT01326845|Study Director|Novartis Pharmaceuticals|862-778-8300|
11644|NCT01326910|Joyce Hauze, Sr. Specialist Clinical Quality Systems and Process|Johnson & Johnson Consumer and Personal Products Worldwide|928-277-0715|jhauze@its.jnj.com
11645|NCT01327300|Dr. Baharak Moshiree|University of Florida|(352)273-8393|bmoshiree@med.miami.edu
11646|NCT01327339|GSK Response Center|GlaxoSmithKline|866-435-7343|
11647|NCT01327599|Doug Hubatsch, Therapeutic Unit Head, Global Medical Affairs|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
11648|NCT01327703|Robert Winkler, MD, VP, Clinical Development and Operations|Aptalis Pharma US, Inc.|1-800-472-2634|
11649|NCT01328041|GSK Response Center|ViiV Healthcare|866-435-7343|
11650|NCT00879619|Nicole Macaranas, Clinical Research Specialist|University of California, Irvine|714-456-6550|nicole.macaranas@uci.edu
11651|NCT00879645|Brahm Goldstein|Ikaria Inc|908-238-6495|brahm.goldstein@ikaria.com
11652|NCT00879697|Raphael Dias|University of São Paulo|55 81 9728 6878|raphaelritti@gmail.com
11445|NCT00992407|Clinical Research Director|R&D Clinical Research, Seoul KOREA|+82 2 2094 -4518|
11446|NCT00992433|Hana El Sahly, MD|Baylor College of Medicine|713-798-2058|hanae@bcm.edu
11447|NCT01054729|Clinical Trial Disclosures|Gilead Sciences, Inc.||ClinicalTrialDisclosures@gilead.com
11448|NCT01054742|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp||ClinicalTrialsDisclosure@merck.com
11449|NCT01054820|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11450|NCT01054885|GSK Response Center|GlaxoSmithKline|866-435-7343|
11451|NCT01054976|Business Unit Director|Jan-Cil Korea|82 2 2094-4537|
11452|NCT01055132|Ross Franklin|Johnson & Johnson Vision Care|1-904-443-1379|RFrankl1@its.jnj.com
11453|NCT01055171|Dr. Michael Saladin|Medical University of South Carolina|843-792-5306|saladinm@musc.edu
11454|NCT01055223|GSK Response Center|GlaxoSmithKline|866-435-7343|
14318|NCT01915108|Dr. Sangjin Park|assistant professor|82-53-620-3366|apsj0718@naver.com
14319|NCT01916226|GSK Response Center|GlaxoSmithKline|866-435-7343|
14320|NCT01918033|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
14321|NCT01918085|Henrik Sigaard Knoth|Coloplast|+ 45 4911 3469|dkhsk@coloplast.com
14322|NCT01919606|Robert Dorian, MD|St.Barnabas Medical Center|973-322-5512|rdorian@sbhcs.com
14323|NCT01921101|Dr. Carol Braunschweig, Professor|University of Illinois at Chicago|3129962575|braunsch@uic.edu
14324|NCT01682603|Dr. Hann-Chorng Kuo|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|886-3-8561825 ext 2113|hck@tzuchi.com.tw
14325|NCT01682681|Clinical Research Associate, Medical affairs|Janssen Korea, Location: 25F, LS , Yongsan Tower, 191, Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|82-2-2094-4837|
14326|NCT01683019|Dr. Bill Phillips|NeoSync, Inc.|949-333-2906|bill@neosync.com
14327|NCT01683526|Michael Silverberg|Beth Israel Medical center|2124202377|msilverberg2@chpnet.org
14309|NCT01903876|Dr. Laura Salazar|Georgia State University|404-413-1396|lsalazar1@gsu.edu
14310|NCT01904071|Dr. Eitan Dickman, Director of EM Ultrasound|Maimonides Medical Center|718-283-6057|edickman@maimonidesmed.org
14311|NCT01906515|Dr Wael N Awada|Cairo University School Of Medicine|00201006481958|waoool@hotmail.com
14312|NCT01907113|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
14313|NCT01908127|Dr. Mehrsa Paryab|Tehran University of Medical Sciences|00989121091675|drmparyab@yahoo.com
14314|NCT01909713|Elizabeth M Nieman|Galderma Laboratories, L.P.|817-961-5130|elizabeth.nieman@galderma.com
14315|NCT01911260|Ana Paula Poblacion|Federal University of Sao Paulo|+55 11 55391783|anapoblacion@yahoo.com.br
14316|NCT01913041|Dr. Jie Yi|Peking Union Medical College Hospital, Anesthesia Department|+86 10 69152025|neyil@pumch.cn
14317|NCT01914926|Christian Fromm, MD; Director of Research|Maimonides Medical Center|718-283-6391|cfromm@maimonidesmed.org
12519|NCT01046565|Ronald W. Gottschalk, MD / Medical Director|Galderma Laboratories, L.P.|817-961-5358|ron.gottschalk@galderma.com
12704|NCT00859430|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12705|NCT00859469|Joshua Leinwand|Columbia University|212-305-4076|jcl2125@columbia.edu
12706|NCT00859508|Heidi Hausner, Clinical Research Manager|Synthes USA HQ, Inc.|610-719-5707|hausner.heidi@synthes.com
12707|NCT00859521|Manager, Biopharmaceutics|Teva Pharmaceuticals USA|1-866-384-5525|clinicaltrialqueries@tevausa.com
12708|NCT00859547|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|ZymoGenetics|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com
12709|NCT00859573|Michael J. Mancino, M.D.|University of Arkansas for Medical Sciences|501-526-8442|mjmancino@uams.edu
12710|NCT00859638|Dr. Julie Richardson|McMaster University|(905) 525-9140 ext 27811|jrichard@mcmaster.ca
12711|NCT00859833|Sheldon Litwin|Univesity of Utah|801-581-7715|sheldon.litwin@hsc.utah.edu
12712|NCT00859898|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb||Clinical.Trials@bms.com
12713|NCT00860028|Dr. Stephanie O'Malley|Yale School of Medicine|203-974-7590|stephanie.omalley@yale.edu
12714|NCT00870103|Alcon Clinical|Alcon Research Ltd|888.451.3937; 817.568.6725|medinfo@alconlabs.com
12715|NCT00870194|Chief Medical Officer|Eli Lilly and Company|1-800-LILLYRX|clinicaltrials@amylin.com
12716|NCT00870467|Global Medical Services|Abbott|800-633-9110|
12717|NCT00870545|Dr. Linda Nichols|Memphis VAMC|901 523-8990 ext 5082|linda.nichols@va.gov
12718|NCT00870584|Study Director|Novartis Pharmaceuticals|862-778-8300|
12719|NCT00870688|Lohmueller|Desitin|0049(0)40-59101 ext 373|lohmueller@desitin.de
12720|NCT00870896|Thomas Truncale|University of South Florida|813 974 8952|ttruncal@health.usf.edu
12721|NCT00871117|GSK Response Center|GlaxoSmithKline|866-435-7343|
12722|NCT00871234|Samir K. Gupta, MD, MS|Indiana University School of Medicine|317-274-7926|sgupta1@iupui.edu
11653|NCT00879775|Sang-Yeon Suh, M.D.,Ph.D|Department of Family Medicine, Dongguk University Ilsan Hospital, Republic of Korea|0082-031-961-7490|fmmodel@gmail.com
11654|NCT00879879|Dr. Jeffrey Krischer, Principal Investigator|SunCoast CCOP Research Base|813-396-9245|ccop@epi.usf.edu
11655|NCT00879970|GSK Response Center|GlaxoSmithKline|866-435-7343|
11656|NCT00879996|Dr. Richard Blondell|SUNY Buffalo|716-898-4971|blondell@buffalo.edu
11657|NCT00880009|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11658|NCT00880022|sheila h ridner|vanderbilt university|615-322-0831|Sheila.Ridner@Vanderbilt.edu
11770|NCT00936481|Kanika Bagai, MD, Assistant Professor|Vanderbilt Universit|6153220283|kanika.bagai@vanderbilt.edu
11771|NCT00936598|Professor|University of Pittsburgh|412-623-5965|bovbjergdh@upmc.edu
11772|NCT00936741|Medical Director|Corcept Therapeutics|650-327-3270|info@corcept.com
11773|NCT00936897|Study Director|Amgen Inc.|866-572-6436|
11774|NCT00937040|VP Medical Affairs, CNS|Ortho-McNeil Janssen Scientific Affairs, LLC|609-730-2136|
11775|NCT00937105|Loretta Szczotka-Flynn OD, PhD|University Hospitals Eye Institute|216-844-3609|loretta.szczotka@uhhospitals.org
11776|NCT00937118|John Mayberry, MD|Oregon Health & Science University|503-494-5300|mayberrj@ohsu.edu
11777|NCT00937391|Therapeutic Area Head|BAYER||clinical-trials-contact@bayerhealthcare.com
11778|NCT00937495|Steven Attia, D.O.|University of Wisconsin||sa2@medicine.wisc.edu
11779|NCT00937547|Dr. Jorge Sánchez-Lander Corresponding Author|Instituto de Oncología Dr. Luis Razetti, Caracas Venezuela|582129870165|animamotrix@live.com
11780|NCT00937768|Dr. R. Jeffrey Karnes|Mayo Clinic|507 284-4430|Karnes.R@mayo.edu
11781|NCT00938015|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11782|NCT00938041|GSK Response Center|GlaxoSmithKline|866-435-7343|
11783|NCT00938314|Chief Scientific Officer|Stem Cell Therapeutics Corp.|403.245.5495 ext 226|adavidoff@stemcellthera.com
14328|NCT01683838|Chief Scientific Officer|Acorda Therapeutics, Inc.|914-347-4300 ext 5102|ablight@acorda.com
14329|NCT01684033|Jessie Lemp, GMA Brand Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
14330|NCT01684046|Jessie Lemp, GMA Brand Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
14331|NCT01684436|Vice President  Medical Affairs,|Allergan, Inc|714-246-4500|clinicaltrials@allergan.com
14332|NCT01684826|Frank Everaerts|Philips|+31630728782|frank.everaerts@philips.com
14333|NCT01684839|Dr. Chao Chen|The Second Hospital of Tangshan|86-13700350471|ts_chenchao@163.com
14334|NCT01685320|Prof. Massimiliano Carassiti|Campus Bio-medico University|+39-06-225411952|m.carassiti@unicampus.it
14335|NCT01686451|Dr. JiFei Tang|Department of Cardiology, the Second Affiliated Hospital, Wenzhou Medical University, Zhejiang province, Wenzhou, 325000, China|+8615968766021|jiftang@126.com
14336|NCT01686633|GSK Response Center|GlaxoSmithKline|866-435-7343|
14337|NCT01686646|GSK Response Center|GlaxoSmithKline|866-435-7343|
14338|NCT01687036|Markus Stühlinger, MD|Medical University Innsbruck, Department of Internal Medicine III, Cardiology|+43 512 504 ext 81 320|markus.stuehlinger@uki.at
14339|NCT01688310|Dr. Peter Millard|Catholic University of Mozambique Medical School|2078663503|pmillard@mac.com
14453|NCT01698814|Terri Pasquine, Sr. Clinical Project Lead|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
14454|NCT01699022|Dr. Shravanti Bhowmik|SPARC|02266455645 ext 5626|shravanti.bhowmik@sparcmail.com
14455|NCT01699373|Dr Lim Yean Chin|Changi General Hospital|+65 68503831|yean_chin_lim@cgh.com.sg
14456|NCT01699763|Carmine Greene|Bayer Healthcare, LLC,  Diabetes Care|574-257-3040|carmine.greene@bayer.com
14457|NCT01699815|Virginia C. Muckler|Duke University School of Nursing|919-684-9307|chris.muckler@duke.edu
14458|NCT01700517|Dr Lucio Honorio de Carvalho Júnior|Madre Teresa´s Hospital|+55 31 33398000|luciohcj@gmail.com
14459|NCT01701375|Ivana Gojo, MD|Johns Hopkins University|410-502-7726|Igojo1@jhmi.edu
12723|NCT00871286|Rakesh Chandra|Northwestern|312-695-8182|rchandra@nmff.org
12724|NCT00871338|GSK Response Center|GlaxoSmithKline|866-435-7343|
12725|NCT00871351|Vice President, Late Stage Development Group Leader|Merck Sharp & Dohme Corp.||ClinicalTrialsDisclosure@merck.com
12726|NCT00871377|Christopher M. DeGiorgio, MD|UCLA School of Medicine|310-206-3753|cmd@mednet.ucla.edu
12315|NCT01474538|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12316|NCT01474915|Andrew Otey|The Ohio State University Department of Anesthesiology|6142933559|Andrew.otey@osumc.edu
12317|NCT01475097|Debra Mansfield|GE Healthcare|609-514-6329|dabra.mansfield@ge.com
12318|NCT01475175|AdOpt CRT Clinical Research Specialist|Medtronic CRDM|800-328-2518 ext 62736|medtronicCRMtrials@medtronic.com
12319|NCT01475474|Victoria Mackinnon, Vice President, Regulatory, Clinical & Quality|Renew Medical, Inc.|1-888-987-2929|victoria@renew-medical.com
12320|NCT01475734|GSK Response Center|GlaxoSmithKline|866-435-7343|
12321|NCT01475851|GSK Response Center|GlaxoSmithKline|866-435-7343|
12322|NCT01475955|Manager of Clinical Studies|DUSA Pharmaceuticals, Inc||houlihana@dusapharma.com
12323|NCT01476202|GSK Response Center|GlaxoSmithKline|866-435-7343|
12324|NCT01476696|Chief Medical Officer|Eli Lilly and Company|800-545-5979|
12325|NCT01476722|Jami Kern, Ph.D.|alcon Blobal Medical Affairs|1-888-451-3937|
12326|NCT01476748|Dr. JI Einarsson|BWH|617-525-8582|jeinarsson@partners.org
12327|NCT01477450|Richard Branson|University of Cincinnati||bransord@uc.edu
12328|NCT01477710|Richard Branson|University of Cincinnati|513-558-6785|bransonrd@uc.edu
12329|NCT01477892|Pf. Han-suk Kim|Seoul National University Hospital|+82-2-2072-0647|kimhans@snu.ac.kr
12330|NCT01478009|Dr. Chang-Seop Lee|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|82-63-276-8284|lcsmd@jbnu.ac.kr
11784|NCT00938327|GSK Response Center|GlaxoSmithKline|866-435-7343|
11785|NCT00938392|GSK Response Center|GlaxoSmithKline|866-435-7343|
11786|NCT00889928|Sheryl Helsinger|Ethicon Endo Surgery, Inc|513-337-3079|SHelsing@its.jnj.com
11787|NCT00890084|Boehringer Ingelheim Call Center|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com
11788|NCT00890097|Dana Sager, Clinical Manager Group Leader|Alcon Research, Ltd.|1-888-451-3937|alcon.medinfo@alcon.com
11789|NCT00890201|Marcelo A. Beltran, M.D. - Department of Surgery - Hospital de La Sererna|Hospital de La Serena|56 51 485923|beltran_01@yahoo.com
11790|NCT00890409|Prof. Xiaomei Shao|Children's Hospital, Fudan University|86-21-64931913|zhou_wenhao@yahoo.com.cn
11791|NCT00890591|Howard Kessler|Daiichi Sankyo Pharma Development|732-590-5032|hmkessler@dsus.com
11792|NCT00890656|Stefan Fader, M.D./Associate Professor|The University of Texas M. D. Anderson Cancer Center|713/745-4613|eharriso@mdanderson.org
11364|NCT00944645|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
11365|NCT00944697|Director of Medical Operations|Mundipharma Research GmbH|44 01223424900|info@contact-clinical-trials.com
11366|NCT00945035|Executive Vice President, Clinical and Quantitative Sciences|Merck Sharp & Dohme Corp|1-800-672-6372|
11367|NCT00945100|Ray Kraker, M.S.P.H.,  Director of PEDIG Coordinating Center|Jaeb Center for Health Research|(813) 975-8690|rkraker@jaeb.org
11368|NCT00945295|JoAnn Harnar, Research Nurse|New Mexico VA Healthcare System|505-256-5701|Joann.Harnar@va.gov
11369|NCT00945321|Senior Vice President, Global Clinical Development|Merck Sharp & Dohme Corp.|1-800-672-6372|ClinicalTrialsDisclosure@merck.com
11370|NCT00945477|James Knost, M.D.|Illinois CancerCare, P.C.|309-243-3000|jknost@illinoiscancercare.com
11371|NCT00945555|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com
11372|NCT00998582|Dr. Jason Baker|Minneapolis Medical Foundation|612-873-2705|baker459@umn.edu
11373|NCT00998738|Dr. Charles Loprinzi|Mayo Clinic|507-266-6247|cloprinzi@mayo.edu
